Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9009308002047622,-1.8675447784242627,0.0,1.0,0.51,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.7772851317007653,-1.857798133361707,0.0,0.8578370283208088,0.54,13/33,15.24%,ARC;NGF;GRID2;NLGN3;GRIK4;GRIK1;CX3CR1;BCR;NLGN2;CEL;CACNA1A;NLGN4Y;BTBD9
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.8927614148475266,-1.8514474687035998,0.0,0.680597972882625,0.62,4/20,4.25%,DUSP4;DUSP6;DUSP2;PPP5C
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.8153387484786216,-1.848291503156921,0.0,0.5423515096408419,0.62,11/34,9.26%,DUSP4;DUSP6;UBASH3B;PTPN9;DUSP2;PTPRO;PTPRB;PTPRF;PTPRZ1;PTPRJ;PTPRS
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7349408558899464,-1.8356360136106131,0.0,0.5614933276281657,0.69,2/68,0.03%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.9069830495639535,-1.830361541697147,0.0,0.500995730038599,0.69,2/10,0.68%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8950358727889527,-1.819531504378019,0.0,0.5084228904569611,0.74,2/17,0.03%,CYP1A2;UGT2B15
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.748293834660597,-1.8122279813942856,0.0,0.48563501190062314,0.76,7/44,3.55%,CDH4;CDH20;ZNF703;CDH5;CDH19;CSK;CDH13
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.6515435406541614,-1.8093453075671635,0.0,0.4442792322983803,0.76,19/101,13.36%,NPAS4;ARC;NGF;NMU;NPTX2;GRID2;NLGN3;DLGAP4;GRIK4;SLC8A3;GRIK1;CX3CR1;BCR;NLGN2;CEL;SNCAIP;DLGAP1;CACNA1A;GRM2
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.7081815652590088,-1.7838614655900362,0.0,0.5700008022891985,0.9,2/44,0.68%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.7710129507052923,-1.7827142008053292,0.0,0.5272056267215789,0.9,9/26,9.80%,GRID2;NLGN3;DLG5;AGRN;SYNDIG1;WNT7A;EPHB2;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.8643677693049254,-1.7736992551027853,0.0,0.5388067285320782,0.9,1/13,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.6811068396360663,-1.766314366792249,0.03571428571428571,0.5486230454486545,0.92,6/54,2.80%,RFX6;PER2;GRP;CELA2A;GCK;ITPR2
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.9131833112236104,-1.762997687722911,0.0,0.5236148094945197,0.93,1/8,0.12%,RFX6
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.9695341668015279,-1.7595650477203826,0.0,0.5076126547749579,0.94,3/8,1.81%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8185854645678463,-1.7502724159703205,0.03225806451612903,0.5361481427005055,0.94,6/27,6.06%,CYP1A2;EPHX2;ELOVL6;LTC4S;FADS1;HPGD
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.8136418663537011,-1.7405481575084487,0.03125,0.5301417080439892,0.95,7/18,12.11%,WNT3A;GPC6;MDGA1;GPC4;WNT7A;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.8136418663537011,-1.7405481575084487,0.03125,0.5301417080439892,0.95,7/18,12.11%,WNT3A;GPC6;MDGA1;GPC4;WNT7A;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.7211790224307594,-1.734977661662337,0.03333333333333333,0.53806045882497,0.98,4/31,5.23%,ARC;MFSD2A;CLDN4;BCL9L
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.9085797510998986,-1.7330117064221573,0.0,0.5274634289840345,0.98,1/8,1.63%,PHLDB2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.8059507656027819,-1.7259224739173697,0.0,0.5455586925487709,0.99,3/20,2.34%,DNMT1;FOS;GATAD2A
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7084542315249471,-1.7143166532884775,0.043478260869565216,0.5942342149600193,1.0,3/36,4.66%,IL7R;H1-4;RAD50
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.9158088300978322,-1.707392200668582,0.02702702702702703,0.6201825731158704,1.0,2/9,3.90%,GCK;NR4A3
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.8944614777777118,-1.7037696726272697,0.0,0.6203366940336427,1.0,4/11,7.64%,NOX4;TST;MTHFR;CBS
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.641557229684599,-1.7029981203533762,0.0,0.59892621613671,1.0,17/80,10.53%,DUSP4;SPRED3;SPRY4;SPRED2;DUSP6;SPRED1;FOXO1;PRKCD;APOE;EPHB2;PTPRJ;PRDM15;WNK2;IGBP1;EMILIN1;PTPRR;DAB2IP
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.8292731897523626,-1.690908009030257,0.0,0.6506642657419541,1.0,3/18,2.34%,DNMT1;FOS;GATAD2A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.8292731897523626,-1.690908009030257,0.0,0.6506642657419541,1.0,3/18,2.34%,DNMT1;FOS;GATAD2A
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.8170857311368664,-1.6815748270511692,0.0,0.6957898919201837,1.0,4/17,7.52%,NPAS4;ARC;APOE;SHANK1
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.916730667780938,-1.6784270387265734,0.0,0.7016221918725338,1.0,2/7,0.72%,TACR3;GRK5
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.8673788176429807,1.6772295171320286,0.0,1.0,0.75,1/16,0.01%,GPR62
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.7402830910253334,-1.676971780114445,0.0,0.6891054475436579,1.0,5/35,3.34%,PER2;FBP2;G6PC3;ENO3;PC
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.6771417393563582,-1.6760683237048226,0.0,0.6764814528853511,1.0,12/49,10.35%,SPRED3;EYA4;SPRED2;SPRED1;PRKCD;RNF168;BRCC3;ERCC8;ANKLE1;FXR2;WRAP53;ATR
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.8728166259500258,-1.6727878253287816,0.0,0.6625518145107373,1.0,1/12,0.54%,SPRY4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.8728166259500258,-1.6727878253287816,0.0,0.6625518145107373,1.0,1/12,0.54%,SPRY4
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.8480607615742417,-1.6726224572418067,0.0,0.6434820295085113,1.0,1/10,0.41%,MT1G
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.7555931419214812,-1.669438351770552,0.0,0.6473783099204969,1.0,1/25,0.12%,RFX6
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.8665871506653667,1.6690040921735463,0.0,1.0,0.77,2/22,4.01%,GPR62;SCTR
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.8470992268148307,-1.6622320311443244,0.0,0.6809918374502654,1.0,1/14,0.19%,PER2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8051956735406497,-1.6587765133751236,0.0,0.6897952427864443,1.0,1/24,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.8322900488581815,-1.6584703126272529,0.05,0.6731352758115436,1.0,4/15,7.52%,ARC;WNT7A;EPHB2;SHANK1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7941925638032548,-1.6579346356642668,0.0,0.6587839352902332,1.0,1/33,0.01%,CYP1A2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.8904400444096868,-1.6575824332333704,0.0,0.6430232931297302,1.0,2/13,0.70%,NPAS4;ADRA1A
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.7353998088504978,-1.6564243891840198,0.05555555555555555,0.637368934970873,1.0,4/25,7.52%,ARC;WNT7A;EPHB2;SHANK1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.8860569827971169,-1.6553859411336957,0.02857142857142857,0.6299582427574297,1.0,1/9,0.56%,APOB
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.5724099793976062,-1.65177249529441,0.0,0.6387200937372309,1.0,22/131,10.99%,DUSP4;EYA4;DUSP6;UBASH3B;PPEF1;PTPN9;PPM1M;DUSP2;PTPRO;PPP5C;PTPRB;PTPRF;PTPRZ1;PTPRA;PTPRJ;CTDSP1;PPP2R5D;PTPRE;PTPRS;PPM1H;PTPRR;CTDSP2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.7751836388385176,-1.6510665403396945,0.05263157894736842,0.6280707619073089,1.0,3/22,1.81%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.6702955677740817,-1.649238839272823,0.0,0.625456933412968,1.0,4/26,5.70%,PM20D1;DDAH2;ACER2;ACER3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.9195506274313113,-1.646640070516918,0.0,0.6260391679912191,1.0,1/12,0.12%,RFX6
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.7251668332151316,-1.6423992836545018,0.03125,0.6389656500733155,1.0,4/16,13.63%,FOXO1;DDX11;AQP1;SPIDR
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.5859663932355736,-1.6413913307465502,0.0,0.6312664357856639,1.0,16/89,8.36%,NPAS4;RFX6;CAMK1G;SPRED2;WWC1;DUSP15;CFC1;SPTBN4;GPC4;DNAJB5;ABCC8;PRR36;KIRREL2;TTBK1;PCP4;KCNIP1
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.8366775941259977,-1.6363916920487458,0.0,0.656580272308961,1.0,1/12,0.60%,NIPAL1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.8420623966706561,-1.6361440454152496,0.024390243902439025,0.6460009092610917,1.0,1/18,0.17%,EIF2S3B
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.905907582860397,-1.6297600756101076,0.02564102564102564,0.6703111571160169,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.755104845084233,-1.6294851359096365,0.0,0.6596019616999479,1.0,4/17,16.70%,FGF1;APOE;SEC14L2;ABCG1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.7700481581013798,-1.6293307944605115,0.025,0.6487618255661816,1.0,8/17,15.99%,AOAH;NEU4;FBXO27;NGLY1;FBXO44;ADAMTS9;FUCA1;SAMHD1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.8815616105744507,1.6290599579507112,0.0,1.0,0.95,3/16,3.52%,AQP3;ANXA1;GPR151
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9157187234130892,-1.627011861465352,0.0,0.650926842120381,1.0,2/8,0.68%,CYP1A2;EPHX2
prerank,GO_Biological_Process_2021__omega-hydroxylase P450 pathway (GO:0097267),-0.962229319325595,-1.6246299430284137,0.0,0.6550755488995267,1.0,1/6,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.7503120528065487,-1.6218453323708928,0.0,0.6616080740856769,1.0,4/20,10.89%,NGF;RAB35;RAPGEF1;NTRK1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.6335627632158493,-1.619650338585477,0.038461538461538464,0.6626874999120297,1.0,5/51,3.34%,PER2;FBP2;G6PC3;ENO3;PC
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.8646606855347452,-1.6193516620734343,0.0975609756097561,0.6522397240125156,1.0,1/11,0.27%,GABRE
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.6583279837204259,-1.619285781939589,0.045454545454545456,0.6416654617219665,1.0,1/41,0.07%,IL7R
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.9440893925943346,-1.6116847243180739,0.0,0.6775258292550299,1.0,1/10,0.17%,EIF2S3B
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.8767481622586955,-1.6089957656034655,0.0,0.6838521981628016,1.0,4/6,12.33%,NR4A1;NR4A3;NR1D1;NUPR1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.8365164682584988,1.6085946156266266,0.0,1.0,0.99,2/13,6.32%,ESR1;GPER1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.8919336539552946,-1.606906646871047,0.0,0.6833423195474744,1.0,1/12,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.97536454620063,-1.6053335470361034,0.0,0.6814982347515174,1.0,1/6,0.19%,PER2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.6284928735097324,-1.6041995511619491,0.05,0.6768316429545638,1.0,11/67,10.78%,ARC;ADRA1A;NMU;CRHR2;CACNG4;NLGN3;EPHB2;SLC8A3;MPP2;NLGN2;SHISA7
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.7316325821086723,-1.59821705031437,0.0,0.7065566776175715,1.0,5/38,3.34%,PER2;FBP2;G6PC3;ENO3;PC
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.8218614769461456,-1.598099709051498,0.03571428571428571,0.6964957790673834,1.0,4/13,12.50%,TEFM;EARS2;TFB1M;SLC25A33
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6955465870227904,1.5938380578347484,0.0,1.0,0.99,16/62,6.05%,CLEC5A;ITGB2;C3AR1;TLR2;ITGAX;TNFRSF1B;LILRB3;FCGR3A;TFEC;VSIG4;ITGAM;NFAM1;PTAFR;TRIM25;FGL2;CLEC12A
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.7987662129581744,-1.593137582858877,0.0625,0.7199609153441202,1.0,1/11,0.07%,IL7R
prerank,GO_Biological_Process_2021__cytidine to uridine editing (GO:0016554),-0.9070563956861761,-1.5892068525341112,0.0,0.7358548548721764,1.0,1/6,1.86%,APOBEC3H
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.7411084394382533,-1.5863326806914158,0.0,0.7498496386016603,1.0,3/13,8.85%,PTCD2;IWS1;SAFB2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.7216632203534807,-1.5861739346073065,0.0,0.7401502955098548,1.0,4/16,12.86%,RNF168;PCGF1;KDM2B;RING1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.679284231226779,-1.5851422273203588,0.038461538461538464,0.7371147646448852,1.0,13/30,18.67%,GLYATL1;DDAH2;GLUD2;FPGS;ALDH4A1;KYAT1;PYCR3;AADAT;ALDH18A1;SLC39A8;RIMKLB;GLUD1;DDAH1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6051481795261021,-1.58350558431314,0.043478260869565216,0.7381021997581246,1.0,10/61,5.86%,CYP1A2;APOB;GPC6;ABCA4;GPC2;CYP4V2;SDC3;APOE;AGRN;GPC4
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.5795499693793686,-1.5806673588165865,0.047619047619047616,0.7507166567326901,1.0,13/98,8.36%,RFX6;PER2;DRD4;CELA2A;GCK;ITPR2;APOE;RHBDF1;MYO18A;ABCC8;ADAM8;ENSA;APBB3
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.6136539698990934,-1.58026583959941,0.04,0.7426795447334051,1.0,9/64,6.06%,CYP1A2;EPHX2;LIPC;ELOVL6;HACD1;LTC4S;MLYCD;FADS1;HPGD
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),-0.8407341701711764,-1.579644684498425,0.029411764705882353,0.7380706905927135,1.0,3/9,5.64%,TSKU;IFT88;PDZD7
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.827724956695958,-1.5794724803531044,0.0,0.7296652061249853,1.0,1/9,1.49%,ZNF703
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.5543617493267362,-1.5787482905576316,0.0,0.7268182356514398,1.0,32/103,20.37%,ARC;PACSIN2;RND3;MAST2;KLHL20;CFAP410;APOE;SH3KBP1;PLD2;PAK6;RHOBTB2;SYNE3;FGD1;FGD5;WASF3;PACSIN3;BIN1;ZNF135;CAPZB;MICAL3;SIPA1L3;MICAL1;SH3D19;CSPG5;RHOA;RHOBTB1;MAST4;MAST1;ARAP3;PAK5;LRCH3;CDC42BPB
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.6366843092100253,-1.578407558522826,0.0,0.7205903751353434,1.0,16/65,14.46%,NPAS4;WNT3A;SLITRK6;KIRREL3;GRID2;NLGN3;WNT7A;PCDHB6;SDK2;NLGN2;CBLN4;PCDHB9;LRRTM3;NRXN2;DBNL;NLGN4Y
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5904682853102983,-1.5770896621688153,0.0,0.7202636247832211,1.0,7/116,4.40%,CYP1A2;PER2;AOAH;THEM4;PC;PDZD11;MECR
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.6174939521935492,-1.576620368313625,0.0,0.7156913058593855,1.0,11/53,9.10%,ADGRF4;CLDN4;WWC1;LAMA3;ESRP1;DSG2;ADGRG6;PERP;GPRC5A;ITGB4;DMKN
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.870782023088715,-1.576305733330091,0.05714285714285714,0.7098314763474909,1.0,1/8,2.30%,FOXO1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.8435237748235591,-1.5748475669699256,0.027777777777777776,0.7019520759474666,1.0,2/8,5.52%,GLA;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.8435237748235591,-1.5748475669699256,0.027777777777777776,0.7019520759474666,1.0,2/8,5.52%,GLA;KHSRP
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.8548788563747454,-1.5744092416700999,0.0,0.6969714856231048,1.0,3/8,10.89%,NGF;RAPGEF1;NTRK1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.7424231152341829,-1.5632771144199826,0.08108108108108109,0.7641714004351239,1.0,7/18,18.65%,NDST3;XYLT1;HS6ST2;CSGALNACT1;B3GAT3;EXT1;EXT2
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8237964626691032,-1.563065927963719,0.05555555555555555,0.7569344218760009,1.0,2/11,1.63%,OSR1;PHLDB2
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.7298429221522951,-1.5609592118836704,0.047619047619047616,0.7659986763765176,1.0,8/14,23.81%,ST3GAL2;B4GALNT1;ST6GALNAC3;ST3GAL5;ST6GALNAC5;ST8SIA2;ST8SIA4;ST8SIA3
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.8600235965651548,-1.5604448919500755,0.03571428571428571,0.7522901750823398,1.0,2/11,5.70%,ACER2;ACER3
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.8600235965651548,-1.5604448919500755,0.03571428571428571,0.7522901750823398,1.0,2/11,5.70%,ACER2;ACER3
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.8327154252960309,-1.5596138359981464,0.03571428571428571,0.7500756826143931,1.0,1/15,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.6704696661363168,1.558329594879793,0.013513513513513514,1.0,1.0,64/88,30.04%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;RPL36;RPS27A;RPS19;RPL41;SRP19;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;RPSA;RPL7A;RPS13;RPL11;RPS7;RPL23A;RPL7;RPLP2;RPLP0;RPS14;RPS6;SRP14;RPL38;SEC62;RPL23;RPS15;RPL24;RPL18;RPL35;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;RPL27;RPS24;RPL29;RPS18;RPLP1;RPS3;RPS23;RPL34;RPL14;RPS29;RPS8;RPL5;SRP9;RPL6;RPL10A
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.8548212018546053,-1.558241298449749,0.05263157894736842,0.7561680316848397,1.0,3/11,1.81%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.8217420208662146,-1.5577669169584027,0.02857142857142857,0.7358060531297529,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.8217420208662146,-1.5577669169584027,0.02857142857142857,0.7358060531297529,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.8217420208662146,-1.5577669169584027,0.02857142857142857,0.7358060531297529,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.7532943260484868,-1.5529914466537975,0.02564102564102564,0.7559712133005474,1.0,3/14,6.48%,OSR1;TWIST1;WNT7A
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.8399859573315083,-1.55201101133181,0.08108108108108109,0.7450618272729252,1.0,2/12,5.40%,PER2;GYS1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.8399859573315083,-1.55201101133181,0.08108108108108109,0.7450618272729252,1.0,2/12,5.40%,PER2;GYS1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.7113507518609281,-1.5487882158036135,0.023809523809523808,0.758438472332211,1.0,3/15,9.16%,IL11;CDH5;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.8197821360486477,1.5485771867255687,0.029411764705882353,1.0,1.0,2/19,0.50%,LRP4;SMAD6
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.6758348687653335,1.5483328644940453,0.013157894736842105,1.0,1.0,63/85,30.04%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;RPL36;RPS27A;RPS19;RPL41;SRP19;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;RPSA;RPL7A;RPS13;RPL11;RPS7;RPL23A;RPL7;RPLP2;RPLP0;RPS14;RPS6;SRP14;RPL38;RPL23;RPS15;RPL24;RPL18;RPL35;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;RPL27;RPS24;RPL29;RPS18;RPLP1;RPS3;RPS23;RPL34;RPL14;RPS29;RPS8;RPL5;SRP9;RPL6;RPL10A
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.7238431578865528,-1.5482560144788844,0.03125,0.754214841161596,1.0,8/22,15.56%,DDX11;SMARCB1;ERBB2;SMARCA4;MARS1;PIH1D1;BNC1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.8314421520955176,-1.5477045906055964,0.05263157894736842,0.7496503088813414,1.0,1/11,0.68%,MFSD2A
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.9151116386781659,-1.5476484994593267,0.02564102564102564,0.7429299654486081,1.0,2/5,2.34%,ADAMTS12;FGF1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.8763818334049394,1.5443172169704296,0.0,1.0,1.0,3/10,8.56%,BLK;ANXA1;CDKN2A
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9336088543924007,-1.5435595891126321,0.03333333333333333,0.7634485431109839,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.8114051816931901,-1.540865829716032,0.03125,0.7750336948481349,1.0,6/14,12.11%,GPC6;PTPRF;GPC4;PTPRS;SLITRK2;LRFN4
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.824288076709028,-1.5388844259824366,0.07142857142857142,0.7802608571328652,1.0,3/10,12.50%,TEFM;TFB1M;SLC25A33
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.5614586993970964,-1.5372421271816985,0.0,0.7853884544216959,1.0,25/142,11.27%,DUSP4;EPHX2;DUSP6;PPEF1;PTPN9;DUSP15;PPM1M;DUSP2;PTPRO;PPP5C;PTPRB;THNSL2;PNKP;PTPRF;PTPRZ1;PTPRA;PTPRJ;CTDSP1;PPP2R5D;PTPRE;PTPRS;PPM1H;PTPRR;CTDSP2;ALPL
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.873209052501174,-1.5370663567248921,0.024390243902439025,0.7786479560042768,1.0,2/6,6.16%,NMU;MYOCD
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.8470912340056708,1.5360741529022133,0.06349206349206349,1.0,1.0,2/12,3.40%,TBX1;ROGDI
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.8044906140056008,-1.536011072190238,0.03225806451612903,0.779984359109644,1.0,6/15,15.23%,ADAMTS12;NEU4;FBXO27;NGLY1;FBXO44;ADAMTS9
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.7258942190484208,-1.5345509391958236,0.0,0.7844469305504793,1.0,5/20,10.06%,LIN28B;TRIM71;KHSRP;DGCR8;AGO2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.8846651616964197,-1.5333177958877389,0.02857142857142857,0.7854454434757817,1.0,3/7,4.28%,NPAS4;DRD4;NLGN3
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.8396278062392829,-1.5331838596080558,0.0625,0.7793362394030968,1.0,1/10,0.56%,APOB
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8218189312553146,-1.5325133534968713,0.03125,0.7775525264520531,1.0,5/10,15.25%,DDX11;SMARCB1;SMARCA4;MARS1;PIH1D1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.6999943247104758,-1.5319277218229381,0.030303030303030304,0.7736484769876715,1.0,5/21,10.81%,DRD4;CBARP;CACNB1;HPCA;GNB5
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.7654028780614333,-1.5315117171534092,0.02857142857142857,0.7701899626758025,1.0,2/12,1.89%,GCK;PPP1R3E
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.8267182543884721,-1.5286087739473833,0.03225806451612903,0.7820906530493322,1.0,2/10,4.87%,SMPD3;SMPD4
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8805537097973122,1.5285306191406793,0.046875,1.0,1.0,1/12,0.44%,TBX1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.8447572337481936,1.5273680670871574,0.046153846153846156,1.0,1.0,3/14,10.17%,ENDOG;H1-0;DNASE2
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7348986196728727,-1.5255621475278172,0.03125,0.7964969030474199,1.0,5/24,5.08%,SPRED3;SPRED2;SPRED1;TWIST1;SMYD2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6992495927982194,-1.5253577624892163,0.041666666666666664,0.7907306549169723,1.0,6/29,8.95%,GLA;DDAH2;KHSRP;ASS1;CX3CR1;PKD2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.6808444578013363,1.5250762297610527,0.0,1.0,1.0,26/51,18.84%,ITGB2;CYTIP;ITGAX;TNFRSF1B;PTPRC;LILRB3;FCGR3A;SASH3;ITGAM;NFAM1;PTAFR;CLEC12A;ADGRE1;HCK;CD80;CD244;CSF3R;CEACAM8;HK3;IGSF6;PSTPIP1;TAGAP;MYO1F;ALOX5AP;FPR1;PARVG
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.7252565874392891,1.5249005923626462,0.014084507042253521,1.0,1.0,6/29,6.28%,GATA4;PKP2;MYBPC3;HEY2;TGFB1;MESP1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7284465130962164,-1.5246340995108143,0.12121212121212122,0.7883350807694937,1.0,3/15,2.90%,SMYD5;APOBEC3H;PIWIL2
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6910073079140497,-1.5244478756970283,0.029411764705882353,0.7826155715721288,1.0,5/43,1.81%,DUSP4;SPRED3;SPRED2;DUSP6;SPRED1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.7164745182828127,-1.5243745235671122,0.07142857142857142,0.7765155793550538,1.0,4/20,3.86%,PER2;ADRA1A;ADRA1B;KCNMB2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.7036475965864366,-1.523811295846627,0.05714285714285714,0.7748891503757387,1.0,5/26,10.56%,ARC;NLGN3;TGFA;EPHB2;HFE
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6372820733628631,-1.5227445465537512,0.024390243902439025,0.7768050899171698,1.0,5/23,14.38%,IL11;CDH5;SERPINE1;NUPR1;MAPK7
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.7713344566512131,-1.520916774055727,0.10714285714285714,0.7815951788995311,1.0,5/14,9.41%,GLA;ACER2;NEU4;ACER3;NEU3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.8273203672228117,-1.520658239654606,0.058823529411764705,0.7769699080672244,1.0,2/9,3.98%,ARC;GRID2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.7763166643223112,1.5199400544476411,0.03076923076923077,1.0,1.0,5/21,14.18%,ENDOG;H1-0;GPER1;DNASE2;ERN2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.7105261080591759,1.5178631852892437,0.0,1.0,1.0,10/42,14.59%,PCLAF;POLE2;DTL;UBE2L6;TRIM25;FAAP20;POLD4;RPA3;RPS27A;ISG15
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.803829592846938,-1.5176537294388137,0.03225806451612903,0.7896857528103844,1.0,1/15,1.94%,CDH5
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.8173212758383751,-1.5148512937355867,0.0,0.8006100821009279,1.0,3/10,5.64%,TSKU;IFT88;PDZD7
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.7274107240898315,1.5143655667205174,0.015384615384615385,1.0,1.0,2/25,0.92%,LRP4;ITGB2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8092083069379019,1.5139011905003537,0.0,1.0,1.0,3/19,2.83%,TBX1;SMAD6;LRP2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.9224597652190665,1.5131800598642482,0.0,1.0,1.0,2/9,3.01%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.6251573410480071,-1.5128615410428803,0.0,0.8082100927981173,1.0,7/32,13.00%,APOH;PNPLA3;DGKD;APOE;PGS1;LPL;GK5
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8518519010820812,1.5126375616573564,0.0,1.0,1.0,2/13,3.37%,PKP2;GJC3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.898169078534703,1.5122873096825875,0.0,1.0,1.0,1/9,0.27%,GATA4
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.6570781576871536,-1.5121165458157895,0.045454545454545456,0.8070936263071681,1.0,10/44,15.98%,PER2;PRDM5;HDAC10;HDAC3;RCOR2;MIER2;SIRT7;BAZ2A;HDAC5;MIDEAS
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.8640274344251703,-1.5115332925599907,0.023255813953488372,0.8051084093279491,1.0,1/10,1.71%,DGKD
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7245370642685052,-1.5109678647895193,0.0,0.8018349825870075,1.0,3/22,3.49%,CYP1A2;LIPC;STS
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.938903723650816,-1.5100840209931388,0.02857142857142857,0.7999207585130085,1.0,1/7,2.41%,PRKCD
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.8468369482653687,-1.5098726960802547,0.027777777777777776,0.7950051066830283,1.0,2/8,9.26%,NGF;PTPRS
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.7419447460994166,-1.5097723749841296,0.05263157894736842,0.7896268463794471,1.0,2/17,0.90%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.7026926850989235,-1.5093547333326305,0.06060606060606061,0.7875277609154059,1.0,3/20,2.90%,SMYD5;APOBEC3H;PIWIL2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.8441546976727267,-1.5085087286185233,0.05555555555555555,0.7865181486997127,1.0,4/12,1.81%,SPRED3;SPRED2;OSR1;SPRED1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.6845959974938471,-1.508034963208402,0.030303030303030304,0.7836329437773558,1.0,9/27,18.79%,BOC;MEGF10;MYOCD;BNIP2;PTBP1;FGFR2;ABL1;SRF;MAPK12
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8757310994223245,1.507076617827829,0.014705882352941176,1.0,1.0,1/9,2.76%,ACE2
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8757310994223245,1.507076617827829,0.014705882352941176,1.0,1.0,1/9,2.76%,ACE2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.649980470525896,-1.5068553690764392,0.0,0.7872541809492497,1.0,13/31,18.19%,CDH20;CDH5;CDH19;SELL;CDH13;SELP;PCDHB6;CDH12;PCDHB9;CDH22;CDH9;CDH17;CDH11
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.9242071134242064,-1.5066461413144745,0.0,0.7822322808769587,1.0,2/6,5.28%,MFSD2A;APOE
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6620468239093883,-1.50648247096867,0.037037037037037035,0.7773859092436506,1.0,5/27,13.17%,ARC;APOE;EPHB2;SHISA7;CYP46A1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.7734516991491327,-1.5049006614295946,0.08,0.7817899976277636,1.0,10/34,11.97%,NPAS4;GABRE;DRD4;GRID2;NLGN3;MPP2;GABRA5;INSYN2A;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.8398895204747229,-1.5029237512698996,0.08333333333333333,0.7889669953505432,1.0,4/7,10.07%,PLK3;CDK1;GBF1;STX5
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.8514419332462941,-1.5012897582657259,0.02564102564102564,0.7960421916871839,1.0,2/6,5.43%,PRKCD;SLC30A10
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.8967561343844457,-1.5008354810284252,0.023255813953488372,0.793431850429187,1.0,2/9,3.89%,DRD4;HRH1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6806609315174615,-1.499733776317949,0.03225806451612903,0.7952208249590113,1.0,5/18,11.38%,NLGN3;WNT7A;SHANK1;NLGN2;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.7516750015840723,1.4985894390448644,0.015625,1.0,1.0,7/21,15.85%,CIDEB;GPER1;MOAP1;MMP9;PINK1;PLAUR;BBC3
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),0.9070706911326534,1.4983980994036878,0.0,1.0,1.0,2/7,2.05%,ITGB2;ANXA1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.9185220233645615,1.4975810688507203,0.0,1.0,1.0,2/7,7.23%,SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.7827391194488842,1.4975272434822176,0.03389830508474576,1.0,1.0,2/14,5.45%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.8465502523019108,-1.4972753113571637,0.06666666666666667,0.801267211178194,1.0,1/8,4.15%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.8465502523019108,-1.4972753113571637,0.06666666666666667,0.801267211178194,1.0,1/8,4.15%,PDZD11
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.9001977174236593,1.4942417390251113,0.0,1.0,1.0,2/8,4.99%,GATA4;HEY2
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.9585783136093109,1.493852605887691,0.0,1.0,1.0,2/5,3.47%,TBX1;SIX4
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.8663538696051882,1.492731308031857,0.0,1.0,1.0,2/10,5.93%,MICB;RNF26
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.639597986549032,1.4920055079932077,0.038461538461538464,1.0,1.0,59/97,27.05%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;RPL36;RPS27A;RPS19;RPL41;SRP19;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;RPSA;RPL7A;RPS13;SPCS2;RPL11;RPS7;RPL23A;RPL7;RPLP2;RPLP0;RPS14;RPS6;ZFAND2A;SRP14;RPL38;SEC62;RPL23;RPS15;RPL24;RPL18;RPL35;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;RPL27;RPS24;RPL29;RPS18;RPLP1;RPS3;RPS23;RPL34
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.8137463449591549,-1.4907639553970748,0.06976744186046512,0.8390933912251543,1.0,4/16,4.95%,SPRED3;SPRED2;SPRED1;PARD3
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.7766852071549419,-1.4905857445871271,0.07894736842105263,0.8343498392055991,1.0,1/11,0.10%,NPAS4
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.7272431505060937,1.4898994101211382,0.027777777777777776,1.0,1.0,4/32,3.01%,LRP4;SMAD6;NOTUM;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.7659282391680291,-1.489740382759401,0.06060606060606061,0.8337899997181146,1.0,2/11,1.89%,GCK;PPP1R3E
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.8878683575702622,1.489125467188159,0.02857142857142857,1.0,1.0,3/11,7.49%,MYRF;SOX10;PLP1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.7763456658169761,-1.4887824622799994,0.09090909090909091,0.8339989701263041,1.0,1/8,1.71%,SLC25A37
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.854097136581326,1.4882520742474323,0.034482758620689655,1.0,1.0,1/8,1.57%,TLR2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.6525553270818202,1.4881957377501496,0.01282051282051282,1.0,1.0,54/87,27.05%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;RPL36;RPS27A;RPS19;RPL41;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;RPSA;RPL7A;RPS13;RPL11;RPS7;RPL23A;RPL7;RPLP0;RPS14;RPS6;EIF4A2;RPL38;RPL23;RPS15;RPL24;RPL18;RPL35;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;RPL27;RPS24;RPL29;RPS18;RPLP1;RPS3;RPS23;RPL34
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.6590897189269297,1.4880182120273364,0.027777777777777776,1.0,1.0,30/66,20.86%,RASGRP4;ITGB2;C3AR1;CYTIP;ARHGAP9;ITGAX;TNFRSF1B;GMFG;CCL5;PTPRC;SASH3;ITGAM;NFAM1;CLEC12A;WAS;HCK;CD244;CSF3R;HK3;PSTPIP1;TAGAP;MYO1F;IL5;ALOX5AP;FPR1;PARVG;ADGRE3;PGLYRP1;PIK3R6;CD300LF
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.804352892994839,1.4879349654422305,0.03278688524590164,1.0,1.0,1/14,0.55%,ESR1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.7112910476564651,1.4873787014271858,0.02631578947368421,1.0,1.0,10/43,14.59%,PCLAF;SYCP1;DTL;UBE2L6;TRIM25;FAAP20;POLD4;RPA3;RPS27A;ISG15
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.7625491941150025,-1.4872812151529493,0.05128205128205128,0.8372300341418626,1.0,1/15,0.34%,SKAP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),-0.8524775187707553,-1.4872646472308353,0.10526315789473684,0.8318732673519835,1.0,2/6,0.90%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.9576030295457494,1.4866976928848685,0.0,1.0,1.0,1/5,0.08%,SQOR
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.7879955804925526,1.4861578858060573,0.014084507042253521,1.0,1.0,4/22,6.51%,MYBPH;MYBPC3;C12ORF57;CAV3
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5946505643052611,-1.485782911934202,0.038461538461538464,0.8391802856431051,1.0,10/74,6.58%,CYP1A2;EPHX2;PNPLA3;ELOVL6;LTC4S;FADS1;HPGD;FAAH2;GLYATL2;SLC27A2
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.6877208811920378,-1.4854489560993367,0.06451612903225806,0.8352709054454112,1.0,3/27,1.45%,ARC;ABHD17A;LZTS3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.697403535663638,-1.4852710434604868,0.0,0.8309519352361595,1.0,6/21,13.46%,GRIN3A;APOE;DLG5;SHANK1;PTPRS;NEURL1
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.7943192313144846,-1.4848010307545614,0.061224489795918366,0.8282438234515171,1.0,1/8,0.44%,DRD4
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.90475880907757,-1.483919489408217,0.04878048780487805,0.8226601559166444,1.0,2/5,6.48%,OSR1;WNT7A
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.90475880907757,-1.483919489408217,0.04878048780487805,0.8226601559166444,1.0,2/5,6.48%,OSR1;WNT7A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.7509391854090632,1.4832253232966277,0.0,1.0,1.0,6/22,9.80%,GATA4;C3;TGFB1;FLT4;NODAL;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.8246328681576723,-1.482472755339041,0.0967741935483871,0.8257096451072038,1.0,2/8,3.90%,ADAMTS1;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.7527655046096289,1.4823679050088412,0.015625,1.0,1.0,6/21,9.80%,GATA4;C3;TGFB1;FLT4;NODAL;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.8196759362137207,1.4820379414080713,0.029850746268656716,1.0,1.0,2/10,11.03%,TGFB1;TAF7
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.797960802853962,-1.4814906039944082,0.16216216216216217,0.8278290071107716,1.0,2/9,0.68%,APOB;MFSD2A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7757963365233886,-1.4814383788448706,0.06451612903225806,0.823452651565801,1.0,2/11,3.90%,ADAMTS1;NR4A3
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.6894704407934544,-1.480326297485135,0.0,0.8255597046844887,1.0,2/31,1.45%,ARC;LZTS3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.9046302180302487,-1.4798223723560384,0.02702702702702703,0.8242272518821605,1.0,3/5,9.46%,FOXO1;TRPC3;MLIP
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.7706235982157322,-1.47980605162573,0.12195121951219512,0.8195185969487744,1.0,3/8,15.36%,WNK2;COMMD1;WNK3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.718177521232068,-1.4796994612559171,0.0625,0.8150402807881741,1.0,5/21,5.57%,DRD4;CSK;WWP2;APOE;RHBDF1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.6938284323585922,-1.4794597762616402,0.03225806451612903,0.8113037199475838,1.0,3/17,12.18%,ACER2;ACER3;PLPP2
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.9333717695986383,1.4794121882527986,0.014084507042253521,1.0,1.0,2/6,4.51%,SLC22A3;SLC18A2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.8923124832214626,-1.4790089089468046,0.0,0.8079538435613394,1.0,1/9,1.20%,OSR1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7354031242755144,1.4764042150301107,0.0,1.0,1.0,6/28,9.94%,GATA4;CCDC39;MESP1;DAND5;TBX6;MMP21
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5162157962123398,-1.476122210992225,0.0,0.8213703579923297,1.0,13/51,14.69%,CDH4;KIRREL3;DSG2;CDH13;PVR;IGSF21;AMIGO2;PCDHB6;SDK2;BSG;NECTIN3;ROBO4;DSCAML1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.940226657815652,-1.476092527369737,0.04081632653061224,0.8166500478189831,1.0,3/5,1.81%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),-0.861178394473318,-1.4746406919037922,0.125,0.8166341608448262,1.0,1/5,2.37%,PDE3A
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),-0.861178394473318,-1.4746406919037922,0.125,0.8166341608448262,1.0,1/5,2.37%,PDE3A
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.7842621421860603,-1.4743299321855152,0.075,0.8142631693113278,1.0,1/10,0.68%,MFSD2A
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6131290579992177,-1.473293287442279,0.0,0.8155469653255584,1.0,6/27,11.38%,NLGN3;WNT7A;SLC8A3;SHANK1;NLGN2;GRIN1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.6511201497310485,-1.4730268956701837,0.0625,0.8120622248700686,1.0,11/27,20.84%,PER2;ATOH7;CRY1;OPN5;PER3;PPP1CA;CRTC1;PPP1CB;PML;FBXL6;BHLHE40
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7712846703401113,-1.4726924423009644,0.044444444444444446,0.809350941890593,1.0,1/12,0.43%,GMNC
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.7430870124831097,-1.4726816458201148,0.07407407407407407,0.804726079365504,1.0,4/13,16.00%,DNMT1;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.7717894367142428,1.4725748854286285,0.04411764705882353,1.0,1.0,6/18,17.76%,ITGAX;SIX4;FGF2;SOX9;WNT5B;AGT
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.7515807058006296,-1.4717662166627945,0.07692307692307693,0.8063571390367181,1.0,3/14,7.29%,MFSD2A;TWIST1;PLIN5
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7645021362792237,-1.4702858574269493,0.13157894736842105,0.8103730100848204,1.0,1/8,1.02%,GLYATL1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.6915160829338566,-1.470036682372136,0.06896551724137931,0.8074931707761202,1.0,7/30,16.05%,MFSD2A;APOE;PLIN5;SCARB1;CHP1;NR1H2;CTDNEP1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.8210956171990379,-1.469564604187196,0.05,0.8049623603856186,1.0,1/10,1.63%,PNPLA3
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.9234883732624333,1.469146197135393,0.0,1.0,1.0,2/8,3.01%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.9234883732624333,1.469146197135393,0.0,1.0,1.0,2/8,3.01%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.832170418337918,1.4689333524111563,0.07462686567164178,1.0,1.0,1/10,0.55%,ESR1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.8772573079604206,1.468596479792567,0.0,1.0,1.0,4/10,8.30%,MCM2;MCMDC2;DONSON;MCM3
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),0.864992957289471,1.4684078059245735,0.027777777777777776,1.0,1.0,1/7,0.27%,AQP3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.836875059146983,1.4683582042760537,0.03333333333333333,1.0,1.0,4/10,9.51%,GATA4;STK26;REST;PINK1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.7269534500658386,-1.4680845023793052,0.0625,0.8091553677604544,1.0,7/18,18.15%,NPTX2;DLGAP4;SLC8A3;DLGAP1;HTR2C;DLGAP3;AKAP9
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),0.9605317684035412,1.467825317011813,0.015873015873015872,1.0,1.0,1/5,0.93%,SLC22A3
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.851226868140431,-1.467115904915152,0.11428571428571428,0.8116569517768045,1.0,2/9,2.05%,DRD4;CBARP
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.8021520421541295,-1.4669836723458318,0.05263157894736842,0.8079763709667702,1.0,2/8,3.52%,IL11;KIT
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.8774897417016144,-1.4652116658693852,0.02702702702702703,0.8145635802498904,1.0,1/8,1.16%,ENTPD2
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8584636423716887,1.464803453488622,0.0,1.0,1.0,3/9,7.14%,GATA4;HEY2;DAND5
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.779109834939896,-1.4640114146347563,0.0967741935483871,0.817303226946685,1.0,2/10,9.11%,ADAM8;CLPTM1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.6443566857300357,-1.4630255958949931,0.07142857142857142,0.8184803775240488,1.0,11/43,15.98%,PRDM5;HDAC10;HDAC7;FLNA;HDAC3;RCOR2;MIER2;SIRT7;BAZ2A;HDAC5;MIDEAS
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.8909750841854815,-1.4621124768123612,0.05263157894736842,0.8157925122821038,1.0,3/5,9.83%,CD14;SARM1;TICAM2
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.8909750841854815,-1.4621124768123612,0.05263157894736842,0.8157925122821038,1.0,3/5,9.83%,CD14;SARM1;TICAM2
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.8642350866549533,1.458990065722258,0.014084507042253521,1.0,1.0,1/10,0.44%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),-0.8451758950737789,-1.4589554628861439,0.13157894736842105,0.830685513445172,1.0,3/5,6.16%,KIT;OLFM2;MYOCD
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),-0.9287535137094508,-1.4584706352252934,0.0,0.8291411812498647,1.0,2/8,2.34%,OSR1;FGF1
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.9382802402908706,1.458429139708458,0.01639344262295082,1.0,1.0,1/6,0.93%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.8615589266067647,1.457928569273608,0.03076923076923077,1.0,1.0,1/9,1.38%,BLK
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.5505402606381811,-1.4565930005825711,0.0,0.8359713259025401,1.0,14/95,12.61%,ARC;CPSF1;NUP210;MAGOHB;POM121C;NUP42;NUP214;AAAS;SRRM1;SRSF4;SYMPK;UPF2;NXF5;U2AF2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.8344043833266761,1.455971952220426,0.056338028169014086,1.0,1.0,2/9,5.45%,RORC;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.8707384889576928,-1.455742634260527,0.0425531914893617,0.8369395229361601,1.0,3/6,11.89%,IL11;RAB11FIP1;RAB11FIP3
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.7896839975830017,-1.4552003638864486,0.07317073170731707,0.835460597571738,1.0,4/9,13.46%,ANAPC2;DAB2IP;NEUROD2;NEURL1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.590574750197429,-1.4551963414713196,0.0,0.8312787201173255,1.0,8/62,5.23%,SPRED3;SPRED2;ZNF703;PHLDB2;SPRED1;BAMBI;TWIST1;BCL9L
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.838210592291504,-1.4544481688955333,0.075,0.8324753985323345,1.0,1/6,0.97%,CLDN4
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.7764356162843188,-1.4540256288562794,0.038461538461538464,0.8311148322701288,1.0,2/9,0.90%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.9182331888834959,1.4539800894662176,0.014285714285714285,1.0,1.0,3/7,7.49%,MYRF;SOX10;PLP1
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.8353553713478925,-1.45382926888991,0.08108108108108109,0.8275978751889064,1.0,2/7,10.53%,EGR1;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6939841978687953,-1.4531849700846622,0.08823529411764706,0.8267797075404731,1.0,9/19,20.78%,SPRY4;EPHB2;STAMBP;DAB2IP;SLIT2;SPRY1;SPRY2;TGFB2;LZTR1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.7450213455161631,-1.4530341005233571,0.02631578947368421,0.8235350050663077,1.0,5/15,16.05%,MFSD2A;PLIN5;SCARB1;NR1H2;CTDNEP1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.7020027235538524,-1.4529730221833126,0.12195121951219512,0.8196816457330107,1.0,7/12,26.46%,PCM1;PEX14;CAMSAP3;DAG1;GCC2;BCCIP;BICD1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8017560564686037,-1.452724372863519,0.03225806451612903,0.817213836814377,1.0,3/12,10.98%,CDH5;CLIP3;MAPRE1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.6724741153854997,-1.4525169676385543,0.08823529411764706,0.8149116690236407,1.0,4/15,17.26%,TENT4A;AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__lymphocyte apoptotic process (GO:0070227),-0.9100235621696908,-1.4511798434165162,0.047619047619047616,0.8185987582257812,1.0,1/5,2.85%,CLC
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5707500779563469,-1.45016641610325,0.0,0.8203636280281642,1.0,7/48,13.97%,NGF;SRGAP2;NYAP2;DAB2IP;MNX1;TAOK2;DBNL
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.9471240893400298,1.4497592119437614,0.03125,1.0,1.0,1/6,2.83%,LRP2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.8437488651705967,1.449116979902894,0.03125,1.0,1.0,1/10,1.02%,MCUB
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6067119248802094,1.4477207110574688,0.0,1.0,1.0,18/105,10.88%,CLEC5A;ESR1;C1QB;C3AR1;TLR2;OSCAR;FCGR3A;MMP19;VSIG4;CASR;SLC7A7;P2RY6;ITGA2;MMP9;PSAP;DAB2;HCK;ANPEP
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.9031105897431748,1.4475169736241182,0.07407407407407407,1.0,1.0,1/6,1.38%,BLK
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.8427732462956623,1.4460793646603665,0.04838709677419355,1.0,1.0,2/10,4.29%,SLC12A7;SLC12A3
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.8427732462956623,1.4460793646603665,0.04838709677419355,1.0,1.0,2/10,4.29%,SLC12A7;SLC12A3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7451157276153272,-1.4455241568965118,0.0975609756097561,0.8438664204215638,1.0,3/18,1.81%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.9394617773048192,-1.4450609046458456,0.021739130434782608,0.8424474908242249,1.0,1/5,0.27%,GABRE
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.957730941964685,1.4449416162173414,0.0,1.0,1.0,2/6,4.01%,GPR62;SCTR
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.7153646336770844,-1.443985791630823,0.058823529411764705,0.8460669784256905,1.0,1/13,1.16%,ENTPD2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.7492944109238349,-1.443086794504663,0.05555555555555555,0.8478705423048645,1.0,7/16,16.71%,WWC1;NEK8;DLG5;MOB3B;WWC2;VGLL4;MARK3
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.7801109028089594,-1.4429339345778116,0.03225806451612903,0.8448167746328498,1.0,4/13,16.00%,DNMT1;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.6795020376657663,1.4410209860736258,0.024390243902439025,1.0,1.0,9/44,14.59%,PCLAF;DTL;UBE2L6;TRIM25;FAAP20;POLD4;RPA3;RPS27A;ISG15
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),-0.7870488625753777,-1.4407909647266206,0.11428571428571428,0.8506124268229475,1.0,2/7,10.98%,MAP10;KIF4B
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),-0.7870488625753777,-1.4407909647266206,0.11428571428571428,0.8506124268229475,1.0,2/7,10.98%,MAP10;KIF4B
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.6513304605245741,-1.4405134222268916,0.1,0.8485970775633679,1.0,11/26,20.84%,PER2;ATOH7;CRY1;OPN5;PER3;PPP1CA;CRTC1;PPP1CB;PML;FBXL6;BHLHE40
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.8318567963774528,1.440425178973142,0.03278688524590164,1.0,1.0,1/10,0.44%,TBX1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6853599276946678,1.4400016594132095,0.0136986301369863,1.0,1.0,11/28,19.12%,NRAP;TBX1;TMEM204;HEY2;CHRNB1;POPDC2;DUSP29;SGCZ;WNT5B;MTLN;FBXO40
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.6673111449037828,1.4397953369909657,0.02631578947368421,1.0,1.0,14/49,6.10%,CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;FCGR3A;TFEC;VSIG4;ITGAM;SLC7A7;NFAM1;FGL2;CLEC12A;ADGRE1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.7968732883676697,-1.4396343998102845,0.07142857142857142,0.8500786394789862,1.0,3/9,3.91%,SLC38A5;SLC6A20;SLC6A17
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),-0.7817933548638059,-1.4391982106754193,0.046511627906976744,0.8494160929168914,1.0,2/9,6.57%,CRLS1;CPNE6
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.6934354432391737,-1.4391362166267296,0.11764705882352941,0.8458444043827483,1.0,10/17,25.00%,NEU4;NEU3;B4GALNT1;ST6GALNAC3;ST3GAL5;ST6GALNAC5;ST8SIA2;ST8SIA4;ST8SIA3;CLN6
prerank,GO_Biological_Process_2021__pronephros development (GO:0048793),-0.8512500962132554,-1.4390819423606787,0.125,0.8421740420262717,1.0,1/6,1.20%,OSR1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.9347017966233568,1.4385856933460153,0.014925373134328358,1.0,1.0,1/5,0.92%,NOX5
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.7865279053140107,1.436898519877605,0.03076923076923077,1.0,1.0,7/14,15.65%,TMEM100;FGF2;MESP1;VEZF1;BTG1;SOX9;SFRP4
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.8643207921648761,-1.435935736793024,0.07894736842105263,0.8559989936718201,1.0,2/7,9.15%,DNAJC30;SLC30A5
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5785492932098635,-1.4335951806423275,0.0,0.867605595615927,1.0,13/45,9.80%,WNT3A;GPC6;GRID2;NLGN3;DLG5;MDGA1;GPC4;SYNDIG1;WNT7A;LHFPL4;EPHB2;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.834794501049638,-1.432737118087156,0.08695652173913043,0.8681136414434631,1.0,2/6,8.74%,BNIPL;BNIP2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.778564090298085,1.4314923189406727,0.0,1.0,1.0,3/18,4.99%,GATA4;SMAD6;HEY2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.6879475244233824,1.431086897685963,0.030303030303030304,1.0,1.0,11/28,13.40%,ESR1;ANXA1;WNT8B;SSTR1;TGFB1;H2AZ1;GPER1;SOCS2;RAMP3;CRHBP;GGT5
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.6040987632200467,-1.4310260141293043,0.03125,0.8741851055804037,1.0,9/39,13.46%,MYO10;PRKCD;AGRN;FSCN1;FXR2;RAB5A;TRPM2;CAPZB;NEURL1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.7890256560962496,-1.430740263825907,0.1891891891891892,0.8717583504934079,1.0,5/9,17.83%,KDM7A;KDM8;KDM2B;KDM4B;KDM2A
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.9418489259493956,1.4301849962016393,0.018867924528301886,1.0,1.0,1/5,2.02%,GAD1
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),0.9467352863246385,1.4301431331606371,0.0,1.0,1.0,1/6,1.38%,BLK
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.9032401597606299,1.4299395343665158,0.015625,1.0,1.0,2/8,2.68%,TMEM100;RRAS
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.8561721279596101,1.4298619947533164,0.05660377358490566,1.0,1.0,1/5,1.57%,TLR2
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.5674546986066797,-1.4297833838692855,0.11538461538461539,0.8732030930366259,1.0,15/40,22.03%,NGF;LIMK1;SLIT2;PLXNA4;GOLGA4;ISLR2;DBNL;MAP3K13;RHOA;NTRK2;PLXNA2;MAPT;ROBO2;PLXNC1;MAP6
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.8335812181894936,-1.4297705705230916,0.05555555555555555,0.8693974856304705,1.0,1/8,1.94%,CDH5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.7447426532521433,-1.4286737354821701,0.125,0.8724930291382083,1.0,4/12,7.29%,TWIST1;NR4A3;MLYCD;PLIN5
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.7626782696369131,-1.4283976413206445,0.14285714285714285,0.8699905635508557,1.0,4/11,14.11%,OSR1;PKD2;SLIT2;FGFR2
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.7971765464848319,1.427346334065698,0.04285714285714286,1.0,1.0,4/15,6.50%,TNFRSF1B;AHR;IL12A;IL27
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.85762307394355,-1.4270327012870359,0.09523809523809523,0.8750095234699304,1.0,2/7,3.71%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.8624037472111771,-1.4267387715122968,0.15625,0.8726435476423701,1.0,2/5,6.72%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.7270500319488086,-1.426420646275474,0.09375,0.8706107329330056,1.0,2/8,9.35%,FOXO1;AQP1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7196308026896298,1.4261034625530953,0.056338028169014086,1.0,1.0,4/25,8.88%,GATA4;CCDC39;MESP1;TBX6
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.9322853163614373,-1.4247671917153342,0.16129032258064516,0.8757475012914041,1.0,1/6,0.19%,PKD1L1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.8102323652106412,1.424699553173712,0.029850746268656716,1.0,1.0,2/14,5.82%,ACAA2;BOK
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5717152467953982,-1.4240358943268112,0.06060606060606061,0.8726942847940615,1.0,12/51,18.97%,NUP210;TRIM71;POM121C;NUP42;NUP214;AAAS;AGO2;POLR2F;POLR2C;NUP37;TNRC6A;NUP98
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5717152467953982,-1.4240358943268112,0.06060606060606061,0.8726942847940615,1.0,12/51,18.97%,NUP210;TRIM71;POM121C;NUP42;NUP214;AAAS;AGO2;POLR2F;POLR2C;NUP37;TNRC6A;NUP98
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.6519617349877993,-1.4240030256376512,0.09090909090909091,0.8692232949125952,1.0,4/18,12.60%,TSKU;APOE;SCARB1;SOAT1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.7103485362267132,-1.423734191716155,0.08333333333333333,0.8670656825867278,1.0,1/14,1.29%,SEC24C
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.6079231020405916,-1.4230590978415523,0.08823529411764706,0.8668739381002319,1.0,11/28,24.88%,LIN28B;TRIM71;DGCR8;AGO2;ZC3H7B;PUS10;SNIP1;TARBP2;ADAR;TUT7;DROSHA
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.6181021103945976,-1.4228704937564467,0.045454545454545456,0.8640782668541874,1.0,15/64,14.81%,MYO10;TBC1D10A;TBC1D16;IFT88;DCDC2;FSCN1;TBC1D22B;TBC1D2;FXR2;RAB5A;TBC1D8;TRPM2;CAPZB;SDCCAG8;RABEP2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.7300552066392013,-1.4226101380962823,0.05405405405405406,0.862090765651325,1.0,4/17,6.02%,MFSD2A;LCN12;APOE;SLC25A17
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.46734029206527483,-1.4226099929574796,0.0,0.8584378386782263,1.0,14/169,8.08%,CYP1A2;DDAH2;PC;HGFAC;BPHL;UPB1;PAPSS2;APOE;MAN1A1;GSR;F11;ACOX3;MPP2;UPP1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7674966608416692,1.4220771218116972,0.015151515151515152,1.0,1.0,3/15,4.99%,SMAD6;TNFRSF1B;HEY2
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.833692314742986,-1.422070972284121,0.15789473684210525,0.8543816114416778,1.0,3/9,8.79%,SMPD3;PRKCD;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.833692314742986,-1.422070972284121,0.15789473684210525,0.8543816114416778,1.0,3/9,8.79%,SMPD3;PRKCD;NSMAF
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.7307939249242843,1.4212368638167718,0.06153846153846154,1.0,1.0,2/24,2.20%,LRP4;SMOC1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.5185015956944315,-1.4208417272365617,0.058823529411764705,0.858697268087789,1.0,9/113,6.23%,RFX6;CNGA3;ARX;SLC38A5;GPC6;KLHL41;ADCYAP1;CFC1;ABCC8
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.6082856024164343,1.4207496252229161,0.02531645569620253,1.0,1.0,17/112,9.23%,NLRP4;EOLA1;NOX5;LRRC19;ANXA1;S100A13;TNFRSF1B;TRIL;ACE2;PTPRC;SFTPD;NFAM1;RNF26;NLRP12;IGF2BP2;AFAP1L2;PLD4
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),0.9250071154706558,1.420615113391441,0.016666666666666666,1.0,1.0,2/5,7.23%,SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),0.9250071154706558,1.420615113391441,0.016666666666666666,1.0,1.0,2/5,7.23%,SLC22A3;SLC6A4
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.7817068172149038,-1.4198654895948257,0.034482758620689655,0.8612636500592804,1.0,4/11,16.00%,DNMT1;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),-0.8052511064608258,-1.4195725954832974,0.12195121951219512,0.8601609926991682,1.0,1/6,0.89%,EIF5AL1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.8689510981536008,-1.4185104937280986,0.08333333333333333,0.8588581586813578,1.0,2/5,5.46%,DPM3;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.8689510981536008,-1.4185104937280986,0.08333333333333333,0.8588581586813578,1.0,2/5,5.46%,DPM3;DPY19L3
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.7575384363749575,-1.4178209435710971,0.08,0.859987141452354,1.0,8/24,11.97%,NPAS4;DRD4;GRID2;NLGN3;MPP2;INSYN2A;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.8984533225718823,1.4176793375004881,0.019230769230769232,1.0,1.0,2/7,5.64%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.7324422226633082,-1.4169977968256087,0.125,0.8575488347347303,1.0,1/13,0.07%,IL7R
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.7324422226633082,-1.4169977968256087,0.125,0.8575488347347303,1.0,1/13,0.07%,IL7R
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.758510151242759,1.4168456679200607,0.030303030303030304,1.0,1.0,6/19,11.47%,IL21R;PTPRC;NFIL3;IFNK;AXL;CD244
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.8231447238497529,-1.4156974067033252,0.047619047619047616,0.8627451867790968,1.0,4/9,8.53%,PEX7;DHRS7B;LPCAT2;PLA2G4C
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.7879173898904321,-1.4155572674859545,0.06666666666666667,0.8597809405417436,1.0,1/7,1.63%,PNPLA3
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8274519738169068,-1.4153701034744295,0.1282051282051282,0.8571821691601536,1.0,1/6,2.58%,KMT2B
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.7846869714483468,-1.413929076522024,0.13953488372093023,0.8614101676784425,1.0,4/7,18.65%,NDST3;CSGALNACT1;EXT1;EXT2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.9454299896976827,1.4136037312114862,0.0,1.0,1.0,1/6,0.27%,GATA4
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.825566878629594,-1.4135069718768003,0.046511627906976744,0.8600684044769229,1.0,4/9,13.17%,APOE;ADH4;CEL;CYP46A1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6072119882375346,-1.4134675142046769,0.04,0.856767967351499,1.0,2/34,5.58%,NOX4;TGFA
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.8680636682696288,1.4124813286774833,0.014285714285714285,1.0,1.0,3/8,8.30%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.8235849940188167,1.4119332840446657,0.06451612903225806,1.0,1.0,2/7,4.68%,ADAD2;ADARB2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.7374515679172324,-1.411657073900157,0.07894736842105263,0.8640298870167517,1.0,6/13,19.66%,SMPD3;RAB7A;SNF8;SDCBP;SDC4;TSG101
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7865147492076513,1.4114437275603373,0.028985507246376812,1.0,1.0,1/15,1.51%,CASQ2
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.7638546340880711,1.4107839256982238,0.03125,1.0,1.0,3/11,9.34%,CCL5;POU2F3;REST
prerank,PanglaoDB_Augmented_2021__Macrophages,0.5921531510117546,1.4106330059605225,0.02631578947368421,1.0,1.0,34/120,11.85%,CLEC5A;ITGB2;C3AR1;CYTIP;TLR2;ITGAX;TNFRSF1B;CCL5;AHR;PTPRC;FCGR3A;SLC37A2;LYVE1;TFEC;SASH3;VSIG4;ITGAM;SLC7A7;SCIMP;NFAM1;PTAFR;CPM;FGL2;CLEC12A;ADGRE1;P2RY6;MMP9;DAB2;CHIT1;HCK;CD80;SYK;HPGDS;CSF3R
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.6241501878140816,-1.4105297174393996,0.06896551724137931,0.8659872337047377,1.0,4/26,8.65%,TEAD2;WWC1;TEAD4;AMOTL1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6800419560406884,1.4103338508613383,0.0821917808219178,1.0,1.0,3/28,3.40%,AQP3;TBX1;ROGDI
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.8479835498080659,-1.4101248786568554,0.06451612903225806,0.8649821949478853,1.0,2/5,13.55%,CX3CR1;CARD9
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7550422157053899,1.4100007587252186,0.0,1.0,1.0,6/31,5.64%,SMOC1;MAB21L1;HIPK1;C3;FREM2;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.817520509075759,1.408967931653839,0.09375,1.0,1.0,1/9,3.84%,STOML2
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.6592652824629439,-1.4084135244935272,0.10526315789473684,0.8705206982256037,1.0,7/19,21.28%,GCK;CRY1;NUPR1;PGP;C1QTNF12;CLK2;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.8073663306251949,1.4078799608148738,0.046153846153846156,1.0,1.0,6/11,19.13%,ITGB2;HLA-F;ITGAM;SYK;IL4;F2RL1
prerank,GO_Biological_Process_2021__columnar/cuboidal epithelial cell differentiation (GO:0002065),0.8840044992515893,1.407591273652877,0.05084745762711865,1.0,1.0,3/5,10.11%,GATA4;ROS1;NPY
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.6756536265585574,1.407176439418366,0.07462686567164178,1.0,1.0,9/34,15.85%,CIDEB;GPER1;MOAP1;MMP9;PINK1;IGF1;HGF;PLAUR;BBC3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8469914547771895,1.4066954278054298,0.07462686567164178,1.0,1.0,2/9,5.64%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8193004608679342,-1.4066756854902775,0.11428571428571428,0.8766229889049959,1.0,1/7,0.50%,TSKU
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.6080516223903202,-1.4053178530519237,0.03333333333333333,0.8815788180725281,1.0,4/32,10.98%,CDH5;CLIP3;TRIM54;MAPRE1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.7182264258353368,-1.4048642922911974,0.0,0.8810218128700197,1.0,2/14,5.33%,NR4A3;MLYCD
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.6912086512850213,1.4047761082820693,0.0375,1.0,1.0,8/33,18.21%,TBX1;SOX10;SEMA3A;ERBB4;SEMA3B;SEMA3F;HTR2B;FN1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.786900372570196,-1.404212789023229,0.0,0.8819415398604017,1.0,3/9,6.84%,PER2;PIWIL2;CRY1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.8489751124721862,1.4041915220990506,0.01639344262295082,1.0,1.0,2/9,5.45%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8752702551130109,1.404125733449033,0.029850746268656716,1.0,1.0,2/6,8.56%,ANXA1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.607299136173003,-1.4040309483118774,0.0,0.8792686934151729,1.0,3/21,5.48%,RASSF2;RAD50;PDGFD
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),-0.8212567426195214,-1.4040050050616433,0.07894736842105263,0.8760209436268331,1.0,1/8,0.50%,TSKU
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5389207431144365,-1.4038800953449195,0.10344827586206896,0.8735526738448333,1.0,25/67,20.50%,DTX1;PRAG1;MAML1;POFUT1;WWP2;CCN3;JAG2;CHAC1;BEND6;DLK2;ZBTB7A;NIBAN2;ZMIZ1;LLGL1;NEURL1;DLL1;TCIM;NOTCH1;JAG1;TGFB2;TSPEAR;TSPAN14;ARRB1;AAK1;NOTCH4
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.8383735263452912,1.4034864223616152,0.0625,1.0,1.0,3/10,10.41%,IYD;DIO1;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.7993572404376877,1.4028613838152246,0.057971014492753624,1.0,1.0,3/12,10.49%,HLA-F;IL12A;AXL
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.6453570079185059,1.4021278799979269,0.03896103896103896,1.0,1.0,14/60,6.01%,CLEC5A;ITGB2;C3AR1;TLR2;ITGAX;CSF2RA;SP100;TNFRSF1B;APOL6;PTPRC;TFEC;ITGAM;PTAFR;FGL2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.7107993115765207,-1.4019419924637437,0.10344827586206896,0.8813614847698769,1.0,7/21,15.85%,NDST3;XYLT1;HS6ST2;SULF2;GPC1;B3GAT3;EXT1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.6042167969457272,-1.4014783317959298,0.08571428571428572,0.8773999556428578,1.0,5/33,8.80%,NUP210;POM121C;NUP42;NUP214;AAAS
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.6042167969457272,-1.4014783317959298,0.08571428571428572,0.8773999556428578,1.0,5/33,8.80%,NUP210;POM121C;NUP42;NUP214;AAAS
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.7531474211821307,-1.40132903244926,0.125,0.8745917615015568,1.0,5/18,11.97%,NPAS4;GRID2;MPP2;GRIN1;ARRB2
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.7941477243141358,1.400781370021231,0.04285714285714286,1.0,1.0,1/13,1.26%,BACE2
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.8707747554424493,1.4003297255529177,0.046875,1.0,1.0,1/7,0.55%,ESR1
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7927045423884624,1.3990935467936059,0.078125,1.0,1.0,2/9,11.65%,BLK;SYK
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.8317239491737751,-1.398796388973832,0.06818181818181818,0.8867772561789241,1.0,1/6,3.90%,NR4A3
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.6726426326050488,-1.3982271990121802,0.0975609756097561,0.886274342940556,1.0,2/15,12.16%,IWS1;NXF5
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.7722996947179513,-1.3981399048832988,0.058823529411764705,0.8835695134066487,1.0,5/11,16.05%,MFSD2A;PLIN5;SCARB1;NR1H2;CTDNEP1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7932271151919549,-1.3972429238874136,0.15789473684210525,0.8855412585361647,1.0,2/8,6.84%,GCK;CRY1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.8682466995943555,-1.3968255839281947,0.04878048780487805,0.8846835323062983,1.0,1/5,1.28%,MIDN
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.8338139652164055,-1.3966552744568579,0.0625,0.8822739442427621,1.0,2/6,8.46%,PDZD7;JAG2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.8484286251957681,-1.395903604673613,0.07692307692307693,0.8831938566900671,1.0,3/8,12.95%,KLHL41;MYOCD;GPC1
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.9305973441366888,1.395848200547006,0.017857142857142856,1.0,1.0,2/5,2.83%,TBX1;LRP2
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.8820160187665731,1.3958423472507304,0.0,1.0,1.0,2/6,6.15%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.9022420123996474,1.3953190412784113,0.03389830508474576,1.0,1.0,1/5,3.08%,PTPRC
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.8491565329893459,1.3948370385965108,0.07407407407407407,1.0,1.0,2/7,2.52%,SGO1;BUB1
prerank,GO_Biological_Process_2021__regulation of nephron tubule epithelial cell differentiation (GO:0072182),-0.8418270006576618,-1.3945382458813274,0.1282051282051282,0.8883865964217901,1.0,1/6,1.20%,OSR1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.7249526383477464,-1.3945243283609785,0.08823529411764706,0.8853219253235416,1.0,4/15,12.35%,CACNG4;NLGN3;NLGN2;CACNG2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.6739577651058228,1.394513251182876,0.05405405405405406,1.0,1.0,3/26,4.99%,GATA4;TBX1;HEY2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.8611199553977774,-1.3939339671080273,0.029411764705882353,0.8851971077812301,1.0,1/5,0.97%,PDE10A
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.9318485213969581,1.3938891449377122,0.030303030303030304,1.0,1.0,1/6,1.96%,SLFN14
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.7451643391461107,1.3935381606771442,0.13043478260869565,1.0,1.0,1/14,1.57%,TLR2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.6052269211754371,1.3930654054819496,0.04,1.0,1.0,35/76,21.27%,RASGRP4;IL21R;ITGB2;ARHGAP9;GP1BA;ITGAX;TNFRSF1B;GMFG;LILRB3;FCGR3A;SASH3;ALOX12;TGFB1;ITGAM;NFAM1;CLEC12A;WAS;FLI1;HCK;CD244;CSF3R;HK3;PSTPIP1;TAGAP;VWF;ITGA2B;MYO1F;FPR1;PARVG;P2RX1;ADGRE3;PIK3R6;CD300LF;PDE6B;FERMT3
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.8406794310341992,-1.3929540126311313,0.04878048780487805,0.8876743944881001,1.0,2/7,5.43%,PRKCD;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.6453076209984836,1.3922752336173783,0.02857142857142857,1.0,1.0,7/40,10.26%,LMOD3;LMOD1;SCIN;C15ORF62;BAIAP2L1;VASP;HCK
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.6393602685734173,-1.3914350543655658,0.1111111111111111,0.8926241633595002,1.0,5/25,13.01%,PRKCD;PID1;PTPRE;SLC27A4;AHSG
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.7144491597400365,-1.391176495658292,0.15625,0.8909554118226866,1.0,4/20,8.00%,ARC;CRHR2;SLC8A3;MPP2
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.6767080384237121,-1.3902453627595315,0.10344827586206896,0.8928307037503831,1.0,8/24,12.40%,ARC;CACNG4;NLGN3;SHANK1;NLGN2;SHISA7;CACNG2;CNIH3
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.7757926109755536,-1.3901568005032146,0.1,0.890619968503985,1.0,2/9,4.15%,PC;PDZD11
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.8556291924388613,-1.3897319187264765,0.225,0.8840808463541118,1.0,1/5,5.28%,APOE
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.8556291924388613,-1.3897319187264765,0.225,0.8840808463541118,1.0,1/5,5.28%,APOE
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.8556291924388613,-1.3897319187264765,0.225,0.8840808463541118,1.0,1/5,5.28%,APOE
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.8813238348224484,-1.389328365160538,0.1,0.8836172545663626,1.0,3/5,9.75%,PER2;PID1;TFDP1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.7733716428655567,-1.3869561063538058,0.07692307692307693,0.8923494110602995,1.0,1/7,0.92%,TYRP1
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.7733716428655567,-1.3869561063538058,0.07692307692307693,0.8923494110602995,1.0,1/7,0.92%,TYRP1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7500351154153038,1.3862507468518381,0.0625,1.0,1.0,4/16,15.88%,MCM2;MCMDC2;HMGA1;RECQL4
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7556895142786526,1.3859531676772814,0.07352941176470588,1.0,1.0,3/20,6.54%,PTPRC;NFAM1;CD81
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.6866495339306885,-1.3858706039146584,0.06060606060606061,0.8952473479807714,1.0,5/14,16.70%,APOB;SCARB1;LPL;NR1H2;ABCG1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7433288827905544,-1.385735550430013,0.125,0.8901664065430039,1.0,2/7,9.35%,FOXO1;AQP1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7433288827905544,-1.385735550430013,0.125,0.8901664065430039,1.0,2/7,9.35%,FOXO1;AQP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.7426169854209522,-1.3856323162177395,0.1891891891891892,0.8875063606147073,1.0,2/8,4.40%,PTPRO;PTPRB
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.7140397875466287,-1.3855588759290292,0.10344827586206896,0.8850096507449835,1.0,4/13,10.58%,SRGAP2;PPP1R9B;FGD1;FGD5
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7236172380768977,1.3847906248422084,0.04411764705882353,1.0,1.0,5/24,6.82%,MYRF;KIF14;ITGAX;TNFRSF1B;JAM2
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.8084105673809835,1.3843585391146138,0.08333333333333333,1.0,1.0,4/9,13.71%,CCL5;SFTPD;TAFA4;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.7865939246444735,1.3841643614514914,0.06557377049180328,1.0,1.0,2/11,6.32%,AMBP;GPER1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7363176449356269,1.384043766284015,0.03076923076923077,1.0,1.0,4/20,4.93%,ESR1;CCL5;FGF2;FLT1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7961767910010491,1.3839715227635696,0.0392156862745098,1.0,1.0,3/12,6.28%,GATA4;HEY2;MESP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.7231840147045698,-1.383457466503411,0.10714285714285714,0.8951175153558334,1.0,2/14,0.90%,ADRA1A;ADRA1B
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5889663286057798,1.3832092706822159,0.037037037037037035,1.0,1.0,56/104,27.05%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;RPL36;RPS27A;RPS19;RPL41;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;RPSA;RPL7A;RPS13;RPL11;RPS7;RPL23A;RPL7;RPLP2;RPLP0;RPS14;RPS6;RPL38;RPL23;RPS15;RPL24;RPL18;RPL35;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;RPL27;RPS24;UPF1;RPL29;RPS18;RPLP1;NCBP1;RPS3;RPS23;RPL34
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.7685972425190385,-1.3831609210664741,0.07142857142857142,0.8942461359803134,1.0,1/11,0.34%,SKAP1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7462752153937195,1.3817045262994958,0.140625,1.0,1.0,2/14,11.28%,STK26;RAPGEF6
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.8670810069008373,1.381662090821784,0.07692307692307693,1.0,1.0,1/7,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.8388993290072344,-1.380082373629325,0.12195121951219512,0.9100506960039493,1.0,2/6,3.91%,SLC6A20;SLC6A17
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.551673136090403,-1.3796201663940348,0.125,0.9098510218291995,1.0,9/42,14.71%,TSKU;APOB;LIPC;APOE;SCARB1;CEL;SOAT1;AKR1C1;OSBPL5
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8370412192014675,1.3788751242680048,0.057692307692307696,1.0,1.0,1/9,0.50%,SMAD6
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.7635992421409394,-1.3785235113596137,0.06060606060606061,0.914030135561747,1.0,2/14,0.90%,ADRA1A;ADRA1B
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.835429401748834,-1.3781794729920904,0.06666666666666667,0.9127752077790389,1.0,2/5,8.74%,BNIPL;BNIP2
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8111796853019242,-1.3779048113586227,0.17073170731707318,0.9110560087003807,1.0,2/6,7.44%,SIGIRR;TRIB1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.5725329527565582,-1.3777843958572515,0.09090909090909091,0.9085945252602486,1.0,7/41,11.15%,GCK;NUP210;POM121C;NUP42;NUP214;AAAS;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.5957641895279867,-1.3777598762771375,0.08823529411764706,0.9056798356033277,1.0,6/44,5.99%,SPRED3;SPRED2;SPRED1;CDH5;PUM3;HSPB1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.8702076296997767,-1.3775438630464991,0.15625,0.9038606879969681,1.0,2/7,5.31%,PUM3;PNKP
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.589032044754132,-1.3775135449379525,0.0967741935483871,0.9010273876196924,1.0,2/38,1.08%,EPHX2;SYNJ2
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.8435064518199361,-1.377483415352088,0.05263157894736842,0.898212666261284,1.0,2/5,8.63%,CELA2A;ERN1
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),0.9160638601890465,1.377377709890745,0.07142857142857142,1.0,1.0,3/5,7.23%,SLC22A3;SLC18A2;SLC6A4
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.818251592900478,1.3771051316345395,0.05357142857142857,1.0,1.0,2/8,4.99%,GATA4;HEY2
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.8625925737071198,-1.377071413722558,0.1,0.8946704216007961,1.0,2/5,9.93%,SMYD5;KMT5C
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.8625925737071198,-1.377071413722558,0.1,0.8946704216007961,1.0,2/5,9.93%,SMYD5;KMT5C
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.7262540588705708,-1.376899123088736,0.11363636363636363,0.8930086226986715,1.0,6/9,21.98%,PID1;SELPLG;SBNO2;PTGIS;CHI3L1;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6850338916405879,-1.3768806892422087,0.11764705882352941,0.8902104014241455,1.0,8/14,17.92%,PNKP;KMT5C;WRAP53;KDM4D;SMCHD1;SHLD2;SHLD1;MAD2L2
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.7457922032633671,1.3767366323996084,0.12698412698412698,1.0,1.0,4/12,17.32%,ANXA1;CD80;TNFSF4;MYB
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.8232697629431368,1.376701260486418,0.06060606060606061,1.0,1.0,1/9,0.39%,NEK2
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.5391042360197478,-1.3763798724066254,0.058823529411764705,0.8898544060773838,1.0,11/86,7.82%,RFX6;PER2;CELA2A;GCK;MIDN;ITPR2;DOC2B;ABCC8;CAPN10;CCN3;ENSA
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.8158188169455398,-1.375956376013093,0.07142857142857142,0.8896830682497017,1.0,1/8,4.94%,SP7
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.9112860741444495,1.3755860701025933,0.01694915254237288,1.0,1.0,2/5,6.15%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.9112860741444495,1.3755860701025933,0.01694915254237288,1.0,1.0,2/5,6.15%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.9112860741444495,1.3755860701025933,0.01694915254237288,1.0,1.0,2/5,6.15%,SLC28A1;SLC28A3
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.5875235507376235,-1.3749476686614808,0.13043478260869565,0.8918760161472701,1.0,6/33,7.51%,DRD4;MIDN;APOE;RAB11FIP1;RHBDF1;CCN3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.7453942753506517,-1.374490903853633,0.10416666666666667,0.8909745028391555,1.0,4/7,22.16%,EMILIN1;SLIT2;CD200R1;ADTRP
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.821517483977972,-1.3744487191333683,0.16129032258064516,0.8883627866586972,1.0,1/6,4.24%,ANO7
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.8059691614288291,1.3737603137177263,0.07042253521126761,1.0,1.0,2/11,5.10%,WNT5A;ARIH2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.8379815595013443,1.3734618561417773,0.03225806451612903,1.0,1.0,1/7,0.27%,GATA4
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.8265397716677931,-1.3733651102676374,0.18421052631578946,0.891079197829659,1.0,2/6,13.65%,NLGN2;NRXN2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.7931261355457849,-1.3726833925384987,0.125,0.8922528145286789,1.0,4/8,13.46%,ANAPC2;DAB2IP;NEUROD2;NEURL1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.5642533929431625,-1.371162779448627,0.06896551724137931,0.8967737091432538,1.0,12/47,8.99%,GALR3;GRP;NMU;HCRTR2;SORCS2;GPR149;NXPH4;ADCYAP1;NXPH2;GLRA3;HCRTR1;CYSLTR1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.7735305288314049,1.3701662344449046,0.1016949152542373,1.0,1.0,2/12,6.28%,GATA4;MESP1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),0.8853581088021276,1.37008279023938,0.06451612903225806,1.0,1.0,2/6,2.68%,MICB;TCF7
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7174230471195497,1.3697373103342727,0.06060606060606061,1.0,1.0,6/16,19.31%,CCL5;P2RY12;MAPK3;CSF1R;THBS1;CSF1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.7913763006935604,-1.369300238280628,0.1111111111111111,0.9032726503312513,1.0,4/10,14.11%,OSR1;PKD2;SLIT2;FGFR2
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.5964421483946888,-1.3685613172119981,0.08823529411764706,0.9043081085617167,1.0,9/38,15.50%,DTX1;PPP5C;MLF1;TERT;POLR2F;POLR3A;BAZ2A;POLR2C;TAF1B
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.8356565109917393,-1.3685583463289,0.08823529411764706,0.9014821457224614,1.0,3/8,9.31%,NR4A1;CCN3;CORO1B
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.8289354455206268,-1.3684948580729592,0.05405405405405406,0.8993805377637025,1.0,2/10,7.72%,SKAP1;ASS1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.5795680877224232,-1.368410275610636,0.14285714285714285,0.8973360178184611,1.0,14/59,16.53%,TBC1D10A;TBC1D16;IFT88;DCDC2;TBC1D22B;TBC1D2;CROCC;TBC1D8;SDCCAG8;RABEP2;CCDC88A;MARK4;ENTR1;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.6052547960956054,-1.367927150582144,0.037037037037037035,0.8975868647788335,1.0,5/32,8.05%,PER2;FOXO1;ASCL1;CX3CR1;HES1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.860876045183397,1.3675297500452235,0.031746031746031744,1.0,1.0,2/7,8.16%,TGFB1;ACMSD
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.8648206552070622,-1.366706767415403,0.14705882352941177,0.9001993507070215,1.0,1/6,2.95%,HDAC10
prerank,GO_Biological_Process_2021__metanephric nephron tubule development (GO:0072234),-0.875405817881577,-1.3666594654020197,0.09523809523809523,0.8976476469269239,1.0,2/5,8.95%,OSR1;PKD2
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.8788283326933107,-1.3665210257534428,0.05,0.8958075057189766,1.0,1/5,0.68%,MFSD2A
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7709094143144463,1.3662642086679657,0.07547169811320754,1.0,1.0,3/14,7.14%,GATA4;HEY2;DAND5
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7973709044812625,1.3662429413589288,0.047619047619047616,1.0,1.0,1/11,1.66%,MYRF
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.671116458283787,-1.3661926624133036,0.08823529411764706,0.8950192888806234,1.0,2/11,6.40%,GFI1B;CBFB
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7070867352887864,-1.3661651822038856,0.04,0.8924634876881221,1.0,4/18,8.95%,DDAH2;TMEM106A;ASS1;PKD2
prerank,GO_Biological_Process_2021__centromeric sister chromatid cohesion (GO:0070601),0.8927615554246797,1.3657029446347637,0.07142857142857142,1.0,1.0,2/5,2.52%,SGO1;BUB1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6786203968651736,-1.3651422823725257,0.09090909090909091,0.8956983073973909,1.0,7/14,12.38%,SELE;PODXL2;SELL;CX3CR1;ITGA4;SELP;SELPLG
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8348296766208823,1.3645210789770905,0.07936507936507936,1.0,1.0,1/9,0.39%,NEK2
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.681963724724981,-1.3639254930926696,0.14705882352941177,0.9001165993635172,1.0,8/13,27.19%,ADAT2;ALKBH8;TRMT9B;CTU1;MTO1;URM1;ELP4;ELP3
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6546853765270314,-1.3633304763650655,0.0967741935483871,0.9003958202429443,1.0,7/29,4.67%,DUSP4;LAMA3;COL12A1;DUSP2;COL4A2;MMP2;COL8A1
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.811693871419821,-1.3628053062624303,0.1568627450980392,0.8998619031524168,1.0,3/6,1.81%,SPRED3;SPRED2;SPRED1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.8576566557512435,1.3627288035947862,0.09375,1.0,1.0,2/6,1.15%,RAB34;MAPKAPK3
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.8089317390709645,1.362720308078079,0.11594202898550725,1.0,1.0,1/7,0.44%,TBX1
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.7700645821294358,1.3625685879478329,0.0625,1.0,1.0,5/18,10.28%,SGO1;SYCP1;IHO1;MEIOB;RNF212B
prerank,GO_Biological_Process_2021__positive regulation of epithelial tube formation (GO:1905278),0.9196838643749259,1.3621117198600652,0.01694915254237288,1.0,1.0,2/5,4.64%,SIX4;FGF2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.5799089037001279,-1.3609675718774086,0.13636363636363635,0.9066975246848485,1.0,4/33,6.87%,RFX6;GCK;DOC2B;CAPN10
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.8102489160044004,-1.3609629389004665,0.10810810810810811,0.904067766374026,1.0,1/8,0.34%,SKAP1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7455728173886615,-1.3593108232299818,0.15,0.9095802510726128,1.0,5/10,18.15%,NPTX2;DLGAP4;DLGAP1;DLGAP3;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.8411488665008154,-1.3593024281836195,0.11428571428571428,0.9069153667671438,1.0,2/9,9.22%,OSR1;COMMD1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.5917643041524112,-1.3590842713176423,0.06666666666666667,0.9052760870760733,1.0,4/28,6.48%,OSR1;TWIST1;PTCH1;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.49378086810599,-1.3587651822922853,0.03571428571428571,0.9041918582046414,1.0,20/91,14.38%,AOAH;METRNL;SIGIRR;CDH5;PRKCD;TYRO3;IFI16;GRID2;APOE;MEFV;TRIB1;CCN3;SERPINE1;PTPRS;SHARPIN;NR1D1;MVK;CRK;SMPDL3B;MAPK7
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.7285172500802284,1.3587220326305367,0.13846153846153847,1.0,1.0,3/12,17.19%,BLK;SYK;IL4
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.7965069827276929,-1.3579967563121507,0.12903225806451613,0.9055399528582124,1.0,2/11,3.86%,MT1G;IFI16
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.8410709576631277,1.3575396635180048,0.1111111111111111,1.0,1.0,2/7,13.43%,ANXA1;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.6023137879641833,-1.3573934018725484,0.10344827586206896,0.9060460513999946,1.0,10/26,14.00%,CD14;TYRO3;SARM1;RAB7B;PTPRS;TICAM2;DAB2IP;NR1D1;NLRP2B;SMPDL3B
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.7635954414590682,-1.3568881104393977,0.12121212121212122,0.9059254664707816,1.0,1/9,5.28%,APOE
prerank,GO_Biological_Process_2021__nodal signaling pathway (GO:0038092),-0.8301513349823246,-1.3568352145527363,0.13157894736842105,0.9034009398825781,1.0,1/5,4.61%,CFC1
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.7316995337634292,-1.3568255991055858,0.15,0.9007671179004131,1.0,2/5,12.39%,EGR1;NAB2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.7037098709001502,-1.35651757095167,0.17857142857142858,0.899797344236174,1.0,3/15,6.81%,ACER2;ACER3;DHFR
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.7378467961281349,-1.3564357481640166,0.21052631578947367,0.8976002251060707,1.0,2/10,7.29%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.6914435432258165,1.3561927883913734,0.08928571428571429,1.0,1.0,5/25,11.65%,ITGB2;ANXA1;CCL5;PIK3CG;SYK
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8287132783890796,-1.3561291365981512,0.10256410256410256,0.8962354086550465,1.0,2/6,9.93%,BUD23;METTL15
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.6958940299894968,1.3559834291169743,0.0684931506849315,1.0,1.0,5/28,11.13%,MICB;AIM2;TRAF3IP2;ZDHHC11;STAT1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5769042019224495,-1.3557842126683226,0.10810810810810811,0.8954913890323444,1.0,4/23,7.44%,SIGIRR;TYRO3;IFI16;TRIB1
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.8118256270955077,-1.3550976642528927,0.16279069767441862,0.8960554729187435,1.0,4/6,18.67%,DDAH2;ASS1;ALDH18A1;DDAH1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.6085087491968532,-1.3549943803755535,0.19444444444444445,0.893691118045553,1.0,9/24,16.39%,WWP2;CHAC1;BEND6;DLK2;ZBTB7A;NIBAN2;NEURL1;DLL1;TCIM
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7972431371793665,1.35468382898694,0.08571428571428572,1.0,1.0,4/11,14.93%,TBX1;WNT5A;STAT1;SOX9
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.8434820211557014,1.3543963728458237,0.05172413793103448,1.0,1.0,2/6,9.07%,TCF7;LEF1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.7345410231193368,1.3530874789492533,0.13333333333333333,1.0,1.0,2/10,5.45%,TNFRSF1B;TGFB1
prerank,GO_Biological_Process_2021__regulation of myoblast proliferation (GO:2000291),-0.8234121211051519,-1.3526335141234427,0.21428571428571427,0.9036558561380855,1.0,2/5,6.12%,KLHL41;MEGF10
prerank,GO_Biological_Process_2021__negative regulation of T cell apoptotic process (GO:0070233),0.8364410115893445,1.3525960302130273,0.07462686567164178,1.0,1.0,1/5,2.84%,CCL5
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.8432479779521149,1.3521345117450534,0.05970149253731343,1.0,1.0,3/8,10.49%,PTPRC;NFIL3;AXL
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.5862654085966889,1.3519567646072588,0.07407407407407407,1.0,1.0,11/90,7.70%,AQP3;SMAD6;ESR1;MICB;MAPKAPK3;ANXA1;WNT8B;TGFB1;HSD17B2;IL12A;SOCS2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.911004564849134,1.3518043825220463,0.03125,1.0,1.0,2/5,6.54%,LRP2;CD81
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6894291215834695,1.3517375561708844,0.07042253521126761,1.0,1.0,1/22,0.55%,ESR1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.5499767564590344,-1.3517324591153628,0.0967741935483871,0.9058481092070267,1.0,8/46,11.93%,GCK;NUP210;POM121C;NUP42;NUP214;AAAS;ZBTB7A;NOA1
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.808671967976326,-1.3516543056057242,0.11764705882352941,0.9036774931136844,1.0,2/6,10.73%,RPF2;NOL8
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6859963091225785,-1.3516064501195333,0.17142857142857143,0.9011978351979801,1.0,6/16,20.34%,CPSF1;ERN1;CSTF2;CPSF4;TSEN2;FAM98B
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.8707279099373493,-1.35120307840055,0.12195121951219512,0.9007348878404232,1.0,1/6,1.68%,UBASH3B
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.8215933901704682,-1.3511581110063982,0.14285714285714285,0.8984771948353669,1.0,1/7,2.58%,KMT2B
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.6819485567275082,-1.3511249418357947,0.1111111111111111,0.8960330404927678,1.0,3/11,11.55%,MT1G;AQP1;HSF1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.9127758965631992,-1.3509323208046216,0.021739130434782608,0.8917005796950315,1.0,2/5,6.36%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.9127758965631992,-1.3509323208046216,0.021739130434782608,0.8917005796950315,1.0,2/5,6.36%,PEX7;DHRS7B
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.7400805925911185,1.3507184385640767,0.14864864864864866,1.0,1.0,1/13,1.37%,CAVIN1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7956153193661709,1.3503975218819573,0.109375,1.0,1.0,3/10,2.43%,MYRF;ITGAX;TNFRSF1B
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.7399026956860423,-1.3502996040888162,0.1111111111111111,0.8923764275365619,1.0,4/10,19.77%,HSF1;TFCP2;C5AR1;MED1
prerank,GO_Biological_Process_2021__AV node cell to bundle of His cell communication (GO:0086067),0.8297741025434381,1.350277217479762,0.125,1.0,1.0,1/5,3.37%,GJC3
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.6015408447804771,1.3494858863291253,0.041666666666666664,1.0,1.0,19/59,19.48%,MICB;ADA;PTPRC;IFNK;LCP1;PIK3CG;NLRC3;IRF4;TNFSF4;CD44;MSN;ZAP70;IL4;CRTAM;ITK;CD4;CD8B;F2RL1;RASGRP1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),-0.8011809800748825,-1.3490513582245136,0.24324324324324326,0.8958055726413441,1.0,1/8,2.95%,HDAC10
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7212768730847126,1.349003708849429,0.1323529411764706,1.0,1.0,4/16,16.71%,SLC9A2;SLC5A2;SLC9C1;SLC5A1
prerank,GO_Biological_Process_2021__negative regulation of anion transport (GO:1903792),-0.8559936308488635,-1.3484596709695826,0.15789473684210525,0.8961913635308666,1.0,1/5,0.27%,GABRE
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8348459075552765,1.3482537366086178,0.017543859649122806,1.0,1.0,3/7,9.69%,IL12A;CDKN2A;SOD2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.7484942515142536,1.347759761918576,0.09375,1.0,1.0,6/15,10.26%,TBX1;MESP1;TBX6;IKZF1;GDF11;HCK
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.5773153071863744,-1.3476037315260947,0.125,0.8982592836163237,1.0,4/36,4.05%,IL7R;P2RY10;SELL;CD247
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7882394519115161,-1.3472686527069446,0.2222222222222222,0.8976596656804181,1.0,1/10,0.36%,GRP
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.639069336834096,-1.3466962197269101,0.034482758620689655,0.8983877660595229,1.0,2/12,12.50%,MPV17;SLC25A33
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6581843106103437,-1.3463394266048803,0.09375,0.8979464693596962,1.0,7/15,12.38%,SELE;PODXL2;SELL;CX3CR1;ITGA4;SELP;SELPLG
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.7397281444236783,1.3458287382985576,0.0625,1.0,1.0,3/17,2.43%,MYRF;ITGAX;TNFRSF1B
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6587069423436525,1.3458203886649827,0.08974358974358974,1.0,1.0,5/41,5.26%,SMOC1;MAB21L1;SIX4;HIPK1;FREM2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.7873232430617587,1.3453142883049356,0.09859154929577464,1.0,1.0,1/9,4.86%,C3
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.799100850753963,1.345237152642971,0.11864406779661017,1.0,1.0,2/8,11.65%,BLK;SYK
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.6482354862901314,1.3449870969160689,0.1111111111111111,1.0,1.0,8/37,15.19%,C3AR1;ACE2;SGCG;COL4A3;STAT1;TRDN;SGCZ;PLN
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7538128386070045,1.3448989737731383,0.140625,1.0,1.0,2/13,11.28%,STK26;RAPGEF6
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.7920102355070866,-1.3440505299176106,0.11764705882352941,0.9076964085063699,1.0,1/7,12.30%,CTPS2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.8202801640442592,1.3439580444149568,0.08771929824561403,1.0,1.0,1/8,0.44%,TBX1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7145225880918529,1.3436629183623021,0.1388888888888889,1.0,1.0,1/18,1.51%,CASQ2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.7445448120406861,-1.3427077696863132,0.2127659574468085,0.9120615546003705,1.0,3/9,11.02%,PAH;GSTZ1;KYAT1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.8654531752316541,1.3421140041738624,0.045454545454545456,1.0,1.0,2/7,6.54%,NFAM1;CD81
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.8493890927412079,1.341753681152909,0.046875,1.0,1.0,1/8,0.50%,CLEC5A
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.615867019207216,1.341690031062167,0.08108108108108109,1.0,1.0,1/56,0.01%,GPR62
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.7458256254177309,-1.341509920870503,0.1,0.9158635538620925,1.0,2/8,12.48%,ZNF703;GPX1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.9056539399588166,1.341328192051007,0.09259259259259259,1.0,1.0,1/6,1.38%,BLK
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.7518127216023689,-1.3413178746042966,0.10526315789473684,0.9143037582864262,1.0,2/12,4.53%,NRDE2;IWS1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.7894174677146457,-1.3410539791549156,0.21621621621621623,0.9105214569831345,1.0,1/5,1.63%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.7894174677146457,-1.3410539791549156,0.21621621621621623,0.9105214569831345,1.0,1/5,1.63%,PHLDB2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6569486196272059,1.3404857394568042,0.11428571428571428,1.0,1.0,8/27,14.27%,NRAP;ALPK2;HEY2;CAV3;MYH11;IGF1;CHRNB1;SGCZ
prerank,GO_Biological_Process_2021__meiotic sister chromatid segregation (GO:0045144),0.8591619876705703,1.3403052384264962,0.10909090909090909,1.0,1.0,1/5,0.71%,SGO1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8042384684852534,1.3398850659799009,0.08771929824561403,1.0,1.0,2/7,10.49%,BLK;AXL
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5840750541838206,-1.3396428623248149,0.13333333333333333,0.91470598976463,1.0,9/32,11.48%,NR4A1;CDH5;CDH13;PRSS3;CCN3;FSTL1;LPXN;CORO1B;EMP2
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.6840469863682868,1.339636723353624,0.045454545454545456,1.0,1.0,4/21,5.41%,LRAT;LRP2;CYP3A4;CYP4F12
prerank,GO_Biological_Process_2021__regulation of t-circle formation (GO:1904429),-0.8010782284127131,-1.3395947048114016,0.2391304347826087,0.9126338322702224,1.0,3/5,17.93%,SLX4;RTEL1;ERCC1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.49414522067957833,-1.3392263710842665,0.03225806451612903,0.9122408881184115,1.0,7/83,4.37%,GPR78;GPR3;ADGRG3;ADRA1A;ADRA1B;LGR5;ADCYAP1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.8571383792011439,1.3392247449875678,0.08771929824561403,1.0,1.0,1/7,0.27%,AQP3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.5841304421150801,-1.3391757267094837,0.11428571428571428,0.9100729227395502,1.0,9/21,23.38%,APOE;DLG5;SHANK1;NEURL1;DBNL;LRP8;CUX2;DHX36;NLGN1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8172153167053675,1.3386133941505791,0.06944444444444445,1.0,1.0,1/11,0.44%,TBX1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.7522621622429835,-1.3379965149549198,0.2,0.9139124486264637,1.0,4/11,10.07%,PLK3;CDK1;GBF1;STX5
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.6596740983734108,1.337909921186449,0.12121212121212122,1.0,1.0,5/21,19.01%,FGF2;TGFB1;PRR5L;DDR2;THBS1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.6275169745077104,-1.3377901387722642,0.11764705882352941,0.9122404858680411,1.0,5/26,13.01%,PRKCD;PID1;PTPRE;SLC27A4;AHSG
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.8661689831393045,1.337761523231947,0.03333333333333333,1.0,1.0,1/5,2.05%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.6022891107807703,-1.3374714011371116,0.11538461538461539,0.9113650986087005,1.0,6/15,19.83%,RAD50;SLX4;RTEL1;ERCC1;ATM;NBN
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.6544245863663035,1.3371044010766275,0.0625,1.0,1.0,10/25,19.13%,WNT5A;PTPRC;SASH3;CLCF1;SCIMP;CD244;TNFSF4;LACC1;DNAJB9;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.9459043572578405,1.3368654688538077,0.017857142857142856,1.0,1.0,1/5,3.01%,WNT5A
prerank,GO_Biological_Process_2021__lipid hydroxylation (GO:0002933),0.8916179162024498,1.3368517337169696,0.08620689655172414,1.0,1.0,2/5,4.01%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.624615896084612,-1.3366843239061645,0.06666666666666667,0.9130009306413579,1.0,5/17,12.86%,RNF168;PCGF1;KDM2B;PCGF6;RING1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.5297805757187624,-1.3360417072545663,0.07692307692307693,0.9136580024124976,1.0,14/40,20.39%,GCK;GLA;KHSRP;CRY1;WDTC1;AKR1C3;PROX1;SNAI2;FYN;PTGIS;OPN3;PGP;C1QTNF12;CLK2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6954000674086204,1.3359687628380739,0.13043478260869565,1.0,1.0,3/18,6.14%,LMOD3;LMOD1;SCIN
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.6815419913838175,1.3351742704189555,0.1875,1.0,1.0,2/14,7.70%,STAT5A;SOCS2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.7161798890159083,1.3349469162683472,0.11267605633802817,1.0,1.0,1/16,0.39%,NEK2
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6091204539944493,-1.3346410606201369,0.0625,0.9186286287529921,1.0,5/29,10.78%,ARC;APOE;EPHB2;RAB5A;SHISA7
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.7825510050077589,-1.3343060556129291,0.12121212121212122,0.9177828030920478,1.0,4/6,21.13%,NPHS1;JAG1;MAGI2;PODXL
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),-0.8594707345891126,-1.3342990453923094,0.06451612903225806,0.9153865033450712,1.0,2/6,5.28%,APOB;APOE
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.8487103608632393,1.334063384660297,0.03389830508474576,1.0,1.0,1/6,3.49%,PTX3
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6906984708592121,1.3319424100692623,0.07352941176470588,1.0,1.0,7/17,25.88%,BORA;GPSM2;PSRC1;RAE1;DCTN1;TACC3;ANKRD53
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5098800758090172,-1.3319307693049247,0.06451612903225806,0.9245601477326415,1.0,8/46,17.47%,SPRY4;FLNA;WASHC2C;CRK;LIMS1;CRKL;CSPG5;ABL1
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.8294645605304906,1.331840434792842,0.06779661016949153,1.0,1.0,3/7,10.92%,CCL5;SFTPD;TAFA4
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6751260833932724,-1.3317093755947982,0.16216216216216217,0.923410875221107,1.0,1/15,0.85%,CPSF1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.6776310589903722,1.3313035074305561,0.1111111111111111,1.0,1.0,10/29,19.42%,HSPA1L;HSPA8;CHCHD4;DNAJB1;SDF2L1;HSPA5;HSPE1;HSPA2;BAG1;DNAJB4
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8103562737471521,1.3312372989466634,0.08823529411764706,1.0,1.0,1/8,2.76%,ACE2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.615205504839109,1.3310730480770852,0.05128205128205128,1.0,1.0,16/53,24.41%,COX6A1;NDUFB11;NDUFS2;NDUFA2;NDUFB10;NDUFB4;NDUFB9;COX4I1;COX7B;COX6B1;COX6C;COX7C;UQCRFS1;NDUFA1;COX5A;NDUFB2
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.7417892072141138,-1.3310462895404753,0.20689655172413793,0.9242878990540054,1.0,3/8,21.47%,MID1;MAPRE1;CHAMP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.623036203142588,-1.3302245080559245,0.11904761904761904,0.925673330366038,1.0,4/35,4.95%,SPRED3;SPRED2;SPRED1;PARD3
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7400282787757986,1.328556662376543,0.0821917808219178,1.0,1.0,3/16,7.49%,MYRF;SOX10;PLP1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5749730403736035,-1.3285400460569066,0.15384615384615385,0.9322774316048459,1.0,6/33,13.22%,ENTPD2;ADPRM;DNASE1L1;RNASET2;NUDT18;PABPC4
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.6237164735244368,-1.3282044762072125,0.08823529411764706,0.9312294886035404,1.0,2/20,1.31%,GCK;G6PC3
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.8741050395546555,-1.3279901520799635,0.16666666666666666,0.9306232004207562,1.0,1/6,3.89%,HRH1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.8002870238695099,-1.327698294178393,0.0975609756097561,0.9298024309841489,1.0,2/6,7.64%,TST;CBS
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.8101247175689474,-1.3270085974640378,0.2,0.93075823970109,1.0,5/6,16.61%,SLC25A29;SLC38A5;SLC3A2;SLC36A4;SLC16A10
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.8380305363270336,1.3264489649823574,0.1346153846153846,1.0,1.0,1/5,10.33%,ALDOB
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.8287791586665116,-1.3262572237222,0.13157894736842105,0.9319978178278185,1.0,1/5,12.30%,CTPS2
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.8194219474655708,1.326000493070766,0.05263157894736842,1.0,1.0,1/9,0.93%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6687048359950404,-1.3258028256534748,0.11428571428571428,0.9320435120392928,1.0,4/14,23.35%,CPEB1;UNK;RBM24;DHX36
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.8080345508402909,-1.325661633194164,0.20930232558139536,0.9302582524922589,1.0,1/5,8.03%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7909608917117003,1.3255692687499698,0.16666666666666666,1.0,1.0,4/9,14.60%,APOLD1;TMEM100;VEZF1;BTG1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.6646974606546734,-1.3254500060621648,0.16666666666666666,0.9288400681054387,1.0,5/17,14.47%,PARD3;FSCN1;PATJ;MARK2;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.7777384917644153,-1.323612096076458,0.1794871794871795,0.9357150656775763,1.0,4/8,16.58%,PDE3A;RNF157;PDE3B;CDC34
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.6151824317159954,1.3231938279037345,0.03896103896103896,1.0,1.0,16/54,24.41%,COX6A1;NDUFB11;NDUFS2;NDUFA2;NDUFB10;NDUFB4;NDUFB9;COX4I1;COX7B;COX6B1;COX6C;COX7C;UQCRFS1;NDUFA1;COX5A;NDUFB2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta1 production (GO:0032908),-0.7994749693294433,-1.322588618056161,0.16666666666666666,0.9387079139177286,1.0,1/5,0.50%,TSKU
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.7059206576475207,1.3224462864045003,0.11940298507462686,1.0,1.0,5/18,18.75%,CCL5;DAZL;DDX3X;BOLL;UHMK1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.7776835283561913,1.3213451919668593,0.12698412698412698,1.0,1.0,2/10,13.25%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.7965933717953861,-1.3210053406843194,0.17073170731707318,0.944102252797238,1.0,1/5,6.39%,KDM7A
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6914608040278959,-1.3206244287577207,0.058823529411764705,0.9387497433805485,1.0,5/10,19.83%,EXO1;SMARCAL1;SLX4;ERCC1;NBN
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6914608040278959,-1.3206244287577207,0.058823529411764705,0.9387497433805485,1.0,5/10,19.83%,EXO1;SMARCAL1;SLX4;ERCC1;NBN
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6914608040278959,-1.3206244287577207,0.058823529411764705,0.9387497433805485,1.0,5/10,19.83%,EXO1;SMARCAL1;SLX4;ERCC1;NBN
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6967795327004734,1.3200130627508377,0.15254237288135594,1.0,1.0,5/18,11.90%,SLC22A3;ABCG2;ABCC2;ABCC11;SLC47A1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.781561589587439,-1.3200100747688917,0.21621621621621623,0.9397276291212795,1.0,2/6,9.80%,ADRA1A;NLGN2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.5112739811946988,-1.3197774282156516,0.06451612903225806,0.9384544759131865,1.0,15/51,25.36%,ADAMTS12;CAPN2;RAB7A;AFG1L;DAB2IP;MALT1;HTRA2;RSPRY1;MYLIP;CTSC;CTSV;TCIRG1;PRKN;SIAH2;CTSO
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.669625430130416,1.3196414559916567,0.10606060606060606,1.0,1.0,6/19,18.64%,PTPRC;SASH3;CLCF1;TNFSF4;IL4;DNAJB9
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8621824268002328,1.319376769061438,0.05357142857142857,1.0,1.0,1/6,0.50%,SMAD6
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.6515661822064319,-1.3189630020288663,0.1794871794871795,0.9403035162387626,1.0,8/15,29.10%,PCM1;CEP83;HOOK3;C2CD3;PIBF1;CSNK1D;CEP192;BBS4
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8117989916292492,1.3176801295893086,0.11666666666666667,1.0,1.0,1/7,0.50%,SMAD6
prerank,GO_Biological_Process_2021__ADP transport (GO:0015866),-0.7988823388855766,-1.3176154146437595,0.17777777777777778,0.9454262994614914,1.0,3/5,14.93%,SLC17A9;SLC25A42;SLC25A41
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.7894269766661516,-1.3175944109417614,0.1891891891891892,0.9432078991515249,1.0,1/7,4.15%,PDZD11
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.5495170505320239,-1.3172949900910265,0.12121212121212122,0.9422514725677398,1.0,7/41,11.15%,GCK;NUP210;POM121C;NUP42;NUP214;AAAS;ZBTB7A
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.6738049462676993,1.3162722600560968,0.09859154929577464,1.0,1.0,5/18,10.43%,ITGB2;TRIL;ITGAM;SCIMP;NR1H4
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6296067348578932,-1.3156528498470736,0.17647058823529413,0.9481986122816157,1.0,7/19,20.05%,TRIM71;PTPRZ1;KDM2B;PROX1;TAFA1;TAFA3;INSM1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.6917335410556409,1.3156363880960893,0.13432835820895522,1.0,1.0,7/18,23.27%,DAB2;CHMP3;MSN;MAPK3;DENND10;MAP2K1;RAB21
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),-0.7683003009885905,-1.3149093967530057,0.14634146341463414,0.9497938377666878,1.0,1/6,1.38%,METRNL
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7469468981299074,-1.314778233522989,0.22857142857142856,0.9480003901480968,1.0,2/6,4.94%,DNMT1;SMARCB1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.6204553323888259,-1.3144736647517417,0.16129032258064516,0.9472481091030224,1.0,1/19,0.63%,RASSF2
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.6502281872802405,1.3139810796704636,0.125,1.0,1.0,4/26,10.37%,MGST1;ABCG2;SLC26A6;SLC13A4
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.5727793300048071,-1.3132673137348805,0.17857142857142858,0.9511342938226517,1.0,11/39,17.37%,SLC25A29;SLC38A5;SLC6A20;ABCC8;SLC3A2;PKD2;SLC7A5;TRPM2;SLC6A9;SLC36A4;PKD2L1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6629208084414813,1.3131154659180169,0.1076923076923077,1.0,1.0,12/42,16.16%,TBX1;LOX;FLT1;HEY2;TGFB1;FLT4;ID1;CYP1B1;AGGF1;SYK;RASA1;ANGPTL3
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.8591488313520548,-1.3129627782202824,0.13333333333333333,0.9476438441703056,1.0,1/5,4.44%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.8591488313520548,-1.3129627782202824,0.13333333333333333,0.9476438441703056,1.0,1/5,4.44%,PAPSS2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.8562364404099599,1.312756269204475,0.06060606060606061,1.0,1.0,1/6,0.92%,NOX5
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.8176011041335669,1.312367005552236,0.10606060606060606,1.0,1.0,2/7,11.53%,WAS;RHOU
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.801999602212477,-1.3122376110721679,0.2682926829268293,0.9494900706425925,1.0,3/6,18.43%,SERPINB9;CARD9;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.7951079011699814,1.3121321414564124,0.11594202898550725,1.0,1.0,1/7,3.01%,WNT5A
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.5062212062726945,-1.3120720529622727,0.05555555555555555,0.9481311888418824,1.0,5/80,2.82%,ADGRF4;EHF;CLDN4;LAMA3;ESRP1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.8745182954574251,1.311246498424005,0.07462686567164178,1.0,1.0,2/6,6.54%,C1QB;CD81
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.46532695698813836,-1.3108607105402146,0.047619047619047616,0.9515617192635267,1.0,33/182,15.50%,DUSP4;EPHX2;FBP2;GCK;G6PC3;DUSP15;BCKDK;ACYP2;PTPRB;THNSL2;PLA2G2C;PNKP;PLA2G5;EPHB2;PPIP5K1;PLA2G4C;PFKFB3;PFKP;ALPL;PLCZ1;AGPAT2;PLPP2;LPL;GK5;PLPPR3;G6PD;GFPT2;LHPP;NT5C;XYLB;ITPK1;PPP1CA;ITPKA
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.775782886400277,1.3108072907538293,0.1111111111111111,1.0,1.0,1/12,1.98%,RORC
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7684319528169058,1.310681660301272,0.14285714285714285,1.0,1.0,1/10,0.92%,ITGB2
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.7751454049202542,-1.3106240699700695,0.1935483870967742,0.9505427834278071,1.0,2/8,13.63%,DDX11;SPIDR
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),0.8510263904982888,1.3104708159034566,0.06666666666666667,1.0,1.0,2/5,9.07%,TCF7;LEF1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.621668850580688,1.309880788498199,0.05714285714285714,1.0,1.0,13/49,17.71%,ANXA1;CCL5;PTPRC;CD81;HLA-A;CD80;IL7;TNFSF4;HLA-DPB1;PDCD1LG2;ZAP70;IL4;SIRPG
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6967612394492144,1.309740426323791,0.16923076923076924,1.0,1.0,4/20,13.83%,BUB1;SHCBP1L;PIF1;RMI2
prerank,GO_Biological_Process_2021__positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),0.873178757688926,1.3090045384147602,0.04918032786885246,1.0,1.0,1/5,2.05%,ANXA1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.7537954340390777,1.3081381353734889,0.1388888888888889,1.0,1.0,2/13,4.59%,TULP1;RP1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.8178768987705728,-1.3078131785874993,0.23684210526315788,0.9606356804749552,1.0,1/5,5.61%,MTHFR
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.5429607836874754,1.3070556907337978,0.07692307692307693,1.0,1.0,25/150,10.99%,OLFML1;TBX1;TIMP3;CAVIN1;C1QTNF1;STEAP4;TLR2;ADAM33;APOL6;ACOX2;LMOD1;AOX1;LOX;ECM2;C3;ACTA2;NQO1;DAB2;CYP1B1;DCN;ADRB1;ANGPTL2;COL1A1;ADGRL4;CFD
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.5905129214715864,1.3068786648365516,0.10666666666666667,1.0,1.0,11/45,18.26%,ANXA1;CCL5;PTPRC;IGF1;CD80;SYK;TNFSF4;HLA-DPB1;PDCD1LG2;IL4;AGER
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6509759542525702,1.3064118601656973,0.1232876712328767,1.0,1.0,4/29,8.88%,GATA4;CCDC39;MESP1;TBX6
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6432771914433163,1.3063947831220337,0.1267605633802817,1.0,1.0,5/23,15.20%,AQP3;CYP4F12;RAB11A;AQP4;ADCY7
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.6984231612041151,1.306212661459944,0.1016949152542373,1.0,1.0,1/18,0.55%,ESR1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.6507183764763703,1.3059203709934826,0.125,1.0,1.0,7/20,18.35%,CCL5;IL12A;JAM2;PLA2G7;IL4;AGER;CREB3
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6019139163624885,1.3053213490145306,0.2,1.0,1.0,5/34,15.25%,ESR1;GPER1;KDM3A;UBE3A;WBP2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.7797932261408853,1.3052314628095518,0.1774193548387097,1.0,1.0,3/9,6.87%,AMBP;ABCG2;ABCC2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.7797932261408853,1.3052314628095518,0.1774193548387097,1.0,1.0,3/9,6.87%,AMBP;ABCG2;ABCC2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7259665814001139,1.3051103317380668,0.16129032258064516,1.0,1.0,3/12,9.34%,ANXA1;GPER1;REST
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.797388491923047,1.3050389467681287,0.140625,1.0,1.0,3/5,15.98%,FLI1;P2RY12;VWF
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.6726368938505768,1.3042882667986448,0.136986301369863,1.0,1.0,3/22,5.23%,MYBPH;MYBPC3;NMUR2
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.7661346902865127,-1.3038134977563487,0.15,0.9779891100834157,1.0,3/6,19.77%,TFCP2;C5AR1;MED1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.7311643245938574,-1.3032781738562547,0.19230769230769232,0.9779563881675397,1.0,7/11,19.54%,KIT;SERPINB8;CCN3;CAMSAP3;DSP;JUP;VCL
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.6411756201328502,-1.3027752696457982,0.15625,0.9782255044638322,1.0,1/15,0.70%,ADRA1A
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.7992611707133777,-1.3026609681974135,0.14705882352941177,0.9744895191141467,1.0,2/5,10.98%,GAS2L2;MAPRE1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.7992611707133777,-1.3026609681974135,0.14705882352941177,0.9744895191141467,1.0,2/5,10.98%,GAS2L2;MAPRE1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.8042512381946759,1.3021236563325107,0.14285714285714285,1.0,1.0,2/6,8.62%,TLR2;PRDX4
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.5830342534898312,-1.3020027588083405,0.15151515151515152,0.9750644373824581,1.0,13/38,24.93%,PRKCD;PID1;PTPRE;SLC27A4;SNX5;AHSG;SIK2;C1QTNF12;PIP4K2B;PTPN2;GKAP1;SORL1;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8136661361649583,1.3019685259945575,0.125,1.0,1.0,2/10,3.08%,BLK;PTPRC
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6343821721841192,-1.3009822746179647,0.16129032258064516,0.9772305690848349,1.0,4/11,10.73%,LIPC;APOE;ALB;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.7212318006375454,1.30091505187061,0.12162162162162163,1.0,1.0,2/14,3.35%,GPR55;LILRB3
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.5970939163046592,1.3007316647697105,0.08108108108108109,1.0,1.0,18/70,13.08%,ST6GALNAC1;CAPN13;STEAP4;SCGB3A2;PLEKHS1;AHR;SFTPA1;ITGB6;SYT2;SFTPD;VSIG2;CYP4F12;SMIM22;MUC4;DUOX1;TMC4;TRIM29;FOXM1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.6277203118365156,-1.3003909210734756,0.16129032258064516,0.9772994645656853,1.0,7/19,15.55%,BUD23;NSUN4;TFB1M;METTL15;MRM1;ZCCHC4;FBL
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.8209381643513565,-1.3003163684879557,0.11764705882352941,0.9752196866683536,1.0,4/7,9.99%,TESMIN;CLDN16;LETM2;SLC4A11
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6573552544176441,-1.3000862527664414,0.17857142857142858,0.9742377475202113,1.0,2/17,13.01%,CDH5;LLGL1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5466577860534996,-1.2999228196663928,0.13333333333333333,0.9727339937255154,1.0,3/34,8.85%,PTCD2;IWS1;SAFB2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.591832385125802,1.2992831228548005,0.07894736842105263,1.0,1.0,6/65,7.23%,SLC22A3;GAD1;HSPA8;SLC18A2;SLC17A8;SLC6A4
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.7123192979501864,-1.2992735893020295,0.16,0.9734691009705719,1.0,1/14,1.16%,ENTPD2
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5534151411829253,-1.2992728268583655,0.08823529411764706,0.9712209044325336,1.0,5/37,8.80%,NUP210;POM121C;NUP42;NUP214;AAAS
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.8090075381430354,-1.299084148416462,0.2222222222222222,0.965643903325869,1.0,3/5,9.34%,NOP9;TBL3;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.8090075381430354,-1.299084148416462,0.2222222222222222,0.965643903325869,1.0,3/5,9.34%,NOP9;TBL3;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.8090075381430354,-1.299084148416462,0.2222222222222222,0.965643903325869,1.0,3/5,9.34%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7835146858137021,1.2987457251126548,0.1694915254237288,1.0,1.0,1/7,7.70%,SOCS2
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6497824116398865,-1.298685271414698,0.1590909090909091,0.9648293917638129,1.0,4/13,2.98%,TPH1;PAH;HDC;MOXD1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.751238681953488,-1.298514891118904,0.1282051282051282,0.9633387783980764,1.0,5/12,16.71%,WWC1;DLG5;WWC2;VGLL4;MARK3
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.7670423142630021,1.2983897886468823,0.11864406779661017,1.0,1.0,2/12,6.51%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.7006536883370524,-1.2983837267101284,0.25925925925925924,0.9620164494262048,1.0,1/8,2.99%,TEFM
prerank,GO_Biological_Process_2021__progesterone metabolic process (GO:0042448),-0.8241949407293543,-1.298259546903659,0.1951219512195122,0.9605712299093413,1.0,3/5,13.81%,AKR1C3;CYP46A1;AKR1C1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6247725498025045,-1.2974659361444556,0.21621621621621623,0.9621870245883144,1.0,2/13,15.40%,PPP5C;PPP1CA
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.6000696612192599,-1.2973334971811066,0.16666666666666666,0.9607800380766695,1.0,11/17,27.97%,PKD2;TGFBR3;PHF2;PROX1;NF1;PRKCSH;CEBPA;COBL;NIPBL;WNT4;ARID5B
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.7429553067784063,-1.2970333005945176,0.16666666666666666,0.9559278925305073,1.0,1/6,0.57%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.7429553067784063,-1.2970333005945176,0.16666666666666666,0.9559278925305073,1.0,1/6,0.57%,TACR3
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.7429553067784063,-1.2970333005945176,0.16666666666666666,0.9559278925305073,1.0,1/6,0.57%,TACR3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.6553713974614259,1.29652690016179,0.13432835820895522,1.0,1.0,1/25,0.44%,RAB34
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8759190920601932,1.295928306109288,0.07462686567164178,1.0,1.0,3/5,5.64%,C1QB;C3;ITGAM
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.7020377372633372,-1.2957503140300748,0.21875,0.9597931988661459,1.0,4/12,18.77%,TTC21A;CILK1;DYNC2I1;IFT43
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.7483563536790884,1.295553685242423,0.0967741935483871,1.0,1.0,3/14,4.93%,ESR1;FGF2;FLT1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.7016964766403525,-1.2954598235308248,0.1388888888888889,0.9589465565909134,1.0,3/14,13.09%,ENTPD2;ADPRM;NUDT18
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.49249576686557817,-1.2954011642670258,0.043478260869565216,0.9569643000408786,1.0,23/169,9.79%,DUSP4;IL7R;NR4A1;FOS;BCL6;BCL2A1;EGR1;JUNB;DUSP2;MSC;CFLAR;NR4A3;KLF10;PHLDA2;SERPINB8;TRIB1;CCN1;HES1;PTPRE;SERPINE1;PFKFB3;FOSL1;TGIF1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.616926539732569,1.2950625406512422,0.13043478260869565,1.0,1.0,7/34,7.56%,RASGRP4;ESR1;GPR55;LPAR1;FGF2;FLT1;P2RY6
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6391452262682403,1.29487412284447,0.15151515151515152,1.0,1.0,4/20,8.49%,CYP4F12;LPIN3;CYP26B1;LDHD
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.7144689873060153,-1.2945068632068208,0.24324324324324326,0.9588119734902683,1.0,3/8,11.45%,RNF113A;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7317177978941025,-1.2942037019463644,0.2857142857142857,0.9581937201555847,1.0,2/9,5.50%,KIT;KITLG
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.7419050252829157,-1.293820431373702,0.23076923076923078,0.958049798025325,1.0,2/7,10.93%,SLC27A2;SLC27A4
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.6307070018694665,1.2936706407385512,0.16176470588235295,1.0,1.0,5/30,5.45%,GATA4;SMAD6;TNFRSF1B;HEY2;TGFB1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5761172956976736,-1.2934483750082475,0.1111111111111111,0.9574359665537703,1.0,6/33,13.08%,PLK3;MRRF;CDK1;GBF1;STX5;ATG2A
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.6277863526520665,-1.2932068223408086,0.17857142857142858,0.9562614362369886,1.0,1/24,1.08%,SYNJ2
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.8081920091568549,-1.29192459156338,0.22727272727272727,0.9595894234957166,1.0,4/5,16.37%,ASCL1;MNX1;DLL1;POU3F2
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.8362039391569153,-1.2910876316668092,0.10526315789473684,0.9608148672123213,1.0,1/5,3.52%,KIT
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.5069640527379226,-1.2910183775950959,0.07692307692307693,0.9589876682050914,1.0,9/65,12.61%,ARC;TST;MAGOHB;POM121C;NUP214;SRRM1;SRSF4;NXF5;U2AF2
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.6638255720353027,1.2910080958938495,0.11428571428571428,1.0,1.0,3/22,4.99%,TBX1;LRP2;HEY2
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.6072529908294283,-1.2907886583589234,0.16666666666666666,0.9580061820157192,1.0,6/10,27.00%,ZBTB7A;G6PD;MED1;ABCB10;ALAS1;DMTN
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.7125683142854399,1.29066714763979,0.1794871794871795,1.0,1.0,5/17,16.01%,C3AR1;C3;NT5E;PSTPIP1;TXNIP
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.771247267359528,1.2903660865791888,0.1506849315068493,1.0,1.0,3/9,8.30%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.7834716230622896,1.290003501300342,0.18181818181818182,1.0,1.0,1/6,6.06%,IL12A
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),0.8087054467092547,1.2896571247078588,0.13725490196078433,1.0,1.0,1/5,3.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),0.8087054467092547,1.2896571247078588,0.13725490196078433,1.0,1.0,1/5,3.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.6651500531727181,1.2892796983158594,0.1076923076923077,1.0,1.0,9/28,21.32%,SLC9A2;SLC26A6;ATP6AP1;SLC4A1;ATP1A4;SLC9C1;LACC1;SLC9B1;SLC4A2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.5693033874037685,1.2888895416508948,0.10810810810810811,1.0,1.0,36/78,19.37%,OIT3;SLC28A1;LECT2;ITIH2;RORC;ABCC6;BHMT;IYD;TSHR;CYP3A4;CYP3A5;FMO5;CYP4F12;SLC10A1;HSD17B2;TMEM45B;SLC6A4;SLC22A7;DIO1;ALDOB;NR1H4;KLB;SMLR1;C4BPB;SLC15A1;KNG1;ANGPTL3;SLC5A9;PLG;PON3;ACKR2;SLC23A1;SERPINA10;HNF1A;ASGR1;PDZK1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6534890698440633,1.2888862831833772,0.14925373134328357,1.0,1.0,4/23,5.45%,PKP2;MYBPC3;LRP2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7078403631833556,1.2888418875614849,0.10606060606060606,1.0,1.0,3/13,20.40%,HSPA5;DNAJB9;WFS1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.5744474289886814,1.2887845693663555,0.11842105263157894,1.0,1.0,18/75,6.10%,CLEC5A;C1QB;ITGB2;C3AR1;TLR2;ITGAX;TNFRSF1B;LILRB3;FCGR3A;SASH3;GPIHBP1;VSIG4;ITGAM;NFAM1;PTAFR;FGL2;CLEC12A;ADGRE1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6184968202924127,1.2886853364868434,0.12121212121212122,1.0,1.0,5/28,11.79%,GALNTL5;TOPAZ1;SYCP3;JAM2;MEIOC
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.6899297975540364,-1.2883934205508414,0.1724137931034483,0.9679883923817795,1.0,3/9,9.89%,GBP2;GBP4;BATF2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.7635222110156781,1.2882187099207634,0.1506849315068493,1.0,1.0,3/8,12.38%,BACE2;ITM2A;ITM2C
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.7339782633291819,1.2880693207807585,0.15384615384615385,1.0,1.0,3/8,19.01%,TGFB1;DDR2;THBS1
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.7082755704144951,-1.2879595766553567,0.21621621621621623,0.9677329655271422,1.0,6/8,26.01%,KYAT1;KYAT3;AADAT;ACSM1;ACAA1;KMO
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.6983187612643605,-1.2878392653839663,0.15555555555555556,0.9660915609640958,1.0,3/8,21.48%,ST3GAL2;ST3GAL4;PARN
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.7067706275374662,-1.2877901936162603,0.3125,0.9641804615837188,1.0,2/11,9.81%,NAA40;METAP2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.6475272803039512,1.2876335545918565,0.1,1.0,1.0,7/27,15.65%,NOTUM;PTPRC;CYP26B1;RPL13;RANBP3L;TGM2;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.7459377491205996,1.2875671779579312,0.13114754098360656,1.0,1.0,3/7,13.43%,VSIR;IL12A;TNFSF4
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.8497402978658597,1.2873587033603167,0.13793103448275862,1.0,1.0,2/6,10.11%,GATA4;NPY
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.744624147886926,1.2866672598705322,0.125,1.0,1.0,2/13,3.01%,CCL5;WNT5A
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.49982297337086984,-1.2863640942263685,0.08695652173913043,0.969060290123056,1.0,6/40,10.98%,KIFC1;MAP10;AAAS;FLNA;KIFC2;KIF4B
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.753509162392019,1.2854835609523516,0.16901408450704225,1.0,1.0,3/12,11.84%,WNT5A;TGFB1;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.806824583431975,1.2850555540951856,0.13114754098360656,1.0,1.0,3/6,14.98%,IRF1;TNFSF4;GLI3
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.7346377989060515,1.284679828852796,0.14285714285714285,1.0,1.0,4/10,21.70%,CDKN2A;HMGA1;HMGA2;B2M
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.5539730175013764,-1.2845085024462766,0.15,0.974592777583543,1.0,6/28,6.28%,P2RY10;SKAP1;KLRC1;SELL;CD247;LTB
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.6931665952403677,1.2841294016391998,0.12698412698412698,1.0,1.0,2/19,3.84%,MCUB;STOML2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.749504026850631,1.284023243674557,0.15873015873015872,1.0,1.0,3/15,8.73%,FGF2;FLT1;COL4A3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.6804373423502321,-1.2837918116823508,0.28125,0.97554820789803,1.0,2/11,6.16%,MTHFR;MYOCD
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.759171636957828,1.2837197169659897,0.11267605633802817,1.0,1.0,4/8,23.33%,ACE2;ATP6AP2;MME;CTSZ
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.759171636957828,1.2837197169659897,0.11267605633802817,1.0,1.0,4/8,23.33%,ACE2;ATP6AP2;MME;CTSZ
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.7775850908939791,-1.2835654254993794,0.2558139534883721,0.9747004571323078,1.0,2/5,15.25%,SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.6520354514707553,-1.2835217015846887,0.13157894736842105,0.9727913890839774,1.0,10/17,29.65%,PCM1;CEP83;HOOK3;GOLGB1;C2CD3;PIBF1;CSNK1D;CEP192;BBS4;NUDCD3
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.7872841469989632,-1.2834940311355265,0.25,0.9708904969159398,1.0,2/6,9.80%,NLGN3;NLGN2
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),-0.7578878742547654,-1.2826012531957784,0.2777777777777778,0.9727545902485062,1.0,1/6,3.90%,NR4A3
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6718833949599277,-1.282529780907227,0.14705882352941177,0.9710735114156858,1.0,7/14,15.25%,DDX11;SMARCB1;MACROH2A2;SMARCA4;SIRT7;MARS1;PIH1D1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.6805088291564015,-1.2822987093660303,0.1891891891891892,0.9699124480574643,1.0,1/10,0.92%,TYRP1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6510633362714491,-1.2821033427908537,0.2,0.9687864192027494,1.0,3/14,11.55%,MT1G;AQP1;HSF1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7704292552672669,-1.2820854341185903,0.09090909090909091,0.9668240271563562,1.0,1/7,3.91%,LIN28B
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.8211905569463485,-1.281594781414989,0.21428571428571427,0.9671182082954215,1.0,2/5,9.41%,NEU4;NEU3
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.7834535566238137,-1.2813815799754709,0.15384615384615385,0.9658855461676811,1.0,1/5,6.46%,UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.484233860014125,-1.2813197019714477,0.041666666666666664,0.9641506107954345,1.0,10/80,11.55%,GPR3;PER2;ELOVL6;ADCYAP1;PPARGC1B;GNAS;ALMS1;HDAC3;PEMT;HSF1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6697157773529949,-1.2811043170020049,0.17647058823529413,0.9631080908281265,1.0,1/12,1.52%,DNMT1
prerank,GO_Biological_Process_2021__glycerol transport (GO:0015793),0.8302443684186976,1.2810882778278392,0.15789473684210525,1.0,1.0,1/5,0.27%,AQP3
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.7790136777485142,1.281081317921829,0.140625,1.0,1.0,1/11,0.93%,SLC22A3
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.6517954730267588,-1.2810318884376237,0.2222222222222222,0.9614754294587923,1.0,2/14,3.40%,CDH5;F11R
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.807154982880518,1.2804964789920146,0.12698412698412698,1.0,1.0,1/7,0.47%,ENPP2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.7088316391487676,-1.2803899042158509,0.20454545454545456,0.9623709917290361,1.0,4/11,14.38%,ASS1;PKD2;HDAC3;MAPK7
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell chemotaxis (GO:2000510),0.7879286922858777,1.2802098666445887,0.14035087719298245,1.0,1.0,1/5,6.06%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.5507941160067009,-1.2800450482163894,0.11538461538461539,0.9619603481544307,1.0,4/36,5.72%,SPRY4;ACER2;PTPRO;FZD7
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.5758873236230172,-1.2799644349602586,0.25,0.9602221226789328,1.0,4/25,6.39%,NAA40;FOXO1;ESCO2;DSCC1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.48669592982573057,-1.279307061020975,0.08695652173913043,0.96090835594486,1.0,4/82,1.65%,NGF;RASSF2;IL11;WNT3A
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.5975202074120017,-1.2790197920077708,0.12,0.9603267991335277,1.0,9/30,11.38%,SYNJ2;WNT3A;NLGN3;WNT7A;PLD2;SNCB;NLGN2;RAB5A;CEL
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.63361882137497,-1.2787953009496784,0.16129032258064516,0.9596595813290637,1.0,5/16,14.76%,PNP;PRPSAP1;RRM2;RRM2B;GART
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5515115105851401,-1.2786577127939298,0.08333333333333333,0.9581748406969706,1.0,8/32,16.06%,CPSF1;LSM10;TTF2;SNRPB;SYMPK;CSTF2;CPSF7;PCF11
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.5264749500991273,-1.2783865597153476,0.08333333333333333,0.9578363997230861,1.0,13/68,14.81%,TBC1D10A;TBC1D16;IFT88;DCDC2;TRAPPC12;TBC1D22B;TBC1D2;ALMS1;RAB5A;TBC1D8;NPRL2;SDCCAG8;RABEP2
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.4611839374542562,-1.2782134353911483,0.15,0.9568283229877645,1.0,29/115,22.24%,PLK3;COG4;MYO18A;STX6;UBXN2A;TRAPPC12;GOLGA8A;CDK1;TMED4;FAM174B;GBF1;TICAM2;STX5;ZNF501;BLZF1;GOLGA8B;COG7;TRAPPC11;PLK5;DNAJC28;UBXN2B;GOLGB1;GCC2;CUL7;COG2;ATP8B2;TMED3;NSFL1C;PRMT5
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.4810657156853669,-1.2780496375704784,0.07692307692307693,0.9553585422740235,1.0,23/74,19.74%,SLITRK6;S100B;PARD3;SPTBN4;WNT7A;DHFR;EPHB2;RTN4RL2;SLITRK2;TAOK2;LLGL1;FGFR2;MARK2;DSCAML1;ARHGAP35;PARD6B;CDK5;PAK3;MTR;BRSK1;RAB10;DRD2;MAPT
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.5513261146983699,-1.2778941051727413,0.2727272727272727,0.9539528964174501,1.0,1/35,0.22%,NOX4
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.6466523180720228,-1.27715937121415,0.27586206896551724,0.9532422798766768,1.0,1/15,0.62%,MLPH
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.6466523180720228,-1.27715937121415,0.27586206896551724,0.9532422798766768,1.0,1/15,0.62%,MLPH
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.8654230011940027,1.2768657993870216,0.15517241379310345,1.0,1.0,1/5,3.01%,IHO1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.7551205136091704,1.2768068256036147,0.09523809523809523,1.0,1.0,1/14,1.38%,BLK
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.6696264999970029,-1.2763812246441912,0.17647058823529413,0.9549683624090093,1.0,3/13,10.44%,CFC1;ACVR1;GDF7
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7903284529071197,-1.275845298086413,0.2765957446808511,0.9553905572083293,1.0,3/6,9.84%,SLC6A17;SLC3A2;SLC7A5
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.44317899228886076,-1.2752816992036569,0.058823529411764705,0.9559260828558067,1.0,21/123,12.43%,RFX6;CNGA3;ARX;VWA5B2;ADCYAP1;CFC1;SLC17A6;ELAVL3;ABCC8;LHFPL4;TTBK1;INA;KCNIP1;HPCA;KCNB2;ADGRA1;TAGLN3;ALCAM;GRIA4;PCSK1;CELF4
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6784731980539025,1.2750174750256347,0.1527777777777778,1.0,1.0,6/17,19.15%,CASQ2;CASP7;HTR1B;CRHBP;TGM2;RYR3
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.5780121605320011,1.2748112695552218,0.14473684210526316,1.0,1.0,6/49,13.90%,ITGB2;TGFB1;CD81;RAMP3;SYK;LDLRAP1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6895471994773495,-1.274518699264668,0.1282051282051282,0.9570334940041063,1.0,3/12,11.24%,CLDN4;AKR1C3;KLHL3
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.7476528398309641,-1.2736321823293932,0.2,0.958652035288839,1.0,4/8,16.80%,PLA2G5;PLIN5;FGFR2;RHOA
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.7232179594426679,1.273463869772878,0.2,1.0,1.0,2/13,4.99%,TBX1;HEY2
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),0.8069097653419639,1.2732284279943362,0.1896551724137931,1.0,1.0,3/7,17.62%,NPR2;GUCY2F;NPPA
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.6211282820340367,-1.2726496394980447,0.13513513513513514,0.9605213326972531,1.0,2/19,6.44%,GANC;MAN1A1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.7567151834510359,-1.2725537670678195,0.14634146341463414,0.9589310473059522,1.0,2/5,19.05%,ASCL1;CHD5
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.49852320051258564,-1.2723870784105038,0.125,0.9576318699771676,1.0,4/55,6.84%,RFX6;GCK;VGF;CRY1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.7004445933462321,-1.2721279399832401,0.1891891891891892,0.9568493711944521,1.0,3/11,6.81%,MTHFR;MTHFD1L;DHFR
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7969958776198552,-1.271741572391848,0.2702702702702703,0.9565237343887892,1.0,2/6,17.29%,PEX14;ETF1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.8139243936663444,-1.2709799226294403,0.13953488372093023,0.9560175791898329,1.0,3/8,13.17%,APOE;CEL;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.8139243936663444,-1.2709799226294403,0.13953488372093023,0.9560175791898329,1.0,3/8,13.17%,APOE;CEL;CYP46A1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell apoptotic process (GO:0034392),-0.8145895387993278,-1.2709655633554076,0.18604651162790697,0.9541451369338592,1.0,2/5,1.52%,APOH;DNMT1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.7564671711076818,-1.2704541050614553,0.2857142857142857,0.9545589128599318,1.0,1/6,4.31%,MAML1
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.8187907952293599,1.2704224788948135,0.21428571428571427,1.0,1.0,1/5,10.81%,EIF6
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5475039615981532,-1.2702282655418304,0.15384615384615385,0.9533425565699939,1.0,14/60,14.75%,NGF;VWC2;DTX1;ASCL1;HES1;PCP4;BEND6;MMD2;NEUROD2;BIN1;CDK5RAP2;BRINP1;IMPACT;DLL1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7647811684645877,1.2700904611462285,0.1864406779661017,1.0,1.0,2/7,10.78%,BOK;TP53BP2
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.8233339229669054,1.2700326056562288,0.12903225806451613,1.0,1.0,1/6,2.96%,ARHGAP24
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.6467195626113857,-1.2697379289167154,0.22580645161290322,0.9517632401849728,1.0,1/14,0.62%,MLPH
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.6467195626113857,-1.2697379289167154,0.22580645161290322,0.9517632401849728,1.0,1/14,0.62%,MLPH
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.7321629095156456,-1.269221316675792,0.2,0.9520947118191939,1.0,5/6,24.98%,TENT4A;LARP4B;ELAVL4;RBM24;METTL16
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.8510127379219466,1.2688695539945882,0.13559322033898305,1.0,1.0,3/6,13.64%,PLEKHH2;SCIN;VIL1
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),-0.8144293115768854,-1.2678394034438358,0.18421052631578946,0.955739843305091,1.0,1/6,1.54%,COL13A1
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.7454616226413934,1.267637355081565,0.13636363636363635,1.0,1.0,1/11,0.27%,GATA4
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.7573023857605492,1.2676320639250884,0.15151515151515152,1.0,1.0,3/9,14.59%,SP100;IFIT1;ISG15
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.6737657940310412,1.2676044028788864,0.13846153846153847,1.0,1.0,6/16,11.88%,ESR1;SSTR1;H2AZ1;GPER1;RAMP3;CRHBP
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),0.7823524691323345,1.2673899483411613,0.22413793103448276,1.0,1.0,2/6,17.32%,PRDM12;MYB
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.6286655373131933,1.2672461106848663,0.07352941176470588,1.0,1.0,4/26,4.69%,PTPRC;C17ORF99;SASH3;CLCF1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6287762183471363,1.2671880234368162,0.12121212121212122,1.0,1.0,9/23,25.70%,DAO;ABHD14B;LIAS;GNMT;GRHPR;BPNT2;SULT4A1;SULT6B1;SULT2A1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.8182027455060271,-1.2671311339692435,0.24390243902439024,0.9570074927518676,1.0,3/5,12.34%,LIPC;APOE;LPL
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.747790710184165,-1.2665961131952206,0.19047619047619047,0.9577984681980779,1.0,4/6,21.99%,SNX33;RHOA;SNX9;SNX18
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.6524510698004626,1.2665231580245395,0.234375,1.0,1.0,2/13,8.27%,PHKA1;PHKG1
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.7852441506296887,1.266365160426933,0.1,1.0,1.0,2/6,6.20%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.7786461003746179,1.2663270709617167,0.18840579710144928,1.0,1.0,3/10,14.93%,TBX1;STAT1;SOX9
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.7174394872632543,-1.2657578907372966,0.20588235294117646,0.9594725491736421,1.0,2/9,5.64%,KIT;PDZD7
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.6417776144183301,1.2657162433640654,0.15584415584415584,1.0,1.0,1/32,0.55%,ESR1
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),-0.7509008431672649,-1.2657144801077835,0.3157894736842105,0.9578233492639088,1.0,3/5,19.30%,FGFR2;RAB26;IGSF3
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.5291495077543855,1.2656501066880037,0.04819277108433735,1.0,1.0,71/145,28.81%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;MRPL34;EEF1A1;RPL36;RPS27A;RPS19;RPL41;GGT5;CARNS1;YARS2;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;COPS5;RPSA;RPL7A;RPS13;RPL11;RPS7;RSL24D1;RPL23A;RPL7;RPLP2;RPLP0;RPS14;RPS6;RHD;RPL38;RPL23;RPS15;RPL24;RPL18;RPL35;ASMT;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;MRPL28;RPL27;RPS24;RPL29;RPS18;RPLP1;IGF2BP3;MRPL10;RPS3;RPS23;RPL34;PCSK5;RPL14;RPS29;RPS8;MRPL37
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.7789808270196876,1.2655139293909292,0.171875,1.0,1.0,3/12,4.99%,TMEM100;RRAS;HEY2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.6431719902190495,-1.265287870560079,0.18181818181818182,0.9575046870442573,1.0,3/15,7.29%,PRKCD;TWIST1;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.7049132621430417,1.2652737926624213,0.15384615384615385,1.0,1.0,5/13,19.31%,CCL5;MAPK3;CSF1R;THBS1;CSF1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.8295397639986225,1.2652396250947575,0.11320754716981132,1.0,1.0,2/6,11.13%,IL21R;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.8295397639986225,1.2652396250947575,0.11320754716981132,1.0,1.0,2/6,11.13%,IL21R;STAT1
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.8211110953982936,1.265176164868055,0.125,1.0,1.0,3/6,8.30%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.8211110953982936,1.265176164868055,0.125,1.0,1.0,3/6,8.30%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.7409028967844975,1.264873889540553,0.14925373134328357,1.0,1.0,2/14,4.99%,TBX1;HEY2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.6770675040021504,1.264526870323666,0.14925373134328357,1.0,1.0,3/21,5.95%,TULP1;ACTG1;JCHAIN
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.8277674335882313,1.2644604107306303,0.11764705882352941,1.0,1.0,1/7,2.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.7956526373491526,1.2644267264641371,0.18571428571428572,1.0,1.0,4/7,16.44%,PLA2G10;IQCF1;GLRA1;POMZP3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.6587207335875838,-1.26441540686938,0.25,0.9598578935520614,1.0,3/16,11.22%,NRDE2;AGO2;TERT
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5517165610355165,-1.2633842700787818,0.10344827586206896,0.9626141629542652,1.0,10/29,19.04%,NDST3;XYLT1;CHST11;CHST12;CHST8;CSGALNACT1;B3GAT3;EXT1;EXT2;PXYLP1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.7304554367768548,-1.2630956759696128,0.2903225806451613,0.9622058059563998,1.0,3/7,14.98%,P3H4;P3H3;PLOD3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.7738717129155775,1.2630917205664465,0.14754098360655737,1.0,1.0,1/9,0.50%,SMAD6
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.46350637427376823,-1.2628328146877879,0.15789473684210525,0.9614431788742488,1.0,10/116,6.23%,RFX6;POU3F1;EHF;NPTX2;BCHE;ETV1;ADCYAP1;CFC1;SLC17A6;ABCC8
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.47695286019816585,-1.2627370048205981,0.09523809523809523,0.9600004884843674,1.0,14/80,13.61%,NGF;WNT3A;BAMBI;DDX11;APOE;RALB;MEN1;HES1;ZNF618;HFE;TERT;RIPK2;MED25;KDM4D
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.750964592820895,1.2622904727261925,0.16923076923076924,1.0,1.0,3/8,17.19%,ANXA1;TNFSF4;IL4
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.6056981765252446,1.2620925680664257,0.20588235294117646,1.0,1.0,2/23,1.05%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.5151903762323896,-1.2618898878271825,0.21052631578947367,0.9617536499015654,1.0,12/35,22.80%,FOXO1;ZDHHC23;ZDHHC5;HHAT;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3;PORCN;ZDHHC20;CREBBP;ZDHHC8
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7649754854100789,-1.2617600336799106,0.2222222222222222,0.9602886865468421,1.0,3/6,12.34%,APOB;SCARB1;LPL
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.7934360045625616,1.2616696606937627,0.15,1.0,1.0,1/7,3.01%,WNT5A
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.7314856552916111,-1.261406353530664,0.1388888888888889,0.9599158590237503,1.0,4/8,25.80%,NLGN2;NRXN2;NLGN1;TMEM108
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.4985748865699193,-1.261239496234891,0.23076923076923078,0.9591377901785177,1.0,5/31,8.81%,PRDM5;KMT2B;SMYD2;MEN1;DYDC1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.5770223196927317,-1.2611113017078794,0.16,0.9579026812994962,1.0,6/27,15.21%,SMYD5;DNMT1;MACROH2A2;DNMT3A;MPHOSPH8;MORC2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.8187765571453312,-1.2610332117036585,0.25,0.9564562147486225,1.0,4/5,16.80%,MYO9B;SLIT3;SLIT2;RHOA
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell cytokine production (GO:0002729),0.8358093753324907,1.260958079528651,0.09090909090909091,1.0,1.0,2/5,5.33%,CD160;HLA-F
prerank,GO_Biological_Process_2021__regulation of natural killer cell cytokine production (GO:0002727),0.8358093753324907,1.260958079528651,0.09090909090909091,1.0,1.0,2/5,5.33%,CD160;HLA-F
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.7103798151469682,-1.2607742319473692,0.11363636363636363,0.9556082912978873,1.0,5/9,24.81%,PTCH1;GRAMD1B;OSBPL7;GPLD1;LRP6
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5757871832739533,1.260356267518496,0.18421052631578946,1.0,1.0,16/55,19.52%,ACE2;FOXA3;BCO1;MISP;CD99;HSD11B2;CLCA1;FLI1;NR1H4;HNF4G;EPCAM;PIEZO2;VIL1;SLC44A3;NOS2;KRT8
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7353696086683212,-1.2603086903674976,0.275,0.9556514626351187,1.0,4/6,19.95%,SLC25A37;LDB1;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.8172835703250056,1.2601406336370808,0.13846153846153847,1.0,1.0,1/7,1.51%,CASQ2
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.8172835703250056,1.2601406336370808,0.13846153846153847,1.0,1.0,1/7,1.51%,CASQ2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.5253846450113855,-1.2600882203108452,0.25925925925925924,0.9547008575580099,1.0,14/47,18.20%,NGF;LIMK1;AGRN;CPNE6;SYT17;GOLGA4;ISLR2;RNF157;DBNL;SYT3;DLL1;MAP3K13;PLCB1;PPIB
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6805439599366001,1.2599678938538161,0.1791044776119403,1.0,1.0,3/14,13.71%,PTPRC;ITGA2;P2RY12
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.666715484781527,-1.2599389430699042,0.21428571428571427,0.9534053991585923,1.0,1/8,0.79%,PLK3
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.7478774730626353,1.2596958979853528,0.22058823529411764,1.0,1.0,2/9,1.15%,RAB34;MAPKAPK3
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6775438712622867,1.25961480528309,0.0967741935483871,1.0,1.0,6/19,19.31%,CCL5;MAPK3;MTUS1;CSF1R;THBS1;CSF1
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.7695492801679615,-1.2590286995975841,0.18518518518518517,0.953980036848896,1.0,1/5,4.24%,PTCH1
prerank,GO_Biological_Process_2021__metanephric collecting duct development (GO:0072205),-0.7695492801679615,-1.2590286995975841,0.18518518518518517,0.953980036848896,1.0,1/5,4.24%,PTCH1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.7833141350261661,-1.2589340223259502,0.1951219512195122,0.9525599761444634,1.0,4/5,21.66%,HES1;RNF10;NOTCH1;SKI
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.47244236449587196,-1.258895540533083,0.037037037037037035,0.9508792191493337,1.0,13/97,9.00%,PM20D1;SMPD3;THEM4;PC;PDZD11;MLYCD;MTHFR;MTHFD1L;DHFR;CPN1;FPGS;NSMAF;ACOT1
prerank,GO_Biological_Process_2021__hexose import across plasma membrane (GO:0140271),0.815237301192672,1.2586415070481165,0.10526315789473684,1.0,1.0,2/5,16.71%,SLC5A2;SLC5A1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7251542313595536,1.2584409855205896,0.18032786885245902,1.0,1.0,2/11,10.78%,BOK;TP53BP2
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.6996927559741968,-1.2581695338596064,0.16666666666666666,0.9520989978796929,1.0,3/11,9.16%,APOH;F11;SERPINE1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6371057892104666,-1.2577593400940272,0.17647058823529413,0.9515915193282964,1.0,6/18,21.43%,TRIM71;AGO2;TERT;ZC3H7B;SNIP1;TARBP2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6524540492516844,1.2577467822457096,0.13793103448275862,1.0,1.0,4/22,11.65%,ITGB2;CCL5;PIK3CG;SYK
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.5525781578296464,-1.2576707202184019,0.16216216216216217,0.9502394194619393,1.0,14/39,22.43%,TGFA;SH3KBP1;RAB7A;PTPRJ;GPRC5A;DAB2IP;SPRY1;SPRY2;BTC;TSG101;PTPN3;ZFYVE28;PTPN2;DUSP3
prerank,GO_Biological_Process_2021__fat-soluble vitamin catabolic process (GO:0042363),0.7826773662463832,1.25732165807985,0.08620689655172414,1.0,1.0,3/7,8.24%,CYP3A4;CYP4F12;CYP26B1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.7052532356181905,1.257280007974874,0.22388059701492538,1.0,1.0,2/11,10.97%,BUB1;WEE2
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.6946955339462115,1.2572361266515666,0.18181818181818182,1.0,1.0,2/15,6.54%,ANXA1;CD81
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.7413503244121261,1.257207970636058,0.1774193548387097,1.0,1.0,2/7,6.20%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.6302833234101805,-1.257198280898264,0.21212121212121213,0.950318189091347,1.0,3/16,14.47%,PTPRJ;CORO1A;SCRIB
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.4362815638208486,-1.2571389923217637,0.0,0.9488417061539758,1.0,29/150,16.30%,MFSD2A;GCK;TYRP1;SLC25A37;DDAH2;PPP1R3E;EGR1;PIWIL2;UPF3A;ERBB2;PLIN5;ASS1;CTC1;PCIF1;PKD2;FXR2;SCARB1;NR1D1;STN1;LDB1;PTH1R;CIRBP;CHP1;BRPF3;ZCCHC4;NR1H2;SLC6A9;CTDNEP1;RPS27L
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.6344266992424281,1.2571385584372632,0.19696969696969696,1.0,1.0,5/37,6.28%,TBX1;MYBPC3;ALPK2;HEY2;MESP1
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.7513099244784754,1.2568452400892085,0.234375,1.0,1.0,6/9,16.81%,GP1BA;CPB2;PLAUR;PLAU;PLAT;PLG
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.58754580361568,-1.2563150837183785,0.2413793103448276,0.9507905277480179,1.0,3/16,11.75%,BTN3A2;BACH2;CD8A
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7682086515627549,1.256152911745386,0.1774193548387097,1.0,1.0,3/9,17.76%,SIX4;SOX9;AGT
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.5071242489903179,1.256097769620199,0.10588235294117647,1.0,1.0,11/183,7.34%,SQOR;COX6A1;RAB34;ENPP2;CAVIN1;ACAA2;STAT5A;C3;CCNG2;PTGER3;ANGPTL4
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),0.8086140610739236,1.2557766831162027,0.08928571428571429,1.0,1.0,2/5,15.82%,JAM2;CD44
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.5745059788607217,-1.255567521525564,0.15625,0.9521807210896077,1.0,3/22,9.15%,MT1G;SLC30A10;SLC30A5
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.7479194872886663,1.2555079944361882,0.1746031746031746,1.0,1.0,2/10,3.42%,LRP2;CYP3A4
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.621017053671518,1.2555022704859886,0.1891891891891892,1.0,1.0,7/37,10.21%,LPAR1;ANXA1;ROGDI;SIX4;MESP1;PRDM12;NDUFS2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.801887877553631,1.2553240506275254,0.1896551724137931,1.0,1.0,1/5,5.87%,TRIM25
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5768368596619794,-1.2549595881884414,0.1935483870967742,0.9533561022645365,1.0,6/27,11.45%,CDH5;PRKCD;KANK4;CLIP3;MAPRE1;SLIT2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.6884482141102873,1.2547727461871037,0.19672131147540983,1.0,1.0,1/15,0.92%,NOX5
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.7450176625188769,1.254728891582501,0.19696969696969696,1.0,1.0,3/10,10.54%,ENPP2;CYP1B1;PPT1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6274809017907521,1.2547212575945355,0.15492957746478872,1.0,1.0,7/26,11.20%,TEX101;SLC25A31;SYCP1;BANF2;SYCP3;CRISP1;ASB17
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7322480908586146,1.2547120195210484,0.19402985074626866,1.0,1.0,4/12,13.43%,CD81;HLA-A;SYK;TNFSF4
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.4772347070700193,-1.254068636898459,0.16,0.9547887537014595,1.0,14/96,12.61%,CPSF1;NUP210;IWS1;MAGOHB;POM121C;NUP42;NUP214;AAAS;SRRM1;SRSF4;SYMPK;UPF2;NXF5;U2AF2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.5146935646708574,-1.2539527304910063,0.17391304347826086,0.9536048715354736,1.0,4/47,1.16%,ADGRF4;EHF;ANXA8;ENTPD2
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.7417089705958222,1.2537047266952535,0.2,1.0,1.0,2/6,12.19%,HIGD1C;COX7A2
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7417048311362526,1.2534579809341033,0.1746031746031746,1.0,1.0,3/10,17.76%,SIX4;SOX9;AGT
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.7484775573075888,-1.2530612814904056,0.25,0.9551621214099525,1.0,2/6,18.50%,AQP1;NGB
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.829141039995753,1.2529650928415748,0.1864406779661017,1.0,1.0,1/6,4.64%,FGF2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.7575181051772586,1.2528946157153251,0.1896551724137931,1.0,1.0,2/6,22.49%,AXL;CXCL12
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.5097384466308099,1.2528305017698145,0.04938271604938271,1.0,1.0,42/175,21.80%,CLEC5A;APOL1;BLK;TLR2;TRIM58;SP100;PTX3;TRIM62;SFTPD;C3;TRIM25;JCHAIN;RNF187;IFIT1;ZDHHC11;HCK;PIK3CG;CFD;DDX3X;TRIM68;SYK;TRIM77;TIFA;IFI6;CYBA;ISG15;COLEC12;CYLD;ZAP70;IL4;BPIFB1;AGER;MASP2;NOS2;MASP1;TRIM5;IGLL1;PGLYRP1;PGLYRP2;TKFC;B2M;WFDC11
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.6707092181119647,-1.252196052550603,0.20930232558139536,0.9569478072847368,1.0,3/11,10.81%,PEX7;PEX13;PEX14
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.7556636008617679,-1.2519964659526657,0.18518518518518517,0.9562858575026628,1.0,2/9,13.63%,DDX11;SPIDR
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.728896121301025,1.2519784835012724,0.1875,1.0,1.0,4/10,8.87%,TMOD4;LMOD3;LMOD1;PGM5
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.7735016362087366,1.2514767554611566,0.1875,1.0,1.0,3/7,14.93%,TBX1;MYO3B;SOX9
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.6671781435631347,1.251399550321153,0.20588235294117646,1.0,1.0,1/24,0.27%,AQP3
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.795418464613947,1.2509984133036491,0.20754716981132076,1.0,1.0,2/7,5.44%,LRAT;BCO1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.8088966914044174,-1.2508105329272496,0.18181818181818182,0.9590220598239824,1.0,1/5,5.28%,APOE
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7926876422066433,-1.250751448068619,0.2222222222222222,0.9575048884007916,1.0,4/7,17.66%,SMYD5;PRDM15;ESRRB;NCOA3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.7006761300135029,-1.2506989897555472,0.34285714285714286,0.9543581953841628,1.0,1/8,1.12%,ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.7006761300135029,-1.2506989897555472,0.34285714285714286,0.9543581953841628,1.0,1/8,1.12%,ABHD17A
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.7645139380588823,-1.250085905614825,0.1875,0.9550708244693644,1.0,4/5,21.63%,TENT4A;LARP4B;ELAVL4;RBM24
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.7214924952134267,1.2500377210264138,0.13846153846153847,1.0,1.0,2/12,4.99%,SMAD6;HEY2
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.828170739776709,1.2494361661617828,0.16129032258064516,1.0,1.0,1/5,5.45%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.828170739776709,1.2494361661617828,0.16129032258064516,1.0,1.0,1/5,5.45%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.6690144217648847,-1.2493617959499999,0.3225806451612903,0.9567569707110182,1.0,4/10,16.00%,APOBEC3H;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6422493018471288,1.249230573607394,0.1527777777777778,1.0,1.0,2/32,1.52%,TULP1;ROPN1B
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.5872357630789614,1.2491421270993097,0.13333333333333333,1.0,1.0,6/56,5.93%,AQP3;TBX1;MICB;WNT8B;WNT5A;HSD17B2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),0.7981765065711617,1.2490953890873775,0.20754716981132076,1.0,1.0,2/6,9.87%,HTR5A;HTR1B
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.49692887359535637,-1.2484473030610783,0.14814814814814814,0.9589754665379393,1.0,4/36,11.22%,DCPS;TRIM71;KHSRP;ZC3H12D
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5657183499813617,-1.2482942109903374,0.23333333333333334,0.9563116862215625,1.0,4/24,16.74%,CPSF1;SYMPK;PCF11;LEO1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5657183499813617,-1.2482942109903374,0.23333333333333334,0.9563116862215625,1.0,4/24,16.74%,CPSF1;SYMPK;PCF11;LEO1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.7350099725468948,1.2480226250705722,0.17543859649122806,1.0,1.0,2/10,6.51%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.653539912964863,-1.2479857891797554,0.22857142857142856,0.955790296225566,1.0,1/13,1.91%,NAA40
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6582324906716831,1.2478613071016489,0.13846153846153847,1.0,1.0,3/20,12.18%,SLC12A7;SLC12A3;ATP1A4
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.46189941471988244,-1.247751906553769,0.047619047619047616,0.9555507969814145,1.0,4/69,2.82%,DUSP4;EHF;CLDN4;ESRP1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.7443745653119074,1.2477505062089183,0.2,1.0,1.0,3/10,15.82%,ENPP2;VIL1;CD44
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.7163384216074713,-1.2474234142074019,0.1875,0.9552867455402257,1.0,3/8,9.41%,GLA;NEU4;NEU3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7479751279113014,1.2469313741186385,0.1875,1.0,1.0,4/9,19.31%,IL12A;MAPK3;CSF1R;CSF1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.7302460779965076,-1.2468722538639863,0.1388888888888889,0.956114340706532,1.0,1/9,1.54%,COL13A1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.7231675751553815,1.2466201858060535,0.18461538461538463,1.0,1.0,2/9,7.63%,AQP3;SLC26A6
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.6701095251635892,1.2465552438610468,0.1875,1.0,1.0,4/16,12.96%,SIX4;JAM2;IGF1;ERVW-1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.6210675191598279,1.2464564255247366,0.13559322033898305,1.0,1.0,4/27,11.65%,ITGB2;CCL5;PIK3CG;SYK
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.802919897686583,1.2455671101098744,0.25862068965517243,1.0,1.0,1/6,3.74%,OLAH
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.6683407157238195,1.245114187818788,0.21739130434782608,1.0,1.0,9/24,19.42%,HSPA1L;HSPA8;DNAJB1;SDF2L1;HSPA5;HSPE1;HSPA2;BAG1;DNAJB4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.582118923602254,-1.2447807700735194,0.10714285714285714,0.9631929868462776,1.0,6/29,10.93%,MFSD2A;LCN12;APOE;SLC27A2;CPT1A;SLC27A4
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.6874504750506045,-1.2444704472856567,0.21951219512195122,0.9626387029553083,1.0,3/12,10.37%,CRLS1;PLA2G5;PGS1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),-0.7559021916449871,-1.2444667960365805,0.21875,0.9609510524597207,1.0,3/7,21.63%,CPEB1;UNK;RBM24
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.6795025940103643,1.2444466755596308,0.1506849315068493,1.0,1.0,3/23,5.29%,TLR2;MYRF;SOX10
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.6309745567271988,1.2443860315516617,0.15517241379310345,1.0,1.0,10/31,13.32%,SLC22A3;SLCO1A2;ABCG2;SLC17A8;SLC22A24;SLC22A25;ABCC11;SLC13A4;SLC4A1;SLC22A6
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7737548417344082,-1.2443664778850487,0.25,0.9597479111386573,1.0,3/6,17.25%,TTBK1;NUPR1;TAFA3
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.7850020890767857,-1.2441666976995251,0.1951219512195122,0.9588507197747976,1.0,2/6,12.42%,TIE1;PROX1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.6624440892375189,1.2440559544843388,0.19718309859154928,1.0,1.0,2/21,13.25%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7223603648294185,1.2440296882975588,0.18461538461538463,1.0,1.0,4/9,24.11%,BOK;HSPA5;TMEM33;AGR2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.652443250432471,-1.2439146780750678,0.25,0.9580570874914122,1.0,2/13,6.90%,MYO18A;STX6
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),-0.7512653569935716,-1.2435110401352611,0.2222222222222222,0.9579426488905587,1.0,1/6,3.98%,GRID2
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.7463748114348475,1.2432107494593114,0.2571428571428571,1.0,1.0,5/9,18.27%,PLA2G10;IQCF1;GLRA1;POMZP3;SERPINA10
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8101899462986258,1.2431878922677808,0.1896551724137931,1.0,1.0,2/5,17.76%,ACE2;AGT
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7747011318324717,1.2430518379681317,0.2,1.0,1.0,2/7,12.59%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7747011318324717,1.2430518379681317,0.2,1.0,1.0,2/7,12.59%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.7307443252441544,-1.2427096440937586,0.2,0.9591539994824031,1.0,4/7,23.79%,GTF2H2;ARRB2;ARRB1;DRD3
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.5322031111828764,-1.2426858690439182,0.16,0.957565201063843,1.0,6/45,5.50%,MFSD2A;TEAD2;COL13A1;KIT;TEAD4;KITLG
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.7610339472532263,1.242556938972233,0.19402985074626866,1.0,1.0,1/7,6.02%,KCNA5
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.6318000033067277,-1.2424226158320677,0.24324324324324326,0.9569787621782166,1.0,8/13,28.72%,ALKBH8;TRMT9B;CTU1;MTO1;URM1;ELP4;ELP3;ELP1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.42689851309107457,-1.2424073352263203,0.13333333333333333,0.9553496033829392,1.0,21/152,8.54%,SPRED3;TSKU;TRIB2;SPRED2;OSR1;ADAMTS12;SPRED1;BAMBI;DTX1;FOXO1;TWIST1;TWIST2;HDAC7;PTCH1;MYOCD;ASCL1;MEN1;HOPX;HES1;USH2A;EFEMP1
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.5379015045846192,1.242108052378049,0.17073170731707318,1.0,1.0,25/70,18.33%,RASGRP4;ITGB2;TLR2;ITGAX;LILRB3;FCGR3A;NR1I3;ITGAM;NFAM1;PTAFR;CLEC12A;MMP9;HCK;CD244;CSF3R;SERPINB1;CEACAM8;HK3;IGSF6;PSTPIP1;TAGAP;MME;MYO1F;ALOX5AP;FPR1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.5050312356338558,-1.2417492338598008,0.15384615384615385,0.9561845280143886,1.0,7/43,15.29%,METRNL;CARM1;SYAP1;TFE3;LPL;CMKLR1;CDS1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.6954369563124989,1.2414492834654545,0.14925373134328357,1.0,1.0,2/12,7.63%,AQP3;SLC26A6
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.462688174043687,-1.241419978021246,0.13636363636363635,0.955727522016667,1.0,12/83,7.95%,SPRY4;TRIB2;FGF1;PRKCD;FGF18;KIT;APOE;PDGFD;ERBB2;ADAM8;TRIB1;PTPRJ
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.6216376437541047,-1.241400693345227,0.20588235294117646,0.9541338219316556,1.0,1/13,0.43%,NGF
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.7050891648387912,1.2406831509191116,0.16129032258064516,1.0,1.0,3/12,8.24%,CYP3A4;CYP3A5;CYP26B1
prerank,GO_Biological_Process_2021__regulation of T-helper 1 cell differentiation (GO:0045625),0.8569378464954489,1.2405948672332099,0.109375,1.0,1.0,4/5,13.43%,ANXA1;IL27;CD80;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.7464392238249667,-1.2401618739580258,0.2222222222222222,0.9555496901884682,1.0,1/5,3.66%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.7464392238249667,-1.2401618739580258,0.2222222222222222,0.9555496901884682,1.0,1/5,3.66%,NRDE2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.6801655425068707,1.240123850080309,0.2463768115942029,1.0,1.0,4/15,17.42%,STOML2;ATP5PF;ATP5F1E;ATP5MC3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5636515858024684,1.2399962077986435,0.12345679012345678,1.0,1.0,4/82,3.51%,FBXO48;PSMB9;KIF14;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.7996317037782108,1.2399675862803214,0.22580645161290322,1.0,1.0,2/8,3.84%,GLRX;STOML2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.5777246905666996,-1.2398941571122701,0.23333333333333334,0.9549492607796468,1.0,3/18,10.89%,NGF;RAPGEF1;NTRK1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.6365239831776228,-1.239714837748243,0.25,0.9538840090043638,1.0,1/10,0.59%,BUD23
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.7059639845612773,-1.2394248333903999,0.3333333333333333,0.9532640076501561,1.0,1/6,6.78%,NBDY
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.8055804338020599,1.2391436411075107,0.24193548387096775,1.0,1.0,1/5,2.91%,AOX1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.6599918903463073,1.239113338318371,0.2,1.0,1.0,1/18,0.44%,RAB34
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.6233880380791404,1.2390192519919145,0.10666666666666667,1.0,1.0,8/43,14.64%,TULP1;TLR2;PTPRC;SFTPD;HCK;SYK;CYBA;TGM2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6605949292568752,1.2386167837274527,0.2463768115942029,1.0,1.0,7/18,19.13%,SYK;IRF4;TNFSF4;ISG15;IL4;TIGIT;F2RL1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.7158232353873891,1.2385401917957304,0.2459016393442623,1.0,1.0,2/12,9.51%,ACOX2;PINK1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.7337572181219159,1.2383669993925135,0.22413793103448276,1.0,1.0,2/8,9.95%,LMOD3;IGF1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.5066932895618554,-1.2380956856616427,0.17391304347826086,0.9563684742006748,1.0,9/49,8.68%,PER2;NR4A1;IL11;METRNL;FOXO1;NR4A3;CLIP3;PID1;SDF4
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.6760253921493482,-1.2378716668363727,0.2682926829268293,0.9557218804552207,1.0,4/7,22.00%,ACADS;PCCA;PCCB;PCK2
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.5084297693815426,1.2377461146634499,0.10256410256410256,1.0,1.0,53/154,25.66%,PWP2;SLFN14;RPL21;RPL37A;RPL18A;RPL9;NOB1;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;EXOSC2;EXOSC8;RPL36;RPS19;RPL41;NOP53;ERN2;RPL27A;RPL32;RPL35A;RPL7A;RPL11;RPS7;RPL23A;RPL7;RPLP2;WDR36;RPLP0;EXOSC4;RPS14;RPS6;RPL38;RPL23;RPS15;WDR18;RPL24;RPL18;RPL35;RPS27;RPL8;IMP3;RPL10;RPS28;SENP3;RPL27;RPS24;EMG1;RPL29;WDR12;RPLP1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.586151336944951,-1.2376130266912013,0.17857142857142858,0.9550531078165753,1.0,4/31,8.95%,ARC;NLGN3;EPHB2;PKD2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.5429293399927945,-1.2373810985890774,0.2727272727272727,0.9543622706089302,1.0,4/70,0.97%,ADGRF4;NIPAL1;ANXA8;CLDN4
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.7840043096096275,1.23722494109626,0.21875,1.0,1.0,3/6,12.38%,BACE2;ITM2A;ITM2C
prerank,GO_Biological_Process_2021__innate immune response in mucosa (GO:0002227),0.7673800577597801,1.2370627049577487,0.21666666666666667,1.0,1.0,3/5,18.92%,IL4;BPIFB1;NOS2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.8033299808626382,1.237040296767013,0.20634920634920634,1.0,1.0,2/5,17.76%,ACE2;AGT
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.5538647225967398,1.2369614251275227,0.13414634146341464,1.0,1.0,9/76,6.52%,ITGB2;MAPKAPK3;TLR2;TRIL;SFTPA1;SFTPD;ITGAM;SCIMP;SCARA3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.78218396393698,1.236760914366077,0.19047619047619047,1.0,1.0,4/8,16.77%,HEY2;TGFB1;SOX9;HEY1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.715049124998482,1.2365094253975484,0.24561403508771928,1.0,1.0,5/10,16.43%,CD99;PIK3CG;GPR183;MSN;ZAP70
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.8029075176085192,1.2362024700348218,0.09433962264150944,1.0,1.0,4/8,18.29%,CASQ2;CAV3;KCNAB1;KCNE3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.5917536339331606,1.235620113090082,0.18571428571428572,1.0,1.0,9/31,25.88%,BORA;CHMP3;GPSM2;PSRC1;RAE1;DCTN1;TACC3;CHMP1A;ANKRD53
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.5501261185588622,-1.2353484220756998,0.2,0.9607025631373848,1.0,3/36,5.28%,TSKU;APOB;APOE
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.7536244255861961,-1.2352109198291545,0.15789473684210525,0.9594702729871425,1.0,3/6,18.55%,CCN3;SLIT2;GREM1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6253754325482297,1.2351301433954351,0.18461538461538463,1.0,1.0,1/32,0.39%,NEK2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.680917009843089,1.2350714119283885,0.21739130434782608,1.0,1.0,1/17,0.44%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.5682393029748789,-1.2346146588773819,0.22857142857142856,0.9604235995539181,1.0,4/22,8.74%,BOC;OLFM2;MYOCD;BNIP2
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.667513679328069,-1.2341140294546464,0.17647058823529413,0.9606477787039953,1.0,6/9,26.39%,NR4A3;GNB3;UCN;SGIP1;EIF2AK4;STAT3
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.6191161241212905,1.2338223525084564,0.16666666666666666,1.0,1.0,4/28,10.99%,CCL5;VAPB;IFIT1;DDX3X
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.7551664546653681,1.2336936251235036,0.23728813559322035,1.0,1.0,2/8,15.19%,MYBPC3;PLN
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.5378390872191189,-1.2336490672232925,0.2,0.9608470388034165,1.0,13/54,14.75%,PACSIN2;CDH13;CD151;APOE;CLIP3;LRSAM1;HIP1;RAB5A;SNX33;PACSIN3;RUBCN;RUFY1;DLL1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6725813368806646,-1.2335232958684126,0.3157894736842105,0.9596470000296538,1.0,3/7,16.46%,EMP1;EMP2;EMP3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.653368934465815,1.233237367028626,0.1875,1.0,1.0,5/22,13.85%,CDC25A;DTL;RAB11A;CCND1;FBXO5
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.7757625907780767,1.2331972980977057,0.17857142857142858,1.0,1.0,1/7,1.73%,LMOD3
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4414888678339885,-1.2331769190780386,0.06666666666666667,0.9597028433410699,1.0,8/139,2.67%,CYP1A2;GRP;APOB;GCK;APOH;BCHE;PAH;LIPC
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.6763395124946215,1.2330582276395785,0.1388888888888889,1.0,1.0,5/17,19.31%,OSCAR;GPR183;CSF1R;ANXA2;CSF1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.518186059752351,1.2329901185263314,0.1388888888888889,1.0,1.0,14/77,13.32%,SLC22A3;MGST1;ABCC6;SLCO1A2;ABCG2;CA14;SLC26A6;CA1;SLC22A24;SLC22A25;ABCC11;SLC4A1;CA13;SLC22A6
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.7172612004001024,-1.2328202486804953,0.2,0.9562286553127085,1.0,1/8,5.99%,HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.7172612004001024,-1.2328202486804953,0.2,0.9562286553127085,1.0,1/8,5.99%,HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.7172612004001024,-1.2328202486804953,0.2,0.9562286553127085,1.0,1/8,5.99%,HSPB1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.7207368094982255,1.2326521501824508,0.19117647058823528,1.0,1.0,4/11,17.19%,LEF1;IRF4;TNFSF4;IL4
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6853574158170603,1.2323408544417545,0.1875,1.0,1.0,5/17,19.31%,CCL5;MAPK3;CSF1R;THBS1;CSF1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.6723722481606345,-1.2317653589587871,0.2619047619047619,0.958585326477812,1.0,2/7,7.64%,MTHFR;CBS
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.7250416665139466,1.2317284962327524,0.23076923076923078,1.0,1.0,1/12,1.51%,CASQ2
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.7617490870776475,-1.2311914965401702,0.2619047619047619,0.959143769233893,1.0,3/5,23.38%,NLGN2;NRXN2;NLGN1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.5118312330581599,-1.2310189427610179,0.16129032258064516,0.9582705071973432,1.0,18/47,22.13%,HNRNPL;CELF5;SRRM4;FXR2;ZBTB7A;NOVA1;CELF4;PTBP1;SMU1;THRAP3;RBMX;RBFOX2;KHDRBS1;RBM11;CELF2;RBM25;RBM24;RBM8A
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5789365248627365,1.230942535219557,0.21212121212121213,1.0,1.0,8/30,27.75%,VSIR;IGF1;NR1H4;NLRC3;IL4;GHRL;CACTIN;PTPN6
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.7239774865800561,-1.230806897178953,0.2564102564102564,0.957519127956512,1.0,1/7,3.71%,DDX11
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.7506606519560266,-1.2306595781298881,0.2631578947368421,0.9564140064911512,1.0,1/5,6.84%,CRY1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.6430166528856476,1.2306139440906287,0.14925373134328357,1.0,1.0,4/25,9.69%,GATA4;REST;PINK1;SOD2
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.646946385761607,-1.2306122354616924,0.275,0.9549569174278054,1.0,1/10,0.70%,FBP2
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.7923513713328327,1.2304071398407137,0.25,1.0,1.0,1/5,8.66%,NODAL
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.5976338822728846,1.2303259156792314,0.17142857142857143,1.0,1.0,7/33,12.36%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6989958032497278,1.2296793587095818,0.20833333333333334,1.0,1.0,3/13,9.95%,FGF2;ERBB4;IGF1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.6971622593285314,-1.2295640675743265,0.21621621621621623,0.9575051475758968,1.0,1/6,1.52%,DNMT1
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.6910435553894132,1.2293600123005035,0.1896551724137931,1.0,1.0,3/12,9.95%,TNFRSF1B;PTPRC;IGF1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6907724691171524,1.2285498109813309,0.14285714285714285,1.0,1.0,4/15,6.06%,CD160;HLA-F;SH2D1B;IL12A
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.7461261529418143,-1.228299216344444,0.18181818181818182,0.9610137904598901,1.0,1/6,2.77%,RNF168
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.7022347645850887,-1.2282609203422468,0.22580645161290322,0.9597214690409146,1.0,2/10,3.52%,TYRP1;KIT
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.6445556816453983,1.2280702738548144,0.16417910447761194,1.0,1.0,2/26,5.42%,MCUB;CASR
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5796893054326245,1.2278148408521425,0.1891891891891892,1.0,1.0,1/31,0.39%,NEK2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.760041598910859,-1.2277541858782537,0.20930232558139536,0.9605767970678328,1.0,3/6,23.74%,HSPA1A;LAPTM5;PRKN
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.70014998443901,1.227680871212262,0.2857142857142857,1.0,1.0,2/10,3.93%,LOX;CHCHD4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.7717328496950009,1.2275763105455482,0.2459016393442623,1.0,1.0,3/7,19.32%,EXOSC2;EXOSC8;EXOSC4
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.7717328496950009,1.2275763105455482,0.2459016393442623,1.0,1.0,3/7,19.32%,EXOSC2;EXOSC8;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.7582241298479403,-1.227549927872156,0.2553191489361702,0.9598303156127651,1.0,1/6,2.73%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.7653758128008938,1.2272717029542983,0.125,1.0,1.0,2/7,10.54%,AXL;PPT1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.820425268759938,-1.2268921647507067,0.1951219512195122,0.9610112864202547,1.0,2/5,3.71%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6351981682343091,-1.2266265089872637,0.19230769230769232,0.9605243567707131,1.0,3/17,8.95%,DDAH2;ASS1;PKD2
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.7011350799365046,-1.2258528370728228,0.2857142857142857,0.961723682597447,1.0,1/6,9.26%,PTPRS
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.6164245287868239,1.2257890777354703,0.2727272727272727,1.0,1.0,5/19,13.43%,VSIR;TGFB1;IL12A;NR1H4;TNFSF4
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7414760293947692,1.2255897620347496,0.22950819672131148,1.0,1.0,2/9,7.56%,CASQ2;P2RY6
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.6832613537302018,-1.2248714702207262,0.36363636363636365,0.9642972583253585,1.0,1/6,2.59%,PSAT1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.6200069653680943,1.2245294970610467,0.2,1.0,1.0,8/27,22.93%,CENPU;OIP5;CENPX;ITGB3BP;CENPL;RBBP7;CENPN;CENPM
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.6200069653680943,1.2245294970610467,0.2,1.0,1.0,8/27,22.93%,CENPU;OIP5;CENPX;ITGB3BP;CENPL;RBBP7;CENPN;CENPM
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.530946545229131,1.224521286847415,0.16666666666666666,1.0,1.0,22/105,13.43%,AMBP;ITGB2;MICB;OSCAR;AHR;FCGR3A;GPR151;CD160;C17ORF99;SFTPD;C3;HLA-F;SH2D1B;CD81;CD99;HLA-A;LAIR2;IRF1;COL1A1;SYK;IRF4;TNFSF4
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6642745576715372,1.224293359654708,0.22580645161290322,1.0,1.0,1/15,2.84%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.772178626724882,-1.2242254858980601,0.3055555555555556,0.9656730009979352,1.0,3/6,11.45%,RNF113A;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.7499666179352091,1.2232504447898966,0.2,1.0,1.0,4/9,19.13%,GPER1;SOD2;ADRB1;F2RL1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.47411040978348334,-1.2230889975094341,0.15384615384615385,0.9688602711263232,1.0,19/56,19.54%,CDH20;ZNF703;CDH5;CDH19;GJB6;FSCN1;CDH12;FBF1;PATJ;CDH22;TRPV4;PARD6B;RHOA;PRKCA;CD9;CDH9;CDH11;JUP;VCL
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.5791014860421289,1.2230357597214319,0.18461538461538463,1.0,1.0,8/29,27.75%,VSIR;IGF1;NR1H4;NLRC3;IL4;GHRL;CACTIN;PTPN6
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.7437648459785302,1.2229321988301343,0.26,1.0,1.0,1/5,10.60%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.5278824199308396,-1.2227253097034532,0.25925925925925924,0.9688525993074009,1.0,7/45,10.33%,EYA4;RNF168;HDAC10;DDX11;BRCC3;ERCC8;WRAP53
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5821396322288162,1.2226900737192314,0.22077922077922077,1.0,1.0,7/40,17.72%,TBX1;SOX10;SEMA3A;ERBB4;SEMA3B;SEMA3F;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.565950682671933,-1.2224082113263048,0.26666666666666666,0.9687985397548742,1.0,3/22,11.62%,CDH5;CCN1;UBE2O
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7011120430541977,1.2223667868387573,0.21666666666666667,1.0,1.0,1/10,0.49%,LRP4
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6642230725071625,-1.2222707526614476,0.2222222222222222,0.9677020741885037,1.0,6/12,22.16%,CCN3;SLIT2;MIA3;PLCB1;GREM1;ADTRP
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7490126643149344,1.2222182468231242,0.16071428571428573,1.0,1.0,2/10,12.59%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6516923042359246,1.2219325483596943,0.14516129032258066,1.0,1.0,5/21,13.41%,ANXA1;PTPRC;STOML2;CD80;IRF4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6204705480102491,1.221791589736403,0.15714285714285714,1.0,1.0,4/27,11.39%,ACAA2;PINK1;IGF1;HGF
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.7606240870790688,1.2212235645626641,0.18461538461538463,1.0,1.0,2/11,3.47%,TBX1;SIX4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.6514415478593452,-1.2210844867730688,0.2647058823529412,0.9709808899424563,1.0,2/9,7.29%,TWIST1;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.711142173762769,-1.2209789058092697,0.28,0.9698382555358173,1.0,5/8,23.38%,NR4A3;CRH;NPAS2;SGIP1;NLGN1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.6212283721929659,1.2208783819696947,0.19672131147540983,1.0,1.0,7/24,12.58%,ITGB2;ITGAX;PKP2;IZUMO1;ITGA5;RNASE10;CTNNA3
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.687149493856833,-1.2206367012142922,0.2857142857142857,0.9678863691065172,1.0,1/10,4.20%,ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.687149493856833,-1.2206367012142922,0.2857142857142857,0.9678863691065172,1.0,1/10,4.20%,ASCC2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.4536664048166496,-1.2205808124640591,0.1,0.9665704598677475,1.0,25/93,18.43%,PDE10A;PDLIM3;CALD1;TYRO3;COL4A2;PARVA;SLIT3;FSTL1;RASSF8;AMOTL1;RNF150;GPR161;EDNRA;EML1;SLIT2;ANTXR1;ADAMTS9;ADGRL2;COL4A1;DENND2A;NAV1;PTPN21;CDH11;CHST3;NTM
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6934452863971906,1.2200123666510607,0.19117647058823528,1.0,1.0,3/18,6.54%,BLK;NFAM1;CD81
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.718949192650892,-1.2198824587853623,0.2564102564102564,0.9683791343533225,1.0,2/8,7.29%,MFSD2A;PLIN5
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.6795816445737016,1.2198731151135254,0.20833333333333334,1.0,1.0,1/14,0.42%,NRAP
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.6218967365393526,1.2197843464852958,0.2777777777777778,1.0,1.0,5/18,21.70%,CD81;HLA-A;TNFSF4;IL4;B2M
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),0.7715609944530528,1.2197629400444863,0.25,1.0,1.0,2/5,19.54%,SLC47A1;SLC7A3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.572369566463081,-1.2196544433456469,0.23529411764705882,0.967685156314839,1.0,2/24,5.40%,PER2;GYS1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.7970875270648139,-1.2195737525866386,0.2127659574468085,0.9663073302489771,1.0,4/5,18.82%,MYOCD;SRF;GREM1;NOTCH1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.603935724242062,1.2195080925725652,0.18840579710144928,1.0,1.0,7/31,12.36%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.6726180892749091,-1.2185518866636653,0.2972972972972973,0.9689296691239626,1.0,2/7,9.26%,GRIN3A;PTPRS
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.7373209448256551,1.218527738677425,0.21666666666666667,1.0,1.0,1/12,0.27%,GATA4
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle contraction (GO:0060452),-0.7900295924468788,-1.2183834127621915,0.2926829268292683,0.9679190088624151,1.0,1/5,0.70%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.6612163415160135,1.2175938901213295,0.19696969696969696,1.0,1.0,1/21,0.27%,AQP3
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.6033633649575807,-1.2171211772676844,0.1724137931034483,0.9711676063695324,1.0,8/24,21.22%,GCK;CRY1;ZNF692;SIRT7;PGP;C1QTNF12;CLK2;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.54874923471058,-1.2170549185789086,0.25,0.9699066464517218,1.0,11/33,13.96%,NGF;VWC2;ASCL1;PCP4;BEND6;DLX1;MMD2;NEUROD2;PROX1;BRINP1;IMPACT
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.6080417630223253,1.2169981188071723,0.2571428571428571,1.0,1.0,8/29,22.75%,ESR1;TRIM25;CRHBP;ZNF366;WBP2;BRCA1;GHRL;LOC400499
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.7168313468418259,-1.216806112240217,0.2647058823529412,0.9692168865830503,1.0,3/7,24.94%,CDK6;DLL1;BMP4
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.6747416256064528,1.2168033445921362,0.20833333333333334,1.0,1.0,2/12,18.57%,NDC80;NUF2
prerank,PanglaoDB_Augmented_2021__Microglia,0.5438705944802704,1.2165684013993319,0.11594202898550725,1.0,1.0,31/94,18.84%,C1QB;IL21R;ITGB2;C3AR1;ITGAX;TNFRSF1B;PTPRC;FCGR3A;SASH3;VSIG4;ITGAM;NFAM1;PTAFR;FGL2;CLEC12A;P2RY6;HCK;HPGDS;CSF3R;GPR183;P2RY12;HK3;IGSF6;TAGAP;COLEC12;MYO1F;CSF1R;CD4;ALOX5AP;FPR1;PARVG
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.8002781393818261,1.2163305899778132,0.1774193548387097,1.0,1.0,1/5,1.31%,TIMP3
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.7021328983964116,-1.2162455988078713,0.2857142857142857,0.9694579951194501,1.0,3/10,12.90%,PACSIN2;RAB35;WASHC2C
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.5194183638547534,-1.216111305916574,0.16666666666666666,0.968386709023783,1.0,5/35,8.80%,NUP210;POM121C;NUP42;NUP214;AAAS
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6379374125616897,1.215760658062524,0.21052631578947367,1.0,1.0,1/18,2.41%,SP100
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.6779232416571219,-1.215520242504431,0.37142857142857144,0.9693960312405622,1.0,3/9,17.66%,ECSIT;ABL1;SZT2
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),-0.6998986915848457,-1.2153034156778608,0.3333333333333333,0.9687340118792372,1.0,4/5,28.41%,PPP1R9B;DRD2;DRD3;ADCY8
prerank,GO_Biological_Process_2021__regulation of NAD(P)H oxidase activity (GO:0033860),0.769745989594447,1.215124833543452,0.31343283582089554,1.0,1.0,3/5,22.60%,RFK;AGT;PARK7
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7427645072371477,-1.2149940621449147,0.35714285714285715,0.9686142512880137,1.0,1/6,5.69%,JADE2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6251296062918037,-1.214988573053534,0.19444444444444445,0.9671016758096413,1.0,5/11,24.93%,SNX5;C1QTNF12;GKAP1;SORL1;ZBTB7B
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.5533396694150143,1.2149477691776225,0.17105263157894737,1.0,1.0,11/56,24.63%,PSMB9;MCM2;MCM3;RPS27A;PSMC5;ORC4;PSMB6;PSMD6;PSMA3;PSMA7;GMNN
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),0.7450199751342195,1.2148160023412282,0.23809523809523808,1.0,1.0,5/8,19.13%,IFNK;LCP1;CD244;GPR183;F2RL1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.7675632521498608,-1.2146806820101421,0.2857142857142857,0.9666034765188232,1.0,2/5,18.85%,LIG3;XRCC4
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.6607365260696957,1.2142269977997957,0.25396825396825395,1.0,1.0,2/13,8.27%,PHKA1;PHKG1
prerank,GO_Biological_Process_2021__type B pancreatic cell development (GO:0003323),-0.7179733972572676,-1.2141822689765098,0.21621621621621623,0.9672268453485964,1.0,3/6,24.94%,CDK6;DLL1;BMP4
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.8041443693812877,1.2140165839561954,0.18461538461538463,1.0,1.0,1/6,1.31%,TIMP3
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),-0.7594058269638382,-1.2139723147415038,0.24390243902439024,0.9663721874427652,1.0,3/5,22.27%,NR1H2;ABCA13;ABCB4
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.5719123584752936,-1.2137792875393065,0.21428571428571427,0.9659444786394187,1.0,10/24,17.83%,KDM7A;KDM8;KDM2B;KDM3B;PHF2;HR;KDM4D;KDM1B;KDM4B;KDM2A
prerank,GO_Biological_Process_2021__water transport (GO:0006833),0.6990921743740504,1.2137756997532354,0.25757575757575757,1.0,1.0,1/11,0.27%,AQP3
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),-0.7554178452034013,-1.2137341821362002,0.23214285714285715,0.9644925806750566,1.0,1/5,2.18%,SLC25A29
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.6447997971224333,-1.2136441170740095,0.3,0.9633568703684959,1.0,8/18,21.63%,MAML1;CCN3;HDAC3;HDAC5;FBXO22;NOTCH1;HDAC4;RBM24
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6860008476180294,1.2136168995551457,0.2222222222222222,1.0,1.0,1/11,5.35%,LMO2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6489411929184977,1.2134162867911558,0.19047619047619047,1.0,1.0,6/24,14.74%,FGF2;FLT1;TGFB1;CD81;P2RY12;TNFAIP8L3
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.7763648537533983,-1.2130897775380203,0.2894736842105263,0.9640026669199565,1.0,2/6,2.34%,OSR1;FGF1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.7812469541294909,-1.213068979911506,0.2608695652173913,0.9625162451007311,1.0,2/6,14.38%,ASS1;MAPK7
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.5379271265506099,-1.212811307172743,0.19444444444444445,0.9622308319738989,1.0,5/27,9.15%,KCNIP3;KCNE1;DPP6;KCNIP1;SLC30A5
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7996948719984285,-1.2123301774187423,0.3,0.9626099189395865,1.0,2/6,11.02%,PAH;KYAT1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.7437391697205921,1.2122839900141704,0.21818181818181817,1.0,1.0,4/8,17.19%,RORC;LEF1;GPR183;IL4
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.6117424231979761,-1.2121824422939818,0.21052631578947367,0.9615301579509984,1.0,6/18,25.18%,F11R;DAB2IP;RRP1B;SH3BP4;HRAS;BCAS3
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.5936753024000418,-1.2120885922253333,0.19230769230769232,0.9603655494106793,1.0,2/20,2.20%,MT1G;FOS
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.7591737416923554,1.2118834921699104,0.22807017543859648,1.0,1.0,2/6,3.13%,BHMT;CHDH
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5147255455683036,1.2116773477687295,0.1375,1.0,1.0,29/99,18.84%,ITGB2;C3AR1;TLR2;ITGAX;TNFRSF1B;PTPRC;FCGR3A;SASH3;ITGAM;NFAM1;PTAFR;FGL2;CLEC12A;ADGRE1;IFIT1;PSAP;HCK;CSF3R;PLAU;HK3;IGSF6;TAGAP;CD44;MYO1F;CSF1R;FN1;ALOX5AP;FPR1;PARVG
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.740332070495642,1.2116306567952502,0.2,1.0,1.0,2/8,5.45%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.6656504647758726,-1.211613768281962,0.2903225806451613,0.9609439223104999,1.0,4/11,18.55%,ECM1;AHSG;RFLNB;GREM1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.5908646297403236,1.2115776835337766,0.1935483870967742,1.0,1.0,1/20,0.47%,ENPP2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.7335734625872904,-1.2114763831923898,0.2553191489361702,0.960003665238509,1.0,2/5,17.47%,MARK2;ABL1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.7810688671341439,1.2113561425437658,0.20588235294117646,1.0,1.0,1/6,10.21%,NDUFS2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7868011119506872,1.211268558037444,0.2571428571428571,1.0,1.0,1/6,2.83%,LRP2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6726043292642407,1.2108074441799361,0.21739130434782608,1.0,1.0,4/14,15.59%,ARHGAP24;PIK3CG;KBTBD7;KBTBD6
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6484151138409244,1.2108058768452585,0.26153846153846155,1.0,1.0,4/16,14.93%,TBX1;MYO3B;ZIC1;SOX9
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.7834419706657317,1.2107491711030338,0.27419354838709675,1.0,1.0,1/6,5.45%,TGFB1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.7867709059416065,1.2107216147456532,0.21818181818181817,1.0,1.0,2/5,9.51%,REST;PINK1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.6801810373583439,1.2106674749839903,0.27941176470588236,1.0,1.0,4/14,17.42%,STOML2;ATP5PF;ATP5F1E;ATP5MC3
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.6056177089471901,1.2106176650504081,0.2608695652173913,1.0,1.0,8/29,22.93%,CENPU;OIP5;CENPX;ITGB3BP;CENPL;RBBP7;CENPN;CENPM
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.6699605467996342,1.2105929616491193,0.21875,1.0,1.0,2/11,3.01%,LRP4;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.7348963909688229,1.2105919948329054,0.18181818181818182,1.0,1.0,4/9,21.70%,CDKN2A;HMGA1;HMGA2;B2M
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.631505089814914,1.2105107936898463,0.24193548387096775,1.0,1.0,2/14,9.95%,REST;IGF1
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),-0.769756548366858,-1.210487413461125,0.24489795918367346,0.9619197033533619,1.0,1/5,2.18%,SLC25A29
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6121694526778441,1.2097987911625987,0.3088235294117647,1.0,1.0,2/23,5.64%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.4507844260555542,-1.209607444931053,0.12,0.9634353453073791,1.0,4/91,4.37%,GPR3;PER2;ELOVL6;ADCYAP1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.6083353589683875,-1.2094140591188183,0.29411764705882354,0.9629332237861908,1.0,3/16,6.84%,GCK;BCKDK;CRY1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8113751053466312,1.209382496019926,0.2545454545454545,1.0,1.0,1/5,7.63%,SLC26A6
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.7495582896884341,1.20932462336996,0.189873417721519,1.0,1.0,3/8,17.53%,BTG1;STK17B;STK17A
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.7311108499489379,1.2092448933034634,0.24615384615384617,1.0,1.0,2/9,1.05%,ENPP2;PLA2G10
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.4934877185311603,-1.2090060804117782,0.13043478260869565,0.9628040596739986,1.0,5/60,2.67%,UGT2B15;RFX6;APOB;TPH1;LIPC
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.42844166343242923,-1.208627019241584,0.14285714285714285,0.962740735102621,1.0,19/157,10.89%,ARC;TSKU;MFSD2A;LZTS3;WNT3A;PRAG1;PTPN9;GPC2;PTPRO;APOE;STYXL1;ARSB;MINAR1;RAPGEF1;PTPRS;RTN4RL2;NCS1;DAB2IP;NTRK1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.5332271454064668,-1.2086069496440888,0.2702702702702703,0.9613272122734391,1.0,8/44,15.97%,GMNC;ESCO2;DSCC1;CTC1;ATR;STN1;BRPF3;CCDC88A
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5226736747662758,1.2085777959402317,0.17105263157894737,1.0,1.0,17/115,12.81%,C2ORF78;NEK2;TEX101;SLC25A31;GALNTL5;SYCP1;BANF2;TOPAZ1;LRRC46;DAZL;IQCF1;BCL2L14;ASB17;PDCL2;MEIOC;STRA8;EFCAB10
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.7269684995621382,1.2085514752645372,0.2465753424657534,1.0,1.0,3/11,8.30%,MCM2;MCMDC2;MCM3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.7389035934598049,-1.207991801993396,0.3684210526315789,0.9619187607535874,1.0,3/8,12.08%,RAB7B;PTPRS;SLC15A4
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.6873597132055201,1.207654370005245,0.18571428571428572,1.0,1.0,1/12,0.40%,COX6A1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.5098019522102498,1.2075565072933159,0.16470588235294117,1.0,1.0,15/123,11.65%,AMBP;APOL1;ITGB2;SCGB3A2;LRP2;SFTPD;ITGAM;JCHAIN;CD81;STAB2;RAMP3;DAB2;PPT1;HPR;SYK
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5420058755595646,-1.2075027259253077,0.20588235294117646,0.9621393625073098,1.0,3/24,9.15%,MT1G;SLC30A10;SLC30A5
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.6542540179047059,1.207461560664555,0.2153846153846154,1.0,1.0,4/18,19.32%,INTS5;EXOSC2;EXOSC8;EXOSC4
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),-0.7190276192411094,-1.2072157310735976,0.3157894736842105,0.9602839083038566,1.0,1/5,5.64%,PDZD7
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),-0.7190276192411094,-1.2072157310735976,0.3157894736842105,0.9602839083038566,1.0,1/5,5.64%,PDZD7
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.8148997797718787,1.207203703819872,0.21818181818181817,1.0,1.0,2/5,10.99%,EIF6;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.8093214780506077,1.2064442798531287,0.26785714285714285,1.0,1.0,2/5,10.99%,USP50;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.6770767859635616,-1.206167717810043,0.2631578947368421,0.9627106742947193,1.0,4/6,30.49%,CEP250;MARK4;BICD1;PARD6A
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.5562433028860182,1.20600046562213,0.20270270270270271,1.0,1.0,11/51,14.67%,ANXA1;TNFRSF1B;CCL5;PTPRC;SFTPD;VSIG4;IL27;CD80;TNFSF4;HLA-DPB1;PDCD1LG2
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.7677279005909009,-1.2056412028179921,0.25,0.9633171967779316,1.0,3/6,10.78%,APOE;LHFPL4;SHISA7
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.48665645507112587,-1.2056193014740884,0.21739130434782608,0.9619393841654125,1.0,12/67,11.63%,AOAH;METRNL;CDH5;PRKCD;TYRO3;IFI16;APOE;MEFV;CCN3;SHARPIN;NR1D1;MVK
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5129977247893878,1.2054732267599617,0.15853658536585366,1.0,1.0,18/115,9.85%,GATA4;MYH1;NRAP;TMOD4;MYH8;PRRX1;CASQ2;MYH4;ASB5;LMOD1;SIX4;SGCG;NID1;CAV3;CKMT2;MMP9;KLHL38;ANGPTL2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.7883703031904463,1.2053342683430432,0.2857142857142857,1.0,1.0,1/6,3.06%,AHR
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.7697208319823698,-1.205298927401884,0.2826086956521739,0.9604638122999848,1.0,1/6,4.53%,IWS1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.7697208319823698,-1.205298927401884,0.2826086956521739,0.9604638122999848,1.0,1/6,4.53%,IWS1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.5364869020793008,-1.2052915427015267,0.17391304347826086,0.9590107656853101,1.0,9/46,14.23%,PER2;LIMK1;CRY1;USP4;MINAR1;ARRB2;U2AF2;CHP1;SIRT7
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.6129031309475353,-1.2045847656904083,0.1935483870967742,0.9605607153155554,1.0,9/17,27.02%,ERBB2;FLNA;SIRT7;BNC1;EIF2AK3;WDR75;DHX33;WDR43;UBTF
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.6055535759670555,-1.2045537761110217,0.2,0.9591546784129228,1.0,5/13,26.81%,CLIP3;CAMSAP3;ARHGAP21;SPG11;DYNC1I2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.5113961977140004,-1.2042570492730362,0.20689655172413793,0.958649748889925,1.0,14/36,24.88%,PIWIL2;TRIM71;KHSRP;DGCR8;AGO2;DTD1;PIWIL1;MAPT;XPO5;TARBP2;PARN;TUT7;PLD6;DROSHA
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.6988532711170679,1.2040808576740143,0.21311475409836064,1.0,1.0,3/13,15.81%,CEP55;CHMP3;MITD1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5594635181306037,1.2040451526662734,0.22077922077922077,1.0,1.0,22/71,17.35%,CCDC60;CCDC187;LRRC46;C11ORF16;ECT2L;VWA3B;FAM81B;CFAP126;MAP3K19;DYDC2;CCDC39;ANKUB1;RSPH10B;ZMYND10;DCDC2B;AKAP14;DRC3;MORN5;EFHB;DNAH3;DNAI1;BPIFB1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),0.7532823840191978,1.2036082228106648,0.22784810126582278,1.0,1.0,3/7,17.53%,BTG1;STK17B;STK17A
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.5827898642868348,1.2033487696341083,0.17142857142857143,1.0,1.0,6/40,13.90%,ITGB2;CAV3;CD81;RAMP3;SYK;LDLRAP1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.675133068244586,-1.2028073951867695,0.34210526315789475,0.9630077520439775,1.0,3/8,20.94%,EPHB2;NFIB;NCAM1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.5698213940779493,-1.202711134883113,0.2608695652173913,0.9619237240610226,1.0,5/18,22.44%,MSTO1;ALB;MARK2;TRAK2;MARK1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.7055621228700498,1.2022414024198353,0.24561403508771928,1.0,1.0,1/7,9.07%,LEF1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.485209573698152,-1.2022306830542986,0.17857142857142858,0.9624585589161934,1.0,6/38,10.77%,MFSD2A;SARM1;KIAA0319;LZTS1;DAB2IP;BCL11A
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.5567169836785697,1.2019495165518366,0.1625,1.0,1.0,13/58,15.45%,ENPP2;PLA2G10;RENBP;CYP3A4;CYP3A5;ERAP2;PPT1;LVRN;ANPEP;GADL1;PLA2G7;CLN8;SIAH1
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.7424126477938542,-1.2019015986005537,0.24390243902439024,0.962503589083166,1.0,2/6,15.49%,FRRS1L;FYN
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.6485752485572317,1.2016327981957942,0.2727272727272727,1.0,1.0,1/13,2.41%,SP100
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.6542529259937905,-1.2015861269107615,0.28205128205128205,0.9623153450661035,1.0,1/10,3.06%,DCPS
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.6326959097740339,1.2012989595116188,0.24615384615384617,1.0,1.0,3/21,12.59%,POLE2;RPA3;RPS27A
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.593970190066554,1.2011552936237075,0.22972972972972974,1.0,1.0,9/35,22.93%,CENPU;HAT1;OIP5;CENPX;ITGB3BP;CENPL;RBBP7;CENPN;CENPM
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6236803533802436,1.2007407496288978,0.23076923076923078,1.0,1.0,4/22,13.26%,SLC12A7;SLC12A3;CYP4F12;PDK4
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.6601208383153269,1.2006950898487572,0.1864406779661017,1.0,1.0,4/15,17.93%,CRLF1;IL27;STAT1;OAS2
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.6915167740216593,-1.200649325639909,0.37142857142857144,0.9643920903066301,1.0,3/7,5.28%,APOB;LIPC;APOE
prerank,GO_Biological_Process_2021__pharyngeal arch artery morphogenesis (GO:0061626),-0.736723900123176,-1.2005864493776803,0.3076923076923077,0.9631661576002873,1.0,3/5,24.94%,HES1;TGFB2;BMP4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5586933119650527,1.2005407671724668,0.22666666666666666,1.0,1.0,1/34,0.39%,NEK2
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.6642246335525108,-1.2005013308767356,0.23529411764705882,0.9620493729409502,1.0,4/11,17.62%,SOX12;PKD2;DLL1;NF1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.7334624611202047,1.2004526677039744,0.2857142857142857,1.0,1.0,3/8,12.31%,CCL5;PIK3CG;GPR183
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.662249225290656,1.2004330502437566,0.19402985074626866,1.0,1.0,4/21,11.13%,AIM2;TRAF3IP2;ZDHHC11;STAT1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.5644414227739469,1.2003780450563568,0.16923076923076924,1.0,1.0,4/35,14.86%,NEK2;RPS27A;CDC14A;ANLN
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.6491612508543789,-1.2001773548299393,0.23529411764705882,0.9617997170649059,1.0,5/7,24.91%,RAD50;ERCC1;ATM;NBN;SMG6
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5243583614016439,1.2001039255997314,0.21333333333333335,1.0,1.0,9/52,15.85%,CIDEB;BOK;GPER1;MOAP1;MMP9;PINK1;DCN;PLAUR;BBC3
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5924085971061784,-1.2000335211199398,0.20588235294117646,0.9608986464325787,1.0,3/11,21.32%,SPAST;SIRT7;CTDP1
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.7724883530015625,-1.1999309655608088,0.29411764705882354,0.959874208977517,1.0,2/7,10.37%,CRLS1;PGS1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.5353358343160143,-1.1996869485993975,0.2,0.9595659536314821,1.0,8/31,10.56%,GRP;GCK;ADCYAP1;DOC2B;CAPN10;CRH;NLGN2;HFE
prerank,GO_Biological_Process_2021__maintenance of protein location in extracellular region (GO:0071694),0.7818661448657739,1.1996567092589996,0.2222222222222222,1.0,1.0,2/5,18.23%,DAND5;FBN2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.6852350824505328,1.198989013810631,0.22580645161290322,1.0,1.0,1/12,2.05%,ANXA1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.617798543243156,1.1987684912635526,0.2608695652173913,1.0,1.0,3/21,10.17%,ENDOG;H1-0;DNASE2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.730855761471646,-1.1986592124200568,0.2702702702702703,0.9618766156636951,1.0,1/5,17.06%,MTMR1
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.7554324618978452,-1.1985561044455537,0.35,0.9609598344996504,1.0,2/5,18.58%,GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6155056723470484,1.1984799992051838,0.234375,1.0,1.0,2/20,2.84%,ADA;CCL5
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.761205900291302,1.1974323979099972,0.17647058823529413,1.0,1.0,1/7,4.71%,SFTPD
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.761205900291302,1.1974323979099972,0.17647058823529413,1.0,1.0,1/7,4.71%,SFTPD
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5019542032283907,1.1972906823911829,0.14634146341463414,1.0,1.0,29/122,19.48%,GATA4;GPR55;ALKAL2;CCL5;PTPRC;FGF2;TGFB1;SCIMP;GPER1;FLT4;ERBB4;P2RY6;NODAL;ATP6AP1;RAMP3;IL26;GPR183;TNFAIP8L3;ALOX15;OPRM1;CD44;PRXL2C;MAPK3;HTR2B;CSF1R;AGER;CD4;F2RL1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of blood vessel remodeling (GO:0060312),0.8025032780033836,1.1970286077831502,0.2033898305084746,1.0,1.0,2/5,6.91%,TGFB1;FLT4
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.6705678934183121,-1.1969198112945107,0.27586206896551724,0.9653289915453214,1.0,2/7,13.55%,CX3CR1;CARD9
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.5044755500486574,1.1967688210582563,0.1744186046511628,1.0,1.0,8/122,7.49%,GPR62;TMEM100;TRIL;STMN4;SOX10;LRRC3B;LY6H;PLP1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.7254419334864106,1.196657652996087,0.22388059701492538,1.0,1.0,3/10,19.13%,PLEKHH2;VIL1;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7475804266601302,1.1966569025203502,0.26666666666666666,1.0,1.0,1/6,6.32%,GPER1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.5765297326271307,-1.1964427648709133,0.18181818181818182,0.9660571104060055,1.0,4/23,7.64%,NOX4;TST;MTHFR;CBS
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7559291813157332,1.1961896218488666,0.19047619047619047,1.0,1.0,1/9,1.66%,MYRF
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.7028007506558338,1.1960410342651555,0.288135593220339,1.0,1.0,1/7,10.49%,AXL
prerank,GO_Biological_Process_2021__bundle of His cell action potential (GO:0086043),0.7944909585091172,1.1957463430176614,0.19672131147540983,1.0,1.0,1/5,6.02%,KCNA5
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6977981870295615,1.1952559135071716,0.16666666666666666,1.0,1.0,2/11,11.13%,IL12A;STAT1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6157879236080609,1.19521205747915,0.19718309859154928,1.0,1.0,4/29,18.55%,TRAPPC3L;RAB6D;RAB6B;GABARAPL2
prerank,GO_Biological_Process_2021__nephron tubule development (GO:0072080),-0.7986261769143512,-1.1950702371308124,0.28,0.9698646039783884,1.0,1/5,1.20%,OSR1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7597327630597998,1.195039871434992,0.2727272727272727,1.0,1.0,1/6,9.69%,SOD2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.7121591256805345,-1.1949962984858988,0.3170731707317073,0.9686920011766909,1.0,1/5,10.82%,PLEKHM1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.47041219730495604,1.194825679922347,0.14772727272727273,1.0,1.0,55/184,25.66%,PWP2;RPL21;RPL37A;RPL18A;RPL9;NOB1;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;EXOSC2;EIF6;EXOSC8;RPL36;RPS19;RPL41;NOP53;RPL27A;RPL32;RPL35A;GLUL;RPL7A;RPL11;RPS7;RPL23A;RPL7;RPLP2;ZNF622;WDR36;RPLP0;EXOSC4;RPS14;RPS6;RPL38;RPL23;RPS15;WDR18;RPL24;RPL18;RPL35;RIOK2;RPS27;RPL8;IMP3;RPL10;RPS28;SENP3;RPL27;RPS24;EMG1;RPL29;WDR12;RPLP1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.6834192989769408,-1.1946663344268023,0.21875,0.9682286742701547,1.0,5/9,26.67%,PGAP1;STX18;TBC1D20;SORL1;RINT1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle tissue development (GO:0045843),0.7921812097750578,1.1946600656619324,0.22807017543859648,1.0,1.0,1/5,5.45%,TGFB1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.6967215095534084,1.1943859172322977,0.265625,1.0,1.0,1/10,1.39%,ADA
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.5557105728834403,1.1942173331619288,0.18309859154929578,1.0,1.0,22/63,15.17%,ITGB2;CYTIP;TLR2;ITGAX;AHR;PTPRC;FCGR3A;SASH3;HLA-F;ITGAM;NFAM1;PTAFR;FGL2;HLA-DMA;HCK;CD80;NAPSB;EPCAM;HLA-DPB1;HK3;IGSF6;TAGAP
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.6943633339984363,1.1940663311170872,0.22857142857142856,1.0,1.0,3/11,15.86%,SCIMP;SCARA3;COLEC12
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.5406499451516767,1.1940154249933213,0.20512820512820512,1.0,1.0,9/48,17.19%,ENPP2;RAB11A;MCC;MARVELD3;VIL1;SOX9;DOCK5;GLUL;IL4
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7011045893598646,-1.1939931057359432,0.3142857142857143,0.9690726741080945,1.0,1/11,0.19%,PER2
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.7455840289295997,1.193566294973661,0.2962962962962963,1.0,1.0,5/8,23.79%,PDE6A;CNGA1;PDE6B;PDE6G;GNGT1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4328508818837054,-1.1935275288467215,0.16666666666666666,0.9695416195817905,1.0,30/149,11.21%,SPRY4;KCNIP3;MYO10;TEAD2;PRDM5;RAI14;DPPA2;PIWIL2;DSG2;KIT;COL4A2;RND3;PARD3;TEAD4;KITLG;PTPRF;FZD7;ERBB2;MID1;FSTL1;HES1;FBXO15;ITGA4;DCBLD2;NACC1;ZFX;WWC2;ARHGAP42;ADGRA3;NAV2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5807434885824236,1.193094339736985,0.2638888888888889,1.0,1.0,7/28,18.29%,PIK3R3;FGF2;FLT1;TGFB1;P2RY12;TNFAIP8L3;WASHC1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7157937471670472,1.1929062839099742,0.19696969696969696,1.0,1.0,3/11,12.38%,BACE2;ITM2A;ITM2C
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6063772424019214,-1.1927606713044898,0.3055555555555556,0.9710013231924187,1.0,2/12,6.03%,SIGIRR;MEFV
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.6778064146999906,-1.1926128537986236,0.2631578947368421,0.9701245486831306,1.0,2/7,9.16%,APOH;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7217595487284716,-1.1925254066210467,0.34146341463414637,0.9690030126270369,1.0,1/5,1.68%,UBASH3B
prerank,GO_Biological_Process_2021__proline transmembrane transport (GO:0035524),-0.7532583294335482,-1.1924817876540923,0.26666666666666666,0.9677612564337909,1.0,1/5,2.98%,SLC6A20
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7626042152535821,-1.1924801871834372,0.29545454545454547,0.9663587038882345,1.0,1/5,4.51%,TST
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.557729510735901,-1.1924076136852162,0.24242424242424243,0.9651654079988891,1.0,3/22,6.17%,IBA57;NDOR1;HSCB
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.6987410064583507,1.1923677047416719,0.24074074074074073,1.0,1.0,2/10,19.36%,MOAP1;BLOC1S2
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.615738256501221,-1.192175278809837,0.2702702702702703,0.9645697728037567,1.0,2/15,1.65%,OSR1;WNT3A
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.7172254400362716,-1.1918273328387479,0.22727272727272727,0.9644873690390231,1.0,1/7,2.77%,RNF168
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6754085845909279,1.1917558494879679,0.26666666666666666,1.0,1.0,3/12,19.67%,PTPRC;GLI3;RAG1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.7941132747674957,1.1916965257596661,0.2807017543859649,1.0,1.0,3/6,8.79%,ANXA1;STOML2;HLA-A
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.5933275244473317,1.1915347340823108,0.2028985507246377,1.0,1.0,9/27,27.38%,NOX5;ATP6V0E2;ATP1A4;UCP1;SLC46A1;HVCN1;SLC36A3;ATP1A1;ATP6V0D1
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.7767686829425089,-1.1914568943135821,0.3142857142857143,0.9643847717340799,1.0,4/5,22.25%,SIRT7;FBL;FBLL1;CREBBP
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.5711479407923593,1.1912404064910214,0.18055555555555555,1.0,1.0,8/42,9.80%,AQP3;ESR1;ANXA1;WNT8B;CCL5;TGFB1;SOCS2;CYP1B1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.48825370095496656,-1.1909072329905952,0.19047619047619047,0.9650577311530819,1.0,16/53,19.74%,PLK3;MAP10;CLIP3;PCM1;TUBGCP2;CLIP2;SPAST;SLK;CHP1;CCDC88A;CAMSAP3;TRPV4;RHOA;CCDC88B;HOOK3;MAPT
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.7759125587284653,1.1906424663417312,0.2542372881355932,1.0,1.0,3/6,12.31%,CCL5;PIK3CG;GPR183
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.554137211173169,1.190575854474593,0.16883116883116883,1.0,1.0,15/49,19.90%,PSMB9;TIMP3;VSIR;A2ML1;SERPINB7;SERPIND1;SPOCK3;SERPINE3;SERPINB1;KNG1;AGT;VTN;SERPINA10;SERPINB5;SERPINF1
prerank,GO_Biological_Process_2021__negative regulation of macrophage migration (GO:1905522),-0.713156091806628,-1.1900647018935608,0.3023255813953488,0.9665436489895612,1.0,3/6,23.84%,EMILIN1;CD200R1;C5
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5579877291009611,1.1900468425992878,0.22857142857142856,1.0,1.0,1/32,0.44%,RAB34
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7179522931425661,1.190000725753387,0.3125,1.0,1.0,3/9,17.62%,NPR2;GUCY2F;NPPA
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.5927707233054142,1.189740925526976,0.13636363636363635,1.0,1.0,4/28,11.53%,HSPA1L;ARIH2;PINK1;RHOU
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.6568285126906968,-1.1897079845996332,0.3076923076923077,0.9662351123268187,1.0,3/5,16.04%,SMARCB1;PIH1D1;AUTS2
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.7136728866179163,-1.1895647529415725,0.35294117647058826,0.9653383556994755,1.0,2/5,15.84%,SPATA7;ZDHHC3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.6904143459462174,-1.1895281802109645,0.3611111111111111,0.9640993221019732,1.0,2/9,9.11%,RALB;LRSAM1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6456406231027747,1.1893739322767343,0.27692307692307694,1.0,1.0,2/12,4.64%,ANXA1;FGF2
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.6861226316363673,1.1893162347820552,0.288135593220339,1.0,1.0,6/16,18.34%,PRDM12;OPRM1;MME;CHRNB2;OPRL1;PTGES
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.6834330448459167,1.1893128353413827,0.2833333333333333,1.0,1.0,1/10,2.31%,RENBP
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.5520737828970955,1.1892519987943357,0.2328767123287671,1.0,1.0,16/52,23.25%,CDC25A;CCNG2;CCND1;CDKN1B;CDK5R1;CCND2;CCNE2;CCNI;CDKN1A;CCNA2;PKMYT1;CDKN2C;CCNB1;CCNI2;CDK5R2;CCNB3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.5437062155660599,1.1891706132796689,0.17333333333333334,1.0,1.0,13/60,24.88%,PSMB9;SNAP23;HLA-F;HLA-A;CYBA;PSMC5;PSMB6;B2M;TAP1;PSMD6;PSMA3;PSMA7;HLA-B
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6564174940111525,1.188768535532572,0.3225806451612903,1.0,1.0,3/10,25.06%,TGFB1;MAP2K1;MYCN
prerank,GO_Biological_Process_2021__cardiolipin biosynthetic process (GO:0032049),-0.8190400761143957,-1.1885570824099532,0.32432432432432434,0.9663275861410273,1.0,2/5,10.37%,CRLS1;PGS1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6744543718719825,-1.1885010640205205,0.2682926829268293,0.9637159033757329,1.0,5/6,30.88%,DPH1;DPH5;DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6744543718719825,-1.1885010640205205,0.2682926829268293,0.9637159033757329,1.0,5/6,30.88%,DPH1;DPH5;DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__regulation of thymocyte apoptotic process (GO:0070243),-0.739057501107838,-1.1882649273938821,0.3333333333333333,0.963010633394198,1.0,1/5,6.60%,ADAM8
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.7110181350242033,-1.1879143497404345,0.2702702702702703,0.9630122950819672,1.0,1/7,1.25%,IL11
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.684437464379078,-1.1879095665955817,0.2972972972972973,0.9616463201953261,1.0,2/9,3.47%,DUSP4;DUSP2
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4643536886781752,-1.1878204965996175,0.23809523809523808,0.9605854711108084,1.0,13/65,17.79%,PLK3;SMYD5;FGF1;PRDM15;RAB11FIP3;ESRRB;MYO19;FGFR2;DLL1;ENTR1;NCOA3;EFHC1;PLK5
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.7497598395443644,1.1875872852615401,0.2909090909090909,1.0,1.0,1/6,10.20%,ITGA5
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5306634498146834,1.1875468700593148,0.2112676056338028,1.0,1.0,15/75,17.01%,DENND1C;AQP3;ELMO3;CARD14;DTX2;TRIM25;UPK1B;POLD4;TMEM79;TMC4;TJP3;ALOX15;SPINT1;UPK3A;SLC14A1
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.666640721552197,-1.187229228036542,0.30303030303030304,0.9612724374775196,1.0,4/10,13.61%,DDX11;ZNF618;MED25;KDM4D
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.48779981717836246,-1.187078371968389,0.13636363636363635,0.9603953563319881,1.0,10/42,18.09%,NEU4;FBXO27;DAB2IP;DNASE1L1;RNASET2;PABPC4;NGLY1;FBXO44;ADAMTS9;HTRA2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5769764968195114,-1.1870320688295868,0.19444444444444445,0.9592607653763515,1.0,9/21,26.09%,NAB2;ICE1;CHD8;CEBPA;DHX36;BRF2;ZNF345;RPTOR;POLR3F
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.6094310514495767,-1.1869872843430291,0.21621621621621623,0.9580894292559842,1.0,1/15,1.38%,METRNL
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.6626916256132924,-1.1868200794894483,0.2222222222222222,0.9574797783063934,1.0,3/6,19.42%,FSTL1;GREM1;CHRDL1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7148781016198755,-1.1867196773571314,0.2777777777777778,0.9563739773441944,1.0,1/7,3.60%,NOP9
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5581659685055353,1.1864498545316808,0.22058823529411764,1.0,1.0,3/30,14.84%,KIF14;CDKN1B;CDKN1A
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.6543994353660085,-1.186391233488314,0.2894736842105263,0.9565042455501549,1.0,2/13,12.66%,RNF168;EAPP
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.7662562327023515,1.1860237503851725,0.23333333333333334,1.0,1.0,1/5,4.99%,HEY2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5826108555628957,1.1859689146042067,0.23684210526315788,1.0,1.0,7/31,17.07%,CASQ2;MYBPC3;SGCG;TRDN;CSRP3;SGCZ;MYH7
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.6828627662423219,1.1858247236459023,0.29577464788732394,1.0,1.0,2/11,6.32%,PLA2G10;GPER1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6832672730935679,-1.1857492237243916,0.2222222222222222,0.9574483562847222,1.0,3/13,8.79%,SMPD3;PRKCD;NSMAF
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7451706764420641,-1.185606778339062,0.4,0.9566843650292426,1.0,2/5,20.45%,RAB7B;GCC2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.45763308054763546,1.1854396918379577,0.14457831325301204,1.0,1.0,22/153,10.66%,SQOR;SMAD6;BACE2;TIMP3;C1QTNF1;SMOC1;LMOD1;LOX;GNG12;ITGBL1;HEY2;SCARA3;UACA;COL4A4;ENPP4;COL4A3;CYP1B1;DCN;ANGPTL2;ITGA5;COL1A1;ADGRL4
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.7298976188814978,1.1854330060685139,0.265625,1.0,1.0,1/7,6.02%,KCNA5
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein particle clearance (GO:0010986),0.7641239549131754,1.1850729497631407,0.3620689655172414,1.0,1.0,3/5,18.25%,GPIHBP1;LDLRAP1;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.4455230541006879,-1.1850722159273872,0.09090909090909091,0.9570908993661914,1.0,18/74,20.24%,CDH5;SMPD3;LIMK1;SYNPO;RAB7A;EMILIN1;DAB2IP;SNF8;SLX4;SPIDR;SDCBP;PIH1D1;SDC4;PRKCA;ERCC1;ICE1;TSG101;STX18
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.6134535460850863,1.1849763914899119,0.2911392405063291,1.0,1.0,1/22,0.39%,NEK2
prerank,GO_Biological_Process_2021__multinuclear osteoclast differentiation (GO:0072674),0.772350457984115,1.1847008282066773,0.234375,1.0,1.0,1/5,6.54%,CD81
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.7025078571982775,1.1845892493822987,0.2222222222222222,1.0,1.0,3/11,17.19%,CD81;TNFSF4;IL4
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.49763619690534633,-1.1843111631850454,0.2222222222222222,0.9585246323111586,1.0,6/42,10.33%,EYA4;RNF168;BRCC3;RADX;ERCC8;WRAP53
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.458259256798248,-1.1842196921338675,0.15384615384615385,0.9574858610496193,1.0,13/90,12.61%,CPSF1;NUP210;MAGOHB;POM121C;NUP42;NUP214;AAAS;SRRM1;SRSF4;SYMPK;UPF2;NXF5;U2AF2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.4779751355427867,1.1841685405930917,0.15476190476190477,1.0,1.0,54/165,25.66%,PWP2;RPL21;RPL37A;RPL18A;RPL9;NOB1;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;EXOSC2;EIF6;EXOSC8;RPL36;RPS19;RPL41;NOP53;RPL27A;RPL32;RPL35A;RPL7A;RPL11;RPS7;RPL23A;RPL7;RPLP2;WDR36;RPLP0;EXOSC4;RPS14;TSR3;RPS6;RPL38;RPL23;RPS15;WDR18;RPL24;RPL18;RPL35;RIOK2;RPS27;RPL8;IMP3;RPL10;RPS28;SENP3;RPL27;RPS24;EMG1;RPL29;WDR12;RPLP1
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.7552394583215281,1.1837775783191178,0.2916666666666667,1.0,1.0,2/7,15.06%,ERBB4;FOXB1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5428641096684784,-1.183707391134351,0.25,0.9586192472712218,1.0,8/35,17.41%,PHLDB2;MAP10;ERBB2;IGBP1;MARK2;CAMSAP3;MARK4;TRAF3IP1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.45928534772718466,-1.1837025715824803,0.16666666666666666,0.9572878316500119,1.0,4/57,1.81%,P2RY10;CD38;IGLL3P;IL16
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.5547089999134852,-1.1836371527690155,0.18518518518518517,0.9561764343367463,1.0,7/25,15.97%,KIT;CDH13;PTPRO;ARFIP2;SRGAP2;ABLIM3;CCDC88A
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.38198191421972205,-1.1835706431289874,0.09090909090909091,0.9551663090689126,1.0,63/250,19.54%,EMP1;CFAP221;IFT88;ABCC4;KIT;CDH13;DCDC2;MKS1;PTPRO;CNGA4;EXOC7;CFAP410;SCLT1;EHD4;PARVA;TTC36;PCM1;CEP83;FSCN1;TMEM138;ARFIP2;FLNA;GBF1;SRGAP2;RILPL1;PPP1R9B;DZIP1L;FGD1;FGD5;CLUAP1;ASAP1;EMP2;EHD3;RAB11FIP3;CFAP44;ABLIM3;CEP250;AVIL;FBF1;CILK1;DNAH5;CFAP70;SDCBP;DYNC2I1;B9D1;IFT81;CCDC88A;AHI1;EMP3;CCDC57;TCTN1;TEKT3;CEP290;ARMC9;TRAF3IP1;KIF27;CYS1;IFT43;NOTCH1;CEP41;KIF24;IFT52;VCL
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.48692707631713417,-1.1834991383794626,0.25,0.9541001435206234,1.0,13/57,15.55%,BUD23;NSUN4;TRDMT1;METTL1;TFB1M;METTL8;PCIF1;METTL6;TRMT61B;TRMT61A;ALKBH8;ZCCHC4;FBL
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.6559295196492619,-1.183367887854075,0.275,0.9532915207192292,1.0,3/11,6.59%,PAH;FADS1;RGN
prerank,GO_Biological_Process_2021__caveolin-mediated endocytosis (GO:0072584),-0.7117491354900447,-1.1833458170026439,0.3333333333333333,0.9520744229281344,1.0,1/5,2.68%,PACSIN2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.7004558654628591,-1.1832752106288877,0.3235294117647059,0.9509778608700866,1.0,3/8,19.85%,APOE;ABL1;DNM2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.4820818118653022,1.1831971724563786,0.12643678160919541,1.0,1.0,63/160,27.33%,RPL21;RPL37A;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;EXOSC8;RPL36;RPS27A;RPS19;RPL41;RPS11;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;RPSA;RPL7A;RPS13;RPL11;RPS7;RPL23A;RPL7;RPLP2;RPLP0;EXOSC4;RPS14;RPS6;CNOT8;RPL38;RPL23;RPS15;CSDE1;RPL24;PNLDC1;RPL18;RPL35;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;RPL27;RPS24;ZFP36;UPF1;RPL29;RPS18;RPLP1;NCBP1;RPS3;RPS23;RPL34;PAN2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5292186975114627,1.1830789572819695,0.2716049382716049,1.0,1.0,10/77,9.23%,RASGRP4;RRAS;WNT5A;PTPRC;HIPK1;FLT1;ARIH2;TGFB1;FLT4;PLD4
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5458482329143821,1.1829342531857356,0.22727272727272727,1.0,1.0,9/37,18.12%,CCL5;CRLF1;CLCF1;IL12A;ERBB4;IGF1;PARP14;IL4;CSF1R
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.5943502371249637,-1.1827294225198923,0.2553191489361702,0.9516786476045304,1.0,1/12,0.17%,COL22A1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),-0.7652421411600381,-1.1825826658275183,0.3269230769230769,0.9508972708354946,1.0,2/5,22.95%,ITGA4;PLPP3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.7051366516817097,1.1823323940648214,0.2318840579710145,1.0,1.0,4/8,22.71%,RAMP3;GRM6;CXCL12;CALCR
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.727353163399748,1.182285142773768,0.32727272727272727,1.0,1.0,4/7,21.62%,ALDOB;GLYCTK;TPI1;TKFC
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),0.7713423991093125,1.1822526938104345,0.15873015873015872,1.0,1.0,2/6,17.19%,CD81;IL4
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),0.7713423991093125,1.1822526938104345,0.15873015873015872,1.0,1.0,2/6,17.19%,CD81;IL4
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.693008394615206,1.182208424427725,0.35714285714285715,1.0,1.0,2/12,6.28%,SMAD6;MESP1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.7272648525091863,-1.1821600284146256,0.20689655172413793,0.9506237404160465,1.0,2/8,8.03%,TMEM106A;CX3CR1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.774434138414781,1.1818673554791643,0.29508196721311475,1.0,1.0,3/7,19.85%,CKMT2;CKB;CKM
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.6251425929053365,-1.1814124477933856,0.2926829268292683,0.95237099904055,1.0,3/11,5.97%,LTC4S;FADS1;PLA2G5
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5917353397422022,-1.1813809969856501,0.24324324324324326,0.9512039441458918,1.0,5/10,22.46%,MUS81;DNASE1L1;FBH1;XRN2;SETMAR
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.7942484507778838,1.1813525844212955,0.25925925925925924,1.0,1.0,1/6,1.39%,ADA
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.5547612906908257,-1.1813359324365171,0.2647058823529412,0.9499819667600916,1.0,4/17,10.00%,NMU;MYOCD;CNN1;KCNB2
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.7155568449803897,1.1811233893779534,0.265625,1.0,1.0,1/9,1.89%,TMEM100
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.5764424488665739,-1.180753034338879,0.2222222222222222,0.9510265671555646,1.0,2/21,2.20%,MT1G;FOS
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.49712100907004053,-1.18067096363458,0.2727272727272727,0.9499433843239977,1.0,15/46,15.88%,GLA;SMPD3;STS;SMPD4;NEU4;ESYT3;NEU3;ST3GAL2;B4GALNT1;ST6GALNAC3;ST3GAL4;ESYT1;PGAP1;SUMF2;FUCA1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.41335058882799525,-1.1805575506065384,0.2631578947368421,0.9490174795348032,1.0,22/131,14.69%,ARC;NGF;SLITRK6;DCDC2;S100B;PARD3;SPTBN4;WNT7A;EPHB2;SHANK1;SLITRK2;SRGAP2;NYAP2;DAB2IP;ALCAM;MNX1;TAOK2;LLGL1;IMPACT;DBNL;FGFR2;DSCAML1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.7899715180391469,1.1805406339738314,0.31343283582089554,1.0,1.0,1/5,4.80%,STAT5A
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.668048177737185,1.180183754203527,0.2647058823529412,1.0,1.0,3/9,19.81%,GNAT3;ASIC1;PKD1L3
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.7473981880288091,1.1799630523097582,0.25862068965517243,1.0,1.0,3/6,22.03%,TCN1;AMN;CBLIF
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.7167948920750884,-1.1798956705199053,0.275,0.9501747231811583,1.0,1/6,8.03%,CX3CR1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6354837153770392,-1.1794224910630005,0.2558139534883721,0.9501937268967653,1.0,2/9,6.80%,MTHFR;MTHFD1L
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.4138173854109947,-1.1794161727187953,0.09090909090909091,0.9489446273330435,1.0,14/58,14.21%,RASSF2;DUSP15;SH3RF1;FZD7;MAP3K10;WNT7A;CCN2;SH3RF3;DAB2IP;TAOK2;DUSP19;CARD9;TRAF3;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.7519371920211877,1.1794029005611704,0.3013698630136986,1.0,1.0,2/5,18.12%,MAPK3;CSF1R
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.4838332981652414,1.1782625469585142,0.18604651162790697,1.0,1.0,14/169,7.49%,GPR62;ENPP2;MYRF;GJC3;SHISA6;STMN4;SOX10;ST18;MOBP;FAM181B;HTR5A;NFE2L3;LY6H;PLP1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6702607707762738,1.1777664134885815,0.25,1.0,1.0,5/19,13.85%,CDC25A;DTL;RAB11A;CCND1;FBXO5
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.6544762333995072,-1.177734109191959,0.325,0.9530904292109696,1.0,2/12,12.66%,RNF168;EAPP
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.6291121306937688,-1.1776787557259343,0.23076923076923078,0.9519365960242595,1.0,5/8,30.88%,DPH1;DPH5;DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6010614582606839,1.1776714355762996,0.2463768115942029,1.0,1.0,4/26,5.45%,GATA4;SMAD6;HEY2;TGFB1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.5595784640051846,-1.1773071723223112,0.2647058823529412,0.9524314974769394,1.0,3/21,6.17%,IBA57;NDOR1;HSCB
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.6898794664464951,1.1771205149724797,0.25757575757575757,1.0,1.0,3/10,19.04%,STEAP4;COX17;ATOX1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.45168901497561575,-1.176454192790252,0.15384615384615385,0.954167171551416,1.0,13/93,12.61%,CPSF1;NUP210;MAGOHB;POM121C;NUP42;NUP214;AAAS;SRRM1;SRSF4;SYMPK;UPF2;NXF5;U2AF2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.5889297579701003,-1.1758956571900987,0.2972972972972973,0.9549058256813816,1.0,7/20,19.31%,ADRA1A;GRIN1;TRPM2;JPH3;TRPV4;JPH4;JPH1
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),-0.6365707636546011,-1.1757654363983683,0.30434782608695654,0.9542512628865903,1.0,4/11,10.09%,APOH;APOE;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.489882760102535,-1.175763156652811,0.19047619047619047,0.9529894210900113,1.0,9/47,9.39%,TSKU;WNT3A;PRAG1;PTPN9;PTPRO;APOE;MINAR1;PTPRS;RTN4RL2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),0.7596128611811647,1.175698031469996,0.2786885245901639,1.0,1.0,1/5,6.51%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5713751042781581,1.1756949898142535,0.2318840579710145,1.0,1.0,13/38,23.14%,CCL5;IL12A;F7;PLA2G7;ZNF580;MAPK3;CSF1R;CREB3;THBS1;F2RL1;CSF1;CXCL12;VEGFC
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.6666810437496096,1.1755074557142644,0.2535211267605634,1.0,1.0,2/16,5.51%,NEK2;BORA
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5928573367357587,-1.1753624123727433,0.28125,0.9530994568308545,1.0,6/12,28.98%,MSTO1;MAPT;TRAK2;TRAK1;MTM1;CLUH
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.6168502856983689,-1.1752198206823221,0.2702702702702703,0.9522601267173006,1.0,5/12,24.93%,SNX5;C1QTNF12;GKAP1;SORL1;ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.7899212428417464,1.175145868031061,0.25,1.0,1.0,2/5,18.64%,HSPA5;DNAJB9
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4978426166017197,1.174994494607746,0.18518518518518517,1.0,1.0,21/72,17.11%,TULP1;TYR;CRYBB1;CABP4;COL18A1;GPR179;COL1A1;DHRS3;FSCN2;CRYBB3;GRM6;CRYBG3;RABGGTB;ROM1;PDE6C;GNAT2;SLC24A1;PRPH2;GUCY2F;CHRNB2;TULP2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.6961924622325608,1.174810859532648,0.25757575757575757,1.0,1.0,3/11,11.84%,HLA-F;TGFB1;TGFB3
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5675638117954299,1.1746629500054477,0.23943661971830985,1.0,1.0,7/37,13.41%,ANXA1;PTPRC;STOML2;SFTPD;VSIG4;CD80;IRF4
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.6810707971034019,1.174428520390752,0.19047619047619047,1.0,1.0,5/15,19.32%,SLFN14;EXOSC2;EXOSC8;ERN2;EXOSC4
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6917781149564167,1.1737073305642118,0.2714285714285714,1.0,1.0,5/12,12.62%,ANXA1;CCL5;FLT1;MSMP;RPS19
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.709491910286591,1.173482054774665,0.23728813559322035,1.0,1.0,1/10,3.84%,STOML2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.6549829559046648,-1.1732068885848952,0.275,0.9579439215581401,1.0,3/15,10.54%,KLHL20;GBF1;DOP1B
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.7390153102806827,1.1730090803544237,0.22857142857142856,1.0,1.0,2/6,18.12%,MAPK3;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.6549694374533773,1.1730014261893287,0.2878787878787879,1.0,1.0,6/9,26.91%,F7;F8;A2M;TFPI;F10;F3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.4612835413843271,-1.1727790596814343,0.20689655172413793,0.9581983476698641,1.0,6/72,8.42%,CELA2A;GCK;FOXO1;CPEB1;CAPN10;SYAP1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.7535799415035359,1.1725769616684645,0.24193548387096775,1.0,1.0,1/6,5.45%,TGFB1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.7502099853648779,1.172315164686163,0.32653061224489793,1.0,1.0,2/8,12.72%,SCIN;TMSB10
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5386061971281769,1.1719093224254222,0.2638888888888889,1.0,1.0,5/40,12.05%,CLIC1;SLC26A6;SLC13A4;SLC4A1;GLRA1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6582361989032025,1.1718893625958986,0.25,1.0,1.0,1/12,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5073617706900313,1.1718581065491647,0.24050632911392406,1.0,1.0,21/79,23.25%,CDC25A;SPDYA;CCNG2;CDKN2A;CCND1;CDKN1B;CDK5R1;CCND2;CCNE2;CCNI;INCA1;CDKN1A;LATS2;CCNA2;PKMYT1;CDKN2C;PSRC1;CCNB1;CCNI2;CDK5R2;CCNB3
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.587485749531534,-1.1717331999728822,0.22580645161290322,0.9599645352516959,1.0,2/13,10.78%,EPHB2;SHISA7
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.6597898890193625,1.1714840069085954,0.3333333333333333,1.0,1.0,1/9,0.93%,SLC22A3
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5079743487272039,1.1714471756868583,0.25,1.0,1.0,20/73,17.11%,TULP1;TYR;CRYBB1;CABP4;COL18A1;GPR179;COL1A1;DHRS3;FSCN2;CRYBB3;CRYBG3;RABGGTB;ROM1;PDE6C;GNAT2;SLC24A1;PRPH2;GUCY2F;CHRNB2;TULP2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.4275470147530759,-1.171430296107791,0.15789473684210525,0.9597247047705726,1.0,25/140,13.96%,SPRED3;RASSF2;TRIB2;SPRED2;UBASH3B;SPRED1;PRKCD;TWIST1;PARD3;HSPB1;EPHB2;CEP85;MEN1;TRIB1;PID1;EMILIN1;DAB2IP;SLIT2;LDLRAD4;DEPTOR;DUSP19;CHP1;NLRP2B;CAMK2N1;IMPACT
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.43346484365820304,-1.1714244752524243,0.13793103448275862,0.958523895984628,1.0,14/65,11.43%,ADAMTS1;APOH;SPRED1;CREB3L1;COL4A2;VASH1;ANGPT4;GTF2I;MINAR1;MECP2;SERPINE1;EMILIN1;DAB2IP;NIBAN2
prerank,PanglaoDB_Augmented_2021__Platelets,0.48997536842909356,1.1713968975158167,0.14814814814814814,1.0,1.0,38/136,21.47%,ITGB2;NOX5;C3AR1;GP1BA;ITGAX;TNFRSF1B;GMFG;CCL5;FCGR3A;SASH3;ALOX12;ITGAM;NFAM1;FGL2;CLEC12A;ITGA2;HLA-A;F7;DAB2;HCK;CD244;CSF3R;P2RY12;MFSD2B;HK3;VWF;MAP3K7CL;ITGA2B;MYO1F;ALOX5AP;FPR1;THBS1;P2RX1;ADGRE3;PIK3R6;CD300LF;FERMT3;MYL9
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.6316779946827671,1.171181890861736,0.3283582089552239,1.0,1.0,2/16,5.64%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5326444324605654,1.1710695308741474,0.2236842105263158,1.0,1.0,13/62,24.88%,PSMB9;SNAP23;HLA-F;HLA-A;CYBA;PSMC5;PSMB6;B2M;TAP1;PSMD6;PSMA3;PSMA7;HLA-B
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),-0.6327090026145405,-1.1703954091850077,0.3225806451612903,0.9604144258771969,1.0,2/6,11.48%,PTPRO;EMP2
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.7396057046631015,-1.1703814816941656,0.30952380952380953,0.9591594718965046,1.0,4/5,23.79%,GTF2H2;ARRB2;ARRB1;DRD3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-0.6285560532323903,-1.1701367206001645,0.325,0.9588280768632014,1.0,3/7,29.68%,GNAS;DRD3;GNG2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5389671356272889,1.1700957591602301,0.26582278481012656,1.0,1.0,7/54,17.38%,SMAD6;TMEM100;TGFB1;NODAL;TGFB3;GDF9;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.7489631230647854,1.1696682579065136,0.35384615384615387,1.0,1.0,1/6,2.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.5946811687514924,-1.1694992558759758,0.3333333333333333,0.9595853749612474,1.0,2/12,1.90%,DRD4;PAH
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.739541228842362,-1.1694097597635336,0.3023255813953488,0.9586736417899195,1.0,1/6,7.95%,PTPRJ
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.7120380186418506,1.169409417392532,0.28846153846153844,1.0,1.0,1/7,2.31%,RENBP
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.728643069110271,1.1692860201430646,0.3050847457627119,1.0,1.0,1/6,2.80%,GMFG
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.5414420571687195,1.1692129407729999,0.19736842105263158,1.0,1.0,12/57,12.73%,ST6GALNAC1;CAPN13;PLEKHS1;CLCA4;CYP4F12;MAP3K19;FUT2;MUC4;DUOX1;CP;TMC4;TRIM29
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.4542280273530711,-1.1690670362730706,0.22727272727272727,0.958587376879126,1.0,8/89,2.74%,ADGRF4;EHF;ANXA8;CLDN4;EMP1;SLC25A37;BCL2;LAMA3
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7499763138919258,-1.168973484367107,0.2553191489361702,0.9575672731120334,1.0,3/5,19.74%,PPP5C;PPP1CA;MAPT
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.7750674442956678,-1.1685690530697985,0.35,0.9577625421025887,1.0,1/6,0.70%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.627917908795179,1.1684307393150284,0.28205128205128205,1.0,1.0,2/18,9.25%,GPER1;RAMP3
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.4843757948422695,1.168343242277449,0.1411764705882353,1.0,1.0,19/183,15.56%,NEK2;CDC25A;MCM2;BUB1;HSPA8;POLQ;TGFB1;H2AZ1;NDC80;MCM3;RAD54L;SUV39H1;TRAIP;CKS1B;CCND1;CDKN1B;FBXO5;TTK;HMGA1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4560687962090447,-1.1682918345760311,0.20833333333333334,0.9574169633315179,1.0,9/121,4.37%,GPR78;GPR3;GALR3;ADGRG3;GRK5;ADRA1B;LGR5;CRHR2;ADCYAP1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.6619218285714709,1.1682890615458332,0.2753623188405797,1.0,1.0,1/12,6.02%,KCNA5
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.723047015901945,1.168242234843777,0.3387096774193548,1.0,1.0,1/7,5.93%,HSD17B2
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.7351968805336979,-1.1682268202420498,0.3235294117647059,0.9564024116967729,1.0,1/6,2.90%,PIWIL2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.6416598534063197,1.1678584011072082,0.29508196721311475,1.0,1.0,4/16,15.81%,CEP55;CHMP3;KLHDC8B;MITD1
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),-0.6781146676278553,-1.1677562020134378,0.35,0.9566170229925429,1.0,4/6,22.29%,MECP2;MPHOSPH8;KDM1B;KMT2A
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6125680320908728,1.1674009010242932,0.2537313432835821,1.0,1.0,6/26,13.26%,TNFRSF1B;CCL5;C3;NR1H4;EIF6;PDK4
prerank,GO_Biological_Process_2021__hydrogen peroxide biosynthetic process (GO:0050665),0.8219500652876586,1.167396764252453,0.2830188679245283,1.0,1.0,2/5,13.70%,DUOX1;CYBA
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.4887604888727388,-1.1673019142757803,0.20833333333333334,0.956960985922415,1.0,10/40,19.27%,EARS2;LARS2;VARS1;WARS2;PARS2;MARS1;CARS1;YARS1;FARSA;HARS2
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6553396244710438,1.166478698402402,0.27419354838709675,1.0,1.0,1/11,0.49%,LRP4
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.754258745993539,1.1662392070526248,0.27586206896551724,1.0,1.0,2/7,21.58%,ERBB4;LHX6
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.6757421706535328,-1.1661943480526131,0.3191489361702128,0.9593799475593016,1.0,3/8,16.61%,CRYM;SLC7A5;SLC16A10
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.6653015607905304,1.166125488402571,0.32786885245901637,1.0,1.0,1/13,3.54%,SLC37A2
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.7216472111831955,1.166030238091675,0.26666666666666666,1.0,1.0,3/6,20.84%,AGER;NOS2;PIK3R6
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.48587566838891477,-1.1656343555534627,0.19047619047619047,0.9602932342581817,1.0,19/61,21.35%,CPSF1;TRDMT1;METTL1;POP1;ADAT2;CSTF2;TRMT61A;THG1L;QTRT2;QTRT1;WDR4;CPSF4;TSEN2;TRMT9B;ADAT1;CTU1;FAM98B;DTWD1;TRMT1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7628789944787652,1.1655720483123935,0.3230769230769231,1.0,1.0,1/5,9.69%,SOD2
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.7140522180194147,1.1655596786943616,0.32142857142857145,1.0,1.0,1/6,2.31%,RENBP
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.7279234505470293,1.1655238825754497,0.29508196721311475,1.0,1.0,4/8,18.56%,ALOX12;ALOX15B;ALOX15;ALOX12B
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.7279234505470293,1.1655238825754497,0.29508196721311475,1.0,1.0,4/8,18.56%,ALOX12;ALOX15B;ALOX15;ALOX12B
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.6785624288050272,1.1655123192339911,0.3770491803278688,1.0,1.0,1/12,3.54%,SLC37A2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.7144504825451352,-1.1652160071730444,0.3157894736842105,0.960446194131462,1.0,4/6,24.79%,SLIT2;ALCAM;ROBO2;PTPRM
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),0.7770602106116689,1.1649689779920873,0.2857142857142857,1.0,1.0,1/6,1.73%,LMOD3
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.4539907920138281,-1.164771296823109,0.13636363636363635,0.960617218073347,1.0,23/85,13.73%,ST3GAL3;XYLT1;GPC6;CHPF2;UST;GPC2;SDC3;HS6ST2;AGRN;GPC4;B4GALT2;CHST11;CHST12;ST3GAL2;CHSY1;CSGALNACT1;CHST6;PRELP;VCAN;GPC1;B3GAT3;ST3GAL4;B4GALT4
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),-0.7337282141062575,-1.164655639301416,0.2972972972972973,0.9598290007687996,1.0,4/6,22.72%,WNT7A;LRFN4;SEMA4A;VSTM5
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.6313841438480579,-1.1644554235580749,0.3548387096774194,0.9592453897024271,1.0,1/11,1.05%,BTN3A2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.7136436558758942,-1.1644197872516813,0.3076923076923077,0.9581299662022235,1.0,3/6,19.84%,APOE;FYN;HOMER1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.6942483904279859,-1.1643368997450056,0.3333333333333333,0.9572010998151687,1.0,1/7,2.70%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4016349104078171,-1.1641866752018075,0.05263157894736842,0.9564947524785598,1.0,9/90,10.28%,EIF2S3B;EIF5AL1;PIWIL2;JMJD4;UPF3A;ERBB2;PCIF1;AGO2;FXR2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.44380575265297945,-1.1641631490255673,0.25925925925925924,0.9553505675556875,1.0,6/64,4.34%,SPRED2;SPRED1;FGF1;ESRP1;FGF18;TRIM71
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.4759396988525313,1.1641170068976752,0.20253164556962025,1.0,1.0,10/128,7.34%,GATA4;TIMP3;C1QTNF1;ACOX2;AARD;LMOD1;COL18A1;C3;BOK;ANGPTL4
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.586805980621578,1.164073172758416,0.2537313432835821,1.0,1.0,10/27,24.83%,PTX3;TRIM62;TRIM25;TRIM68;CD4;TRIM5;HLA-DRB1;LY6E;CIITA;TMPRSS4
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.7630705449423056,1.1639666951985475,0.3125,1.0,1.0,1/5,8.64%,TCAF2
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.5068870369576512,1.1638835391596427,0.32051282051282054,1.0,1.0,15/78,17.35%,CAPN13;CCDC60;PLEKHS1;EYA2;VWA3B;MAP3K19;FUT2;MUC4;AKAP14;MORN5;DNAH3;MROH9;DNAI1;CHST9;BPIFB1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.6403637435640126,1.1637895141596502,0.29850746268656714,1.0,1.0,9/17,24.45%,PWP2;RPS5;RPS19;RPSA;RPS14;RPS15;RPS27;RPS28;ABT1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.6359344289557725,1.1636984167290005,0.18571428571428572,1.0,1.0,3/18,1.38%,MICB;C3AR1;BLK
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.741080973779096,-1.1636364336987959,0.3953488372093023,0.95578276078928,1.0,1/5,16.70%,ABHD12
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.5719488129133854,-1.1636318725071768,0.2777777777777778,0.9545693540414009,1.0,5/14,19.71%,MLYCD;MVK;TDO2;ACACB;PPCS
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.7485447151033942,1.1634390785076227,0.3389830508474576,1.0,1.0,2/7,6.54%,VSIR;CD81
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6373751544266064,1.1624418080252887,0.21052631578947367,1.0,1.0,2/15,5.45%,ESR1;TGFB1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6691846139972482,1.1622728047579174,0.328125,1.0,1.0,1/9,4.48%,PHKA1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.604452795629558,-1.1621667825327104,0.3055555555555556,0.9579212084547309,1.0,4/20,8.05%,IL7R;KIT;OCIAD2;HES1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.7932759840343073,1.162034125890573,0.2413793103448276,1.0,1.0,1/6,2.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.6967731719971697,1.1617179335666314,0.29850746268656714,1.0,1.0,2/10,12.59%,CCDC39;ZMYND10
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.5675737160402663,1.1615202755200398,0.2835820895522388,1.0,1.0,7/23,18.21%,WNT5A;IGF1;CDKN1A;BMI1;DDR2;AGT;FN1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.734504515174064,1.161450393296478,0.25,1.0,1.0,1/11,0.60%,TULP1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.6932788178159903,-1.1614187661027653,0.3181818181818182,0.9598793390044478,1.0,2/7,15.36%,WNK2;WNK3
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.525121188557859,-1.161310668547403,0.2916666666666667,0.9590657838350021,1.0,9/46,14.23%,PER2;PIAS3;CRY1;USP4;MINAR1;ARRB2;U2AF2;CHP1;SIRT7
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5300947356684095,1.1611646165309983,0.27941176470588236,1.0,1.0,9/43,18.12%,CCL5;CRLF1;CLCF1;IL12A;ERBB4;IGF1;PARP14;IL4;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.6008250222502418,1.16083512070957,0.2698412698412698,1.0,1.0,7/20,21.69%,VSIR;NR1H4;AXL;TNFSF4;PDCD1LG2;HLA-DRB1;DDIT3
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.767914020315656,1.1607660847255974,0.3333333333333333,1.0,1.0,3/5,21.62%,ALDOB;GLYCTK;TKFC
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.767914020315656,1.1607660847255974,0.3333333333333333,1.0,1.0,3/5,21.62%,ALDOB;GLYCTK;TKFC
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.7026288454026419,-1.1607633536016637,0.2916666666666667,0.9571271631115497,1.0,1/5,6.44%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.7026288454026419,-1.1607633536016637,0.2916666666666667,0.9571271631115497,1.0,1/5,6.44%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.7026288454026419,-1.1607633536016637,0.2916666666666667,0.9571271631115497,1.0,1/5,6.44%,MAN1A1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.6015509670292298,1.1606667110576687,0.2807017543859649,1.0,1.0,2/21,2.85%,TBX1;DNAH11
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.559527654997968,1.1606111102414496,0.24390243902439024,1.0,1.0,17/39,26.42%,PWP2;NOB1;RPS16;RPS5;RPS19;RPSA;RPS7;RPS14;TSR3;RPS6;RPS15;RIOK2;RPS27;RPS28;RPS24;EMG1;RIOK3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.6745032478348958,1.1602226629121262,0.288135593220339,1.0,1.0,1/9,0.49%,LRP4
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6860034097496397,-1.1602180545882155,0.3783783783783784,0.9578967372172259,1.0,3/6,19.85%,ATP10A;ASAP1;DNM2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6108160333212016,1.1599739166796934,0.36065573770491804,1.0,1.0,6/19,25.52%,SLC12A3;CYP4F12;ATP1A4;SCNN1G;SCNN1A;ATP1A1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.5238382832275326,-1.1595597404730398,0.2647058823529412,0.9589537180100827,1.0,2/16,12.84%,MGARP;KIF1C
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.48122986014194596,-1.1593308147645014,0.22727272727272727,0.9584907492307989,1.0,7/46,12.47%,PM20D1;SMPD4;ASS1;PNPLA1;PAM;PCSK1;SPTSSB
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.5424298826675261,-1.1591551201822725,0.25925925925925924,0.9578124833069067,1.0,8/32,16.33%,SMPD3;RAB3D;RAB7A;SNF8;RAB5A;RAB27A;SDCBP;SDC4
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5236325665254329,-1.1591170256907761,0.20588235294117646,0.9566494907910216,1.0,10/36,19.83%,IFT88;PCM1;KIF17;CLUAP1;DYNC2I1;IFT81;TRAF3IP1;IFT43;IFT52;DYNLRB1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.4640088685605016,1.1589220902038633,0.2087912087912088,1.0,1.0,22/173,13.71%,GATA4;ESR1;RRAS;LRP2;FGF20;GFRAL;FGF2;TGFB1;GPER1;ERBB4;RAMP3;F7;PINK1;AXL;MYDGF;PIK3CG;CD80;KLB;HGF;IL26;NOP53;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.7195879138710457,-1.1588347888956527,0.35135135135135137,0.9562991716058584,1.0,3/6,11.55%,EPHB2;ANAPC2;NEUROD2
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6577611099259669,1.1587335302184891,0.273972602739726,1.0,1.0,1/10,0.44%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.6804952292599019,1.1587234098867008,0.3275862068965517,1.0,1.0,3/10,6.32%,GATA4;TGFB1;GPER1
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5377863827905297,1.158677029624543,0.25675675675675674,1.0,1.0,5/33,12.47%,ESR1;NLRP12;NR1H4;STAT1;NLRC3
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.535219458412588,-1.158608839700552,0.20689655172413793,0.9558059723736612,1.0,9/26,25.29%,RNF168;LDB1;EAPP;LEO1;BRD4;TCERG1;WDR43;RECQL5;ZMYND11
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.4694825996629185,1.158598065962657,0.22093023255813954,1.0,1.0,21/154,14.93%,TBX1;ESR1;MGST1;RORC;TNFRSF1B;WNT8B;WNT5A;AHR;SSTR1;H2AZ1;GPER1;RAMP3;NR1H4;AXL;CD80;CRHBP;STRA8;PDK4;TNFSF4;PDCD1LG2;SOX9
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.6160813208154264,1.1582210612970738,0.2898550724637681,1.0,1.0,5/18,16.77%,HEY2;TGFB1;ASPN;SOX9;HEY1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.6846014244012405,-1.1582021541583019,0.325,0.9560319520982572,1.0,1/6,2.30%,FOXO1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.7098727918461336,-1.1577671301314647,0.2926829268292683,0.9560781047636876,1.0,4/6,11.00%,SH3RF1;PNP;NKAP;PRDM1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.5282412412900888,1.1575489406274713,0.22666666666666666,1.0,1.0,12/54,24.54%,PSMB9;NQO1;NR1H4;PDK4;OAZ2;PSMC5;AZIN1;PSMB6;PSMD6;PANK2;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5265634982866125,1.1571828106214608,0.28205128205128205,1.0,1.0,9/46,15.87%,SMAD6;TGFB1;NODAL;DAB2;GDF11;BMP3;TGFB3;TTK;GDF9
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.5566153863498259,1.1568300690762439,0.3064516129032258,1.0,1.0,15/33,25.10%,SLCO1A2;SLC10A1;SLC16A8;ABCC2;SLC51A;ABCC11;NR1H4;SLC16A1;SLC10A5;SLCO2B1;ABCG5;GHRL;CEACAM1;STARD5;SLC10A4
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.6140278952642036,1.1563070379928384,0.3333333333333333,1.0,1.0,2/13,9.34%,ANXA1;REST
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),0.6883762642539977,1.155955607296229,0.3387096774193548,1.0,1.0,3/9,8.49%,CYP3A4;CYP4F12;LDHD
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.49582114368237357,1.155725361783172,0.2222222222222222,1.0,1.0,22/120,18.21%,GATA4;TBX1;PKP2;MYBPC3;SGCG;ALPK2;TGFB1;MESP1;DAND5;ERBB4;MMP21;HEG1;CDKN1B;POPDC2;CSRP3;SGCZ;CDKN1A;SOX9;CACYBP;MYH7;HTR2B;FN1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6703521510298616,1.155373327293611,0.21052631578947367,1.0,1.0,3/13,6.06%,CD160;HLA-F;IL12A
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.7230206450733669,1.1553677093283579,0.3050847457627119,1.0,1.0,2/8,2.83%,TBX1;LRP2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.5668132541926448,-1.1552395709424026,0.3125,0.9639119175603277,1.0,3/11,10.73%,LIPC;APOE;SCARB1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.662437127140055,-1.1552041176734444,0.2619047619047619,0.9628751953999118,1.0,2/7,2.59%,HDC;PSAT1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5740956349689668,1.1550866401491406,0.3076923076923077,1.0,1.0,2/26,6.80%,PLA2G10;LPIN3
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6929871718681379,-1.1550134957322113,0.2777777777777778,0.9623411041318163,1.0,9/10,30.68%,ASCL1;DLL1;POU3F2;TGFBR1;EPOP;ID2;DLL4;SHH;MYT1L
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.4755512045872407,-1.1546966002272656,0.18518518518518517,0.9620223810093269,1.0,11/42,14.05%,GLA;SMPD3;STS;SMPD4;NEU4;ESYT3;NEU3;B4GALNT1;ST6GALNAC3;ESYT1;ST3GAL5
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.4778120837732577,-1.1540793298517824,0.25,0.9625238553369098,1.0,17/87,14.48%,NGF;MFSD2A;BCL2;LIMK1;ERBB2;CPNE6;SYT17;SLC25A33;GOLGA4;ISLR2;RNF157;DNPH1;DBNL;KLHL22;SDCBP;SYT3;RPS6KA3
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5574354755212174,-1.153906239191538,0.3157894736842105,0.962045587139294,1.0,4/15,9.39%,SARM1;DHFR;MORN4;RTN4RL2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.6009255850774349,1.1535143872677651,0.21428571428571427,1.0,1.0,2/20,2.83%,DISC1;LRP2
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.7251451591937037,-1.1529354656046773,0.40540540540540543,0.9644647548054743,1.0,4/6,25.58%,FYN;NTRK2;DOCK3;SRC
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.5354345732960475,-1.1529352153875898,0.18518518518518517,0.9632576649997102,1.0,8/22,23.36%,EIF4EBP1;HES1;HSF1;KLHL18;CCDC57;PRKCA;DUSP3;PKN2
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.7630889670472618,1.1528755959343562,0.37254901960784315,1.0,1.0,2/5,21.85%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.7630889670472618,1.1528755959343562,0.37254901960784315,1.0,1.0,2/5,21.85%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.46863755014545805,-1.152741122268084,0.2857142857142857,0.9626562057069507,1.0,5/40,5.28%,APOB;APOH;PNPLA3;LIPC;APOE
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.5624002017384173,-1.1526665670615985,0.2222222222222222,0.9617022126187904,1.0,4/18,7.79%,GRID2;SLC17A6;GRIK4;GRIK1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.658794528348903,-1.1524904978598849,0.34210526315789475,0.9610688332787691,1.0,5/6,33.07%,PIH1D1;FBL;NOP58;ZNHIT6;PRPF31
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.5776117279595153,1.1524088045476484,0.28125,1.0,1.0,8/34,22.93%,CENPU;OIP5;CENPX;ITGB3BP;CENPL;RBBP7;CENPN;CENPM
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6313946473107125,1.1522828476915763,0.29508196721311475,1.0,1.0,1/24,2.62%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6062698880564522,1.1518044512929508,0.35384615384615387,1.0,1.0,8/17,29.55%,SCIN;SOX9;SOX6;BMP1;PTHLH;TRPS1;SCX;SOX5
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.6837225254317176,1.1517814811692095,0.29310344827586204,1.0,1.0,2/9,14.59%,RPS27A;ISG15
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.7215911422153006,-1.151520034819669,0.40625,0.9632269463664176,1.0,1/6,0.70%,FBP2
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.7103252033188387,-1.1514533061714103,0.2978723404255319,0.9622405316236989,1.0,4/6,23.47%,CRYM;SLC7A5;SLC16A10;SLC7A8
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.7010344989028084,1.1510595719537997,0.29411764705882354,1.0,1.0,3/8,19.13%,C3;ALOX15;F2RL1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.7635907932727878,1.1507397071817311,0.30158730158730157,1.0,1.0,1/5,18.79%,TMEM33
prerank,GO_Biological_Process_2021__apoptotic chromosome condensation (GO:0030263),0.7684807647943332,1.1506199905402883,0.2982456140350877,1.0,1.0,2/5,14.18%,GPER1;ERN2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5116081722739838,-1.1506071915127818,0.23076923076923078,0.9639162542961092,1.0,3/25,16.22%,TRIM54;CAMSAP3;TRPV4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.516229012607529,-1.1505865966694693,0.3055555555555556,0.9627731043196937,1.0,7/23,21.30%,FSCN1;AVIL;AUTS2;ARPC2;WASF2;OCLN;PLCE1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.6310911847033651,-1.1503956433068938,0.2727272727272727,0.9621950327594794,1.0,4/10,25.40%,ICE1;CHD8;CEBPA;RPTOR
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.6914487757849073,-1.150351887925428,0.38461538461538464,0.9613025204855148,1.0,2/5,27.27%,CYP46A1;RFTN1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.7011971777374314,-1.1501496040876582,0.3333333333333333,0.960780275996079,1.0,3/7,23.47%,SLC4A11;CNNM4;SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),0.7802035717773013,1.1501251540338395,0.3137254901960784,1.0,1.0,1/6,1.73%,LMOD3
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6852867420280239,1.1500335538790252,0.3548387096774194,1.0,1.0,2/10,7.16%,ALPK2;MYH11
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.753492489937735,1.149844975927734,0.2923076923076923,1.0,1.0,4/5,24.66%,NLRP12;TAF7;HSPH1;CIITA
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.6779292975288139,-1.1497610438248012,0.38,0.9607844737560638,1.0,2/5,15.56%,KCNE1;KCNH2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5893289796937158,1.1497322470105866,0.30303030303030304,1.0,1.0,3/25,6.05%,AIM2;VSIR;USP50
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.6471533683102781,1.1496824619924597,0.2702702702702703,1.0,1.0,1/12,5.35%,LMO2
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.7581726746832849,1.149626989555603,0.38333333333333336,1.0,1.0,1/5,6.32%,GPER1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.6055239552633379,1.1495908568805897,0.2602739726027397,1.0,1.0,6/23,11.79%,SGO1;SLC25A31;SYCP3;MEIOB;TDRD9;MEIOC
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6636359135116249,1.149552830392579,0.23943661971830985,1.0,1.0,1/15,0.71%,SGO1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.6794916153166648,-1.1493629348682803,0.34285714285714286,0.9607886611639895,1.0,3/6,23.81%,ST3GAL2;ST3GAL4;ST8SIA3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5217049656369039,-1.1492771964074113,0.20588235294117646,0.9599721253905561,1.0,5/17,14.46%,UPB1;UPP1;NT5C1A;UPP2;NT5C
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6141383862468477,1.1491750652227397,0.36923076923076925,1.0,1.0,5/15,12.37%,CCL5;HSD3B7;PIK3CG;GPR183;MSMP
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.6207634756684546,-1.149106236074403,0.3333333333333333,0.9582057199605938,1.0,2/7,13.27%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.6207634756684546,-1.149106236074403,0.3333333333333333,0.9582057199605938,1.0,2/7,13.27%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.724095097823324,1.1490397291353094,0.25806451612903225,1.0,1.0,1/7,2.84%,CCL5
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.815221851916845,1.1489821863543845,0.375,1.0,1.0,1/5,4.59%,RP1
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.815221851916845,1.1489821863543845,0.375,1.0,1.0,1/5,4.59%,RP1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6541652006307113,1.1488468503199643,0.30357142857142855,1.0,1.0,5/12,18.56%,ALOX12;ALOX15B;PLA2G7;ALOX15;ALOX12B
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),0.7533340177214998,1.1486828216182003,0.3392857142857143,1.0,1.0,1/5,2.05%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.6000275342330929,-1.148472957535805,0.3333333333333333,0.9592917082508964,1.0,4/12,11.45%,TRIB1;SERPINE1;CORO1B;SLIT2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.5665308367062758,-1.1479478234435805,0.3142857142857143,0.959575721417923,1.0,3/16,5.43%,BCL2;IL16;SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.8053847168731609,1.1478627869531763,0.3492063492063492,1.0,1.0,2/5,11.84%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.5899811144528706,-1.147650416214621,0.23333333333333334,0.9593730962611849,1.0,1/12,0.41%,MT1G
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.5857718580257912,-1.1475396019299873,0.3023255813953488,0.9585989480530496,1.0,2/7,6.16%,NMU;MYOCD
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.4760781182117816,-1.146954751498407,0.19047619047619047,0.959436774043786,1.0,14/38,20.11%,PRKCD;SMYD2;CRY1;RADX;ANKLE1;FXR2;CASP9;RFWD3;SIRT7;ABL1;NPAS2;KMT5A;MAPT;MCL1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7447532761115245,-1.1469304726774827,0.3225806451612903,0.9583186040428853,1.0,2/5,19.35%,ETS1;PML
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.5664476682130448,-1.1465574631789173,0.2727272727272727,0.9584811789240745,1.0,6/18,21.01%,CDH13;RGN;NEUROD2;CMKLR1;MAPT;GPR143
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),-0.7106203165244919,-1.1462621457660818,0.2727272727272727,0.9582121196682336,1.0,3/5,23.33%,CSGALNACT1;IDUA;ANGPT1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.6599694669995074,1.1462534198845633,0.2833333333333333,1.0,1.0,1/10,2.46%,PKP2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5093416775307685,-1.1462126310976553,0.16129032258064516,0.9572028851606361,1.0,8/36,13.36%,GRID2;GRIN3A;GRIK4;GRIK1;DAGLA;GRIN1;GRIA4;GRM2
prerank,GO_Biological_Process_2021__positive regulation of establishment of endothelial barrier (GO:1903142),-0.7102627733733134,-1.1457637479452345,0.38461538461538464,0.956154217812603,1.0,2/5,3.40%,CDH5;F11R
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell development (GO:1901552),-0.7102627733733134,-1.1457637479452345,0.38461538461538464,0.956154217812603,1.0,2/5,3.40%,CDH5;F11R
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.5239710812947426,-1.1456402016038136,0.21052631578947367,0.9554429623858463,1.0,5/22,10.09%,APOH;PHLDB2;APOE;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.4379494454817594,-1.145551311942631,0.2222222222222222,0.9546991365382712,1.0,8/35,21.68%,CRLS1;FADS1;CPNE6;AGPAT5;DHDDS;DOLPP1;CLN3;CPNE7
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.5542901502730245,1.1455505920330928,0.24691358024691357,1.0,1.0,3/29,9.10%,HSPA1L;HSPA8;HSPA5
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.6662393613364109,1.145496833937548,0.3230769230769231,1.0,1.0,4/10,17.76%,TOR1A;COPS4;COPS5;GPS1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.6657176623524346,-1.1454465477782898,0.38235294117647056,0.9538886091858109,1.0,1/5,8.91%,LIG3
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),-0.7014950987510087,-1.1454315336023257,0.375,0.9527721672553939,1.0,2/5,19.78%,NOTCH1;FSHR
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.42868966293542127,-1.145349502639228,0.2608695652173913,0.9517950818061108,1.0,18/75,16.20%,SMYD5;DNMT1;IFI16;CTCF;POLR1A;MECP2;MACROH2A2;DNMT3A;PHF2;GPX1;POLR2F;MPHOSPH8;KDM1B;MORC2;TAF1B;HDAC5;MYBBP1A;TAF1D
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.7223048324964394,1.1453471294245445,0.2857142857142857,1.0,1.0,2/7,11.47%,GPR55;IL7
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5600309528480905,1.1452293656254435,0.2608695652173913,1.0,1.0,9/43,10.99%,ST6GALNAC1;ACSL5;CYP4F12;ADAMDEC1;TMEM45B;KLF15;MUC17;CLCA1;CFD
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.6559142318394713,-1.1448477941721553,0.2972972972972973,0.952304805017175,1.0,3/5,28.22%,CTDP1;RPRD1A;RPAP2
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.7294685527134778,-1.144747132893998,0.37142857142857144,0.9502566635190433,1.0,3/5,26.78%,KIF17;KIF5C;KIF3B
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.7294685527134778,-1.144747132893998,0.37142857142857144,0.9502566635190433,1.0,3/5,26.78%,KIF17;KIF5C;KIF3B
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.43945296359315594,-1.1444933978714973,0.2727272727272727,0.9496953128802819,1.0,8/53,12.50%,GCK;NUP210;POM121C;NUP42;NUP214;AAAS;ZBTB7A;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6155985400743436,1.144367933150418,0.2923076923076923,1.0,1.0,5/22,14.74%,FGF2;FLT1;TGFB1;P2RY12;TNFAIP8L3
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.7326723941553808,1.1441133165059691,0.32142857142857145,1.0,1.0,1/7,9.34%,REST
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6478883857530345,1.1440993725069937,0.34285714285714286,1.0,1.0,3/12,11.65%,ITGB2;CD81;SYK
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.7507076364932088,1.1439000339059353,0.3333333333333333,1.0,1.0,1/6,13.43%,TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.612836589830382,1.143785229777621,0.3055555555555556,1.0,1.0,2/21,3.35%,GPR55;LILRB3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6226678743719527,1.143493059508704,0.2898550724637681,1.0,1.0,3/17,5.02%,PTPRC;SFTPD;VSIG4
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.5002462083058501,1.1433517421465105,0.24675324675324675,1.0,1.0,12/69,19.15%,CASQ2;ACE2;CAV3;KCNG2;CYP2J2;NPR2;ATP1A4;TRDN;PLN;NPPA;AGT;RYR3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.548200184595298,1.143272186081248,0.2676056338028169,1.0,1.0,8/43,15.02%,SMAD6;KIF14;RPL13A;HSPA5;DDX3X;NLRC3;NOP53;TFIP11
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.6765727733886162,1.1431833578978656,0.35,1.0,1.0,4/11,9.29%,GSDMA;AIM2;GSDME;NLRC4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6981437296313945,1.1430715388197719,0.3620689655172414,1.0,1.0,1/7,8.18%,NDC80
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6981437296313945,1.1430715388197719,0.3620689655172414,1.0,1.0,1/7,8.18%,NDC80
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.6138829468850223,-1.142956103024691,0.3157894736842105,0.9533975346181383,1.0,5/13,13.88%,TWIST1;SLC30A10;TERT;RBL1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6530534108430892,1.1428802085946912,0.3125,1.0,1.0,4/13,11.84%,TGFB1;NODAL;DAB2;TGFB3
prerank,GO_Biological_Process_2021__cell differentiation involved in metanephros development (GO:0072202),-0.685790956633155,-1.1426655518641609,0.3333333333333333,0.9531390620535508,1.0,1/7,1.20%,OSR1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.5646824123073437,1.1426555024900567,0.3235294117647059,1.0,1.0,8/34,13.41%,C1QB;C3AR1;C3;CD81;CPB2;C4BPA;C4BPB;IRF4
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.5210695452224976,-1.1423050041323775,0.2,0.9532369557473445,1.0,2/18,5.08%,KMT2B;SMYD2
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.6793535132758974,1.1422958553052118,0.3181818181818182,1.0,1.0,2/12,6.28%,WNT8B;MESP1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.45431385259763124,-1.1422860418152947,0.21428571428571427,0.9521163616765661,1.0,16/54,22.11%,TCOF1;DUSP2;RABEPK;PA2G4;WDR74;CDK4;SLC19A1;RRP12;PES1;MYBBP1A;MCM4;TBRG4;FARSA;SORD;PLK4;RRP9
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.587192984218537,1.1413580685207592,0.30985915492957744,1.0,1.0,1/24,0.49%,LRP4
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.7084267490410459,1.1413336700057868,0.3157894736842105,1.0,1.0,2/9,19.62%,ERBB4;FIS1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6579810528566634,1.1413185907175538,0.35384615384615387,1.0,1.0,1/12,7.23%,SLC6A4
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.6003839097569516,1.1412265374400234,0.35294117647058826,1.0,1.0,2/21,6.28%,TBX1;MESP1
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.6923358707178169,-1.1410030763048287,0.32432432432432434,0.955223446147987,1.0,3/5,15.99%,RRM2;RRM2B;SAMHD1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6104225219906028,1.1408243098927109,0.2857142857142857,1.0,1.0,1/18,2.84%,CCL5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.6942335438887497,-1.1408223719963384,0.35714285714285715,0.9544913932197647,1.0,4/6,18.10%,OLFM2;MYOCD;FGFR2;SRF
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.6496882061581288,-1.1407570137594296,0.2727272727272727,0.9535419032977266,1.0,4/9,23.21%,GALNT13;POGLUT3;GALNT2;GALNT1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5761608636033809,1.1406678397498637,0.28,1.0,1.0,4/38,4.86%,TULP1;PTPRC;SFTPD;C3
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.6936727071678455,1.1406390418480183,0.4,1.0,1.0,1/7,10.81%,EIF6
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.7088277463973177,-1.140088658757275,0.32432432432432434,0.9545312474491744,1.0,4/8,25.40%,CLEC16A;MLST8;LARP1;RPTOR
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5576254536727407,-1.1400883382991611,0.3333333333333333,0.9533989446645372,1.0,6/11,23.37%,PSAT1;CBS;SEPHS1;SERINC5;SRR;PSPH
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5047017350383998,-1.1398395514137822,0.3125,0.9529917212119815,1.0,2/24,2.20%,DUSP6;GFI1B
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.7086320090193553,-1.1397897000250188,0.3548387096774194,0.9520485006765657,1.0,1/6,3.91%,LIN28B
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.7631297173107775,1.1395588963463827,0.30434782608695654,1.0,1.0,1/6,2.87%,HSPA8
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.5202227197249193,-1.139131060979453,0.2,0.9529678915517431,1.0,9/19,27.17%,CAP2;GRM2;GABBR2;NF1;DRD2;PALM;DRD3;CAP1;GNAI2
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.6527240130658457,-1.1391208586018733,0.27906976744186046,0.9518595222871425,1.0,3/13,9.03%,XKR7;MEGF10;RHOBTB2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.6470520606161702,1.1390283431916377,0.3064516129032258,1.0,1.0,2/9,20.02%,IFIT1;MSH6
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.7395867943500556,1.1385956539251936,0.31666666666666665,1.0,1.0,3/6,17.62%,SOD2;ADRB1;NPPA
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.6482007672947537,-1.138589385079137,0.3333333333333333,0.9521917443432303,1.0,3/8,17.75%,EGR1;NAB2;C5AR1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.5554915162474723,-1.1383150457355082,0.25806451612903225,0.951955350763389,1.0,6/14,21.31%,EGR1;PIAS3;ZMIZ1;PIAS4;HDAC4;RASD2
prerank,GO_Biological_Process_2021__determination of left/right asymmetry in lateral mesoderm (GO:0003140),0.7325449355389045,1.1376428382820611,0.3548387096774194,1.0,1.0,1/5,7.14%,DAND5
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.615200683488297,1.137373461730176,0.3076923076923077,1.0,1.0,3/17,5.58%,BANF2;H1-0;HAT1
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.7136446284963703,-1.1370845183119174,0.3333333333333333,0.9548889647480419,1.0,2/5,21.13%,FSCN1;PODXL
prerank,PanglaoDB_Augmented_2021__T Cells,-0.43922473452159383,-1.137063570635602,0.2857142857142857,0.9537835477794014,1.0,12/91,6.28%,IL7R;P2RY10;SKAP1;BCL2;IL16;EEF1B2P3;JUNB;SELL;DUSP2;CD247;CCL4L2;LTB
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.7167289964770464,-1.136970079844464,0.39473684210526316,0.9529969268180419,1.0,4/7,22.23%,GALE;TKTL1;PGM2;GALT
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.5356065407653294,1.1369241157414138,0.28169014084507044,1.0,1.0,6/35,19.70%,HSPA1L;ARIH2;PINK1;RHOU;ATP5IF1;TOMM7
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5422397525977358,1.1365183469646947,0.2857142857142857,1.0,1.0,7/43,11.13%,TLR2;SP100;CCL5;WNT5A;SLC26A6;RPL13A;STAT1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5499026292816594,1.13649316875605,0.2916666666666667,1.0,1.0,8/30,24.41%,NDUFB11;NDUFS2;NDUFA2;NDUFB10;NDUFB4;NDUFB9;NDUFA1;NDUFB2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.5465647480980276,-1.136327428486944,0.28205128205128205,0.9540738875432578,1.0,5/12,19.88%,ACO1;ASS1;IDH2;GLUD1;ACO2
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.45995140203266854,1.1362591418970829,0.24324324324324326,1.0,1.0,22/131,11.92%,OLFML1;LRP4;ESR1;TIMP3;C1QTNF1;PRRX1;LMOD1;WNT5A;LOX;PCDH18;GPER1;TNFRSF10A;ITGA2;ACTA2;OSMR;DCN;ANGPTL2;ITGA5;COL1A1;ADGRL4;CALB1;COL6A2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5465257838961335,-1.1359393153086363,0.3333333333333333,0.9546668335962643,1.0,4/18,17.90%,BCL2;NLRP1;CDK5;ATN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.5972186062416815,1.1356891045155233,0.3188405797101449,1.0,1.0,5/24,14.67%,BLK;SFTPD;VSIG4;CD80;PDCD1LG2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5822848376171796,-1.1353265976658267,0.23076923076923078,0.9555237329812644,1.0,5/11,14.46%,UPB1;UPP1;NT5C1A;UPP2;NT5C
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5339098905066113,1.1351630971383504,0.24242424242424243,1.0,1.0,7/32,20.31%,MCM2;POLE2;MCM3;RPA3;LRWD1;ORC4;POLE3
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.5783076894308253,1.1351244970633536,0.2714285714285714,1.0,1.0,4/27,3.47%,GATA4;LRP2;WNT5A;SIX4
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.4762385657012725,1.1350091512547984,0.2375,1.0,1.0,33/90,20.86%,ITGB2;CYTIP;ARHGAP9;BLNK;ITGAX;GMFG;PTPRC;SASH3;ITGAM;NFAM1;CLEC4C;JCHAIN;WAS;IKZF1;HCK;CD80;NAPSB;CD244;GPR183;ITM2C;PSTPIP1;TAGAP;CD37;MYO1F;CD4;ALOX5AP;PARVG;IL3RA;SERPINF1;IL17RB;IGLL1;PIK3R6;CD300LF
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),0.7342929735096825,1.1347286375978582,0.30357142857142855,1.0,1.0,3/5,24.59%,PIK3CG;GPR183;CXCL16
prerank,GO_Biological_Process_2021__regulation of immunoglobulin mediated immune response (GO:0002889),0.7256772407522201,1.1345181927900325,0.3225806451612903,1.0,1.0,2/5,17.19%,TNFSF4;IL4
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6026174776063543,1.1342883155579655,0.359375,1.0,1.0,1/17,1.10%,PSMB9
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.5252359048120476,-1.13428300929044,0.17391304347826086,0.9578362972628942,1.0,4/28,4.24%,MFSD2A;CDH5;F11R;GJB6
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.6276651338459455,-1.1339052107429826,0.3448275862068966,0.9579926056459004,1.0,6/13,14.98%,P3H4;JMJD4;EGLN3;P3H3;P3H1;PLOD3
prerank,PanglaoDB_Augmented_2021__Basophils,0.48929020501920045,1.13387082579748,0.2597402597402597,1.0,1.0,36/99,20.86%,CLEC5A;C3AR1;TLR2;ITGAX;LILRB3;FCGR3A;NFIL3;TFEC;VSIG4;ITGAM;NFAM1;PTAFR;FGL2;CLEC12A;ID1;HTR1B;HCK;HGF;CSF3R;GPR183;MBOAT1;GRM6;HK3;CD44;PLG;IL4;MYO1F;CSF1R;CD4;FPR1;STAB1;IL3RA;P2RX1;ADGRE3;PIK3R6;CD300LF
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.5321306145492587,1.1336605871704248,0.30434782608695654,1.0,1.0,12/48,18.56%,PLA2G10;ELOVL2;ALOX12;CYP4F12;PTGR1;CYP2J2;CYP1B1;ALOX15B;ALOX15;SCD;DEGS1;ALOX12B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5581898601134585,-1.1333665430002378,0.3103448275862069,0.95882610690195,1.0,9/21,23.86%,PTPRJ;IQSEC1;LIMS1;COL16A1;ABL1;S100A10;TSC1;DUSP3;PPM1F
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.4395339704830529,-1.1332404019689426,0.2,0.9580565324039688,1.0,10/87,8.42%,NR4A1;GCK;FOXO1;PRKCD;NR4A3;MGARP;SLC30A10;CPEB1;CAPN10;SYAP1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.5654129014414383,-1.1332231681162588,0.21621621621621623,0.957057924658203,1.0,5/16,14.46%,NLGN3;NLGN2;CEL;NRXN2;NLGN4Y
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.47772333493687325,1.1329261330106557,0.21978021978021978,1.0,1.0,13/136,15.16%,NEK2;CDC25A;PSMB9;KIF14;DTL;FBXL7;CEP72;RAB11A;CEP70;CCND1;FBXO5;DYNLL1;TUBA4A
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.45589403941597817,-1.1328843009638492,0.32,0.9570661970588134,1.0,7/34,13.96%,RASSF2;RAD50;PDGFD;PPP2R5D;TAOK2;CHP1;IMPACT
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.4562042332537409,-1.1326742572195572,0.23529411764705882,0.9564987317563749,1.0,3/70,2.30%,RFX6;GCK;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6805372871055411,1.1325839343805462,0.2878787878787879,1.0,1.0,2/10,7.25%,FGF2;ERBB4
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.5670739847718707,1.1320722723819947,0.28,1.0,1.0,8/35,18.75%,TNFRSF1B;CCL5;IL27;HLA-DPB1;CRTAM;SIRPG;CD4;TIGIT
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5448183284934803,-1.131675101514293,0.2857142857142857,0.9589721389349212,1.0,4/11,20.73%,POLD3;XPC;ERCC1;INO80
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.3837839699532874,-1.1313013749779393,0.19047619047619047,0.9589289340151802,1.0,38/154,20.04%,NGF;DTX1;CELF5;THEM4;YDJC;SLC17A6;ELAVL3;NKAIN3;TTBK1;INA;AKAP7;SNCB;SRRM3;HPCA;ADGRA1;MMD2;TAGLN3;ABLIM3;BRINP1;CDK14;CPNE4;JPH3;ERC2;FBXO44;LINGO1;RBPMS;SYN1;GALNT9;FXYD7;PRKCA;CSDC2;PTPN5;BRSK1;POU6F2;GPHN;FBLL1;PAK5;MAPK4
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.5896871776542983,1.1312715675127052,0.38235294117647056,1.0,1.0,6/29,12.62%,CCL5;WNT5A;TRIM62;SH2D1B;IFNK;RPS19
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6647187706743791,-1.1312153775724965,0.2727272727272727,0.9580990105254469,1.0,2/5,19.97%,BDP1;BRF1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.41175359296441777,-1.1309896898998975,0.2727272727272727,0.9575820930533182,1.0,14/74,16.70%,SMPD3;PRKCD;PIWIL2;UPF3A;ERBB2;GSAP;PCIF1;NSMAF;FXR2;CIRBP;LRRTM3;ZCCHC4;RPS27L;ABCG1
prerank,GO_Biological_Process_2021__regulation of T cell tolerance induction (GO:0002664),-0.6912118426539204,-1.130865811298633,0.4358974358974359,0.9568210544374968,1.0,1/5,2.85%,CLC
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5761258137348803,1.1299714527862015,0.25,1.0,1.0,6/31,11.68%,CCL5;PTPRC;CRLF3;ERBB4;CYP1B1;IL26
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.6801945475698263,-1.129872134119751,0.35135135135135137,0.9583323895240994,1.0,3/7,13.28%,SELE;SELP;ST3GAL4
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.7292558090884667,1.1294677495674916,0.4098360655737705,1.0,1.0,1/8,2.15%,CDHR5
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.5468495910116093,1.1293092157896651,0.3055555555555556,1.0,1.0,9/37,19.23%,IL12A;CA1;LCP1;SOD2;TALDO1;MSN;CFL1;ANXA2;RPLP0
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.5083725523581799,-1.1291050446176891,0.3,0.9596933968890814,1.0,5/26,9.84%,SLC25A29;SLC38A5;SLC6A20;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5870368484858767,1.1288697384038302,0.3283582089552239,1.0,1.0,4/21,15.19%,CASQ2;CAV3;HTR1B;PLN
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.6661974054245661,1.1288195223032396,0.22950819672131148,1.0,1.0,3/9,12.77%,FAXDC2;SCIN;PITHD1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.548954692596863,-1.128665913820462,0.29411764705882354,0.9600082134740937,1.0,3/21,11.32%,DGKD;PGS1;DAGLA
prerank,GO_Biological_Process_2021__cellular response to magnesium ion (GO:0071286),0.7861373885721417,1.128295706863989,0.4153846153846154,1.0,1.0,1/5,1.96%,SLFN14
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5037291357038295,-1.128028846541987,0.26666666666666666,0.9610060307400499,1.0,13/36,22.43%,TGFA;ERBB2;SH3KBP1;PTPRJ;DAB2IP;SPRY1;SPRY2;BTC;TSG101;PTPN3;ZFYVE28;PTPN2;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.5649030175758616,-1.1279484717175108,0.2647058823529412,0.9600990851695002,1.0,2/16,4.31%,WWC1;MAML1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5515811468001919,1.1279017763984478,0.2835820895522388,1.0,1.0,5/31,7.60%,TECRL;ELOVL2;ACOX2;CYP4F12;HACD4
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.6787456316272846,1.127831323221127,0.3582089552238806,1.0,1.0,5/10,21.95%,ATP6AP1;ATP1A4;PDK4;LACC1;SLC26A4
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.4750011389086081,-1.1276659690762196,0.15789473684210525,0.9599738255829409,1.0,20/53,23.23%,NSUN4;TRDMT1;METTL1;TFB1M;ADAT2;TRMT61A;PUS7;THG1L;QTRT2;QTRT1;WDR4;TRMT9B;PUS7L;CTU1;DTWD1;TRMT1;PARN;APOBEC3G;ADAR;ANKRD16
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.7347548444751322,-1.1275837839456817,0.37254901960784315,0.959102582924483,1.0,2/5,2.98%,SLC25A29;SLC6A20
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.4946740643536479,1.1275173295059273,0.27631578947368424,1.0,1.0,9/72,5.02%,C1QB;STEAP4;INMT;CRLF1;SFTPA1;CLDN18;SFTPD;C3;VSIG4
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5337471834195936,1.127466374131642,0.32432432432432434,1.0,1.0,9/39,19.23%,IL12A;CA1;LCP1;SOD2;TALDO1;MSN;CFL1;ANXA2;RPLP0
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.6863246376515492,-1.1273505339625332,0.37142857142857144,0.9588004966552182,1.0,3/5,23.81%,ST3GAL2;ST3GAL4;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.5775121808850024,1.126913354536899,0.31343283582089554,1.0,1.0,3/23,8.64%,ITGB2;ITGAM;TCAF2
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6275522979262508,1.1266971548073579,0.375,1.0,1.0,3/16,5.45%,TNFRSF1B;CLCF1;TGFB1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.5963795853146795,-1.1266221826139078,0.3333333333333333,0.9602633975274594,1.0,4/10,13.27%,LAMA3;CD151;ITGB4;PLEC
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.43977139180763686,-1.1263941275349305,0.2692307692307692,0.9599121732703159,1.0,3/64,1.65%,NGF;IL11;WNT3A
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.6949038505987777,1.1259804501773598,0.3684210526315789,1.0,1.0,1/7,3.20%,POLQ
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.7093578402422556,-1.125975586949536,0.3142857142857143,0.9600946774355769,1.0,3/7,10.35%,SLC25A17;SLC27A2;PEX13
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.5680695730944763,1.125750679710915,0.2876712328767123,1.0,1.0,3/25,9.10%,HSPA1L;HSPA8;HSPA5
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6920568038580035,1.1257371134664436,0.359375,1.0,1.0,2/9,13.08%,SP100;FOXM1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.6713212188109853,1.1255879937375624,0.30303030303030304,1.0,1.0,1/8,1.01%,MICB
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.7084717832384171,-1.1254463623131026,0.34782608695652173,0.9604219450952458,1.0,3/5,19.66%,SDCBP;SDC4;TSG101
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.5849519797223286,1.1250298892651003,0.3055555555555556,1.0,1.0,1/25,0.49%,LRP4
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.6504916790258,1.1244937957748002,0.3333333333333333,1.0,1.0,5/15,15.27%,SLC25A31;SYCP3;TDRD9;MEIOC;BRDT
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.5458103342269267,1.1239660509224336,0.3333333333333333,1.0,1.0,1/30,0.39%,NEK2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.6754963052712224,-1.1237628849579382,0.42105263157894735,0.9646477281844195,1.0,2/7,12.08%,ZDHHC5;SLC15A4
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.4924631918537011,-1.1233956901416255,0.2647058823529412,0.9648403300307532,1.0,3/25,7.52%,PHLDB2;F11R;SHANK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6933749619694383,1.123286707797236,0.35384615384615387,1.0,1.0,3/9,17.19%,IRF4;TNFSF4;IL4
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.7143555798826572,-1.1231630506900157,0.4411764705882353,0.9645502119941568,1.0,3/6,22.78%,PMM2;GMDS;PMM1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5979675741950561,1.1230186655145347,0.27692307692307694,1.0,1.0,3/28,7.14%,GATA4;HEY2;DAND5
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.6626726528026393,1.1230091036459524,0.30303030303030304,1.0,1.0,4/11,16.88%,AQP3;SLC26A6;AQP4;UPK3A
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.553603040032825,-1.1229505329634566,0.3142857142857143,0.9639556510037747,1.0,1/12,0.22%,NOX4
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.47739068521989925,-1.1226690102162344,0.2962962962962963,0.9639719450479092,1.0,21/70,17.65%,CBARP;FGF1;VAX2;VGF;FZD7;MID1;MPP2;MSI1;SRRM3;B4GALNT1;DLX1;FHOD3;MNX1;RCOR2;AADAT;LINGO1;CSNK1E;CSPG5;POU3F2;IGDCC4;RBFOX2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.502457092775678,-1.1225195313123044,0.3870967741935484,0.9634434675452866,1.0,6/28,15.97%,KIT;CDH13;PTPRO;ARFIP2;ABLIM3;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7177542260963444,1.122514193739213,0.25862068965517243,1.0,1.0,1/7,1.98%,RORC
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.660934440324737,-1.1222598186369044,0.2857142857142857,0.9620224212243813,1.0,4/7,21.66%,PARD3;ADGRG6;NF1;SKI
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.660934440324737,-1.1222598186369044,0.2857142857142857,0.9620224212243813,1.0,4/7,21.66%,PARD3;ADGRG6;NF1;SKI
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.41833775600248757,-1.1222166865907528,0.11538461538461539,0.9610827699841686,1.0,17/79,10.15%,ADAMTS1;FIBIN;COL13A1;CALD1;TWIST2;COL12A1;COL6A3;COL4A2;MMP2;LOXL1;TPM2;MYOCD;CNN1;FSTL1;EMILIN1;EDNRA;TAGLN
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.4570746065250866,-1.1218372657188282,0.2727272727272727,0.9612935982285502,1.0,12/50,15.23%,GANC;NEU4;FBXO27;MAN1A1;AGA;ST3GAL2;ST6GALNAC3;ST3GAL4;NGLY1;ADAMTS13;FBXO44;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5725884342003863,-1.1216286179709882,0.2777777777777778,0.9611215942898644,1.0,6/17,16.33%,SMPD3;RAB7A;SNF8;ATP9A;SDCBP;SDC4
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.45399031077496654,-1.12133104701463,0.20833333333333334,0.9609022352833583,1.0,8/53,11.87%,WNT3A;BAMBI;APOE;RALB;MEN1;HFE;TERT;RIPK2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7395608201877033,1.1213064523148637,0.36363636363636365,1.0,1.0,1/7,2.05%,ANXA1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5993944936057702,1.1212653474750427,0.34210526315789475,1.0,1.0,2/20,3.01%,PLA2G10;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.797020298170909,1.1210687058582043,0.30357142857142855,1.0,1.0,1/5,1.31%,TIMP3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.723022545995132,1.120739840116035,0.3333333333333333,1.0,1.0,1/5,12.88%,OTUD4
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5858635445141531,1.120575341301663,0.4090909090909091,1.0,1.0,6/18,26.20%,RPS27A;SEL1L;SYVN1;RNF5;AMFR;DERL2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5039496990278362,1.1203126601565525,0.24096385542168675,1.0,1.0,16/85,19.01%,ENPP2;RRAS;WNT5A;FGF2;FLT4;MMP9;RAB11A;PIK3CG;RHOB;VIL1;SOX9;DOCK5;ZNF580;AGT;BCAR1;THBS1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.4651848877700725,1.12017040858171,0.28,1.0,1.0,17/107,18.08%,NEK2;HSPA1L;SYCP1;GAD1;BUB1;ZC2HC1C;HTR5A;CLGN;TALDO1;MEP1B;TTK;ALOX15;ART3;TULP2;TNP1;NAA11;HSPA2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.6177388107031175,-1.1201642191873946,0.3125,0.9639579192719578,1.0,1/12,1.38%,METRNL
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.5692668165414394,1.1198265792256314,0.328125,1.0,1.0,7/24,25.09%,TCN1;ABCG2;AMN;SLC23A1;SLC46A1;CBLIF;SLC52A1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.655918737544713,-1.1196526019754875,0.3888888888888889,0.9648155847387045,1.0,3/6,12.23%,JCAD;ADAMTS3;CCBE1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5090297005114736,-1.1194570699966653,0.17857142857142858,0.964386645719799,1.0,4/25,9.35%,TXNL4A;KHSRP;SRRM1;SRSF4
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.6267475007848512,-1.1192238720913967,0.41935483870967744,0.9640695634037799,1.0,4/12,16.00%,APOBEC3H;MPHOSPH8;MORC2;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.6265484110612474,1.11905889953125,0.35714285714285715,1.0,1.0,4/12,22.58%,IFIT1;PLN;ATP5IF1;PAM16
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.5805986208215692,-1.1189883580055713,0.358974358974359,0.9626313487691867,1.0,4/9,19.90%,NFATC3;NFATC4;NFAT5;NFATC1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.5805986208215692,-1.1189883580055713,0.358974358974359,0.9626313487691867,1.0,4/9,19.90%,NFATC3;NFATC4;NFAT5;NFATC1
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.6841181474345375,1.1189623796037897,0.3709677419354839,1.0,1.0,3/9,16.31%,IL12A;CDKN1A;MME
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.49386530677015933,-1.118797973181185,0.3103448275862069,0.9621909630549695,1.0,2/23,1.89%,GCK;PPP1R3E
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.5922056254411224,-1.1187124376371882,0.3333333333333333,0.961341482275254,1.0,4/13,10.09%,APOH;APOE;SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.6624527566849934,1.1186871486281518,0.3559322033898305,1.0,1.0,4/10,11.65%,ITGB2;TGFB1;ITGAM;SYK
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.7254937753548288,1.1186826340072495,0.3898305084745763,1.0,1.0,1/5,22.48%,CCNB1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-0.7320588074007949,-1.1183096514473714,0.40540540540540543,0.9615179371064697,1.0,2/5,21.22%,HIP1;PTPN2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.4397564522574177,-1.1178181280115609,0.3103448275862069,0.962181850259355,1.0,18/47,19.04%,XYLT1;GPC6;GPC2;SDC3;HS6ST2;AGRN;GPC4;GPC1;B3GAT3;IDUA;HGSNAT;EXT1;FUCA1;GUSB;SDC4;GLB1;EXT2;PXYLP1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.6059060789556119,-1.1178102069298665,0.2727272727272727,0.9611465691048214,1.0,1/12,0.87%,KCNK6
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.7438635573726327,1.1176530641957578,0.36538461538461536,1.0,1.0,2/6,6.87%,ABCG2;ABCC2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.6854077034724718,1.1175691666795475,0.3235294117647059,1.0,1.0,3/9,16.35%,EXOSC2;EXOSC8;RPS21
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5905982453637746,1.1173846014228508,0.34782608695652173,1.0,1.0,6/17,23.04%,AXL;IL7;SYK;ZAP70;IL4;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.6204606765132947,-1.1172313733594392,0.4,0.9616681028798332,1.0,4/6,19.85%,SMARCB1;PIH1D1;AUTS2;ARRB1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6996293527492433,1.1171383342393484,0.4166666666666667,1.0,1.0,1/6,14.84%,CDKN1A
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6616754066413958,-1.1170592838548201,0.38235294117647056,0.9611532812563233,1.0,3/9,10.90%,PNP;NT5C1A;AMPD3
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.6897639619878861,-1.116842184451769,0.3939393939393939,0.960984283258027,1.0,2/5,18.27%,CRH;SYT7
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7297036313431472,-1.1168384609796103,0.38461538461538464,0.9599235942036584,1.0,3/5,17.06%,PRKCD;DLL1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5741637127724466,-1.1164539693412394,0.2857142857142857,0.960381644342574,1.0,3/13,17.26%,AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__negative regulation of serine-type peptidase activity (GO:1902572),-0.7178533837767394,-1.1163242084147467,0.3488372093023256,0.9596831181505738,1.0,1/5,0.77%,ANXA8
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7007943502881934,1.116232674444047,0.34615384615384615,1.0,1.0,1/6,6.28%,MESP1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5881762283107813,1.1156876001583498,0.36065573770491804,1.0,1.0,5/14,24.11%,HSPA5;COPS5;DNAJB9;TMEM33;AGR2
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.6738496692044345,-1.115565528091603,0.4318181818181818,0.9610919394295486,1.0,2/6,11.24%,EMILIN1;COLGALT1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.4912776248531477,1.1154848062011464,0.2682926829268293,1.0,1.0,19/74,15.82%,TLR2;SP100;CCL5;WNT5A;TRIM62;HLA-F;PTAFR;TRIM25;SLC26A6;HLA-A;RPL13A;IRF1;HCK;STAT1;TRIM68;IRF4;HLA-DPB1;AQP4;CD44
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.5770354898413552,1.115240801132477,0.3,1.0,1.0,3/26,10.11%,GATA4;CCDC39;NPY
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.6200151862620802,1.1148505545242335,0.3194444444444444,1.0,1.0,2/10,15.36%,SDS;SDSL
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.5456138863261514,1.1148132633792862,0.2463768115942029,1.0,1.0,13/35,31.54%,CENPU;OIP5;CENPX;ITGB3BP;CENPL;RBBP7;CENPN;CENPM;ANP32E;CENPO;ACTR6;CENPP;CENPK
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.6337455991975414,-1.1144593310809385,0.325,0.9634013888125621,1.0,5/8,20.31%,DDAH2;ASS1;SLC39A8;DDAH1;NOS1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.5885851025881678,1.1143836554318804,0.3114754098360656,1.0,1.0,6/15,25.60%,ODAD1;ZMYND10;DNAI1;ODAD2;CCDC63;ODAD3
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.42421752916529937,-1.1143482470092234,0.19047619047619047,0.962686283816688,1.0,5/107,2.41%,NOX4;ETV5;FOS;FOXO1;PRKCD
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.639263701334791,-1.114001612933197,0.3111111111111111,0.9628589423107148,1.0,4/11,11.87%,IRF5;NLRP1;NOD1;RIPK2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4283061441029507,-1.1138955532638972,0.25925925925925924,0.9620994071759452,1.0,10/82,4.70%,COL22A1;COL13A1;P3H4;LAMA3;COL12A1;COL6A3;COL4A2;LOXL1;COL8A1;CD151
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.4821679329009588,1.1138300278501292,0.3157894736842105,1.0,1.0,4/78,5.93%,NLRP4;UBE2L6;TRIM25;RNF26
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.510287297909563,-1.113396722877136,0.3333333333333333,0.9625670819981109,1.0,1/21,1.88%,DDAH2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.6059572874946944,1.1133376418830918,0.36923076923076925,1.0,1.0,6/18,18.56%,ELOVL2;ALOX12;CYP2J2;ALOX15B;ALOX15;ALOX12B
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.40950530744588626,-1.1133163266540533,0.25,0.9617475407790155,1.0,22/62,24.49%,TRDMT1;METTL1;METTL6;TRMT61B;ADAT2;TRMT61A;ALKBH8;PUS7;THG1L;QTRT2;PUS10;QTRT1;PUSL1;WDR4;TRMT9B;CTU1;DTWD1;MTO1;TRMT1;ANKRD16;TARBP1;URM1
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.6971586782960555,1.1131734393633015,0.3484848484848485,1.0,1.0,2/8,11.44%,EXOSC2;EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.6971586782960555,1.1131734393633015,0.3484848484848485,1.0,1.0,2/8,11.44%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.5156924632206793,-1.1131401059533848,0.20833333333333334,0.9613632119688936,1.0,6/20,15.55%,BUD23;NSUN4;TFB1M;GAR1;ZCCHC4;FBL
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.6458043765312468,-1.1130215765515437,0.37142857142857144,0.9607941712333622,1.0,2/9,7.64%,TST;CBS
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),0.7322596132822692,1.1129581476707462,0.42105263157894735,1.0,1.0,1/5,19.13%,F2RL1
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),0.735561613248384,1.1128615150663133,0.375,1.0,1.0,3/5,25.65%,PLAU;VIL1;ALOX5
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.5548958480227898,-1.1125881619589622,0.3333333333333333,0.9599375244567983,1.0,3/14,13.20%,NANOS3;AGO2;TNRC6C
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.5548958480227898,-1.1125881619589622,0.3333333333333333,0.9599375244567983,1.0,3/14,13.20%,NANOS3;AGO2;TNRC6C
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.5829387402722802,-1.1125671228753529,0.3611111111111111,0.9589865866547912,1.0,1/13,1.52%,DNMT1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.5816527990178106,-1.1124385052523535,0.375,0.9584687838796957,1.0,2/12,1.71%,ADRA1A;DGKD
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5419323514937155,-1.1116442281122532,0.2972972972972973,0.9595822422712662,1.0,3/16,7.95%,NR4A3;PDGFD;PTPRJ
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.616080567975907,-1.1114733119003137,0.4,0.9590802781466243,1.0,6/14,24.88%,LIN28B;AGO2;TARBP2;ADAR;TUT7;DROSHA
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.6777421021224472,1.1114553846576691,0.34375,1.0,1.0,1/7,3.01%,WNT5A
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.6600798629941762,-1.1114539038616873,0.3333333333333333,0.9581036939686954,1.0,2/7,15.86%,SLC8B1;LETM1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.654458222352367,1.1108944323841707,0.3888888888888889,1.0,1.0,1/9,2.05%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.5239078942892609,1.110813470206056,0.26666666666666666,1.0,1.0,9/43,24.54%,PSMB9;NQO1;OAZ2;PSMC5;AZIN1;PSMB6;PSMD6;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7159141268445058,1.1105870222689858,0.40350877192982454,1.0,1.0,3/8,23.06%,LY6H;CHRNB2;CHRNA3
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.5039414259677761,-1.1104528566263994,0.2692307692307692,0.9600723476933463,1.0,7/27,17.64%,GPC6;GPC2;GPC4;GPC1;FYN;CDK5;STX8
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.568147404750891,1.1099510622229536,0.37681159420289856,1.0,1.0,2/12,9.55%,NODAL;DAB2
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.6562519205426157,1.1099091466647115,0.3484848484848485,1.0,1.0,1/9,3.06%,AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.6562519205426157,1.1099091466647115,0.3484848484848485,1.0,1.0,1/9,3.06%,AHR
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.6394097481990694,-1.10974652182085,0.30952380952380953,0.9611486401602407,1.0,1/6,2.31%,BCL6
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.657304231652354,1.1096899187775457,0.4375,1.0,1.0,4/10,24.66%,PTX3;TRIM5;LY6E;CIITA
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.4543813067805305,1.109611621140157,0.24050632911392406,1.0,1.0,39/182,27.43%,COX6A1;ACAA2;CASP7;ATP5PF;ATP6AP1;NDUFS2;ATP5F1E;MRPL34;COX7A2;PDK4;NDUFA2;COX17;TIMM17A;ATP5MC3;ETFB;NDUFB4;ATP6V1D;COX4I1;ATP6V0B;COX7B;COX6B1;COX6C;IDH1;COX7C;UQCRFS1;NDUFA1;COX5A;ATP5ME;TIMM10;NDUFB2;VDAC1;SLC25A6;SLC25A11;IDH3G;ISCU;VDAC3;GPX4;HCCS;DLST
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.5219993775518409,-1.1095856827672663,0.3125,0.9606777436812082,1.0,7/26,15.44%,BCL2;QRICH1;ERN1;CHAC1;DAB2IP;BAG6;TMEM117
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.7598808516980591,1.1094538687907398,0.35,1.0,1.0,2/5,14.59%,UBE2L6;ISG15
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6524894533471282,1.1094035256844998,0.3880597014925373,1.0,1.0,2/10,13.08%,SP100;FOXM1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5747979110477868,1.1091831816637145,0.35064935064935066,1.0,1.0,3/26,3.01%,ANXA1;CERS3;WNT5A
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.572674149076045,-1.1091553770590035,0.3469387755102041,0.9609718235111311,1.0,4/11,16.84%,PACSIN2;SNX33;PACSIN3;SNX9
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.604909352243731,1.1091188774276903,0.3484848484848485,1.0,1.0,5/16,25.52%,ATP6AP1;ATP1A4;LACC1;KCNJ2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.5471578798161129,1.1090067804234827,0.3389830508474576,1.0,1.0,7/32,19.13%,AMBP;DNAJA1;PINK1;MARVELD3;CYLD;NPPA;F2RL1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.7069432439019733,1.108989928545687,0.32786885245901637,1.0,1.0,3/7,15.02%,DCLRE1A;DCLRE1C;TFIP11
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.6714093525244984,-1.1089758449014082,0.37209302325581395,0.9604410800050447,1.0,2/8,15.36%,WNK2;WNK3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.569741670765745,1.108967258945308,0.3698630136986301,1.0,1.0,7/27,28.65%,WNT5A;ISG15;USP18;CACTIN;PTPN6;OAS1;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5141197658379942,1.1088558182030097,0.25316455696202533,1.0,1.0,15/60,13.22%,AQP3;PLA2G10;BACE2;CAPN13;ACE2;MANF;MISP;SMIM22;HSD11B2;MUC17;MUC4;CLCA1;TMC4;TJP3;EPCAM
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.7131408428282645,1.1088233382475103,0.4153846153846154,1.0,1.0,3/8,19.15%,SLFN14;THBS1;RYR3
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.6637693798725739,-1.1085810266287122,0.4358974358974359,0.9606890427712161,1.0,1/6,5.55%,PTPRF
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5598527292037175,-1.1082154678729474,0.2972972972972973,0.9609212428628792,1.0,3/14,11.22%,TRIM71;KHSRP;ZC3H12D
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.5379291596790061,-1.1080027860566264,0.3125,0.9605748258636461,1.0,3/15,5.76%,ADAMTS1;NR4A3;CCN4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6171857171239198,1.1078755335462789,0.3283582089552239,1.0,1.0,5/11,22.94%,ST18;MMP9;PLAUR;PARK7;PRR7
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.6531836241051164,1.1078103153758097,0.29850746268656714,1.0,1.0,4/14,5.66%,TNFRSF1B;TRIL;WNT5A;SCIMP
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5392316201608909,1.1077257707338088,0.3382352941176471,1.0,1.0,5/32,15.43%,ACAA2;FAXDC2;NPC1L1;PLPP6;FDFT1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6578424158468443,1.1075311233375644,0.3559322033898305,1.0,1.0,4/11,11.65%,ITGB2;TGFB1;ITGAM;SYK
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.6279176851209168,1.1073694547583335,0.38095238095238093,1.0,1.0,1/11,3.19%,GLRX
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.5694047016776198,1.1072889403837196,0.28169014084507044,1.0,1.0,2/25,2.70%,CASQ2;MYBPC3
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.5832674310326884,1.106750653914869,0.34328358208955223,1.0,1.0,1/16,3.42%,CYP3A4
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.5630062746742976,1.1067396668648166,0.31343283582089554,1.0,1.0,4/32,3.47%,GATA4;LRP2;WNT5A;SIX4
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),0.7834299916911236,1.1066229512184416,0.3559322033898305,1.0,1.0,2/5,11.51%,PKP2;NEFM
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.4151137231546546,-1.1064381333347726,0.17391304347826086,0.9642412509703643,1.0,18/103,10.53%,RFX6;ARX;CKMT1B;WWC1;DUSP15;RGS16;CACNG4;HS6ST2;PTPRF;ABCC8;PRR36;ASS1;HES1;EPB41L4B;MSI1;WNK2;NKD2;DAB2IP
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.6437161322497924,-1.1060738147957556,0.3611111111111111,0.9643170912624293,1.0,3/6,26.93%,NF1;INSM1;WNT4
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.488752911569051,1.1056653723548815,0.3246753246753247,1.0,1.0,11/67,13.70%,EOLA1;TLR2;WNT5A;SCIMP;NLRP12;AFAP1L2;C1QTNF4;SYK;NLRC3;TNFSF4;CYBA
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.569293972363893,-1.1054428173471795,0.325,0.9643470965931051,1.0,1/10,1.79%,BCL2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.569293972363893,-1.1054428173471795,0.325,0.9643470965931051,1.0,1/10,1.79%,BCL2
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.627966335612813,1.105335173212918,0.3384615384615385,1.0,1.0,3/11,16.04%,TPGS1;TTLL2;TTLL4
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.6834908687624419,1.1051853168200176,0.3880597014925373,1.0,1.0,3/7,23.15%,SYK;IL4;VAMP7
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-0.6673235213278979,-1.1051645867766415,0.39473684210526316,0.9640896667634303,1.0,1/6,5.45%,HS6ST2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.5380151228110396,1.105026074213557,0.35384615384615387,1.0,1.0,3/35,3.08%,ANXA1;TCF7;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of respiratory burst (GO:0060267),0.760966040393096,1.104959982077339,0.3382352941176471,1.0,1.0,2/5,12.62%,JCHAIN;RPS19
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.5250710684108454,-1.1048911810394597,0.3333333333333333,0.9637723204752472,1.0,1/19,0.56%,APOB
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.7146154754301727,1.1043288655809305,0.39344262295081966,1.0,1.0,1/5,24.41%,LAGE3
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6917454411941177,1.1040536155750507,0.421875,1.0,1.0,1/6,13.49%,NOP53
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6592111422930436,1.1038163736973707,0.3939393939393939,1.0,1.0,2/12,5.42%,CASQ2;CASR
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.4313607039651712,-1.1037518768788692,0.3448275862068966,0.9662944950458144,1.0,9/66,12.33%,GCK;NUP210;POM121C;NUP42;NUP214;AAAS;PFKFB3;ZBTB7A;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5668295785027153,1.1035806908153585,0.3384615384615385,1.0,1.0,10/24,22.35%,WNT5A;CD160;HLA-F;SCIMP;HLA-A;TNFSF4;LACC1;F2RL1;B2M;RAET1G
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.5599717717522318,1.1035009197594547,0.29411764705882354,1.0,1.0,4/27,3.47%,GATA4;LRP2;WNT5A;SIX4
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6738002908314598,-1.1032158502777607,0.39473684210526316,0.9670615389955224,1.0,1/7,3.06%,DCPS
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.6731876690690537,1.1032042138523406,0.3684210526315789,1.0,1.0,2/7,14.06%,CAV3;CSRP3
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.7092053362426683,-1.1027309792962185,0.43902439024390244,0.9676612030762775,1.0,1/7,5.99%,HSPB1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6585854549084985,1.1026377104227019,0.4098360655737705,1.0,1.0,2/9,6.06%,FGF2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.5006965498079493,1.1026344321908843,0.3108108108108108,1.0,1.0,6/59,11.84%,PLA2G10;TGFB1;GPER1;ATP6AP1;IGF1;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.33393392475830275,-1.102564281915016,0.15384615384615385,0.9671758392509968,1.0,71/459,15.61%,PER2;CD38;GMNC;PRDM5;ZNF703;FOXO1;BCL6;GATAD2A;TWIST1;HDAC10;TWIST2;IKZF4;CREB3L1;IFI16;TRIM71;KLF10;WWP2;LBH;PRICKLE1;THAP7;MAP3K10;CTCF;KDM8;HIC2;DHFR;ASCL1;CRY1;CIART;MEN1;NANOS3;PHC2;HES1;PA2G4;PCIF1;CNOT9;MECP2;NACC1;SFMBT1;MTERF3;CBY1;IGF2BP1;FXR2;HDAC3;ATR;TLE2;DAB2IP;NR1D1;PEX14;NKAP;ZBTB7A;NIBAN2;MLX;RCOR2;PCGF6;LDB1;PROX1;HEXIM2;RING1;SMARCA4;MPHOSPH8;SBNO2;KCTD1;ZBTB4;PIAS4;LIMS1;YWHAQ;PUS7;NR1H2;LANCL2;EIF2AK3;HDAC5
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7068017029980554,1.1025393185342607,0.41935483870967744,1.0,1.0,1/6,3.01%,WNT5A
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.4322949692055715,1.1025234639450028,0.25274725274725274,1.0,1.0,109/355,26.35%,NOTUM;APOL1;ITIH2;CSF2RA;SDC2;UBE2L6;LOX;STOML2;SFTPA1;RPL21;SFTPD;C3;RPL37A;RPL18A;RPL9;SERPIND1;USP6;RPL3;RPL15;RPL13;RPL13A;RPS16;MMP15;RPS9;IGF1;RPS3A;RPS5;MRPL34;EEF1A1;RPL36;CP;RPS27A;RPS19;RPL41;PIGH;IGFBP6;TGOLN2;YARS2;RABGGTB;RPS11;UBE2M;PCMT1;KNG1;RPL27A;RPS4X;RPS12;RPL32;RPS21;RPL35A;GNMT;PLAT;PLG;COPS5;PENK;RPSA;RPL7A;RPS13;SPCS2;RPL11;RPS7;FN1;SERPINA10;RSL24D1;RPL23A;RPL7;RPLP2;RPLP0;CSF1;LAMB2;GGCX;PAPPA2;RPS14;RPS6;PAPPA;WFS1;PRSS23;RPL38;RPL23;RPS15;PARP4;RPL24;PLOD2;RPL18;RPL35;ASMT;RPS27;RNF5;TF;RPL8;IGFBP5;RPL10;RPS15A;RPS28;RPS20;MRPL28;RPL27;RPS24;UBA3;APLP2;CPE;RPL29;RPS18;RPLP1;FDXR;MGAT4A;IGFBP7;IGF2BP3;MRPL10;BAP1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5132649514319879,-1.1024731906665426,0.4,0.9664208534615801,1.0,2/26,3.86%,PER2;KCNMB2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5267444781281547,1.1023527717723136,0.37662337662337664,1.0,1.0,11/38,20.29%,ITGB2;ACE2;TGFB1;ITGAM;SYK;CYBA;CDKN1A;AGT;THBS1;F2RL1;ROMO1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.46544179216060766,-1.10230585659523,0.38461538461538464,0.9657876292898109,1.0,13/47,17.48%,MTHFR;MTHFD1L;DHFR;GLUD2;ASS1;FPGS;OGDH;IDH2;AADAT;GPT2;ALDH18A1;SLC19A1;ME2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.5943081707544375,-1.1022418850154105,0.45454545454545453,0.9650057016302037,1.0,5/15,18.98%,PKD2;GRIN1;CPSF7;TMEM120B;FARSA
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5323744213146895,-1.1019802567605,0.21621621621621623,0.9646900707071775,1.0,2/13,5.64%,KIT;PDZD7
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.4758341452266721,-1.1018594625970064,0.19047619047619047,0.9640157621446633,1.0,10/45,15.26%,TRIM67;GPC6;GPC2;GPC4;RALB;GBF1;HFE;GPC1;SPIDR;CSNK1E
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.6218768854957064,1.101736375206478,0.36764705882352944,1.0,1.0,2/11,6.32%,CD160;GPER1
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.6870243655323316,-1.1015496981302384,0.42857142857142855,0.9638514101727788,1.0,1/5,4.83%,EXOC7
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.5737022032348256,-1.1015176407322598,0.3611111111111111,0.961896876279968,1.0,5/12,18.30%,CRYM;OGDH;HYKK;AADAT;PHYKPL
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.5737022032348256,-1.1015176407322598,0.3611111111111111,0.961896876279968,1.0,5/12,18.30%,CRYM;OGDH;HYKK;AADAT;PHYKPL
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.5617248527354162,1.1012233680019683,0.273972602739726,1.0,1.0,5/30,9.34%,LRRC19;CCL5;POU2F3;LEF1;REST
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.6988570085295104,1.1011105685922238,0.4406779661016949,1.0,1.0,2/6,26.42%,GLRA1;CARTPT
prerank,GO_Biological_Process_2021__negative regulation of retinoic acid receptor signaling pathway (GO:0048387),0.7524307672135135,1.1009320165905065,0.39344262295081966,1.0,1.0,2/5,19.31%,CYP26B1;PRAME
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.4619991494057534,1.1005902606415843,0.30952380952380953,1.0,1.0,10/128,8.90%,GPR62;LRP4;TRIL;LMOD1;CTHRC1;SHISA6;SOX10;PLP1;DAAM2;PPP1R1B
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.6997422048734506,1.1005421237118131,0.41509433962264153,1.0,1.0,1/8,10.60%,RAB11A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.5488462348313409,1.1004591622065512,0.3770491803278688,1.0,1.0,1/17,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6151851636492293,-1.0997574859772137,0.37142857142857144,0.966625652338029,1.0,1/7,12.30%,CTPS2
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6916723029295392,1.0997238914654774,0.3275862068965517,1.0,1.0,3/8,23.27%,DAB2;MSN;RAB21
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.6353676412087289,1.0993668126103047,0.31746031746031744,1.0,1.0,5/10,29.63%,IFNK;LCP1;F2RL1;CD74;SLC11A1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.6590252786915916,-1.0992435244088665,0.36666666666666664,0.9671294811615979,1.0,2/8,10.98%,MID1;MAPRE1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.4452039388000004,1.0988404211457559,0.2891566265060241,1.0,1.0,30/126,18.31%,GATA4;NRAP;CASQ2;RRAD;MYBPC3;ASB5;LMOD1;HAMP;LOX;SGCG;FGF2;GPIHBP1;HEY2;CAV3;CKMT2;KLHL38;COL21A1;CTNNA3;CKB;TRDN;CSRP3;PLN;RXRG;NEXN;ART3;SLC5A1;MYH7;NPPA;OBSCN;MTTP
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4501565145432861,-1.098165500008453,0.3333333333333333,0.9692242424688011,1.0,5/41,9.35%,NGF;IFI16;SH3RF1;IGBP1;AQP1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.532489545495797,1.098128929426508,0.3783783783783784,1.0,1.0,4/34,3.47%,TMOD4;LMOD3;LMOD1;SIX4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.6211833707292297,-1.09768055102388,0.3488372093023256,0.9696797027168114,1.0,3/8,20.51%,KCNE1;KCNH2;KCND3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5090898756091906,-1.09761180703042,0.2857142857142857,0.968842498308962,1.0,9/21,25.40%,TWIST1;FOSL1;SRF;MED1;MED16;DHX36;SETX;MED17;MED4
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.6401447825741529,1.0975462826282198,0.36507936507936506,1.0,1.0,3/11,11.47%,WNT5A;AXL;IL7
prerank,GO_Biological_Process_2021__response to acetylcholine (GO:1905144),0.7509212468783106,1.0974767226001083,0.4,1.0,1.0,2/5,23.06%,CHRNB2;CHRNA3
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5092187703935243,1.0972967815781043,0.32857142857142857,1.0,1.0,9/52,8.13%,ITGB2;CCL5;PTPRC;GPR151;SASH3;ITGAM;SH2D1B;CD81;IFNK
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.5703979484272101,1.097259962072973,0.3384615384615385,1.0,1.0,2/23,7.63%,GPER1;SLC26A6
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.543019227692725,1.0968414059103917,0.31343283582089554,1.0,1.0,5/27,12.89%,CCL5;IL12A;GSDME;DDX3X;IFI6
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.46027348607503243,1.0967690170576385,0.2916666666666667,1.0,1.0,26/104,23.06%,PANX3;SLC9A2;SLC12A7;SLC12A3;SLC17A8;SLC26A6;SLC4A1;GLRA1;ATP1A4;SLC15A1;CHRNB1;PIEZO2;SLC25A18;SLC24A1;CHRNB2;P2RX1;PKD1L3;SLC25A22;SLC1A6;MCOLN1;SLC4A2;LRRC8A;SLC26A4;SLC24A5;AQP11;CHRNA3
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.6036228088894726,1.0966936712589825,0.3333333333333333,1.0,1.0,1/19,1.26%,BACE2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.44815580966965546,1.0965933861356005,0.32558139534883723,1.0,1.0,28/173,11.88%,OIT3;TBX1;APOLD1;TIMP3;C1QTNF1;TMEM100;S100A13;CYYR1;LMOD1;INMT;LOX;LYVE1;GPIHBP1;FLT1;ABCG2;ELK3;FLT4;STAB2;ID1;RAMP3;FLI1;CYP1B1;DCN;ANGPTL2;CLDN5;ADGRL4;F8;CRHBP
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.682523287993698,1.0963498651880001,0.36666666666666664,1.0,1.0,3/5,24.46%,NPR2;CD4;ZFP36
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.682523287993698,1.0963498651880001,0.36666666666666664,1.0,1.0,3/5,24.46%,NPR2;CD4;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.6353362969948781,1.096077084521455,0.375,1.0,1.0,3/13,11.57%,SP100;WAS;SPOCK3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.5912499478056016,1.0960745727851695,0.42857142857142855,1.0,1.0,7/19,31.49%,PPT1;ACSL3;SCD;FASN;FITM2;ACLY;GCDH
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.6975151208136066,-1.0959456798426193,0.425531914893617,0.9729311764547254,1.0,3/5,22.89%,IRGM;GPLD1;ATG7
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.632141156457594,1.0956522380799432,0.3898305084745763,1.0,1.0,2/12,2.77%,GAD1;DAO
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.5462706041652018,1.0955148749286647,0.3333333333333333,1.0,1.0,6/34,11.14%,ACOX2;WNT5A;GPR151;IER5;CDKN2A;CD80
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.624741761051569,1.095177961587287,0.3787878787878788,1.0,1.0,1/13,3.01%,WNT5A
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.7147944543672291,1.095151292701948,0.3392857142857143,1.0,1.0,2/8,8.97%,ENPP2;PON1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.43372689909219886,1.094951076623183,0.22727272727272727,1.0,1.0,75/388,20.70%,CLEC5A;ITGB2;C3AR1;MGST1;ARHGAP9;TLR2;OSCAR;ITGAX;TCN1;TNFRSF1B;GMFG;HSPA8;PTPRC;LILRB3;PTX3;SNAP23;C3;ITGAM;NFAM1;PTAFR;CLEC4C;FGL2;CLEC12A;FCAR;ENPP4;PRDX4;MMP9;PSAP;FTH1;CHIT1;ANPEP;CFD;DDX3X;FLG2;SYK;EEF1A1;ARHGAP45;ORMDL3;CD63;A1BG;TMC6;PLAUR;SERPINB1;PLAU;CEACAM8;PDAP1;CYBA;DYNLL1;PGAM1;HK3;LAMP2;FTL;CD44;ATP6AP2;PRDX6;EEF2;MME;RHOG;DEGS1;ANXA2;LAMTOR3;FPR1;ATP6V1D;STOM;ACTR1B;SURF4;HRNR;P2RX1;CYSTM1;IMPDH2;PYGL;ADGRE3;APAF1;PGLYRP1;SRP14
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.508419246251013,-1.094885638733674,0.3333333333333333,0.9750259360732279,1.0,5/28,13.39%,MFSD2A;ABCA4;ATP10A;ATP9A;ABCC1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.34739078549067665,-1.0948223460583617,0.18181818181818182,0.9742153742841021,1.0,44/277,16.30%,CPSF1;HNRNPL;DDX41;RNF113A;TXNL4A;CWF19L1;LSM7;MAGOHB;PDCD7;DHX8;SRRM4;ERN1;SRRM1;SRSF4;KIN;SUGP1;GTF2H2;SNRPB;GPATCH1;SYMPK;HNRNPF;PRPF18;DDX46;NOVA1;U2AF2;CSTF2;PTBP1;POLR2F;SF3A2;SMU1;ERCC2;ZMAT5;IK;HNRNPUL1;CPSF7;GEMIN5;POLR2C;GPKOW;RBMX;RBMX2;PCF11;SNRPN;RALY;RBM41
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.594536806277588,-1.094761683729878,0.37777777777777777,0.9734212882489005,1.0,4/12,21.68%,PLIN5;LPL;OSBPL8;OSBPL11
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.5055633626491995,1.0947436072306118,0.35526315789473684,1.0,1.0,1/43,0.39%,NEK2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5458284047132935,1.0945044253922886,0.3230769230769231,1.0,1.0,6/33,21.32%,SLC9A2;SLC26A6;SLC4A1;SLC9C1;SLC9B1;SLC4A2
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.5948927553291521,1.0939601790630291,0.39705882352941174,1.0,1.0,4/20,7.05%,LYVE1;FGF2;TGFB1;STAB2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.6753838712804306,-1.093691595175379,0.3,0.9756714603446277,1.0,2/5,10.46%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.5966246994888718,1.093670416674435,0.4393939393939394,1.0,1.0,7/11,33.43%,CCT7;CCT8;CCT2;CCT6A;DKC1;MEPCE;CCT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.5966246994888718,1.093670416674435,0.4393939393939394,1.0,1.0,7/11,33.43%,CCT7;CCT8;CCT2;CCT6A;DKC1;MEPCE;CCT3
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.4610179634578151,1.0932081685495594,0.3170731707317073,1.0,1.0,19/110,25.20%,PSMB9;MCM2;MCM3;GRWD1;NAP1L2;RPA3;RPS27A;SOX9;PSMC5;ORC4;PSMB6;H2BC18;RBX1;PSMD6;PSMA3;CHAF1A;PSMA7;GMNN;CETN2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4760028478737365,1.0931554772045153,0.3023255813953488,1.0,1.0,15/97,16.13%,PCLAF;MCM2;POLE2;DONSON;TICRR;CDK2AP1;RAD1;MCM3;POLD4;GRWD1;RPA3;PIF1;RMI2;RECQL4;SET
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.45814202694934963,-1.0929699180523325,0.391304347826087,0.976515267023579,1.0,9/53,9.37%,KCNIP3;KCNJ16;KCNMB2;WWP2;KCNE1;DPP6;KCNIP1;FLNA;KCNJ6
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.7088824933256385,1.092246467759135,0.46296296296296297,1.0,1.0,5/7,26.46%,HLA-F;HLA-A;B2M;HLA-B;LNPEP
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),0.6833253881568648,1.0920661172718968,0.3898305084745763,1.0,1.0,1/6,2.59%,BHMT
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6599067980005102,1.092036482943481,0.4090909090909091,1.0,1.0,3/8,16.57%,RP1;SOX9;RPGRIP1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5008441716596964,1.0916534803565294,0.35,1.0,1.0,2/56,3.51%,PSMB9;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.6304263335056199,-1.0916045871529414,0.32432432432432434,0.979671376117235,1.0,1/5,2.34%,FGF1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5827810623920877,-1.0916017583762025,0.28125,0.978654064200187,1.0,3/13,6.94%,TSKU;SPTBN4;EPHB2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.4761871824196831,-1.0915659000270133,0.3225806451612903,0.9778006578771428,1.0,12/51,18.97%,NUP210;PIAS3;POM121C;NUP42;NUP214;AAAS;BCL11A;RNF212;PIAS4;NUP37;SUMO2;NUP98
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5116757866729201,1.0912295380886576,0.3076923076923077,1.0,1.0,9/51,24.54%,PSMB9;FBXL7;PSMC5;PSMB6;RBX1;PSMD6;ATF5;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.6661065982313645,-1.0910796286206255,0.4166666666666667,0.978242038873198,1.0,1/8,1.81%,IL16
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.41754106314722567,-1.091013986307266,0.2857142857142857,0.9774348605121395,1.0,12/58,11.43%,ADAMTS1;APOH;SPRED1;COL4A2;VASH1;ANGPT4;GTF2I;MINAR1;MECP2;EMILIN1;DAB2IP;NIBAN2
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.5693029022057448,-1.0908051234050578,0.36585365853658536,0.9770692417061729,1.0,1/10,2.95%,HDAC10
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.5146674899362865,-1.0907792748069487,0.35,0.9761624076455729,1.0,7/21,22.03%,MYO10;KIF1C;CCDC88A;CCDC88B;HOOK3;KIF5C;MAP6
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.4318445495245359,1.0907005226999176,0.25,1.0,1.0,74/386,20.70%,CLEC5A;ITGB2;C3AR1;MGST1;ARHGAP9;TLR2;OSCAR;ITGAX;TCN1;TNFRSF1B;GMFG;HSPA8;PTPRC;LILRB3;PTX3;SNAP23;C3;ITGAM;NFAM1;PTAFR;CLEC4C;FGL2;CLEC12A;FCAR;ENPP4;PRDX4;MMP9;PSAP;FTH1;CHIT1;ANPEP;CFD;DDX3X;FLG2;EEF1A1;ARHGAP45;ORMDL3;CD63;A1BG;TMC6;PLAUR;SERPINB1;PLAU;CEACAM8;PDAP1;CYBA;DYNLL1;PGAM1;HK3;LAMP2;FTL;CD44;ATP6AP2;PRDX6;EEF2;MME;RHOG;DEGS1;ANXA2;LAMTOR3;FPR1;ATP6V1D;STOM;ACTR1B;SURF4;HRNR;P2RX1;CYSTM1;IMPDH2;PYGL;ADGRE3;APAF1;PGLYRP1;SRP14
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.6159000707771161,-1.090510847003154,0.40540540540540543,0.9758427548497028,1.0,1/7,8.91%,LIG3
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7154933483347998,1.0903490767429629,0.4262295081967213,1.0,1.0,2/6,22.62%,TCAF2;ABCB1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.6948916371400253,1.0902073148096454,0.4444444444444444,1.0,1.0,1/6,2.61%,ACSL5
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.6216012430056709,1.0897724734655563,0.4098360655737705,1.0,1.0,3/8,18.92%,IL4;BPIFB1;NOS2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.6333339852375399,-1.0896900573775794,0.45454545454545453,0.9772340266564032,1.0,5/8,24.84%,GALNT13;GALNT2;GALNT1;GALNT11;EOGT
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4288623865554081,1.0896673015275837,0.24175824175824176,1.0,1.0,44/441,11.68%,GPR62;TBX1;ESR1;TLR2;LPAR1;LRRC19;S100A13;LRP2;CCL5;WNT5A;FGF20;PTPRC;GFRAL;SCTR;TRIM62;FGF2;FLT1;TRAF3IP2;TGFB1;BOK;TRIM25;GPER1;FLT4;GSDME;ERBB4;NLRP12;CASP10;C1QTNF4;RAMP3;F7;PINK1;RRAGA;DCN;IGF1;AXL;MYDGF;PIK3CG;DDX3X;CD80;KLB;TRIM68;ECT2;HGF;IL26
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.675371136406394,1.0894784469193373,0.4,1.0,1.0,2/9,21.69%,HSPA5;DDIT3
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.513785719514681,1.088903585960529,0.35064935064935066,1.0,1.0,5/37,5.41%,SLC12A7;FAM20A;SLC12A3;TRPV6;CYP4F12
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.5015044006041597,-1.0889029132331545,0.23529411764705882,0.9787246510145268,1.0,2/22,3.40%,PHLDB2;F11R
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.7015159037415443,1.0888174629199803,0.4603174603174603,1.0,1.0,1/6,14.26%,PCMT1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.4294738638098347,1.0887997437896613,0.2696629213483146,1.0,1.0,74/391,20.70%,CLEC5A;ITGB2;C3AR1;MGST1;ARHGAP9;TLR2;OSCAR;ITGAX;TCN1;TNFRSF1B;GMFG;HSPA8;PTPRC;LILRB3;PTX3;SNAP23;C3;ITGAM;NFAM1;PTAFR;CLEC4C;FGL2;CLEC12A;FCAR;ENPP4;PRDX4;MMP9;PSAP;FTH1;CHIT1;ANPEP;CFD;DDX3X;FLG2;EEF1A1;ARHGAP45;ORMDL3;CD63;A1BG;TMC6;PLAUR;SERPINB1;PLAU;CEACAM8;PDAP1;CYBA;DYNLL1;PGAM1;HK3;LAMP2;FTL;CD44;ATP6AP2;PRDX6;EEF2;MME;RHOG;DEGS1;ANXA2;LAMTOR3;FPR1;ATP6V1D;STOM;ACTR1B;SURF4;HRNR;P2RX1;CYSTM1;IMPDH2;PYGL;ADGRE3;APAF1;PGLYRP1;SRP14
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.49188961188559593,-1.0887241254651665,0.2857142857142857,0.9782137102529809,1.0,6/29,11.98%,MT1G;NR4A1;HSPB1;ERN1;DAB2IP;MAPKAPK2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.5072099569135734,-1.0886553135705104,0.3684210526315789,0.9773977954610001,1.0,6/19,22.27%,NAXE;OSBPL6;NR1H2;ABCA13;NFKB1;ABCB4
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5791505489610459,1.0886105573913678,0.38028169014084506,1.0,1.0,7/23,14.27%,SIX4;SGCG;MYL6;PGM5;POPDC2;CSRP3;SGCZ
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.515235507440024,-1.0885914441660594,0.24,0.9765689984361126,1.0,4/28,12.62%,MFSD2A;CHKA;PEMT;SLC44A5
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.7161013384834921,1.0884997508631973,0.4444444444444444,1.0,1.0,2/5,11.44%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.7161013384834921,1.0884997508631973,0.4444444444444444,1.0,1.0,2/5,11.44%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.7161013384834921,1.0884997508631973,0.4444444444444444,1.0,1.0,2/5,11.44%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.7161013384834921,1.0884997508631973,0.4444444444444444,1.0,1.0,2/5,11.44%,EXOSC2;EXOSC8
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.5486903244689838,1.0884664775473758,0.31666666666666665,1.0,1.0,6/23,10.43%,SLCO1A2;SLC10A1;ABCC2;SLC51A;ABCC11;NR1H4
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.599435909796971,1.0884041016189292,0.4393939393939394,1.0,1.0,3/14,20.22%,PTPRC;EPCAM;HMGA2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5496060602477728,1.0883813062951428,0.38461538461538464,1.0,1.0,2/32,2.07%,RAB34;S100A13
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.4406062362578752,-1.088380503698779,0.17391304347826086,0.9761490968760779,1.0,19/96,15.85%,NUP210;P3H4;HDAC10;RNF113A;LOXL1;PIAS3;POM121C;NUP42;SENP1;NUP214;AAAS;P3H3;BCL11A;RNF212;EEF1AKMT1;SIRT7;PIAS4;PLOD3;NUP37
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.7200658467701345,-1.0882267509476276,0.4722222222222222,0.9757300557700596,1.0,1/7,1.86%,APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.5274450401303789,-1.088038483272181,0.4166666666666667,0.975224794946131,1.0,3/9,16.70%,FGF1;PTH1R;ABCG1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.7150391362096062,1.0878186963374352,0.4444444444444444,1.0,1.0,2/8,5.65%,SLC38A3;SLC7A7
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.7093150058184313,1.0876344267982292,0.43548387096774194,1.0,1.0,1/7,5.58%,HAT1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.7093150058184313,1.0876344267982292,0.43548387096774194,1.0,1.0,1/7,5.58%,HAT1
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),-0.6435448559505981,-1.0875350069878709,0.39473684210526316,0.9759384062839535,1.0,1/6,2.85%,CLC
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.5227736217943181,1.087454402287075,0.39436619718309857,1.0,1.0,7/37,10.98%,CLIC1;GP1BA;ACTG1;CD99;MEGF11;MYL12A;PIK3CG
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.7659754315749124,1.0873085361658943,0.4,1.0,1.0,2/5,14.86%,KANK2;ANLN
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.7165718341364854,1.0870069108415883,0.4426229508196721,1.0,1.0,3/7,15.94%,DNAJA1;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.6562880484714398,1.086703493758985,0.3684210526315789,1.0,1.0,3/8,19.79%,MESP1;SNAI1;TBX19
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.7039970838693813,-1.086661483235749,0.42105263157894735,0.9774471398089589,1.0,3/5,16.36%,CROCC;CCDC88A;ENTR1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.5635135917794507,-1.0863882589335823,0.40540540540540543,0.977144232495769,1.0,6/14,25.62%,RAD50;ERCC1;MSH3;RAD52;SMC6;XRCC3
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.6152277725627018,-1.08637773287538,0.4166666666666667,0.9761915241785512,1.0,4/7,23.79%,GNA14;GNA11;DRD2;DRD3
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.6333657756589742,-1.086360783578271,0.4358974358974359,0.9752840732848972,1.0,1/7,9.26%,PTPRS
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.6958030602918703,1.0861013755306805,0.3939393939393939,1.0,1.0,2/7,6.82%,CCL5;JAM2
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.5509163439088988,-1.0858932575744669,0.37209302325581395,0.9748292145893138,1.0,3/10,13.28%,APOH;SERPINE1;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.5509163439088988,-1.0858932575744669,0.37209302325581395,0.9748292145893138,1.0,3/10,13.28%,APOH;SERPINE1;ST3GAL4
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.6142551086225759,1.0854738794148895,0.4153846153846154,1.0,1.0,2/10,4.99%,TMEM204;HEY2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.7239115471034206,1.08541436473384,0.43103448275862066,1.0,1.0,3/6,24.01%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.7239115471034206,1.08541436473384,0.43103448275862066,1.0,1.0,3/6,24.01%,HEY2;HEY1;ENG
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.545397264116716,1.0854074020391007,0.35384615384615387,1.0,1.0,3/24,1.93%,RASGRP4;GPR55;LPAR1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.3848722687796252,-1.0853686391769926,0.2916666666666667,0.9753078353789446,1.0,24/96,20.75%,CHD4;HNRNPL;DDX11;TTF2;CEP85;ZDHHC5;ITGA4;NOP14;URB2;NEU3;UBE2O;RFWD3;PTBP1;SSRP1;PABPC4;GART;NCAPD2;TBRG4;NUP98;DCAF1;HDGF;ABCB10;XPO5;POLG
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6124586501025487,-1.085259464879146,0.46153846153846156,0.9746062883742004,1.0,3/5,18.62%,MUS81;SLX4;FBH1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.6619963192321167,1.0851220435701348,0.4576271186440678,1.0,1.0,2/10,7.67%,ANXA1;NLRP12
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.49105955724177075,1.0850274073353887,0.3333333333333333,1.0,1.0,19/48,20.86%,PTPRC;FCGR3A;POU2F3;ITGAM;NFAM1;PTAFR;JCHAIN;FGL2;GNAT3;ASIC5;HCK;CSF3R;HK3;SOX9;KLF3;P2RX1;IL17RB;ADGRE3;CD300LF
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.6832356966686142,1.0850097074517253,0.5,1.0,1.0,2/7,11.22%,SHISA6;GRIN2D
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.6175393590619067,-1.0848630912894863,0.47058823529411764,0.9747681157971285,1.0,3/8,19.88%,PNKP;AK8;AK7
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.6510528476521258,-1.0844191231191733,0.358974358974359,0.9751161830609575,1.0,3/8,21.53%,PLEKHM1;PIP4K2B;CLN3
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.7145551917429142,1.0843225785280057,0.42857142857142855,1.0,1.0,1/5,16.42%,MSN
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.7145551917429142,1.0843225785280057,0.42857142857142855,1.0,1.0,1/5,16.42%,MSN
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.6512320930362685,1.0842937560325752,0.39285714285714285,1.0,1.0,3/9,17.72%,HTR5A;HTR1B;HTR2B
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.6977142562502842,-1.0841730224932549,0.38461538461538464,0.9749044100947611,1.0,1/5,10.06%,AGO2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.5438162721798183,-1.0841018665251638,0.3333333333333333,0.9740772039924287,1.0,5/12,29.66%,ABCG1;CLN3;NCSTN;ADAM19;ABCA7
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.5662174924961193,1.0839892776850029,0.43283582089552236,1.0,1.0,1/31,0.47%,ENPP2
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.6515499093476784,1.0838487051787695,0.4230769230769231,1.0,1.0,2/10,14.45%,PIK3R3;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),0.673208005565854,1.083720794531089,0.44642857142857145,1.0,1.0,3/6,28.69%,OAS2;OAS1;OASL
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.6238465647124681,1.0836093129921924,0.4246575342465753,1.0,1.0,3/11,10.70%,BAIAP2L1;LCP1;GAS2L3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.506134450714933,-1.083575737369855,0.27586206896551724,0.9745823016082242,1.0,1/23,0.92%,NMU
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7271881363199775,-1.0835224936311105,0.43243243243243246,0.9737856749106913,1.0,3/6,17.06%,PRKCD;DLL1;PRKCA
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.7146439908565491,1.083489837596612,0.4067796610169492,1.0,1.0,1/5,3.08%,PTPRC
prerank,GO_Biological_Process_2021__neurotransmitter loading into synaptic vesicle (GO:0098700),0.7149054627860045,1.083254534351795,0.4,1.0,1.0,2/5,6.07%,SLC18A2;SLC17A8
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.6508974470340053,1.0829893805621593,0.4067796610169492,1.0,1.0,3/8,29.75%,PIK3CG;PIK3C2G;PIK3CB
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4054144174382794,-1.0829714572341813,0.23076923076923078,0.9743900023400776,1.0,30/141,12.11%,CLDN4;CDH4;CDH20;SELE;CDH5;CDH19;KIRREL3;GPC6;DSG2;SELL;CLDN15;CDH13;GRID2;CLDN16;PTPRF;GPC4;CDH26;ACVR1;PVR;IGSF21;AMIGO2;SELP;PTPRS;PCDHB6;SDK2;SLITRK2;BSG;ALCAM;CDH12;LRFN4
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.4325761940717421,-1.0829518250053816,0.3793103448275862,0.9734525248460786,1.0,11/62,17.26%,NUP210;TRIM71;POM121C;NUP42;NUP214;AAAS;AGO2;POLR2F;POLR2C;NUP37;TNRC6A
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.567031223370811,1.0829501265896901,0.36363636363636365,1.0,1.0,5/27,15.25%,ESR1;KANK2;VPS18;ZNF366;WBP2
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.6565783169124532,1.0823086481619972,0.45454545454545453,1.0,1.0,2/7,23.45%,HERPUD1;BCAP31
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.4269052798307751,-1.0819528298965972,0.22727272727272727,0.9757232664001955,1.0,19/95,19.01%,NGF;ITPR2;THEM4;ECSIT;RALB;ARPC3;CDK1;GNA14;NOD1;ADCY2;CDK4;ATF1;RPS6KA3;PPP1CA;PRKAR2A;PLCB1;IRAK4;FGF17;PPP2R1B
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.43021661074424555,-1.0818957471808293,0.2857142857142857,0.9748432770474297,1.0,12/34,19.90%,RAD50;CTC1;ZSCAN4;WRAP53;TERT;STN1;GAR1;ANKRD28;DCLRE1B;RTEL1;ZBTB48;TNKS1BP1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.6725960362329249,1.0818447598249636,0.40298507462686567,1.0,1.0,2/10,12.59%,CCDC39;ZMYND10
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),0.6952776695464994,1.0815941749500533,0.3793103448275862,1.0,1.0,3/5,28.41%,PLN;VDAC1;SLC30A1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.6903004196961846,1.0815585772247993,0.4067796610169492,1.0,1.0,1/7,3.08%,PTPRC
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.5353795051413414,-1.0815293174671536,0.3076923076923077,0.9750316872045279,1.0,4/17,8.53%,PNPLA3;AUP1;PLIN5;PLA2G4C
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.4219926353137984,-1.0815159349311736,0.3333333333333333,0.9740831166250346,1.0,6/63,5.48%,TSKU;APOB;EPHX2;LIPC;APOE;CYP7B1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.6481019936147753,1.0815029536741967,0.38235294117647056,1.0,1.0,6/11,26.88%,ART1;ART3;NDUFAF5;PARK7;PADI2;PRMT1
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5291458786399523,1.0815003849855647,0.2987012987012987,1.0,1.0,6/47,16.42%,TBX1;ANXA1;TGFB3;ALOX15B;SOX9;MSN
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),0.6945335078930619,1.0812461420923651,0.4067796610169492,1.0,1.0,2/5,6.28%,HEY2;MESP1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.5811422452257591,-1.0811655358360548,0.3235294117647059,0.9742577171882123,1.0,2/10,20.68%,RAPGEF1;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.6597456148060369,-1.0810796319875904,0.3488372093023256,0.9734961463375498,1.0,1/6,10.06%,AGO2
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.6098570641248621,1.0809537825907225,0.38095238095238093,1.0,1.0,2/9,11.65%,STAT5A;SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.6098570641248621,1.0809537825907225,0.38095238095238093,1.0,1.0,2/9,11.65%,STAT5A;SYK
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5201682821462474,-1.0807490650165001,0.3684210526315789,0.9734868399591743,1.0,4/20,3.90%,ADAMTS1;DNMT1;MMP2;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.675152206662962,-1.0804984558627349,0.47058823529411764,0.9731803848778254,1.0,1/7,1.68%,UBASH3B
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.4711469370506654,1.080476812358013,0.34285714285714286,1.0,1.0,9/64,13.30%,CLIC1;APOL1;SLC12A7;SLC12A3;SLC26A6;GLRA2;SLC4A1;GLRA1;ANO2
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.4531061969608766,1.0804072369935274,0.34146341463414637,1.0,1.0,68/195,27.05%,RPL21;RPL37A;MRPS34;RPL18A;RPL9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;MRPL34;EEF1A1;RPL36;RPS27A;RPS19;RPL41;YARS2;RPS11;RPL27A;RPS4X;RPS12;EEF2;RPL32;RPS21;RPL35A;GFM2;COPS5;RPSA;RPL7A;RPS13;RPL11;RPS7;RSL24D1;RPL23A;RPL7;RPLP2;RPLP0;RPS14;RPS6;MRPS2;RPL38;RPL23;RPS15;RPL24;RPL18;RPL35;ASMT;DARS2;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;MRPL28;RPL27;RPS24;RPL29;RPS18;RPLP1;IGF2BP3;MRPL10;RPS3;RPS23;RPL34
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.5562590374231826,-1.0801299390514352,0.4375,0.9732986423021738,1.0,2/19,1.87%,WNT3A;SELE
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.4942831742940601,1.0799706278169172,0.30434782608695654,1.0,1.0,4/39,12.65%,TENT5B;DAZL;MEIOC;BOLL
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5607858773523188,-1.0799513152347315,0.32432432432432434,0.9728800040657843,1.0,3/13,19.74%,MGARP;SPAST;MAPT
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.5677961884341062,-1.0798464563860966,0.37777777777777777,0.9723211131250388,1.0,2/11,5.28%,DDAH2;APOE
prerank,GO_Biological_Process_2021__regulation of glomerular mesangial cell proliferation (GO:0072124),-0.6731285064017916,-1.079640760901597,0.43902439024390244,0.9718197115278537,1.0,3/5,24.94%,IL6R;PDGFB;BMP4
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.46474726612498496,-1.0796378007298626,0.3333333333333333,0.9708546472661578,1.0,6/23,18.16%,RNF168;PCGF1;KDM2B;RING1;LEO1;UBE2E1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.5755958648872244,1.079568163413206,0.36619718309859156,1.0,1.0,6/14,29.63%,PIK3CG;MSN;CRTAM;RASGRP1;TNFSF14;SLC11A1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6344912146462585,-1.0794728963017601,0.358974358974359,0.9703978951157567,1.0,3/7,23.21%,AGO2;TARBP2;ADAR
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.6395580909110163,1.0793481259391597,0.423728813559322,1.0,1.0,3/9,19.13%,C15ORF62;WASHC1;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.6395580909110163,1.0793481259391597,0.423728813559322,1.0,1.0,3/9,19.13%,C15ORF62;WASHC1;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.5751392883147418,1.0792608344337755,0.36486486486486486,1.0,1.0,3/15,10.97%,NODAL;IGF1;WEE2
prerank,MSigDB_Hallmark_2020__Coagulation,0.4614647232095726,1.0789670304996537,0.2716049382716049,1.0,1.0,24/98,19.22%,TIMP3;GP1BA;ANXA1;S100A13;ACOX2;GNG12;C3;PROZ;ITGA2;MMP9;MMP15;CPB2;CFD;F8;PLAU;LAMP2;MMP11;VWF;PLAT;PLG;FN1;MASP2;THBS1;A2M
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.6771632023646941,1.0788798442836052,0.36507936507936506,1.0,1.0,3/10,18.27%,CCL5;CRTAM;CD4
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.7312446342666651,1.0785886400240614,0.3968253968253968,1.0,1.0,2/5,7.72%,SLC26A6;SLC51A
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.6424700167440976,-1.0784626254783762,0.40625,0.9722888409682844,1.0,2/8,18.50%,WASF3;WASF2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.4316707039663958,-1.0781866428628613,0.375,0.9721825417104328,1.0,22/99,17.47%,PHLDB2;PRKCD;F11R;CAPN2;RND3;FSCN1;RHOBTB2;TAOK2;CORO2B;CORO1A;CRK;SORBS3;MARK2;CCDC88A;MLST8;CAMSAP3;ARHGAP35;RHOA;RHOBTB1;PAK3;TRAF3IP1;ABL1
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.7126826296235321,1.0774836253776532,0.4264705882352941,1.0,1.0,2/5,23.74%,ATP6AP1;NOTCH2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.3686279626243813,-1.0774246551503681,0.19047619047619047,0.9734789378452829,1.0,11/165,3.20%,IL7R;ETV5;NGF;TRIB2;DUSP6;PTCD2;IL1RL2;TPH1;EMP1;ETV1;RGS16
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.6818516535990449,1.0771623293039858,0.47619047619047616,1.0,1.0,3/6,16.42%,TGFB1;TGFB3;MSN
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.4771625534514795,1.0771337724966705,0.2875,1.0,1.0,9/70,12.54%,GATA4;ACAA2;PELI3;MMP9;PINK1;IGF1;DDX3X;HGF;PLAUR
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.520618562096449,1.077007389729678,0.375,1.0,1.0,21/46,23.91%,PWP2;RPL3;EIF6;DDX3X;RPS5;MRPL20;MPV17L2;RPS19;NOP53;RPSA;RPL11;RSL24D1;RPL23A;RPLP0;RPS14;MRPS2;RPS15;RPL24;RPS27;RPL10;RPS28
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.6234902761225597,-1.076579183990615,0.41935483870967744,0.975333211633426,1.0,4/7,31.93%,SYT7;GREM1;SUCO;LEPR
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.6995890971680307,1.0765098430892845,0.43636363636363634,1.0,1.0,2/5,18.82%,ACSL3;CNST
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.6419619542532027,1.0761410276721664,0.4393939393939394,1.0,1.0,2/11,6.32%,C1QTNF1;GPER1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6260714237373247,-1.076033499013782,0.4634146341463415,0.9763719891088251,1.0,5/7,31.34%,FNTA;MAPT;PRKAA2;TPPP;EP300
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.7054084442113255,1.076033174572157,0.4444444444444444,1.0,1.0,2/6,11.13%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.7054084442113255,1.076033174572157,0.4444444444444444,1.0,1.0,2/6,11.13%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.668103458298187,-1.075774653480027,0.5142857142857142,0.9761082654723793,1.0,4/6,32.72%,SNPH;UNC13C;SNAP25;UNC13A
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.43415532138010193,-1.0757413909585096,0.2413793103448276,0.9752164303558303,1.0,7/34,12.88%,DNAJC30;WWC1;CAPN10;NUP214;AAAS;ATP9A;REEP6
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.658259179931339,1.0757386664869941,0.45614035087719296,1.0,1.0,3/6,20.24%,SLC25A18;SLC25A22;SLC1A6
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.4832779014292161,1.0756216081874717,0.3333333333333333,1.0,1.0,12/82,6.57%,C1QB;GPR55;ADAM28;APOL6;FAM20A;C3;VSIG4;FMO5;MAP3K19;CPM;FGL2;ANKUB1
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.7000985918366027,-1.0755689138969624,0.41304347826086957,0.9746752465986412,1.0,4/6,15.99%,PNP;NT5C1A;NUDT18;SAMHD1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.40237461128532265,-1.0754284416213218,0.24,0.9739678218132257,1.0,9/95,7.49%,RASSF2;TRIB2;UBASH3B;SPRED1;ADCYAP1;HSPB1;CEP85;TRIB1;CCN1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.54880128676364,1.0751434702729703,0.3283582089552239,1.0,1.0,2/16,6.51%,PKP2;CAV3
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5458745567029654,-1.0750671563026033,0.375,0.9739582075104462,1.0,5/14,16.05%,MFSD2A;PLIN5;SCARB1;NR1H2;CTDNEP1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.4799105836335614,1.07469038041335,0.34328358208955223,1.0,1.0,4/57,5.00%,AQP3;ZACN;HAMP;TRPV6
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.689159647983133,1.0742015114166108,0.46551724137931033,1.0,1.0,1/6,2.59%,BHMT
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.48919694492636884,1.0738072076157963,0.3333333333333333,1.0,1.0,2/40,2.87%,GAD1;HSPA8
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6653435667353775,1.0737905855162733,0.4626865671641791,1.0,1.0,1/5,6.82%,JAM2
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.6848088926810538,-1.0737017046855977,0.45652173913043476,0.9772464064752953,1.0,1/5,1.84%,GLA
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.6908722829584064,-1.0736364609450761,0.42857142857142855,0.9764134316845503,1.0,4/7,13.61%,DDX11;ZNF618;MED25;KDM4D
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5289303022093693,-1.0732109091388526,0.38235294117647056,0.9766097626310979,1.0,5/14,16.64%,NAMPT;RNLS;NAXE;PARP16;PTGIS
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.6651414421773136,-1.0731309445774477,0.425,0.9758900320565037,1.0,3/7,21.68%,PLIN5;LPL;OSBPL11
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6353885503243164,-1.0731191774602733,0.42105263157894735,0.9749915242028221,1.0,6/9,24.50%,CCN3;HDAC3;HDAC5;NOTCH1;HDAC4;HDAC1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6909814136799051,1.0729958434133655,0.49230769230769234,1.0,1.0,2/7,19.53%,TRMT10A;TRNT1
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.6995859419801874,-1.0729933628363642,0.45454545454545453,0.9744547880786512,1.0,1/5,3.47%,ABCC4
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.4953294939750614,1.0729307888968418,0.375,1.0,1.0,17/44,27.45%,CHCHD4;TIMM22;PINK1;TOMM20;TIMM17A;FIS1;TOMM7;ROMO1;PAM16;BCAP31;TIMM10;SLC25A6;FBXO7;TOMM34;AIP;TIMM21;HK2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.7069485276667644,1.072599914200871,0.4482758620689655,1.0,1.0,1/5,16.26%,DOCK5
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6826023762503887,-1.0724607387256817,0.5128205128205128,0.9750672624914146,1.0,4/6,28.50%,ATP9A;EIPR1;PRKN;ARFIP1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.6023308337416494,-1.0724442260786566,0.4722222222222222,0.9741860035827243,1.0,2/7,9.27%,FOXO1;IGBP1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.7148241200365983,-1.0722905855562754,0.42105263157894735,0.9734997497956585,1.0,6/8,26.70%,KIT;FGFR2;CHD8;CLMP;COBL;NIPBL
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.5796933574854863,-1.0722604098077886,0.4358974358974359,0.9726631089840676,1.0,1/12,1.56%,AGBL1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.724589684700631,1.0722098979795522,0.3898305084745763,1.0,1.0,3/5,23.20%,ALDH9A1;BBOX1;TMLHE
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.724589684700631,1.0722098979795522,0.3898305084745763,1.0,1.0,3/5,23.20%,ALDH9A1;BBOX1;TMLHE
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),0.7378440932026429,1.0721372374812939,0.42592592592592593,1.0,1.0,1/5,6.02%,KCNA5
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),0.7378440932026429,1.0721372374812939,0.42592592592592593,1.0,1.0,1/5,6.02%,KCNA5
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4469996659542524,1.0720877499835695,0.3333333333333333,1.0,1.0,13/140,11.39%,NRAP;TMOD4;LMOD3;ELMO3;LMOD1;SCIN;BAIAP2L1;NLRP5;WAS;LCP1;FHOD1;GAS2L3;RHOB
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.48944762701480315,1.071446238194825,0.4,1.0,1.0,7/49,15.88%,MCM2;ANXA1;MCMDC2;PIF1;RPS27A;HMGA1;RECQL4
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.6122748120705775,1.0713611647732553,0.4,1.0,1.0,1/10,4.80%,STAT5A
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.6218938090564775,1.0712783250717166,0.39344262295081966,1.0,1.0,3/12,7.60%,TECRL;ELOVL2;HACD4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.7231929483180901,1.071215991882505,0.43859649122807015,1.0,1.0,1/6,19.13%,F2RL1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.548946198953506,1.0711677246761149,0.38461538461538464,1.0,1.0,1/25,1.32%,DISC1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5997990749875121,1.0710877664441099,0.421875,1.0,1.0,4/11,22.49%,CCL5;PLA2G7;CREB3;CXCL12
prerank,MSigDB_Hallmark_2020__E2F Targets,0.42948209374749363,1.0709262135844562,0.29545454545454547,1.0,1.0,22/189,15.56%,CDCA3;CDC25A;MCM2;DONSON;TK1;H2AZ1;RAD1;MCM3;CDKN2A;PRDX4;SUV39H1;PSMC3IP;DCK;NAA38;EXOSC8;CKS1B;RPA3;CDKN1B;ING3;CDKN1A;SPC25;HMGA1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.5433735504099397,-1.0708457511660563,0.4230769230769231,0.9756725799304979,1.0,4/13,21.52%,PNP;AK8;AK7;NMNAT3
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.6578942975835491,1.0707265254702365,0.3620689655172414,1.0,1.0,1/7,2.80%,GMFG
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),0.7277354805672711,1.0706802496430061,0.43333333333333335,1.0,1.0,1/5,2.83%,LRP2
prerank,GO_Biological_Process_2021__response to cocaine (GO:0042220),0.7001158697952403,1.0703940921622288,0.3333333333333333,1.0,1.0,3/5,17.10%,CRHBP;TGM2;CHRNB2
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.5095979384227785,1.0703544813373196,0.37681159420289856,1.0,1.0,6/32,13.46%,CASQ2;ANXA1;GRK7;SOCS2;TRDN;MTCH1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.44564905725423987,-1.0702327665581066,0.3448275862068966,0.9766938830511603,1.0,3/20,5.67%,BOD1L1;PPP1R14D;STYXL1
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.6379523855059741,1.0702232824199112,0.43859649122807015,1.0,1.0,3/6,29.09%,TBCE;TBCC;VBP1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.46862308569499456,1.0701710356511778,0.35,1.0,1.0,13/84,11.85%,RASGRP4;C19ORF38;SLFN14;GMFG;LOX;NR1I3;PKLR;CLEC12A;HEMGN;CA1;SLC4A1;CD244;CSF3R
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.5486698231310826,-1.0700335521760633,0.4186046511627907,0.9762416566657198,1.0,5/17,13.81%,HSD3B2;AKR1C3;STARD3NL;CYP46A1;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),0.7272022330367118,1.069954873534675,0.45,1.0,1.0,3/5,23.45%,TGM2;FIS1;BCAP31
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.4266692710771066,-1.069885190764385,0.32142857142857145,0.9757216093796937,1.0,11/66,11.38%,ACAD10;MECR;ACADS;SLC25A17;GLYATL2;SLC27A2;ECHDC2;ECHS1;PEX13;SLC27A4;CEL
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.48234142663981544,1.0698271963541341,0.3611111111111111,1.0,1.0,1/43,0.44%,RAB34
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5931966388403871,1.0697708925396963,0.375,1.0,1.0,2/16,10.26%,BAIAP2L1;HCK
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.43417483069927354,-1.0691296365939156,0.2857142857142857,0.9768908867791308,1.0,2/25,3.96%,ADAMTS1;LSM10
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.5531410277091039,1.0688716608853996,0.36363636363636365,1.0,1.0,2/32,5.45%,BACE2;TGFB1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.6176682431575006,1.068832969870551,0.48484848484848486,1.0,1.0,4/16,7.05%,LYVE1;FGF2;TGFB1;STAB2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.44109303275392375,-1.068658094085993,0.36363636363636365,0.9774271097503173,1.0,7/72,4.05%,IL7R;P2RY10;SKAP1;BCL2;IL16;SELL;CD247
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.6404422411223947,1.0686104629882953,0.4166666666666667,1.0,1.0,2/10,10.09%,MESP1;WNT8A
prerank,GO_Biological_Process_2021__glycerol-3-phosphate metabolic process (GO:0006072),-0.631977139330416,-1.0680899812193978,0.3170731707317073,0.978249988921691,1.0,3/5,21.86%,GPD1;GK5;GK
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.5233169915557632,-1.068027375462666,0.46875,0.9774289098975537,1.0,7/14,28.15%,IGBP1;MTMR1;SMG5;PPP1R16B;SMG6;SRC;INPP5K
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5970262577226436,1.0680025079055628,0.43661971830985913,1.0,1.0,2/17,1.05%,SLC28A1;PLA2G10
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.608420332352183,1.0679619809071688,0.43548387096774194,1.0,1.0,1/12,2.46%,PKP2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.47331247694016215,-1.0676828565822318,0.45161290322580644,0.9775528663064609,1.0,6/33,11.22%,GLA;DDAH2;APOE;DHFR;SCARB1;TERT
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.6800863265323693,-1.0676290020920196,0.43333333333333335,0.9767477009673896,1.0,3/6,28.78%,CFAP100;MTCL1;PAFAH1B1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5739901461159416,1.0676203761512053,0.391304347826087,1.0,1.0,3/18,5.45%,PKP2;MYBPC3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6369224818799787,1.0674994460313167,0.4745762711864407,1.0,1.0,1/8,3.01%,WNT5A
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.42262301921709344,-1.0673912767342795,0.25,0.9765718427069427,1.0,5/54,5.48%,TSKU;APOB;CYP4V2;APOE;CYP7B1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.42200038748107027,-1.0673628341139314,0.3333333333333333,0.9757419015076866,1.0,6/62,5.48%,TSKU;APOB;EPHX2;LIPC;APOE;CYP7B1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.40432123987036633,-1.0673536148862242,0.15789473684210525,0.9748590721092548,1.0,14/85,8.54%,ADGRF4;EMP1;LAMA3;COL12A1;COL4A2;FRMD6;RND3;RHBDF1;ERBB2;CNN1;PARVA;CA3;PERP;EFEMP1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.4208691397881099,-1.0673509112130442,0.25,0.973923506780935,1.0,9/56,12.34%,MFSD2A;FOXO1;KLF10;FADS1;RALB;CLEC16A;ALB;AKR1C3;LPL
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.6967141242228209,1.067259821653277,0.4838709677419355,1.0,1.0,1/5,2.77%,DAO
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.6761137682373979,1.0672044001594239,0.45901639344262296,1.0,1.0,4/9,15.85%,STRAP;MUC4;SOX9;PBLD
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.5324910226658343,1.067113957482799,0.352112676056338,1.0,1.0,7/23,20.24%,ABCC2;SLC26A6;SLC22A6;SLC25A18;SLC25A22;SLC46A1;SLC1A6
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4648148517088445,-1.067000041354151,0.3333333333333333,0.9740229218818777,1.0,10/36,19.27%,LARS2;VARS1;QRSL1;WARS2;MARS1;CARS1;YARS1;GATB;FARSA;HARS2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.57241283039019,1.0667801389561673,0.43661971830985913,1.0,1.0,3/19,10.20%,TMEM204;CNMD;ITGA5
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.40646025192382035,-1.0662022693865933,0.34615384615384615,0.9755074632875843,1.0,3/86,2.30%,NOX4;ETV5;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5719248607038826,1.0661675462368387,0.38571428571428573,1.0,1.0,8/15,34.13%,NOP10;CCT7;CCT8;CCT2;CCT6A;DKC1;CCT3;SHQ1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.5901986005824527,-1.0658048769834807,0.39473684210526316,0.9758087004744767,1.0,1/5,21.94%,AXIN1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6052098985970196,1.0657149901903178,0.43333333333333335,1.0,1.0,2/12,9.14%,RENBP;B4GALNT2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.6130957374834978,1.0654800667144382,0.3870967741935484,1.0,1.0,3/12,14.59%,DNAJA1;PINK1;ISG15
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.48826155419651646,1.0653612141284312,0.358974358974359,1.0,1.0,2/41,2.87%,GAD1;HSPA8
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.45458450399063455,-1.0652951089691363,0.3333333333333333,0.9765702510040247,1.0,12/42,15.05%,NOX4;DDAH2;ASPG;MTHFR;CBS;ASS1;KYAT1;KYAT3;PYCR3;AADAT;GPT2;ALDH18A1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5009944288291256,-1.0649365606041126,0.3142857142857143,0.9769646960313708,1.0,1/22,0.92%,TYRP1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.59918173741517,-1.0649171926415688,0.43902439024390244,0.9760595372077437,1.0,3/6,24.32%,WWP2;CTTNBP2NL;SNCA
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.6340033458673251,1.0647666670259608,0.4166666666666667,1.0,1.0,2/7,21.15%,LEF1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6087301563707541,1.0645618496303744,0.43859649122807015,1.0,1.0,1/12,1.57%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.4162568426485999,-1.0644978398939768,0.2,0.9763185490409916,1.0,6/29,7.35%,BAMBI;TWIST1;TWIST2;HDAC7;PTCH1;MEN1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.5028238811954544,-1.06428175821491,0.30303030303030304,0.9759423829007976,1.0,6/21,19.74%,LIMK1;GOLGA4;ISLR2;DBNL;MAP3K13;MAPT
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.6951840865336253,1.0641143045426251,0.42857142857142855,1.0,1.0,1/5,9.69%,SOD2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.5490697821904367,1.0640610198471288,0.39436619718309857,1.0,1.0,2/18,3.01%,LRP4;WNT5A
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.5041659396257682,-1.063419249739515,0.34615384615384615,0.9777120142082287,1.0,8/17,29.47%,SLX4;RTEL1;ATM;SMG5;DHX36;SMG6;PARP1;TERF1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5719585402599819,1.0633521271477684,0.34328358208955223,1.0,1.0,2/18,2.43%,TIMP3;TNFRSF1B
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.631057764417192,1.0628929519364658,0.48148148148148145,1.0,1.0,1/12,1.41%,ELOVL2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.5567164719177693,-1.062570821551189,0.2962962962962963,0.9792895856252553,1.0,2/7,13.29%,USH2A;ERCC2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.5252709627935702,1.0623792965360563,0.34782608695652173,1.0,1.0,3/39,3.01%,TBX1;WNT8B;WNT5A
prerank,GO_Biological_Process_2021__Schwann cell differentiation (GO:0014037),-0.6437532723774962,-1.0622716150895644,0.4782608695652174,0.9793290988006577,1.0,4/5,22.99%,ADGRG6;GPC1;NF1;ERBB3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.4906167858884644,-1.0617429473632511,0.39285714285714285,0.9798393807890353,1.0,6/29,16.80%,PDZD11;PARD3;MARK2;SCRIB;CAMSAP3;RHOA
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.5986911215312316,1.0616639484939876,0.43103448275862066,1.0,1.0,4/12,17.19%,TNFRSF1B;MMP9;IGF1;IL4
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.3907873534145735,-1.0615300651229371,0.3888888888888889,0.9797438986413428,1.0,35/168,12.37%,EFNB1;TRIB2;RAI14;CALD1;LAMA3;COL12A1;CDH13;COL4A2;SYNPO;PTPRO;GOLIM4;RND3;KITLG;PTPRF;RHBDF1;EHD4;PARVA;MID1;CAP2;THSD7A;NPHS1;FSTL1;GPRC5A;RASSF8;EFEMP1;CCN2;EDNRA;EPB41L5;NTN4;DAB2IP;NAV2;ANTXR1;ITGA3;PTH1R;NFIB
prerank,GO_Biological_Process_2021__CRD-mediated mRNA stabilization (GO:0070934),-0.7135580618821564,-1.0614114340358392,0.46808510638297873,0.9792189268936254,1.0,1/5,10.26%,IGF2BP1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.6498103811441159,-1.0613103424080612,0.4444444444444444,0.9785876324855626,1.0,3/5,26.64%,CDK5;SNCA;PLAA
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.6089960905390466,1.0612893488518027,0.38095238095238093,1.0,1.0,1/10,4.99%,HEY2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5113144790509113,-1.0609820284383178,0.3888888888888889,0.9787482387679386,1.0,11/26,19.04%,XYLT1;CHPF2;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;B3GAT3;CSPG5;CHST3;PXYLP1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.5272672515748611,-1.060921112902838,0.3333333333333333,0.9780114677606891,1.0,6/18,16.80%,PARD3;MYO18A;FBF1;SIPA1L3;CAMSAP3;RHOA
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.6355387689880508,1.0608878565699515,0.4576271186440678,1.0,1.0,3/10,15.85%,STRAP;MUC4;PBLD
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.5155659747037545,-1.0608745927158092,0.4642857142857143,0.977222580757472,1.0,1/23,0.17%,COL22A1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6029278559824532,-1.060735862709305,0.42105263157894735,0.9768895542677312,1.0,1/8,3.52%,KIT
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.6520475610124601,1.0607207171316118,0.39344262295081966,1.0,1.0,3/7,22.60%,CHCHD4;NOS2;PARK7
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5636436425981927,1.0605847948923715,0.4,1.0,1.0,6/13,23.67%,GAD1;GLUL;ACOT4;PM20D2;ASPA;QPRT
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4249092203946443,-1.0604918097629183,0.22727272727272727,0.9766105603116246,1.0,9/46,9.80%,GRID2;NLGN3;DLG5;SYNDIG1;WNT7A;EPHB2;PTPRJ;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.509731924479072,-1.060459945581619,0.36363636363636365,0.975771862462423,1.0,5/22,14.98%,NR4A3;PID1;MRAP2;GFPT2;SDHAF4
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5182276004462845,1.0604026162003823,0.373134328358209,1.0,1.0,2/24,4.64%,ANXA1;FGF2
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.6054223194538557,-1.0603247494168726,0.4782608695652174,0.975187939763564,1.0,1/7,0.34%,SKAP1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.5642905217234284,1.0602067626341058,0.373134328358209,1.0,1.0,7/23,16.77%,NOTUM;HEY2;TGFB1;FBXO5;SOX9;DDR2;HEY1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5829835809055817,1.060077922037919,0.4307692307692308,1.0,1.0,4/12,25.52%,PLN;KCNJ2;RGS2;ATP1A1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.42253473997467156,1.0597904254058648,0.3793103448275862,1.0,1.0,29/230,14.93%,TBX1;ITGB2;ROPN1B;PIK3R3;FGF20;FAM20A;FAXDC2;FGF2;C3;CARD14;TGFB1;CDK2AP1;GPER1;FLT4;ERBB4;MMP9;PRR5L;PINK1;DAB2;RSPO1;MYDGF;ECT2;HGF;CCND1;PLAUR;NOP53;CCND2;PPP2R5A;SOX9
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.48270584042030074,1.059773836187155,0.4,1.0,1.0,9/74,11.39%,ENPP2;ITGB2;PTPRC;TGFB1;CD81;IGF1;ITGA5;CD80;HGF
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.5946470380780282,1.059592934911188,0.4,1.0,1.0,5/13,24.13%,GPER1;PPP2R5A;APOD;CEACAM1;ADRA2A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.5194419397806691,1.059285439663079,0.4084507042253521,1.0,1.0,3/29,6.51%,PKP2;KCNA5;CAV3
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.6533430201128156,-1.05925150858625,0.46,0.9775208209113478,1.0,1/5,9.35%,AQP1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.7371443204047059,-1.0590120555058147,0.3055555555555556,0.9772156791694165,1.0,4/5,19.95%,SLC25A37;LDB1;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.6133676345139467,-1.0587814951427812,0.47058823529411764,0.9769775532715893,1.0,2/8,12.42%,GRID2;PROX1
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),0.7082089771380936,1.0584798773389037,0.4727272727272727,1.0,1.0,1/5,10.43%,NR1H4
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.3558941635263916,-1.0584623574600414,0.16666666666666666,0.9770717816459269,1.0,27/109,21.37%,NGF;GPC2;APOE;STYXL1;ARSB;RAPGEF1;DAB2IP;NTRK1;CUX1;SLIT2;PLXNA4;P3H1;AVIL;MARK2;MAP3K13;ZNF804A;ARHGAP35;RHOA;PLK5;NTRK2;PLXNA2;ROBO2;CUX2;FZD1;MAGI2;CUL7;PLXNC1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5708573160512072,-1.058427091612841,0.38461538461538464,0.9762506236378814,1.0,3/9,23.21%,AGO2;TARBP2;ADAR
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.4456190321624137,-1.058317632517202,0.3125,0.975643024795235,1.0,4/27,10.81%,PEX7;SLC25A17;PEX13;PEX14
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5618591364928582,1.0580902328093504,0.35714285714285715,1.0,1.0,2/19,4.99%,GATA4;HEY2
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.560702213221906,-1.0580842580313754,0.3333333333333333,0.9752483869130426,1.0,5/13,18.55%,ADAMTS12;EFEMP1;SNAI2;RFLNB;GREM1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5027140698268335,-1.0577569835638863,0.36363636363636365,0.9755422786450173,1.0,8/34,13.28%,SELE;GRID2;PVR;IGSF21;AMIGO2;SELP;ALCAM;NECTIN3
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.6113014035630935,-1.0577481309853838,0.3902439024390244,0.9746463204397892,1.0,1/6,14.72%,ERC2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6509736124063361,1.0577032491706713,0.45901639344262296,1.0,1.0,2/10,13.25%,CASQ2;TRDN
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6509736124063361,1.0577032491706713,0.45901639344262296,1.0,1.0,2/10,13.25%,CASQ2;TRDN
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.5454438225072722,-1.0576613763373415,0.44,0.9740160739711637,1.0,2/15,11.22%,ATR;TERT
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.3779468571331229,-1.057658335451015,0.35714285714285715,0.9731232023901999,1.0,22/146,13.39%,NTSR2;ENTPD2;SPHKAP;CDH20;FGF1;GJB6;S100B;TMEM132C;APOE;SYNDIG1;PTPRZ1;IGSF21;KCNIP1;NFATC3;HEPN1;ETS1;ADGRA1;MMD2;CMTM5;BRINP1;LRRTM3;BAALC
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.6450728358121055,1.0574629462405858,0.43333333333333335,1.0,1.0,1/7,5.87%,TRIM25
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.6672155956911245,1.057415256740076,0.4262295081967213,1.0,1.0,2/5,21.83%,TALDO1;RPE
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.6603419274885112,1.0573654519392055,0.48333333333333334,1.0,1.0,1/7,2.36%,SLC12A7
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5479031409705823,1.057277785063222,0.3611111111111111,1.0,1.0,4/22,11.88%,AIM2;REST;HTR1B;CRHBP
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6147925324255761,1.05725401922057,0.5238095238095238,1.0,1.0,2/8,13.42%,WNT5A;CHRNB1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.4894754748605753,-1.0571831824404778,0.34375,0.9734970424160457,1.0,4/24,14.26%,RHEX;STAT5B;ETS1;ZNF16
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5458420805387751,1.0569084954321062,0.39705882352941174,1.0,1.0,7/24,16.31%,LMOD3;LRP2;GPER1;ATP6AP1;TGM2;OPRM1;MME
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.49374177033626626,1.056678885478686,0.41025641025641024,1.0,1.0,10/46,24.54%,PSMB9;BHMT;NQO1;OAZ2;PSMC5;AZIN1;PSMB6;PSMD6;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.6189324237377568,-1.0566633451703549,0.358974358974359,0.9740281728905164,1.0,1/8,8.52%,VPS8
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.6409615523330462,1.0566144967764215,0.4074074074074074,1.0,1.0,1/9,5.63%,NPC1L1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4960885977382642,1.056560274338282,0.39473684210526316,1.0,1.0,13/62,19.13%,CCL5;FGF2;FLT1;GPER1;DCN;IGF1;MYDGF;PIK3CG;HGF;SOX9;AGT;FN1;F2RL1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.6291037900224216,1.0565155778720192,0.48484848484848486,1.0,1.0,6/10,21.49%,CCL5;MSMP;MSN;ZAP70;CRTAM;CCL25
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.6336150081717031,1.0563133788539991,0.45901639344262296,1.0,1.0,1/11,4.90%,TMEM35A
prerank,GO_Biological_Process_2021__regulation of ribonuclease activity (GO:0060700),0.6809332757039906,1.0562708215712302,0.46296296296296297,1.0,1.0,3/5,28.69%,OAS2;OAS1;OASL
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.48818916254953304,-1.0562646936012448,0.4,0.9742952544321021,1.0,2/24,1.79%,NGF;BCL2
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6089597455759074,1.0561248912978376,0.36666666666666664,1.0,1.0,1/10,8.98%,LCP1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.45754078513424745,1.0560599517746976,0.3974358974358974,1.0,1.0,7/85,12.09%,CDC25A;PCLAF;DTL;IL12A;SCARA3;CCND1;SDE2
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.5662534214453229,1.0558500115730522,0.4375,1.0,1.0,4/18,14.06%,ALPK2;HEY2;MYH11;CSRP3
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5908352746810848,1.055563568968918,0.43661971830985913,1.0,1.0,3/12,10.52%,ACTG1;WAS;FHOD1
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.6367490876061244,-1.0553411281832064,0.43902439024390244,0.9758627985834999,1.0,2/6,19.78%,LHFPL2;FSHR
prerank,PanglaoDB_Augmented_2021__Pericytes,0.4242501204968594,1.055204575613039,0.3291139240506329,1.0,1.0,22/124,13.30%,TIMP3;C1QTNF1;PRRX1;STEAP4;ADAM33;LMOD1;ANGPT2;ECM2;GPIHBP1;PCDH18;DAAM2;ACTA2;NT5E;DCN;ANGPTL2;COL1A1;ADGRL4;ANPEP;PDE5A;COL6A2;ASPN;ZIC1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.5411864995124449,-1.0549777840651677,0.3611111111111111,0.9760751715264592,1.0,6/15,13.88%,TWIST1;SLC30A10;MARCHF5;TERT;RBL1;CDK6
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.6342125147324915,1.0548679092390219,0.45454545454545453,1.0,1.0,3/11,16.12%,DCK;ERH;SLC25A19
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5416708336796039,1.0544277595151983,0.39436619718309857,1.0,1.0,5/17,19.37%,SLC22A3;SLC47A1;SLC25A19;SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.6272111708685626,1.0543877100559524,0.4117647058823529,1.0,1.0,2/9,27.31%,CELSR1;VANGL2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.5724438202740001,-1.0543055037336608,0.36585365853658536,0.976759351808712,1.0,1/8,1.74%,SIGIRR
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.6195702375773288,-1.0542272106291966,0.4523809523809524,0.9761056032065467,1.0,1/6,1.45%,PRDM5
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.5645164745333365,1.054057440447535,0.4117647058823529,1.0,1.0,6/20,25.51%,UBE2U;RAG1;ATXN7L3;PAF1;WAC;RNF20
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.5773131135119087,1.054003232167271,0.39655172413793105,1.0,1.0,2/12,10.43%,ADA;DCK
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.6409984169083943,-1.0536624499298048,0.5,0.976893231506561,1.0,2/7,15.58%,ASS1;ASL
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.5083617748336325,-1.053635930763547,0.375,0.9760705207271365,1.0,7/24,13.09%,PNP;MLYCD;PRTFDC1;NUDT4B;NT5C1A;AMPD3;NUDT18
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.6001064114583584,-1.0535614315328485,0.46153846153846156,0.9745732636558215,1.0,1/6,1.84%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.6001064114583584,-1.0535614315328485,0.46153846153846156,0.9745732636558215,1.0,1/6,1.84%,GLA
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-0.6479091036690984,-1.0534318706004508,0.42857142857142855,0.9742115072972027,1.0,1/5,0.34%,SKAP1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6343825494170316,1.0534232668316141,0.463768115942029,1.0,1.0,1/11,5.58%,HAT1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5106656412178362,1.053413077068074,0.38571428571428573,1.0,1.0,4/43,2.70%,MYH8;CASQ2;LMOD3;MYBPC3
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.5834082294506163,-1.0532760191170139,0.35135135135135137,0.9737200930970094,1.0,4/6,40.14%,PDCD2;KAT7;ACE;THPO
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.6695878740827805,1.0532525271342255,0.42105263157894735,1.0,1.0,1/7,9.34%,REST
prerank,MSigDB_Hallmark_2020__Myogenesis,0.43667284741747814,1.0529908915701598,0.4074074074074074,1.0,1.0,22/162,14.84%,MYBPH;MYH1;MYH8;CASQ2;MYH4;MYBPC3;SGCG;FGF2;TGFB1;CAV3;CKMT2;MYH11;ATP6AP1;NQO1;IGF1;COL1A1;CFD;COL6A2;CKB;CHRNB1;CSRP3;CDKN1A
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.664225563640703,-1.0527871392519286,0.45714285714285713,0.9740368410119433,1.0,1/6,0.68%,EPHX2
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.6141194738662693,-1.052553869813709,0.4318181818181818,0.9737416142990998,1.0,3/5,38.45%,NCK1;ABCA7;PTPN1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.5114595427612244,1.052426940949386,0.3918918918918919,1.0,1.0,6/44,11.84%,TBX1;WNT5A;SIX4;TGFB1;COL1A1;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),0.7287000930803236,1.0518473225666898,0.5357142857142857,1.0,1.0,3/5,25.89%,PLN;CRYAB;INSIG1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.4433857949723457,1.0517151035171683,0.38823529411764707,1.0,1.0,30/118,17.42%,ITGB2;CYTIP;ANXA1;ITGAX;TNFRSF1B;PTPRC;FCGR3A;SASH3;VSIG4;ITGAM;SCIMP;NFAM1;PTAFR;FGL2;CLEC12A;ADGRE1;HLA-DMA;HLA-A;DAB2;HCK;AXL;HLA-DPB1;HK3;IGSF6;PDCD1LG2;TAGAP;FTL;XCR1;GPR68;MYO1F
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.46737458826983214,-1.0516208686041806,0.3902439024390244,0.9757992858228929,1.0,6/19,16.57%,SLC39A11;SLC30A10;SLC30A5;TRPM2;SLC30A8;SLC39A8
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6733835083464617,1.0516167515477213,0.42424242424242425,1.0,1.0,2/7,15.25%,UBE3A;WBP2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.6314948740444384,-1.0516155759317922,0.45,0.9749316658256835,1.0,3/7,8.78%,SH3RF1;HLA-DRA;TWSG1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.3017239410115399,-1.0514438040428136,0.0,0.974467786082345,1.0,306/1778,15.63%,NPAS4;RFX6;PER2;CD38;POU3F1;SKAP1;ETV5;NR4A1;EHF;TBX15;ZNF25;OSR1;TEAD2;ZNF808;ZNF99;PRDM5;ZNF703;ZNF70;WNT3A;ERG;ARID3B;ZNF408;ARX;BAMBI;ZNF534;ETV1;ZNF860;CREB3L4;GFI1B;FOS;CHD4;FOXD4L5;ZFPL1;FOXO1;BCL6;OR7D2;GATAD2A;ZNF496;ZSCAN21;KMT2B;WWC1;TWIST1;EGR1;ZNF607;ZNF215;HDAC10;TESMIN;TWIST2;ZNF485;IKZF4;ZNF777;JUNB;ZBTB9;KIT;ZNF773;CREB3L1;MSC;ZNF514;IFI16;NR4A3;VAX2;BHLHA9;ASCC2;ZNF664;LHX2;POFUT1;KLF10;RFX1;MLF1;ZNF133;WWP2;ZNF48;ZNF470;WBP2NL;SP7;SMARCB1;ZNF69;QRICH1;ZNF835;ZFP3;APOE;TEAD4;TGFA;ZNF641;LBH;PIAS3;FZD7;PRICKLE1;FADS1;SOX12;CARM1;THAP7;ERBB2;MYOCD;ZNF701;ZNF596;MAP3K10;ZNF287;KDM7A;CBFB;ZNF575;WNT7A;MAFG;ZNF33B;ATOH7;BACH2;LBHD1;ZNF347;CTCF;KDM8;NFX1;HIC2;DHFR;ASCL1;CRY1;SPIN2B;CIART;IRF5;SMARCAL1;SPDEF;BARX2;ZNF623;ZNF117;ZNF492;PCGF1;MEN1;LRRFIP1;PHC2;STAT5B;ZNF239;KDM2B;ZSCAN4;CRABP2;HOPX;MKX;ACVR1;TFAP2D;ZNF212;KDM3B;HES1;FANK1;PRDM15;CTDSP1;ZNF275;APBB3;PAK6;ZNF845;ZSCAN12;EFEMP1;NFATC3;PA2G4;PPARGC1B;E2F6;SAFB2;ZNF75A;ZNF764;ZNF195;ZNF846;MAMLD1;MECP2;ZNF14;ZNF316;ZNF765;FOSL1;TFDP1;NACC1;ZFX;TGIF1;WWC2;ZNF3;BATF2;RRM2;SFMBT1;MTERF3;ZNF692;BPTF;ZNF79;ZNF594;CBY1;HDAC3;DLX1;TLE2;GDF7;NEUROD6;CARF;ZFHX4;POU6F1;DAB2IP;NR2C1;SNF8;GTF2H2;PKNOX2;ETS1;HMGN5;NR1D1;BCL11A;PEX14;PHF2;ZNF501;NKAP;ZFAT;FSTL3;ZNF611;PRDM1;CUX1;ZNF589;SP140;ZBTB7A;GMEB1;ZNF66;SNX5;XPC;ATF3;NIBAN2;ZFP62;NEUROD2;HSF1;ZMIZ1;TFE3;ZNF549;ZNF729;RLF;ZNF331;DPRX;TRIM44;MLX;RCOR2;EPC2;PAX3;CDK5RAP2;PCGF6;ZNF586;LDB1;CREB3L2;NFIB;NAB2;PROX1;IL31RA;HEXIM2;ZNF415;ATF1;SP2;ZBTB47;ZNF135;RING1;ZNF263;ZNF578;HR;RNF10;MAP3K12;TFCP2;CREM;SMARCA4;ZNF157;ZNF557;CDK14;CRK;GON4L;ESRRB;MPHOSPH8;CAND2;ZNF136;HIVEP1;TRIM45;GTF2IRD1;ZNF268;SBNO2;BCL11B;TCF20;ZNF334;KCTD1;ZNF16;BAZ2A;ZNF707;ZNF569;RPS6KA3;NAT14;ZBTB4;ZNF627;SNAI2;ZNF28;ZFP82;PIAS4;SEC14L2;ZNF2;ZNF688;LIMS1;ESRRG;YWHAQ;BRD3;SRCAP;ZNF785;ELOA;NR1H2;ZNF780B;ZNF254;BNC1;LANCL2;ZNF324;ZNF717;THRAP3;KCNH2;E4F1;EBF4;HDAC5;USP16
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.595484129604218,1.051415508055459,0.4482758620689655,1.0,1.0,3/14,17.62%,CAV3;CSRP3;NPPA
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),0.6709804168668188,1.051388260022785,0.41818181818181815,1.0,1.0,4/7,27.93%,DDX60;TKFC;RIOK3;USP17L2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.4816454518156693,1.051010403263228,0.3924050632911392,1.0,1.0,12/59,20.27%,LMOD1;CAV3;C15ORF62;BAIAP2L1;VASP;PINK1;HCK;CDK5R1;ALOX15;CARMIL1;LMOD2;PSRC1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5876878388837263,-1.0509958252305522,0.42105263157894735,0.9749249717817631,1.0,2/11,4.95%,DGKD;PARD3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6570735561589222,-1.050904858349402,0.4418604651162791,0.9742547618672555,1.0,2/6,10.46%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.712887368613665,-1.0508977795671863,0.4722222222222222,0.9733658432889095,1.0,1/6,8.05%,FSCN1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.6045458824621971,1.0507164300127911,0.423728813559322,1.0,1.0,4/13,17.88%,WAS;VIL1;CD44;CARMIL1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.6829372327864781,-1.050697540956408,0.4166666666666667,0.973163589644214,1.0,1/6,0.70%,FBP2
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.674691933810324,1.0505200605043303,0.4696969696969697,1.0,1.0,2/7,19.13%,C3;F2RL1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.6556032854929412,1.0504795792465738,0.39705882352941174,1.0,1.0,2/8,19.13%,C3;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5228545918767196,-1.050443526485276,0.4375,0.9729100500337161,1.0,6/15,24.43%,TMEM106A;MAPK7;NFKB1;HPN;MAPK8;PDGFB
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.45296145163488544,-1.0502677337525084,0.2702702702702703,0.9725537570872225,1.0,4/25,10.81%,PEX7;SLC25A17;PEX13;PEX14
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5436804988342753,1.049993965831023,0.42028985507246375,1.0,1.0,9/28,21.15%,CD160;HLA-F;ITGAM;IL12A;HLA-A;CRTAM;NOS2;RASGRP1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4096467783835555,1.0493752720427194,0.3626373626373626,1.0,1.0,50/250,19.48%,GATA4;NOX5;TLR2;ANXA1;S100A13;WNT5A;PTPRC;STOML2;C3;TGFB1;SCIMP;NFAM1;IL12A;IL27;FLT4;NODAL;HLA-A;AFAP1L2;C1QTNF4;CYP1B1;IRF1;NR1H4;PIK3CG;CD80;CD244;IL7;SYK;IL26;IRF4;TNFSF4;CYBA;ALOX15B;HLA-DPB1;ISG15;LACC1;ZNF580;POLR1C;IL4;CRTAM;ITK;HTR2B;AGT;CSF1R;AGER;CD4;NFKB2;TIGIT;NOS2;F2RL1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.6075413353188048,-1.0491367441454567,0.36585365853658536,0.9748276950231326,1.0,2/10,2.68%,DUSP6;WWC1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.6438773484509195,-1.048798937980755,0.5526315789473685,0.9750369574045645,1.0,3/8,25.21%,VHL;ADIPOR1;NF2
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.5275019963967216,-1.0485802227449559,0.34210526315789475,0.9746925710786732,1.0,2/13,3.55%,IL16;CDH13
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.5387095530372012,-1.0485356816140143,0.40476190476190477,0.9739245924284798,1.0,2/14,8.38%,DNAJC30;PID1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.6146046076426392,1.0481830033272976,0.453125,1.0,1.0,1/13,4.70%,SHISA6
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.4227015478536869,1.0481294104251468,0.37209302325581395,1.0,1.0,20/194,11.39%,TBX1;ITGB2;NOX5;GML;GSDMA;MCM2;TLR2;AHR;CASP7;CIDEB;BOK;RFK;DUX4;DDIT4;TNFRSF10A;CASP10;IRF1;TRAIP;BCL2L14;RHOB
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.576497225573532,1.0480247101850784,0.3972602739726027,1.0,1.0,7/20,19.13%,CAVIN1;TGFB1;DUOX1;P2RY12;CSF1R;THBS1;F2RL1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.49135827807974075,-1.0477285304994772,0.42424242424242425,0.9751615769749977,1.0,7/23,12.82%,ADAMTS12;XYLT1;CHST11;CHST12;CHST8;CSGALNACT1;SULF2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.576092289289916,1.0476826729215218,0.4027777777777778,1.0,1.0,2/14,7.25%,FGF2;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5473389070574803,-1.047638113265793,0.375,0.9745742089071527,1.0,1/13,0.44%,DRD4
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.6801466490321879,1.0473430674226416,0.5178571428571429,1.0,1.0,2/6,10.20%,ARHGAP24;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.4224502331804903,1.047257263133867,0.375,1.0,1.0,46/237,19.31%,ENPP2;ITGAX;CCL5;PIK3R3;PTPRC;VSIR;SYNE2;ACTG1;FLT1;TGFB1;SEMA3A;GPER1;SMIM22;TCAF2;MMP9;LEF1;HSPA5;F7;DAB2;SOD2;IGF1;COL1A1;RAB11A;LAMC2;HGF;SEMA3B;PLAU;VIL1;FBXO5;SOX9;SEMA3F;ANGPTL3;DDR2;DOCK5;IL4;SNAI1;WNT5B;CARMIL1;BCAR1;VTN;CSF1R;FN1;WASHC1;THBS1;F2RL1;CSF1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.4971194426089724,-1.046781498432977,0.38235294117647056,0.9763083564440821,1.0,1/18,0.19%,PKD1L1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.6133299461715104,-1.0467701550266761,0.5151515151515151,0.9754392243465131,1.0,2/7,8.55%,KIT;NFATC3
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.42846753328484716,-1.0466879562704057,0.36,0.9747508196914401,1.0,10/61,15.75%,ADAMTS12;CAPN2;HM13;RHBDD1;NR1D1;BAG6;NGLY1;FBXO44;OTUD7A;MALT1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.5975455773792723,-1.0466812418072384,0.43333333333333335,0.9738974449657221,1.0,4/6,28.84%,SPATA7;TCTN1;NPHP4;TCTN2
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.6231639006454384,1.0464593080921887,0.4,1.0,1.0,3/9,9.54%,ABCC6;ABCC2;ABCC11
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.6591496431345564,-1.0463812038488385,0.46511627906976744,0.9738631429546842,1.0,1/5,0.17%,COL22A1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5455661044554464,1.046250774082622,0.4262295081967213,1.0,1.0,1/22,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.6671501414154554,1.0460275256260778,0.43283582089552236,1.0,1.0,2/6,18.10%,CD63;RAB38
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.6671501414154554,1.0460275256260778,0.43283582089552236,1.0,1.0,2/6,18.10%,CD63;RAB38
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.48901631226466474,-1.0459142522066713,0.4838709677419355,0.9744287396407386,1.0,1/22,0.43%,NGF
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.7084608405577949,1.0457565825562143,0.49019607843137253,1.0,1.0,2/5,26.59%,BCAR1;EDNRB
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.613797832788203,1.045097699284161,0.48484848484848486,1.0,1.0,2/11,7.97%,CARD14;TNFRSF10A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5305427558563118,1.0447789309073916,0.4375,1.0,1.0,3/16,21.79%,NLRP12;NLRC3;GHRL
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.6474212153322874,1.0444414564882183,0.4666666666666667,1.0,1.0,2/7,21.66%,HSPA5;SEC62
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.6377330781107161,1.0443441659481076,0.4307692307692308,1.0,1.0,5/9,29.55%,SOX9;SOX6;LOXL2;GDF5;SOX5
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.43916787442688604,1.0440351507797059,0.43023255813953487,1.0,1.0,31/118,19.16%,C1QB;C3AR1;MGST1;TLR2;PTPRC;FCGR3A;LYVE1;TFEC;VSIG4;LMO2;ABCG2;FGL2;CLEC12A;DAB2;FLI1;HCK;ANPEP;TAF7;HGF;CSF3R;HK3;BMI1;CD44;VWF;TXNIP;ADGRG1;ITGA2B;CSF1R;STAB1;THSD1;IL3RA
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.575635618253141,-1.0440183466964383,0.45714285714285713,0.9788696264660777,1.0,2/11,3.62%,SPRY4;CREB3L1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.40832002284662755,-1.0440072403986234,0.36,0.9780156180405646,1.0,17/70,18.80%,SPRY4;PRKCD;APOE;MYOCD;SLC8A3;MEN1;PTPRJ;DAB2IP;PKIA;HEXIM2;SPRY1;PRKAR2A;ABL1;NF1;SPRY2;IPO7;GADD45A
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.6545634730526858,1.0439010129280442,0.40350877192982454,1.0,1.0,2/6,11.13%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.6545634730526858,1.0439010129280442,0.40350877192982454,1.0,1.0,2/6,11.13%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.4438590960036814,1.0438405359449576,0.3563218390804598,1.0,1.0,19/104,13.42%,TMOD4;MYH8;CASQ2;LMOD3;MYH4;MYBPC3;LMOD1;UTS2;CAV3;CKMT2;MYH11;MYL6;ACTA2;MYL12A;MYH13;MYOT;GLRA1;TRDN;CHRNB1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.5182760570675702,-1.0426236233635293,0.4375,0.9809179379141469,1.0,4/24,9.70%,ABHD17A;WNT3A;MDGA1;SLITRK2
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.5978990568018262,-1.042516751387009,0.39473684210526316,0.9803561084728576,1.0,3/8,18.26%,DHFR;RTN4RL2;MTR
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.516106089812177,-1.0419279193257533,0.40540540540540543,0.9801621246667394,1.0,2/19,9.55%,BCKDK;ECHS1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.516106089812177,-1.0419279193257533,0.40540540540540543,0.9801621246667394,1.0,2/19,9.55%,BCKDK;ECHS1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.35471561281788977,-1.041491256011472,0.26666666666666666,0.9804014813980614,1.0,38/234,16.30%,CPSF1;HNRNPL;DDX41;RNF113A;TXNL4A;CWF19L1;LSM7;MAGOHB;PDCD7;DHX8;SRRM1;SRSF4;SUGP1;SNRPB;GPATCH1;SYMPK;HNRNPF;DDX46;NOVA1;U2AF2;CSTF2;PTBP1;POLR2F;SF3A2;SMU1;ZMAT5;IK;HNRNPUL1;CPSF7;GEMIN5;POLR2C;GPKOW;RBMX;RBMX2;PCF11;SNRPN;RALY;RBM41
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.6640381471525095,1.0414078027317333,0.40625,1.0,1.0,3/7,22.36%,IFIT1;STAT1;DYNLT1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5526845494676814,1.0413495444465881,0.5223880597014925,1.0,1.0,3/16,7.63%,ABCG2;ABCC2;SLC26A6
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5744226522680779,1.0411236498174326,0.5,1.0,1.0,1/14,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.5164118880634823,1.0410125628584848,0.4,1.0,1.0,2/28,11.79%,TENT5B;MEIOC
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),0.7140546634574096,1.0409536232188976,0.48333333333333334,1.0,1.0,1/6,7.82%,PRDM12
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-0.7004736030362408,-1.0406347876152275,0.4,0.9825664397385574,1.0,3/5,27.17%,PARN;TOE1;XRN1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4323699812601398,-1.0403110047395663,0.3103448275862069,0.9826766230119465,1.0,3/30,6.23%,GCK;FOXO1;ABCC8
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.47515236982058656,1.0398146521026392,0.40540540540540543,1.0,1.0,10/44,19.04%,MGST1;GLRX;PRDX4;NQO1;SOD2;NDUFS2;FTL;PRDX6;NDUFB4;ATOX1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.3874728727305623,-1.0397386865757863,0.38461538461538464,0.9836467171640482,1.0,33/127,17.39%,NPTX2;EDARADD;RGS16;ADCYAP1;CFC1;SLC17A6;ELAVL3;SEZ6L;ABCC8;HOPX;IGSF21;PCP4;DPP6;KCNIP1;WSCD2;KCNB2;TGFBR3;NTRK1;ADGRA1;GRIA4;PCSK1;NOVA1;PROX1;CELF4;SERTM1;JPH3;SLC30A8;CDH22;PCDH17;MAFB;PLPPR1;SVOP;PAK3
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.6397476878835825,-1.0396836055432577,0.4722222222222222,0.9828837629775521,1.0,2/6,11.15%,ERCC8;ZBTB7A
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.5106684031313607,1.0396509245672696,0.4305555555555556,1.0,1.0,6/28,13.71%,ADA;CYP1B1;PIK3CG;SYK;PLAU;P2RY12
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.6492960583447664,-1.0394851643696268,0.4883720930232558,0.9824756987220932,1.0,2/5,12.67%,GLA;ST6GALNAC3
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),0.5697241154141122,1.0393824066644588,0.45454545454545453,1.0,1.0,3/14,13.49%,PINK1;COX7A2;NOP53
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.4786324181303163,1.0392012011397835,0.38571428571428573,1.0,1.0,9/51,13.15%,ITGB2;ACOX2;WNT5A;CIDEB;ITGAM;DDIT4;RAMP3;HPR;CDKN1B
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5521254776870105,-1.0390487385749374,0.4594594594594595,0.9827495640467087,1.0,1/12,1.08%,SYNJ2
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.502310374275291,1.03903925502263,0.4875,1.0,1.0,4/49,7.25%,TBX1;SOX10;SEMA3A;ERBB4
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.4006755196748611,-1.038833781027518,0.3,0.9824431738560694,1.0,15/61,16.57%,SLC25A29;SLC38A5;SLC6A20;SLC3A2;LRRC8B;SLC7A5;ABCC1;SLC25A42;SLC13A3;SLC16A7;SLC25A41;SLC19A1;SLC6A9;SLC36A4;SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.6575103785769205,-1.0387867712117942,0.4864864864864865,0.9817469612168461,1.0,1/8,8.38%,PID1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.6854412150931908,1.0387687404442127,0.5223880597014925,1.0,1.0,4/5,30.73%,HLA-F;CEACAM1;SPI1;LGALS9
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.4073060475398378,-1.0386973301439621,0.42857142857142855,0.9810897279907407,1.0,11/53,15.23%,CELA2A;NEU4;APOE;FBXO27;LRSAM1;DAB2IP;NR1D1;BAG6;NGLY1;FBXO44;ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.5024722152685049,-1.038545724981156,0.5,0.9807102032788403,1.0,3/10,25.72%,DAB2IP;LRP8;COBL
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6140372629738563,1.0382256793184812,0.4375,1.0,1.0,1/11,4.64%,FGF2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.4496013194312608,1.0377014784143639,0.3815789473684211,1.0,1.0,9/69,14.67%,TNFRSF1B;CCL5;WNT5A;TGFB1;HCK;AXL;CD80;TNFSF4;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.5404388055396521,-1.0373627665497007,0.41935483870967744,0.9832952776954578,1.0,5/16,15.36%,CDH13;RHBDF1;ERBB2;WDR54;MVB12A
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5898198719757204,1.0372716848200858,0.5,1.0,1.0,2/13,13.61%,SLFN14;RPP40
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.4439317076358259,-1.03702574908026,0.34615384615384615,0.9834916761903997,1.0,6/34,14.46%,SYNJ2;NLGN3;SNCB;NLGN2;CEL;NLGN4Y
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.4776958457705766,-1.037011021005153,0.34782608695652173,0.9826597095211818,1.0,14/31,28.78%,PEX14;BICDL2;MAPT;TMEM201;TRAK2;CLN3;RAB6A;BICDL1;UXT;BICD1;ARHGAP21;TRAK1;HTT;PAFAH1B1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.6457036713629654,1.0369613911446294,0.47619047619047616,1.0,1.0,1/8,1.05%,PLA2G10
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.3946428159352968,-1.036656443923263,0.3888888888888889,0.9830316826744939,1.0,22/127,13.08%,POU3F1;SPHKAP;CDH20;SLC17A6;ELAVL3;SEZ6L;TTBK1;IGSF21;PCP4;SRRM4;SNCB;HPCA;KCNB2;NEUROD6;SHISA7;ADGRA1;MMD2;TAGLN3;GRIA4;CELF4;BRINP1;LRRTM3
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.47073972895778105,-1.0357496757587776,0.41025641025641024,0.9851550534223348,1.0,2/21,16.18%,TRIM54;CAMSAP3
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5536741698765466,-1.0357206257836868,0.3333333333333333,0.9843988427225931,1.0,5/12,14.46%,UPB1;UPP1;NT5C1A;UPP2;NT5C
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.4062534778513387,-1.0356700976099158,0.27586206896551724,0.9837314128972525,1.0,9/34,18.62%,DDX11;MMS22L;BOD1L1;SMARCAL1;ATR;RFWD3;SAMHD1;RTEL1;FBH1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.4721865316323053,1.035610946466897,0.47297297297297297,1.0,1.0,6/71,5.82%,SLC9A2;SLC12A7;SLC5A2;SLC12A3;TRPV6;KCNJ15
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.43131222804594394,-1.035569649532757,0.3333333333333333,0.9831400478661555,1.0,4/35,6.48%,OSR1;KIT;SP7;WNT7A
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.5903629157651237,-1.035233491864492,0.4482758620689655,0.9833603150411631,1.0,5/10,28.78%,SHANK1;PCDH15;CLN3;MYO7A;PAFAH1B1
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),0.6411992263056093,1.035152104630293,0.43333333333333335,1.0,1.0,5/5,35.89%,CSRP3;HTR2B;TCAP;TTN;RYR2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4939998676353198,1.0350335359008884,0.43661971830985913,1.0,1.0,3/33,9.07%,WNT5A;PDE6A;LEF1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.4842632456697651,-1.0341338471970782,0.4117647058823529,0.9848453839385835,1.0,2/22,1.46%,GCK;ENO3
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.4842632456697651,-1.0341338471970782,0.4117647058823529,0.9848453839385835,1.0,2/22,1.46%,GCK;ENO3
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.6771652860527858,1.0340436355649876,0.4482758620689655,1.0,1.0,2/5,15.36%,SDS;SDSL
prerank,GO_Biological_Process_2021__purine ribonucleoside catabolic process (GO:0046130),0.7027474428012662,1.0336402114596088,0.5671641791044776,1.0,1.0,2/5,8.58%,ADA;ENPP4
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.40778540238125804,-1.0335233103783465,0.32,0.9857352182906923,1.0,35/96,18.25%,ADAMTS1;TEAD2;RAI14;P3H4;COL12A1;COL4A2;RND3;TEAD4;PTPRF;RHBDF1;FZD7;PARVA;B4GALT2;MID1;CAP2;FSTL1;AMOTL1;GNA11;NLGN2;DAB2IP;PACSIN3;ANTXR1;GPC1;AMOTL2;SERPINH1;SNAI2;COL5A2;INHA;COL4A1;FKBP9;RBFOX2;DAG1;PTPN21;CHST3;ADCY6
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.623833148634716,1.0330497737118283,0.5,1.0,1.0,1/11,4.64%,FGF2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.6021238228924923,1.0329446373498934,0.47619047619047616,1.0,1.0,4/9,33.95%,ATP6AP2;THBS1;LGALS9;PTGS2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.601701603064244,1.0328468968774465,0.4626865671641791,1.0,1.0,5/11,32.55%,HSPA5;SEC62;CHMP4B;SGTB;SEC61G
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.5240337393037323,-1.03282427823401,0.56,0.9868968853061378,1.0,2/15,7.51%,MIDN;CCN3
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5303794336365089,1.0326417690830962,0.4626865671641791,1.0,1.0,1/21,5.45%,TGFB1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.5628309504636987,-1.0323785393819207,0.42105263157894735,0.9871128983889255,1.0,4/12,13.65%,NPHS1;SHANK1;NLGN2;NRXN2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.46447904926310124,-1.032351915198726,0.4375,0.9862989032877456,1.0,6/18,16.57%,SLC39A11;SLC30A10;SLC30A5;TRPM2;SLC30A8;SLC39A8
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.4647078815623368,1.0322926611473184,0.4057971014492754,1.0,1.0,9/40,18.21%,WNT5A;IGF1;FTH1;NLRC3;CDKN1A;BMI1;DDR2;AGT;FN1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.650427488663252,1.032232646350983,0.4461538461538462,1.0,1.0,2/6,21.37%,TRDN;ATP2A2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.6635038008363843,1.0322325647023087,0.5166666666666667,1.0,1.0,2/7,17.91%,HGF;BCAR1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.6635038008363843,1.0322325647023087,0.5166666666666667,1.0,1.0,2/7,17.91%,HGF;BCAR1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5406541748940131,1.0322189957952914,0.421875,1.0,1.0,3/17,7.16%,ALPK2;MESP1;MYH11
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5374077944016765,1.0321164893054935,0.5483870967741935,1.0,1.0,4/21,11.13%,CLCF1;STAT5A;SOCS2;STAT1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.5840782262967825,1.031991995558401,0.46153846153846156,1.0,1.0,2/14,5.45%,CLCF1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.44623268991205767,1.0319391429650062,0.4025974025974026,1.0,1.0,15/54,17.19%,ANXA1;CCL5;PTPRC;SASH3;CLCF1;IL12A;CD81;CD80;IL7;GPR183;TNFSF4;HLA-DPB1;PDCD1LG2;CHRNB2;IL4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3934741877475785,-1.031611852547451,0.2631578947368421,0.987345482186094,1.0,4/72,7.44%,TRIB2;PLK3;PRICKLE1;TRIB1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.48844707071947346,1.0315023258753269,0.4722222222222222,1.0,1.0,4/40,6.28%,GATA4;SGCG;HEY2;MESP1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.5777901533821043,1.031338789291342,0.4307692307692308,1.0,1.0,1/14,5.58%,HAT1
prerank,GO_Biological_Process_2021__plasminogen activation (GO:0031639),-0.6581885567278649,-1.031327922094571,0.5121951219512195,0.9872137990939387,1.0,2/6,7.33%,APOH;F11
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5836306995638463,1.030818899068419,0.4426229508196721,1.0,1.0,3/15,20.22%,PTPRC;EPCAM;HMGA2
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6233293200769329,1.0304414802390227,0.47540983606557374,1.0,1.0,1/9,2.02%,GP1BA
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.49466635816475746,-1.0301939051296531,0.3181818181818182,0.9896806146907413,1.0,13/37,17.50%,CFAP46;RP1L1;JHY;AAAS;GAS2L2;CDK5RAP2;SPAST;TPPP3;CHP1;NCKAP5L;MARK4;CCDC40;NAV1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.6597805521083634,1.0300092759422448,0.4603174603174603,1.0,1.0,5/7,23.60%,ERAP2;HLA-A;B2M;TAP1;ERAP1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.44829135507788853,-1.029971556313994,0.37037037037037035,0.9894235061315669,1.0,5/21,12.71%,DPM3;DPY19L3;RXYLT1;TMTC4;FKTN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.6623118738510316,1.0297735312075709,0.45614035087719296,1.0,1.0,2/8,21.37%,CAV3;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.41683171827459914,-1.0293369067200373,0.46153846153846156,0.9907354420152238,1.0,13/37,22.46%,DDX11;PNKP;KMT5C;WRAP53;KDM4D;SPIDR;SMCHD1;SHLD2;SHLD1;MAD2L2;RAD51AP1;MGMT;SETMAR
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),0.6370464288744693,1.0293174745673028,0.4696969696969697,1.0,1.0,3/6,17.62%,NPR2;GUCY2F;NPPA
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.4633608306637202,1.0288985563474393,0.4,1.0,1.0,24/90,20.48%,RASGRP4;TRIM58;SLFN14;GMFG;SNAP23;STAT5A;LMO2;HEMGN;VASP;SLC4A1;ZC3HAV1;PIK3CG;CD244;ARHGAP45;TALDO1;MFSD2B;ADCY7;CD44;ITGA2B;RHOG;RGS10;P2RX1;FAM117A;TMC8
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.42545556332368073,1.0288294448099975,0.3888888888888889,1.0,1.0,24/117,24.63%,PSMB9;MCM2;MCMDC2;POLE2;CDK2AP1;MCM3;POLD4;RPA3;RPS27A;HMGA1;RECQL4;LRWD1;PSMC5;DDX23;ORC4;PSMB6;POLE3;GINS1;HELB;PSMD6;PSMA3;POLG2;PSMA7;GMNN
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.5871302257128717,-1.0286367168667634,0.4318181818181818,0.9909358529089959,1.0,1/5,10.61%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.5871302257128717,-1.0286367168667634,0.4318181818181818,0.9909358529089959,1.0,1/5,10.61%,SNF8
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.42360996480539953,-1.0283893940410789,0.25,0.9908386937969754,1.0,11/62,16.06%,CPSF1;LIN28B;TENT4A;MAGOHB;SRRM1;SRSF4;SYMPK;U2AF2;CSTF2;CPSF7;PCF11
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.4995439971949132,-1.0283592862441033,0.4074074074074074,0.9900401321028595,1.0,5/18,18.93%,CPEB1;HSF1;CPSF7;ZC3H14;CCNT1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.4971599760482965,-1.0283470466523488,0.39473684210526316,0.9892306580054071,1.0,4/15,12.85%,METTL8;PCIF1;TRMT61B;TRMT61A
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.6700836171219688,-1.028311346552477,0.55,0.9884348737455889,1.0,1/5,1.38%,ADAMTS12
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.410723485920385,-1.028023335579451,0.4117647058823529,0.9884138742545395,1.0,37/128,24.03%,EFR3B;BCL2;CELF5;SLC17A6;ELAVL3;ASCL1;TTBK1;ICAM5;SRRM4;NTRK1;ADGRA1;MMD2;GRIA4;NOVA1;PROX1;CELF4;LRRTM3;ERC2;SYN1;POU3F2;PAK3;PTPN5;NF1;NOTCH1;ROBO2;PAK5;MAPK4;CUX2;ELAVL4;FEZF2;TMEM179;SLITRK3;SCRT1;ST8SIA3;CACNA1B;ATRNL1;SNAP91
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6300792392834069,-1.0279746134436638,0.4411764705882353,0.987755095808784,1.0,2/6,16.70%,APOE;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.6952672051741502,1.027647603547191,0.5,1.0,1.0,2/5,22.88%,DCN;MLLT11
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4234509003571171,1.0274955902026408,0.39080459770114945,1.0,1.0,17/133,11.68%,ESR1;LRP2;FGF20;GFRAL;FGF2;TGFB1;ERBB4;RAMP3;F7;PINK1;AXL;MYDGF;PIK3CG;CD80;KLB;HGF;IL26
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.5291955821017237,1.0269251747308592,0.4090909090909091,1.0,1.0,5/26,12.11%,SYCP1;IHO1;MEIOB;RNF212B;STAG3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.5353380050591882,-1.02669443951932,0.52,0.9902715211534954,1.0,1/17,4.15%,PDZD11
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4249050343987238,1.0266839624805595,0.43333333333333335,1.0,1.0,28/143,23.68%,LRP4;NOTUM;PSMB9;WNT5A;SHISA6;MESP1;DAB2;MCC;IGFBP6;DKK2;SOX9;GLI3;SFRP4;CYLD;LATS2;PSMC5;PSMB6;DKKL1;RBX1;DDIT3;FRZB;PTPRU;PSMD6;PSMA3;TBX18;DRAXIN;TMEM170B;AMFR
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.45012847295676334,1.0266731956081643,0.4523809523809524,1.0,1.0,3/59,7.28%,NEK2;GPER1;DUX4
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.5111474241275796,1.0265717609058918,0.4507042253521127,1.0,1.0,5/27,18.26%,ITGB2;ITGAM;SYK;IL4;AGER
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.3770760874754753,-1.0264301125917037,0.3157894736842105,0.9902734790026321,1.0,20/157,12.43%,ARC;NGF;TSKU;IFT88;ADCYAP1;RAB35;GPRIN1;GPRIN3;APOE;WNT7A;EPHB2;SHANK1;SAMD14;SRGAP2;PPP1R9B;NYAP2;DAB2IP;MNX1;TAOK2;RASGRF1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5492099665559713,1.0264083196543994,0.49230769230769234,1.0,1.0,4/18,8.71%,CASQ2;CAV3;TCAF2;MMP9
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.5300010945410187,1.0263836241209834,0.4788732394366197,1.0,1.0,6/30,13.71%,CLIC1;GP1BA;ACTG1;MYL12A;PIK3CG;P2RY12
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.43414730366560705,-1.026273163060601,0.5,0.9880077413191123,1.0,10/58,15.42%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;F5;ANKRD28
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.43414730366560705,-1.026273163060601,0.5,0.9880077413191123,1.0,10/58,15.42%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;F5;ANKRD28
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.43414730366560705,-1.026273163060601,0.5,0.9880077413191123,1.0,10/58,15.42%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;F5;ANKRD28
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5559561471336864,1.026231397588225,0.4492753623188406,1.0,1.0,4/22,19.13%,TLR2;DDX3X;CYBA;F2RL1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5371637579217674,1.0261301401248046,0.417910447761194,1.0,1.0,4/19,18.17%,RGPD1;RGPD3;RGPD4;KPNA5
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5570678853967701,1.026046080472103,0.4264705882352941,1.0,1.0,7/16,29.55%,SOX9;SOX6;BMP1;LOXL2;SCX;GDF5;SOX5
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.5892947918029514,1.0256752857843636,0.4827586206896552,1.0,1.0,2/10,3.13%,BHMT;CHDH
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.5258746016232503,-1.0255290752580022,0.4583333333333333,0.9891708633418875,1.0,2/9,8.61%,CFLAR;CD53
prerank,GO_Biological_Process_2021__definitive hemopoiesis (GO:0060216),0.6962635731360445,1.0253474145700072,0.515625,1.0,1.0,1/5,4.33%,HIPK1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5822897168350617,1.0252770849059216,0.4482758620689655,1.0,1.0,1/10,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.5603242676046437,1.0251649604488222,0.4117647058823529,1.0,1.0,1/15,2.05%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6001767700262584,1.024791499694215,0.5409836065573771,1.0,1.0,4/11,24.66%,PTX3;TRIM5;LY6E;CIITA
prerank,GO_Biological_Process_2021__regulation of T-helper 1 type immune response (GO:0002825),0.6955797911343021,1.0247467381780726,0.5081967213114754,1.0,1.0,1/5,6.50%,IL27
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.6150794636743103,-1.0247145340401767,0.5945945945945946,0.9906123977618776,1.0,5/10,22.77%,XYLT1;CSGALNACT1;B3GAT3;PXYLP1;B3GAT1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6120304134885197,1.024673215397509,0.45588235294117646,1.0,1.0,3/10,17.09%,B3GNT9;B4GAT1;B3GALT2
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6155217525803025,1.0241505964916855,0.47692307692307695,1.0,1.0,1/11,6.54%,CD81
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.3518639546586592,-1.0240167605377866,0.35714285714285715,0.9919418229131773,1.0,26/127,13.38%,KCNIP3;EFR3B;F11R;PDZD11;PTCH1;TMEM150A;SPTBN4;RAB3D;EHD4;ZDHHC23;TTC7A;PRAM1;DPP6;FLNA;TTC7B;TMEM88;KCNB2;NKD2;BSG;EMP2;RAB40A;EHD3;RAMP1;MRAP2;PPIL2;RAB40C
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.5816637452220726,-1.0236986274123119,0.43243243243243246,0.9920640444856161,1.0,4/10,19.40%,SLIT3;ACVR1;NOTCH1;TGFB2
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.5915829008874087,-1.023611128782832,0.5526315789473685,0.991432106402722,1.0,2/7,20.72%,DENND1A;DENND4B
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.5983986279973463,-1.0235862186791684,0.5128205128205128,0.9906797506949907,1.0,4/9,24.88%,AGO2;TERT;TARBP2;DROSHA
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.5546072000667668,-1.0235221380989177,0.45714285714285713,0.9892516764744443,1.0,1/11,1.08%,SYNJ2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.5546072000667668,-1.0235221380989177,0.45714285714285713,0.9892516764744443,1.0,1/11,1.08%,SYNJ2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.6925133830708009,1.0234073862100594,0.5384615384615384,1.0,1.0,3/5,30.66%,MAPK3;RPS6KA5;CDK9
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.48137873307642665,1.0232376931119518,0.5,1.0,1.0,2/46,3.45%,RAB34;HHIP
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.5021547033543301,1.0231881745636808,0.390625,1.0,1.0,6/35,15.62%,CCL5;SCIMP;SH2D1B;IFNK;CYBA;DDX60
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.492244304897926,-1.0231359123667296,0.375,0.9893999128224785,1.0,2/24,3.86%,PER2;IFI16
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.6559828267081249,1.0229558032354422,0.4626865671641791,1.0,1.0,1/8,3.07%,DONSON
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.4958393899736967,-1.0225945428800216,0.4482758620689655,0.990044346975074,1.0,7/27,14.73%,APOH;FSTL1;JAG2;VCAN;LPL;TIMP1;COL5A2
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.5938792148683245,-1.0225814742796566,0.46153846153846156,0.9892358939258676,1.0,3/7,24.90%,PLIN5;GPLD1;SORL1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.5107914516538947,1.0225367249263513,0.4057971014492754,1.0,1.0,14/29,32.89%,ACAA2;NPC1L1;PLPP6;FDFT1;MSMO1;SQLE;INSIG2;INSIG1;HMGCR;HMGCS1;ACLY;DHCR24;IDI2;IDI1
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.6296838948854908,1.0224648426979437,0.43103448275862066,1.0,1.0,1/6,7.14%,DAND5
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.6127017953616867,-1.0218271404545436,0.45714285714285713,0.990350797817217,1.0,1/7,2.82%,TMEM106A
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6008121238972072,1.021796131197883,0.5081967213114754,1.0,1.0,1/11,2.31%,RENBP
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.5096989803935472,-1.0216945545915384,0.37142857142857144,0.989785013374448,1.0,4/12,33.30%,SEC14L2;H6PD;MBTPS2;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4659479663737255,1.0213574281300504,0.3728813559322034,1.0,1.0,7/36,20.02%,MYBPC3;AHSA1;DNAJB1;ALDOB;DYNLL1;GABARAPL2;MSH6
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4971733977785122,1.0212469010472576,0.391304347826087,1.0,1.0,5/27,14.18%,SLFN14;EXOSC2;EXOSC8;NUDT16L1;ERN2
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),-0.6402821609157089,-1.0209073013923855,0.48,0.990392550462808,1.0,1/5,5.75%,GSTZ1
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),-0.6402821609157089,-1.0209073013923855,0.48,0.990392550462808,1.0,1/5,5.75%,GSTZ1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.4168344493164611,-1.020850473279038,0.34615384615384615,0.9897558916394718,1.0,7/42,5.86%,XYLT1;GPC6;GPC2;SDC3;HS6ST2;AGRN;GPC4
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.5151835947390707,1.0206192450371088,0.5081967213114754,1.0,1.0,4/25,11.13%,CLCF1;STAT5A;SOCS2;STAT1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.39945085188769924,-1.0205310947123347,0.3333333333333333,0.9899147298707707,1.0,14/67,14.54%,GMNC;NR4A1;TRIM35;HPGD;MYOCD;MEN1;NUPR1;HEXIM2;BRINP1;NLRP2B;CDK6;CAMK2N1;SCRIB;PPP1R13B
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.5656587558768046,-1.0202703953220909,0.41379310344827586,0.9897966914791104,1.0,5/12,29.64%,FNTA;ZBTB7B;NIPBL;SAP30BP;AKAP8L
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.40991581296817486,1.0200431176969371,0.38636363636363635,1.0,1.0,35/229,24.92%,ESR1;CDC25A;ACTL6A;PSMB9;USP50;USP6;TOMM20;JOSD2;RPS27A;OTUD4;USP13;TFPT;CYLD;YOD1;USP18;PSMC5;COPS5;CCNA2;OTUD1;TAF9B;PSMB6;HCFC1;SPATA2;NFKBIA;BRCA1;OTUB1;ATXN7L3;TAF10;PSMD6;PSMA3;IFIH1;ACTR5;PSMA7;USP31;FOXO4
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5269535677778668,1.0200399258352009,0.5138888888888888,1.0,1.0,8/19,30.09%,SEMA3A;SEMA3B;SEMA3F;SEMA6A;SEMA4C;SEMA7A;SEMA4G;SEMA3E
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.7105855194015094,1.0196420344545098,0.54,1.0,1.0,2/6,8.79%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.7105855194015094,1.0196420344545098,0.54,1.0,1.0,2/6,8.79%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.45799811604297047,-1.0195715432924872,0.42424242424242425,0.9909525711102458,1.0,9/35,18.11%,CDH5;PRKCD;PPP6R1;ENSA;SYMPK;PTBP1;PPP1R7;PPIA;CAMTA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.687483523520016,1.0194268351976667,0.49230769230769234,1.0,1.0,3/7,28.67%,CYBA;F2RL1;PJA2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.6479267003613522,-1.019386122053289,0.5121951219512195,0.9898036509181324,1.0,2/5,27.04%,NRXN2;HTT
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.6479267003613522,-1.019386122053289,0.5121951219512195,0.9898036509181324,1.0,2/5,27.04%,NRXN2;HTT
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.43182498432351757,-1.0193066359104639,0.42857142857142855,0.9891107902607381,1.0,7/47,8.05%,PER2;WNT3A;WNT7A;ASCL1;PCM1;CX3CR1;HES1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.5885204051523252,-1.0192863858854937,0.45652173913043476,0.9883711975286601,1.0,3/7,7.04%,SLC16A9;PNP;SLC2A9
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.7293260466727707,1.0192144620873425,0.5714285714285714,1.0,1.0,2/5,15.94%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6274096740057954,-1.0190653133520031,0.5365853658536586,0.988159335311862,1.0,3/5,19.60%,ABCC4;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.4342399845863765,-1.019023258833746,0.38235294117647056,0.9874696136912117,1.0,12/56,12.40%,NPTX2;CACNG4;DLGAP4;SHANK1;CRH;NLGN2;SHISA7;GRIN1;GRIA4;DLGAP1;CACNG2;CNIH3
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.5141480690554037,1.018919379709638,0.4225352112676056,1.0,1.0,14/28,32.89%,ACAA2;NPC1L1;PLPP6;FDFT1;MSMO1;SQLE;INSIG2;INSIG1;HMGCR;HMGCS1;ACLY;DHCR24;IDI2;IDI1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6191937790537765,-1.0181823115422983,0.4318181818181818,0.988871489559505,1.0,3/5,27.80%,MIA3;ADTRP;AKT1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.38308100239905624,-1.018115090391909,0.3684210526315789,0.9882300707896408,1.0,12/101,7.49%,DRD4;RASSF2;TYRO3;TIE1;KIT;ADCYAP1;RAD50;VAC14;ERBB2;EPHB2;EPHA6;CCN1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5621389622098792,1.0181146347101973,0.453125,1.0,1.0,9/15,35.49%,ITGB6;FN1;ITGB8;HIF1A;LGALS9;ITGAV;SMAD3;PTGS2;SMAD4
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5699776984739191,1.0180881393320285,0.5076923076923077,1.0,1.0,3/13,23.19%,SCTR;UCP1;ULK1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.33702849372568283,-1.0180068119676506,0.35294117647058826,0.9876612824521989,1.0,34/177,13.65%,KCNIP3;ABHD17A;EFR3B;F11R;PDZD11;PTCH1;TMEM150A;AGRN;SPTBN4;RAB3D;EHD4;ZDHHC23;TTC7A;PRAM1;DPP6;ITGA4;FLNA;TTC7B;NLGN2;TMEM88;KCNB2;SYNE3;NKD2;BSG;EMP2;RAB40A;EHD3;RAMP1;MRAP2;PPIL2;CYP46A1;RAB40C;FRMPD1;NRXN2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.525603444395674,-1.0177787217446863,0.43902439024390244,0.9875938897474857,1.0,3/13,7.64%,MFSD2A;PTCH1;STAT5B
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.7108138711596751,1.0174962564878192,0.5409836065573771,1.0,1.0,1/5,5.06%,TICRR
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.5182642222311338,-1.0170643437493112,0.3333333333333333,0.9887528485139899,1.0,5/12,31.03%,CTPS2;CDA;CRMP1;DPYSL2;DPYSL4
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.536385864963415,-1.0170134432562312,0.3235294117647059,0.9880661007327037,1.0,5/19,15.37%,LRSAM1;SNX33;PACSIN3;RUBCN;NR1H2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5159968153445963,1.0166742222021217,0.4050632911392405,1.0,1.0,6/25,23.06%,TGFB1;GPR183;P2RY12;THBS1;F2RL1;ELANE
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.589560883749242,1.0166085645001823,0.5263157894736842,1.0,1.0,1/12,4.40%,TRIM62
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),-0.6664828492324806,-1.0165020748836562,0.5319148936170213,0.9887354247713325,1.0,2/5,25.25%,BMP4;PAX2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.49645437970183226,-1.0161826011643542,0.4666666666666667,0.989047368256252,1.0,4/12,14.02%,PDE3A;APOE;AQP1;HTR2C
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.34564346274907437,-1.0160234393720449,0.3888888888888889,0.9885994055898633,1.0,26/123,13.38%,KCNIP3;EFR3B;F11R;PTCH1;TMEM150A;SPTBN4;RAB3D;EHD4;ZDHHC23;TTC7A;PRAM1;DPP6;FLNA;TTC7B;TMEM88;KCNB2;NKD2;BSG;EMP2;RAB40A;EHD3;RAMP1;MRAP2;PPIL2;NECTIN3;RAB40C
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.6821085415426881,1.0159870573205827,0.5245901639344263,1.0,1.0,2/6,6.51%,C12ORF57;CAV3
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.6120062998116094,1.0159171733328172,0.4788732394366197,1.0,1.0,1/11,1.89%,TMEM100
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.4992180842366632,-1.015877872076072,0.5,0.9881996138457765,1.0,2/17,2.70%,PER2;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of response to food (GO:0032096),0.6603887177974843,1.0158613633180031,0.4745762711864407,1.0,1.0,2/5,26.42%,SPX;CARTPT
prerank,GO_Biological_Process_2021__positive regulation of activation of Janus kinase activity (GO:0010536),0.6981194690178644,1.0158586098959472,0.4482758620689655,1.0,1.0,1/5,2.84%,CCL5
prerank,GO_Biological_Process_2021__regulation of activation of Janus kinase activity (GO:0010533),0.6981194690178644,1.0158586098959472,0.4482758620689655,1.0,1.0,1/5,2.84%,CCL5
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.5711550900273883,1.0156534076200825,0.5161290322580645,1.0,1.0,3/11,25.22%,SLCO1A2;SLCO2B1;SLCO6A1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5610361510769215,1.0150995038635624,0.47761194029850745,1.0,1.0,3/14,10.26%,CCL5;TGFB1;HCK
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.5214832277939712,1.0149731324028965,0.42857142857142855,1.0,1.0,5/26,8.79%,TLR2;LYG2;IL12A;STAB2;HLA-A
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.4799742182351793,1.0147677559557613,0.4375,1.0,1.0,9/38,18.04%,FRAT1;TCF7;HEY2;FZD8;LEF1;CCND2;HEY1;WNT5B;WNT6
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.42449970320321667,-1.0146375152114049,0.5151515151515151,0.9908092600214824,1.0,10/55,10.35%,ACAD10;CYP4V2;MECR;ACADS;SLC25A17;SLC27A2;ECHDC2;ECHS1;ADH4;PEX13
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.41356657600297514,1.0146343244693352,0.4117647058823529,1.0,1.0,32/133,23.46%,ANXA1;PTPRC;UBE2L6;VSIR;SFTPD;VSIG4;TRIM25;IL12A;NLRP12;LEF1;NR1H4;AXL;NLRC3;TNFSF4;ISG15;PDCD1LG2;ADCY7;CYLD;FN1;AGER;TIGIT;THBS1;F2RL1;HLA-DRB1;DDIT3;GHRL;RPS6KA5;APOD;ZFPM1;ELANE;IFIH1;CEACAM1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.3783325546824085,-1.014501032717696,0.2777777777777778,0.9903254414476886,1.0,17/92,14.02%,RNF113A;NRDE2;TXNL4A;KHSRP;MAGOHB;PDCD7;DHX8;SRRM1;SRSF4;PPP1R9B;SNRPB;PRPF18;NOVA1;PTBP1;SMU1;RP9;ZMAT5
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.4769672545627511,-1.014462703411924,0.41935483870967744,0.9896413914491674,1.0,2/23,1.46%,GCK;ENO3
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.6691484936256793,1.0141841920350165,0.5,1.0,1.0,2/5,29.72%,CYBA;GRN
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5499034299313189,1.0141265973819265,0.49230769230769234,1.0,1.0,6/20,19.60%,TPGS1;AGBL5;TTLL2;TTLL4;NAA11;GGCX
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.4129120981787549,1.01410637337989,0.4942528735632184,1.0,1.0,25/182,14.93%,TBX1;PIK3R3;FGF20;FAM20A;FAXDC2;FGF2;C3;CARD14;TGFB1;CDK2AP1;GPER1;FLT4;ERBB4;MMP9;PINK1;DAB2;RSPO1;MYDGF;DDX3X;HGF;CCND1;PLAUR;CCND2;PPP2R5A;SOX9
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5650512491023546,1.0140328764650968,0.5405405405405406,1.0,1.0,3/16,16.20%,TGFB1;FLT4;DDR2
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),-0.6286855387110475,-1.0139919468626575,0.4473684210526316,0.9891857784475372,1.0,5/7,10.52%,HDC;HNMT;AMDHD1;CARNMT1;UROC1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),-0.6286855387110475,-1.0139919468626575,0.4473684210526316,0.9891857784475372,1.0,5/7,10.52%,HDC;HNMT;AMDHD1;CARNMT1;UROC1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.608858808752074,-1.0138574016456643,0.48484848484848486,0.9887874945051199,1.0,2/9,11.48%,PARVA;EMP2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.4574151658769112,1.013613567335955,0.4246575342465753,1.0,1.0,12/49,19.02%,ROPN1B;C15ORF62;RTKN;WAS;ARHGDIG;RHOB;RHOU;CELSR1;ADGRG1;CFL1;RHOG;PLEKHG7
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.6027416354549744,1.0136005695995867,0.582089552238806,1.0,1.0,4/11,19.22%,VSIG4;C4BPA;C4BPB;A2M
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.4590810672001927,-1.012976724008894,0.34615384615384615,0.9901224839291515,1.0,8/32,13.42%,GSTT2B;GSTZ1;GSTM5;GSR;CHAC1;GSTK1;GPX1;G6PD
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.4798092690119068,1.012721707960967,0.47435897435897434,1.0,1.0,1/50,0.19%,DENND1C
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.4482482424092179,1.0126245324930285,0.4375,1.0,1.0,14/95,11.39%,GATA4;ITGAX;RRAS;WNT5A;HIPK1;FGF2;FLT1;ANGPTL4;NODAL;CYP1B1;ITGA5;AGGF1;MYDGF;RHOB
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.6515137019707373,1.0125505881283983,0.5576923076923077,1.0,1.0,3/7,10.23%,VSIR;HLA-A;IRF1
prerank,GO_Biological_Process_2021__metanephric nephron tubule morphogenesis (GO:0072282),0.6902609551874654,1.0123039422844193,0.55,1.0,1.0,1/5,14.93%,SOX9
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.4753513038807586,-1.0119442160414593,0.32,0.9922089633739433,1.0,3/18,8.95%,OSR1;PTCH1;PKD2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.5325467822041218,1.0118320652276334,0.45588235294117646,1.0,1.0,2/13,13.61%,RPP38;RPP40
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.561593493167231,1.0118240828369471,0.5,1.0,1.0,4/13,25.52%,PLN;KCNJ2;RGS2;ATP1A1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.3582291488094417,-1.0115844552807827,0.5,0.9921974701147274,1.0,35/118,18.67%,ADAMTS1;EPHX2;TBC1D16;GPC6;PC;RND3;PTPRF;RHBDF1;B4GALT2;PLIN5;CAP2;ASS1;EPB41L4B;ECHS1;GNA11;ALDH4A1;CITED4;CHKA;DAB2IP;PACSIN3;GPC1;AMOTL2;AADAT;GPT2;GALNT18;SH3D19;ADGRL2;FKBP9;RBFOX2;DAG1;PTPN21;CHST3;ADCY6;SYT7;DDAH1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.44922387275273995,1.0112604289308433,0.4588235294117647,1.0,1.0,11/92,14.93%,NEK2;BUB1;IHO1;BORA;GPER1;RAB11A;ECT2;KLHL13;RMI2;FBXO5;SOX9
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.46340553792963274,-1.0112561712678336,0.3939393939393939,0.9923388388821898,1.0,7/18,23.72%,CUX1;DBNL;LRP8;CUX2;CUL7;DHX36;SS18L2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.6508046163795672,1.0111453065348073,0.5,1.0,1.0,1/5,15.63%,CNTN2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.621422122505098,1.0111448317853344,0.453125,1.0,1.0,3/9,17.09%,B3GNT9;B4GAT1;B3GALT2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.4221041611679998,-1.0109705617655158,0.5,0.9924094889386785,1.0,10/32,14.38%,PDE3A;ADCYAP1;APOE;PDE7B;CAP2;ADGRG6;AQP1;ADCY2;HTR2C;MAPK7
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.40634665250563584,1.0108966001554083,0.45121951219512196,1.0,1.0,53/192,25.66%,PWP2;RPL21;RPL37A;INTS5;RPL18A;RPL9;NOB1;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;EXOSC2;EXOSC8;RPL36;RPS19;RPL41;NOP53;RPL27A;RPL32;RPL35A;RPL7A;RPL11;RPS7;RPL23A;RPL7;RPLP2;WDR36;RPLP0;EXOSC4;RPS14;RPS6;RPL38;RPL23;RPS15;WDR18;RPL24;RPL18;RPL35;RPS27;RPL8;IMP3;RPL10;RPS28;SENP3;RPL27;RPS24;INTS2;EMG1;RPL29;WDR12;RPLP1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.5974855034115343,1.0107257288536053,0.4166666666666667,1.0,1.0,6/9,40.05%,HERPUD1;BCAP31;SVIP;UBQLN1;UBQLN2;USP14
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41332494659683733,-1.0106906298933007,0.27586206896551724,0.9923509074811786,1.0,9/43,15.56%,KCNJ16;KCNMB2;KCNE1;WNK2;FLNA;KCNJ6;GABBR2;WNK3;KCNH2
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.6293333424134568,-1.0106690180479927,0.5454545454545454,0.9916122002550116,1.0,1/6,7.98%,AFG1L
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.5498974473976271,-1.0102163261079768,0.4166666666666667,0.9922926264760299,1.0,4/8,20.21%,GLA;FUCA1;GUSB;GBA2
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.6050067858090777,-1.0101361492623757,0.5405405405405406,0.9916839820609636,1.0,2/6,28.06%,INO80;DBF4B
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.48893367778455615,1.0098899218626456,0.5,1.0,1.0,3/25,9.80%,ENPP2;LPIN3;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.5761880467134326,-1.0098715476972735,0.4523809523809524,0.9916846872824099,1.0,2/11,5.28%,PC;APOE
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.5807708411265566,-1.0096376927892021,0.47058823529411764,0.9916503234323409,1.0,2/6,9.35%,RHCG;AQP1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.4830979562006862,-1.0096064602191415,0.4117647058823529,0.9900413173434566,1.0,7/15,27.64%,FAM171A1;PHACTR1;RHOA;ARRB1;KCTD13;SRC;ZYX
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.4830979562006862,-1.0096064602191415,0.4117647058823529,0.9900413173434566,1.0,7/15,27.64%,FAM171A1;PHACTR1;RHOA;ARRB1;KCTD13;SRC;ZYX
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.5718694569404768,-1.0094505078826972,0.48148148148148145,0.9897168781238256,1.0,8/16,26.84%,PTPRJ;LIMS1;COL16A1;ABL1;S100A10;TSC1;PPM1F;TEK
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.42734064622923307,1.0094493711006083,0.4936708860759494,1.0,1.0,23/111,18.86%,SLC22A3;TCN1;LRP2;SLC18A2;SLCO1A2;ABCG2;SLC6A4;SLC22A24;SLC22A25;RAMP3;ABCC11;PPT1;CHMP3;SLC47A1;SLC22A6;MFSD2B;AMN;CLN8;TXNIP;SLC22A4;RAB38;SLC23A1;DENND10
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.4612476102022164,1.0093552541909874,0.5232558139534884,1.0,1.0,7/60,10.09%,FRAT1;TCF7;WNT8B;WNT5A;FZD8;LEF1;WNT8A
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.6944551056576015,1.0093234051615003,0.6031746031746031,1.0,1.0,2/6,18.52%,STOML2;MTLN
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.4998975195975709,1.0092208830003804,0.5070422535211268,1.0,1.0,6/35,23.50%,HAT1;GRWD1;NAP1L2;SOX9;H2BC18;CHAF1A
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.6148186951061146,-1.0091787333811744,0.48936170212765956,0.9897308476856704,1.0,2/7,17.47%,APOE;ABL1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4711466429116395,1.0091485228107788,0.4605263157894737,1.0,1.0,5/40,10.99%,TLR2;LRRC19;NLRP12;C1QTNF4;DDX3X
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.5559966885664033,-1.0086272266433494,0.4166666666666667,0.9907343062769535,1.0,2/12,8.95%,CCDC22;PKD2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5500187450836925,1.0085723144363252,0.4927536231884058,1.0,1.0,4/15,19.01%,CD160;GPER1;SFRP4;THBS1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.6231778161689685,-1.0084864131897981,0.4722222222222222,0.9902705158149147,1.0,3/7,14.75%,SYAP1;CORO1B;MARS1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5971537375002467,-1.0083157338507345,0.38461538461538464,0.989958574695974,1.0,1/10,8.38%,PID1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.4038457957748123,1.0081198098029063,0.4044943820224719,1.0,1.0,37/238,24.92%,ESR1;CDC25A;ACTL6A;PSMB9;USP50;USP6;TOMM20;JOSD2;RPS27A;OTUD4;USP13;TOR1A;COPS4;TFPT;CYLD;YOD1;USP18;PSMC5;COPS5;CCNA2;GPS1;OTUD1;TAF9B;PSMB6;HCFC1;NFKBIA;BRCA1;OTUB1;TAF10;PSMD6;PSMA3;IFIH1;ACTR5;SENP3;PSMA7;USP31;FOXO4
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.5548000091417079,-1.0079343258694082,0.45454545454545453,0.9902045548342984,1.0,6/14,21.28%,FZD7;CCN3;HDAC3;HDAC5;NOTCH1;HDAC4
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5638216682470203,-1.0078849397630947,0.3235294117647059,0.989579891525073,1.0,1/11,5.28%,APOE
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4896047146577708,-1.0075411944806876,0.375,0.989709841801209,1.0,2/19,5.65%,BRCC3;USP36
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.4437246825976016,-1.007410789034082,0.38095238095238093,0.9893530411567366,1.0,6/37,9.29%,DRD4;GPRC6A;DHFR;IRF5;GLRA3;RHBDD1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4730546537937628,1.0073496065149323,0.5333333333333333,1.0,1.0,12/50,23.06%,TLR2;ANXA1;PTPRC;AFAP1L2;CD244;SYK;ZNF580;NOS2;F2RL1;DDIT3;PARK7;ELANE
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5301679327883055,1.0071818895619793,0.4603174603174603,1.0,1.0,5/22,11.68%,CCL5;CRLF3;ERBB4;CYP1B1;IL26
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta activation (GO:1901388),0.6883316187201082,1.007098133179646,0.4827586206896552,1.0,1.0,2/5,18.78%,ITGB6;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.3414788093789412,-1.0065951942824929,0.4,0.9910687114307655,1.0,34/203,14.48%,NGF;APOB;VWC2;ZNF703;BOC;BAMBI;TWIST1;SP7;BCL9L;KITLG;CCN4;CARM1;PLA2G5;ASCL1;CCN1;ACVR1;PCP4;SYAP1;PA2G4;BNIP2;CCN2;BEND6;DLX1;MMD2;NEUROD2;LPL;GPC1;CMKLR1;BRINP1;ZNF268;IMPACT;SDCBP;EDN3;RPS6KA3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.528699085065937,1.0063644664800213,0.5384615384615384,1.0,1.0,4/21,20.14%,FUT2;CYP1B1;ALOX12B;SERINC1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5518940017588057,-1.0060796907731715,0.5,0.990851544873129,1.0,2/9,13.63%,FHL2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5518940017588057,-1.0060796907731715,0.5,0.990851544873129,1.0,2/9,13.63%,FHL2;CHP1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4591218796967111,-1.00587469376411,0.32142857142857145,0.9905065232383807,1.0,10/22,32.40%,EAPP;LEO1;BRD4;CCNT1;TCERG1;THOC1;HMGN1;ALYREF;CDK13;KAT7
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.5719170145215401,1.005868134563697,0.5636363636363636,1.0,1.0,4/13,23.45%,RNFT1;USP13;HERPUD1;BCAP31
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5112411333380308,1.0058410076060427,0.4605263157894737,1.0,1.0,3/34,3.01%,ANXA1;CERS3;WNT5A
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.5287019692258565,1.005675065625048,0.453125,1.0,1.0,2/17,9.51%,HSPA5;PINK1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.44934072796405844,1.0053618713330796,0.475,1.0,1.0,13/83,11.39%,GATA4;ITGAX;RRAS;WNT5A;HIPK1;FGF2;FLT1;ANGPTL4;NODAL;CYP1B1;AGGF1;MYDGF;RHOB
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4669338589714256,1.0053449690999665,0.47368421052631576,1.0,1.0,9/58,17.38%,SMAD6;TMEM100;TGFB1;NODAL;TGFB3;VSTM2A;SOX9;GDF9;MAPK3
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.6178850190285208,1.0052359392322365,0.5087719298245614,1.0,1.0,3/8,17.09%,UGT8;GBA3;B3GALT2
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.5336636131043415,-1.0049545357515262,0.4358974358974359,0.9919272429232685,1.0,4/10,12.42%,TIE1;SCUBE1;FSTL1;PROX1
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.612517424255738,-1.0048293471145264,0.48484848484848486,0.9914435748267305,1.0,2/7,4.51%,PM20D1;TST
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4616595749198398,1.0047833297650048,0.5205479452054794,1.0,1.0,10/50,11.65%,AIM2;CIDEB;USP50;GPER1;UACA;NODAL;NLRC4;REST;DDX3X;SYK
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.573799290266176,1.0047176767937278,0.49122807017543857,1.0,1.0,4/16,19.13%,BLK;AXL;IL4;F2RL1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.4635064972665029,-1.00458154242965,0.40625,0.9912716887740103,1.0,1/18,0.77%,ATP6V0D2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.6106773136728385,1.0043788639323254,0.484375,1.0,1.0,2/9,10.54%,AXL;PPT1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.6497542797751596,-1.0041830337151978,0.5365853658536586,0.9915259158513243,1.0,2/5,28.98%,MAPT;CLUH
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5170609105109012,1.0040347293938725,0.5079365079365079,1.0,1.0,6/13,33.60%,SLC25A18;SLC25A22;SLC1A6;SLC25A11;SLC25A13;SLC25A30
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.6369386595181737,-1.004023942328316,0.45652173913043476,0.991319742740839,1.0,2/5,27.43%,ADIPOR1;APPL2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.43441412120671946,-1.0039432043026606,0.4444444444444444,0.9907806828699033,1.0,16/64,17.47%,PRKCD;F11R;RND3;FSCN1;RHOBTB2;TAOK2;CORO2B;CORO1A;CRK;CCDC88A;MLST8;ARHGAP35;RHOA;RHOBTB1;PAK3;ABL1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.40729920577100825,1.0037279117490852,0.4444444444444444,1.0,1.0,18/126,19.22%,ARHGAP9;ARHGAP31;ARHGAP24;ARHGDIG;ARHGAP28;ECT2;RHOB;RHOU;ARHGAP45;ARHGAP15;FOXM1;TGM2;TAGAP;RASGRF2;RHOG;OBSCN;RHOQ;A2M
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5561124644402117,-1.0036259423689506,0.4827586206896552,0.9908854360257733,1.0,3/8,21.19%,TRMT61B;MTO1;RPUSD4
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.4308851865660631,1.0032296137766366,0.4230769230769231,1.0,1.0,11/100,14.96%,SMAD6;MAPKAPK3;TNFRSF1B;WNT5A;IL12A;AXL;CD80;GGT5;TNFSF4;PDCD1LG2;LIAS
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.5938796793601357,-1.0032133955484452,0.5,0.9910817939463429,1.0,4/11,18.98%,PKD2;GRIN1;CPSF7;FARSA
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5914840518322987,1.003131130134951,0.484375,1.0,1.0,5/9,36.81%,ATP5MC3;ATP5PB;ATP5F1D;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.4658638927335377,-1.0029437690888006,0.45161290322580644,0.9910256591802411,1.0,7/22,14.38%,PDE3A;ADCYAP1;PDE7B;CAP2;ADGRG6;ADCY2;MAPK7
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.3595160128250636,-1.002941325815249,0.42857142857142855,0.990236607052014,1.0,16/67,16.88%,CPSF1;LSM10;TTF2;POLR1A;GTF2H2;SNRPB;SYMPK;CSTF2;POLR2F;POLR3K;ERCC2;CPSF7;TAF1B;PCF11;TAF1D;SMN1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.483390990064076,1.0027657916810166,0.4927536231884058,1.0,1.0,9/43,21.37%,CASQ2;ACE2;NPR2;ATP1A4;TRDN;NPPA;AGT;RYR3;ATP2A2
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.6815748087128715,1.0026876873188322,0.5344827586206896,1.0,1.0,3/6,24.55%,CDKN1A;MME;HYAL1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5049582091650094,-1.0025107416704235,0.4117647058823529,0.9906618933373239,1.0,2/12,6.94%,SPTBN4;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.6768785158296624,1.002471620816108,0.59375,1.0,1.0,1/5,3.47%,SIX4
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.46650962917396216,1.0023802024139183,0.5131578947368421,1.0,1.0,10/51,10.43%,AMBP;DBH;DAO;SLC18A2;FTCD;SHD;SLC22A7;F7;ALDOB;NR1H4
prerank,GO_Biological_Process_2021__cellular response to vitamin D (GO:0071305),0.6723392422272838,1.002357205656973,0.5333333333333333,1.0,1.0,1/5,17.66%,CYP24A1
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.6123474851998716,1.0023447100453053,0.5,1.0,1.0,2/8,7.16%,LMOD3;MYH11
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.6514629807046148,-1.0022553964687617,0.5277777777777778,0.9907205807883656,1.0,1/6,7.86%,FNTA
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4063633458156873,1.0021556656431483,0.4588235294117647,1.0,1.0,77/283,24.26%,PCLAF;MCM2;POLE2;DONSON;RPL21;RPL37A;TICRR;RPL18A;RPL9;RAD1;MCM3;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;GRWD1;MRPL34;EEF1A1;RPA3;RPL36;PIF1;RPS27A;RPS19;RPL41;YARS2;RMI2;RPS11;RPL27A;RPS4X;RPS12;RECQL4;XAB2;SET;EEF2;RPL32;RPS21;RPL35A;COPS5;RPSA;RPL7A;RPS13;RPL11;RPS7;RSL24D1;RPL23A;RPL7;RPLP2;ORC4;RPLP0;RPS14;RPS6;POLE3;RPL38;GCNT1;BRCA1;RPL23;HELB;RPS15;RPL24;RPL18;RPL35;RAD9B;ASMT;PTMS;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;MRPL28;RPL27;RPS24
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.6054474376333647,-1.002080322066897,0.47368421052631576,0.9902764488598389,1.0,1/7,3.84%,CCDC22
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.4629399586572467,-1.0020695243652902,0.5,0.9895247902840582,1.0,3/15,13.28%,APOH;SERPINE1;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.6039332538238116,1.0018572587099044,0.5555555555555556,1.0,1.0,1/8,2.84%,CCL5
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.6017489231776625,1.0017066873094946,0.5454545454545454,1.0,1.0,3/10,18.72%,SLC5A2;SLC5A1;HNF1A
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.6027219307525143,1.0016469360774383,0.5,1.0,1.0,4/10,21.70%,KANK2;VPS18;ZNF366;BRCA1
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.6323445747261942,1.001541151974824,0.5303030303030303,1.0,1.0,1/6,12.13%,VPS18
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.5491928408349416,1.001506580070199,0.5072463768115942,1.0,1.0,1/16,0.97%,ACTL6A
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3982740090516013,-1.001190611495217,0.36363636363636365,0.9911698488832679,1.0,7/54,8.46%,DTX1;WWC1;MAML1;POFUT1;ASCL1;HES1;JAG2
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.5396958331260809,-1.001015345697338,0.43902439024390244,0.9908176109444286,1.0,4/7,18.06%,GLUD2;ASS1;ALDH18A1;GLUD1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.41689345500227837,-1.0008213866190316,0.3076923076923077,0.990682327094058,1.0,15/82,14.57%,TRIB2;UBASH3B;SPRED1;PTPRO;PTPRB;HSPB1;CEP85;SLC8A3;TRIB1;DAB2IP;DEPTOR;DUSP19;CHP1;CAMK2N1;PRKRIP1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.5821735565322257,1.000770152725116,0.5901639344262295,1.0,1.0,1/12,2.31%,RENBP
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.6257591766922203,1.000757903916498,0.46808510638297873,1.0,1.0,3/7,9.54%,ABCC6;ABCC2;ABCC11
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.5763787307479912,1.000699358505598,0.47692307692307695,1.0,1.0,5/12,18.92%,WNT5A;SYK;CYBA;NOXO1;NOS2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.5720704392054039,-1.0005584575986002,0.5142857142857142,0.9904789821049158,1.0,2/10,11.90%,JMJD4;IRGM
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.6708050496816106,1.0005254240725652,0.532258064516129,1.0,1.0,1/6,3.51%,FBXL7
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.45569255838687583,1.0005120057258432,0.4788732394366197,1.0,1.0,3/49,6.06%,SMAD6;MAPKAPK3;IL12A
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.540199504332866,1.00021480692713,0.47619047619047616,1.0,1.0,3/15,13.17%,BOK;RNFT1;USP13
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2905297016779969,-1.0,1.0,0.9912538339011728,1.0,273/1744,14.82%,NPAS4;RFX6;PER2;GALR3;POU3F1;SKAP1;ETV5;NR4A1;EHF;PLK3;TBX15;KCNIP3;ZNF25;OSR1;IL11;TEAD2;ZNF808;ZNF99;PRDM5;ZNF70;WNT3A;ERG;ARID3B;ZNF408;ARX;ZNF534;ETV1;ZNF860;CREB3L4;GFI1B;FOS;CHD4;FOXD4L5;FOXO1;BCL6;FGF1;GATAD2A;ZNF496;ZSCAN21;WWC1;TWIST1;EGR1;ZNF607;ZNF215;HDAC10;TWIST2;ZNF485;IKZF4;ZNF777;JUNB;ZBTB9;KIT;CDH13;ZNF773;CREB3L1;MSC;ZNF514;IFI16;NR4A3;VAX2;BHLHA9;PTCH1;MAML1;ADCYAP1;SAP130;LHX2;KLF10;RFX1;ZNF133;GABPB2;WWP2;ZNF48;ZNF470;SP7;SMARCB1;ZNF69;SMYD2;ZNF835;BCL9L;ZFP3;APOE;TEAD4;TGFA;ZNF641;PIAS3;AGRN;SOX12;THAP7;ERBB2;MYOCD;ZNF701;ZNF596;ZNF287;KDM7A;CBFB;BCLAF3;ZNF575;WNT7A;MAFG;ZNF33B;ATOH7;BACH2;ZNF347;CTCF;NFX1;CRYM;HIC2;ASCL1;CRY1;IRF5;SMARCAL1;SPDEF;BARX2;ZNF623;PCGF1;MEN1;CCN1;LRRFIP1;STAT5B;ZNF239;KDM2B;ZSCAN4;HOPX;MKX;ACVR1;TFAP2D;ZNF212;KDM3B;HES1;PRDM15;SENP1;CTDSP1;ZNF275;PID1;ZNF845;ZSCAN12;NFATC3;PPARGC1B;E2F6;SAFB2;ZNF75A;SSBP3;CDK1;PKD2;ZNF764;ZNF846;MAMLD1;MECP2;SERPINE1;ZNF14;ZNF316;ZNF765;IGBP1;RARB;FOSL1;MLIP;TFDP1;NACC1;ZFX;TGIF1;WWC2;ZNF3;BATF2;MACROH2A2;POU2AF1;AGO2;CITED4;ZNF692;BPTF;ZNF79;ZNF594;DNMT3A;HDAC3;DLX1;NEUROD6;CARF;ZFHX4;POU6F1;DAB2IP;NR2C1;SNF8;GTF2H2;PKNOX2;ETS1;NR1D1;BCL11A;PHF2;ZNF501;NKAP;FSTL3;ZNF611;PRDM1;CUX1;ZNF589;SP140;ZBTB7A;GMEB1;ATF3;GRIN1;ZFP62;NEUROD2;HSF1;NAMPT;ZMIZ1;RGMA;TFE3;ZNF549;ZNF729;RLF;DPRX;RIPK2;MLX;RCOR2;EPC2;PAX3;PCGF6;ZNF586;LDB1;CREB3L2;NFIB;CDK4;PROX1;HEXIM2;FHL2;MED25;ZNF415;ATF1;SP2;ZBTB47;ZNF135;ZNF263;ZNF578;RBL1;HR;RNF10;TNRC6C;TFCP2;CREM;SMARCA4;ZNF157;ZNF557;CRK;MIER2;ESRRB;ZNF136;HIVEP1;GTF2IRD1;ZNF268;IMPACT;SBNO2;BCL11B;FRK;TCF20;FGFR2;ZNF334;SDCBP;SIRT7;KCTD1;ZNF16;ZNF707;ZNF569;MAPK7;KDM1B;RPS6KA3;PER3;ZBTB4;RTF1;ZNF627;SNAI2;ZNF28;DLL1;ZFP82;PIAS4
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.5485108939015847,0.9998636641319593,0.5185185185185185,1.0,1.0,4/11,22.62%,CRHBP;OPRM1;SLC38A2;ABCB1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.5860531391127061,-0.9997234952875941,0.5384615384615384,0.9913457552729944,1.0,1/7,2.49%,SLC38A5
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.4847114887477787,-0.9993683673545509,0.5666666666666667,0.9914375294528673,1.0,6/23,14.46%,SYNJ2;NLGN3;SNCB;NLGN2;CEL;NLGN4Y
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.5851153007638892,-0.9992458978356981,0.5135135135135135,0.9910754248121306,1.0,3/7,13.63%,RAMP1;FKTN;CHP1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5254876417247655,-0.9990374508345156,0.4642857142857143,0.9908272413973189,1.0,5/11,17.79%,PLK3;FBXO31;RFWD3;RPS27L;PLK5
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.48512651126667694,0.9990010092120556,0.453125,1.0,1.0,7/33,13.64%,GP1BA;ANXA1;FGF2;ACTG1;DUOX1;PLAU;VIL1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.595632193906207,-0.9988313871990088,0.5,0.990568129262375,1.0,1/8,10.84%,DAPK2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.46738921711798703,-0.9987261019845679,0.42857142857142855,0.9899925787715558,1.0,9/41,17.73%,SPRY4;PRKCD;APOE;PTPRJ;DAB2IP;DUSP19;SPRY1;NF1;SPRY2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.5942881320051234,-0.9986448273177837,0.525,0.9894066391073291,1.0,4/8,26.39%,IL23A;STAT4;TYK2;STAT3
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.38771507433482755,-0.9984969492358249,0.42857142857142855,0.9891831726393172,1.0,22/94,14.23%,EYA4;KCNIP3;OSR1;BOC;RAI14;GPC6;KIAA1549;FZD7;MID1;CAP2;GPR161;B4GALNT1;ZFHX4;DAB2IP;ADAMTS3;SLIT2;FHOD3;ANTXR1;PRTG;AMOTL2;GTF2IRD1;AADAT
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.42074199954073466,0.9984257847704635,0.49411764705882355,1.0,1.0,15/127,11.88%,ESR1;RORC;CCL5;AHR;SSTR1;CASP7;TGFB1;H2AZ1;GPER1;P2RY6;SLC26A6;RAMP3;CYP1B1;NR1H4;CRHBP
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.5807267240893428,0.9983210886807548,0.5,1.0,1.0,6/14,32.40%,INTS5;TRNT1;PTCD1;INTS2;SSB;INTS6
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.387318209658887,-0.9982753915299741,0.38461538461538464,0.989072953127744,1.0,28/79,23.90%,HNRNPL;CELF5;SRRM4;SRSF4;FXR2;ZBTB7A;NOVA1;CELF4;U2AF2;PTBP1;CIRBP;SMU1;THRAP3;RBMX;RBFOX2;NUP98;KHDRBS1;PCBP4;RBM11;CELF2;RBM25;RBM24;RBM8A;SF3B4;SFSWAP;DAZAP1;PUF60;SON
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.49298171864018203,0.9980124679962602,0.4861111111111111,1.0,1.0,3/28,8.64%,ITGB2;ITGAM;TCAF2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.5835389913795763,0.9978587203325875,0.46296296296296297,1.0,1.0,3/10,20.88%,NDC80;NUF2;BOD1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4372802711225036,-0.9978568878812754,0.45714285714285713,0.9894366744795721,1.0,2/21,3.40%,ENO3;IFT88
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.40859567810407654,-0.9978050869569299,0.41935483870967744,0.9888079551374506,1.0,2/39,2.30%,GCK;FOXO1
prerank,MSigDB_Hallmark_2020__Complement,0.42162663021630215,0.9977656470756606,0.4942528735632184,1.0,1.0,29/158,19.48%,PSMB9;GP1BA;S100A13;CCL5;CASP7;C3;ITGAM;CPM;ERAP2;WAS;CASP10;HSPA5;MMP15;F7;IRF1;PIK3CG;F8;C4BPB;CP;PLAUR;CDK5R1;PLA2G7;LAMP2;PLAT;PLG;RHOG;FN1;ATOX1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.43253756402434257,0.9975858803170393,0.45348837209302323,1.0,1.0,11/111,6.51%,CHRNA9;ESR1;C3AR1;C1QTNF1;LPAR1;WNT5A;NMUR2;TRPC7;GPER1;PTGER3;CAV3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.49092732253054694,-0.9969558377564051,0.5555555555555556,0.990365103610329,1.0,1/15,0.68%,MFSD2A
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.5317271779965731,0.9967624091827081,0.5147058823529411,1.0,1.0,7/17,19.18%,ANXA1;FCGR3A;FLG;TGM2;FN1;THBS1;TGM6
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.583872299130139,0.9967572433292831,0.4827586206896552,1.0,1.0,4/8,36.03%,AGER;EFNA1;GRN;PICALM
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4202370157539099,0.9963749852028763,0.4230769230769231,1.0,1.0,16/112,13.32%,TMEM213;MACC1;ACE2;IYD;CYP3A5;SLC22A8;ITGB6;SLC12A3;NPHS2;SCIN;MUC4;EPB41L4A;EMX1;CALB1;ATP10B;SLC22A6
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.5285795248238262,0.9963532790917468,0.49295774647887325,1.0,1.0,4/25,14.84%,FGF2;HGF;DACH1;CDKN1A
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.5573485504486227,0.996150501608178,0.49206349206349204,1.0,1.0,1/11,1.58%,PPP1R3B
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5662009810990933,-0.995980309212825,0.5,0.9921786057062713,1.0,4/8,14.65%,ACER2;SERPINE1;PDE3B;SNAI2
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.41916598820594114,0.9958810066126985,0.4691358024691358,1.0,1.0,28/130,14.11%,GATA4;SLC28A1;CLDN2;CDHR5;ACSL5;ACE2;COL18A1;CYP3A4;NR1I3;SOX10;CYP4F12;NPC1L1;LCT;ABCG2;TMEM45B;ABCC2;SLC51A;CA1;MUC17;CLCA1;ALDOB;NR1H4;ANPEP;SLC15A1;TMC4;ASPN;VIL1;TREH
prerank,GO_Biological_Process_2021__C-terminal protein deglutamylation (GO:0035609),-0.6511562583614778,-0.9957445824381338,0.5588235294117647,0.9921001808321255,1.0,1/5,1.56%,AGBL1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5242294684725267,-0.9956672611562332,0.45,0.9915612272320773,1.0,2/10,13.15%,XYLT1;B3GAT3
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4877097422987068,-0.9956611777077882,0.4827586206896552,0.9907761431250051,1.0,3/15,13.35%,EMC4;EMC8;BAG6
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.569080888670972,0.9954609730612485,0.4918032786885246,1.0,1.0,3/12,11.13%,AIM2;IRF1;STAT1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5088420599011478,-0.9951630342199498,0.4230769230769231,0.9912374616923834,1.0,2/21,1.79%,EYA4;BCL2
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.5460794317075546,0.9950152484202498,0.5441176470588235,1.0,1.0,1/16,1.57%,TLR2
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6396253543960295,0.9949825834099224,0.5166666666666667,1.0,1.0,2/5,13.43%,STOML2;TNFSF4
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6233244417823227,0.994809430837694,0.5522388059701493,1.0,1.0,2/6,16.57%,RP1;RPGRIP1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3910574788248477,-0.9946078965048811,0.4074074074074074,0.9921351938691152,1.0,16/58,19.83%,RNF168;POLM;RAD50;BRCC3;SMARCAL1;LIG3;ERCC8;ZBTB7A;PIAS4;DCLRE1B;MDC1;KDM2A;ERCC1;XRCC4;ATM;NBN
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.6294190710776144,0.9944365444402902,0.5,1.0,1.0,2/7,12.36%,C4BPA;C4BPB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.6294190710776144,0.9944365444402902,0.5,1.0,1.0,2/7,12.36%,C4BPA;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.6294190710776144,0.9944365444402902,0.5,1.0,1.0,2/7,12.36%,C4BPA;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.568255449843827,0.9940151184529378,0.5072463768115942,1.0,1.0,3/15,19.13%,PELI3;TRAIP;F2RL1
prerank,"GO_Biological_Process_2021__regulation of blood coagulation, intrinsic pathway (GO:2000266)",0.6341080093633277,0.9939548595216768,0.4909090909090909,1.0,1.0,2/5,19.22%,F8;A2M
prerank,"GO_Biological_Process_2021__negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",0.6341080093633277,0.9939548595216768,0.4909090909090909,1.0,1.0,2/5,19.22%,F8;A2M
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.6404255319148936,0.9936843656505908,0.4666666666666667,1.0,1.0,5/5,35.97%,VEGFC;RIN3;VEGFD;VEGFB;VEGFA
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.3396554578550162,-0.9932780346701661,0.6666666666666666,0.9948234982774864,1.0,43/223,17.39%,EFNB1;SLITRK6;SHC3;LAMA3;GFRA2;PTPRO;NLGN3;S100B;PARD3;SPTBN4;SH3KBP1;DOK5;WNT7A;SLIT3;EPHB2;EPHA6;PTPRA;SPTB;TNR;SLITRK2;DOK6;NTN4;BSG;NIBAN2;SLIT2;LAMA2;TAOK2;ANOS1;GPC1;LLGL1;ROBO4;FGFR2;MAPK7;EVL;DSCAML1;FYN;LRTM2;AUTS2;ARHGAP35;PARD6B;PRKCA;CDK5;PAK3
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3804477924417167,-0.9932515120626668,0.4583333333333333,0.9941054645350499,1.0,18/80,21.91%,KIF2B;KDELR1;COG4;KIF15;GBF1;KIF4B;KIF26A;ATP9A;KIF1C;COG7;DNAJC28;ERGIC1;TAPBP;STX18;PITPNB;ATP9B;TMED3;RAB6A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.47610460970706187,0.9932319082404454,0.4927536231884058,1.0,1.0,8/45,15.81%,CEP55;RTKN;ECT2;RHOB;KLHDC8B;ANLN;RASA1;MITD1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5200004012493263,0.9932109823981671,0.49295774647887325,1.0,1.0,1/30,0.55%,ESR1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.5212532326178145,-0.9930511302796191,0.5172413793103449,0.9938358543295903,1.0,2/11,8.29%,SHANK1;CHRNA1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5740187746507257,0.9929191532167565,0.5571428571428572,1.0,1.0,3/12,19.31%,CYP26B1;DHRS3;PRAME
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),0.6262136008057582,0.9928875604065527,0.47368421052631576,1.0,1.0,2/6,15.97%,PPT1;ATP6AP2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.49111239352960184,-0.992702057708564,0.425,0.9938795260032425,1.0,3/13,14.81%,PEX7;DHRS7B;TMEM86B
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5200243648890102,0.992647480088355,0.49295774647887325,1.0,1.0,3/24,13.25%,GPER1;P2RY6;TRDN
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.517268868386511,-0.9925846225514311,0.44680851063829785,0.9934318836465876,1.0,2/17,10.61%,HPGD;SNF8
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.64313077974996,0.9922888243619292,0.5,1.0,1.0,1/5,8.89%,RAD54L
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.6474088582537557,0.9920120833882975,0.55,1.0,1.0,3/6,30.28%,SYK;CD27;PPP2R3C
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5093164884946861,0.9919657766706105,0.5,1.0,1.0,4/22,19.01%,GPER1;CYLD;AGT;THBS1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5215887078725308,-0.9915525055340882,0.5,0.9953723041646889,1.0,1/14,0.34%,SKAP1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.46832130709836245,0.9915326646776204,0.4782608695652174,1.0,1.0,5/35,9.34%,ITGB2;WNT5A;ITGAM;DDIT4;REST
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.5412439659403977,-0.9911807542513184,0.475,0.9955818715943707,1.0,1/9,9.81%,METAP2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.5649325150984335,0.9907326656423968,0.4444444444444444,1.0,1.0,3/13,26.58%,CD81;RAB29;RPS3
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.6092665391319251,-0.9905581716138172,0.5405405405405406,0.9964928260661176,1.0,2/6,10.53%,PDCD7;AKR1C3
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.37977805185494445,0.9904992248141908,0.4883720930232558,1.0,1.0,55/341,15.23%,ITGB2;TLR2;AIM2;RORC;ANXA1;ITGAX;CSF2RA;TNFRSF1B;TCF7;CCL5;HSPA8;WNT5A;CRLF1;FGF2;CLCF1;STAT5A;TGFB1;ITGAM;PTAFR;IL12A;GPER1;GSDME;SLC26A6;NLRP12;SOCS2;IFNK;IFIT1;MMP9;NPR2;RPL13A;LEF1;OSMR;IRF1;HCK;DUOX1;AXL;STAT1;CD80;HGF;IL7;RHOU;SYK;IL26;CSF3R;CRHBP;CCND1;RPS27A;CDKN1B;IRF4;LDLRAP1;LIFR;CDKN1A;AQP4;SOX9;ALOX15
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.47718258180758827,0.9904750129481358,0.5066666666666667,1.0,1.0,5/33,16.14%,UBE2L6;TRIM25;NLRC3;ISG15;CYLD
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.4458318727356258,-0.9904617173027828,0.40625,0.9960556675350506,1.0,6/18,24.98%,LIN28B;DXO;RBM24;YTHDF1;RIDA;METTL16
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.38035255321908973,-0.990386196582736,0.52,0.9954412606322983,1.0,15/110,12.90%,TBC1D10A;KLHL20;STX6;RAB7A;SNX32;GBF1;STX5;DOP1B;SNF8;RAB5A;SNX5;EMP2;UBE2O;EHD3;WASHC2C
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.38033952179472474,-0.9900145243590958,0.4482758620689655,0.995727902235067,1.0,11/62,18.93%,IWS1;GTF2H2;POLR2F;SSRP1;ERCC2;RTF1;ELOA;POLR2C;ELOF1;LEO1;CCNT1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.6882982027001298,0.9900027560356256,0.5362318840579711,1.0,1.0,3/6,28.67%,CYBA;F2RL1;PJA2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4956582903210151,-0.9899601152219818,0.4594594594594595,0.9951036108019079,1.0,1/14,1.79%,BCL2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.4276611824220447,0.9898703198328478,0.4605263157894737,1.0,1.0,15/109,16.53%,CYTIP;KIF14;CCL5;IL12A;ADAMDEC1;FUT2;ARHGDIG;PIK3CG;PLXNA3;PLAU;KNG1;TGM2;RASA1;TGFBI;ADGRG1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.5632472691981463,0.9897216940688678,0.5409836065573771,1.0,1.0,2/16,11.13%,ST18;STAT1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.4458027012540675,-0.9897189977549259,0.47058823529411764,0.9949018978596706,1.0,2/16,4.98%,NR4A3;TRPC3
prerank,GO_Biological_Process_2021__positive regulation of NK T cell activation (GO:0051135),0.6629317949216191,0.9896620447212243,0.532258064516129,1.0,1.0,2/5,19.19%,IL12A;HSPH1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.5169403836861758,0.9895671251862816,0.4714285714285714,1.0,1.0,1/22,2.41%,SP100
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.5784152506925611,-0.989205828480895,0.5263157894736842,0.9954210969691638,1.0,3/5,25.80%,NTRK2;MAPT;TMEM108
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4298134611758461,-0.9891470219911774,0.48484848484848486,0.9948538956154896,1.0,6/39,5.76%,ADAMTS1;DNMT1;CDH13;MMP2;NR4A3;CCN4
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.6021063959193753,0.9890538067582041,0.5538461538461539,1.0,1.0,1/6,7.16%,MYH11
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.5980770295462503,-0.9885617735143902,0.47058823529411764,0.9957818669405347,1.0,1/5,2.18%,SLC25A29
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.5003790252227062,-0.9884675981031614,0.4,0.9952152690445328,1.0,3/12,15.13%,CD14;TICAM2;ITPK1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.664855996585967,0.9883253123884549,0.5384615384615384,1.0,1.0,4/6,27.45%,PINK1;ATP5IF1;TOMM7;HK2
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.5196203290569495,0.9879625818453697,0.5142857142857142,1.0,1.0,5/20,15.85%,TGFB1;NODAL;DAB2;TGFB3;PBLD
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.3969483831774169,-0.9879509165954882,0.3333333333333333,0.9956552444294209,1.0,22/92,17.32%,CDH20;SLITRK6;CDH5;CDH19;KIRREL3;NLGN3;FSCN1;FLNA;PCDHB6;SDK2;NLGN2;CDH12;PCDHB9;NRXN2;DBNL;CDH22;LIMS1;TRPV4;PARD6B;RHOA;CDK5;CDH9
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.6095289480704563,0.9879468546481655,0.5423728813559322,1.0,1.0,2/7,24.51%,AGER;EFNA1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.5071638340426565,0.9875972870702454,0.4864864864864865,1.0,1.0,2/22,3.35%,GPR55;LILRB3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3967280151201005,-0.9874754916137893,0.42857142857142855,0.9961276632898038,1.0,9/82,12.92%,KIF2B;SEC24C;HLA-DQB1;HLA-DRA;KIF15;RAB7A;KIF4B;KIF26A;CAPZB
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5119771611731038,0.9874667746326171,0.5217391304347826,1.0,1.0,1/20,1.02%,MCUB
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.6481964780072133,0.9873865643652673,0.5645161290322581,1.0,1.0,1/6,5.66%,SCIMP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.42609771942829006,-0.987324246117281,0.42424242424242425,0.9958159088641094,1.0,2/30,3.96%,ADAMTS1;LSM10
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.4649490127054664,0.9870206952034036,0.52,1.0,1.0,8/75,11.02%,TULP1;ANXA1;SFTPD;BOK;SCIN;PON1;DAB2;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6183998738257277,0.9869065438847713,0.5645161290322581,1.0,1.0,2/7,19.70%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.6222804386934528,-0.9867425756324487,0.5416666666666666,0.996618240812281,1.0,1/5,9.35%,AQP1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5977292819513038,0.9861788108200317,0.5263157894736842,1.0,1.0,1/7,13.25%,TRDN
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.46638146458206153,0.9860561295102815,0.48717948717948717,1.0,1.0,9/54,16.16%,ASB5;WNT5A;DTL;VSIR;C4BPA;C4BPB;CDKN1B;OAZ2;ANGPTL3
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.5620082202089098,-0.9860435209055677,0.48484848484848486,0.9977498416564552,1.0,1/9,5.33%,MLYCD
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5431777316236374,0.9857583001628738,0.515625,1.0,1.0,4/16,13.43%,TNFRSF1B;HLA-F;HLA-A;TNFSF4
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.5151391528867573,-0.9857515968071248,0.5,0.9976687352882502,1.0,5/15,12.42%,PTCH1;TRIM71;PKD2;ALDH1A2;PROX1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.40395928120325686,0.985384295861494,0.4675324675324675,1.0,1.0,13/134,7.49%,LRP4;TIMP3;PRRX1;TLR2;TRIL;TSPAN11;LMOD1;FBXL7;SLC38A3;SFTPA1;PCDH18;SCARA3;PLP1
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.6394354709023012,0.9851406588985513,0.5573770491803278,1.0,1.0,2/7,15.65%,TMEM79;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5232251273058048,0.985049268904758,0.4406779661016949,1.0,1.0,4/20,15.07%,BUB1;TEX14;FBXO5;TTK
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.49373778168763477,-0.9849559088019084,0.41379310344827586,0.9990507676032094,1.0,9/21,16.68%,PNP;PRPSAP1;NT5C1A;GPX1;DNPH1;FHIT;NT5C;GART;ITPA
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.5953226801553346,0.9848718305004481,0.546875,1.0,1.0,2/9,17.72%,ADGRG1;HTR2B
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.4135753715440998,0.9846836686895223,0.5,1.0,1.0,32/137,19.31%,ITGB2;TLR2;CCL5;PTPRC;TGFB1;IL12A;RPL9;WAS;HLA-DMA;CDKN2A;MMP9;HLA-A;RPS9;RPS3A;STAT1;CD80;IL7;RPS19;IRF4;CCND2;IGSF6;ZAP70;FYB1;IL4;CRTAM;ITK;DEGS1;CD4;STAB1;NOS2;CD8B;CSF1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6596502146403806,0.9838883620793738,0.6379310344827587,1.0,1.0,3/6,22.63%,RNF26;HOOK2;HOOK1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.56486098051745,0.9838570568289152,0.5675675675675675,1.0,1.0,3/13,7.63%,ACSL5;C3;SLC26A6
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5034440674763231,0.9837577393384938,0.5076923076923077,1.0,1.0,4/24,15.45%,TGFB1;PPT1;CLN8;SIAH1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5236526987387136,0.9837525509498134,0.5396825396825397,1.0,1.0,7/23,14.84%,IL12A;GPER1;OGN;SOD2;TGFB3;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.34034023780394057,-0.9836967356683831,0.8,1.0,1.0,62/370,15.70%,ARC;PTCD2;PNPLA3;PACSIN2;AUP1;MAST2;MSTO1;KLHL20;SMPD4;COG4;CFAP410;NIPSNAP2;APOE;HPS3;PEX7;MYO18A;SH3KBP1;FANCG;MTFR2;PLD2;UBXN2A;TFB1M;PLIN5;RAB7A;AFG1L;TRAPPC12;PAK6;GOLGA8A;PKD2;TMED4;FAM174B;GBF1;TICAM2;SYNE3;FGD1;DOP1B;FGD5;WASF3;PEX14;ZNF501;TERT;PACSIN3;BIN1;SPTSSB;BLZF1;SLC25A33;ZNF135;REEP6;CAPZB;TTC17;MICAL3;SIPA1L3;CFAP61;GOLGA8B;TTC29;MICAL1;SH3D19;TOR1B;COG7;CSPG5;EIF2AK3;MIA3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.5586648085990258,-0.9836505345290485,0.5555555555555556,1.0,1.0,4/10,24.05%,PID1;VAT1;PRKN;PLD6
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.5381865976377345,0.9836081396545723,0.5694444444444444,1.0,1.0,2/20,5.00%,FAM20A;TRPV6
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.6332722421295612,0.9833139190695157,0.5384615384615384,1.0,1.0,2/7,17.66%,JCHAIN;NOXO1
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.5917146644352334,-0.983104025619147,0.5666666666666667,1.0,1.0,3/9,17.37%,ABCC8;PKD2;PKD2L1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.4354582898113504,0.9830466256839046,0.5844155844155844,1.0,1.0,7/95,5.42%,AQP3;CASQ2;WNT5A;SYT15;SYT2;TRPV6;CASR
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.5336753663519902,-0.9829288119116522,0.4864864864864865,1.0,1.0,4/10,25.62%,RAD50;ERCC1;SMC6;XRCC3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.49967427465004555,0.9828902464121488,0.55,1.0,1.0,2/22,2.61%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.4521662420919604,0.9828656138548476,0.5131578947368421,1.0,1.0,10/68,15.15%,LRP4;ACTG1;TGFB1;VASP;MARVELD2;MARVELD3;MYOT;TGFB3;TJP3;FBLIM1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.5461013077491195,-0.9828483630227449,0.47368421052631576,1.0,1.0,4/11,18.55%,ADAMTS12;EFEMP1;SNAI2;GREM1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.5229707873760034,-0.9827116209173085,0.5,1.0,1.0,4/9,21.31%,PIAS3;PIAS4;HDAC4;RASD2
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.5607970283399641,0.9823894169393819,0.5263157894736842,1.0,1.0,4/11,23.02%,RNFT1;USP13;HERPUD1;AQP11
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.34152579834096214,-0.9823012984535446,0.3333333333333333,1.0,1.0,26/165,14.48%,HNRNPL;PIWIL2;NRDE2;LIN28B;TENT4A;KHSRP;MAGOHB;PDCD7;DHX8;SRRM4;SRRM1;SRSF4;KIN;PPP1R9B;SNRPB;HNRNPF;PRPF18;NOVA1;U2AF2;PTBP1;SF3A2;SMU1;RP9;PABPC4;ZMAT5;HNRNPUL1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.556373890133346,-0.9820740791373083,0.4772727272727273,1.0,1.0,2/7,18.26%,MTHFR;MTR
prerank,GO_Biological_Process_2021__extracellular exosome biogenesis (GO:0097734),0.63479336988298,0.9820255050224186,0.546875,1.0,1.0,2/5,17.02%,RAB11A;COPS5
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.37457664161260157,-0.9816865745265128,0.5909090909090909,1.0,1.0,7/78,4.34%,NR4A1;SPRED2;SPRED1;FGF1;ESRP1;FGF18;TRIM71
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.561046230337868,0.9816571169382944,0.5588235294117647,1.0,1.0,4/14,9.80%,DHRS13;BCO1;RDH13;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.6680140328168944,0.9813295128042736,0.5,1.0,1.0,1/5,15.25%,WBP2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3050443459330334,-0.9812651520724198,0.5555555555555556,1.0,1.0,96/567,14.65%,PER2;ETV5;PLK3;KCNIP3;ZNF25;OSR1;PRDM5;GFI1B;BCL6;GATAD2A;WWC1;TWIST1;HDAC10;IFI16;NR4A3;PTCH1;SAP130;KLF10;ZNF133;WWP2;ZNF69;SMYD2;THAP7;ZNF596;CBFB;CTCF;NFX1;CRYM;ASCL1;CRY1;SPDEF;PCGF1;MEN1;LRRFIP1;ZNF239;KDM2B;HES1;NFATC3;E2F6;ZNF75A;ZNF764;ZNF846;MECP2;IGBP1;RARB;MLIP;TGIF1;WWC2;ZNF3;MACROH2A2;ZNF692;BPTF;ZNF79;DNMT3A;HDAC3;DLX1;POU6F1;DAB2IP;NR2C1;NR1D1;BCL11A;NKAP;PRDM1;CUX1;ZNF589;ZBTB7A;ATF3;HSF1;MLX;LDB1;NFIB;PROX1;HEXIM2;FHL2;MED25;SP2;ZNF263;CREM;SMARCA4;ZNF557;MIER2;ZNF136;HIVEP1;GTF2IRD1;ZNF268;IMPACT;FRK;FGFR2;SDCBP;SIRT7;KCTD1;KDM1B;PER3;ZBTB4;RTF1;SNAI2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.44402019471128884,0.9808853922496535,0.5,1.0,1.0,9/67,15.81%,NOX5;ROPN1B;CEP55;RTKN;ECT2;RHOB;ANLN;RASA1;MITD1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.5675143196198686,0.9804902571973373,0.4576271186440678,1.0,1.0,2/12,4.68%,ADAD2;ADARB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.4883241336508291,-0.9796632025810569,0.4418604651162791,1.0,1.0,1/15,1.63%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.4883241336508291,-0.9796632025810569,0.4418604651162791,1.0,1.0,1/15,1.63%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.564372067858227,-0.9793952739472268,0.5476190476190477,1.0,1.0,5/7,23.23%,ACVR1;NOTCH1;JAG1;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.5996929221645395,0.9793791859827014,0.5555555555555556,1.0,1.0,3/10,15.02%,DCLRE1A;DCLRE1C;TFIP11
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.5364534974946668,0.9793474927649626,0.4868421052631579,1.0,1.0,3/15,15.99%,ANXA1;NDUFS2;METTL14
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.322466821837752,-0.979283645872983,0.6153846153846154,1.0,1.0,64/384,16.38%,PER2;CD38;PRDM5;ZNF703;FOXO1;BCL6;GATAD2A;TWIST1;HDAC10;TWIST2;IKZF4;CREB3L1;IFI16;KLF10;WWP2;LBH;PRICKLE1;THAP7;MAP3K10;CTCF;KDM8;HIC2;ASCL1;CRY1;CIART;MEN1;PHC2;HES1;PA2G4;MECP2;NACC1;SFMBT1;MTERF3;CBY1;HDAC3;TLE2;DAB2IP;NR1D1;PEX14;NKAP;ZBTB7A;NIBAN2;MLX;RCOR2;PCGF6;LDB1;PROX1;HEXIM2;RING1;SMARCA4;MPHOSPH8;SBNO2;KCTD1;ZBTB4;PIAS4;LIMS1;YWHAQ;NR1H2;LANCL2;HDAC5;MIDEAS;MYBBP1A;BAHD1;VGLL4
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.6068839408125061,0.9790042416324245,0.5967741935483871,1.0,1.0,2/7,8.73%,HIPK1;COL4A3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.5209572099230542,-0.978805267161091,0.47058823529411764,1.0,1.0,4/17,8.50%,MTHFR;MTHFD1L;DHFR;FPGS
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.4460299578956767,0.9787305420150731,0.547945205479452,1.0,1.0,15/50,21.20%,SLCO1A2;SLC10A1;ABCG2;SLC16A8;ABCC2;SLC26A6;SLC51A;ABCC11;NR1H4;SLC16A12;SLC16A1;SLC6A12;SLC10A5;SLCO2B1;SLC16A3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.3895870790004231,-0.9784696146931193,0.43478260869565216,1.0,1.0,14/60,19.54%,SKAP1;ACER2;CDH13;PTPRA;EMP2;LDB1;SLK;CDK6;CAMSAP3;RHOA;NF1;JAG1;JUP;VCL
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.4898925168814814,-0.9784096811653894,0.42105263157894735,1.0,1.0,2/10,10.47%,VASH1;MARCHF5
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.3710487474581184,-0.9781600836378214,0.4838709677419355,1.0,1.0,13/81,6.91%,FIBIN;PAMR1;CLEC14A;CALD1;COL12A1;COL6A3;CREB3L1;COL4A2;MMP2;MYOCD;CNN1;PARVA;SLIT3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.5330760407221984,0.9781564513041263,0.5147058823529411,1.0,1.0,1/16,6.51%,CAV3
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.5232442600569135,0.9780384136588811,0.47761194029850745,1.0,1.0,3/17,11.13%,AIM2;IRF1;STAT1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.46486511993323004,0.9777012896652597,0.4861111111111111,1.0,1.0,8/41,17.40%,WNT5A;HEY2;TGFB1;LEF1;HGF;SOX9;HEY1;SNAI1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.5944948407831954,0.9775787865988366,0.5625,1.0,1.0,3/10,24.63%,TICRR;WDR18;GMNN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.5508385477580212,-0.9772693831675426,0.5365853658536586,1.0,1.0,4/8,21.21%,CACNG4;CACNG2;GPHN;CACNG3
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.5508385477580212,-0.9772693831675426,0.5365853658536586,1.0,1.0,4/8,21.21%,CACNG4;CACNG2;GPHN;CACNG3
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.6301652536794757,0.9771436051305306,0.5636363636363636,1.0,1.0,2/6,14.98%,SIX4;GLI3
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5011073482265732,0.9770822131594488,0.5441176470588235,1.0,1.0,1/17,2.80%,GMFG
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.45419011670341314,0.9770459341362671,0.527027027027027,1.0,1.0,16/52,28.69%,CCL5;VAPB;IFIT1;ZC3HAV1;DDX3X;ISG15;OAS2;PPID;IFIH1;NR5A2;PARP10;ISG20;SRPK1;OAS1;FKBP6;OASL
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.6281947672350511,-0.9769241337127725,0.5833333333333334,1.0,1.0,3/6,10.76%,RAB7B;DAB2IP;NR1D1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.397852728797643,-0.9766749822714591,0.5,1.0,1.0,4/31,7.91%,P2RY10;CD247;S100B;HOPX
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.4534895174166722,0.9764996442609184,0.5194805194805194,1.0,1.0,1/49,0.39%,NEK2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.5882515412163488,0.9764656540966689,0.5161290322580645,1.0,1.0,3/11,17.88%,LCP1;FHOD1;CARMIL1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5833813356667799,0.9764295144868068,0.5645161290322581,1.0,1.0,4/11,20.26%,CHMP3;MAPK3;DENND10;MAP2K1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.42061963270601865,0.9762872006981834,0.4567901234567901,1.0,1.0,30/79,29.39%,PSMB9;UBE2L6;TRIM25;IRF1;IL7;LPAR6;ISG15;DDX60;TXNIP;USP18;PARP14;TRIM5;CSF1;PROCR;B2M;TAP1;PSMA3;IFIH1;LAP3;LY6E;PARP9;EPSTI1;IFIT3;CASP8;ISG20;CD74;OAS1;OASL;TMEM140;CMPK2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.45194602499595177,-0.9760493437921166,0.4482758620689655,1.0,1.0,12/25,16.33%,GPC6;GPC2;OVGP1;SDC3;AGRN;GPC4;GPC1;IDUA;HGSNAT;FUCA1;GUSB;SDC4
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.4315901852917984,-0.9759342585251516,0.5263157894736842,1.0,1.0,5/26,10.53%,IL11;CDH5;ITGA4;SERPINE1;AKR1C3
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.45284353232235586,-0.9759275774070675,0.46153846153846156,1.0,1.0,9/33,19.95%,RHEX;STAT5B;ETS1;LDB1;CDK6;ZNF16;MAFB;MED1;ABCB10
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.4727341447125992,0.9756917029159174,0.5454545454545454,1.0,1.0,4/44,9.95%,TBX1;SGCG;CAV3;IGF1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.5146147087359915,-0.9756160019169156,0.45714285714285713,1.0,1.0,3/9,18.26%,DHFR;RTN4RL2;MTR
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4588544859789096,0.9756100336575342,0.5540540540540541,1.0,1.0,10/57,7.36%,PTPRH;CLDN2;ANXA10;ACE2;LIPH;ITGB6;CLDN18;PTGR1;MISP;SMIM22
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.5578450866252964,0.9754218438112642,0.543859649122807,1.0,1.0,2/7,9.39%,PTGER3;OSMR
prerank,GO_Biological_Process_2021__regulation of apoptotic cell clearance (GO:2000425),0.6875337313764782,0.9753616431242147,0.6065573770491803,1.0,1.0,3/5,20.86%,C3;TGM2;CD300LF
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.561654565677365,0.975184988150957,0.5263157894736842,1.0,1.0,4/15,24.15%,EIF6;PDK4;PANK2;PRKAB2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5331964999897137,0.9751422522154378,0.5254237288135594,1.0,1.0,5/15,20.22%,MESP1;ITGA2;SNAI1;TBX19;HMGA2
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.5863359759440556,0.975057890789455,0.46296296296296297,1.0,1.0,1/9,5.06%,TICRR
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.440823414801006,-0.9748541790977773,0.43478260869565216,1.0,1.0,6/32,12.13%,SPRY4;SCAI;EPHB2;STAMBP;DAB2IP;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.5869257006233269,0.974814843076886,0.5714285714285714,1.0,1.0,5/7,37.99%,TRDN;CALM1;GSTO1;GSTM2;CALM3
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4515382881291417,0.9741675344529936,0.5,1.0,1.0,13/45,26.01%,KIF14;CEP55;NDC80;RAB11A;CHMP3;KIF18A;NUF2;PSRC1;BOD1;CCNB1;CHMP1A;ANKRD53;CDCA5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6280614544708614,0.9734982775288586,0.5740740740740741,1.0,1.0,1/5,14.57%,GPSM2
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.5761978273880112,0.973223483537165,0.5161290322580645,1.0,1.0,6/9,24.88%,HLA-A;NLRC4;PGLYRP1;PGLYRP2;HLA-DRB1;HLA-B
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.45036437665042045,-0.9729386087953975,0.5405405405405406,1.0,1.0,2/16,5.65%,BUD23;USP36
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.43312574510275903,0.9728673821068372,0.4935064935064935,1.0,1.0,9/97,7.04%,GATA4;LRP4;SMAD6;WNT5A;GNG12;ABCG2;MESP1;SCARA3;UACA
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.5463527991949261,-0.9727614478221267,0.53125,1.0,1.0,3/7,23.41%,ITGA3;FYN;INSR
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.6003630909414628,0.9726736305730457,0.55,1.0,1.0,3/11,17.00%,ERBB4;FOXB1;SLC22A4
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4984494061669103,0.9725732126524814,0.5970149253731343,1.0,1.0,8/23,30.09%,SEMA3A;SEMA3B;SEMA3F;SEMA6A;SEMA4C;SEMA7A;SEMA4G;SEMA3E
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.3974318094377459,0.972561421129438,0.5116279069767442,1.0,1.0,30/135,18.51%,AQP3;PRG4;PLEKHG6;PLEKHS1;LIPH;ITGB6;VSIG2;FMO5;BOK;MISP;BAIAP2L1;EPN3;ITGA2;CDKN2A;ITGA5;ANPEP;LAMC2;ECT2;TMC4;TRIM29;EPCAM;AP1M2;ANLN;ALOX15;BMI1;SPINT1;TM4SF20;LY6D;AGER;SERPINB5
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5790149108405293,0.972307686769755,0.5753424657534246,1.0,1.0,4/12,24.60%,PHF23;PINK1;FEZ1;FEZ2
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.42889566215115177,0.9722954307381847,0.46153846153846156,1.0,1.0,11/72,15.33%,TBX1;LRP2;GSDME;MYO3B;COL4A3;COL1A1;MARVELD2;GRXCR2;PIEZO2;CDC14A;GRXCR1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.4670976968166909,-0.9722540619936161,0.3611111111111111,1.0,1.0,5/17,18.25%,CRY1;ADCY2;ADCY3;PRKAR2A;ADCY6
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.5385713730026733,-0.9722451423992386,0.6,1.0,1.0,1/6,1.84%,GLA
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.40311742279662394,0.9721543699783837,0.44155844155844154,1.0,1.0,16/116,15.23%,AMBP;TSHR;FCGR3A;GPR27;SCTR;RNF26;GPHB5;RAMP3;ADRB1;HCK;RXFP2;SYK;NLRC3;GGT5;ADCY7;ALOX15
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.606429431768716,0.9718280575859494,0.5737704918032787,1.0,1.0,1/7,5.58%,HAT1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.5289339612505072,-0.971822100818504,0.38235294117647056,1.0,1.0,2/8,9.41%,NEU4;NEU3
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5519529157138706,0.97181538311414,0.5522388059701493,1.0,1.0,1/11,6.14%,SCIN
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.6381936387363849,0.9716558557102591,0.5223880597014925,1.0,1.0,2/5,19.31%,ATP6AP1;CSF1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.44109423343185084,-0.9714225609799995,0.5416666666666666,1.0,1.0,8/37,17.47%,SKAP1;CDH13;PTPRJ;EMP2;CDK6;LIMS1;COL16A1;ABL1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.6030026096815307,0.9713451130846836,0.5178571428571429,1.0,1.0,3/7,20.22%,NUDT16L1;TFIP11;HMGA2
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.49959353250340116,0.9711782290243149,0.5757575757575758,1.0,1.0,9/28,27.22%,ART1;ZC3HAV1;ART3;PARP14;PARP4;PARP15;PARP9;PARP10;PARP8
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.5713483233961627,-0.9711581670340376,0.5121951219512195,1.0,1.0,1/9,5.28%,APOE
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.5859693816777256,-0.9709346724361362,0.5,1.0,1.0,2/6,13.42%,PRPSAP1;G6PD
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.5609584585753447,0.9707475092167652,0.5333333333333333,1.0,1.0,1/12,2.84%,CCL5
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5432540544678022,-0.970592250337217,0.6153846153846154,1.0,1.0,1/10,9.26%,PTPRS
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6077501612505409,0.9705385137157106,0.5645161290322581,1.0,1.0,1/11,6.54%,CD81
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.41067711306105975,0.9705045992139435,0.5340909090909091,1.0,1.0,14/139,17.70%,PSMB9;DISC1;TLR2;FRAT1;TGFB1;DAAM2;RSPO1;COL1A1;DDX3X;DKK2;SFRP4;ATP6AP2;PSMC5;WNT5B
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.49821753237471206,0.9701101697958546,0.47297297297297297,1.0,1.0,5/21,20.00%,CDKN2A;CDKN1B;DYNLL1;CDKN1A;CDKN2C
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.6137026414209794,0.9699994931510293,0.5245901639344263,1.0,1.0,1/6,1.41%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.6137026414209794,0.9699994931510293,0.5245901639344263,1.0,1.0,1/6,1.41%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.6137026414209794,0.9699994931510293,0.5245901639344263,1.0,1.0,1/6,1.41%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.6137026414209794,0.9699994931510293,0.5245901639344263,1.0,1.0,1/6,1.41%,ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.4606668609984916,0.9696142348512745,0.5394736842105263,1.0,1.0,3/44,7.14%,SMAD6;LRP2;DAND5
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.5488218816988264,0.9695061864077276,0.6060606060606061,1.0,1.0,2/11,13.61%,RPP38;RPP40
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.4576572445830957,0.9694622517017987,0.5512820512820513,1.0,1.0,4/44,13.85%,NEK2;BORA;IGF1;FBXO5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5653052994359313,-0.9691552681151797,0.5428571428571428,1.0,1.0,3/10,6.16%,WNT3A;FZD7;MYOCD
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.6246773320809365,0.9687089477323462,0.6307692307692307,1.0,1.0,1/7,6.20%,CCDC39
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4521535839286076,-0.9686116373345317,0.48148148148148145,1.0,1.0,8/26,17.23%,CACNB1;ITGA4;NTRK1;GRIN1;CACNA1A;ABCC1;FYN;CDK5
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.5828937923799475,0.9685541979633703,0.5588235294117647,1.0,1.0,3/8,23.45%,TGM2;FIS1;BCAP31
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.46876719203477446,-0.9682943731244742,0.4,1.0,1.0,4/18,19.94%,CDH13;DBNL;ELMO1;FARP2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.4086102782069794,-0.9679980809004952,0.4090909090909091,1.0,1.0,5/37,9.37%,KCNJ16;KCNMB2;KCNE1;FLNA;KCNJ6
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.6059527497279074,0.9679141665658733,0.5396825396825397,1.0,1.0,4/6,36.19%,TRNT1;PTCD1;SSB;HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.401043657367953,-0.9679105047859069,0.44,1.0,1.0,8/57,14.48%,MFSD2A;BCL2;ERBB2;SLC25A33;DNPH1;KLHL22;SDCBP;RPS6KA3
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3899808326944041,-0.9677823535486376,0.42857142857142855,1.0,1.0,9/84,12.92%,KIF2B;SEC24C;HLA-DQB1;HLA-DRA;KIF15;RAB7A;KIF4B;KIF26A;CAPZB
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3753006728651756,-0.967766076776176,0.4,1.0,1.0,17/83,17.47%,PRKCD;F11R;RND3;FSCN1;RHOBTB2;TAOK2;TRPM2;CORO2B;CORO1A;CRK;CCDC88A;MLST8;ARHGAP35;RHOA;RHOBTB1;PAK3;ABL1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.5678931595540166,0.9676896635149762,0.5166666666666667,1.0,1.0,1/8,8.74%,VAMP1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4013490978213293,0.9673681963013752,0.5301204819277109,1.0,1.0,21/99,18.94%,ENPP2;CCL5;PTPRC;CRLF1;CLCF1;TGFB1;IL12A;CD81;ERBB4;IGF1;ITGA5;CD80;HGF;CD44;PARP14;IL4;AGT;VTN;IL5;CSF1R;DLG4
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),-0.5886467129479801,-0.967327308109242,0.55,1.0,1.0,1/5,5.72%,FZD7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.5328538968639456,-0.9672244256972832,0.5121951219512195,1.0,1.0,3/8,10.53%,TWIST1;STAMBP;DAB2IP
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.6092176756768107,-0.9670991061756741,0.6363636363636364,1.0,1.0,3/5,32.69%,SFSWAP;PRPF39;SNRPC
prerank,GO_Biological_Process_2021__glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),0.6644676507855887,0.9670654147524737,0.6142857142857143,1.0,1.0,1/5,3.99%,GFRAL
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.4793626529900962,0.9669467191829391,0.5074626865671642,1.0,1.0,12/32,24.44%,C3;RSPO1;PPT1;LRPAP1;LDLRAP1;IL4;VTN;B2M;HNRNPK;RAB21;TF;PROM2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.5115667119545735,0.9668508870035495,0.527027027027027,1.0,1.0,7/23,26.46%,ERAP2;LVRN;ANPEP;GGT5;CHAC2;ERAP1;LNPEP
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5345321624983485,0.9666633453961182,0.5692307692307692,1.0,1.0,2/13,12.65%,DAZL;BOLL
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4630220816461191,0.9665074448624418,0.5342465753424658,1.0,1.0,9/44,17.72%,WNT5A;HEY2;TGFB1;LEF1;HGF;RANBP3L;SOX9;SNAI1;HTR2B
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.5471059025651991,0.9665068678535781,0.6086956521739131,1.0,1.0,3/19,10.09%,FRAT1;WNT8B;WNT8A
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5449867985601154,0.966266196209062,0.5714285714285714,1.0,1.0,1/13,3.08%,PTPRC
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.4188782492040892,-0.9662486853413902,0.4722222222222222,1.0,1.0,5/33,12.84%,MGARP;HSPB1;AP3B2;SPAST;KIF1C
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5914996211978013,0.9661918714099794,0.5441176470588235,1.0,1.0,3/8,24.66%,UBE2M;RBX1;UBA3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.48318112844300626,0.9658705351117136,0.5645161290322581,1.0,1.0,4/25,11.02%,ELOVL2;ACSL5;PPT1;ACSL3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.43063218196307784,0.965812208176178,0.5362318840579711,1.0,1.0,3/42,4.02%,PLA2G10;LIPI;LIPH
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.46636140196021625,0.9656799449942145,0.5342465753424658,1.0,1.0,4/31,10.78%,HIPK1;BOK;DDIT4;TP53BP2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5237973405695632,0.9653877293352764,0.5901639344262295,1.0,1.0,7/20,19.31%,CCL5;MSN;IL4;MAPK3;CSF1R;THBS1;CSF1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.3963287874090346,0.965333829925291,0.5555555555555556,1.0,1.0,16/104,11.92%,TIMP3;PRRX1;TLR2;ADAM33;LMOD1;PCDH18;ABI3BP;MMP9;ACTA2;DAB2;DCN;ANGPTL2;COL1A1;ADGRL4;LAMC2;COL6A2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5142030604454674,0.9653085198197013,0.5,1.0,1.0,1/16,0.78%,SLC25A31
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),0.6542605477042609,0.9652852257070833,0.6166666666666667,1.0,1.0,3/5,29.63%,NR1H4;PANK2;FGFR4
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.5337061214476784,-0.9652209617425672,0.45161290322580644,1.0,1.0,2/8,6.72%,AGBL1;AGBL3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.49959379039390545,0.9648926216871159,0.5223880597014925,1.0,1.0,6/24,21.37%,PKP2;CAV3;CTNNA3;PLN;DSC2;ATP2A2
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.3919593342966231,-0.9644721208937984,0.4444444444444444,1.0,1.0,8/62,9.06%,P2RY10;PRAG1;MYO9B;F11R;APOE;SCAI;STARD8;BCR
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.5742557432701332,0.9641012671559165,0.5833333333333334,1.0,1.0,2/8,12.31%,C17ORF99;GPR183
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.624308159365476,-0.9639414484388221,0.5675675675675675,1.0,1.0,2/6,16.59%,KCNE1;GDI1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.44394563744974225,0.9638310710723167,0.5540540540540541,1.0,1.0,16/70,27.19%,UBE2L6;LOX;USP6;MMP15;PIGH;RABGGTB;UBE2M;GNMT;PLAT;GGCX;PARP4;PLOD2;UBA3;CPE;BAP1;LOXL2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5371743764243888,-0.963625930510665,0.5172413793103449,1.0,1.0,2/16,1.79%,EYA4;BCL2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5371743764243888,-0.963625930510665,0.5172413793103449,1.0,1.0,2/16,1.79%,EYA4;BCL2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.5980600184556453,0.9634652992151501,0.6111111111111112,1.0,1.0,3/7,17.72%,NR1H4;ACSL3;HTR2B
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.6083090379143936,0.9634356904452523,0.5333333333333333,1.0,1.0,2/5,19.31%,P2RY12;CSF1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.602286400310174,0.9634160712037454,0.5737704918032787,1.0,1.0,2/8,18.08%,DNAJB1;HSPA2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.3879220416377262,-0.9633179323333433,0.4230769230769231,1.0,1.0,10/30,23.21%,TRIM71;AGO2;TNRC6C;ZC3H7B;TNRC6A;XPO5;SNIP1;NOTCH4;TARBP2;ADAR
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.4884052911632594,-0.9632715263047547,0.43333333333333335,1.0,1.0,6/12,34.66%,TET3;KMT2A;ZNF335;TET2;SETD1A;SETD1B
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.4704882086272063,-0.9630244184105251,0.6071428571428571,1.0,1.0,3/16,9.25%,MIDN;CCN3;CRH
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.45037369513728787,-0.9629969665069178,0.53125,1.0,1.0,6/25,12.13%,ZNF703;FSTL1;TWSG1;TGFBR3;FSTL3;ITGA3
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.42026828555503537,-0.9629412860647055,0.43333333333333335,1.0,1.0,6/30,13.88%,PLK3;GFI1B;PKD2;CDK4;RBL1;CDK6
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.46559358131552264,0.9629137029217487,0.5294117647058824,1.0,1.0,8/34,21.63%,SLC12A7;LRP2;SLC47A1;GLUL;SLC22A4;SLC46A1;SLC1A6;LRRC8A
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.5714702121056293,-0.9628659572874817,0.48484848484848486,1.0,1.0,4/7,33.60%,BRPF3;KAT7;MEAF6;ING5
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.579607923828058,-0.9627571172031887,0.5,1.0,1.0,1/7,4.35%,KDELR1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.4580427324594651,0.9626684372353859,0.5454545454545454,1.0,1.0,6/43,17.62%,UBE2L6;CALB1;RPS27A;SIAH1;TGFBI;NPPA
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5653897125258254,0.9625929996058235,0.5151515151515151,1.0,1.0,2/11,17.91%,HGF;BCAR1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.4756777180206475,-0.9625409259110099,0.45161290322580644,1.0,1.0,6/18,23.19%,PPP1R35;ENSA;CHP1;ZCCHC9;PTPA;PPP1R16B
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6362933945432685,0.9624604814343121,0.6274509803921569,1.0,1.0,1/5,15.19%,PLN
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.592057935586083,0.9624175487202844,0.5576923076923077,1.0,1.0,1/6,17.19%,IL4
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5500829249192077,0.9623068371395419,0.5538461538461539,1.0,1.0,3/17,15.06%,ERBB4;TGFB3;FOXB1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.6426904442943923,0.9622287335778239,0.5230769230769231,1.0,1.0,1/5,10.14%,AIF1L
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.4708073600923921,-0.9615202501505473,0.4166666666666667,1.0,1.0,3/14,15.13%,CD14;TICAM2;ITPK1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.42007136752105617,-0.9614620940987766,0.43478260869565216,1.0,1.0,5/16,23.09%,GSAP;LRRTM3;ABCG1;SLC2A13;CASP3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.5182050434715535,-0.9613671895319378,0.5,1.0,1.0,6/11,23.24%,PPCDC;PANK1;PPCS;DCAKD;ACOT7;SLC25A16
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.5182050434715535,-0.9613671895319378,0.5,1.0,1.0,6/11,23.24%,PPCDC;PANK1;PPCS;DCAKD;ACOT7;SLC25A16
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.5182050434715535,-0.9613671895319378,0.5,1.0,1.0,6/11,23.24%,PPCDC;PANK1;PPCS;DCAKD;ACOT7;SLC25A16
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.48853086958453085,0.9610820511002575,0.582089552238806,1.0,1.0,4/26,14.77%,KIF14;CXCR5;ECT2;CDC14A
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.5665922946247877,0.9610450340796214,0.5737704918032787,1.0,1.0,1/9,1.58%,PPP1R3B
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.42737376017733125,-0.9609878352680934,0.4375,1.0,1.0,24/73,19.40%,CDH4;CDH20;CDH5;CDH19;CSK;DSG2;CDH13;PVR;FSCN1;SDK2;NLGN2;CDH12;NECTIN3;CDH22;LIMS1;TRPV4;PARD6B;DSP;CDH9;CDH17;CDH11;OCLN;JUP;TGFB2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.49919144136708904,-0.9609781030099701,0.5161290322580645,1.0,1.0,3/10,6.40%,SH3RF1;HLA-DRA;CBFB
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.3710658357712197,-0.9609397566405599,0.5,1.0,1.0,7/43,9.31%,NR4A1;PRKCD;KIT;PARVA;CCN3;CX3CR1;CORO1B
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.514345825439275,0.9607888995668467,0.5666666666666667,1.0,1.0,2/16,2.61%,ELOVL2;ACSL5
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.543790921260144,0.9607262152877001,0.5254237288135594,1.0,1.0,2/11,9.77%,IFIT1;ZDHHC11
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5067211353694011,-0.9607181193500082,0.5263157894736842,1.0,1.0,2/10,10.41%,EMC4;EMC8
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.5337209275785432,0.9605278766782422,0.5671641791044776,1.0,1.0,7/13,30.13%,MMP9;CSF1R;CD4;CSF1;HLA-DRB1;CASP8;IL15
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4665918511221343,0.9599768737477438,0.5645161290322581,1.0,1.0,5/28,12.52%,CA14;SLC26A6;CA1;SLC4A1;CA13
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.6439640159526732,0.9598518797425512,0.6065573770491803,1.0,1.0,3/5,29.63%,RPS23;COL5A1;SLC11A1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.6144160775851583,0.9597095692862838,0.5573770491803278,1.0,1.0,4/7,31.14%,DDX3X;PARP10;GPS2;SASH1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 cell differentiation (GO:2000321),-0.636148955031653,-0.9597006111132254,0.575,1.0,1.0,2/6,16.19%,MALT1;IL23A
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.6236058697093559,0.9591355764952639,0.576271186440678,1.0,1.0,2/6,9.51%,PRR5L;PINK1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.5640737213314941,0.9589235582800913,0.5737704918032787,1.0,1.0,6/10,33.07%,SLC25A18;SLC25A22;SLC1A6;PRAF2;SLC1A3;SLC25A13
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.39828563330630523,0.9589224298892308,0.5135135135135135,1.0,1.0,13/103,11.90%,LRP4;TIMP3;PRRX1;TMEM100;TSPAN11;LMOD1;FBXL7;PCDH18;SCARA3;DCN;ANGPTL2;GFRA1;SLC47A1
prerank,GO_Biological_Process_2021__positive regulation of plasminogen activation (GO:0010756),-0.5804796694640837,-0.9589046167828728,0.5869565217391305,1.0,1.0,2/5,23.27%,PLGRKT;HPN
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.38709580628554263,0.9587979516331043,0.6086956521739131,1.0,1.0,40/205,19.48%,GATA4;TBX1;GPR55;LPAR1;ALKAL2;CCL5;PTPRC;GFRAL;FGF2;FLT1;TGFB1;SCIMP;GPER1;FLT4;GSDME;ERBB4;P2RY6;NODAL;ATP6AP1;RAMP3;IGF1;MYDGF;PIK3CG;IL26;GPR183;TNFAIP8L3;ALOX15;OPRM1;CD44;PRXL2C;MAPK3;HTR2B;CSF1R;AGER;CD4;ALOX12B;ZNF622;TRIM5;F2RL1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.47430056743001736,-0.9586201918065115,0.5161290322580645,1.0,1.0,2/14,9.41%,DGKD;NEU3
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.5549098856061305,-0.95835049978449,0.59375,1.0,1.0,2/6,7.51%,PARVA;CCN3
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),0.6210866660698597,0.9581670331798148,0.5714285714285714,1.0,1.0,2/5,17.72%,PTGER3;HTR2B
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5314385606432166,-0.9580938672157564,0.5142857142857142,1.0,1.0,4/11,25.58%,PPIB;PRKN;TBC1D20;EIF2AK4
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.3877632716753595,-0.9580099269853192,0.5,1.0,1.0,6/50,6.86%,SLC16A9;SLC25A29;SLC38A5;SLC6A20;SLC6A17;SLC3A2
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.4570906768541824,-0.9580044758214339,0.48148148148148145,1.0,1.0,1/21,0.50%,TSKU
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.5246685080151076,0.9579732266710043,0.5428571428571428,1.0,1.0,3/12,17.96%,SEMA3A;LAMC2;RHOG
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6260647977735604,0.9578301917044207,0.6031746031746031,1.0,1.0,3/8,27.65%,ITGA5;VTN;HIF1A
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.4225648076243697,0.9576411351998168,0.5357142857142857,1.0,1.0,9/85,12.59%,FRAT1;TCF7;WNT8B;WNT5A;FZD8;LEF1;WNT8A;DDX3X;RPS27A
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5175850009617546,-0.9574290435945272,0.4594594594594595,1.0,1.0,3/13,15.47%,PACSIN2;PID1;CSPG5
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4321746066410543,0.9572648759088993,0.5441176470588235,1.0,1.0,3/41,4.02%,PLA2G10;LIPI;LIPH
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5538537544110349,0.9569979983970065,0.5909090909090909,1.0,1.0,3/13,21.00%,RENBP;CHST4;PGM3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3623297020136877,-0.9568609100348545,0.4,1.0,1.0,5/85,1.98%,SPRED3;SPRED2;ZNF703;SPRED1;BAMBI
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.4013647022922468,0.9566325873677531,0.5813953488372093,1.0,1.0,39/188,19.31%,CAVIN1;ITGAX;CCL5;PIK3R3;VSIR;SYNE2;ACTG1;FLT1;TGFB1;SEMA3A;GPER1;SMIM22;TCAF2;MMP9;LEF1;HSPA5;F7;DAB2;SOD2;IGF1;DUOX1;COL1A1;LAMC2;HGF;SEMA3B;PLAU;VIL1;SEMA3F;ANGPTL3;IL4;SNAI1;WNT5B;CARMIL1;BCAR1;CSF1R;WASHC1;THBS1;F2RL1;CSF1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.5763409020839599,0.95644866301399,0.6197183098591549,1.0,1.0,5/9,18.00%,ALOX12;ALOX15B;ALOX15;SCD;DEGS1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.5979126577098948,0.956430534468942,0.6290322580645161,1.0,1.0,1/6,1.92%,DBH
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.524143219938174,0.956331263566011,0.59375,1.0,1.0,5/13,27.77%,SLC26A6;SLC13A4;SLC26A4;SLC25A11;SLC26A11
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.5747836499587676,-0.956283713731262,0.5319148936170213,1.0,1.0,1/6,2.18%,SLC25A29
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.49087698452612827,-0.9561994999453568,0.5172413793103449,1.0,1.0,3/17,9.29%,AUP1;HM13;RHBDD1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.4618166705193022,-0.9560866969314187,0.48717948717948717,1.0,1.0,5/15,14.46%,UPB1;UPP1;NT5C1A;UPP2;NT5C
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5693892948578902,0.9560767990502776,0.6,1.0,1.0,1/11,6.91%,FLT4
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.551375742583819,0.9560757684664065,0.559322033898305,1.0,1.0,3/11,25.52%,ATP1A4;KCNJ2;ATP1A1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.42420034198830975,0.9560603021782716,0.5125,1.0,1.0,7/65,14.67%,TLR2;TNFRSF1B;WNT5A;AXL;CD80;TNFSF4;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.4279854540724129,-0.9558804988147002,0.48148148148148145,1.0,1.0,5/33,8.05%,PER2;PTPRZ1;ASCL1;CX3CR1;HES1
prerank,GO_Biological_Process_2021__chylomicron remodeling (GO:0034371),-0.650779651288938,-0.9557660517470653,0.6052631578947368,1.0,1.0,2/5,5.28%,APOB;APOE
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4204810455757851,0.9556886327141657,0.5,1.0,1.0,10/63,15.23%,LMOD1;KANK3;C15ORF62;BAIAP2L1;VASP;ARHGAP28;HCK;VIL1;RASA1;ALOX15
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.5822462055977059,-0.9553819553489191,0.6585365853658537,1.0,1.0,2/8,5.75%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.5822462055977059,-0.9553819553489191,0.6585365853658537,1.0,1.0,2/8,5.75%,PDPR;GSTZ1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.622913279110321,0.9552898033974533,0.543859649122807,1.0,1.0,2/5,20.56%,BOK;APAF1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5022271616783966,0.9552034141971517,0.5645161290322581,1.0,1.0,1/23,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.43596172081372797,-0.954792482590121,0.5142857142857142,1.0,1.0,2/21,3.85%,PPP1R35;PPP6R1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4549891538571776,-0.9547411895765419,0.5714285714285714,1.0,1.0,2/23,2.05%,DRD4;CBARP
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6241114396026485,0.9545418070285782,0.5555555555555556,1.0,1.0,1/5,6.51%,CAV3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.4099248353089887,-0.9542687510800237,0.6153846153846154,1.0,1.0,5/39,16.47%,GCK;ERN1;LPL;SLC30A8;EIF2B3
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.4053203163626537,0.9542571779086372,0.5714285714285714,1.0,1.0,19/102,12.32%,OIT3;AMBP;SLC28A1;CLDN2;BHMT;DAO;LRP2;CYP3A4;SLC5A2;SLC22A8;SCIN;ABCC2;SLC22A7;PON1;F7;ALDOB;NR1H4;SLC47A1;SMLR1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.4187421229819348,-0.954215567492463,0.56,1.0,1.0,5/32,13.35%,EMC4;STX5;EMC8;EMD;BAG6
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3692127745986391,-0.9540883820633232,0.5806451612903226,1.0,1.0,9/46,5.86%,APOB;GPC6;ABCA4;GPC2;CYP4V2;SDC3;APOE;AGRN;GPC4
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.5022617888818769,-0.9534692189911192,0.5,1.0,1.0,1/8,6.60%,ADAM8
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),0.6434939645291263,0.95322714786322,0.6140350877192983,1.0,1.0,3/5,22.60%,MMP9;PLAUR;PARK7
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.445226165167735,0.9531024165989846,0.631578947368421,1.0,1.0,6/49,11.81%,FRAT1;WNT8B;HSPA8;LIX1;WNT8A;CHMP3
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.4960441885614,-0.9529701443200089,0.47058823529411764,1.0,1.0,2/9,11.38%,GRIN3A;GRIN1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.3800942239648789,-0.9529590675274393,0.47368421052631576,1.0,1.0,16/107,13.19%,SPHKAP;CELF5;SLC17A6;ELAVL3;TTBK1;TNR;SRRM4;HPCA;NEUROD6;ADGRA1;MMD2;GRIN1;GRIA4;CELF4;LRRTM3;FRRS1L
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),-0.633489861120264,-0.9526048930192613,0.6,1.0,1.0,2/5,12.42%,GRID2;PROX1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.5800850675977028,0.9525697299953971,0.58,1.0,1.0,1/8,9.75%,SUV39H1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.4816914703721957,0.9525656161563922,0.5142857142857142,1.0,1.0,13/32,19.23%,C1QTNF1;GP1BA;F7;CPB2;F8;PLAUR;PLAU;KNG1;PLAT;PLG;VTN;A2M;TFPI
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.5365892708110271,-0.952564660472876,0.525,1.0,1.0,1/5,24.90%,SORL1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.5929419334354247,-0.9525214855760569,0.5789473684210527,1.0,1.0,4/8,10.90%,PNP;PRTFDC1;NT5C1A;AMPD3
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.43649054403533394,0.952503776597563,0.5584415584415584,1.0,1.0,2/57,4.64%,NEK2;FGF2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.610774350819275,0.9519671036393484,0.5901639344262295,1.0,1.0,5/10,25.89%,ZC3HAV1;PARP14;PARP15;PARP9;PARP10
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.483947624612576,0.951749726637905,0.5757575757575758,1.0,1.0,10/28,27.65%,WNT5A;C1QTNF4;AXL;IL7;PARP14;CSF1;CD300LF;PARP9;CD74;HIF1A
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.5351584793117573,-0.9515869357980571,0.5,1.0,1.0,2/7,17.17%,RAB5A;RAB22A
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.536336782421242,0.9515173103596896,0.5230769230769231,1.0,1.0,6/14,20.15%,GPER1;SOD2;TGFB3;CDKN1B;CDKN1A;PRKG1
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.5672581890065356,-0.9515087740097616,0.5,1.0,1.0,2/5,18.82%,HES1;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5020715522784309,-0.950967194667342,0.525,1.0,1.0,3/11,11.45%,PDE3A;PTPRJ;SLIT2
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.38482575849165485,-0.9508829854455856,0.5238095238095238,1.0,1.0,28/85,18.23%,MYO10;ADAMTS12;RAI14;CALD1;COL4A2;MMP2;RND3;LOXL1;FZD7;PARVA;MID1;FSTL1;CXCL14;GPR161;EDNRA;SLIT2;ANTXR1;AMOTL2;SERPINH1;GFPT2;SNAI2;BNC1;ADGRL2;COL4A1;CTTNBP2NL;PTPN21;CDH11;CHST3
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.4933882328970709,0.9507254022960024,0.5555555555555556,1.0,1.0,4/26,8.22%,MYH8;MYH4;MYBPC3;MYL6
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.4933882328970709,0.9507254022960024,0.5555555555555556,1.0,1.0,4/26,8.22%,MYH8;MYH4;MYBPC3;MYL6
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.46593684796746254,0.9504211399118185,0.5571428571428572,1.0,1.0,4/41,5.45%,ANXA1;FGF2;STAT5A;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.6098777906428885,0.9502817657254259,0.5538461538461539,1.0,1.0,3/6,31.75%,AQP11;UBXN1;SVIP
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.3892669581738906,-0.9501557779913186,0.6666666666666666,1.0,1.0,2/31,1.87%,WNT3A;SELE
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.48866405092548915,0.9496846799538056,0.5571428571428572,1.0,1.0,1/17,2.40%,TCN1
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.48866405092548915,0.9496846799538056,0.5571428571428572,1.0,1.0,1/17,2.40%,TCN1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.40758358441124937,0.9496204590506241,0.5128205128205128,1.0,1.0,11/68,18.08%,HSPA8;DNAJB1;PON1;HSPA5;NR1H4;DDX3X;APOM;NOP53;TFIP11;CARMIL1;HSPA2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.5219981173098168,0.9495829739814262,0.5833333333333334,1.0,1.0,1/17,1.37%,CAVIN1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.45816660981107954,-0.9495198549508151,0.40625,1.0,1.0,7/32,7.86%,APOH;TBC1D10A;HGFAC;IFI16;PRSS3;F11;PERP
prerank,GO_Biological_Process_2021__negative regulation of adaptive immune response (GO:0002820),0.6197493404462426,0.9493932833004863,0.5454545454545454,1.0,1.0,2/5,15.23%,CD160;ALOX15
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.6198785101822208,0.9493538016403353,0.6212121212121212,1.0,1.0,1/5,9.07%,LEF1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.4576945889202353,-0.9492614380752316,0.5806451612903226,1.0,1.0,1/15,3.06%,DCPS
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5165153666354135,0.9492248252737038,0.5409836065573771,1.0,1.0,4/17,17.62%,NPR2;ADCY7;GUCY2F;NPPA
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5170756021591622,0.9489239170128551,0.5454545454545454,1.0,1.0,1/17,1.05%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5466935017498784,0.9487874008680655,0.5733333333333334,1.0,1.0,4/10,21.70%,KLF15;TAF7;SET;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5354165143933539,0.9483726547870545,0.5873015873015873,1.0,1.0,4/17,20.27%,SPDYA;CCND1;CCND2;PSRC1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.4247555958871848,0.9482851817337165,0.5753424657534246,1.0,1.0,21/58,18.84%,ITGB2;CYTIP;ARHGAP9;TNFRSF1B;GMFG;PTPRC;SASH3;IKZF1;CXCR5;CD244;GPR183;TNFSF4;PSTPIP1;TAGAP;CD37;ZAP70;MYO1F;SIRPG;CD4;ALOX5AP;PARVG
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.41644406899680486,0.9481743171616744,0.5733333333333334,1.0,1.0,8/96,13.43%,PSMB9;AIM2;TNFRSF1B;CARD14;ST18;TXNDC17;STAT1;TNFSF4
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5147872536739099,0.9480609817234598,0.5833333333333334,1.0,1.0,4/15,17.40%,HEY2;TGFB1;HEY1;SNAI1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3686736456682964,-0.9479457588805567,0.6190476190476191,1.0,1.0,14/91,11.94%,SPRED3;SPRED2;VWC2;SPRED1;BAMBI;BCL9L;CCN3;ACVR1;EMILIN1;DLX1;FSTL3;ZBTB7A;VWC2L;LDLRAD4
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.6173972383712718,0.9476869019424039,0.5409836065573771,1.0,1.0,1/6,19.66%,CBLN1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5195284998475659,0.947656597180299,0.5833333333333334,1.0,1.0,1/13,1.98%,RORC
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.5633506070349219,-0.9475680389216966,0.5581395348837209,1.0,1.0,3/7,27.17%,IMPACT;YY1;MAP3K4
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5544677202248033,0.9473287143500206,0.5303030303030303,1.0,1.0,5/10,29.19%,CD4;CSF1;HLA-DRB1;CD74;DCSTAMP
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.58176538734128,0.9471621799189622,0.5454545454545454,1.0,1.0,2/8,9.82%,IL12A;DCN
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.5683693936662358,0.9468747449249862,0.5735294117647058,1.0,1.0,1/9,3.08%,PTPRC
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.49521287358252053,-0.9466930526203989,0.5,1.0,1.0,4/17,10.76%,RAB7B;TICAM2;DAB2IP;NR1D1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.45252119268198765,0.9465481827459034,0.5945945945945946,1.0,1.0,3/50,3.18%,PCLAF;TYR;DTL
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4316260673884057,0.9465159642796417,0.5735294117647058,1.0,1.0,6/44,7.62%,TNFRSF1B;HIPK1;CIDEB;BOK;MOAP1;DDIT4
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.45890433078783865,-0.9462801932977171,0.5666666666666667,1.0,1.0,7/16,21.58%,WRAP53;CEP135;CORO2B;CHP1;CEP295;PTP4A3;CEP120
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6085987982081208,-0.9461653149955933,0.625,1.0,1.0,1/6,14.38%,MAPK7
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6085987982081208,-0.9461653149955933,0.625,1.0,1.0,1/6,14.38%,MAPK7
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4962358371024467,0.9461640221325437,0.5555555555555556,1.0,1.0,1/22,1.51%,CASQ2
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.40039506272674874,-0.9461273237733471,0.45454545454545453,1.0,1.0,5/22,15.37%,METTL8;PCIF1;TRMT61B;TRMT61A;PUS7
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.5249126852785306,0.9461140413837189,0.5774647887323944,1.0,1.0,3/14,5.45%,PKP2;MYBPC3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.5182124459287955,-0.9457656170203815,0.59375,1.0,1.0,6/11,27.17%,GRM2;GABBR2;DRD2;PALM;DRD3;GNAI2
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.5182124459287955,-0.9457656170203815,0.59375,1.0,1.0,6/11,27.17%,GRM2;GABBR2;DRD2;PALM;DRD3;GNAI2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.38714728984970265,0.9457462736032384,0.6197183098591549,1.0,1.0,15/119,11.19%,GATA4;SLC22A3;TIMP3;C1QTNF1;LMOD1;MLANA;HSD11B2;CYP26B1;DCN;ANGPTL2;IGF1;COL1A1;ADGRL4;CFD;COL21A1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.4632738722084146,0.9456881809282509,0.5362318840579711,1.0,1.0,1/35,1.31%,TIMP3
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.6130883102833872,0.9456641856907294,0.6153846153846154,1.0,1.0,1/10,0.60%,TULP1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.6130883102833872,0.9456641856907294,0.6153846153846154,1.0,1.0,1/10,0.60%,TULP1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.5714346321516001,0.9456531254240127,0.5671641791044776,1.0,1.0,1/11,3.25%,METTL18
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.5718198057014071,-0.9455919636309046,0.5641025641025641,1.0,1.0,1/7,0.91%,KLRC1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.4350326518445123,-0.9455540960645161,0.6111111111111112,1.0,1.0,3/25,3.40%,P2RY10;PRAG1;F11R
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.5343580650467707,0.9454300809053293,0.5151515151515151,1.0,1.0,4/13,22.79%,SLC25A18;ETFB;SLC25A22;UQCRFS1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.49164657527860745,0.9451832918934324,0.5303030303030303,1.0,1.0,4/19,20.22%,NODAL;REST;TAF6L;HMGA2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6313781387675322,-0.9451754313827394,0.6388888888888888,1.0,1.0,3/5,27.45%,PRKCA;DCAF1;PKN1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3502088521674664,-0.9449410059401202,0.45454545454545453,1.0,1.0,14/76,12.43%,NGF;SPRY4;MYO9B;EPHB2;STARD8;STAMBP;BCR;RAPGEF1;DAB2IP;NTRK1;MMD2;EPOR;RALGPS1;RASGRF1
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.6138611232448059,0.9447108251092726,0.6206896551724138,1.0,1.0,1/6,3.81%,HSD3B7
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.38616016892768246,0.944468985996129,0.6136363636363636,1.0,1.0,41/155,23.79%,PSMB9;APOL6;CCL5;UBE2L6;CASP7;TRIM25;FGL2;IFIT1;HLA-DMA;HLA-A;SOD2;IRF1;STAT1;RAPGEF6;IL7;IRF4;ISG15;BTG1;CDKN1A;DDX60;TXNIP;LATS2;USP18;PARP14;OAS2;FPR1;MTHFD2;ARL4A;IDO1;P2RY14;HLA-DRB1;NFKBIA;B2M;TAP1;PSMA3;IFIH1;MT2A;LAP3;LY6E;XAF1;EPSTI1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.5160089508136636,0.9439913333139848,0.5822784810126582,1.0,1.0,3/16,11.84%,VSIR;TGFB1;TGFB3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.47892983072527395,-0.9439876382976294,0.5428571428571428,1.0,1.0,1/11,1.52%,DNMT1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.5015232093277315,-0.9438379222303728,0.4642857142857143,1.0,1.0,3/13,9.34%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5603046478221873,0.943694766453781,0.5925925925925926,1.0,1.0,3/8,32.40%,BLOC1S2;ATF2;BNIP3
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.37643115539507155,0.9434811719230469,0.6292134831460674,1.0,1.0,30/247,14.93%,TBX1;ESR1;TLR2;RORC;TNFRSF1B;WNT8B;WNT5A;AHR;TSHR;SSTR1;H2AZ1;GPER1;P2RY6;SLC26A6;MMP9;RAMP3;RRAGA;GLRA2;NR1H4;AXL;CD80;CRHBP;STRA8;GLRA1;PDK4;TNFSF4;P2RY12;TGM2;PDCD1LG2;SOX9
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.2872024072920703,-0.9433168531476605,1.0,1.0,1.0,132/787,15.61%,PER2;CD38;ETV5;PLK3;KCNIP3;ZNF25;OSR1;PRDM5;ZNF703;GFI1B;FOXO1;BCL6;GATAD2A;WWC1;TWIST1;HDAC10;TWIST2;IKZF4;CREB3L1;IFI16;NR4A3;PTCH1;SAP130;KLF10;ZNF133;WWP2;ZNF69;SMYD2;LBH;PRICKLE1;THAP7;ZNF596;MAP3K10;CBFB;CTCF;KDM8;NFX1;CRYM;HIC2;ASCL1;CRY1;CIART;SPDEF;PCGF1;MEN1;LRRFIP1;PHC2;ZNF239;KDM2B;HES1;PA2G4;E2F6;ZNF75A;FLNA;ZNF764;ZNF846;MECP2;IGBP1;RARB;MLIP;NACC1;TGIF1;WWC2;ZNF3;MACROH2A2;SFMBT1;MTERF3;ZNF692;BPTF;ZNF79;CBY1;DNMT3A;HDAC3;DLX1;TLE2;POU6F1;DAB2IP;NR2C1;NR1D1;BCL11A;PEX14;NKAP;PRDM1;CUX1;ZNF589;ZBTB7A;ATF3;NIBAN2;HSF1;MLX;RCOR2;PCGF6;LDB1;NAB2;PROX1;HEXIM2;FHL2;MED25;SP2;RING1;ZNF263;CREM;SMARCA4;ZNF557;MIER2;MPHOSPH8;ZNF136;HIVEP1;GTF2IRD1;ZNF268;IMPACT;SBNO2;FRK;FGFR2;SDCBP;SIRT7;KCTD1;KDM1B;PER3;ZBTB4;RTF1;SNAI2;PIAS4;ZNF688;LIMS1;YWHAQ;ZNF785;NR1H2;ZNF254;LANCL2;E4F1;HDAC5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.39672692134992316,-0.9432350841660918,0.5172413793103449,1.0,1.0,8/50,9.55%,ACAD10;MECR;ACADS;SLC25A17;SLC27A2;ACOX3;ECHDC2;ECHS1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.5359010624741974,-0.9430552858422577,0.52,1.0,1.0,4/6,21.19%,PUS7;PUS10;PUSL1;RPUSD4
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.491636309052133,-0.9429827766619813,0.5263157894736842,1.0,1.0,3/9,33.30%,SEC14L2;MBTPS2;SREBF2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.5850351602664058,0.9429175728507642,0.589041095890411,1.0,1.0,1/10,4.08%,SYNE2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.47831948397351676,-0.9428621753915437,0.4838709677419355,1.0,1.0,4/14,23.14%,EMD;ANP32B;YWHAE;TPR
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.5388463638601076,-0.9427422166573087,0.5609756097560976,1.0,1.0,2/7,6.16%,WNT3A;MYOCD
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.4395149854155047,-0.9425407751983762,0.46153846153846156,1.0,1.0,5/38,13.28%,MFSD2A;HLA-DRA;DOP1B;RP9;ST3GAL4
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.4816510763768296,-0.9424821811758426,0.5853658536585366,1.0,1.0,1/10,5.28%,APOE
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.42146483689401393,-0.9419916814742827,0.5757575757575758,1.0,1.0,5/32,10.13%,ATP6V0D2;RAB20;RAB7A;ATP6V1E2;ATP6V0A2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.48374585834019884,0.941847659646263,0.5294117647058824,1.0,1.0,6/26,21.70%,HLA-F;IL12A;HLA-A;TNFSF4;HLA-DRB1;B2M
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.46066273866551594,0.9417904545109564,0.59375,1.0,1.0,1/36,0.49%,LRP4
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.4960069066200597,-0.9417318546648906,0.64,1.0,1.0,2/10,7.64%,PSAT1;CBS
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.4084697746214827,0.9416217366876751,0.4931506849315068,1.0,1.0,5/64,12.95%,ROS1;DEPDC5;DDIT4;RRAGA;WDR24
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.4989092842096048,-0.9413922324544668,0.5,1.0,1.0,3/11,5.97%,DRD4;ABCC4;PLA2G5
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.37484540310598574,-0.9413895303485101,0.5806451612903226,1.0,1.0,2/43,3.91%,BUD23;LIN28B
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),-0.6004913697549754,-0.9413313784465115,0.5208333333333334,1.0,1.0,1/5,4.37%,ADCYAP1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),-0.49483767775915855,-0.9412186299626304,0.5357142857142857,1.0,1.0,4/9,7.66%,APOB;LIPC;PLA2G5;MPO
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.3870257231187352,0.9411071821921769,0.6067415730337079,1.0,1.0,9/171,7.74%,AQP3;TRIM58;TYR;C3;LMO2;H1-0;ABCG2;FTCD;CA1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.5529881441638673,0.9409760824669438,0.5625,1.0,1.0,1/11,1.32%,DISC1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.5100864308557604,0.9407389563150503,0.671875,1.0,1.0,8/19,24.96%,LEF1;SYK;IRF4;TNFSF4;HLA-DRB1;DDIT3;ZFPM1;CEBPB
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.5752479422426587,0.9405719603491637,0.5846153846153846,1.0,1.0,1/8,6.20%,CCDC39
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.5344050653633992,0.9405235244175187,0.5522388059701493,1.0,1.0,1/13,2.05%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.41254025530128763,0.9405051265032575,0.5753424657534246,1.0,1.0,9/65,14.94%,TLR2;CCL5;WNT5A;SH2D1B;NLRP12;IFNK;TNFSF4;CYBA;PLA2G7
prerank,PanglaoDB_Augmented_2021__B Cells,0.3903259933056474,0.940263218446776,0.6842105263157895,1.0,1.0,24/111,16.44%,IL21R;CYTIP;ARHGAP9;BLNK;GMFG;PTPRC;SASH3;EBF1;JCHAIN;WAS;IKZF1;FLI1;POLD4;CD80;NAPSB;CD244;IRF4;TNFSF4;PSTPIP1;TAGAP;HMGA1;CD37;MME;SCD
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.6197888670865291,0.9392438062802674,0.6206896551724138,1.0,1.0,1/5,15.81%,TDG
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.430078437236866,-0.9392316166090912,0.5581395348837209,1.0,1.0,2/20,2.44%,BCL2;BCL2A1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.4480725822441347,0.9392055941110894,0.5806451612903226,1.0,1.0,5/38,11.83%,ADA;TGFB1;NODAL;B4GALNT2;RNASE10
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.3602969210826686,-0.9389224937477681,0.45,1.0,1.0,11/55,10.77%,TSKU;WNT3A;PRAG1;PTPN9;PTPRO;APOE;MINAR1;KIAA0319;PTPRS;RTN4RL2;BCL11A
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.6301154031799149,0.9387835147848715,0.6176470588235294,1.0,1.0,1/5,1.57%,TLR2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.39732809451109435,0.9386585073687171,0.5681818181818182,1.0,1.0,17/139,15.63%,PPP1R1C;SHISA6;STMN4;TMEM35A;LY6H;PLP1;PRDM12;VAMP1;DRGX;TCEAL5;NEFM;CLGN;AHNAK2;PIEZO2;VSTM2A;AQP4;CNTN2
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.5917879872632505,0.9385853599649769,0.5692307692307692,1.0,1.0,2/7,26.27%,DDX3X;SPSB4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.5517733232922734,-0.9385840805891265,0.53125,1.0,1.0,2/6,12.11%,USP44;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.5517733232922734,-0.9385840805891265,0.53125,1.0,1.0,2/6,12.11%,USP44;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.4158249185819474,0.9385015855321069,0.6164383561643836,1.0,1.0,4/94,1.57%,ESR1;NOTUM;DISC1;TLR2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.3865771442663671,0.9384457314206102,0.6103896103896104,1.0,1.0,24/119,19.88%,SLC22A3;TCN1;LRP2;SLC38A3;SLC18A2;SLC7A7;ABCG2;ABCC2;SLC6A4;RAMP3;PPT1;CHMP3;AMN;TXNIP;SLC38A4;SLC38A2;SLC22A4;RAB38;SLC23A1;DENND10;SLC7A4;SLC7A3;SLC6A12;SLC7A10
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.39730859302576127,-0.9383525411615189,0.5,1.0,1.0,12/42,24.54%,MGARP;USP36;PID1;MARCHF5;MYO19;SIRT7;HTRA2;MAPT;MIEF2;CYRIB;PRKN;IAPP
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.3813586347380287,0.9382099375905628,0.5955056179775281,1.0,1.0,27/220,12.54%,TBX1;CCL5;PIK3R3;FGF20;ROS1;FAM20A;FAXDC2;FGF2;C3;FLT1;CARD14;TGFB1;CDK2AP1;GPER1;FLT4;ERBB4;PFKFB2;MMP9;PINK1;DAB2;RSPO1;IGF1;AXL;MYDGF;HGF;CCND1;PLAUR
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.3901397882911893,0.9381977883326247,0.5679012345679012,1.0,1.0,15/81,19.48%,TLR2;WNT5A;PTPRC;VSIR;C1QTNF4;IGF1;NR1H4;SYK;NLRC3;CYBA;IL4;OAS2;AGER;THBS1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.45026332457375545,-0.9380937699590148,0.53125,1.0,1.0,2/20,5.28%,EPHX2;APOE
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.5972354183485045,0.9378879203541847,0.6440677966101694,1.0,1.0,3/5,35.97%,THBS1;NOS1AP;VEGFA
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.43739368420344515,0.9376589877712924,0.5652173913043478,1.0,1.0,13/50,18.56%,PLA2G10;ALOX12;CYP4F12;PTGR1;CYP2J2;PON1;CYP1B1;GGT5;ALOX15B;ALOX15;PON3;ALOX5AP;ALOX12B
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5639268093173291,0.9375960339986649,0.6470588235294118,1.0,1.0,3/12,15.59%,SEMA3A;PLXNA3;SEMA3F
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.5712060542140096,-0.9375809448864703,0.5675675675675675,1.0,1.0,3/8,16.19%,CARD9;MALT1;IL23A
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.5226452497809431,-0.9374545728618254,0.5,1.0,1.0,3/10,16.74%,CPEB1;HSF1;LEO1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.5767636627838704,-0.9374026939903791,0.5952380952380952,1.0,1.0,2/8,7.44%,MTHFD1L;GLUD2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.42295968649301924,0.9370551275417816,0.5616438356164384,1.0,1.0,8/55,13.85%,CDC25A;ANXA1;DTL;RAB11A;DDX3X;CCND1;CCND2;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.5031073499760579,0.9369360432399607,0.5694444444444444,1.0,1.0,3/21,1.93%,C3AR1;GPR55;LPAR1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.34840257522632584,-0.9368019230426259,0.6666666666666666,1.0,1.0,29/172,14.21%,ADGRG3;PDE10A;DGKD;BCL2;SPRED1;PDE3A;WWC1;TWIST1;THEM4;HDAC7;CCDC22;DLG5;MINAR1;OTUD3;CCN3;PTPRJ;PRDM15;STAMBP;WWC2;DAB2IP;NR1D1;SLIT2;ARRB2;DEPTOR;NPRL2;NLRX1;EPM2A;RNF157;PDE3B
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.3199199586402385,-0.9364979082945547,0.6,1.0,1.0,31/190,10.15%,NOX4;NGF;NR4A1;FIBIN;PAMR1;ENTPD2;CLEC14A;ENO3;COL13A1;PRKCD;EGR1;TWIST2;COL12A1;COL6A3;COL4A2;MMP2;PTCH1;COL8A1;CCN4;GSTM5;SLIT3;FSTL1;CXCL14;EFEMP1;CCN2;PKD2;ITIH5;EMILIN1;ADAMTS10;EDNRA;TAGLN
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.5713387258983671,-0.936177081789349,0.5490196078431373,1.0,1.0,5/7,32.15%,HMGCL;IVD;BCAT2;BCAT1;MCCC1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.40254411115756245,-0.9361551104939995,0.53125,1.0,1.0,5/35,7.52%,ARC;DCDC2;WNT7A;EPHB2;SHANK1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.41420284147604053,-0.9359728836882709,0.5277777777777778,1.0,1.0,9/39,14.45%,GLA;ST3GAL3;NEU4;ST6GAL2;NEU3;ST3GAL2;ST6GALNAC3;ST3GAL4;IDUA
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.3495361474267863,-0.9358968366987684,0.5882352941176471,1.0,1.0,20/128,13.39%,NTSR2;SPHKAP;CDH20;PTCH1;GJB6;GRIN3A;S100B;ELAVL3;PTPRZ1;TNR;HOPX;DPP6;KCNIP1;SLITRK2;ADGRA1;MMD2;ADCY2;GRIA4;LRRTM3;BAALC
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.4610481387572059,0.9358162376296567,0.5733333333333334,1.0,1.0,5/30,10.60%,ACTG1;USP6;DNAJA1;PINK1;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.45505170960664665,-0.9358148480876939,0.5,1.0,1.0,2/16,5.94%,TWIST1;THAP7
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.4183529804466202,-0.9357648040731347,0.34615384615384615,1.0,1.0,6/29,9.82%,WWC1;PTCH1;NKD1;KIAA0319;PTPRS;WWC2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.419909795792367,0.9357147587794813,0.6075949367088608,1.0,1.0,16/88,19.13%,CCL5;FGF2;FLT1;GPER1;DCN;IGF1;MYDGF;PIK3CG;HGF;NLRC3;NOP53;SOX9;MAPK3;AGT;FN1;F2RL1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5881332071465972,0.9356490952958338,0.5652173913043478,1.0,1.0,1/8,2.05%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4566388071760722,0.9350865378358253,0.5945945945945946,1.0,1.0,2/42,3.16%,TLR2;HAMP
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.5789577692577481,0.9349618085927738,0.6190476190476191,1.0,1.0,1/6,4.40%,TRIM62
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.5344056418473421,0.9348870728440248,0.6065573770491803,1.0,1.0,7/13,38.00%,RAET1G;TUBB4B;TUBB;ULBP3;CLEC2A;CEBPG;ULBP2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.43084624897026724,0.9347601828782579,0.5542168674698795,1.0,1.0,8/54,11.61%,ANXA1;CERS3;WNT5A;ALOX12;COL1A1;FLG;TMEM79;FLG2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3403886660204196,-0.9343932976923839,0.631578947368421,1.0,1.0,16/80,14.21%,RASSF2;DUSP15;SH3RF1;FZD7;MAP3K10;WNT7A;MID1;CCN2;SH3RF3;DAB2IP;TAOK2;DUSP19;RELL2;CARD9;TRAF3;SDCBP
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.44698774681312814,0.9342468748160276,0.6428571428571429,1.0,1.0,12/47,22.34%,FRAT1;SLFN14;GMFG;HEMGN;FAM110A;BORCS6;MFSD2B;ITGA2B;RHOG;FAM117A;FERMT3;SF3B5
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.5731983574464052,0.9342268155716473,0.6142857142857143,1.0,1.0,5/7,37.07%,SFRP4;GCM2;FGFR4;ENPP1;SLC34A2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.5198584394280648,0.9341582573651599,0.6142857142857143,1.0,1.0,3/14,11.29%,TRIM62;TRIM25;TRIM68
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.5992282989780224,0.9341012247766513,0.6129032258064516,1.0,1.0,1/5,5.45%,TGFB1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.4054730390500834,-0.9339033973855952,0.5714285714285714,1.0,1.0,9/31,15.84%,CLIP3;ZDHHC23;ZDHHC5;HHAT;ZDHHC11B;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.33713820422155133,-0.933737372162699,0.5833333333333334,1.0,1.0,19/78,14.11%,ADRA1A;SRL;DNAJC5G;CMYA5;MYL3;CTAGE3P;GREB1;SPTB;HFM1;MYLK3;NT5C1A;PTGR2;DTNA;RGMA;ADCY2;ESRRB;KBTBD12;XPNPEP3;GARNL3
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.36331821024767563,-0.9336136272517717,0.6153846153846154,1.0,1.0,10/58,14.06%,MFSD2A;BCL2;NRDE2;PLIN5;DAB2IP;NUPR1;RUBCN;MTMR8;TIMP1;KLHL22
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.5543956967880039,0.9328741063869666,0.515625,1.0,1.0,1/6,9.70%,NOP10
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.4080178540935829,0.9328243649122483,0.5131578947368421,1.0,1.0,17/51,18.84%,ITGB2;CYTIP;ARHGAP9;GMFG;PTPRC;SASH3;WAS;IKZF1;CD244;PSTPIP1;TAGAP;CD37;ZAP70;SIRPG;CD4;ALOX5AP;PARVG
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.44147720198228857,0.932741107018557,0.6075949367088608,1.0,1.0,13/41,19.90%,TIMP3;SERPINB7;SERPIND1;SPINK6;SPOCK3;SERPINE3;SERPINB1;KNG1;AGT;VTN;SERPINA10;SERPINB5;SERPINF1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.5186130696110539,-0.9326445533477017,0.5806451612903226,1.0,1.0,2/8,4.94%,IWS1;SMARCB1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.33449650259518054,-0.9324360088474054,0.6190476190476191,1.0,1.0,9/121,4.26%,ARC;FIBIN;PAMR1;CLEC14A;CALD1;CDH5;COL4A2;SYNPO;CLDN16
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.4489455638528421,0.9324196520371912,0.5909090909090909,1.0,1.0,1/31,0.78%,SLC25A31
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.5649424667902374,0.9323920958064156,0.6229508196721312,1.0,1.0,2/9,15.65%,CYP26B1;SFRP4
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.40009700890485017,0.9323404746082434,0.5833333333333334,1.0,1.0,15/81,26.35%,PSMB9;PELI3;ST18;RPS27A;PSMC5;MAPK3;PSMB6;NFKBIA;RBX1;PSMD6;RPS6KA5;PSMA3;PSMA7;MAP3K8;IRAK1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.6038613489007104,0.9321904341288558,0.703125,1.0,1.0,1/6,5.67%,SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.5613939392169961,0.931719851215916,0.5714285714285714,1.0,1.0,4/6,38.31%,CYLD;DUSP10;DUSP1;EZR
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.4160411445793272,0.9316115263169308,0.5657894736842105,1.0,1.0,4/58,9.75%,AQP3;ACAA2;PINK1;SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.40469843725439697,-0.9315919901428865,0.5,1.0,1.0,9/34,20.24%,PLK3;CAPN10;PCM1;B3GAT3;EIPR1;PGAP1;CEP290;ICE1;STX18
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.6078455344739275,0.9315047206594392,0.6507936507936508,1.0,1.0,3/5,36.53%,ZFP36;LGALS9;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.3700589923564004,0.9314621816751892,0.6086956521739131,1.0,1.0,49/306,18.27%,TBX1;ENPP2;PIK3R3;FGF20;PTPRC;SPDYA;FAM20A;FAXDC2;FGF2;C3;CARD14;TGFB1;CDK2AP1;GPER1;CD81;FLT4;ERBB4;NODAL;MMP9;RAMP3;PINK1;DAB2;RSPO1;GDF11;IGF1;ITGA5;MYDGF;DDX3X;BMP3;CD80;HGF;TGFB3;CCND1;PLAUR;CCND2;CDKN1A;SOX9;TTK;CD44;GDF9;DDR2;MAPK3;MTCP1;AGT;VTN;IL5;CSF1R;AGER;CD4
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.5481947452015644,0.9310371273029362,0.5932203389830508,1.0,1.0,3/8,18.56%,SCIN;ACSL3;ALOX12B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.5689610782674586,0.9310141922347973,0.6190476190476191,1.0,1.0,1/8,5.32%,ST18
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.47895030231952984,0.9310091196957538,0.546875,1.0,1.0,2/16,13.38%,SNAP23;TOR1A
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.48952231773684474,-0.9310056007659198,0.5135135135135135,1.0,1.0,5/14,17.92%,KMT5C;SLC15A4;SHLD2;SHLD1;MAD2L2
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.3805539764350417,-0.9308156701229015,0.5862068965517241,1.0,1.0,7/51,12.48%,PLK3;FOS;APOE;PKD2;MPV17;AKR1C3;GPX1
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.43885210334252256,-0.9306496699366402,0.625,1.0,1.0,2/16,2.98%,DRD4;MOXD1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.48044851526229443,0.9306185926063228,0.5774647887323944,1.0,1.0,5/25,19.77%,METTL18;SUV39H1;ETFBKMT;EEF2KMT;METTL21C
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.5457433390474381,0.9304482921003432,0.5588235294117647,1.0,1.0,1/8,5.82%,BOK
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.6109540097326648,0.9302797428183219,0.5961538461538461,1.0,1.0,2/6,20.02%,RMI2;MSH6
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.3750586334614117,-0.9301944174268935,0.6086956521739131,1.0,1.0,7/59,10.33%,EYA4;RNF168;RAD50;BRCC3;MECP2;ERCC8;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4073057418208521,0.9301768395416146,0.5952380952380952,1.0,1.0,10/103,6.51%,CHRNA9;ESR1;C3AR1;GPR55;C1QTNF1;LPAR1;NMUR2;GPER1;PTGER3;CAV3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.36323088513626467,-0.9301555393610458,0.5652173913043478,1.0,1.0,20/72,19.50%,MFSD2A;SLITRK6;DCDC2;S100B;PARD3;SPTBN4;WNT7A;SLITRK2;CDHR1;TAOK2;LLGL1;FGFR2;DSCAML1;PARD6B;CDK5;PAK3;UNK;BRSK1;RAB10;DRD2
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.4917900079648093,0.9300921662958065,0.6111111111111112,1.0,1.0,3/11,18.34%,OSMR;IL4;PTGES
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5401906999025611,0.9297614641079964,0.676923076923077,1.0,1.0,2/16,9.51%,A2ML1;PINK1
prerank,GO_Biological_Process_2021__cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),0.6099741734584143,0.9297168459787631,0.6491228070175439,1.0,1.0,2/5,29.19%,CSF1R;DCSTAMP
prerank,GO_Biological_Process_2021__response to macrophage colony-stimulating factor (GO:0036005),0.6099741734584143,0.9297168459787631,0.6491228070175439,1.0,1.0,2/5,29.19%,CSF1R;DCSTAMP
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.3769160160675066,0.9296899155859585,0.5882352941176471,1.0,1.0,29/187,23.03%,CDC25A;ITGB2;MCM2;BUB1;PIK3R3;GLRX;NFIL3;FGL2;DDIT4;SDF2L1;HSPA5;ACSL3;PDAP1;CDKN1A;TUBA4A;CACYBP;SCD;COPS5;HSPE1;ATP6V1D;MTHFD2;HSPA4;TPI1;IDH1;ATP2A2;DDIT3;MLLT11;PLOD2;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of lipoprotein lipase activity (GO:0051006),-0.5813902031837304,-0.9294385206096204,0.525,1.0,1.0,1/5,0.98%,APOH
prerank,GO_Biological_Process_2021__positive regulation of triglyceride lipase activity (GO:0061365),-0.5813902031837304,-0.9294385206096204,0.525,1.0,1.0,1/5,0.98%,APOH
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.41488270985543557,-0.9292710868448721,0.631578947368421,1.0,1.0,9/28,20.69%,CDH5;PRKCD;SYMPK;PTBP1;PPP1R7;PPIA;CAMTA1;MAGI2;PTPA
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.4743147148944429,0.9292668278971198,0.5405405405405406,1.0,1.0,5/30,14.84%,DONSON;DTL;TICRR;NOP53;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.6036236539632036,-0.9290016969216928,0.6666666666666666,1.0,1.0,2/5,15.25%,SMARCB1;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4583922427472015,0.9289854663616658,0.5714285714285714,1.0,1.0,5/26,15.16%,NODAL;DAB2;KANK2;VPS18;ZNF366
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.5396174580485124,0.9286262554821734,0.6515151515151515,1.0,1.0,1/11,4.64%,FGF2
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),0.5817017611322849,0.9284991042636684,0.6190476190476191,1.0,1.0,1/5,3.59%,LOX
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.3243009894769549,-0.9280852304026991,0.5625,1.0,1.0,53/202,19.49%,CFAP221;IFT88;ABCC4;DCDC2;MKS1;CNGA4;EXOC7;CFAP410;SCLT1;EHD4;PARVA;TTC36;PCM1;CEP83;TMEM138;FLNA;PKD2;GBF1;RILPL1;DZIP1L;CLUAP1;ASAP1;EHD3;RAB11FIP3;CFAP44;ABLIM3;CEP250;AVIL;FBF1;TTC17;CILK1;DNAH5;CFAP61;CFAP70;TTC29;DYNC2I1;B9D1;IFT81;AHI1;MARK4;CCDC57;TCTN1;TEKT3;CEP290;ARMC9;TRAF3IP1;KIF27;CYS1;IFT43;NOTCH1;CEP41;KIF24;IFT52
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),0.584682198928052,0.9279981701619092,0.609375,1.0,1.0,3/6,21.70%,MMP9;ANXA2;B2M
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.5241917949466973,-0.9279627798094623,0.7037037037037037,1.0,1.0,2/8,8.54%,KDM2B;EFEMP1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.3545426911778116,-0.9278151290548897,0.6875,1.0,1.0,21/111,15.00%,ARC;CLDN4;LZTS3;PHLDB2;BCL6;SARM1;VASH1;BCL9L;ERBB2;PID1;LZTS1;MARCHF5;ETS1;EMP2;ZNF135;CAPZB;MYO19;FGFR2;MARK2;DLL1;SH3D19
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.42990000406546697,0.9277382288604061,0.6235294117647059,1.0,1.0,4/46,13.31%,ACTL6A;HAT1;LEF1;ING3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.46728492058991267,0.9276784098012882,0.5679012345679012,1.0,1.0,10/35,23.91%,PWP2;NOB1;RPS16;RPS19;TSR2;RPS14;TSR3;HELB;RIOK2;RPS28
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.5355086470292738,-0.9276405970991016,0.5833333333333334,1.0,1.0,4/7,34.47%,VCL;TNFRSF1A;ZDHHC21;ROCK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.41309799652890933,0.9274980530230466,0.5569620253164557,1.0,1.0,12/64,18.12%,BLK;FLT1;FLT4;ERBB4;HCK;SYK;DDR2;ZAP70;IL4;MAPK3;ITK;CSF1R
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.5533175793863113,-0.9274077772947739,0.5813953488372093,1.0,1.0,2/6,17.98%,TGFA;BTC
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.3779854081176155,-0.927357814174547,0.6206896551724138,1.0,1.0,12/83,12.90%,TBC1D10A;STX6;SNX8;RAB7A;RAB7B;SNX32;GBF1;STX5;SNX5;UBE2O;EHD3;WASHC2C
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.5542107020819103,-0.9272913683331697,0.5675675675675675,1.0,1.0,1/5,2.70%,TWIST1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.5938704361620855,-0.9272702423390341,0.5897435897435898,1.0,1.0,2/5,24.30%,CAMSAP3;KIFC3
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.42997200067835156,-0.9272426557423055,0.36363636363636365,1.0,1.0,7/22,11.45%,GRIN3A;SLIT3;HSD3B2;SDF4;TGFBR3;GRIN1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.44831616039310596,0.9270791118350403,0.5652173913043478,1.0,1.0,6/25,28.94%,TGFB1;MAP2K1;ZFP36;MYCN;DDX6;FXR1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3990753816738678,0.9270367664792116,0.5633802816901409,1.0,1.0,9/76,10.08%,RASGRP4;PDE6H;CCL5;PDE6A;C3;GPER1;GRK7;RAMP3;GNG4
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.38579813957803294,0.92695236344808,0.5569620253164557,1.0,1.0,17/94,19.13%,TLR2;CCL5;WNT5A;TGFB1;SCIMP;SH2D1B;NLRP12;IFNK;TNFSF4;CYBA;P2RY12;PLA2G7;DDX60;PLG;AGT;THBS1;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.554439564178435,0.9269186231175423,0.4925373134328358,1.0,1.0,3/10,5.33%,AHR;PTPRC;HLA-F
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.5138953234219301,0.9267271624798321,0.59375,1.0,1.0,3/13,8.79%,SFTPD;JCHAIN;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.45734830102020263,-0.9261604897643082,0.5,1.0,1.0,2/9,9.54%,PHLDB2;EMILIN1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.3445992634166024,-0.9260687954405532,0.631578947368421,1.0,1.0,6/56,6.58%,PER2;LIPC;MLYCD;CYP7B1;OSBPL3;SLC27A2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4822702744175206,0.9260444968130108,0.6119402985074627,1.0,1.0,3/20,14.09%,P2RY6;TRDN;STAC
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.6185713113483453,0.925899258921982,0.6981132075471698,1.0,1.0,2/6,25.14%,DNAJA1;LMAN1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.49198120476011825,0.9258822122011713,0.5285714285714286,1.0,1.0,2/19,10.35%,RENBP;NANS
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.44770805497035254,-0.9254798264186961,0.6923076923076923,1.0,1.0,9/26,15.47%,CHPF2;ARSB;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;IDUA;CSPG5
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.44969466775121925,-0.9252107833260997,0.40625,1.0,1.0,4/11,20.51%,KCNE1;KCNH2;YWHAE;KCND3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4738800804478108,0.9250201647542685,0.5409836065573771,1.0,1.0,1/23,1.96%,SLFN14
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3710378324762335,-0.9249868977458436,0.4666666666666667,1.0,1.0,10/61,15.47%,SKAP1;CDH13;FLNA;EMP2;CRK;RELL2;CDK6;LIMS1;CRKL;CSPG5
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5640607360323653,-0.9247362689734436,0.6,1.0,1.0,1/9,2.70%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5714143618405998,0.9246551811452904,0.6307692307692307,1.0,1.0,2/9,5.16%,C1QTNF1;ALOX12
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.5532807116642147,0.9243193433216493,0.6363636363636364,1.0,1.0,2/9,2.77%,DBH;DAO
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3900281041457131,0.9242057153965177,0.6103896103896104,1.0,1.0,9/93,16.13%,SGO1;KIF14;CEP55;NDC80;RAB11A;CHMP3;TEX14;KIF18A;SET
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4884729276049763,-0.924046016220057,0.5675675675675675,1.0,1.0,6/10,38.91%,NR1H2;ABCD2;MLXIPL;SLC45A3;APOA1;NR1H3
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.4026135279398222,0.9238423535974254,0.6075949367088608,1.0,1.0,21/86,16.23%,BLK;ADAM28;CYTIP;ARHGAP9;AIM2;GMFG;PTPRC;SASH3;WAS;IKZF1;CXCR5;NT5E;CD80;NAPSB;CD244;IL7;PNOC;TAGAP;TMEM156;ZBTB32;CD37
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.4509120608209364,0.9238235282400798,0.5970149253731343,1.0,1.0,3/29,6.51%,PLEKHH2;KANK3;CAV3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.32427854571142284,-0.9237379746831391,0.5454545454545454,1.0,1.0,46/215,14.75%,TSKU;SPRY4;ADAMTS12;UBASH3B;SIGIRR;BCL2;PRKCD;TYRO3;CREB3L1;PTCH2;PTCH1;WWP2;ERBB2;NKD1;CRY1;PLIN5;TRIB1;ACVR1;PTPRJ;CX3CR1;PID1;PTPRE;EMILIN1;NKD2;CBY1;CHAC1;BEND6;RPGRIP1L;DAB2IP;DLK2;SLC27A4;FSTL3;ZBTB7A;NIBAN2;KIF26A;SULF2;GPC1;AHSG;NEURL1;BRAP;RNF157;NLRP2B;SMPDL3B;KLK14;SNAI2;DLL1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.47406491793507216,-0.9236618083772854,0.5641025641025641,1.0,1.0,6/14,15.47%,UST;CHST12;CSGALNACT1;VCAN;B3GAT3;CSPG5
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.45648768062043127,-0.9235764962760223,0.56,1.0,1.0,6/31,13.27%,LAMA3;CD151;ITGB4;BCR;TAOK2;PLEC
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.4556458123898927,-0.9235665815086052,0.5526315789473685,1.0,1.0,2/15,3.40%,CDH5;F11R
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.453491520164107,0.9229084946455476,0.5694444444444444,1.0,1.0,8/37,15.87%,TGFB1;NODAL;DAB2;GDF11;BMP3;TGFB3;TTK;GDF9
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),0.623150188513426,0.9228760718922,0.6507936507936508,1.0,1.0,3/5,30.99%,SOD2;HIF1A;ALAS2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.3372790564535069,-0.9227727288690171,0.5384615384615384,1.0,1.0,14/87,8.54%,ADAMTS1;TEAD2;BOC;CALD1;TWIST1;TWIST2;COL12A1;COL4A2;MMP2;RND3;RHBDF1;PARVA;FSTL1;EFEMP1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.502603825432999,-0.9226550494793928,0.5833333333333334,1.0,1.0,3/9,17.62%,PTCH1;PROX1;NF1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.5017663313245513,0.9225904909707209,0.582089552238806,1.0,1.0,5/26,9.23%,PTPRC;FLT1;TGFB1;FLT4;PLD4
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.40466601652703205,0.9225886202117697,0.6081081081081081,1.0,1.0,10/75,16.71%,SLC9A2;SLC5A2;SLC12A3;SLC6A4;ASIC5;ATP1A4;ASIC1;SLC9C1;SLC24A1;SLC5A1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.6191909996328941,0.9222769763836189,0.6567164179104478,1.0,1.0,1/5,4.86%,C3
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.525933060861808,0.9221707640996093,0.5818181818181818,1.0,1.0,2/9,17.02%,HSPA5;COPS5
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.47165372729943067,0.9217710287894753,0.6111111111111112,1.0,1.0,2/29,6.54%,CD160;CD81
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.5972315345831929,0.9217663214908643,0.6142857142857143,1.0,1.0,1/6,2.05%,ANXA1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.43172604722624075,0.9216806495098828,0.6052631578947368,1.0,1.0,4/43,4.71%,MAPKAPK3;TLR2;SFTPA1;SFTPD
prerank,GO_Biological_Process_2021__sensory perception of sour taste (GO:0050915),0.6213477261667556,0.9216225876582815,0.6833333333333333,1.0,1.0,2/5,19.81%,ASIC1;PKD1L3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4071597351990093,0.9215884959514093,0.6626506024096386,1.0,1.0,15/79,25.17%,PSMB9;FBXL7;CDKN2A;MYO16;KANK2;FBXO5;CDKN1A;PSMC5;PSMB6;CDKN2C;RBX1;PSMD6;PSMA3;PSMA7;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.47979810032363235,-0.9215065174489299,0.6216216216216216,1.0,1.0,1/14,1.60%,BOC
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.5158129520041815,0.9214273838733102,0.6301369863013698,1.0,1.0,4/17,20.37%,AHR;TNFSF4;IL4;IGLL1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.6483396870187474,0.9212403748603689,0.6119402985074627,1.0,1.0,2/5,26.54%,LARP6;NCBP1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.5410285336687658,-0.9209591872658095,0.5777777777777777,1.0,1.0,4/5,37.25%,CTU1;URM1;TRMU;CTU2
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.5624942783499933,0.920915512856813,0.6101694915254238,1.0,1.0,3/7,22.49%,FN1;FERMT3;CXCL12
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.49691438991736914,-0.920874986533939,0.5,1.0,1.0,1/7,2.70%,TWIST1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3320217160483804,-0.9208296200111652,0.6428571428571429,1.0,1.0,15/101,7.65%,NGF;STK40;ADAMTS12;ENO3;CALD1;COL12A1;COL4A2;MMP2;RND3;TPM2;RHBDF1;MYL3;PARVA;CAP2;FSTL1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3986608162805909,0.9208166892047726,0.5443037974683544,1.0,1.0,8/57,14.94%,TLR2;WNT5A;CD81;NLRP12;OSMR;RPS19;TNFSF4;PLA2G7
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.3967997630515903,0.9206473276014561,0.6341463414634146,1.0,1.0,17/111,17.61%,LRP4;TRIL;TSPAN11;FBXL7;SHISA6;TMEM35A;LRRC3B;LY6H;PLP1;TMEM200C;AQP4;GLI3;OLIG2;CNTN2;GFAP;ID4;ZNF536
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),0.6147837170617164,0.9205919813473353,0.6666666666666666,1.0,1.0,4/5,38.52%,SCN1B;SCN5A;SCN2B;SCN10A
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.422513928602247,-0.9203453512011963,0.5517241379310345,1.0,1.0,4/19,17.26%,NRDE2;AGO2;TNRC6C;TNRC6A
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.35678284287901657,-0.9201250476371667,0.631578947368421,1.0,1.0,7/51,10.76%,ADAMTS12;GBP2;SELE;MYLK3;IGBP1;DAB2IP;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.3811468245463974,-0.9201017196308571,0.4594594594594595,1.0,1.0,11/28,24.39%,ERN1;CELF4;U2AF2;CIRBP;THRAP3;RBMX;NUP98;HSPA1A;SF3B4;DAZAP1;SETX
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.4952240186005751,-0.9200403447191168,0.5454545454545454,1.0,1.0,6/12,14.46%,WNT3A;NLGN3;WNT7A;NLGN2;LRRTM3;NLGN4Y
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.5086432748967677,-0.9199581588072623,0.53125,1.0,1.0,3/12,16.28%,PARP11;PARP16;PARP2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.46865818386330277,0.9197823302099286,0.581081081081081,1.0,1.0,1/33,0.27%,GATA4
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.4906139649226133,0.9197640014561625,0.5675675675675675,1.0,1.0,1/18,2.05%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.6412240772219093,0.9194807039235904,0.6785714285714286,1.0,1.0,3/5,27.65%,PINK1;PARK7;HIF1A
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.5976073027745948,0.9191970385979562,0.6833333333333333,1.0,1.0,1/6,21.76%,RPL23
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.43323778008153935,-0.9191780041558062,0.5925925925925926,1.0,1.0,3/17,13.63%,DDX11;HSF1;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.4618881117396527,-0.9189652422082938,0.5833333333333334,1.0,1.0,1/11,0.78%,TRIB2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.45942450412995617,-0.9189375662236144,0.48484848484848486,1.0,1.0,2/23,3.86%,PER2;KCNMB2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.4856845615575341,-0.9188420357106672,0.6410256410256411,1.0,1.0,1/7,0.70%,ADRA1A
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.4108990398918922,-0.9183147537538091,0.5294117647058824,1.0,1.0,10/33,21.54%,IFI16;KPTN;IMPACT;EIF2AK3;MYBBP1A;SZT2;BRSK1;SIK2;PRKAG2;SESN3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.5091430772403487,0.9182436000485377,0.6056338028169014,1.0,1.0,6/16,27.35%,COX17;BCS1L;COX20;COX16;COA3;TIMM21
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.599734579795326,0.9174554007196217,0.6507936507936508,1.0,1.0,2/6,17.17%,VAPB;GRAMD2A
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.5794191820563434,0.9174363015612732,0.6428571428571429,1.0,1.0,2/5,20.57%,KDM3A;TPI1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.5296148560258729,-0.9173076498616194,0.6521739130434783,1.0,1.0,2/8,10.32%,LAMB4;NTN4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.39781036932762853,0.9169633752289101,0.6455696202531646,1.0,1.0,22/112,23.19%,BLK;ROPN1B;GPRIN2;MANF;STMN4;CFAP126;PLP1;PRDM12;NPY;RAB11A;TOR1A;CDK5R1;CARMIL1;CSF1R;AGER;UHMK1;BLOC1S2;PLEKHA1;MICALL1;L1CAM;STMND1;ULK1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5943903362158043,0.9168969693203465,0.6142857142857143,1.0,1.0,2/8,10.21%,ATP6AP1;NDUFS2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.5777736076050288,-0.9166163882701555,0.7,1.0,1.0,4/5,31.72%,IMMP1L;PMPCA;MIPEP;IMMP2L
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.555783744795279,0.9163004119750763,0.6065573770491803,1.0,1.0,6/8,35.89%,CSRP3;HTR2B;TCAP;TTN;INPP5F;RYR2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.45630754395366363,0.916220967658978,0.5915492957746479,1.0,1.0,8/33,12.31%,BLK;AHR;PTPRC;SASH3;CLCF1;CD81;IL7;GPR183
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.6057044733434047,0.916108709096701,0.6029411764705882,1.0,1.0,2/5,8.55%,TAPBPL;HLA-DMA
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5008152576953943,-0.9159788664969057,0.5853658536585366,1.0,1.0,2/9,31.39%,MYLIP;CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5008152576953943,-0.9159788664969057,0.5853658536585366,1.0,1.0,2/9,31.39%,MYLIP;CLTA
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.5127748768117673,0.9156975640385182,0.5942028985507246,1.0,1.0,2/16,13.46%,C3;MTCH1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.3480940634247157,-0.9156806107694019,0.6,1.0,1.0,19/102,11.68%,EFR3B;CELF5;LGR5;CRABP1;CASKIN1;ELAVL3;GALNT13;MEGF10;LHFPL4;PTPRZ1;HES1;INA;MSI1;WNK2;SNCB;SRRM3;HPCA;MMD2;TAGLN3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.351526247682038,0.9156670857320052,0.7126436781609196,1.0,1.0,82/436,19.31%,IL21R;ITGB2;PSMB9;AIM2;RORC;ANXA1;ITGAX;CSF2RA;SP100;TNFRSF1B;CCL5;HSPA8;CRLF1;TRIM62;FGF2;CLCF1;STAT5A;PELI3;CARD14;TRAF3IP2;ST18;HLA-F;TGFB1;ITGAM;PTAFR;TRIM25;IL12A;IL27;SOCS2;CA1;IFNK;IFIT1;MMP9;HLA-A;LCP1;OSMR;SOD2;TXNDC17;IRF1;HCK;DUOX1;STAT1;CD80;TRIM68;HGF;IL7;RHOU;SYK;IL26;CSF3R;CCND1;RPS27A;IFI6;CDKN1B;IRF4;TNFSF4;TALDO1;HLA-DPB1;LIFR;ISG15;CDKN1A;ALOX15;OPRM1;CD44;MSN;PSMC5;CFL1;IL4;MAPK3;OAS2;IL5;CSF1R;FN1;ANXA2;CD4;FPR1;NOS2;TRIM5;IL3RA;PSMB6;RPLP0;CSF1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.4765301035458791,0.915514233187315,0.6,1.0,1.0,2/20,15.01%,HSPA8;LAMP2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.3333759463470629,-0.9153720647890505,0.6428571428571429,1.0,1.0,29/137,15.97%,MFSD2A;PAH;GSTT2B;ACER2;ELOVL6;HACD1;APOE;ACER3;GSTZ1;GSTM5;ASS1;LPCAT2;PLA2G4C;ELOVL1;PAM;ST3GAL2;GSTK1;CHKA;PEMT;PCSK1;PLPP2;SPTSSB;SLC44A5;ST3GAL4;GSTO2;CSNK1G2;ASL;INHA;NFS1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.5103770495500374,-0.9149461397761579,0.6,1.0,1.0,1/7,2.42%,CSK
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2873438049020009,-0.9149218523325523,0.8333333333333334,1.0,1.0,22/354,4.34%,SH2D6;NGF;EFNB1;ATP6V0D2;SPRED2;UBASH3B;SPRED1;FOXO1;FGF1;SHC3;TYRO3;ESRP1;TIE1;FGF18;GFRA2;KIT;COL4A2;MMP2;NR4A3;SH2B2;SHC4;TRIM71
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4051464197197706,0.9147604733868895,0.6493506493506493,1.0,1.0,10/67,16.44%,ACSL5;LIPI;OLAH;LIPH;ACSM3;MBOAT1;CLN8;ACSM6;FDFT1;SCD
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4450082322033384,0.914270569061341,0.6351351351351351,1.0,1.0,14/57,22.60%,SP100;PELI3;GPER1;TNFRSF10A;IGF1;BCL2L14;CYLD;IL4;AGT;THBS1;TMC8;FEM1B;TRADD;PARK7
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5512671469233613,0.9142358249737763,0.6428571428571429,1.0,1.0,1/11,4.65%,MANF
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.49489440504262017,-0.9141677448023072,0.5,1.0,1.0,4/11,21.14%,EAPP;LEO1;BRD4;TCERG1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.5155399017643025,0.9141081240400334,0.5797101449275363,1.0,1.0,1/13,4.33%,DDX20
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4604404234027115,0.9139843923240698,0.6086956521739131,1.0,1.0,7/33,24.55%,RORC;SOX9;CD44;ITGB8;GHRL;SOX6;HYAL1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.4181447062766579,0.9138925938867669,0.6296296296296297,1.0,1.0,16/81,15.56%,AQP3;ESR1;CAPN13;ANXA1;WNT5A;ITGB6;MISP;EPN3;ANPEP;LAMC2;TMC4;TRIM29;EPCAM;AP1M2;BTG1;HMGA1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.4281782397969249,-0.9138437431451674,0.6341463414634146,1.0,1.0,7/23,18.11%,CDH5;PRKCD;SYMPK;PTBP1;PPP1R7;PPIA;CAMTA1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.4383254580506707,0.9137356630080428,0.6486486486486487,1.0,1.0,13/49,23.60%,HAMP;FRRS1;ABCG2;ATP6AP1;FTH1;CP;FTL;NUBP1;SLC46A1;CYBRD1;B2M;CYB561A3;TF
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.4012878467151654,-0.9136790717381431,0.5882352941176471,1.0,1.0,12/58,14.57%,TRIB2;UBASH3B;SPRED1;HSPB1;CEP85;TRIB1;DEPTOR;DUSP19;NPRL2;CHP1;CAMK2N1;PRKRIP1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5514145008707904,0.913590726882517,0.6857142857142857,1.0,1.0,7/10,40.86%,YOD1;INSIG1;DERL2;SVIP;ERLEC1;OS9;UBE2G2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.4163673271593827,-0.9132709680508068,0.7083333333333334,1.0,1.0,13/28,31.62%,TUBGCP2;TPPP3;MAP7D3;TRPV4;CCDC57;AKAP9;MAPT;CSNK1D;TUBG1;PIN1;TPPP;GOLGA2;TUBG2
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.5404623649097352,-0.913141365805798,0.5333333333333333,1.0,1.0,2/8,7.51%,MEGF10;CCN3
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.32673352125954125,-0.9130144957528318,0.6451612903225806,1.0,1.0,12/93,7.65%,ADAMTS1;FIBIN;PAMR1;CALD1;COL12A1;COL6A3;COL4A2;MMP2;MYOCD;CNN1;SLIT3;FSTL1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.4999232324677336,0.9126997929070373,0.6521739130434783,1.0,1.0,4/20,16.70%,MYRF;SOX10;SOX9;PRDM8
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.5793646856130565,0.9126537274137148,0.6271186440677966,1.0,1.0,1/6,6.51%,CAV3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.45212259395696536,0.9125534411176097,0.6176470588235294,1.0,1.0,2/29,7.87%,DONSON;RAD1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.42779899442117425,0.9124695706831774,0.5942028985507246,1.0,1.0,10/45,25.60%,DNAH11;CCDC39;ODAD1;TEKT5;DNAI1;CABYR;ODAD2;CCDC63;DNHD1;ODAD3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.46823851665829397,0.912449572682349,0.5970149253731343,1.0,1.0,6/24,23.03%,PKP2;CAV3;CTNNA3;DSC2;ATP2A2;TBX18
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5509653827615889,0.9122894763692184,0.6129032258064516,1.0,1.0,3/11,12.47%,USP50;DDX3X;NLRC3
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.5254158768353812,-0.912182276420643,0.5294117647058824,1.0,1.0,2/6,16.22%,SLC4A11;TRPV4
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.3879307765424333,0.9117108533868297,0.6216216216216216,1.0,1.0,14/91,17.81%,SGO1;CLDN6;BUB1;TICRR;SALL4;NDC80;MCM3;ERCC6L;PIF1;FBXO5;SET;VASH2;CCNA2;PAICS
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.5736334059732686,0.9116054727204805,0.6721311475409836,1.0,1.0,1/6,6.83%,STK26
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.4528420203819502,0.911603762724055,0.620253164556962,1.0,1.0,10/33,19.13%,TLR2;WNT5A;DDX3X;IL7;SYK;TNFSF4;ALOX15B;CSF1R;AGER;F2RL1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5152461390180539,0.9115680547952666,0.6923076923076923,1.0,1.0,1/15,2.31%,RENBP
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.6380144754601633,-0.9115114053179312,0.6,1.0,1.0,2/5,21.63%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.5185212193937728,-0.9113715847559504,0.5897435897435898,1.0,1.0,1/10,5.28%,APOE
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.38353969983074654,-0.9113148524204738,0.6206896551724138,1.0,1.0,18/84,17.04%,ARC;IKZF4;UPB1;EHD4;MPP2;GLRA3;PKD2;KCNC3;TRMT61B;EHD3;SPAST;CARD9;CPSF7;HGSNAT;LETM1;RBMX;TRIM72;TMEM120B
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4140285274339985,-0.9111444115299322,0.5428571428571428,1.0,1.0,7/29,17.79%,DHFR;TFDP1;RRM2;CDK14;ESRRB;CDK5;BRD4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4269840915351769,0.911082826866304,0.6301369863013698,1.0,1.0,10/42,16.14%,BOK;GSDME;MMP9;PINK1;DDX3X;PLAUR;SIAH1;BBC3;HERPUD1;CYLD
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.4865647970737033,0.9107789851624942,0.5555555555555556,1.0,1.0,5/19,20.26%,IGF1;SOX9;MAPK3;HTR2B;MAP2K1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.34293974538357597,-0.9107056040082477,0.7222222222222222,1.0,1.0,17/58,22.89%,DPM3;ZDHHC23;ZDHHC5;HHAT;ZDHHC16;ZDHHC14;ZDHHC18;PIGQ;ZDHHC3;GPLD1;PORCN;PGAP3;PIGW;ZDHHC20;WIPI1;ZDHHC8;ATG7
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.5251451893797967,0.9105089622559537,0.6351351351351351,1.0,1.0,1/12,0.44%,TBX1
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.47206555952656964,-0.9104293123586576,0.5714285714285714,1.0,1.0,7/14,23.24%,PPCDC;CROT;PANK1;PPCS;DCAKD;ACOT7;SLC25A16
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.49426169088222505,0.9103305108409491,0.59375,1.0,1.0,4/22,18.23%,HHIP;CYP26B1;SFRP4;FBN2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.577816094642286,-0.9101662882168753,0.7,1.0,1.0,1/5,16.70%,ABHD12
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.6181501226626005,0.910148416339722,0.6428571428571429,1.0,1.0,4/5,38.13%,HMGA2;RPS6KA5;MST1;VRK1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.3971794769190584,0.9099581365331528,0.6375,1.0,1.0,25/85,22.14%,GSDMA;TLR2;HAMP;SFTPD;LYG2;JCHAIN;IL12A;STAB2;HLA-A;NLRC4;SYK;RPS19;DEFB109B;ISG15;COLEC12;OAS2;LYG1;STAB1;NOS2;ROMO1;IGLL1;PGLYRP1;PGLYRP2;WFDC11;EPX
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.5855305756332084,-0.9095749665575074,0.625,1.0,1.0,3/5,17.62%,CDK6;DLL1;NF1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.4403533072547202,-0.9095177552306954,0.6666666666666666,1.0,1.0,5/25,10.13%,ATP6V0D2;RAB20;RAB7A;ATP6V1E2;ATP6V0A2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.5089944508998331,-0.909488766907381,0.6216216216216216,1.0,1.0,1/14,0.34%,SKAP1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.45351751586703143,0.9094092502053349,0.5692307692307692,1.0,1.0,5/29,17.93%,TLR2;IRF1;DDX3X;ISG15;OAS2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.35029635534724723,-0.9089984931111376,0.5185185185185185,1.0,1.0,8/68,10.76%,ADAMTS12;GBP2;SELE;SMPD4;PID1;IGBP1;DAB2IP;NR1D1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.4727847185690478,-0.90822743711611,0.5625,1.0,1.0,6/20,19.03%,RAB7A;SNF8;RAB5A;EMP2;STX8;HOOK3
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5390947754719336,0.907995897906773,0.6101694915254238,1.0,1.0,4/10,23.74%,HEY2;HEY1;SNAI1;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.45006857129599553,-0.9078841089108436,0.5172413793103449,1.0,1.0,3/19,7.51%,ADGRG3;HDAC7;CCN3
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5706330688751634,0.9078634555214243,0.5671641791044776,1.0,1.0,1/10,6.83%,STK26
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.31365972318643504,-0.9077878924407068,0.6923076923076923,1.0,1.0,40/257,16.30%,CPSF1;HNRNPL;DDX41;DCPS;RNF113A;TXNL4A;CWF19L1;LSM7;MAGOHB;PDCD7;DHX8;SRRM1;SRSF4;SUGP1;SNRPB;GPATCH1;SYMPK;HNRNPF;DDX46;NOVA1;CELF4;U2AF2;CSTF2;PTBP1;POLR2F;SF3A2;SMU1;ZMAT5;IK;HNRNPUL1;CPSF7;GEMIN5;POLR2C;GPKOW;RBMX;RBMX2;PCF11;SNRPN;RALY;RBM41
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.5304119996174014,0.9073150442661623,0.6984126984126984,1.0,1.0,7/12,23.60%,HLA-F;ERAP2;HLA-A;HLA-DRB1;B2M;TAP1;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.49361333379513395,0.9072158826517749,0.65,1.0,1.0,2/22,10.22%,PTPRC;DUSP22
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.48621017049514803,0.9071295117257004,0.6410256410256411,1.0,1.0,2/21,13.71%,ARHGAP24;P2RY12
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.5468427272792927,0.9070465123369598,0.676923076923077,1.0,1.0,1/8,5.91%,DYDC2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.4601150487479934,0.9069736185266819,0.6111111111111112,1.0,1.0,3/26,5.45%,ANGPT2;FGF2;TGFB1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.4889483461236732,0.9065585766796116,0.6153846153846154,1.0,1.0,3/21,12.88%,TLR2;IRF1;OTUD4
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.31600176245059935,-0.9062134472561681,0.8,1.0,1.0,8/84,5.76%,H19;TEAD2;DSG2;KDELR1;SAPCD2;PHLDA2;TEAD4;AGRN
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.48308094475189034,-0.9060281223333975,0.6451612903225806,1.0,1.0,1/11,1.94%,CDH5
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.564252620509796,0.9059479115505993,0.609375,1.0,1.0,1/7,10.60%,RAB11A
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.4984404348222718,0.9058583641152316,0.5757575757575758,1.0,1.0,1/12,3.52%,GPR151
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5161251842727483,0.9058505371707288,0.6197183098591549,1.0,1.0,3/13,9.95%,H1-0;TGFB1;IGF1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.36315311283522395,0.9051008673629697,0.6941176470588235,1.0,1.0,25/175,12.54%,TIMP3;PRRX1;WNT5A;PTX3;LOX;CRLF1;ECM2;SGCG;CTHRC1;FGF2;FZD8;ABI3BP;TGFB1;ITGA2;ACTA2;DAB2;NT5E;DCN;ITGA5;COL1A1;ANPEP;LAMC2;RHOB;COL6A2;PLAUR
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.49916848427503846,-0.9046814263631203,0.5641025641025641,1.0,1.0,2/11,7.74%,PARD3;ADGRG6
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.4830565343518951,0.9043454122032801,0.6056338028169014,1.0,1.0,4/17,28.69%,NOP53;DDX60;USP17L2;OASL
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.499134129896659,0.9043331672933215,0.7910447761194029,1.0,1.0,1/18,3.84%,STOML2
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.39007777790758075,0.9041873466307974,0.6625,1.0,1.0,13/109,12.72%,ENPP2;CAVIN1;KIF14;FGF20;FGF2;TGFB1;ERBB4;WAS;DUOX1;RHOB;SPOCK3;PLXNA3;TMSB10
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.3515088430871208,-0.9040305247260689,0.5714285714285714,1.0,1.0,17/87,14.26%,DRD4;TYRO3;TIE1;KIT;RAD50;VAC14;ERBB2;EPHB2;EPHA6;INSRR;NTRK1;EMP2;LDB1;RBL1;NPRL2;FGFR2;ZNF16
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.38210205000634917,0.9036812648453725,0.6585365853658537,1.0,1.0,13/96,17.48%,KIF14;WNT5A;STRADA;CARD14;BORA;TNFRSF10A;PINK1;IGF1;ECT2;PRRC1;ADCY7;IL4;STRADB
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5002786865873958,0.9036533261144085,0.5862068965517241,1.0,1.0,3/16,8.71%,HAMP;CAV3;MMP9
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4137872937720252,0.9035010194022574,0.5853658536585366,1.0,1.0,10/64,19.81%,TBX1;ALPK2;HEY2;TGFB1;PINK1;FOXM1;SOX9;HEY1;PRAME;SINHCAF
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.3835687385058962,-0.9034457034527683,0.4230769230769231,1.0,1.0,8/45,13.90%,TBC1D10A;GSAP;PERP;SERPINE2;CSTA;BAG6;TRAF3;CAMK2N1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4150149899093656,-0.9033874733126472,0.5625,1.0,1.0,5/23,10.81%,DRD4;CBARP;EPHB2;PKD2;GNB5
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.49251736093585685,0.9033810701579165,0.6338028169014085,1.0,1.0,4/14,18.14%,SLC5A2;SLC5A9;SLC5A1;SLC23A1
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.5377723074411863,0.9032564555588536,0.65,1.0,1.0,1/12,0.44%,RAB34
prerank,GO_Biological_Process_2021__positive regulation of protein kinase A signaling (GO:0010739),0.5678247259285222,0.903204495561374,0.6909090909090909,1.0,1.0,2/5,22.71%,RAMP3;CALCR
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.4427739807549686,-0.9031424705664892,0.5588235294117647,1.0,1.0,6/14,15.34%,SLC17A9;ABCC4;SLC25A17;SLC25A42;SLC25A41;SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4135508119524821,-0.9030153242853277,0.5,1.0,1.0,4/36,5.23%,ZNF703;BAMBI;TWIST1;BCL9L
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.4928070960991995,-0.9028298892809115,0.6176470588235294,1.0,1.0,2/16,3.62%,SPRY4;CREB3L1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.5390959074134459,-0.9027403716215444,0.5675675675675675,1.0,1.0,3/5,21.50%,XYLB;SORD;CRYL1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.5390959074134459,-0.9027403716215444,0.5675675675675675,1.0,1.0,3/5,21.50%,XYLB;SORD;CRYL1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.5390959074134459,-0.9027403716215444,0.5675675675675675,1.0,1.0,3/5,21.50%,XYLB;SORD;CRYL1
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.5752950998925042,0.902653851568771,0.7,1.0,1.0,2/8,12.04%,BLK;ORMDL3
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.41149687403515417,-0.9020625804379397,0.5714285714285714,1.0,1.0,1/20,6.47%,MTFR2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.3179940244735443,-0.9019743144909306,0.7142857142857143,1.0,1.0,26/166,14.04%,SYT12;TSKU;MLPH;PDLIM3;BCL2;GLA;FOS;WWC1;PAPSS2;KLF10;SLC27A2;GREB1;HES1;IGFBP4;ISG20L2;SLC7A5;SCARB1;NAV2;TMEM164;SLC37A1;FHL2;DEPTOR;HR;RAPGEFL1;BCL11B;FRK
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.35828447778893624,0.9018767850079986,0.6666666666666666,1.0,1.0,55/348,19.31%,ENPP2;KIF14;ANXA1;ITGAX;CCL5;PIK3R3;FGF20;VSIR;SYNE2;FGF2;ACTG1;FLT1;TGFB1;SEMA3A;GPER1;STK26;ERBB4;SMIM22;TCAF2;MMP9;LEF1;HSPA5;PRR5L;F7;DAB2;SOD2;CYP1B1;IGF1;DUSP22;CLDN5;COL1A1;LAMC2;HGF;RHOB;PLXNA3;DACH1;SEMA3B;TMSB10;PLAU;VIL1;ALOX15B;IGSF10;SEMA3F;NEXN;ANGPTL3;IL4;SNAI1;WNT5B;CARMIL1;BCAR1;CSF1R;WASHC1;THBS1;F2RL1;CSF1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5177735757531271,-0.9017708103878102,0.5882352941176471,1.0,1.0,2/9,3.90%,GCK;NR4A3
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),-0.5567979232944813,-0.901392950283745,0.6046511627906976,1.0,1.0,4/7,3.71%,TYRP1;TPH1;MOXD1;DCT
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4781531985581415,0.9013616997429152,0.6376811594202898,1.0,1.0,6/21,33.76%,CHMP3;GPSM2;CHMP1A;CHMP4B;DRG1;CHMP2B
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3582237531565751,-0.9011606999378752,0.5652173913043478,1.0,1.0,14/66,12.95%,SPRY4;VWC2;ADAMTS12;BAMBI;CREB3L1;EMILIN1;DLX1;DAB2IP;FSTL3;NIBAN2;SLIT2;VWC2L;SULF2;GPC1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.41458612449417376,-0.9011078514031539,0.7272727272727273,1.0,1.0,10/31,20.21%,PLEKHG2;TTBK1;COTL1;TPPP3;DBNL;CAMSAP3;PAK3;ABL1;MAPT;GBA2
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5559953066367394,0.900317167781876,0.640625,1.0,1.0,1/9,4.65%,C12ORF57
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3637802532960953,-0.900270787484587,0.5217391304347826,1.0,1.0,9/79,13.51%,PLK3;FOXO1;DHRSX;MEFV;TRIM8;IRGM;TRIM14;NPRL2;EPM2A
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3840466986174282,0.9001772100460005,0.6506024096385542,1.0,1.0,9/120,12.59%,TLR2;AIM2;WNT5A;TRIM62;CARD14;TRIM25;NLRC4;TRIM68;RPS27A
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.4486048521014791,0.9001322777894454,0.620253164556962,1.0,1.0,3/30,6.90%,LRP2;TGFB1;VASP
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4486048521014791,0.9001322777894454,0.620253164556962,1.0,1.0,3/30,6.90%,LRP2;TGFB1;VASP
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.5570447536795324,0.900081026612011,0.6271186440677966,1.0,1.0,3/6,11.47%,GPER1;P2RY6;CD244
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.5318678982329181,-0.899897346012386,0.5813953488372093,1.0,1.0,2/8,16.84%,PKIA;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.5914351814934569,-0.8998129437514147,0.6857142857142857,1.0,1.0,2/5,2.94%,FGF1;FGF18
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),-0.5247620869882182,-0.899548839346596,0.6060606060606061,1.0,1.0,1/7,3.90%,NR4A3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.48786120433232294,0.8994140268692274,0.6785714285714286,1.0,1.0,3/19,15.07%,BUB1;TEX14;TTK
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.48786120433232294,0.8994140268692274,0.6785714285714286,1.0,1.0,3/19,15.07%,BUB1;TEX14;TTK
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.48786120433232294,0.8994140268692274,0.6785714285714286,1.0,1.0,3/19,15.07%,BUB1;TEX14;TTK
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.3176848888433034,-0.8993292378754073,0.7857142857142857,1.0,1.0,31/138,19.02%,GRK5;SYNJ2;KIT;RND3;TENT4A;PIAS3;ERBB2;CAP2;CCN1;EFEMP1;SERPINE1;SFMBT1;TGFBR3;PEX14;ZMIZ1;NFIB;FHL2;CACNA1A;ABCC1;SNAI2;COL5A2;FYN;RBPMS;RASA2;ADGRL2;PRKCA;PTPN21;MT1E;DDAH1;ANXA4;ATXN1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.521598772419146,0.8990293848790795,0.6031746031746031,1.0,1.0,1/13,5.67%,SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.33673919075915,-0.8989084450996092,0.7894736842105263,1.0,1.0,10/95,6.48%,NR4A1;OSR1;ZNF703;FGF1;CDH13;NR4A3;TGFA;FZD7;ERBB2;WNT7A
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.5502102128884092,0.8988583588012947,0.639344262295082,1.0,1.0,2/8,17.72%,PTGER3;HTR2B
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.5587267344224537,0.8988306918092251,0.6271186440677966,1.0,1.0,1/10,0.44%,RAB34
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.32255533970242006,-0.8981278370692941,0.7058823529411765,1.0,1.0,12/180,5.98%,DUSP4;SPRED3;ADRA1A;SPRED2;DUSP6;SPRED1;ADCYAP1;APOE;SLC30A10;PDGFD;PLA2G5;ERBB2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.6087492196899743,0.898057462135159,0.6911764705882353,1.0,1.0,1/6,1.57%,TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.6087492196899743,0.898057462135159,0.6911764705882353,1.0,1.0,1/6,1.57%,TLR2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.5429949184636078,-0.8979151418078812,0.55,1.0,1.0,2/5,12.42%,CCBE1;PROX1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.44895376607407383,-0.8979134034726964,0.6857142857142857,1.0,1.0,2/20,1.94%,NR4A1;CDH5
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.45496577776266933,-0.8977947645267107,0.7037037037037037,1.0,1.0,8/16,27.64%,DOC2B;RAB3D;RAB27A;CACNA1G;NLGN1;KCNB1;STX1A;CACNA1H
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.3961660938659627,-0.8974909396156451,0.5121951219512195,1.0,1.0,4/27,5.33%,EPHX2;BCKDK;APOE;MLYCD
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.44933572117849785,0.8973912110970642,0.6935483870967742,1.0,1.0,5/29,11.13%,ANXA1;STAT5A;MMP9;RAMP3;STAT1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.5066264401297327,-0.8972033051851408,0.5675675675675675,1.0,1.0,1/10,3.52%,KIT
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.4772370688384832,0.8971879800142654,0.6111111111111112,1.0,1.0,4/22,11.65%,ITGB2;CCL5;NT5E;SYK
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4461792993293213,0.8971648455056461,0.6578947368421053,1.0,1.0,7/33,19.13%,FGF2;TGFB1;F7;P2RY12;ZNF580;THBS1;F2RL1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3807457414272876,0.8966768484375265,0.6794871794871795,1.0,1.0,23/120,23.54%,SGO1;BUB1;CENPU;NDC80;ERCC6L;SKA2;DYNLL1;GPSM2;SPC25;TTK;KIF18A;RCC1;NUF2;ITGB3BP;TBCE;CENPL;BUB1B;CENPN;CCNB1;DYNLL2;CENPM;TACC3;RPS27
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.4435663941194004,0.8959438740144718,0.6571428571428571,1.0,1.0,5/40,14.84%,DONSON;DTL;TICRR;NOP53;CDKN1A
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.47851963477848275,-0.8959246846319732,0.6,1.0,1.0,3/15,21.34%,HIP1;NSG2;SGIP1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.3956041700707101,0.8958281047589213,0.6301369863013698,1.0,1.0,18/60,22.73%,VSIR;IL12A;IL27;HLA-A;NR1H4;AXL;CD244;TNFSF4;HLA-DPB1;ISG15;PDCD1LG2;CRTAM;F2RL1;RASGRP1;HLA-DRB1;HLA-DPA1;DDIT3;ZFPM1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5242676547118758,0.8956796042673978,0.6666666666666666,1.0,1.0,5/13,25.70%,ABHD14B;BPNT2;SULT4A1;SULT6B1;SULT2A1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3932332906334681,0.8956234067249793,0.6470588235294118,1.0,1.0,13/86,15.20%,TSHR;FCGR3A;GPR27;SCTR;CD81;GPHB5;RAMP3;ADRB1;HCK;RXFP2;SYK;GGT5;ADCY7
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.4734304385523353,0.8955689272656494,0.6764705882352942,1.0,1.0,1/19,2.46%,PKP2
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.4352608451451121,-0.895474556843418,0.6060606060606061,1.0,1.0,6/15,15.34%,SLC17A9;ABCC4;SLC25A17;SLC25A42;SLC25A41;SLC19A1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.5203783345331936,0.8954631799374282,0.639344262295082,1.0,1.0,7/11,36.27%,STAT1;PARP9;IFNGR1;HSP90AB1;PIAS1;IFNGR2;JAK2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4051965351817053,-0.895344777593812,0.5,1.0,1.0,7/34,8.63%,ADAMTS1;DNMT1;MMP2;NR4A3;CNN1;TAFA5;ERN1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.4344861636267774,-0.8952921316433047,0.6111111111111112,1.0,1.0,1/17,0.97%,CLDN4
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.4827000140274055,0.8952296647879071,0.5833333333333334,1.0,1.0,2/16,3.01%,BUB1;IHO1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.3274525643566898,-0.8952009139479129,0.6923076923076923,1.0,1.0,12/65,13.71%,TYRO3;PARVA;LAMB4;LPXN;ITGA4;USH2A;SRGAP2;RILPL1;NTN4;ANTXR1;PROX1;SIPA1L3
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.444820817767267,0.8950536892438904,0.6351351351351351,1.0,1.0,3/25,9.30%,HSPA8;LCP1;DNAJA1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.5473757306083936,-0.89486264178997,0.59375,1.0,1.0,2/5,21.58%,CEP295;CEP120
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.42411167957522705,0.8946909508214673,0.6493506493506493,1.0,1.0,16/52,25.65%,ACE2;PINK1;CYP1B1;EIF6;FOXM1;CDKN1A;UCP1;STK17A;NOXO1;AGT;THBS1;ROMO1;BRCA1;CCN6;BCO2;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.3885003324094047,-0.894397401343535,0.5641025641025641,1.0,1.0,2/28,2.87%,PHLDB2;ACER2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.4739620800714105,0.8943636879577479,0.5714285714285714,1.0,1.0,2/18,13.90%,MISP;LDLRAP1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4170198163251703,-0.8942914128126589,0.6363636363636364,1.0,1.0,4/30,6.35%,GPC2;PTCH2;PTCH1;MAP3K10
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.4012030566211156,0.8942106855739098,0.6578947368421053,1.0,1.0,18/76,24.83%,CHCHD4;NDUFB11;TMEM126A;NDUFS2;NDUFA2;COX17;BCS1L;NDUFB10;COX20;NDUFB4;SDHAF1;NDUFB9;NDUFAF5;UQCRFS1;NDUFA1;NDUFB2;NDUFAF4;COX16
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.45840077944819957,0.894164352435613,0.6086956521739131,1.0,1.0,2/19,7.62%,HIPK1;DDIT4
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4759037686979956,0.8941414070586109,0.6935483870967742,1.0,1.0,3/25,8.98%,CASQ2;CAV3;KCNS2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3739959187000647,-0.8939401827694442,0.5833333333333334,1.0,1.0,4/59,1.98%,SPRED3;SPRED2;SPRED1;BAMBI
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.47002090949551834,0.8939169626623723,0.6212121212121212,1.0,1.0,1/17,2.02%,GAD1
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.5194548524122867,-0.8938029006463699,0.6756756756756757,1.0,1.0,4/7,23.91%,LIG3;XRCC4;MGMT;LIG1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.5211585812318328,0.8932440499859997,0.6721311475409836,1.0,1.0,1/12,1.25%,MGST1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.3711628040069177,-0.8931142594237239,0.6296296296296297,1.0,1.0,11/44,17.23%,DDX11;CACNB1;ITGA4;NOD1;NTRK1;GRIN1;RIPK2;CACNA1A;ABCC1;FYN;CDK5
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.3044384393710326,-0.8928989063257777,0.7692307692307693,1.0,1.0,28/258,11.61%,GPR3;PER2;TSKU;ADRA1A;ADRA1B;ZNF703;BAMBI;TWIST1;ELOVL6;IFI16;ADCYAP1;BCL9L;APOE;ACVR1;PPARGC1B;GNAS;SERPINE1;CRH;KMT5C;MACROH2A2;ALMS1;AGO2;HDAC3;PEMT;TERT;NIBAN2;HSF1;AGPAT2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.5242193485581073,-0.892898265423829,0.6097560975609756,1.0,1.0,2/7,12.76%,CLIP3;TLCD2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5638039816853748,0.8919722318125702,0.6440677966101694,1.0,1.0,2/7,8.09%,TNFRSF1B;WAS
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.33197724354577846,-0.8919382568003564,0.5925925925925926,1.0,1.0,8/66,11.28%,NGF;TYRO3;ERBB2;PLCL2;PI4KB;NYAP2;NTRK1;PLCZ1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.38631125804448285,0.8915471256869401,0.6301369863013698,1.0,1.0,7/62,13.30%,APOL1;SLC12A7;SLC37A2;SLC12A3;GLRA2;GLRA1;ANO2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.40978396204590933,0.8914889834517572,0.5645161290322581,1.0,1.0,4/51,13.00%,SMAD6;TGFB1;ID1;ID3
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.38894465591824534,-0.8914432556351395,0.6296296296296297,1.0,1.0,11/35,19.85%,LIMK1;APOE;KIAA0319;PTPRS;GOLGA4;ISLR2;DBNL;MAP3K13;ABL1;MAPT;DNM2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.36443279814015983,0.8914365868423846,0.6707317073170732,1.0,1.0,22/130,19.48%,ROPN1B;RRAS;FGF2;USP50;C15ORF62;RTKN;WAS;ARHGDIG;CDKN2A;IGF1;RAPGEF6;RHOB;RERG;CELSR1;GPSM2;CDKN1A;ADGRG1;CFL1;CCNA2;RHOG;PLEKHG7;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.5566446708082592,0.8913315157841211,0.6290322580645161,1.0,1.0,2/7,12.54%,CCL5;PLAUR
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5424635166907319,0.8907874184263438,0.6333333333333333,1.0,1.0,3/6,30.57%,DDX3X;DDX1;SSB
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.499610967808802,0.8903075666325292,0.6619718309859155,1.0,1.0,3/12,22.60%,RFK;AGT;PARK7
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5650216227038797,0.8902476594160881,0.6507936507936508,1.0,1.0,2/8,12.45%,OGN;OMD
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.37573540955349055,-0.8902096626209781,0.625,1.0,1.0,8/45,11.15%,SLC25A29;SLC38A5;SLC6A20;SLC25A45;SLC6A17;SLC3A2;SLC7A5;SLC38A7
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.3932179455256369,0.890184142116451,0.7567567567567568,1.0,1.0,18/90,16.31%,BLK;ADAM28;CYTIP;ARHGAP9;GMFG;PTPRC;SASH3;WAS;IKZF1;CXCR5;NAPSB;CD244;STAG3;PNOC;PSTPIP1;TAGAP;CD37;MME
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.394698432015303,-0.8901726791376273,0.5666666666666667,1.0,1.0,1/28,1.01%,SMYD5
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.53635073805787,-0.8900694609505092,0.6176470588235294,1.0,1.0,2/5,13.63%,RAMP1;CHP1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.501948059148471,0.88991715156943,0.6712328767123288,1.0,1.0,2/14,6.32%,SLC18A2;GPER1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.3957629948668005,-0.8896456050968227,0.5185185185185185,1.0,1.0,4/37,3.89%,GALR3;DRD4;HRH2;HRH1
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5012688294433594,0.8893597269617749,0.6060606060606061,1.0,1.0,2/14,11.39%,IGF1;HGF
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.3737916625886117,-0.8891446800123455,0.5862068965517241,1.0,1.0,5/45,6.58%,PER2;PSAT1;CYP7B1;OSBPL3;SLC27A2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.46569226116370377,0.8891427645328611,0.6721311475409836,1.0,1.0,5/23,22.62%,GLRX;COX17;STAC;PDZK1;ABCB1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.46718837381615597,0.8888394441328732,0.6363636363636364,1.0,1.0,2/24,6.20%,ANXA1;CCDC39
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.5946747608043343,0.8887939502873983,0.7272727272727273,1.0,1.0,1/5,6.54%,CD81
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.5577818685257269,-0.8887047397078062,0.6590909090909091,1.0,1.0,3/6,10.56%,TWSG1;TNFRSF14;HFE
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4176353469367133,0.8886908001351763,0.6133333333333333,1.0,1.0,5/35,11.88%,AHR;SLC26A6;DUOX1;STAT1;CRHBP
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.4431179976121088,-0.8883752135130167,0.5142857142857142,1.0,1.0,6/14,13.81%,CES2;HPGD;PTGS1;AKR1C3;PTGR2;AKR1C1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.4270009029963315,-0.8883729783249859,0.5428571428571428,1.0,1.0,3/11,10.27%,SARDH;ALDH4A1;CHAC1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.5493337587649648,0.8882134382281699,0.6271186440677966,1.0,1.0,1/6,2.36%,ACAA2
prerank,GO_Biological_Process_2021__regulation of phospholipase A2 activity (GO:0032429),-0.5216431664288823,-0.8881650648092732,0.5882352941176471,1.0,1.0,1/5,0.77%,ANXA8
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.6009643695540149,0.888158046859101,0.6379310344827587,1.0,1.0,1/5,10.89%,TRAIP
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3999109297589682,-0.8880793893408503,0.7241379310344828,1.0,1.0,5/42,8.76%,TCOF1;TRIM71;PUM3;NANOS3;PCIF1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.4699181013832948,0.8879752146374909,0.6615384615384615,1.0,1.0,3/18,18.64%,LCP1;FHOD1;RHOQ
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4316542164634973,-0.8879125792689109,0.5833333333333334,1.0,1.0,5/21,20.71%,TGFA;GPRC5A;BTC;TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5007326403341237,-0.8875408793737761,0.6666666666666666,1.0,1.0,2/9,11.70%,CBARP;BIN1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.46892434879634454,0.8873377805011333,0.6825396825396826,1.0,1.0,8/30,24.96%,SFTPD;VSIG4;CD80;PDCD1LG2;TIGIT;HLA-DRB1;CEACAM1;CEBPB
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.45571247904642986,0.8871469498171136,0.65625,1.0,1.0,8/28,25.60%,CCDC39;ODAD1;ZMYND10;DNAI1;ODAD2;DRC1;CCDC63;ODAD3
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.34609036659352466,-0.8868043174334107,0.5555555555555556,1.0,1.0,20/89,15.25%,EHF;MFSD2A;OSR1;PTCH1;TRIM71;TST;RHCG;CDK1;PKD2;CPT1A;TAGLN;GSTK1;ALDH1A2;PROX1;AKR1C1;DNPH1;FGFR2;SNAI2;DLL1;PIH1D1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.44027036883263815,0.886612571391844,0.6883116883116883,1.0,1.0,8/35,25.51%,DTL;TRIM25;RAG1;RBX1;ATXN7L3;PAF1;WAC;RNF20
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.391252403137062,-0.8865972312237648,0.6666666666666666,1.0,1.0,2/23,3.90%,SKAP1;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.4413624743273883,0.8860555396009595,0.6351351351351351,1.0,1.0,6/26,21.15%,SFTPD;VSIG4;CD80;PDCD1LG2;CRTAM;HLA-DRB1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.4053535562669448,-0.8858139542297372,0.5588235294117647,1.0,1.0,7/23,13.73%,ST3GAL3;B4GALT2;ST3GAL2;CHST6;PRELP;ST3GAL4;B4GALT4
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.5148494175780367,0.8857138694260493,0.6607142857142857,1.0,1.0,1/12,3.08%,PTPRC
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.40911289545198304,0.8855638880003385,0.6933333333333334,1.0,1.0,9/72,9.34%,ITGB2;KIF14;TNFRSF1B;CCL5;WNT5A;HLA-F;ITGAM;DDIT4;REST
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.3683357584482373,0.8855421633498771,0.7,1.0,1.0,8/115,6.07%,LRP4;TRIL;TSPAN11;LMOD1;FBXL7;TMEM35A;PCDH18;SLC17A8
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5782276702893477,-0.8854521499626992,0.6956521739130435,1.0,1.0,2/5,20.27%,HMGCL;IVD
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.5374077060033269,-0.885440484012616,0.6304347826086957,1.0,1.0,3/5,31.44%,SETMAR;UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.5374077060033269,-0.885440484012616,0.6304347826086957,1.0,1.0,3/5,31.44%,SETMAR;UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.36347191306254395,-0.885400630083858,0.631578947368421,1.0,1.0,23/77,23.74%,PNKP;EPHB2;MEN1;ENSA;PID1;DAB2IP;SLIT2;P3H1;G6PD;CHP1;IMPACT;CRKL;PPIA;TRAF3IP1;NIBAN1;OCLN;MAPT;INSM1;PTPA;XDH;PLPP3;PPP1R16B;PRKN
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3413108201031429,-0.885304174352243,0.7,1.0,1.0,9/82,7.73%,PM20D1;NGF;BCL2;TYRO3;APOE;SLC30A10;ADAM8;PTPRZ1;KDM2B
prerank,PanglaoDB_Augmented_2021__NK Cells,0.37573213459826754,0.8850733712573337,0.6623376623376623,1.0,1.0,24/81,19.06%,CYTIP;ARHGAP9;ITGAX;GMFG;CCL5;AHR;PTPRC;FCGR3A;SASH3;TGFB1;ITGAM;ITGA2;LAIR2;CD244;THEMIS;PSTPIP1;TAGAP;ZAP70;MYO1F;ITK;SIRPG;TIGIT;PARVG;CD8B
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),-0.5443802230123483,-0.8848375851968832,0.6190476190476191,1.0,1.0,2/6,14.43%,NUDT4B;FHIT
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.3278615611643062,-0.8845793966574638,0.65,1.0,1.0,24/164,13.71%,MFSD2A;SYNJ2;PNPLA3;DGKD;CRLS1;VAC14;PLA2G5;GPD1;CPNE6;PLD2;PI4KB;LPCAT2;PLA2G4C;PGS1;CHKA;PEMT;RAB5A;PITPNM1;AGPAT2;MTMR14;SLC44A5;MTMR8;PITPNM3;RUFY1
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.5186710263972291,0.8843136483029056,0.6111111111111112,1.0,1.0,1/12,3.01%,WNT5A
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.3862904401501578,0.8842888025768244,0.6103896103896104,1.0,1.0,15/91,19.32%,PLA2G10;TLR2;PTPRC;DDIT4;IFIT1;ZDHHC11;IRF1;STAT1;AGBL5;IFI6;ISG15;OAS2;TRIM5;F2RL1;EXOSC4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4871429094108077,0.8841652370214806,0.6811594202898551,1.0,1.0,1/15,2.77%,ACOX2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5148091522311523,0.8838706925836857,0.6461538461538462,1.0,1.0,2/16,8.70%,TNFRSF1B;DAAM2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.3819276278607221,-0.8837694633118064,0.6153846153846154,1.0,1.0,11/26,25.43%,UBE2D4;ANAPC2;CDC26;UBE2E3;UBE2L5;ANAPC13;UBE2L3;ANAPC7;PRKN;UBE2A;UBE2B
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.36234345378749966,0.8837075241520211,0.6811594202898551,1.0,1.0,14/96,11.92%,TIMP3;C1QTNF1;PRRX1;LMOD1;FBXL7;LOX;PCDH18;TGFB1;ACTA2;DCN;ANGPTL2;COL1A1;ADGRL4;COL6A2
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.39630030384684906,-0.8836441283141989,0.6666666666666666,1.0,1.0,3/27,8.81%,KMT2B;MEN1;DYDC1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.543061873012435,0.8835743348195805,0.7285714285714285,1.0,1.0,6/9,40.86%,YOD1;DERL2;SVIP;ERLEC1;OS9;UBE2G2
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.3403601229360921,-0.8830347686828417,0.75,1.0,1.0,11/142,4.51%,NR4A1;TACR3;NPTX2;PDLIM3;FOS;PRKCD;TYRO3;FGF18;JUNB;LHX2;TST
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.5262730078559665,-0.882874004667724,0.6,1.0,1.0,3/5,29.88%,MAPT;PRKAA2;TPPP
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.32495774762046936,-0.8824910991927879,0.6842105263157895,1.0,1.0,13/124,4.53%,FIBIN;PAMR1;ADAMTS12;EMP1;BOC;CALD1;FGF18;COL12A1;COL6A3;COL4A2;MMP2;SDC3;MATN1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.4373319822747998,0.8819752393435876,0.6712328767123288,1.0,1.0,12/46,23.60%,HAMP;FRRS1;ABCG2;ATP6AP1;FTH1;CP;FTL;NUBP1;SLC46A1;CYBRD1;CYB561A3;TF
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.37630239694922385,-0.8818219348090371,0.5757575757575758,1.0,1.0,7/27,13.73%,ST3GAL3;B4GALT2;ST3GAL2;CHST6;PRELP;ST3GAL4;B4GALT4
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3213688567423289,-0.8816721522057674,0.7777777777777778,1.0,1.0,16/125,11.92%,FOXO1;PRKCD;TWIST1;LIN28B;DHRSX;APOE;KHSRP;MEFV;ADAM8;PLIN5;TRIM8;PFKFB3;SNX33;PACSIN3;IRGM;TRIM14
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.39325275129565807,-0.8813262334507378,0.65625,1.0,1.0,5/40,8.54%,DGKD;SHC3;SLC30A10;TGFA;EFEMP1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.3240914910908883,-0.8811940789082133,0.7916666666666666,1.0,1.0,10/67,8.66%,APOB;CLDN4;APOH;PAH;DSG2;PTPRF;CPN1;ADGRG6;EPB41L4B;ALB
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.5285331734720293,-0.8810325141502784,0.6153846153846154,1.0,1.0,2/6,16.19%,CARD9;IL23A
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.43852924789443765,0.8809230900246472,0.6056338028169014,1.0,1.0,5/23,12.54%,PDE6H;GPER1;MMP9;AFAP1L2;PLAUR
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.4162502987349053,0.8808893049707697,0.6666666666666666,1.0,1.0,5/49,15.09%,CASQ2;WAS;CHMP3;VIL1;PSTPIP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.427833927691605,-0.8806109555176436,0.6060606060606061,1.0,1.0,2/13,3.90%,KIT;NR4A3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.39977622031369314,0.88059204463026,0.6973684210526315,1.0,1.0,6/67,9.72%,TMOD4;LMOD3;LMOD1;SIX4;PGM5;EPB41L4A
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.4644471373452125,0.8801809260119859,0.647887323943662,1.0,1.0,3/18,16.71%,SLC5A2;SLC5A9;SLC5A1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.4259955060145835,0.8800009713339149,0.6176470588235294,1.0,1.0,1/40,0.49%,LRP4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.42558488706406084,0.8799550543123452,0.6911764705882353,1.0,1.0,6/36,9.29%,AIM2;S100A13;WNT5A;USP50;NLRP12;NLRC4
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5567920037033373,0.8799276820915177,0.6730769230769231,1.0,1.0,1/6,4.05%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.510138339395502,0.8797666060675131,0.6666666666666666,1.0,1.0,6/8,41.95%,SPX;CARTPT;BBS2;MKKS;PPARA;LEP
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.5262353446952788,-0.8795789663879753,0.5526315789473685,1.0,1.0,1/8,2.41%,PRKCD
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.539286590962815,0.8792796878488998,0.6551724137931034,1.0,1.0,2/9,15.97%,PPT1;ATP6AP2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.38872886540560664,-0.8792311385032795,0.631578947368421,1.0,1.0,7/36,17.41%,PHLDB2;SKA1;GAS2L2;MAPRE1;MARK2;CAMSAP3;TRAF3IP1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.5691976727922659,0.8788920662181376,0.6891891891891891,1.0,1.0,1/6,13.43%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5167106573770093,0.8786743162879563,0.6428571428571429,1.0,1.0,6/11,35.38%,DDX3X;PARK7;KAT5;TERF2IP;RAPGEF3;CAMK1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.31506759569508425,-0.8786709997442185,0.7368421052631579,1.0,1.0,8/153,4.12%,CD38;SKAP1;BTN3A2;BCL2;CSK;HLA-DQB1;CD247;SH2B2
prerank,GO_Biological_Process_2021__androgen biosynthetic process (GO:0006702),-0.537328083875003,-0.8785557009899969,0.6190476190476191,1.0,1.0,2/6,19.77%,HSD3B2;MED1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3579442899791992,0.8783083975848207,0.7333333333333333,1.0,1.0,17/162,16.67%,LRP4;NOTUM;PSMB9;WNT5A;ALPK2;SHISA6;DAB2;MCC;HIC1;IGFBP6;DKK2;SOX9;GLI3;SFRP4;CYLD;LATS2;PSMC5
prerank,GO_Biological_Process_2021__glomerulus vasculature development (GO:0072012),-0.5088810127560733,-0.8782671857712937,0.59375,1.0,1.0,1/6,1.20%,OSR1
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.47173778838084385,-0.8781457671359653,0.6129032258064516,1.0,1.0,2/12,10.53%,EGR1;AKR1C3
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.508134970096467,0.8780312413261923,0.6933333333333334,1.0,1.0,2/14,16.85%,NLRP5;CFL1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5307015562078196,0.8779701454345816,0.6764705882352942,1.0,1.0,2/9,17.38%,TGM2;MAPK3
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5307015562078196,0.8779701454345816,0.6764705882352942,1.0,1.0,2/9,17.38%,TGM2;MAPK3
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4800661762559026,0.8778945128117529,0.6071428571428571,1.0,1.0,1/19,0.49%,LRP4
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4916994436622967,0.8777409685481191,0.6716417910447762,1.0,1.0,3/18,8.79%,HLA-F;IL12A;HLA-A
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.3244353289245491,-0.8776120925618011,0.8,1.0,1.0,6/106,5.93%,EYA4;PRDM5;PRKCD;HDAC10;USP36;CARM1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.4034654170651173,0.8773165964753062,0.7317073170731707,1.0,1.0,3/63,7.97%,PSMB9;CARD14;TNFRSF10A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.39910142093101014,0.8772725084533175,0.7142857142857143,1.0,1.0,8/77,11.39%,RRAS;WNT5A;FGF2;STAT5A;TGFB1;FLT4;PIK3CG;RHOB
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.3776413023158695,-0.8771976438382362,0.5714285714285714,1.0,1.0,1/31,0.70%,FBP2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.3446102446933747,-0.877057412596977,0.5909090909090909,1.0,1.0,7/75,5.28%,NR4A1;APOH;TIE1;FGF18;CDH13;VASH1;APOE
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.48228726507591435,0.876830857381271,0.6351351351351351,1.0,1.0,6/18,27.35%,COX17;BCS1L;COX20;COX16;COA3;TIMM21
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.48856144589659134,0.8766607972780924,0.640625,1.0,1.0,4/13,20.30%,RFK;PAICS;ADSS1;IMPDH2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.4449673898044374,-0.8765711001534755,0.6153846153846154,1.0,1.0,2/16,2.63%,OSR1;XYLT1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.5575834162178688,0.8764594582675646,0.7391304347826086,1.0,1.0,1/6,2.02%,GAD1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.3635179955034638,-0.8762122650661711,0.6666666666666666,1.0,1.0,15/98,15.75%,PER2;PRICKLE1;CRY1;USP4;MINAR1;FBXO4;COMMD1;HDAC3;RIPK2;ARRB2;U2AF2;CHP1;SIRT7;HSPBP1;MALT1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.5611757154420935,0.8761826342428171,0.6515151515151515,1.0,1.0,1/7,11.81%,CHMP3
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.47971553997141614,-0.8758271030511616,0.6285714285714286,1.0,1.0,1/9,6.42%,TNNC2
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.3677949592833195,0.8756523186354737,0.7692307692307693,1.0,1.0,14/102,10.43%,OIT3;AMBP;SLC28A1;ELOVL2;CLDN2;BHMT;ACOX2;CYP3A4;FAXDC2;PON1;F7;NPY1R;ALDOB;NR1H4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5012529663560723,0.8754363754051206,0.5970149253731343,1.0,1.0,3/10,18.33%,STEAP4;ASIC1;ALOX5AP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5012529663560723,0.8754363754051206,0.5970149253731343,1.0,1.0,3/10,18.33%,STEAP4;ASIC1;ALOX5AP
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.4302426274312529,0.8751597701911139,0.6710526315789473,1.0,1.0,4/36,14.76%,DDX20;STRAP;GEMIN4;SNRPD2
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.5758971970628838,0.8751236254143293,0.7213114754098361,1.0,1.0,2/6,27.16%,CYBA;HCCS
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.40177039254208063,0.8749502494202447,0.7066666666666667,1.0,1.0,11/45,19.83%,HSPA1L;HSPA8;DNAJB1;HSPA5;DNAJA1;HERPUD1;HSPE1;HSPA2;HSPH1;DNAJB4;HSPA4
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.541707225467403,-0.8749045837519667,0.5813953488372093,1.0,1.0,1/5,10.33%,WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.541707225467403,-0.8749045837519667,0.5813953488372093,1.0,1.0,1/5,10.33%,WRAP53
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.49144589409711936,0.8747692528054898,0.6949152542372882,1.0,1.0,1/14,5.93%,RNF26
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.4765857715328395,-0.8747198241135545,0.5945945945945946,1.0,1.0,2/11,9.11%,RALB;LRSAM1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.5544124683349729,-0.8742045092946857,0.6666666666666666,1.0,1.0,2/6,8.84%,TTBK1;SELP
prerank,MSigDB_Hallmark_2020__Apical Junction,0.3531368317081134,0.8740901272331646,0.7411764705882353,1.0,1.0,25/180,16.82%,NRAP;CLDN6;RRAS;PIK3R3;PTPRC;CLDN18;TSPAN4;ACTG1;CD99;VASP;ITGA2;MMP9;CLDN5;LAMC2;SYK;CLDN9;LDLRAP1;ALOX15B;RASA1;TGFBI;VWF;NEXN;MSN;YWHAH;FYB1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.3324175879621926,-0.8736856229409673,0.8,1.0,1.0,6/75,3.78%,EHF;MLPH;CLDN4;PDLIM3;LAMA3;DCDC2
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.581871241999754,0.8736433379068308,0.6724137931034483,1.0,1.0,3/7,23.02%,SCTR;AQP4;AQP11
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.31864867638041333,-0.8734197847553617,0.8,1.0,1.0,36/112,21.16%,PTGFRN;PTPRF;RHBDF1;AGRN;ERBB2;TMEM63B;ASS1;TMEM125;PERP;EPB41L4B;HID1;GNA11;INSRR;OGDH;DAB2IP;GPC1;PCDH1;CDS1;MAL2;TMEM117;CAMSAP3;SDC4;DSP;ST14;FKBP9;DAG1;TSPAN1;PTPN21;ADCY6;SYT7;JUP;ACO2;TNKS1BP1;CDC42BPB;HDAC11;EPB41L1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.5518236027515198,0.8732347885907706,0.7288135593220338,1.0,1.0,2/7,17.09%,UGT8;B3GALT2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.5019307704493522,0.8731726689183292,0.6363636363636364,1.0,1.0,1/11,9.95%,IGF1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4253242939577869,-0.8731337395882334,0.5357142857142857,1.0,1.0,1/13,2.70%,TWIST1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2837167622401991,-0.873039338311958,1.0,1.0,1.0,123/966,14.11%,NPAS4;RFX6;CD38;GALR3;POU3F1;SKAP1;ETV5;NR4A1;EHF;OSR1;IL11;TEAD2;WNT3A;ERG;H1-4;BAMBI;ETV1;CREB3L4;FOS;FOXO1;FGF1;ZNF496;ZSCAN21;KMT2B;TWIST1;EGR1;JUNB;CDH13;IFI16;NR4A3;MAML1;ADCYAP1;LHX2;KLF10;GABPB2;WBP2NL;SP7;SMARCB1;QRICH1;BCL9L;APOE;LBH;FZD7;AGRN;SOX12;ERBB2;MYOCD;BCLAF3;WNT7A;LBHD1;CTCF;KDM8;ASCL1;IRF5;BARX2;MEN1;CCN1;STAT5B;ACVR1;HES1;FANK1;PRDM15;SENP1;PID1;NFATC3;PPARGC1B;SSBP3;PKD2;SERPINE1;RARB;FOSL1;MLIP;TFDP1;POU2AF1;AGO2;CITED4;BPTF;HDAC3;DLX1;GDF7;DAB2IP;ETS1;HMGN5;NR1D1;FSTL3;SNX5;XPC;ATF3;GRIN1;NIBAN2;HSF1;NAMPT;ZMIZ1;RGMA;TFE3;RLF;TRIM44;RIPK2;MLX;PAX3;CDK5RAP2;LDB1;CREB3L2;NFIB;PROX1;IL31RA;MED25;ATF1;ZNF263;RBL1;RNF10;MAP3K12;TFCP2;SMARCA4;ESRRB;CAND2;HIVEP1;TRIM45;ZNF268;SBNO2;BCL11B;TCF20;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.5172655700096949,-0.8729834683785335,0.6341463414634146,1.0,1.0,2/6,22.43%,IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.5172655700096949,-0.8729834683785335,0.6341463414634146,1.0,1.0,2/6,22.43%,IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.5059482714234269,-0.8729636872426119,0.6428571428571429,1.0,1.0,3/10,5.93%,BCL6;SOX12;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.3956733577706488,-0.8728847968016795,0.6333333333333333,1.0,1.0,1/28,0.70%,ADRA1A
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4286687096655589,0.8728702534475768,0.6941176470588235,1.0,1.0,4/45,5.26%,SMOC1;MAB21L1;HIPK1;FREM2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.41414465707644615,-0.8726182173032359,0.6333333333333333,1.0,1.0,2/24,2.70%,NGF;TWIST1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.38791420551125677,0.8723952329682045,0.7532467532467533,1.0,1.0,18/76,23.33%,DISC1;SP100;IFIT1;LEF1;DAB2;ARHGAP28;LRPAP1;CDKN1A;TFIP11;PLN;MITD1;EFHB;HMGA2;TMC8;NFKBIA;PARK7;ZFPM1;CTSZ
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.4328793727534327,-0.8718024805076192,0.6818181818181818,1.0,1.0,4/17,10.35%,DTX1;ASCL1;HES1;DLX1
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.5544783297041065,0.8717003676619717,0.6610169491525424,1.0,1.0,2/6,17.09%,UGT8;B3GALT2
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.5544783297041065,0.8717003676619717,0.6610169491525424,1.0,1.0,2/6,17.09%,UGT8;B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5329080321944182,0.8716869788340265,0.6857142857142857,1.0,1.0,5/8,28.14%,NPPA;ALG10B;LRRC38;LRRC55;NOS1AP
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.4447711349599219,0.8715594552987495,0.6714285714285714,1.0,1.0,5/22,19.77%,BHMT;PCMT1;ETFBKMT;EEF2KMT;METTL21C
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.5620578422141835,-0.8713307275774463,0.6842105263157895,1.0,1.0,2/6,8.50%,DHFR;FPGS
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.35523075405864424,-0.8712888057348275,0.6944444444444444,1.0,1.0,2/33,0.98%,CLDN4;APOH
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.46570178234120485,-0.8712352628616995,0.6764705882352942,1.0,1.0,3/10,10.86%,PNP;CBFB;NKAP
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3647206866350352,0.8711640195543332,0.6714285714285714,1.0,1.0,12/143,14.86%,CASQ2;HIGD1C;CHCHD4;TMEM35A;TGFB1;CCDC39;VAMP1;CHMP3;COX7A2;CYBA;SRP19;ANLN
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.4476134805725758,0.8710292743661964,0.6714285714285714,1.0,1.0,11/29,29.70%,C3;GPER1;EIF6;PDK4;CEACAM1;PRKAB2;THRSP;STAR;HSD17B13;FITM2;CREBL2
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.544925818672543,0.871015272945463,0.65625,1.0,1.0,4/7,34.33%,LEF1;CEACAM1;RUNX1;HAX1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.39995567071190025,0.8707251537124291,0.675,1.0,1.0,2/57,5.35%,PSMB9;LMO2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.4181247541204721,0.8707135702590957,0.6285714285714286,1.0,1.0,2/33,7.87%,DONSON;RAD1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.3932638946197978,-0.8704724856544892,0.5142857142857142,1.0,1.0,2/25,1.46%,GCK;ENO3
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),0.5462315740054138,0.8704409204328682,0.6724137931034483,1.0,1.0,2/7,17.10%,HTR1B;CHRNB2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3458084821555399,-0.8703470192249994,0.6818181818181818,1.0,1.0,6/86,7.12%,MT1G;DRD4;CDH5;SLC30A10;RGN;SLC8A3
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.5641371106940619,0.8701918968025388,0.7241379310344828,1.0,1.0,1/6,5.41%,CYP4F12
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5305733359208575,0.8701423128764094,0.6825396825396826,1.0,1.0,3/9,21.61%,RAMP3;ANXA2;RAB29
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.443476327169472,-0.8697470832050306,0.6296296296296297,1.0,1.0,3/15,11.75%,BTN3A2;EMP2;CD8A
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.37769443985199513,0.8697106827622241,0.7402597402597403,1.0,1.0,14/86,19.08%,ITGB2;LYVE1;ECM2;ITGB6;ITGBL1;ITGA2;CD63;CD44;ANGPTL3;VTN;FN1;ITGB8;PARVG;THSD1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5023870436435038,0.8696841468399917,0.6721311475409836,1.0,1.0,3/11,23.27%,DAB2;MSN;RAB21
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.5373650788386386,0.8696779385361874,0.6567164179104478,1.0,1.0,1/9,5.95%,JCHAIN
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.4764647629260602,-0.8695755050138539,0.5714285714285714,1.0,1.0,3/11,23.41%,ITGA3;FYN;INSR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),0.5520921189206216,0.8695104194134796,0.7272727272727273,1.0,1.0,2/5,17.38%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),0.5520921189206216,0.8695104194134796,0.7272727272727273,1.0,1.0,2/5,17.38%,IL12A;CRTAM
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.5265253692726495,-0.8694451440517109,0.717948717948718,1.0,1.0,5/7,39.49%,NCSTN;GALNT11;ADAM10;PSEN1;APH1B
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),-0.5713141971299204,-0.868984289382497,0.6666666666666666,1.0,1.0,1/5,3.11%,UST
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3524592951673631,-0.8686687670454998,0.7857142857142857,1.0,1.0,22/50,27.00%,PHLDB2;PTPRA;PTPRJ;LDB1;SLK;LIMS1;CAMSAP3;COL16A1;RHOA;ABL1;VCL;S100A10;TSC1;DUSP3;PPM1F;DAPK3;BCAS3;PEAK1;MACF1;SRC;TEK;DMTN
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.4620331120474854,0.868520127174177,0.582089552238806,1.0,1.0,1/14,5.06%,TICRR
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2854333302672905,-0.8683470020231038,1.0,1.0,1.0,100/735,14.48%,NPAS4;RFX6;GALR3;SKAP1;ETV5;NR4A1;EHF;OSR1;IL11;WNT3A;ERG;ETV1;CREB3L4;FOS;FOXO1;FGF1;ZSCAN21;WWC1;TWIST1;EGR1;JUNB;CDH13;IFI16;NR4A3;MAML1;ADCYAP1;KLF10;GABPB2;SP7;SMARCB1;BCL9L;AGRN;SOX12;MYOCD;BCLAF3;WNT7A;ASCL1;IRF5;BARX2;MEN1;CCN1;STAT5B;ACVR1;HES1;PRDM15;SENP1;PID1;NFATC3;PPARGC1B;SSBP3;PKD2;SERPINE1;RARB;FOSL1;MLIP;TFDP1;POU2AF1;AGO2;CITED4;BPTF;HDAC3;DLX1;DAB2IP;ETS1;NR1D1;FSTL3;TERT;ATF3;GRIN1;HSF1;NAMPT;ZMIZ1;RGMA;TFE3;RLF;RIPK2;MLX;PAX3;LDB1;NFIB;PROX1;MED25;EAPP;ATF1;ZNF263;RBL1;RNF10;TFCP2;SMARCA4;ESRRB;HIVEP1;ZNF268;SBNO2;BCL11B;TCF20;FGFR2;SIRT7;MAPK7;KDM1B;RPS6KA3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.4701364369303367,-0.8682683737480327,0.6388888888888888,1.0,1.0,3/11,18.17%,FLNA;PKD2;NFKBIE
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.5216428898020813,-0.8682607492202213,0.6052631578947368,1.0,1.0,1/5,12.02%,DUT
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.4685956859577073,-0.8682237288709056,0.6,1.0,1.0,7/15,16.68%,PNP;NT5C1A;GPX1;DNPH1;NT5C;SAMHD1;ITPA
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.5080909308107296,-0.8680213769697515,0.6904761904761905,1.0,1.0,1/7,0.98%,APOH
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3288458188300308,-0.8679794457119776,0.8421052631578947,1.0,1.0,17/99,11.97%,CDH5;BAMBI;FOS;PDE3A;DUSP15;F11R;PARD3;HPGD;WNT7A;LPXN;FNTA;ACVR1;TWSG1;DLX1;TGFBR3;ZMIZ1;ARRB2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.40058657122687585,0.8678110903137767,0.6455696202531646,1.0,1.0,15/46,23.16%,MMP19;SCUBE3;MMP9;LCP1;MMP15;CD44;MMP11;TLL2;PLG;NOXO1;WASHC1;A2M;ADAMTS5;ELANE;BMP1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.5144910185115379,0.8677422401968339,0.7142857142857143,1.0,1.0,4/8,33.79%,PAICS;PRPS1;SHMT2;DPYD
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.36583970439894375,0.8675685064662298,0.7702702702702703,1.0,1.0,20/174,16.01%,CLCA2;MAPKAPK3;ADA;RRAD;TGFB1;IER5;CD81;DDIT4;CDKN2A;EI24;DRAM1;RPL36;CDK5R1;CCND2;ALOX15B;BTG1;CDKN1A;NDRG1;RPS12;TXNIP
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4233299763108416,0.8670470986514583,0.6438356164383562,1.0,1.0,3/38,5.82%,SLC12A7;SLC12A3;KCNJ15
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.5513859498708986,0.8669982545607957,0.6666666666666666,1.0,1.0,1/7,16.07%,THOC6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.5513859498708986,0.8669982545607957,0.6666666666666666,1.0,1.0,1/7,16.07%,THOC6
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.31443440150889107,-0.8665447933740626,0.65,1.0,1.0,26/95,19.61%,GCK;XKR7;HGFAC;SARDH;CACNG4;CRABP1;ABCC8;PRR36;TTBK1;WNK2;HID1;KIF26A;REEP6;IQSEC3;LINGO1;KCNH2;EBF4;CAMSAP3;PLPPR1;HCN3;SYT7;PDE9A;RIMBP2;PTOV1;FBLL1;COL26A1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.3772977746627659,0.8665216732441198,0.7435897435897436,1.0,1.0,23/103,19.22%,TIMP3;BLK;MANF;TGFB1;PSAP;IGF1;CFD;HGF;F8;TGFB3;CD63;A1BG;KNG1;LAMP2;TUBA4A;SELENOP;VWF;PLG;ITGA2B;ITIH4;FN1;THBS1;A2M
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.4362383781940926,0.8664167255048882,0.6933333333333334,1.0,1.0,11/29,30.09%,ANGPT2;SEMA3A;SEMA3B;SEMA3F;THBS1;ELANE;SEMA6A;SEMA4C;SEMA7A;SEMA4G;SEMA3E
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.304381735637381,-0.8663568434253578,0.76,1.0,1.0,15/100,11.57%,EPHX2;STS;MLYCD;CRABP1;FADS1;SLC25A17;ABCC8;SLC27A2;CRABP2;ALB;PEX13;GSTK1;PEX14;CEL;IDH2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.4968524216721949,-0.8663545017554921,0.6571428571428571,1.0,1.0,5/11,20.91%,OGDH;IDH2;AADAT;GPT2;GOT2
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.5117557652948765,0.8661158167569253,0.6607142857142857,1.0,1.0,3/7,22.69%,REST;SOX9;SOX6
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.5536370118685259,0.8660842181345715,0.6296296296296297,1.0,1.0,2/6,22.62%,PDZK1;ABCB1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3481650251168479,0.8658704882579882,0.7906976744186046,1.0,1.0,40/197,25.20%,NEK2;CDC25A;FBXL7;SPDYA;BORA;CCNG2;CRLF3;CEP72;CDKN2A;CEP70;CCND1;FOXM1;CDKN1B;CCND2;CCNE2;DYNLL1;CCNI;CDKN1A;TUBA4A;FBXL3;LATS2;CCNA2;RCC1;PKMYT1;PHLDA1;CEP76;CDKN2C;TPD52L1;CCNB1;DCTN1;ABCB1;MASTL;CCNI2;TACC3;CCNB3;DCTN3;YWHAG;TUBB4B;CDKN2D;CETN2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.39447646618160526,-0.86536957827963,0.6785714285714286,1.0,1.0,3/30,5.67%,PPP6R1;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.44215989122259003,0.8650455451281184,0.6527777777777778,1.0,1.0,2/31,3.20%,ANXA1;SHCBP1L
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.3351323921828467,-0.8649374576883609,0.7391304347826086,1.0,1.0,22/92,13.94%,ST3GAL3;GSTT2B;CHPF2;UST;PAPSS2;GSTZ1;GSTM5;B4GALT2;CBS;CHST11;CHST12;ST3GAL2;CHAC1;GSTK1;CHSY1;CSGALNACT1;CHST6;PRELP;VCAN;ST3GAL4;B4GALT4;GSTO2
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.5339919209731785,-0.8649252570838808,0.6136363636363636,1.0,1.0,2/6,16.22%,SLC4A11;TRPV4
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.3996329443864848,0.8646708609918062,0.7230769230769231,1.0,1.0,9/59,11.85%,TLR2;CSF2RA;TNFRSF1B;TGFB1;OSMR;IRF1;STAT1;IL7;CSF3R
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.39826808070305186,0.8646416218317977,0.676056338028169,1.0,1.0,13/60,20.00%,CDC25A;SPDYA;CRLF3;CDKN2A;MAP3K11;CCND1;CDKN1B;CCNE2;CDKN1A;LATS2;CCNA2;RCC1;CDKN2C
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5120965213109163,-0.8646028184888565,0.6097560975609756,1.0,1.0,2/7,18.09%,SENP1;SENP5
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.421242360720381,0.864589216287286,0.6447368421052632,1.0,1.0,7/34,16.81%,HEY2;CDK5R1;CELSR1;RASA1;ADGRG1;HEY1;PLG
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.3456076449921539,-0.8643989914729275,0.6785714285714286,1.0,1.0,4/54,3.40%,P2RY10;NGF;PRAG1;F11R
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.5756689274951572,0.864121195359947,0.6666666666666666,1.0,1.0,1/5,19.53%,TRNT1
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.393166676841,-0.8639019674504271,0.6451612903225806,1.0,1.0,4/24,8.68%,SYT12;DOC2B;SYT17;SDF4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.5647446788075415,0.8638425365159131,0.6666666666666666,1.0,1.0,1/6,10.60%,RAB11A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.3378325122057029,-0.8638251379864321,0.8095238095238095,1.0,1.0,21/125,12.42%,MFSD2A;SYNJ2;DNAJC30;KLHL17;SLC6A17;PTCH1;MDGA1;JHY;CX3CR1;AMIGO2;MACROH2A2;BPTF;POU6F1;PITPNM1;EML1;GRIN1;TUBGCP2;CDK5RAP2;UTP3;NFIB;PROX1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.5345255876518323,0.8636303582355233,0.6885245901639344,1.0,1.0,2/8,10.62%,DAO;SDS
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.5433239385637461,0.8635750636232533,0.6911764705882353,1.0,1.0,4/7,35.17%,CDCA5;SPI1;VCPIP1;WAPL
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.2816664126376164,-0.863492645210662,1.0,1.0,1.0,62/283,18.15%,CFAP46;CFAP221;IFT88;ABCC4;DCDC2;MKS1;CNGA4;EXOC7;CFAP410;HAUS1;RP1L1;JHY;SCLT1;EHD4;PARVA;TTC36;PCM1;KIF17;CEP83;TMEM138;FLNA;CDK1;CNTRL;GBF1;RILPL1;ALMS1;DZIP1L;RPGRIP1L;CEP135;CLUAP1;MAPRE1;ASAP1;EHD3;RAB11FIP3;CDK5RAP2;CFAP44;ABLIM3;CEP250;AVIL;FBF1;SDCCAG8;CEP152;CILK1;DNAH5;CFAP70;HAUS7;DYNC2I1;CSNK1E;B9D1;IFT81;AHI1;MARK4;CCDC57;CCDC40;TCTN1;TEKT3;CEP290;ARMC9;TRAF3IP1;KIF27;CYS1;AKAP9
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.37510577699437503,-0.8633051288273729,0.6666666666666666,1.0,1.0,3/29,3.62%,FGF1;FGF18;CREB3L1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.402445088212497,-0.8632191701359602,0.6756756756756757,1.0,1.0,4/32,5.57%,DRD4;IL11;APOE;RHBDF1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.38048411468486654,0.8630115538674915,0.6973684210526315,1.0,1.0,21/64,18.84%,ITGB2;CYTIP;TNFRSF1B;CCL5;PTPRC;SASH3;HLA-F;NT5E;GPR183;HLA-DPB1;PSTPIP1;TAGAP;MAF;ZAP70;ITK;SIRPG;CD4;ALOX5AP;TIGIT;ITGB8;PARVG
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.43024432387363964,0.8629880656312753,0.6486486486486487,1.0,1.0,8/26,19.13%,TLR2;WNT5A;IL7;TNFSF4;ALOX15B;CSF1R;AGER;F2RL1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.4889668764503283,0.8629646628297846,0.7164179104477612,1.0,1.0,3/19,16.91%,PFKFB2;IGF1;PRXL2C
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.4889668764503283,0.8629646628297846,0.7164179104477612,1.0,1.0,3/19,16.91%,PFKFB2;IGF1;PRXL2C
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.37986058662591776,0.8627201317015244,0.7088607594936709,1.0,1.0,11/67,20.19%,LMOD1;C15ORF62;BAIAP2L1;VASP;HCK;VIL1;GPSM2;ALOX15;CARMIL1;F2RL1;LMOD2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.4971290799724925,-0.8625851143147703,0.5869565217391305,1.0,1.0,1/7,5.14%,NIPSNAP2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.4373060515796304,0.8624938586293681,0.6708860759493671,1.0,1.0,7/23,23.04%,IL12A;TNFSF4;HLA-DPB1;SIRPG;IGLL1;HLA-DPA1;XRCC6
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.2728929136343482,-0.8623926072494559,1.0,1.0,1.0,57/362,17.62%,GRK5;TRIB2;LMTK3;DGKD;ERG;PRKCD;CSK;PRAG1;LIMK1;BCKDK;STK10;MAML1;MAST2;PNKP;ERBB2;EPHB2;TRIB1;TTBK1;ACVR1;MYLK3;PAK6;ERN1;WNK2;CDK1;BCR;DAPK2;NTRK1;COPS8;MAPKAPK2;TAOK2;CDK4;GK5;MAP3K12;CDK14;CILK1;SIK3;CDK6;FRK;MARK2;CSNK1G2;XYLB;CSNK1E;WNK3;FYN;EIF2AK3;MAP3K13;NEK10;MARK4;MARK3;PI4KA;PRKCA;MATK;CDK5;TSSK4;PAK3;ABL1;GRK4
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.39193660231686694,0.8622211247430571,0.6901408450704225,1.0,1.0,7/48,16.75%,HSPA1L;ARIH2;PINK1;TP53BP2;RHOU;BBC3;YWHAH
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.5516561976839947,0.8620670602064399,0.6612903225806451,1.0,1.0,2/7,24.99%,SIGLEC1;CAV2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.500523875329798,0.8619696979659688,0.7166666666666667,1.0,1.0,2/12,10.43%,TGFB1;NR1H4
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.35298644029581056,-0.86191018448933,0.76,1.0,1.0,9/62,7.86%,MLPH;CLDN4;WWC1;ESRP1;RND3;PTPRF;RHBDF1;CRABP2;PERP
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate metabolic process (GO:1901908),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate catabolic process (GO:1901907),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,GO_Biological_Process_2021__diphosphoinositol polyphosphate metabolic process (GO:0071543),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine pentaphosphate metabolic process (GO:1901906),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,GO_Biological_Process_2021__diadenosine hexaphosphate catabolic process (GO:1901909),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,GO_Biological_Process_2021__adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),-0.5336399174741495,-0.86182599466919,0.6136363636363636,1.0,1.0,1/5,7.22%,NUDT4B
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.3274056167675556,-0.8617741266123609,0.6666666666666666,1.0,1.0,28/106,17.37%,SEZ6;MCOLN3;SEZ6L;CPNE6;RPH3A;TNR;DPP6;SRRM4;WSCD2;KCNJ6;CATSPER2;AP3B2;ADCY2;GRIA4;CACNG2;PROX1;CELF4;CACNA1A;CYP46A1;FRRS1L;C4ORF50;CDH22;SV2B;OTUD7A;KCNH2;TCEAL6;SVOP;PKD2L1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3710114801927271,0.8617060046995785,0.7349397590361446,1.0,1.0,9/89,15.88%,MCM2;MCMDC2;POLQ;MCM3;RAD54L;MEIOB;RPA3;RNF138;RECQL4
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.3823476335253775,0.8616003381447258,0.6973684210526315,1.0,1.0,10/75,15.33%,TBX1;LRP2;GSDME;MYO3B;COL4A3;COL1A1;MARVELD2;GRXCR2;CDC14A;GRXCR1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.5057487645108192,0.8615256720357009,0.6901408450704225,1.0,1.0,2/12,4.59%,TULP1;RP1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.39271038254409896,-0.8613656233269106,0.6451612903225806,1.0,1.0,4/21,12.13%,ZNF703;DLX1;TGFBR3;ITGA3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.3356478776508059,0.8613570691409135,0.8085106382978723,1.0,1.0,57/381,17.83%,GATA4;TBX1;CLEC5A;SMAD6;CAPN13;KIF14;ANXA1;LRP2;WNT5A;FGF20;SIX4;CRLF1;CLCF1;ALOX12;CARD14;FLT4;ANGPTL4;SOCS2;MMP9;LEF1;HSPA5;DNAJA1;PINK1;DAB2;SOD2;IGF1;ITGA5;HCK;NR1H4;AXL;NAA38;PPT1;MYDGF;RPS3A;DDX3X;HGF;IL7;TGFB3;PLAUR;RPS27A;IFI6;PDK4;CCND2;SOX9;FOXB1;RASA1;CD44;THOC6;SET;CFL1;COPS5;IL4;MAPK3;BEX3;MAG;HTR2B;PTRH2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.47954140641536996,-0.8613369180388536,0.6,1.0,1.0,4/11,21.14%,MGARP;SPAST;MAPT;TRAK2
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.5581399890341063,0.8612834482220111,0.75,1.0,1.0,1/7,12.79%,TRMT10A
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.3660138984006721,-0.8612118561487445,0.6451612903225806,1.0,1.0,8/37,12.82%,SCUBE1;MDGA1;HSPB1;RHCG;AKAP7;DCBLD2;CROCC;SULF2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.4371593321157062,0.8609209866822871,0.7096774193548387,1.0,1.0,3/22,11.88%,ACE2;RAMP3;CRHBP
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.3692578727653246,-0.8607632827288235,0.6111111111111112,1.0,1.0,3/20,10.81%,SLC25A17;PEX13;PEX14
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.5606827919585328,0.8607482780113341,0.6521739130434783,1.0,1.0,1/6,4.80%,STAT5A
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.4527081275047397,0.8607195458348749,0.7076923076923077,1.0,1.0,3/19,11.81%,TRIM62;TRIM25;CHMP3
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.5369166823680471,0.8605646462034277,0.68,1.0,1.0,2/11,13.25%,VAPB;TRDN
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.4494937363828566,-0.8604200632838468,0.7297297297297297,1.0,1.0,8/20,18.23%,CHPF2;CHST11;CHST12;CHSY1;CSGALNACT1;VCAN;CSPG5;CHST3
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4175073619331511,-0.8604141394585247,0.6486486486486487,1.0,1.0,5/13,22.40%,MUS81;MDC1;RAD17;RAD9A;NEK11
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.49828374501899597,0.8603207778195754,0.7205882352941176,1.0,1.0,1/16,1.32%,DISC1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.36312854916690585,0.8602663753657543,0.7875,1.0,1.0,3/111,2.36%,AQP3;PSMB9;ACAA2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.40420674559060177,-0.860159093507349,0.625,1.0,1.0,10/26,24.39%,CELF5;LUC7L;CELF4;SF3A2;CELF2;SFSWAP;SF3A3;PUF60;PRPF39;SETX
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.42213797410808973,-0.8600950402714848,0.65625,1.0,1.0,6/27,13.88%,TWIST1;VASH1;SLC30A10;TERT;RBL1;CDK6
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.5383389709905613,-0.8600656020229198,0.6,1.0,1.0,3/5,33.34%,BCAT2;BCAT1;HIBADH
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.4087229276846207,0.8598281627384279,0.68,1.0,1.0,3/47,11.81%,ANXA1;ATP6AP1;CHMP3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.4739827601896233,-0.8598166015086348,0.6216216216216216,1.0,1.0,3/11,15.61%,SMARCB1;PIH1D1;HDAC5
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.5629294764959478,0.8597563201084107,0.7049180327868853,1.0,1.0,3/7,24.01%,HEY2;SNAI1;ENG
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.3490242290994503,-0.85975582568964,0.6206896551724138,1.0,1.0,4/47,3.90%,GCK;ENO3;PC;NR4A3
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.4579372287296382,0.8596316730503685,0.746268656716418,1.0,1.0,5/18,19.48%,PTPRC;IFNK;PIK3CG;MSN;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.38095149483995777,-0.8594501286498469,0.6764705882352942,1.0,1.0,2/24,1.79%,CD38;BCL2
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.4678463306241253,-0.8592131812750858,0.6857142857142857,1.0,1.0,2/15,2.67%,APOH;LIPC
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.39016734546888077,-0.8591577267693675,0.5483870967741935,1.0,1.0,3/31,11.90%,KDM8;NR1D1;IRGM
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4573817003222094,0.8588202636258951,0.6944444444444444,1.0,1.0,1/24,1.57%,TLR2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.49993400127708104,-0.8585025150828343,0.7435897435897436,1.0,1.0,2/8,11.22%,POLR1A;TERT
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.40263638850094474,-0.8584624469345137,0.6153846153846154,1.0,1.0,1/16,1.63%,PNPLA3
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.45248960591674015,0.858392193075156,0.6666666666666666,1.0,1.0,1/15,4.04%,A4GALT
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.4993358356183579,0.8583413202714361,0.6557377049180327,1.0,1.0,2/10,25.52%,ATP1A4;ATP1A1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.47739855476698084,-0.8581301446154689,0.6285714285714286,1.0,1.0,4/13,14.56%,CPSF1;ERN1;CSTF2;CPSF7
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.46135874279696537,0.8580776169665083,0.6451612903225806,1.0,1.0,3/14,22.75%,CRHBP;WBP2;LOC400499
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.4523683696026329,0.8579531414842452,0.6607142857142857,1.0,1.0,1/14,7.91%,SRSF9
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.4863262251141046,-0.8579091498314019,0.78125,1.0,1.0,4/10,23.84%,CCN3;SLIT2;GREM1;C5
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.5941674190091231,0.8577988184122464,0.7301587301587301,1.0,1.0,2/5,20.21%,ABCC2;SLC46A1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.35158917824147534,-0.8576763882053078,0.72,1.0,1.0,2/62,0.56%,TSKU;APOB
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.35872908137128523,-0.8575928265189847,0.6923076923076923,1.0,1.0,7/62,8.92%,SBK1;PRKCD;GALNT13;MAP3K10;TTBK1;ACVR1;CDK1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.4191804363912376,0.8573896953222093,0.7466666666666667,1.0,1.0,9/42,14.59%,SP100;HLA-F;IFIT1;HLA-A;IRF1;STAT1;IFI6;IRF4;ISG15
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.4191804363912376,0.8573896953222093,0.7466666666666667,1.0,1.0,9/42,14.59%,SP100;HLA-F;IFIT1;HLA-A;IRF1;STAT1;IFI6;IRF4;ISG15
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.322280546022797,-0.8572727290144991,0.6666666666666666,1.0,1.0,6/55,15.95%,IFT88;AUP1;RAB7A;KLHL3;ATG2A;LGALS8
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.48972019879127837,0.8571662519990635,0.7076923076923077,1.0,1.0,4/12,17.57%,RENBP;PON1;PON3;ACOT4
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.3870826371233013,0.8570397021558659,0.7105263157894737,1.0,1.0,4/59,8.97%,ENPP2;PLA2G10;LPIN3;PON1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.4569156657700557,0.8568201667878167,0.6811594202898551,1.0,1.0,2/29,8.97%,PLA2G10;PON1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.44080464142124054,0.8567131240474858,0.6714285714285714,1.0,1.0,7/21,33.76%,CHMP3;DENND10;CHMP1A;SORT1;CHMP4B;RILP;CHMP2B
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3733632089987861,0.8563509926941524,0.7164179104477612,1.0,1.0,12/85,15.20%,TSHR;FCGR3A;GPR27;SCTR;GPHB5;RAMP3;ADRB1;HCK;RXFP2;SYK;GGT5;ADCY7
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.333215499276415,-0.8561880496299179,1.0,1.0,1.0,25/167,13.28%,SPRY4;SPRED2;ENO3;EMP1;BCL2;DCPS;RGS16;IKZF4;SELL;PTCH1;PNP;LTB;CDCP1;HOPX;GBP4;TWSG1;SELP;ITIH5;NCS1;ECM1;ALCAM;MAPKAPK2;PTH1R;PLEC;ST3GAL4
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.4321198006769138,0.8560093340092935,0.7088607594936709,1.0,1.0,1/25,0.50%,CLEC5A
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.48897796955669937,-0.8558242088785517,0.7058823529411765,1.0,1.0,2/9,10.13%,FOXO1;ATP6V0A2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.38706218748700355,-0.8556790593462279,0.65625,1.0,1.0,6/27,15.36%,RHCG;WNK2;SLC4A11;KLHL3;SLC30A8;WNK3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.40399186803479636,-0.8556537411377952,0.6818181818181818,1.0,1.0,5/27,6.72%,WNT3A;SLC17A6;SYNDIG1;WNT7A;PLD2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.4659955075551055,-0.8552657846316396,0.7307692307692307,1.0,1.0,1/13,5.28%,APOE
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.5532654659283502,-0.855040864716065,0.6176470588235294,1.0,1.0,2/6,12.42%,WNT7A;PROX1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.5202449655313084,0.8550296977679069,0.7361111111111112,1.0,1.0,2/15,4.59%,TULP1;RP1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.40869148589378274,0.8550065675036604,0.6376811594202898,1.0,1.0,9/41,12.39%,CLDN2;CLDN6;CLDN18;ACTG1;CLDN5;MARVELD2;MARVELD3;ECT2;CLDN9
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.44134741522476506,0.8548176745885208,0.7076923076923077,1.0,1.0,2/25,5.92%,GLRX;NUDT13
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.49323529685149464,0.8547214782471069,0.640625,1.0,1.0,2/12,7.60%,ELOVL2;HACD4
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.5078881363666714,-0.8543505701759624,0.6041666666666666,1.0,1.0,2/8,11.87%,NOD1;RIPK2
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.5102108778254079,0.8543183339843066,0.6833333333333333,1.0,1.0,2/10,21.23%,RHOG;OLFM4
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3444985595786554,0.8542968756362239,0.8068181818181818,1.0,1.0,16/182,12.69%,ESR1;LPAR1;S100A13;WNT5A;TRIM62;TRAF3IP2;TRIM25;NLRP12;CASP10;PINK1;NR1H4;STAT1;TRIM68;ECT2;NLRC3;TIFA
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.33309765125710383,-0.8541282090165364,0.6923076923076923,1.0,1.0,11/64,18.93%,IWS1;GTF2H2;POLR2F;SSRP1;ERCC2;RTF1;ELOA;POLR2C;ELOF1;LEO1;CCNT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4444892528177913,0.8537477984892898,0.6617647058823529,1.0,1.0,5/18,28.35%,PINK1;DCN;FIS1;MIEF1;AURKA
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.479700449830486,-0.8537351540937902,0.6285714285714286,1.0,1.0,1/12,0.70%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4837017202927124,0.8536901277007244,0.6842105263157895,1.0,1.0,3/10,18.92%,PINK1;IL4;NOS2
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.4790946098139271,-0.8536849845358991,0.7027027027027027,1.0,1.0,1/7,15.25%,PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.46950490992618993,0.8536108037386319,0.7121212121212122,1.0,1.0,1/12,4.34%,DEPDC5
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.37679028955131594,0.8535081432684978,0.7195121951219512,1.0,1.0,18/102,17.61%,TRIL;TSPAN11;SLC18A2;SHISA6;SOX10;PLP1;DAAM2;PPP1R1B;RAMP3;TCEAL5;DHRS3;TSPAN7;AQP4;CNTN2;RXRG;GFAP;ID4;ZNF536
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.44843493341468255,0.8533997535591743,0.7297297297297297,1.0,1.0,8/32,22.37%,SP100;TNFRSF10A;DDX3X;THBS1;TMC8;FEM1B;BRCA1;TRADD
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.31924210331818037,-0.853264688897414,0.7741935483870968,1.0,1.0,15/78,11.02%,HDC;HNMT;BCKDK;AMDHD1;SARDH;GSTZ1;CARNMT1;CRYM;GLUD2;CBS;ECHS1;ALDH4A1;OGDH;UROC1;KYAT1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.46563346061548283,0.8531303778192627,0.6212121212121212,1.0,1.0,4/18,11.29%,TRIM62;TRIM25;AXL;TRIM68
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.48006978970497094,-0.853093639216018,0.6341463414634146,1.0,1.0,4/14,11.87%,TBC1D10A;IFI16;PERP;RIPK2
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.4811378964729546,0.8527132440507117,0.7205882352941176,1.0,1.0,1/13,0.44%,TBX1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.31083760633740576,-0.8525014727395362,0.75,1.0,1.0,17/113,12.72%,RGS16;F11R;ADCYAP1;ARHGAP11A;AGRN;ERBB2;PLIN5;FNTA;ASAP3;TBC1D2;RAPGEF1;SRGAP2;GNB5;NTRK1;RGS6;RASGRF1;RGS7
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.40683625977166354,0.8519777056419594,0.6865671641791045,1.0,1.0,5/36,16.14%,AMBP;PINK1;MARVELD3;FOXM1;CYLD
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.4575605041598921,-0.8519345849343422,0.6285714285714286,1.0,1.0,5/11,25.99%,APOE;PORCN;WIPI1;ATG7;ATG10
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),0.5405846709552633,0.8516173750423723,0.7037037037037037,1.0,1.0,1/6,10.98%,PIK3CG
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.4097489813260423,0.8514645720860088,0.6712328767123288,1.0,1.0,6/37,23.69%,TGFB1;ORMDL3;LATS2;GLUL;PARK7;PARP9
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.5331451628464928,0.851136932626751,0.6984126984126984,1.0,1.0,1/7,2.05%,ANXA1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3703652120734717,0.8510933209915663,0.717948717948718,1.0,1.0,13/92,23.03%,PSMB9;CLEC4C;MUC17;MUC4;SYK;MUCL1;PSMC5;PSMB6;MUC16;KRAS;PSMD6;RPS6KA5;PSMA3
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3703652120734717,0.8510933209915663,0.717948717948718,1.0,1.0,13/92,23.03%,PSMB9;CLEC4C;MUC17;MUC4;SYK;MUCL1;PSMC5;PSMB6;MUC16;KRAS;PSMD6;RPS6KA5;PSMA3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3703652120734717,0.8510933209915663,0.717948717948718,1.0,1.0,13/92,23.03%,PSMB9;CLEC4C;MUC17;MUC4;SYK;MUCL1;PSMC5;PSMB6;MUC16;KRAS;PSMD6;RPS6KA5;PSMA3
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.2961357223179239,-0.8509953572420841,0.6875,1.0,1.0,26/161,14.97%,TBC1D10A;TBC1D16;RGS16;F11R;ADCYAP1;ARHGAP11A;AGRN;ERBB2;ASAP3;TBC1D22B;TBC1D2;BCR;RAPGEF1;SRGAP2;ARHGAP42;GNB5;NTRK1;SLC27A4;RGS6;TBC1D8;RASGRF1;RGS7;SIPA1L3;GARNL3;SCRIB;LIMS1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.39444275333546414,-0.8504162206062166,0.6923076923076923,1.0,1.0,3/26,11.64%,STX5;RTP1;EMD
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.5161325351932464,-0.8501822727736891,0.6666666666666666,1.0,1.0,2/6,18.26%,MTHFR;MTR
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.3984991485807137,0.8496283643071861,0.7341772151898734,1.0,1.0,15/46,23.16%,MMP19;SCUBE3;MMP9;LCP1;MMP15;CD44;MMP11;TLL2;PLG;NOXO1;WASHC1;A2M;ADAMTS5;ELANE;BMP1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.5629655340300355,-0.8496175134768368,0.6976744186046512,1.0,1.0,2/6,15.70%,GBF1;MIA3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),0.5170956277036397,0.8495178178885122,0.7241379310344828,1.0,1.0,3/6,23.46%,IL12A;CRTAM;CEACAM1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.3967977917973552,-0.8494154912150913,0.6428571428571429,1.0,1.0,4/29,7.69%,SYT12;CBARP;DOC2B;SYT17
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.4912960437439316,0.8494040629842727,0.6714285714285714,1.0,1.0,2/11,11.57%,WAS;SPOCK3
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.39062692653982095,0.8493834812624579,0.8108108108108109,1.0,1.0,13/66,26.03%,ARHGAP9;RAPGEF6;PLXNA3;ARHGAP15;TDG;ATP5IF1;GPR137B;PRKG1;EPHA1;PPP1R17;PROM2;VAV3;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.4473986751928025,-0.8493162270345322,0.6176470588235294,1.0,1.0,6/13,27.17%,GRM2;GABBR2;DRD2;PALM;DRD3;GNAI2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.37488126257836607,0.8491116300283843,0.6716417910447762,1.0,1.0,2/95,0.97%,ESR1;ACTL6A
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.36278115927982557,-0.8490803999303594,0.6296296296296297,1.0,1.0,6/32,13.46%,GPRC6A;CAPN2;CPEB1;GLRA3;GRIN1;NEURL1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.43526696576863505,-0.8489680566579406,0.6444444444444445,1.0,1.0,2/17,8.53%,SMPD4;PLA2G4C
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5056958255242219,0.8489208533361212,0.671875,1.0,1.0,7/12,43.45%,RHOQ;RAB23;GNAI3;RAN;OPA1;MFN1;ENTPD7
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.3658813725703026,0.8488636269547869,0.7638888888888888,1.0,1.0,18/62,18.75%,CYTIP;RORC;GMFG;CCL5;AHR;PTPRC;SASH3;HPGDS;THEMIS;IRF4;TAGAP;ZAP70;IL4;ITK;SIRPG;IL5;CD4;TIGIT
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.4046462721584272,0.8485655847596572,0.64,1.0,1.0,6/39,17.93%,TLR2;IRF1;DDX3X;NLRC3;ISG15;OAS2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.4333014145428552,0.8485279681298448,0.6617647058823529,1.0,1.0,2/22,10.22%,TLR2;DUSP22
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.4805610379596702,0.8484057362049003,0.7397260273972602,1.0,1.0,2/20,4.64%,SP100;FGF2
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.5200706054916725,0.8483194602740629,0.6617647058823529,1.0,1.0,2/7,13.85%,WEE2;FBXO5
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.45644468316140224,0.8481305876537862,0.6333333333333333,1.0,1.0,2/19,10.43%,ADA;DCK
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.3764623469527203,0.8481165662339175,0.7375,1.0,1.0,15/67,18.78%,ITGB2;ITGB6;ITGBL1;ITGA2;DAB2;ITGA5;HCK;SYK;ISG15;ANGPTL3;FYB1;ITGA2B;BCAR1;FN1;ITGB8
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.39051380784800704,-0.8478879269050086,0.6666666666666666,1.0,1.0,11/35,25.42%,OLFM2;RAB3D;TVP23A;PREB;MIA3;RAB10;STEAP3;TANGO2;ARFGAP3;TANGO6;MON1A
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.4170304925199667,0.8478629058673897,0.75,1.0,1.0,2/32,8.18%,SGO1;NDC80
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.4192178072591905,0.8477833412020477,0.6212121212121212,1.0,1.0,2/23,10.43%,ADA;DCK
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.5302375848182648,0.8476898360834058,0.7222222222222222,1.0,1.0,3/8,25.26%,OPRM1;HRH4;CHRM5
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3890207257827762,0.8476691912787192,0.75,1.0,1.0,2/57,3.94%,CDC25A;PDE6A
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.47348867104535014,-0.8476175717205603,0.6470588235294118,1.0,1.0,2/10,6.65%,H1-4;CTCF
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.40290334665660976,0.8475183786245422,0.75,1.0,1.0,8/46,10.88%,CLDN2;ACE2;CASR;ANGPTL4;MUC17;ALDOB;NR1H4;ANPEP
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.39592052639590297,-0.8474617174739436,0.5652173913043478,1.0,1.0,3/26,13.76%,CD14;TICAM2;TRAF3
prerank,GO_Biological_Process_2021__alditol phosphate metabolic process (GO:0052646),-0.57309461597019,-0.8474368877588766,0.7551020408163265,1.0,1.0,1/5,6.25%,GPD1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.4401153417090329,0.8472421701771541,0.7575757575757576,1.0,1.0,5/30,17.19%,PFKFB2;PINK1;IGF1;PRXL2C;IL4
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.4361797912729175,-0.8470121563701415,0.6486486486486487,1.0,1.0,1/16,0.45%,NR4A1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.48175721248598863,-0.8468222543182247,0.6388888888888888,1.0,1.0,1/12,0.85%,CPSF1
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.4835860776286436,-0.8466341595735015,0.6,1.0,1.0,2/6,11.15%,HES1;GPR157
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.5396985290734233,0.8466025272856077,0.7230769230769231,1.0,1.0,2/6,22.49%,WAS;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.41556439119150096,0.846487992680036,0.6764705882352942,1.0,1.0,8/30,22.36%,LRP4;REST;YWHAH;OMG;MAG;EFNB3;B2M;DYNLT1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.2857919809711197,-0.8462387704319522,1.0,1.0,1.0,19/216,12.16%,IL7R;APOB;SYNJ2;PACSIN2;STX11;TGFA;SH3KBP1;UBXN2A;MOSPD3;LPCAT2;ARPC3;KIAA0319;HIP1;RAB5A;RTP1;EMD;BIN1;ARRB2;SPAST
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.4862834020239553,0.8461798394620824,0.7222222222222222,1.0,1.0,4/10,19.31%,CD81;P2RY12;MTUS1;CSF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.45337045072725785,0.8460199074691002,0.7323943661971831,1.0,1.0,8/23,30.64%,RPS27A;COPS4;COPS5;GPS1;RBX1;CETN2;RAD23B;DDB1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.5476899274571808,0.8460041852022615,0.6779661016949152,1.0,1.0,2/7,22.49%,WAS;CXCL12
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.531336373208027,0.8459029867500198,0.6557377049180327,1.0,1.0,1/6,9.45%,PSAP
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3728019068369462,0.8458366659571448,0.675,1.0,1.0,6/79,15.16%,NEK2;KIF14;CEP72;CEP70;DYNLL1;TUBA4A
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3672326379199003,0.8457812219883429,0.7380952380952381,1.0,1.0,16/58,25.58%,RPS16;RPS19;RPL35A;GLUL;RPL11;RPS7;RPL7;ZNF622;RPS6;RPL38;RPS15;RIOK2;RPS28;RPS24;EMG1;WDR12
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.44416300003988196,0.8456743675069006,0.7419354838709677,1.0,1.0,3/25,10.29%,ACOX2;HSD3B7;CYP39A1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.35691679275712246,-0.8456441629099646,0.7333333333333333,1.0,1.0,5/35,7.77%,KIT;CDH13;PRSS3;FSTL1;LPXN
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.4982465764439463,0.8454289292881545,0.7205882352941176,1.0,1.0,2/14,5.16%,C1QTNF1;ALOX12
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.5054269052562002,-0.8454181070815601,0.7,1.0,1.0,1/7,12.16%,SPAST
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.434409712894086,-0.845324940526894,0.6428571428571429,1.0,1.0,5/26,9.84%,SLC38A5;SLC6A20;SLC6A17;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.40861119068609497,0.8449846763008049,0.7534246575342466,1.0,1.0,9/53,18.12%,BLK;FLT1;FLT4;ERBB4;HCK;SYK;DDR2;ZAP70;CSF1R
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.3542956038120987,-0.8449728798445731,0.6666666666666666,1.0,1.0,11/65,15.70%,SEC24C;PPP6R1;TGFA;TRAPPC9;STX5;PREB;CNIH3;TRAPPC1;F5;ANKRD28;MIA3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.5388652023798217,0.8449574962865595,0.696969696969697,1.0,1.0,2/7,11.84%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.46697598552758207,0.8449350740183672,0.7384615384615385,1.0,1.0,3/16,19.97%,CCDC39;AQP4;CABYR
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.49239241650130644,0.844876247873926,0.71875,1.0,1.0,2/14,13.43%,C17ORF99;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.5379659446322941,0.8448586974599223,0.7636363636363637,1.0,1.0,3/6,36.53%,ATF5;ZFP36L2;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.39333156542394027,-0.8447858257671318,0.7096774193548387,1.0,1.0,7/12,21.58%,CEP135;CORO2B;SPIDR;CEP290;CEP295;PTP4A3;CEP120
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5287868824331612,0.8444263274992944,0.696969696969697,1.0,1.0,3/7,28.68%,OTUB1;PARP10;GPS2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.4089098280622834,-0.8436034791096425,0.5555555555555556,1.0,1.0,3/17,14.65%,TWIST1;ARMC10;SNAI2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.4260673310921334,0.8435374657468826,0.6333333333333333,1.0,1.0,3/29,13.38%,TMEM35A;CAV3;TOR1A
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3556456828949736,0.8430848812348416,0.7472527472527473,1.0,1.0,11/119,16.67%,PSMB9;FRAT1;TGFB1;DAAM2;RSPO1;COL1A1;DDX3X;DKK2;SFRP4;ATP6AP2;PSMC5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.2991906169169644,-0.8430237787597312,0.6842105263157895,1.0,1.0,5/72,10.18%,TRIB2;CCDC22;PRICKLE1;TRIB1;NKD2
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.4898822169275295,0.8428443727606412,0.6349206349206349,1.0,1.0,4/10,29.27%,VIL1;F2RL1;CFL2;NES
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),0.5514398852658254,0.842805171303671,0.7142857142857143,1.0,1.0,1/6,8.66%,NODAL
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.4375712606038388,-0.8428026322339331,0.5526315789473685,1.0,1.0,1/15,3.52%,KIT
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.5077884092505209,0.8426745146465487,0.6363636363636364,1.0,1.0,1/9,6.06%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.4666900433560218,-0.8426108927607108,0.6744186046511628,1.0,1.0,3/7,19.77%,FGFR2;SNAI2;MED1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3448692834422297,0.8424358444443752,0.8170731707317073,1.0,1.0,16/154,15.30%,EOLA1;TRIM58;AHR;PTPRC;ALPK2;PRDM12;RNF187;IGF2BP2;REST;RSPO1;IGF1;TRIM68;TRIM77;AFF2;RASA1;BMI1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.377901389475555,0.8423579026389322,0.726027397260274,1.0,1.0,14/84,19.32%,PLA2G10;TLR2;PTPRC;DDIT4;IFIT1;IRF1;STAT1;AGBL5;IFI6;ISG15;OAS2;TRIM5;F2RL1;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.39101857864249423,-0.8422795008924701,0.6666666666666666,1.0,1.0,6/17,15.86%,ADAM8;RHBDD1;NKD2;PLGRKT;CCBE1;ASTL
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.44936686714945534,0.8421372484142655,0.6197183098591549,1.0,1.0,5/17,26.35%,WNT5A;LIFR;IFIH1;PARP9;IRAK1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immune response to tumor cell (GO:0002842),0.5675839651645361,0.8421236215016945,0.7241379310344828,1.0,1.0,2/5,34.82%,HLA-DRB1;HSPD1
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.5685697985634335,0.8418261518599955,0.6935483870967742,1.0,1.0,2/6,17.38%,HLA-A;CRTAM
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3320136658918879,-0.8417493178637422,0.7857142857142857,1.0,1.0,4/46,9.35%,NGF;SH3RF1;IGBP1;AQP1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.33566357005387265,-0.8416699944439322,0.7272727272727273,1.0,1.0,3/39,1.39%,EHF;ANXA8;IL1RL2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.4985263814264122,-0.8416605139357752,0.6590909090909091,1.0,1.0,1/7,1.52%,DNMT1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.4195742240908488,-0.8416145311979607,0.6578947368421053,1.0,1.0,4/12,14.53%,PUDP;UPP1;UPP2;CDA
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.48188451317233644,0.8413444487878016,0.7213114754098361,1.0,1.0,3/12,14.17%,FTCD;GCHFR;SPR
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.4567728077310439,-0.8413217655442771,0.6585365853658537,1.0,1.0,2/8,14.96%,DSCC1;RFC3
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.4567728077310439,-0.8413217655442771,0.6585365853658537,1.0,1.0,2/8,14.96%,DSCC1;RFC3
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.35070697193715833,-0.8412760707344908,0.7222222222222222,1.0,1.0,14/77,11.97%,CDH5;BAMBI;FOS;DUSP15;F11R;PARD3;HPGD;LPXN;FNTA;ACVR1;TWSG1;TGFBR3;ZMIZ1;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.31118728539385615,-0.8411091865742752,0.7857142857142857,1.0,1.0,14/108,12.97%,GCK;SLC25A37;PPP1R3E;TMEM106A;PIWIL2;UPF3A;ERBB2;CTC1;PCIF1;FXR2;NAMPT;STN1;LDB1;CIRBP
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.501351855311776,-0.8410049778870377,0.6923076923076923,1.0,1.0,5/10,16.93%,KDM7A;KDM3B;HR;KDM4D;KDM4B
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3688561637819247,0.8406827866540085,0.7283950617283951,1.0,1.0,5/67,12.02%,SGO1;MISP;NDC80;RAB11A;KLHDC8B
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.4757334993064978,0.8406306451527016,0.7419354838709677,1.0,1.0,2/14,15.23%,LPIN3;ALOX15
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.495316797619251,-0.8404901231002353,0.7037037037037037,1.0,1.0,1/7,6.82%,ASCL1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.35282152170704106,-0.8404847046925866,0.7083333333333334,1.0,1.0,10/60,13.75%,TRIM71;SH3RF1;WWP2;NFX1;LRSAM1;ERCC8;SH3RF3;MARCHF5;RNF10;RNF157
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.35421452056225033,0.8402575001323589,0.7951807228915663,1.0,1.0,13/129,13.51%,BLK;VSX1;GPRIN2;RP1;MANF;STMN4;PLP1;PRDM12;NPY;PPT1;RAB11A;TOR1A;CDK5R1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.36264417658408976,0.8402568269765821,0.8292682926829268,1.0,1.0,23/117,18.32%,AQP3;CRLF1;A4GALT;ITGB6;GNG12;CLDN18;SCARA3;TMEM54;COL4A4;COL4A3;OSMR;COL1A1;LAMC2;SEMA3B;TRIM29;IGFBP6;FBLIM1;SEMA3F;MMP11;GRAMD2A;SLC44A3;AGER;SERTAD4
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.49197729375077853,-0.8402418942789207,0.6590909090909091,1.0,1.0,2/9,13.94%,RGN;GSTO2
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.35227336689050315,-0.8399758535491685,0.631578947368421,1.0,1.0,33/101,24.24%,TEAD2;CD247;MATN1;PARD3;SHANK1;LPXN;NDUFAF1;HES1;FANCA;HFE;WASF3;PEX14;TUBGCP2;LLGL1;GEMIN5;PARD6B;SNX9;TRAF1;NUP98;CHCHD10;OCLN;PML;TAPBP;AFG3L2;CAPZA1;CREBBP;KMT2A;SEH1L;TPR;TFAP4;SLC7A9;LAMC1;WDR19
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.5755160880001102,-0.8398397754276955,0.6904761904761905,1.0,1.0,3/5,30.20%,SLC15A4;HMGB1;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.4822066128065829,-0.8396902325766054,0.7105263157894737,1.0,1.0,2/8,8.55%,DNMT1;NFATC3
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.4188280781681917,-0.8396375071779496,0.5581395348837209,1.0,1.0,2/12,5.97%,LTC4S;PLA2G5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.41504142197417887,0.8394904553368125,0.7142857142857143,1.0,1.0,5/32,9.29%,AIM2;WNT5A;USP50;NLRP12;NLRC4
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.4637906634682828,0.8392266746221306,0.6857142857142857,1.0,1.0,1/13,3.74%,OLAH
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.38662280830370804,0.8391035152055668,0.7397260273972602,1.0,1.0,5/59,10.99%,CCL5;VAPB;IFIT1;AXL;DDX3X
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4868479677051901,0.8388656875989163,0.6764705882352942,1.0,1.0,3/13,17.70%,DAAM2;SFRP4;WNT5B
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.47896024241415525,0.8385607332272715,0.7164179104477612,1.0,1.0,3/15,18.25%,CAV3;PPT1;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5042319835057938,0.8385043291038143,0.6909090909090909,1.0,1.0,2/11,17.62%,DNAJA1;NPPA
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.3550788484875271,0.8383392355369393,0.7530864197530864,1.0,1.0,15/111,23.03%,PSMB9;WNT5A;PDE6A;FZD8;LEF1;CELSR1;SFRP4;GNAT2;PSMC5;PSMB6;PDE6B;FRZB;PSMD6;PDE6G;PSMA3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.35900442021079343,0.8382524468161012,0.788235294117647,1.0,1.0,12/77,19.55%,SLC5A4;SLC5A2;SLC12A3;SLC6A4;ASIC5;ATP1A4;ASIC1;SLC24A1;SLC5A9;SLC5A1;SLC23A1;SLC6A12
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.3731764161615764,0.8382482536612812,0.7948717948717948,1.0,1.0,13/94,16.77%,TBX1;PKP2;HEY2;TGFB1;FLT4;ERBB4;HEG1;CDKN1B;POPDC2;CDKN1A;SOX9;CACYBP;HEY1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.39100446914784626,-0.8381860872136129,0.7222222222222222,1.0,1.0,5/26,15.97%,HDC;DHRS11;HSD3B2;PYCR3;NFS1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.4683158287153615,-0.8381390776250426,0.7058823529411765,1.0,1.0,1/9,2.54%,GALE
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3006402905928107,-0.837852937943372,0.8823529411764706,1.0,1.0,25/130,16.84%,NOX4;RASSF2;PRKCD;EGR1;ADCYAP1;RALB;TTBK1;CCN1;SYAP1;PAK6;DAB2IP;MMD2;EMP2;IRGM;TAOK2;NAB2;DUSP19;MARK2;CLSPN;PIH1D1;PARP16;CCDC88A;IL23A;RHOA;SNX9
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5528411755237816,0.8377394064180232,0.7605633802816901,1.0,1.0,2/6,30.66%,LARP6;CDK9
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.40079939570454093,0.837716687561161,0.7323943661971831,1.0,1.0,3/44,5.45%,PLA2G10;METTL18;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.5866494856713621,0.8376929977976579,0.803030303030303,1.0,1.0,1/5,3.01%,WNT5A
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.3308372129932397,0.8376565966422371,0.7631578947368421,1.0,1.0,20/183,13.26%,ENPP2;C1QB;LPAR1;GP1BA;CYYR1;LYVE1;A4GALT;VSIG4;ARMCX3;SLC6A4;SOCS2;RAMP3;DAB2;DCN;ADGRL4;CFD;HGF;HPGDS;PLAU;PDK4
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.34590711875746266,0.8376145587013147,0.7349397590361446,1.0,1.0,18/147,12.54%,CLEC5A;C3AR1;TLR2;LPAR1;GP1BA;TNFRSF1B;CCL5;AHR;ROS1;PTAFR;ADGRE1;OSMR;ITGA5;IRF1;AXL;CSF3R;GPR183;PLAUR
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.40619799837937837,-0.8374287833925125,0.6956521739130435,1.0,1.0,5/16,13.53%,IL11;UBASH3B;ACVR1;KIF26A;BRAP
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.4946141536944887,0.8372654259056748,0.6349206349206349,1.0,1.0,2/12,4.59%,PDE6A;RP1
prerank,GO_Biological_Process_2021__regulation of T-helper cell differentiation (GO:0045622),0.5569230205308733,0.8372171138761385,0.7213114754098361,1.0,1.0,4/6,21.15%,IL27;IRF4;MYB;HLA-DRB1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.47694581131166686,-0.8370995260889815,0.7111111111111111,1.0,1.0,4/10,24.10%,WWP2;CCDC40;TSG101;SPEF2
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.31517757678895375,-0.8370363394684218,0.7272727272727273,1.0,1.0,7/58,6.60%,FGF1;FGF18;KIT;PDGFD;ERBB2;MAP3K10;ADAM8
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.5051982952118093,0.8369351303638113,0.7288135593220338,1.0,1.0,1/7,6.51%,CAV3
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.40422582657653633,0.8368368666503476,0.7692307692307693,1.0,1.0,18/51,21.70%,SP100;TRIM62;HLA-F;PTAFR;TRIM25;HLA-A;IRF1;HCK;STAT1;TRIM68;IRF4;HLA-DPB1;CD44;OAS2;TRIM5;HLA-DRB1;HLA-DPA1;B2M
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.3583147682216611,0.8366222222099362,0.7894736842105263,1.0,1.0,8/109,7.49%,LRP4;TRIL;TSPAN11;LMOD1;FBXL7;PCDH18;SCARA3;PLP1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.39494235062609695,0.8364589936543478,0.6973684210526315,1.0,1.0,6/38,19.77%,BHMT;CTCFL;PCMT1;ETFBKMT;EEF2KMT;METTL21C
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5570209612807993,0.8363337924036219,0.7692307692307693,1.0,1.0,2/6,25.89%,PADI2;PARP10
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.4639115257485568,-0.8362372753406375,0.7096774193548387,1.0,1.0,1/8,6.46%,UBE2D4
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.4112801493215559,-0.8361400967052497,0.6363636363636364,1.0,1.0,5/24,10.73%,XKR7;TYRO3;MEGF10;RHOBTB2;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.3790229022191329,-0.8360463065036299,0.7407407407407407,1.0,1.0,3/20,7.82%,BOD1L1;STYXL1;ENSA
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.4630188520956261,-0.8359410301687992,0.7058823529411765,1.0,1.0,6/12,16.68%,PNP;NT5C1A;GPX1;DNPH1;NT5C;ITPA
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.5504656691987325,-0.8358656267697467,0.675,1.0,1.0,3/5,18.82%,CCBE1;PROX1;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.3487133226290037,0.8358405504519062,0.7682926829268293,1.0,1.0,14/131,13.87%,ITGB2;HSPA1L;ARIH2;TGFB1;ITGAM;CD81;TCAF2;PRR5L;PINK1;TP53BP2;ECT2;RHOU;ZIC1;OAZ2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.4450083523106689,-0.8353808356766549,0.6923076923076923,1.0,1.0,5/14,21.76%,COQ2;UBIAD1;COQ9;PDSS2;AIFM2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4886461549298502,0.835091292461975,0.6666666666666666,1.0,1.0,1/11,4.54%,SNAP23
prerank,GO_Biological_Process_2021__regulation of cellular response to hypoxia (GO:1900037),0.5441229002517849,0.8349632699315065,0.7301587301587301,1.0,1.0,1/5,16.54%,CHCHD2
prerank,GO_Biological_Process_2021__positive regulation of defense response to bacterium (GO:1900426),0.5657945078375223,0.8347540538450285,0.7413793103448276,1.0,1.0,1/5,13.70%,CYBA
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.3769394465115808,0.8347113635031459,0.7164179104477612,1.0,1.0,14/57,19.67%,BLNK;PTPRC;NFIL3;CLCF1;NFAM1;IFNK;IKZF1;AXL;ZAP70;IL4;LY6D;CD4;DNAJB9;RAG1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.42711165592595096,-0.8347066082293024,0.7241379310344828,1.0,1.0,1/12,1.49%,ZNF703
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.38320087695826777,-0.8345822651860393,0.6451612903225806,1.0,1.0,2/28,2.97%,BOC;KLHL41
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.44103527989995295,0.8344779239759381,0.6923076923076923,1.0,1.0,4/21,9.95%,LMOD3;TGFB1;MESP1;IGF1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.48060972308946026,0.8342291783582855,0.6964285714285714,1.0,1.0,1/12,5.06%,TICRR
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.44556453854473727,0.8341959175503744,0.7391304347826086,1.0,1.0,5/25,14.06%,LMOD3;SIX4;MYL6;POPDC2;CSRP3
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.37447768162284206,-0.8341817110295138,0.68,1.0,1.0,3/19,14.21%,CFLAR;NUPR1;SDCBP
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.3588753958478063,0.8340002720819667,0.7948717948717948,1.0,1.0,25/100,22.64%,LRRC19;GP1BA;ANXA1;ACE2;WNT5A;PDE6A;GRK7;IRF1;HCK;TNFSF4;P2RY12;ALOX15;LACC1;CYLD;GUCY2F;USP18;PTGES;TRIM5;F2RL1;CNGA1;SPATA2;PDE6B;TKFC;PARK7;PDE6G
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.49019439737168413,0.8337848475961882,0.7258064516129032,1.0,1.0,2/9,8.13%,PTPRC;IFNK
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.5646957241003489,-0.8337699881676306,0.7555555555555555,1.0,1.0,3/5,35.23%,ALKBH3;ALKBH5;FTO
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3667881701770707,0.8334724493174898,0.7368421052631579,1.0,1.0,12/64,30.25%,PSMB9;RPS27A;PSMC5;PSMB6;RBX1;PSMD6;PSMA3;PSMA7;CITED2;HIF1A;PSMB1;ELOB
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.3805711159657218,-0.8334311046973116,0.696969696969697,1.0,1.0,2/15,5.79%,NR4A3;CLIP3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4745674328095646,0.8333271006557785,0.6857142857142857,1.0,1.0,1/10,4.95%,CNMD
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.3749150687301021,-0.8331560212372897,0.5882352941176471,1.0,1.0,6/24,13.81%,CES2;HPGD;PTGS1;AKR1C3;PTGR2;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3373153286985157,0.833152784908186,0.8554216867469879,1.0,1.0,13/198,12.59%,ESR1;TLR2;AIM2;WNT5A;TRIM62;CARD14;NFAM1;TRIM25;NODAL;NLRC4;TRIM68;BEX1;RPS27A
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.49862464914288285,-0.8328634815559841,0.7,1.0,1.0,1/7,1.90%,PAH
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3482700561544666,0.8327507415602688,0.8170731707317073,1.0,1.0,14/150,19.42%,NEK2;PSMB9;TGFB1;BORA;AFAP1L2;CKS1B;CDKN1B;FBXO5;BTG1;CYLD;PSMC5;RCC1;PSMB6;PKMYT1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.27586817401858477,-0.8327084559156936,1.0,1.0,1.0,51/278,16.98%,CDH4;ARX;ETV1;PRKCD;CELF5;PTPRO;NXPH4;VGF;SLC17A6;ELAVL3;NCALD;TTBK1;CACNB1;IGSF21;CXCL14;CCN2;SNCB;GABRA5;CRH;HPCA;DLX1;SLC22A15;CALN1;ADGRA1;MMD2;CDHR1;RGMA;TAGLN3;GRIA4;DLGAP1;CACNG2;CELF4;DEPTOR;BRINP1;LRRTM3;FRRS1L;GABBR2;NAT14;ERC2;DISP2;CDH22;SV2B;LINGO1;FAM81A;SYN1;PCF11;ADGRL2;TCEAL6;DZANK1;RAB26;ELMO1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.4297371904544291,-0.8326505534172629,0.6176470588235294,1.0,1.0,3/11,11.96%,SERPINE1;SERPINE2;PLGRKT
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.5411151998806006,-0.8326082272469615,0.673469387755102,1.0,1.0,1/7,5.97%,PLA2G5
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.395297796555064,0.8325598648528152,0.782608695652174,1.0,1.0,11/64,17.71%,CCL5;ECM2;IL12A;NODAL;SYK;RNASE10;P2RY12;TGM2;ALOX15;ADGRG1;SIRPG
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3186399626442911,-0.8324378790569342,0.7692307692307693,1.0,1.0,10/64,13.81%,GCK;NR4A3;MGARP;SLIT3;STAT5B;AKR1C3;SLIT2;RAMP1;SERPINB9;AKR1C1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.431965326037491,-0.8323242432340545,0.6666666666666666,1.0,1.0,1/13,3.60%,NOP9
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.38019090099998776,0.8318587484189353,0.7777777777777778,1.0,1.0,13/75,18.23%,SMAD6;SMOC1;HEMGN;ATP6AP1;REST;IGF1;HGF;RANBP3L;FBXO5;SOX9;DDR2;ATRAID;FBN2
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),-0.5375025635080868,-0.8317740157719558,0.7142857142857143,1.0,1.0,1/5,6.45%,GLYATL2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.46744451761917094,0.8316037952383443,0.7014925373134329,1.0,1.0,5/14,17.46%,GRWD1;SMARCE1;HMGA1;SET;TNP1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.46744451761917094,0.8316037952383443,0.7014925373134329,1.0,1.0,5/14,17.46%,GRWD1;SMARCE1;HMGA1;SET;TNP1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4616338510170528,0.8315138715518711,0.6764705882352942,1.0,1.0,4/16,27.98%,ISG15;USP18;CACTIN;OAS1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.35117548697015877,0.8312698602529318,0.75,1.0,1.0,6/79,6.87%,SLC22A3;LRP2;SLC38A3;SLC22A8;ABCG2;ABCC2
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3651726332740583,0.8311321422640935,0.75,1.0,1.0,8/88,13.87%,ASB5;WNT5A;DTL;C4BPA;EEF1A1;C4BPB;CDKN1B;OAZ2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.4608006066983937,0.8311028638481409,0.7222222222222222,1.0,1.0,5/14,29.63%,TGFB1;DDR2;DDR1;DPP4;FGFR4
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.3978401544033404,0.8308055475758864,0.7222222222222222,1.0,1.0,5/40,11.39%,ANXA1;STK26;CYP1B1;ECT2;RHOB
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),0.5382323303971218,0.8304011520231924,0.7272727272727273,1.0,1.0,2/6,18.29%,NPPA;KCNE3
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.45892879666948727,-0.8299973859128638,0.6756756756756757,1.0,1.0,4/13,19.48%,HDC;PYCR3;NFS1;GPHN
prerank,GO_Biological_Process_2021__cellular water homeostasis (GO:0009992),0.5832736333700385,0.8299495529207677,0.7924528301886793,1.0,1.0,3/5,23.02%,SCTR;AQP4;AQP11
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.3808539444699479,-0.8298409796024482,0.6666666666666666,1.0,1.0,6/35,12.50%,TEFM;LARS2;QRSL1;MRPS21;NOA1;SLC25A33
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.3518690254343747,0.8296561383078783,0.704225352112676,1.0,1.0,6/77,6.87%,SLC22A3;LRP2;SLC38A3;SLC22A8;ABCG2;ABCC2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.38324906123316604,0.8296187122961084,0.7407407407407407,1.0,1.0,10/46,19.13%,TLR2;WNT5A;SCIMP;C1QTNF4;SYK;TNFSF4;CYBA;AGER;NOS2;F2RL1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.40386586260570373,-0.8294390187833436,0.7575757575757576,1.0,1.0,6/26,11.90%,GALP;SELP;SERPINE1;TNFRSF14;AQP1;IRGM
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3547587388653128,-0.8288667903135878,0.7307692307692307,1.0,1.0,6/35,12.00%,DCPS;NDOR1;AQP1;AKR1C3;ADCY2;ADCY3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.4474456821428136,-0.828529340404207,0.7027027027027027,1.0,1.0,4/13,19.16%,COQ2;UBIAD1;COQ9;PDSS2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.4474456821428136,-0.828529340404207,0.7027027027027027,1.0,1.0,4/13,19.16%,COQ2;UBIAD1;COQ9;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.4460058348579474,-0.8284392881389276,0.6444444444444445,1.0,1.0,5/14,23.43%,CTC1;STN1;BRPF3;FAF1;NPM2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4084495979611167,0.8282142190455888,0.7808219178082192,1.0,1.0,4/44,5.45%,ANGPT2;FGF2;STAT5A;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.43180579768600186,0.8279228314707697,0.7727272727272727,1.0,1.0,1/22,2.41%,SP100
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.45020460675118773,-0.8272978074497132,0.6,1.0,1.0,2/8,28.06%,INO80;DBF4B
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.43064436671049877,0.8272714311883067,0.6338028169014085,1.0,1.0,5/16,29.21%,IFIT1;COLEC12;IFIH1;RIOK3;PQBP1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.4520088225946801,0.8272623606417923,0.7205882352941176,1.0,1.0,7/16,21.15%,IL12A;HLA-A;SYK;TNFSF4;GLI3;HSPH1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.3597649937565783,-0.8270996012141525,0.7096774193548387,1.0,1.0,13/36,22.25%,MAML1;CCN3;JAG2;ZMIZ1;DLL1;NOTCH1;JAG1;TGFB2;TSPAN14;ROBO2;AAK1;NOTCH4;CREBBP
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.5787488425925672,0.8269646126707637,0.8059701492537313,1.0,1.0,4/6,27.26%,TNFRSF10A;CASP8;SPI1;TNFRSF10B
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.5096304428572582,-0.8268903942698277,0.6944444444444444,1.0,1.0,1/8,2.05%,CBARP
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.3833728789367778,0.8268757145905142,0.7397260273972602,1.0,1.0,6/46,14.64%,DISC1;SEMA3A;DDIT4;CDK5R1;CELSR1;CCK
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.4794503916273938,0.8268256432268334,0.703125,1.0,1.0,4/9,29.16%,RPL11;COPS9;HIF1A;RPL5
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.39722133523836795,0.8265434842910665,0.6578947368421053,1.0,1.0,2/33,2.65%,RAB34;ATP6V1G2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4087732811983853,0.8264962699660664,0.746031746031746,1.0,1.0,5/33,9.94%,TBX1;DNAH11;CCDC39;DAND5;MMP21
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.41214856370638026,0.8264465374780876,0.75,1.0,1.0,4/22,13.43%,TLR2;SCIMP;SYK;TNFSF4
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.33136555484653024,-0.8263813536608026,0.8095238095238095,1.0,1.0,9/86,12.92%,KIF2B;SEC24C;HLA-DQB1;HLA-DRA;KIF15;RAB7A;KIF4B;KIF26A;CAPZB
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.49767313438598954,0.8259510198227866,0.75,1.0,1.0,2/9,26.42%,TKFC;RIOK3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.42284113464985784,-0.8257332934864835,0.7333333333333333,1.0,1.0,4/14,14.53%,PUDP;UPP1;UPP2;CDA
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3414636041277684,0.8257149393343974,0.8409090909090909,1.0,1.0,22/225,16.67%,LRP4;NOTUM;PSMB9;FRAT1;WNT5A;SHISA6;TGFB1;DAAM2;DAB2;RSPO1;COL1A1;DDX3X;MCC;IGFBP6;DKK2;SOX9;GLI3;SFRP4;ATP6AP2;CYLD;LATS2;PSMC5
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.34989068631109604,-0.8253742262253243,0.7037037037037037,1.0,1.0,5/31,11.95%,BCL2;KCNJ16;WWP2;KCNJ6;KCNJ1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.4368807575485919,0.8252562975284079,0.6515151515151515,1.0,1.0,5/20,23.81%,TIMM22;MOAP1;HSPA4;ROMO1;TIMM10
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5284819370408899,0.8251379019233578,0.7741935483870968,1.0,1.0,3/9,20.27%,DNAJB1;HSPA2;BAG5
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.3729966489897859,-0.8250290316525166,0.8275862068965517,1.0,1.0,6/18,22.46%,RAD50;SLX4;ATM;NBN;RAD52;SETMAR
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.48038844881782433,0.8249347272210216,0.7096774193548387,1.0,1.0,5/13,12.39%,CLDN2;CLDN6;CLDN18;CLDN5;CLDN9
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4255927217681004,-0.8249068322690771,0.6976744186046512,1.0,1.0,2/12,16.84%,PKIA;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.40514544642301853,-0.8248745195705268,0.6666666666666666,1.0,1.0,2/20,5.28%,PTCH1;APOE
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.29221242013748944,-0.8247872652112116,0.9230769230769231,1.0,1.0,33/161,19.47%,CAMK1G;SBK1;PRKCD;MAST2;GALNT13;MAP3K10;TTBK1;CDK1;ATR;POGLUT3;MAPKAPK2;MAP3K12;MARK2;RPS6KA3;CLSPN;CSNK1G2;CSNK1E;EIF2AK3;MAP3K13;PARP2;MARK3;PRKCA;CDK5;AKT2;GALNT2;MAST4;BRSK1;MAST1;MAPK12;MORC3;STK32C;ATM;CSNK1G1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.3401472590038947,-0.8247196819639792,0.5714285714285714,1.0,1.0,15/41,22.04%,RALB;FSCN1;LRSAM1;CROCC;ASAP1;SDCBP;CCDC88A;MARK4;SDC4;ENTR1;ARHGAP35;STX18;PIP4K2B;CEP120;PLK4
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.38525638938051493,-0.8245775544902082,0.6296296296296297,1.0,1.0,2/16,6.40%,F11R;CBFB
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.41363300204403675,-0.8244012844413353,0.5882352941176471,1.0,1.0,2/12,7.20%,CCDC68;PCM1
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.5327845987865727,-0.8243131699416746,0.7222222222222222,1.0,1.0,2/5,32.74%,XRCC4;SLF2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.5317456530787753,0.8242781175976426,0.6557377049180327,1.0,1.0,2/6,26.52%,TRADD;CASP8
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.48480777615753,-0.8242668132278633,0.7027027027027027,1.0,1.0,5/9,19.98%,KYAT1;KYAT3;AADAT;TDO2;AFMID
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.47055798701986734,-0.8241961134183582,0.6176470588235294,1.0,1.0,3/5,32.42%,SLC6A6;SLC6A13;RIPK1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.36609131407576556,0.8240075349783421,0.775,1.0,1.0,8/67,20.31%,ACTL6A;HAT1;LEF1;TAF5;ING3;TAF6;TAF6L;POLE3
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.4421630309050686,-0.8237510791157134,0.6666666666666666,1.0,1.0,6/12,20.68%,FSCN1;PATJ;SCRIB;CAMSAP3;RHOA;RAP2A
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.3987507575633401,0.8234866933222824,0.7837837837837838,1.0,1.0,8/36,20.27%,HSPA8;METTL18;PINK1;MSN;GFAP;AGT;HCFC1;BAG5
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.505450448798487,0.8234342699645472,0.7575757575757576,1.0,1.0,1/7,5.90%,NPHS2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.46139514865884046,0.8231504855709322,0.7272727272727273,1.0,1.0,3/14,13.43%,SYK;IRF4;TNFSF4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.3384280582324305,0.8230535684627113,0.8488372093023255,1.0,1.0,25/170,25.20%,NEK2;PSMB9;KIF14;CEP72;CEP70;RPS27A;FBXO5;DYNLL1;CDC14A;ANLN;TUBA4A;PSMC5;PSMB6;CEP76;BUB1B;CCNB1;DCTN1;PSMD6;PSMA3;RIOK2;DCTN3;YWHAG;PSMA7;TUBB4B;CETN2
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.4048000194899452,0.822671005661592,0.725,1.0,1.0,7/38,18.23%,ATP6AP1;IGF1;HGF;FBXO5;DDR2;ATRAID;FBN2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4568051640418453,-0.822612701734766,0.625,1.0,1.0,1/10,2.41%,PRKCD
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.4244098140813692,0.8224258286405152,0.8,1.0,1.0,2/22,12.59%,RPA3;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.33322813997267786,-0.8218418047244557,0.7142857142857143,1.0,1.0,8/42,14.38%,F11R;PPP1R35;PLIN5;DAB2IP;ECM1;CSTA;CHP1;MAPK7
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.4528155530656762,0.8215774886294671,0.75,1.0,1.0,2/15,12.19%,PINK1;COX7A2
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.5020439446900615,-0.8213910604076335,0.7045454545454546,1.0,1.0,1/5,6.43%,DOK5
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.527365939619771,-0.821209014420809,0.6410256410256411,1.0,1.0,1/6,1.79%,BCL2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.4285337968821956,0.8209188528470727,0.6619718309859155,1.0,1.0,3/21,10.41%,ANXA1;ACTG1;DUOX1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.3937277974560477,-0.8207005718962115,0.7142857142857143,1.0,1.0,1/14,2.92%,TIE1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.4243463915449882,-0.8202881007079792,0.6666666666666666,1.0,1.0,4/11,14.53%,PUDP;UPP1;UPP2;CDA
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.4243463915449882,-0.8202881007079792,0.6666666666666666,1.0,1.0,4/11,14.53%,PUDP;UPP1;UPP2;CDA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.45889081136080123,0.8202023501651754,0.7096774193548387,1.0,1.0,3/13,26.37%,MPV17L2;TRUB2;COA3
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.48141792177521514,0.8201909473353994,0.8309859154929577,1.0,1.0,3/21,12.62%,CAVIN1;DUOX1;RPS19
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.4669610590625877,-0.8198074079340002,0.6578947368421053,1.0,1.0,2/8,5.97%,DRD4;PLA2G5
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.4669610590625877,-0.8198074079340002,0.6578947368421053,1.0,1.0,2/8,5.97%,DRD4;PLA2G5
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.42889387655461025,-0.8197581215793818,0.5945945945945946,1.0,1.0,5/9,20.57%,CHP1;IMPACT;PKD2L1;TRPV1;RAB11B
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.5008696412018644,0.8196868082240348,0.7301587301587301,1.0,1.0,1/8,5.45%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.532171334206447,0.8196739872519146,0.7301587301587301,1.0,1.0,1/5,10.99%,DDX3X
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.40851763397081997,0.8196163069669218,0.7375,1.0,1.0,3/33,6.90%,LRP2;TGFB1;VASP
prerank,GO_Biological_Process_2021__leukocyte chemotaxis involved in inflammatory response (GO:0002232),0.5486238085868964,0.8188110430339623,0.7457627118644068,1.0,1.0,1/5,25.65%,ALOX5
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3852490531428401,-0.8187623854859515,0.6363636363636364,1.0,1.0,3/27,13.76%,CD14;TICAM2;TRAF3
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.44578828729756587,0.8184612595674817,0.7384615384615385,1.0,1.0,6/16,21.76%,GRWD1;SMARCE1;HMGA1;SET;TNP1;RPL23
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.5351687788556161,0.8183045941796914,0.7285714285714285,1.0,1.0,2/6,16.12%,ABCC11;SLC25A19
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.47563207758291876,0.8182927065194735,0.7910447761194029,1.0,1.0,1/15,3.62%,CD160
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.4852649267835162,0.8182828902846885,0.7931034482758621,1.0,1.0,2/10,18.19%,PTGER3;SPX
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.4194491755636285,0.8181625061696726,0.7704918032786885,1.0,1.0,7/20,33.76%,CHMP3;ATF5;CHMP1A;AURKA;CHMP4B;FBXW5;CHMP2B
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),-0.48260077606253715,-0.8177381272758002,0.6764705882352942,1.0,1.0,1/5,11.63%,MVK
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.5097938330729344,0.8177132445137315,0.7333333333333333,1.0,1.0,1/7,22.08%,PTPRU
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4475230037377149,-0.8176139215652872,0.6666666666666666,1.0,1.0,2/11,9.46%,FOXO1;MLIP
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.4574969675948728,-0.8175368632562791,0.7142857142857143,1.0,1.0,3/8,21.52%,AK8;AK7;AK9
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.3383453502897863,-0.8175245018593276,0.8333333333333334,1.0,1.0,9/45,12.02%,TYRO3;PARVA;LAMB4;LPXN;ITGA4;USH2A;SRGAP2;NTN4;ANTXR1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.3299560189709959,0.8175145186095184,0.8181818181818182,1.0,1.0,28/221,16.81%,BACE2;CAPN13;ADAM33;HTRA4;MMP19;CASP7;TMPRSS11D;CPM;ERAP2;MMP9;MMP15;F7;CPB2;LVRN;FOLH1;ANPEP;HGF;SDE2;PLAU;GGT5;CELA2B;UBE3A;PRSS38;VASH2;MME;MMP23B;PLAT;PLG
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3442271771665657,0.817392899009962,0.8181818181818182,1.0,1.0,12/143,7.03%,TBX1;LPAR1;RRAS;PTPRC;ROS1;GFRAL;FGF2;FLT1;GPER1;CAV3;FLT4;GSDME
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.3414317946156274,0.8173546150621019,0.8470588235294118,1.0,1.0,11/149,10.83%,NEK2;MAPKAPK3;MAK;FLT1;GRK7;STK26;FLT4;ERBB4;PINK1;HCK;MAP3K11
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.495248676338097,0.8173147846118489,0.7121212121212122,1.0,1.0,1/11,4.45%,SYT2
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.41274042007887823,-0.8172600742514481,0.7058823529411765,1.0,1.0,7/15,23.40%,CELF4;CIRBP;THRAP3;RBMX;NUP98;SF3B4;DAZAP1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.31599460852446926,-0.8168522781242049,0.8461538461538461,1.0,1.0,5/71,7.45%,UBXN8;AUP1;FBXO27;MAN1A1;SEL1L2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.5292744355274385,0.8168195583724732,0.6981132075471698,1.0,1.0,1/5,6.70%,CD99
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.42000352074913605,-0.8167041715086987,0.6216216216216216,1.0,1.0,2/13,5.99%,FGF1;HSPB1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.4613865617030983,0.8166961741324648,0.6935483870967742,1.0,1.0,7/15,18.56%,ALOX12;PON1;ALOX15B;ALOX15;PON3;ALOX5AP;ALOX12B
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.36103179410251907,-0.8164946778266141,0.7727272727272727,1.0,1.0,3/30,7.93%,OSR1;CCN1;ACVR1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.4231237818485846,0.8161781826136053,0.7246376811594203,1.0,1.0,2/26,5.29%,MYRF;SOX10
prerank,GO_Biological_Process_2021__adult heart development (GO:0007512),-0.49463464597866874,-0.8155476615965096,0.6666666666666666,1.0,1.0,1/5,5.37%,SCUBE1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.45438970063943596,0.815496085452749,0.726027397260274,1.0,1.0,1/15,0.47%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.3718848233457408,0.8153143032536194,0.8157894736842105,1.0,1.0,6/55,11.84%,BLK;TLR2;TGFB1;GPER1;IGF1;TGFB3
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.41148245725895705,-0.815221413652937,0.5675675675675675,1.0,1.0,4/13,16.86%,UPP2;DUT;NT5C;NTHL1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.41888988202325417,-0.8151001873556081,0.7567567567567568,1.0,1.0,4/18,8.50%,MTHFR;MTHFD1L;DHFR;FPGS
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.428854242936472,0.8150184066039322,0.7727272727272727,1.0,1.0,2/23,11.47%,CCL5;CD244
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.3475287789518843,0.814966998338502,0.825,1.0,1.0,21/157,11.39%,GATA4;ITGAX;SP100;RRAS;WNT5A;CD160;HIPK1;FGF2;FLT1;CNMD;ISM1;ANGPTL4;NODAL;COL4A3;CYP1B1;DCN;AGGF1;CLDN5;MYDGF;STAT1;RHOB
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.49026052674361653,0.814837914785739,0.6984126984126984,1.0,1.0,1/8,3.01%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.38031754122459194,0.8145700967736844,0.7638888888888888,1.0,1.0,8/52,14.59%,CCL5;PTX3;TRIM62;IFIT1;ZC3HAV1;STAT1;CHMP3;ISG15
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.33660961902128417,0.8145004283089413,0.8554216867469879,1.0,1.0,16/125,18.55%,TULP1;ROPN1B;SIX4;DNAJA1;COL1A1;RAB11A;DDX3X;TOR1A;CSRP3;ISG15;LAMP2;TULP2;RPL11;OBSCN;ATP6V1D;GABARAPL2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.3251232276653289,-0.8142708547160886,0.8571428571428571,1.0,1.0,6/60,8.73%,MYO10;PRKCD;LIMK1;CD247;PLD2;ARPC3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.3251232276653289,-0.8142708547160886,0.8571428571428571,1.0,1.0,6/60,8.73%,MYO10;PRKCD;LIMK1;CD247;PLD2;ARPC3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.33318487876559416,-0.8140621674014386,0.6666666666666666,1.0,1.0,4/60,3.44%,RASSF2;ADGRG3;CD14;HDAC7
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.30547151535444067,-0.813991474288189,0.9230769230769231,1.0,1.0,39/150,22.78%,RNF168;POLM;PPP5C;RAD50;TENT4A;BRCC3;MMS22L;FAN1;SMARCAL1;LIG3;SLX4;TRIP13;RFWD3;KDM4D;SPIDR;PIAS4;AP5Z1;SAMHD1;PARP2;DCLRE1B;KDM4B;MDC1;KDM2A;MAD2L2;ERCC1;FBH1;XRCC4;RAD51AP1;ATM;NBN;TNKS1BP1;RAD52;INO80;MCM9;BAZ1B;EYA3;BRIP1;SETMAR;NSD2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.4088923043165304,0.8138298056783683,0.7142857142857143,1.0,1.0,5/27,17.48%,STRADA;TGFB1;RANBP3L;DUSP16;STRADB
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.32534472089128513,0.8136853296373893,0.9230769230769231,1.0,1.0,48/299,21.64%,NOTUM;APOL1;PSMB9;ITIH2;ASB5;SDC2;DTL;FBXL7;C3;ASB14;SOCS2;SERPIND1;ANKRD9;ASB15;SPSB2;RAB11A;ASB17;KLHL2;CP;KLHL13;TGOLN2;KBTBD7;RABGGTB;UBE2M;KNG1;COPS4;FBXL13;FBXL3;KBTBD6;PSMC5;COPS5;PENK;GPS1;RAB38;FN1;SERPINA10;FBXO40;PSMB6;CSF1;LAMB2;WFS1;RBBP7;ASB16;ASB8;FEM1B;PRSS23;PTP4A2;RBX1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.43310702863599326,0.8136636089373087,0.7397260273972602,1.0,1.0,3/20,16.91%,CCDC39;TEKT5;DNAH3
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.42694170556545064,-0.8135723702187065,0.65625,1.0,1.0,1/11,1.85%,H1-4
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.5583078820218886,0.8134631084478211,0.819672131147541,1.0,1.0,4/5,42.68%,VDAC1;SLC25A5;SLC25A4;VPS13D
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.4250189745367021,0.8134349840529511,0.734375,1.0,1.0,6/17,32.47%,GCHFR;SPR;DEGS2;PLPP1;CALM1;NAAA
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.4137787098734501,0.8133460273550464,0.7575757575757576,1.0,1.0,3/29,10.29%,ACOX2;HSD3B7;CYP39A1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.43041957178665075,0.8132070701510586,0.6964285714285714,1.0,1.0,2/18,9.34%,ANXA1;REST
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.31200401319445303,-0.8131301749050277,0.8181818181818182,1.0,1.0,18/112,13.73%,NTSR2;SPHKAP;SLC17A6;ELAVL3;SPTBN4;ABCC8;IGSF21;KCNIP1;SNCB;HPCA;DLX1;NEUROD6;ADGRA1;MMD2;CBLN4;BRINP1;LRRTM3;GABBR2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5246054689133224,0.8130512640120102,0.75,1.0,1.0,1/6,4.99%,HEY2
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.4059903969357274,-0.813026767555394,0.6666666666666666,1.0,1.0,3/23,3.44%,ABHD17A;HDAC10;HDAC7
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.4429907456816545,0.8129231509621455,0.6567164179104478,1.0,1.0,5/13,24.13%,NPC1L1;SLC26A6;SLC5A1;SLC46A1;ADRA2A
prerank,MSigDB_Hallmark_2020__Hypoxia,0.3342685176383367,0.8128478733665244,0.7974683544303798,1.0,1.0,26/174,15.75%,CAVIN1;SDC2;GLRX;LOX;NFIL3;PKLR;CCNG2;ANGPTL4;DDIT4;PHKG1;HSPA5;B4GALNT2;DCN;ALDOB;TGFB3;KDM3A;PNRC1;CP;PLAUR;CDKN1B;BTG1;TGM2;CDKN1A;NDRG1;TGFBI;FOSL2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.38688326750199076,0.812751009539382,0.7297297297297297,1.0,1.0,11/38,23.78%,CCL5;IL12A;OGN;IGF1;STAT1;THBS1;ELN;APOD;XRCC6;ELANE;IGFBP5
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.42987607845669057,0.8127377615864586,0.8055555555555556,1.0,1.0,2/18,13.64%,SCIN;VIL1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.42987607845669057,0.8127377615864586,0.8055555555555556,1.0,1.0,2/18,13.64%,SCIN;VIL1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.33734190016945564,0.8126695360808005,0.7866666666666666,1.0,1.0,12/89,10.66%,TIMP3;PRRX1;ADAM33;LMOD1;FBXL7;PCDH18;DAAM2;ACTA2;DCN;ANGPTL2;COL1A1;ADGRL4
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.35609654545654723,-0.8125281479222131,0.6666666666666666,1.0,1.0,4/23,14.38%,CREB3L1;ATF3;HSF1;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.4140200957969733,-0.8124591929728114,0.6511627906976745,1.0,1.0,5/14,13.53%,IL11;UBASH3B;ACVR1;KIF26A;BRAP
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.4734617573022603,0.8123778508464562,0.7230769230769231,1.0,1.0,1/9,5.45%,TGFB1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3547588056559324,0.8123043090719338,0.8552631578947368,1.0,1.0,10/74,24.54%,PSMB9;DNAJB1;RPS27A;PSMC5;PSMB6;RBX1;DDIT3;PSMD6;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.49287537438781703,0.8122844910774862,0.7313432835820896,1.0,1.0,1/12,0.92%,ITGB2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.43602754623300777,0.8122706748632329,0.7076923076923077,1.0,1.0,2/20,4.64%,PTPRC;FGF2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3440931580476688,0.8121632344729112,0.8717948717948718,1.0,1.0,12/114,13.43%,ESR1;PLA2G10;AIM2;SP100;NLRP12;CDKN2A;TBX6;ID1;CYP1B1;NLRC3;ID3;TNFSF4
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.35196865492218576,-0.8121289919136505,0.75,1.0,1.0,11/56,17.23%,SBK1;PRKCD;MAP3K10;TTBK1;ACVR1;CDK1;MAP3K12;MARK2;WNK3;PRKCA;CDK5
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.5148855543099298,-0.812083967923417,0.8125,1.0,1.0,2/9,23.73%,ZSWIM5;YTHDF1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.521588929605767,0.812061954268343,0.7,1.0,1.0,1/5,23.86%,UBA5
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.521588929605767,0.812061954268343,0.7,1.0,1.0,1/5,23.86%,UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.521588929605767,0.812061954268343,0.7,1.0,1.0,1/5,23.86%,UBA5
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.3246259414009639,-0.8118406436775861,0.8333333333333334,1.0,1.0,8/29,19.90%,RAD50;WRAP53;TERT;GAR1;ANKRD28;PPIA;RTEL1;TNKS1BP1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.2998464340782395,-0.8115381317494855,0.9047619047619048,1.0,1.0,12/125,7.03%,SH2D6;NGF;SHC3;TYRO3;TIE1;GFRA2;KIT;SHC4;PTPRF;ERBB2;EPHB2;EPHA6
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.4475908810522031,0.8115305494762332,0.7887323943661971,1.0,1.0,4/18,7.67%,PSMB9;AIM2;USP50;NLRP12
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.4846896359434042,0.811430419518997,0.7285714285714285,1.0,1.0,1/8,11.39%,RHOB
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.39268792656255586,0.8113705129986474,0.7142857142857143,1.0,1.0,3/28,11.29%,NODAL;DAB2;TRIM68
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.40131091690279774,0.8113481911650141,0.7361111111111112,1.0,1.0,11/29,21.15%,VSIR;SYK;IRF4;TNFSF4;ISG15;PDCD1LG2;IL4;AGER;TIGIT;F2RL1;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.3842266737613998,-0.8113014571979248,0.7027027027027027,1.0,1.0,4/18,8.20%,BCL6;SOX12;CBFB;FANCA
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.4918091670009733,0.8111002022148626,0.7391304347826086,1.0,1.0,1/10,5.63%,NPC1L1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.2894094307755457,-0.8109915851410692,0.9523809523809523,1.0,1.0,22/164,11.57%,NMU;PDLIM3;BCL2;GLA;FOS;GALE;DUSP2;PAPSS2;TST;DLG5;SLC27A2;ASCL1;ASS1;PERP;PCP4;CXCL14;IGFBP4;SLC7A5;SCARB1;CHST8;EMP2;IDH2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.42202649412663945,0.8109737807575039,0.7323943661971831,1.0,1.0,9/18,34.13%,NOP10;CCT7;CCT8;DCP2;CCT2;CCT6A;DKC1;CCT3;SHQ1
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.5351154483984945,0.8103091417345908,0.7333333333333333,1.0,1.0,2/5,30.45%,ZFAND1;KLC1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.4745819363411111,0.8099920134232624,0.7428571428571429,1.0,1.0,3/11,19.13%,VIL1;CARMIL1;F2RL1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.45768616388424144,-0.809708811372545,0.6666666666666666,1.0,1.0,3/8,19.16%,MVK;DHDDS;PDSS2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.3963616964266737,0.8095917235512304,0.7432432432432432,1.0,1.0,7/37,19.15%,PTPRC;FGF2;TRPV6;GRIN2D;SLC24A1;HTR2B;RYR3
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.5399968304650962,0.8094556667848282,0.7619047619047619,1.0,1.0,2/6,12.05%,JAM2;GLRA1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.368382673643844,0.8093413351351019,0.8055555555555556,1.0,1.0,7/69,12.14%,DENND1C;HLA-F;DTX2;VASP;IRF1;ARHGAP45;TMC6
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),0.5454330729572285,0.8093238089036149,0.7454545454545455,1.0,1.0,2/5,29.72%,ALOX5;GRN
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.49337033226261134,0.8092833536418185,0.7049180327868853,1.0,1.0,2/8,14.57%,MISP;GPSM2
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.4735777941676481,-0.8092133315974541,0.65,1.0,1.0,1/8,1.79%,BCL2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.4033513498492393,0.8090576219862898,0.7704918032786885,1.0,1.0,8/23,30.61%,USP50;OTUD4;YOD1;OTUB1;BAP1;USP17L2;USP27X;VCPIP1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.34761529197836166,0.8089386729041674,0.8243243243243243,1.0,1.0,12/138,13.43%,PSMB9;AIM2;TNFRSF1B;CCL5;CARD14;ST18;GPER1;GSDME;TXNDC17;STAT1;CRHBP;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.34815541483511925,-0.8088963892321269,0.6428571428571429,1.0,1.0,5/41,11.64%,PRKCD;NRDE2;FLNA;HDAC3;EMD
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.4465875135403028,-0.8088839120104839,0.6944444444444444,1.0,1.0,5/12,15.47%,UST;CHST12;VCAN;IDUA;CSPG5
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.431646275652555,-0.8085389301504382,0.6875,1.0,1.0,2/12,8.95%,FGF1;PKD2
prerank,GO_Biological_Process_2021__glucocorticoid metabolic process (GO:0008211),0.512460801589318,0.808403076110035,0.819672131147541,1.0,1.0,3/7,23.29%,HSD11B2;YWHAH;CYP21A2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.4220429773000147,0.8082895609243222,0.6901408450704225,1.0,1.0,1/22,2.87%,HSPA8
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.4766563862028794,0.8080247259044988,0.71875,1.0,1.0,1/10,2.52%,BUB1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.43039978357406605,-0.8078970205831778,0.7222222222222222,1.0,1.0,1/9,3.62%,CREB3L1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.32704002376787245,0.8078585357075861,0.8717948717948718,1.0,1.0,23/150,20.89%,GAD1;SYT2;SHISA6;STMN4;HTR5A;LRRC3B;LY6H;PLP1;TCEAL5;GNG4;PDE5A;CALB1;VSTM2A;CNTN2;PENK;ZDHHC22;DLG4;TSHZ1;CBLN1;PRKG1;SLC1A6;LRRTM1;SYT4
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.45834192372298554,-0.8078190739835779,0.6944444444444444,1.0,1.0,1/8,3.66%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.46951916260304527,0.8078059063413493,0.7049180327868853,1.0,1.0,5/9,30.73%,CD4;HLA-DRB1;TMPRSS4;CD74;LGALS9
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.46951916260304527,0.8078059063413493,0.7049180327868853,1.0,1.0,5/9,30.73%,CD4;HLA-DRB1;TMPRSS4;CD74;LGALS9
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.38561797905470624,0.8076245054206364,0.7432432432432432,1.0,1.0,6/52,12.67%,ELOVL2;CERS3;VAPB;HACD4;B3GNT5;PRKD3
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.47127503337910615,0.807590446489652,0.7068965517241379,1.0,1.0,2/10,20.26%,MAPK3;MAP2K1
prerank,GO_Biological_Process_2021__purine ribonucleoside metabolic process (GO:0046128),0.5399248827284926,0.8075088783933024,0.7358490566037735,1.0,1.0,2/5,16.46%,ENPP4;GNMT
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.3061424075362057,-0.8074320072827789,0.85,1.0,1.0,12/111,12.50%,GCK;ATP6V0D2;FOXO1;SH2B2;CPEB1;CAPN10;SYAP1;ATP6V1E2;ATP6V0A2;SLC27A4;NAMPT;SLC25A33
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.5032499552396368,0.8074201378003231,0.7333333333333333,1.0,1.0,1/7,0.54%,TEX101
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.31453681596304867,0.8072614045867703,0.9042553191489362,1.0,1.0,80/486,20.29%,TBX1;TULP1;CDCA7L;TLR2;MYRF;KIF14;S100A13;ITGAX;TNFRSF1B;ACOX2;CCL5;WNT5A;FGF20;TSHR;CRLF1;SPDYA;FGF2;CLCF1;SFTPD;FLT1;TGFB1;CIDEB;IL12A;GPER1;IER5;CD81;FLT4;ERBB4;RNF187;TBX6;LEF1;RAMP3;RPS9;OSMR;IGF1;EXOSC2;HCK;CLDN5;DDX3X;LAMC2;HPR;IL7;TGFB3;CCND1;RPS19;FOXM1;CDKN1B;EPCAM;TNFSF4;CCND2;CYBA;FBXO5;COX17;LIFR;TGM2;SOX9;TTK;RPS4X;COLEC12;GDF9;ADGRG1;IL4;NOXO1;SIRPG;HTR2B;RHOG;CSF1R;FN1;MTLN;THBS1;TAF9B;CSF1;PRAME;EXOSC4;SLC30A2;SINHCAF;HCFC1;HMGA2;RPS6;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.34735515419189467,-0.8072532404411166,0.7894736842105263,1.0,1.0,3/27,6.63%,TACR3;PDE3A;LHFPL2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.48069123205174213,0.8071890754686556,0.7611940298507462,1.0,1.0,2/10,10.54%,NOTUM;PPT1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.48913339855266663,-0.8070519756705442,0.7714285714285715,1.0,1.0,2/7,17.47%,APOE;ABL1
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.534378308016047,0.8069599418039459,0.7301587301587301,1.0,1.0,1/5,11.03%,TAF7
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.35449108282016223,0.8069551817954193,0.7777777777777778,1.0,1.0,10/90,10.47%,TMEM213;CCDC60;SLC22A8;VWA3B;RP1;NPHS2;SCIN;ERBB4;EPB41L4A;SLC4A1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.3708694962433483,0.8069219469773612,0.7777777777777778,1.0,1.0,5/68,7.60%,ELOVL2;CERS3;VAPB;A4GALT;HACD4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3712203537519458,0.8064866046922223,0.7916666666666666,1.0,1.0,5/42,14.60%,BUB1;TGFB1;WEE2;CDKN1B;BTG1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.3657582223655751,0.8063847768282985,0.8095238095238095,1.0,1.0,10/94,13.87%,PLA2G10;ASB5;WNT5A;DTL;TGFB1;C4BPA;CD80;C4BPB;CDKN1B;OAZ2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.5071558337343935,-0.806309168737283,0.75,1.0,1.0,3/6,29.17%,AMPD3;ATIC;HPRT1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3407525671580172,-0.8061778699299986,0.8076923076923077,1.0,1.0,14/42,23.79%,CACNG4;NLGN3;GRIK1;NLGN2;CACNG2;GRM2;CDK5;DRD2;HOMER1;CACNG3;CLN3;GRM7;NLGN1;DRD3
prerank,MSigDB_Hallmark_2020__Androgen Response,0.3400424937454248,0.8060686249440343,0.7837837837837838,1.0,1.0,22/96,23.04%,HERC3;STEAP4;MAK;H1-0;MYL12A;ACSL3;CCND1;SRP19;LIFR;NDRG1;MAF;SELENOP;SCD;SLC38A2;FKBP5;DNAJB9;KRT8;PGM3;PDLIM5;B2M;CENPN;XRCC6
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.5013164055524063,0.8060519816081382,0.7945205479452054,1.0,1.0,1/11,1.98%,LRRC19
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.34776400998768986,-0.8057895428296429,0.6666666666666666,1.0,1.0,8/38,16.67%,MAP3K10;TRIB1;NOD1;RIPK2;MAP3K12;CRKL;MAP3K13;MAP2K7
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.39382322348776944,-0.8057794658276517,0.7931034482758621,1.0,1.0,8/16,23.35%,SMARCB1;SMARCA4;CCNT1;TAF11;CTDP1;RRP1B;HPN;TFAP4
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4607987644999424,0.8057185467336079,0.7272727272727273,1.0,1.0,1/10,7.68%,DNAJB1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.41651280063536766,0.8055295223322959,0.7903225806451613,1.0,1.0,5/28,9.82%,SP100;ANGPT2;FGF2;TGFB1;DCN
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.3174689846741443,0.8054507301238588,0.8607594936708861,1.0,1.0,19/147,10.66%,TIMP3;PRRX1;ADAM33;SMOC1;RRAD;LMOD1;HHIP;FBXL7;LOX;PCDH18;ADAMDEC1;MYH11;OGN;DAAM2;ACTA2;DCN;ANGPTL2;COL1A1;ADGRL4
prerank,GO_Biological_Process_2021__regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),0.5525801475227013,0.8052899849370984,0.7592592592592593,1.0,1.0,1/5,13.38%,TOR1A
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.30242729897540044,-0.8051462207556774,0.9,1.0,1.0,22/97,15.94%,CASKIN1;ELAVL3;CLIP3;PRR36;TTBK1;MPP2;INA;SNCB;SRRM3;NLGN2;HPCA;SHISA7;ADGRA1;MMD2;GRIN1;TAGLN3;BRINP1;JPH3;LINGO1;CSPG5;SYN1;SLC6A9
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.5087360090353183,-0.8050905394089852,0.6666666666666666,1.0,1.0,1/5,12.08%,SLC15A4
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3440694914786046,0.8050349934871485,0.8214285714285714,1.0,1.0,20/121,22.82%,NEK2;CDC25A;FBXL7;BORA;CEP72;CEP70;FOXM1;DYNLL1;CDKN1A;TUBA4A;FBXL3;CCNA2;PKMYT1;PHLDA1;CEP76;TPD52L1;CCNB1;DCTN1;ABCB1;MASTL
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.40744621125211533,0.805019309828452,0.6774193548387096,1.0,1.0,5/19,20.26%,TGFB1;DAB2;PPP2R5A;RHOQ;MRAP
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.2830164306369592,-0.8048488301693979,1.0,1.0,1.0,30/186,14.69%,EFNB1;SHC3;LAMA3;GFRA2;PTPRO;SPTBN4;SH3KBP1;DOK5;SLIT3;EPHB2;EPHA6;PTPRA;SPTB;TNR;DOK6;NTN4;BSG;NTN5;NIBAN2;SLIT2;ALCAM;LAMA2;PLXNA4;ANOS1;NFIB;GPC1;ROBO4;MAPK7;EVL;DSCAML1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.43273087867412874,0.804581753384843,0.7727272727272727,1.0,1.0,5/13,18.92%,NQO1;CYP1B1;GCHFR;SPR;NOS2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.34876572663294614,-0.8045458375038023,0.7692307692307693,1.0,1.0,5/48,11.28%,NGF;PLCL2;PI4KB;NTRK1;PLCZ1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.4187548780467268,0.8044240540705145,0.7142857142857143,1.0,1.0,1/29,1.37%,CAVIN1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.28382373172994624,-0.8043086029337345,0.9166666666666666,1.0,1.0,21/115,16.52%,ENTPD2;SLITRK6;ARX;ETV1;ADCYAP1;CFC1;ABCC8;THSD7A;PCP4;ADGRA1;ATP9A;NFIB;NOVA1;PROX1;SERTM1;NME5;ESRRG;FAM149A;ADGRL2;PCDH17;PLPPR1
prerank,GO_Biological_Process_2021__regulation of intestinal cholesterol absorption (GO:0030300),0.524015017794487,0.804280090048965,0.8,1.0,1.0,1/5,21.53%,ABCG5
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.34353116864296845,-0.8040283362707663,0.7666666666666667,1.0,1.0,9/24,21.86%,ST3GAL2;RRM2;RRM2B;GK5;ST3GAL4;G6PD;ALG11;ALG8;GK
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3893415044809591,0.8039879293386303,0.8493150684931506,1.0,1.0,4/42,13.38%,CEP55;CHMP3;RPS19;TOR1A
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.32442488240604384,-0.8036226555520669,0.8333333333333334,1.0,1.0,7/82,7.12%,DRD4;CDH5;TESMIN;CLDN16;LETM2;RGN;SLC8A3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.44132747243584103,-0.8035268870142347,0.7428571428571429,1.0,1.0,2/13,5.99%,FGF18;HSPB1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.34043061427321675,-0.8034373308341354,0.8,1.0,1.0,10/39,20.21%,CDH5;CLIP3;MAPRE1;CDK5RAP2;CAMSAP3;ABL1;AKAP9;OCLN;MAPT;GBA2
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.4468327618798814,0.8033108247992369,0.7142857142857143,1.0,1.0,3/17,13.70%,PRDX4;DUOX1;CYBA
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.4872870841223836,0.803149295590795,0.7666666666666667,1.0,1.0,2/8,17.19%,PINK1;IL4
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.5321681247565455,0.8031382501393826,0.7540983606557377,1.0,1.0,1/7,16.02%,SLC24A1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.33027742482972494,0.8030780107321236,0.8441558441558441,1.0,1.0,19/171,13.46%,RASGRP4;ESR1;SP100;TMEM204;HHIP;TGFB1;CAV3;GRK7;NLRP12;SOCS2;GPHB5;LRIT3;GNG4;DHRS3;CD80;CD63;IGFBP6;ZIC1;MTCH1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3424223389369422,0.8030474909307617,0.788235294117647,1.0,1.0,20/122,22.82%,NEK2;CDC25A;FBXL7;BORA;CEP72;CEP70;FOXM1;DYNLL1;CDKN1A;TUBA4A;FBXL3;CCNA2;PKMYT1;PHLDA1;CEP76;TPD52L1;CCNB1;DCTN1;ABCB1;MASTL
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.44831759514953773,-0.8024971883867831,0.696969696969697,1.0,1.0,2/10,10.27%,SERPINE2;CHAC1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.3813326083120748,0.8021747470702233,0.7794117647058824,1.0,1.0,16/50,27.35%,CHCHD4;TIMM22;TOMM20;TIMM17A;FIS1;TOMM7;HSPA4;ROMO1;PAM16;BCAP31;TIMM10;SLC25A6;FBXO7;TOMM34;AIP;TIMM21
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.445065290223263,0.8020477341732373,0.7538461538461538,1.0,1.0,6/16,19.62%,BOK;SOD2;IFI6;BBC3;GGCT;FIS1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3982108133371743,-0.801966849222228,0.7419354838709677,1.0,1.0,5/30,8.76%,PRKCD;TCOF1;PUM3;NANOS3;PCIF1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.34219554684052506,0.8018936685044439,0.8048780487804879,1.0,1.0,20/85,24.11%,TNFRSF1B;ACOX2;CCL5;FGF2;CIDEB;RAMP3;HPR;CDKN1B;LRPAP1;HTR2B;TMEM109;OLFM4;RAB29;PARK7;CALCR;PRR7;CTSZ;CCN6;CRYAB;AGR2
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.4458784334766524,0.801874506028701,0.7571428571428571,1.0,1.0,5/17,16.74%,OR51I2;OR52A5;OR8A1;SYT10;OR51M1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.48703107186084227,0.8013526041418657,0.7407407407407407,1.0,1.0,1/7,6.19%,MISP
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.2972746833240207,-0.8008561568500944,0.7894736842105263,1.0,1.0,27/141,14.38%,AOAH;METRNL;ADAMTS12;IL1RL2;IL16;SELE;CDH5;BCL6;PRKCD;TYRO3;APOE;CCN4;MEFV;CCN3;NLRP1;SERPINE1;SHARPIN;ETS1;NR1D1;DAGLA;MVK;LPL;AHSG;ABCC1;SBNO2;SMPDL3B;MAPK7
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4031421066755005,-0.8008147936783099,0.7027027027027027,1.0,1.0,2/16,7.44%,SIGIRR;TRIB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.4668240978306851,-0.8005502187089761,0.7647058823529411,1.0,1.0,3/6,32.08%,DDAH1;NOL3;ENO1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.381608777240532,0.8004030022942965,0.7662337662337663,1.0,1.0,2/34,4.54%,SYT2;SNAP23
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.4433907564224758,-0.8001662530959684,0.7297297297297297,1.0,1.0,1/8,1.97%,ARX
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.3356717390768295,0.800023124471112,0.8513513513513513,1.0,1.0,30/134,19.01%,ITGB2;C3AR1;TLR2;BLNK;ANXA1;CCL5;PTX3;TRAF3IP2;TGFB1;NFAM1;PTGER3;AFAP1L2;NLRC4;PIK3CG;HPR;CRHBP;GGT5;TNFSF4;CYBA;LIAS;ALOX15;CD44;XCR1;GPR68;IL4;TAC4;CSF1R;FPR1;NOS2;THBS1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.3066827377615394,-0.8000225355642346,0.8636363636363636,1.0,1.0,10/65,15.92%,HNRNPL;RAD50;WDR74;ANKLE1;DNASE1L1;HNRNPF;PTBP1;POLR2F;POLR2C;RBMX
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.33984337352737704,0.7998629010471395,0.8414634146341463,1.0,1.0,15/122,20.22%,ESR1;ACTL6A;SUV39H1;SMARCE1;SOX9;BRDT;LRWD1;MYB;SNAI1;TNP1;TAF6L;FAM47E;TCF7L1;HCFC1;HMGA2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.46584073617330174,0.7998265665720593,0.765625,1.0,1.0,2/17,1.40%,BLK;C1QTNF1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.5269732376152885,0.7997907513952999,0.75,1.0,1.0,2/7,9.34%,ANGPT2;F7
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.32431912457247164,-0.7996862003997576,0.8928571428571429,1.0,1.0,13/51,16.99%,MFSD2A;ABCA4;APOE;ATP10A;SCARB1;PITPNM1;ATP9A;ABCC1;OSBPL5;OSBPL8;ABCG1;ATP8A2;PITPNA
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4292174214883866,-0.7996811467380144,0.78125,1.0,1.0,5/11,20.50%,TRIM71;AGO2;TNRC6C;TNRC6A;NOTCH4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.4292174214883866,-0.7996811467380144,0.78125,1.0,1.0,5/11,20.50%,TRIM71;AGO2;TNRC6C;TNRC6A;NOTCH4
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.2942881944908772,-0.7996234549629906,1.0,1.0,1.0,11/134,8.70%,MFSD2A;ATP6V0D2;FOXO1;IFI16;KLF10;FADS1;RALB;KPTN;CLEC16A;ALB;ATP6V1E2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.5007370637656029,-0.7994552623376979,0.7647058823529411,1.0,1.0,2/7,3.72%,UBASH3B;COL4A2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.4842407168785701,-0.7991996795799163,0.8064516129032258,1.0,1.0,1/6,4.37%,ADCYAP1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.33501738909051576,0.7990046244462308,0.775,1.0,1.0,13/87,14.11%,ENPP2;SSTR1;ADGRG4;SLC17A8;MUC17;CLCA1;DCN;ANGPTL2;ALDOB;NR1H4;SMLR1;PIEZO2;TREH
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.35745790234657676,-0.7989952800210667,0.8,1.0,1.0,1/31,0.92%,NMU
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.476056546486292,0.7989742743636604,0.8,1.0,1.0,1/10,1.02%,C3AR1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.5207278107707111,0.7989188322469465,0.8245614035087719,1.0,1.0,1/6,4.99%,HEY2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.41015315957488513,0.7988585139520759,0.7230769230769231,1.0,1.0,1/17,4.48%,PHKA1
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),0.486726170799254,0.7988584241288395,0.7096774193548387,1.0,1.0,2/7,26.42%,CHRNB2;CARTPT
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.3461908902006204,-0.79864115125366,0.8181818181818182,1.0,1.0,7/22,21.95%,PNP;CTPS2;AK8;FHIT;AK7;NMNAT3;NUDT5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.45500579607380043,0.7985415666219666,0.7540983606557377,1.0,1.0,5/16,33.76%,CHMP3;CHMP1A;CHMP4B;DRG1;CHMP2B
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.4639895944787343,0.7982882600817282,0.7272727272727273,1.0,1.0,2/12,14.66%,USP50;AFF2
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.3646145426181764,-0.7982432944919168,0.6785714285714286,1.0,1.0,5/24,10.03%,LIMK1;SYNPO;SHANK1;ASAP3;ALMS1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.38780329293857324,-0.7979001553680112,0.8181818181818182,1.0,1.0,9/39,9.80%,GRID2;NLGN3;DLG5;SYNDIG1;WNT7A;EPHB2;CX3CR1;SLITRK2;NLGN2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.33792542925902574,0.7977706170556581,0.8604651162790697,1.0,1.0,26/109,28.09%,CLDN2;TRIL;SDC2;MMP15;SLC13A4;SOX9;ID4;AGT;SLC44A3;BCAR1;LAMB2;EFNB3;WFS1;SLC4A2;FRZB;PTPRU;SMARCA1;IGFBP5;CHMP1A;CPE;DDR1;FLRT3;SLC26A11;ARHGEF17;SLC31A1;CGNL1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.28838328380163597,-0.7975711055321443,0.9230769230769231,1.0,1.0,30/151,19.47%,CAMK1G;SBK1;PRKCD;MAST2;MAP3K10;TTBK1;ERN1;CDK1;ATR;MAPKAPK2;MAP3K12;MARK2;RPS6KA3;CLSPN;CSNK1G2;CSNK1E;EIF2AK3;MAP3K13;MARK3;PRKCA;CDK5;AKT2;MAST4;BRSK1;MAST1;MAPK12;MORC3;STK32C;ATM;CSNK1G1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),-0.5288328706817893,-0.7975389000488644,0.7083333333333334,1.0,1.0,2/5,13.15%,CSGALNACT1;B3GAT3
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.4929591174528783,0.7973039341388777,0.746268656716418,1.0,1.0,1/9,5.63%,NPC1L1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.41410295602881003,0.7971907474929719,0.7638888888888888,1.0,1.0,4/28,8.79%,TAPBPL;HLA-F;ERAP2;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.525362919778485,-0.7969332790924806,0.7714285714285715,1.0,1.0,1/5,9.26%,PTPRS
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.47263460120704065,0.7969211562520235,0.7794117647058824,1.0,1.0,1/14,2.71%,WNT8B
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.45149846330136995,0.7965303936903153,0.7846153846153846,1.0,1.0,1/12,4.80%,STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.45149846330136995,0.7965303936903153,0.7846153846153846,1.0,1.0,1/12,4.80%,STAT5A
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.2730718731378542,-0.7964228958172141,1.0,1.0,1.0,45/302,13.87%,COL22A1;PLK3;KIF2B;COL13A1;P3H4;LAMA3;KLHL41;COL12A1;TPM4;COL6A3;COL4A2;MAP10;RND3;LOXL1;COL8A1;CD151;TPM2;CLIP3;MYO5C;PCM1;TPM3;SAMD14;ITGB4;RHOBTB2;HIP1;CORO1B;EMILIN1;PPP1R9B;COLGALT1;ADAMTS3;TUBGCP2;EMP2;SNCAIP;CLIP2;P3H1;SPAST;SLK;GGA2;TPPP3;AVIL;PLEC;CORO1A;CHP1;NCKAP5L;MYO19
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),-0.516699809139479,-0.796366866888492,0.7551020408163265,1.0,1.0,1/5,2.05%,CBARP
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.43224599708478734,0.7962118107461416,0.8028169014084507,1.0,1.0,3/22,16.91%,PFKFB2;IGF1;PRXL2C
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.4520417680515952,0.7960665648434095,0.7258064516129032,1.0,1.0,3/13,27.81%,PSAP;ABCB1;ABCA12
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.43655366728796086,0.796021580093124,0.8059701492537313,1.0,1.0,2/17,4.81%,KIF14;STMN4
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.40462496050801233,0.795969986836016,0.8,1.0,1.0,3/26,9.95%,WNT5A;PINK1;IGF1
prerank,GO_Biological_Process_2021__fatty acid omega-oxidation (GO:0010430),-0.5227827853007775,-0.7959407564219083,0.7142857142857143,1.0,1.0,2/5,9.99%,CYP4V2;ADH4
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.4323199520481276,0.7958966239504767,0.7611940298507462,1.0,1.0,5/14,18.92%,NQO1;CYP1B1;GCHFR;SPR;NOS2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.362985715781688,0.7957358846184802,0.8260869565217391,1.0,1.0,6/47,13.30%,APOL1;SLC12A7;SLC12A3;GLRA2;GLRA1;ANO2
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.4564985663554757,0.7957037128846485,0.7169811320754716,1.0,1.0,1/7,5.64%,ITGAM
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.4387218891651261,-0.7956206559802692,0.7777777777777778,1.0,1.0,2/12,1.49%,CELA2A;ZNF703
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.32738295360926506,-0.7954905588819169,0.8181818181818182,1.0,1.0,9/40,19.35%,TWIST1;DDX11;WRAP53;SPIDR;SIRT7;SHLD2;RTEL1;RAD51AP1;PML
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.40530916825961705,-0.7950913785917213,0.59375,1.0,1.0,7/19,16.53%,SEPTIN9;CROCC;CEP135;CCDC88A;MARK4;ENTR1;ARHGAP35
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.3346759849366334,0.7949464060662269,0.8588235294117647,1.0,1.0,24/118,21.79%,NOTUM;LECT2;WNT5A;HHIP;CNMD;RPL13;GDF11;IGF1;COL1A1;BMP3;NPR3;TGM2;SOX9;TRAPPC2;CD44;ALX4;HAPLN2;HAPLN1;ITGB8;COL10A1;BCAN;BPNT2;FRZB;GHRL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.4053370990984601,0.7946750183677768,0.7567567567567568,1.0,1.0,10/37,23.06%,TLR2;AFAP1L2;CD244;SYK;ZNF580;NOS2;F2RL1;DDIT3;PARK7;ELANE
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.4278022433097186,-0.7945872373638857,0.75,1.0,1.0,2/11,13.35%,AUP1;BAG6
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.35434824571933676,0.7945430815789238,0.8082191780821918,1.0,1.0,4/82,5.24%,MCUB;STOML2;TRPV6;TRPC7
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.37055056732440594,0.794527735021881,0.7894736842105263,1.0,1.0,10/51,17.95%,LPAR1;GNAT3;HTR5A;PSAP;NPY1R;HTR1B;P2RY12;ADCY7;OPRM1;OPRL1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.37790679315818,-0.794368068651381,0.7931034482758621,1.0,1.0,7/21,15.86%,ADAM8;RHBDD1;SERPINE2;NKD2;CHAC1;CCBE1;ASTL
prerank,GO_Biological_Process_2021__mesenchymal to epithelial transition (GO:0060231),-0.5182110084493401,-0.7943066361433974,0.7619047619047619,1.0,1.0,1/6,5.72%,FZD7
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.421077136547819,0.7943012047305158,0.7428571428571429,1.0,1.0,6/22,17.32%,PTPRC;CD81;RPS19;TNFSF4;DDX60;MYB
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.34378581882248216,0.7940927837247344,0.8974358974358975,1.0,1.0,6/71,12.35%,ST6GALNAC1;GALNTL5;FUT2;B3GNT9;IGF1;B3GNT5
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.3821268594920549,-0.7940544919949971,0.7222222222222222,1.0,1.0,9/20,23.40%,CELF4;CIRBP;THRAP3;RBMX;LEO1;NUP98;SF3B4;DHX36;DAZAP1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.4764432457448191,0.7940150171918148,0.7586206896551724,1.0,1.0,6/9,29.16%,FBXO5;RPL11;RPS7;RPL23;BAG2;RPL5
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3447278760930176,0.7939697496326146,0.8795180722891566,1.0,1.0,2/75,3.01%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3281692578745697,-0.7938090043413333,0.7619047619047619,1.0,1.0,8/65,9.85%,NGF;ACER2;CFLAR;EGLN3;NLRP1;SENP1;HIP1;NOD1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.5284719535783367,0.7933491643452448,0.7121212121212122,1.0,1.0,5/5,47.16%,NAA30;NAA20;NAA25;NAA15;NAA16
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3499235651359803,0.7930145404333023,0.84,1.0,1.0,10/73,24.54%,PSMB9;RPS27A;FBXO5;PSMC5;PSMB6;BUB1B;CCNB1;PSMD6;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.3053061355554661,-0.7928602929387331,0.84,1.0,1.0,7/28,19.90%,RAD50;WRAP53;TERT;GAR1;ANKRD28;RTEL1;TNKS1BP1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.29804752035205956,-0.7924872031686035,0.8125,1.0,1.0,10/86,10.28%,TRIM71;EIF4EBP1;CPEB1;DHFR;NANOS3;PCIF1;CNOT9;AGO2;IGF2BP1;FXR2
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.3874904596395967,-0.7924868225776895,0.6666666666666666,1.0,1.0,1/8,6.68%,AOC3
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3620136610672132,0.7922262367298745,0.8591549295774648,1.0,1.0,5/57,13.70%,MAPKAPK3;FLT1;FLT4;AXL;CYBA
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.5274786671678291,-0.7920869863248677,0.7575757575757576,1.0,1.0,2/5,27.96%,INHA;ID2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.410739286035288,0.7920702111865193,0.71875,1.0,1.0,6/16,33.07%,SLC25A18;SLC25A22;SLC1A6;PRAF2;SLC1A3;SLC25A13
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4742559483632039,0.7920427839206392,0.734375,1.0,1.0,1/8,4.05%,VSIR
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.3755144318778189,0.7919309935892624,0.8805970149253731,1.0,1.0,12/50,24.62%,NDUFB11;TMEM126A;NDUFS2;NDUFA2;BCS1L;NDUFB10;NDUFB4;NDUFB9;NDUFAF5;NDUFA1;NDUFB2;NDUFAF4
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.3755144318778189,0.7919309935892624,0.8805970149253731,1.0,1.0,12/50,24.62%,NDUFB11;TMEM126A;NDUFS2;NDUFA2;BCS1L;NDUFB10;NDUFB4;NDUFB9;NDUFAF5;NDUFA1;NDUFB2;NDUFAF4
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43959675852991886,0.7917761382584418,0.7567567567567568,1.0,1.0,4/13,31.75%,YOD1;BCAP31;DERL2;SVIP
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.43003510670881573,0.7916121016512975,0.7230769230769231,1.0,1.0,2/11,14.93%,TGFB1;SOX9
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.41024202046246017,0.7915390559934371,0.8115942028985508,1.0,1.0,2/21,4.64%,PTPRC;FGF2
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4499877197165668,-0.7914990427440106,0.7297297297297297,1.0,1.0,1/10,5.14%,NIPSNAP2
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.4471479400722719,0.7913960280698923,0.7605633802816901,1.0,1.0,5/10,29.11%,PINK1;IL4;PARK7;ISCU;PRELID1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.34610049961819644,-0.7913357011866109,0.7777777777777778,1.0,1.0,6/32,13.78%,TRDMT1;METTL1;METTL6;TRMT61B;TRMT61A;ALKBH8
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.36506545389357553,-0.791225521398137,0.7142857142857143,1.0,1.0,6/25,12.77%,USP36;QSOX1;CLEC16A;LZTS1;NUPR1;RUBCN
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),-0.5142770337192448,-0.7912021028389513,0.7297297297297297,1.0,1.0,3/6,28.02%,NOTCH1;LRP6;DLL4
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.4936059273514558,0.7910022818139437,0.7586206896551724,1.0,1.0,2/6,18.94%,CRHBP;DLG4
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.4936059273514558,0.7910022818139437,0.7586206896551724,1.0,1.0,2/6,18.94%,CRHBP;DLG4
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.4396867817043224,-0.790983324352226,0.6976744186046512,1.0,1.0,3/8,3.51%,SLC25A29;SLC6A20;SLC25A45
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.4829635824739471,0.790684345834441,0.7592592592592593,1.0,1.0,3/9,28.69%,DDX60;USP17L2;OASL
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.52043592600583,0.7906813039282536,0.7735849056603774,1.0,1.0,2/6,19.32%,EXOSC2;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.4940180712600347,-0.7906719460219617,0.7741935483870968,1.0,1.0,2/5,16.44%,LDB1;MAFB
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.28991214502739954,-0.7903515558886444,0.95,1.0,1.0,19/122,11.68%,ARX;CACNG4;RND3;S100B;APOE;SLC17A6;ELAVL3;MEGF10;PTPRZ1;ASCL1;HOPX;INA;KCNIP1;MSI1;SRRM3;DLX1;ADGRA1;TMTC4;TAGLN3
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.450319789836137,-0.790043626637218,0.6976744186046512,1.0,1.0,1/7,0.77%,ANXA8
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.37599803176579194,-0.7896784123120392,0.75,1.0,1.0,3/20,9.84%,SLC6A20;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.47880511458181746,0.7896744053741558,0.7647058823529411,1.0,1.0,1/9,10.60%,RAB11A
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.3773688796601685,0.7896240802968008,0.7681159420289855,1.0,1.0,8/38,12.39%,CLDN2;CLDN6;CLDN18;CLDN5;MARVELD2;MARVELD3;ECT2;CLDN9
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.43026381173639927,0.7896011626776681,0.8088235294117647,1.0,1.0,3/20,13.70%,SPDYA;CCND1;CCND2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.4714901669270211,0.7894678293865693,0.803921568627451,1.0,1.0,1/9,9.14%,B4GALNT2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.378722004848771,-0.7894316975036507,0.717948717948718,1.0,1.0,5/18,16.22%,PKD2;AQP1;SLC4A11;WNK3;TRPV4
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.4279689678273326,-0.7891682709344379,0.696969696969697,1.0,1.0,5/11,27.81%,LIG3;XRCC4;DCAF1;LIG1;HMGB1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.38329465946880337,0.7887653982716272,0.8192771084337349,1.0,1.0,1/30,2.46%,PKP2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.39835323807504636,0.7886293880649259,0.782608695652174,1.0,1.0,1/28,1.02%,MCUB
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.3550555567407968,-0.7885520410374796,0.8,1.0,1.0,1/34,0.34%,SKAP1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.3493241504189772,0.7883770432981476,0.8461538461538461,1.0,1.0,7/82,12.09%,MYRF;STOML2;VSIR;CPM;F7;HPR;SDE2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.33458173532482405,0.7883580537602178,0.7894736842105263,1.0,1.0,10/101,14.84%,RRAD;ARHGAP31;RRAS;FGF2;USP50;CDKN2A;IGF1;RAPGEF6;RERG;CDKN1A
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.5340305887132292,0.7881583936293378,0.8153846153846154,1.0,1.0,1/5,4.40%,TRIM62
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.44993848655475704,-0.7879638531821218,0.7666666666666667,1.0,1.0,2/8,16.70%,NR1H2;ABCG1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.37201306296578013,0.7878860482329668,0.8428571428571429,1.0,1.0,5/52,10.29%,ACOX2;HSD3B7;FAXDC2;HSD11B2;CYP39A1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.334114761010442,0.787596592395784,0.8488372093023255,1.0,1.0,12/138,16.67%,PSMB9;TENT5B;HSPA8;IGF2BP2;EXOSC2;EXOSC8;MEIOC;RPS27A;CARHSP1;METTL14;SET;PSMC5
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.36237667375523097,-0.7875144536896815,0.8333333333333334,1.0,1.0,2/27,5.28%,PTCH1;APOE
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.46202486130334997,-0.7867836987874831,0.7692307692307693,1.0,1.0,1/7,10.06%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.46202486130334997,-0.7867836987874831,0.7692307692307693,1.0,1.0,1/7,10.06%,AGO2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.5124531607784746,-0.7867757296855724,0.6285714285714286,1.0,1.0,2/6,10.56%,PTPRF;HFE
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.48144153388425576,-0.7867013492984688,0.8055555555555556,1.0,1.0,5/9,21.53%,SHANK1;ADCY3;BRSK1;DRD2;CLN3
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.3743792031314885,-0.7865628466775905,0.8333333333333334,1.0,1.0,1/13,4.78%,KLHL20
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.34457054391772907,0.7864010143067502,0.8055555555555556,1.0,1.0,20/60,18.84%,ITGB2;CYTIP;ARHGAP9;GMFG;PTPRC;TSHR;SASH3;CD99;WAS;IKZF1;CD244;PSTPIP1;TAGAP;CD37;ZAP70;MYO1F;SIRPG;CD4;ALOX5AP;PARVG
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.2714626128343298,-0.7862844239192937,1.0,1.0,1.0,14/98,15.30%,PNKP;FAN1;POLD3;LIG3;COMMD1;ERCC8;GTF2H2;XPC;COPS8;SLX4;POLR2F;ERCC2;RFC3;POLR2C
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.46221354224546596,0.7862465603156235,0.7241379310344828,1.0,1.0,2/10,3.00%,TYR;IYD
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.34181995270190635,-0.785666308239149,0.8275862068965517,1.0,1.0,12/45,18.55%,NR4A1;CDH13;PARVA;SLIT2;CCBE1;NAXE;RECK;DLL1;MIA3;RSPO3;SRF;GREM1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.41286511894394046,-0.7850057460418118,0.71875,1.0,1.0,6/8,28.15%,OAZ3;AKT2;CTTNBP2NL;IRS2;AKT1;INPP5K
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4482487355929431,0.7849985014803162,0.7833333333333333,1.0,1.0,4/15,19.13%,F7;ZNF580;MTUS1;F2RL1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.3882133499570637,-0.7848086881384393,0.8387096774193549,1.0,1.0,4/14,16.57%,TRPC3;SLC30A10;TRPC6;SLC39A8
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.27765209194714857,-0.7847435953059904,1.0,1.0,1.0,22/148,12.22%,PER2;WNT3A;DCDC2;VAX2;SH3RF1;LHX2;MDGA1;FZD7;ERBB2;WNT7A;ATOH7;ASCL1;CX3CR1;HES1;KIAA0319;PEX13;NEUROD6;EML1;TUBGCP2;NEUROD2;ANOS1;LDB1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.3382100460262481,-0.7845682604918208,0.8095238095238095,1.0,1.0,7/59,10.37%,DGKD;SHC3;SLC30A10;TGFA;ERBB2;EFEMP1;PTPRR
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.41800583634663196,0.7845641529932388,0.7323943661971831,1.0,1.0,2/21,9.25%,GPER1;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3280089556421123,-0.7844471392126864,0.8484848484848485,1.0,1.0,7/38,11.97%,WNT3A;DGKD;SELE;HIP1;SERPINE1;HFE;ARRB2
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.43353131095009184,0.7844010272634245,0.7536231884057971,1.0,1.0,4/11,35.40%,TCHP;YAP1;CCP110;TBC1D7
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4232877425997977,0.7841306709173499,0.828125,1.0,1.0,1/16,3.08%,PTPRC
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.391892619424185,0.7838612234443247,0.7466666666666667,1.0,1.0,5/31,21.02%,CAVIN1;POLR1C;MAPK3;TAF1A;POLR1E
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.5045256623243684,0.783791804187164,0.7017543859649122,1.0,1.0,4/5,22.43%,NR1H4;LDLRAP1;ANXA2;HNRNPK
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4381931337462163,-0.783275092683219,0.6764705882352942,1.0,1.0,4/8,28.60%,PTPRJ;PTPN2;SNCA;NDRG4
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3510481695698369,0.7829757591242453,0.863013698630137,1.0,1.0,5/47,16.68%,FGF2;IMPA1;PLD4;PLCD1;IMPA2
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.49987761062307645,0.782945458447743,0.782608695652174,1.0,1.0,1/7,6.28%,PHF23
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.4871053470273239,0.7829004291411059,0.8055555555555556,1.0,1.0,2/9,15.59%,SEMA3A;SEMA3F
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.3373192063769283,0.7828754800093558,0.8625,1.0,1.0,21/117,26.09%,LRP4;SLC18A2;SHISA6;TMEM35A;TCEAL5;NPY;LIFR;VSTM2A;CNTN2;PLAT;LRRTM1;SYT4;SLC26A4;LSAMP;SULT4A1;RGS4;SNAPIN;PHYHIP;CPE;TCEAL7;FAM171B
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.48144291655855215,0.7828238535562876,0.7647058823529411,1.0,1.0,1/9,4.51%,SLC18A2
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.5322797806645609,-0.782747291648154,0.7142857142857143,1.0,1.0,2/5,23.30%,SF3A2;SF3A3
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),-0.45543793112323755,-0.7827391627903738,0.7380952380952381,1.0,1.0,3/6,25.15%,DRD2;DRD3;SLC8A1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2606222038096674,-0.7824434040054982,1.0,1.0,1.0,29/290,13.00%,ABHD17A;TBC1D10A;RAB20;SEPTIN10;TBC1D16;GRID2;SEPTIN8;STX11;SYNDIG1;STX6;USP4;SEPTIN9;SNX8;SCFD2;TBC1D22B;ARFIP2;FLNA;TBC1D2;CORO1B;TMED4;TICAM2;STX5;CROCC;RAB5A;RTP1;EMP2;TBC1D8;GGA2;CEP250
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.41527987850402154,-0.7823162803518764,0.7142857142857143,1.0,1.0,3/8,20.03%,PCGF1;PCGF6;PCGF5
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.41515132571322433,0.782281793228215,0.8,1.0,1.0,4/18,22.49%,CCL5;PLA2G7;CREB3;CXCL12
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.3316361529609328,0.7822268097952807,0.8088235294117647,1.0,1.0,13/86,11.92%,PRRX1;ADAM33;LMOD1;PCDH18;DAAM2;CPED1;ACTA2;DAB2;DCN;ANGPTL2;COL1A1;ADGRL4;COL6A2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.3265108372831258,0.7821720897401635,0.9024390243902439,1.0,1.0,9/137,6.91%,TBX1;TMEM100;ANXA1;LRP2;CCL5;WNT5A;FLT1;TGFB1;FLT4
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.42263837559006306,-0.781888969698426,0.7954545454545454,1.0,1.0,3/10,14.71%,NT5C1A;UPP2;NME5
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.45197643961339645,0.7818106326288948,0.8028169014084507,1.0,1.0,2/13,13.85%,DONSON;FBXO5
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.45493566306554,-0.7815501169884741,0.8125,1.0,1.0,2/8,11.98%,CX3CR1;MAPKAPK2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.4324907684836977,0.7815325249241069,0.7727272727272727,1.0,1.0,4/16,17.70%,ROS1;ACTA2;TMEM79;WNT5B
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.3132334580005085,0.7813709561905884,0.9390243902439024,1.0,1.0,34/182,28.35%,DTL;UBE2L6;FBXL7;ARIH2;TRIM25;PINK1;SPSB2;RPS27A;ISG15;SIAH1;HERPUD1;UBL7;SYVN1;PCYOX1;RBX1;BUB1B;STUB1;RNF5;AMFR;RNF144B;KCTD10;RNF20;UBA6;FBXO7;SPSB4;BUB3;RNF6;KLHL15;FEM1C;FBXO10;KLHL8;CBLC;RNF213;AURKA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.41066859561578845,-0.7811094387429843,0.7058823529411765,1.0,1.0,5/16,22.43%,ASS1;MIA3;ADTRP;LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.4153791091914205,0.7810475472344544,0.8225806451612904,1.0,1.0,3/14,11.13%,P2RY6;DUOX1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.4135580093369903,0.7810419606231044,0.7413793103448276,1.0,1.0,4/23,13.64%,KANK3;SCIN;TMSB10;VIL1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.3507207233428066,0.7808109355179598,0.8260869565217391,1.0,1.0,2/62,1.05%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.3448399080754378,-0.780663769365845,0.88,1.0,1.0,12/28,27.05%,GRID2;MDGA1;PROX1;CHD5;NTRK2;MAPT;GBA2;NR4A2;LRP6;ZC4H2;KNDC1;RYK
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.3301874766885725,-0.7805285836962839,0.8846153846153846,1.0,1.0,1/38,0.77%,ANXA8
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.3896720429590958,-0.7803268486886505,0.8620689655172413,1.0,1.0,2/15,17.05%,JADE2;KANSL2
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.3896720429590958,-0.7803268486886505,0.8620689655172413,1.0,1.0,2/15,17.05%,JADE2;KANSL2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.4667188862220455,0.7802843574131424,0.8181818181818182,1.0,1.0,1/9,7.43%,CEP72
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.427571238227074,0.7802605483968085,0.7096774193548387,1.0,1.0,3/13,17.93%,SCIN;ACSL3;OAS2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.3462871746680247,-0.7801938244802239,0.8666666666666667,1.0,1.0,3/35,5.00%,GCK;ENO3;NEU4
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.3440592062404199,0.7801809127343011,0.7922077922077922,1.0,1.0,18/88,22.48%,PLA2G10;ACE2;CCL5;TGFB1;RAMP3;CD63;CDKN1A;SFRP4;CHCHD2;IL4;AGT;ANXA2;THBS1;CSF1;ROMO1;NFKBIA;RAB29;CCNB1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.39725016427296855,-0.7800950818908954,0.75,1.0,1.0,4/14,12.34%,FOXO1;PPP5C;PID1;LPL
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.4278875405693235,-0.7800718216365904,0.8611111111111112,1.0,1.0,2/10,7.20%,CCDC68;PCM1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.40225266408036314,0.7797145590834718,0.8142857142857143,1.0,1.0,2/39,6.32%,CASQ2;GPER1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3842035843641098,0.7795628610737946,0.7837837837837838,1.0,1.0,5/27,22.53%,MISP;NDC80;GPSM2;DYNLT1;DCTN1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.3510242780937123,-0.7794837141637599,0.9354838709677419,1.0,1.0,9/30,21.30%,FSCN1;SLIT2;CAPZB;AVIL;AUTS2;ARPC2;WASF2;OCLN;PLCE1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.3353162261828567,-0.7794391289575502,0.84,1.0,1.0,8/53,14.06%,BCL2;USP36;QSOX1;LZTS1;NUPR1;RUBCN;MTMR8;KLHL22
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.3674077878290579,-0.7793251271513059,0.8148148148148148,1.0,1.0,3/24,5.67%,PPP1R35;BOD1L1;STYXL1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.45129208887029804,0.7792215310854167,0.7258064516129032,1.0,1.0,5/12,28.57%,MANF;WFS1;AQP11;ALOX5;CLU
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.48866967384801946,0.7791903586758115,0.7272727272727273,1.0,1.0,1/7,10.22%,DUSP22
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.32507886170732375,-0.7791031460536733,0.7407407407407407,1.0,1.0,15/81,13.95%,CACNG4;KCNG1;KCNE1;SHANK1;CACNB1;CRH;NLGN2;HPCA;SHISA7;GRIN1;JSRP1;GRIA4;CACNG2;CNIH3;JPH3
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4270112566189774,-0.7788575025441528,0.6764705882352942,1.0,1.0,3/11,19.50%,RAB5A;NEURL1;DRD2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3414422435872084,0.7785986210712083,0.8888888888888888,1.0,1.0,7/64,7.56%,ESR1;C3AR1;GPR55;LPAR1;NMUR2;PTGER3;P2RY6
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.3126648035962887,-0.7783956387295211,0.75,1.0,1.0,20/87,13.24%,DRD4;ADRA1B;PDE10A;TPH1;MGAT4C;CATSPERG;PDZD7;RP1L1;RNFT2;TVP23A;TNR;SRRM4;KCNJ6;SLC2A11;CATSPER2;OPRD1;AP3B2;CACNA1A;FRRS1L;CREM
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.41421176531206616,0.7782615804836387,0.765625,1.0,1.0,3/18,15.86%,IFNK;IFIT1;COLEC12
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.4146816303259559,0.7782295966654382,0.7936507936507936,1.0,1.0,1/13,3.08%,PTPRC
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.38532428025069715,-0.7781607144821636,0.8095238095238095,1.0,1.0,2/12,6.16%,APOE;MYOCD
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.41278997036994286,0.7781355656966605,0.7384615384615385,1.0,1.0,1/16,2.77%,DAO
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3821271559280436,0.7780715839357518,0.828125,1.0,1.0,5/27,12.54%,PDE6H;GPER1;MMP9;AFAP1L2;PLAUR
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.38917916476057535,-0.7779653242747245,0.7777777777777778,1.0,1.0,4/17,12.71%,DPM3;RXYLT1;TMTC4;FKTN
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.3120834223499898,0.7777789383198193,0.8953488372093024,1.0,1.0,18/152,13.50%,PANX3;SLC22A3;LRP2;SLC5A4;SLC5A2;SLC12A3;SLC18A2;KCNJ15;KCNA5;KCNG2;KCNS2;TAF7;SLC47A1;ATP1A4;ASIC1;KCNK7;CHRNB1;PIEZO2
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.5086074529324907,-0.7777746875440406,0.7555555555555555,1.0,1.0,2/5,9.82%,WWC1;WWC2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.32919727712249314,0.7776963305365011,0.9240506329113924,1.0,1.0,13/90,19.62%,ITGB2;ITGAM;GPER1;CD81;TCAF2;RAMP3;TP53BP2;STAC;BBC3;YWHAH;RHOG;PDZK1;FIS1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.3037263045842445,-0.7775116939228147,0.8947368421052632,1.0,1.0,18/112,15.97%,GCK;NUP210;CDH5;FZD7;HSPB1;POM121C;NUP42;NUP214;AAAS;ZBTB7A;EMP2;LDB1;KDM4D;SDCBP;PRKRIP1;INHA;NUP37;CCDC88A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.27867489207754936,-0.7773197714257405,0.9444444444444444,1.0,1.0,17/87,17.32%,TRIM71;APOE;DHFR;NANOS3;PCIF1;CNOT9;SERPINE2;IGF2BP1;FXR2;DAB2IP;CSTA;BAG6;CAMK2N1;PUS7;EIF2AK3;CDK5;SAMD4B
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.36733079388309403,-0.7772780899945426,0.8333333333333334,1.0,1.0,1/18,1.52%,DNMT1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.347936161869489,0.7772393697105981,0.84,1.0,1.0,8/63,10.99%,TNFRSF1B;HIPK1;TGFB1;BOK;IL12A;MOAP1;TNFRSF10A;DDX3X
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.3803312165118937,0.7771176669504766,0.7887323943661971,1.0,1.0,7/30,19.94%,USP50;OTUD4;USP13;CYLD;YOD1;OTUD1;SPATA2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.343391015518029,0.7770718522919364,0.8714285714285714,1.0,1.0,7/66,4.60%,ITGB2;CYTIP;ARHGAP9;TCF7;GMFG;PTPRC;SASH3
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4161949801491388,-0.7766661411033011,0.7333333333333333,1.0,1.0,3/11,22.41%,EHD3;CLN3;LAPTM5
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.4854724610204051,-0.7764901911109878,0.7941176470588235,1.0,1.0,2/5,10.68%,ADGRG6;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4521144626854303,-0.7764750274512349,0.8387096774193549,1.0,1.0,4/15,11.22%,APOE;DHFR;SCARB1;TERT
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.40616215095274333,0.776094155955666,0.765625,1.0,1.0,3/19,6.06%,CD160;HLA-F;IL12A
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.509395085239213,0.775852823917134,0.796875,1.0,1.0,1/5,10.43%,DCK
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.50369824653561,-0.7757472820959456,0.7368421052631579,1.0,1.0,3/5,23.23%,ACVR1;TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.3820160627943876,-0.7757470709911045,0.7777777777777778,1.0,1.0,6/29,12.82%,OSR1;WNT7A;CCN3;CREB3L2;NFIB;SULF2
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.3523739433114873,-0.7757279142574459,0.8717948717948718,1.0,1.0,3/24,8.92%,TENT4A;SMC2;CDK1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.43443320584304174,-0.7755609377737431,0.8076923076923077,1.0,1.0,6/12,25.45%,CDK1;CTDNEP1;PRKCA;NEK9;NEK6;LPIN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.489744021838582,0.7754801846851226,0.8,1.0,1.0,2/7,12.04%,CCL5;ORMDL3
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2799638634360599,-0.7753387712829837,0.9333333333333333,1.0,1.0,22/94,23.11%,TRIB2;PRICKLE1;TRIB1;COMMD1;NKD2;HFE;BAG6;SDCBP;FHIT;CSNK1E;HSPBP1;FBXO22;SUMO2;FOXF2;GNA12;N4BP1;ZER1;CEBPA;RNF180;HSPA1A;GIPC1;DESI1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.39221880484103366,-0.7753300828568354,0.8205128205128205,1.0,1.0,2/20,11.45%,DAPK2;SLIT2
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.3660470446025593,0.7753040898271173,0.8421052631578947,1.0,1.0,10/45,21.70%,SYCP1;TK1;SOD2;AQP4;GNMT;RYR3;ALDH9A1;MCOLN1;KCNJ2;B2M
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3049415254113989,-0.7751906800234026,0.9,1.0,1.0,18/65,23.16%,PARD3;ZDHHC23;ZDHHC11B;SYNE3;ZDHHC14;RTP1;TAOK2;NECTIN3;FRMPD1;SDCBP;ZDHHC18;ZDHHC3;RAB10;RAB11B;ZDHHC20;MYO1C;GOLGA7B;BRAF
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.37446976292126705,0.7750628237495428,0.7692307692307693,1.0,1.0,9/48,12.45%,SDC2;LYVE1;FGF2;TGFB1;STAB2;OGN;DCN;HPSE2;OMD
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.32479395792907756,-0.7750547869109795,0.8571428571428571,1.0,1.0,1/39,0.47%,NTSR2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.32447474492654704,0.7750384199699507,0.9024390243902439,1.0,1.0,29/153,19.22%,TIMP3;BLK;SYT15;SYT2;MANF;TGFB1;SCIN;PSAP;IGF1;CFD;HGF;TMEM79;F8;TGFB3;CRHBP;CD63;A1BG;KNG1;LAMP2;TUBA4A;SELENOP;VWF;SYT10;PLG;ITGA2B;ITIH4;FN1;THBS1;A2M
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.30416983320302116,0.7750172818000626,0.92,1.0,1.0,41/188,29.98%,MCM2;H2AZ1;PRDX4;RPS5;ERH;SNRPD2;SET;COPS5;CCNA2;EIF1AX;HSPE1;RPLP0;CCT7;RPS6;IMPDH2;POLE3;SRSF3;G3BP1;GNL3;RPL18;XRCC6;COX5A;PSMA7;VDAC1;PCNA;BUB3;VDAC3;NCBP1;RPS3;RPL34;SRPK1;PRPS2;EEF1B2;DEK;RPL14;NOLC1;RAD23B;HSP90AB1;VBP1;HNRNPC;RPL6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.35917399774409103,0.7748447085807362,0.8028169014084507,1.0,1.0,10/50,19.48%,TLR2;WNT5A;PTPRC;C1QTNF4;SYK;CYBA;OAS2;AGER;THBS1;RASGRP1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.44034551421539175,0.7747065919927493,0.7101449275362319,1.0,1.0,1/10,4.69%,CLCF1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.3640790438953733,0.7746738446214246,0.8260869565217391,1.0,1.0,7/41,22.58%,CHCHD4;HSPA5;TOMM20;TIMM17A;ROMO1;SEC62;PAM16
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.4463323786667035,0.7744165672460777,0.7794117647058824,1.0,1.0,6/17,20.03%,TGFB1;TGFB3;UBE3A;WBP2;THBS1;CATSPERD
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.4660663885430715,0.7744008155942401,0.7272727272727273,1.0,1.0,2/9,2.84%,ADA;CCL5
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.3937297752403809,0.7743425738783531,0.8076923076923077,1.0,1.0,4/35,13.70%,CCL5;TGFB1;TGFB3;CYBA
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.476468499832182,0.774231577420022,0.8142857142857143,1.0,1.0,2/7,10.98%,S100A13;PIK3CG
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.476468499832182,0.774231577420022,0.8142857142857143,1.0,1.0,2/7,10.98%,S100A13;PIK3CG
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.30617090636907834,-0.7741959218191,0.9032258064516129,1.0,1.0,6/54,11.92%,TRIM67;ADCYAP1;STX6;DZIP1L;MMD2;TRIM14
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.42136769906811894,0.774178934628347,0.7971014492753623,1.0,1.0,3/15,23.45%,HSPA5;GABARAPL2;BCAP31
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3625919435911527,0.7741389687106146,0.7846153846153846,1.0,1.0,1/40,0.97%,ACTL6A
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.3656459452273729,0.7739892184956924,0.8840579710144928,1.0,1.0,5/41,11.13%,ANXA1;STAT5A;GPER1;EIF6;STAT1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.3988816640075599,-0.7737795194840503,0.7948717948717948,1.0,1.0,1/14,1.79%,BCL2
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.48861239853345295,0.7737128289155489,0.8153846153846154,1.0,1.0,2/7,16.68%,IMPA1;IMPA2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.32182530777158747,-0.7736433399076905,0.9545454545454546,1.0,1.0,5/41,9.60%,KCNMB2;KCNE1;CHRNA1;GNA14;GNA11
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.36270456307930843,0.773608765397012,0.782051282051282,1.0,1.0,1/51,0.49%,LRP4
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.4271546528117911,-0.7736010186211657,0.7142857142857143,1.0,1.0,2/11,4.00%,BCL2;ACO1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.34946529910289387,-0.7734091348550284,0.7586206896551724,1.0,1.0,4/30,9.31%,CALD1;FSCN3;FSCN1;CORO1B
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.3812590889958414,0.7733653729987733,0.7638888888888888,1.0,1.0,3/30,11.88%,AHR;SLC26A6;CRHBP
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.46302891308931404,0.7732742303475328,0.7704918032786885,1.0,1.0,4/8,38.43%,STUB1;CLU;DNAJB12;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.3587889122423733,-0.7732569510490309,0.8181818181818182,1.0,1.0,1/24,1.52%,DNMT1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.49590363658370795,0.7731291090580318,0.7413793103448276,1.0,1.0,1/7,2.76%,ACE2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.4785408499910243,0.7730153898739853,0.7704918032786885,1.0,1.0,1/7,13.71%,P2RY12
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.4935685781552549,-0.7729927039965984,0.75,1.0,1.0,1/7,1.49%,ZNF703
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.3777856837196061,0.7729441907839948,0.8205128205128205,1.0,1.0,3/39,5.28%,PELI3;ARIH2;TRAF3IP2
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),0.513962858224982,0.7728897482205689,0.8571428571428571,1.0,1.0,1/6,2.46%,PKP2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.39163340134676883,0.7728638745234546,0.7846153846153846,1.0,1.0,4/31,10.98%,CD160;MYO16;IGF1;PIK3CG
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.42405618003427326,0.7728008871323658,0.71875,1.0,1.0,3/13,23.18%,IFIT1;COLEC12;IFIH1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.34826608062027214,0.7727773095603648,0.7397260273972602,1.0,1.0,20/53,30.04%,RPL3;EIF6;MRPL20;NOP53;RPL35A;RPL7A;RPL11;RSL24D1;RPL23A;RPL7;ZNF622;RPLP0;RPL24;RPL10;WDR12;RPL14;BRIX1;RPL5;RPL6;RPL10A
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.39949566561997263,0.7727226646050825,0.782608695652174,1.0,1.0,1/17,1.25%,MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.39949566561997263,0.7727226646050825,0.782608695652174,1.0,1.0,1/17,1.25%,MGST1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.34094697373474026,0.7726497979401683,0.8309859154929577,1.0,1.0,9/97,9.25%,ENPP2;C1QB;FCGR3A;LYVE1;SSTR1;SHISA6;VSIG4;PLP1;RAMP3
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.4067648032147909,0.7717689168326237,0.7894736842105263,1.0,1.0,6/20,27.14%,DDX3X;OGFOD1;G3BP1;CSDE1;RPS23;DDX6
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.39371979174610106,0.771659694770202,0.8732394366197183,1.0,1.0,4/30,11.39%,ANXA1;CYP1B1;ECT2;RHOB
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.4640894607734653,0.7712542283458956,0.8055555555555556,1.0,1.0,4/12,24.82%,PRR5L;ZC3HAV1;CNOT8;UPF1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.3016814242488035,-0.7708941944106692,0.9230769230769231,1.0,1.0,17/57,22.56%,KIT;PARVA;CAPN10;THSD7A;FLNA;INSRR;PHACTR1;ANTXR1;AUTS2;TRPV4;RHOA;FARP2;MYH9;CDC42BPB;RAP2A;PARVB;DTNBP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4004938427639538,0.7708918177905925,0.746268656716418,1.0,1.0,5/23,19.31%,F7;ZNF580;IL4;F2RL1;CSF1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.30153676714979805,-0.770687333306163,0.8857142857142857,1.0,1.0,7/71,12.70%,HNRNPL;ESRP1;SRRM4;ERN1;HNRNPF;U2AF2;PTBP1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.4306645785881033,0.7703476164900273,0.7575757575757576,1.0,1.0,2/12,25.52%,ATP1A4;ATP1A1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3317009658784124,0.7702207314414486,0.8701298701298701,1.0,1.0,22/99,23.25%,CDC25A;CCNG2;DDX3X;CCND1;CDKN1B;CDK5R1;CCND2;CCNE2;CCNI;CDKN1A;CCNA2;MTCP1;CSF1R;PKMYT1;CDKN2C;HMGA2;MAP2K1;ETAA1;CCNB1;CCNI2;CDK5R2;CCNB3
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3734479271146546,0.7702137299088113,0.7702702702702703,1.0,1.0,10/29,30.09%,SEMA3A;SEMA3B;SEMA3F;MAG;RNF6;SEMA6A;SEMA4C;SEMA7A;SEMA4G;SEMA3E
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.4211109886348079,0.7701075774886558,0.7746478873239436,1.0,1.0,1/14,0.89%,APOLD1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.5285406262072614,-0.7697490942268819,0.75,1.0,1.0,1/5,0.91%,KLRC1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.2830028790866148,-0.7695109514001233,1.0,1.0,1.0,8/99,6.58%,EPHX2;ABCA4;MLYCD;CYP7B1;PEX7;FADS1;ABCA9;SLC27A2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.3444092699801107,0.7694461064435725,0.8533333333333334,1.0,1.0,4/69,6.51%,PLEKHH2;HSPA8;KANK3;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.4838107612314511,0.7693303124970224,0.8275862068965517,1.0,1.0,4/8,39.52%,TXNIP;VPS4A;ZFYVE19;BLM
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.45940136823827527,0.7692765676133022,0.8,1.0,1.0,1/8,2.05%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.44849346726308126,0.7690637878026229,0.7878787878787878,1.0,1.0,4/9,32.54%,PARK7;VDAC1;FBXO7;SLC25A5
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.30703344990844583,0.7690233598921199,0.9418604651162791,1.0,1.0,42/180,19.56%,ITGB2;ITGAX;SMOC1;COL18A1;LOX;ECM2;MMP19;NID1;ITGB6;FGF2;ITGAM;JAM2;ADAMTS17;COL4A4;ITGA2;MMP9;COL4A3;MMP15;DCN;COL4A5;MMP21;ITGA5;COL1A1;COL4A6;LAMC2;COL6A2;TEX14;TGFBI;CD44;MMP11;VWF;DDR2;MMP23B;ITGA2B;VTN;FN1;FBN2;HAPLN1;ITGB8;THBS1;ITGAD;LAMB2
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.48385622542260553,0.7689883357271452,0.7586206896551724,1.0,1.0,3/8,18.07%,LCP1;HCK;IL5
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.4633458659884659,0.7688143726483856,0.7903225806451613,1.0,1.0,1/9,9.34%,REST
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.42581570760489135,0.7687397289108395,0.8,1.0,1.0,1/16,4.64%,FGF2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.43616364923155726,-0.7686957768799828,0.7837837837837838,1.0,1.0,1/9,4.59%,ACADS
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.30528325481142293,0.7686938776088253,0.9534883720930233,1.0,1.0,46/180,21.06%,ITGB2;ITGAX;SMOC1;COL18A1;LOX;ECM2;MMP19;NID1;ITGB6;FGF2;ITGAM;JAM2;ADAMTS17;COL4A4;ITGA2;MMP9;COL4A3;MMP15;DCN;COL4A5;MMP21;ITGA5;COL1A1;COL4A6;LAMC2;COL6A2;TGFBI;CD44;MMP11;VWF;DDR2;MMP23B;ITGA2B;VTN;FN1;FBN2;HAPLN1;ITGB8;THBS1;ITGAD;LAMB2;HRNR;COL10A1;ADAMTS5;BCAN;OTOL1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.46236843880070305,0.7686420275745196,0.835820895522388,1.0,1.0,4/12,11.84%,WNT5A;LEF1;WNT8A;TGFB3
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.4874896701802346,0.7675402737803003,0.8070175438596491,1.0,1.0,2/7,12.58%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.4355519174774235,-0.7675312370901322,0.7380952380952381,1.0,1.0,2/7,16.70%,APOE;ABCG1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3603094438972237,0.7675295562288614,0.8421052631578947,1.0,1.0,7/50,12.72%,AIM2;WNT5A;USP50;NLRP12;NLRC4;IGF1;SERPINB1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3507682948717819,0.7674044594547939,0.8472222222222222,1.0,1.0,14/63,27.41%,CCL5;DAZL;C8ORF88;DDX3X;BOLL;EIF1B;UHMK1;EIF4A2;CSDE1;EIF2B2;CEBPB;DDX1;NCBP1;EIF2B5
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.2815063235422892,-0.7669746537727085,1.0,1.0,1.0,8/134,7.95%,SKAP1;BTN3A2;CSK;HLA-DQB1;CD247;HLA-DRA;PRAM1;PTPRJ
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.3781633731418019,0.766623918066926,0.8133333333333334,1.0,1.0,5/34,17.30%,TIMP3;KNG1;CLN8;PLAT;TM4SF20
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.38775362441629774,0.7665575745094816,0.7761194029850746,1.0,1.0,6/19,22.60%,BOK;HERPUD1;CREB3;SYVN1;DDIT3;PARK7
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.4213546846337664,0.7665560452912977,0.7794117647058824,1.0,1.0,4/19,14.06%,SIX4;MYL6;POPDC2;CSRP3
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.29178140749991144,-0.7662873363277444,1.0,1.0,1.0,19/81,20.66%,GPC2;APOE;STYXL1;ARSB;RAPGEF1;DAB2IP;NTRK1;P3H1;AVIL;DBNL;MARK2;ZNF804A;ARHGAP35;PLK5;LRP8;NTRK2;CUX2;FZD1;MAGI2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.3762066887672534,-0.7662205219573737,0.8,1.0,1.0,4/16,22.89%,ATG2A;ATG9B;WIPI1;ATG7
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4282325819572301,0.7661707172649879,0.8064516129032258,1.0,1.0,3/12,24.11%,BOK;TMEM33;AGR2
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.4872851369101561,0.7659988299284042,0.8260869565217391,1.0,1.0,2/8,15.59%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.3273127400253861,0.7657564023395006,0.9166666666666666,1.0,1.0,13/120,13.51%,WNT8B;VSX1;WNT5A;MANF;FZD8;DDIT4;WNT8A;PPT1;ACSL3;EMX1;LHX4;ITM2C;CDK5R1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.4088796904074904,-0.7656935942889468,0.717948717948718,1.0,1.0,2/16,5.33%,NR4A3;MLYCD
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.32690415978902054,-0.7656224203825331,0.78125,1.0,1.0,9/32,17.23%,MMP2;CACNB1;ITGA4;NTRK1;GRIN1;CACNA1A;ABCC1;FYN;CDK5
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.3378189847528642,-0.7651634185658852,0.8620689655172413,1.0,1.0,7/57,8.21%,ADGRG3;IL11;BCL2;KIT;EPHB2;PTPRJ;ITGA4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.36727532717187616,0.7651345509920288,0.8382352941176471,1.0,1.0,6/29,25.14%,B4GALNT2;ASGR2;ASGR1;OSTC;MCFD2;LMAN1
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.2705175583127537,-0.7651053210427767,1.0,1.0,1.0,16/141,10.92%,GPR3;SLC29A3;SYNPO;GRID2;CLDN16;THNSL2;MTHFR;MEFV;NPHS1;PTPRJ;SNCB;MAGIX;MACROH2A2;TENT5C;DLK2;RGS11
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3006199113969391,-0.7650693692315328,0.84,1.0,1.0,6/38,12.29%,DDX11;MMS22L;BOD1L1;SMARCAL1;ATR;RFWD3
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.4055518174744954,0.7650601423402389,0.7419354838709677,1.0,1.0,6/23,24.15%,EIF6;PDK4;BRCA1;CEACAM1;ACADL;PRKAB2
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),0.5063599084802962,0.7650534770872564,0.7777777777777778,1.0,1.0,2/6,17.62%,KCNA5;NPPA
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.29390022669854415,0.7650458016986581,0.9690721649484536,1.0,1.0,54/378,19.31%,RHOXF2;NOX5;C1QTNF1;TLR2;S100A13;ITGAX;WNT5A;PIK3R3;FGF20;VSIR;FGF2;ACTG1;HEY2;TGFB1;NFAM1;CTCFL;GPER1;ACTA2;LEF1;RAMP3;IGF1;CLDN5;EIF6;PIK3CG;DDX3X;IL26;TNFSF4;VSTM2A;SOX9;WBP2;RPS4X;SFRP4;METTL14;EEF2;MSN;SLC38A2;HEY1;ZNF580;POLR1C;IL4;CRTAM;MAPK3;ITK;HTR2B;AGT;RPL11;RPS7;WNT6;FN1;ALOX12B;ITGB8;THBS1;TAF1A;CSF1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.39577538179758903,-0.7647941374515287,0.7575757575757576,1.0,1.0,4/12,14.97%,FLNA;EMP2;TIMP1;LIMS1
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),0.47072144647104797,0.7647900284312893,0.8,1.0,1.0,2/6,5.64%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.43269758477312226,0.7647466339951507,0.828125,1.0,1.0,2/12,12.58%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5133284532700635,0.7644692562062598,0.8382352941176471,1.0,1.0,3/5,30.66%,RNF20;KDM1A;CDK9
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.2907639117621566,-0.7643760905470939,1.0,1.0,1.0,38/211,14.48%,GABRE;GALR3;DRD4;NPTX2;HCRTR2;CHRNA10;HRH2;HRH1;NLGN3;PDE7B;CPNE6;GRIK4;GRIK1;CACNB1;CHRNA1;GLRA3;HTR3B;HCRTR1;SNCB;GABRA5;CRH;PCDHB6;NLGN2;DTNA;CEL;GRIN1;GRIA4;DLGAP1;NOVA1;PCDHB9;CACNA1A;NRXN2;GABBR2;CHRNA2;HTR2C;SDCBP;NLGN4Y;RPS6KA3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.4158134617175086,0.7643569639908139,0.7605633802816901,1.0,1.0,2/14,12.11%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.4158134617175086,0.7643569639908139,0.7605633802816901,1.0,1.0,2/14,12.11%,SYCP1;STAG3
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.3476638321845024,-0.7643438650512074,0.88,1.0,1.0,6/33,13.35%,IFT88;RALB;LRSAM1;RAB5A;NUPR1;NPRL2
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.4681691456915451,-0.7642826869309475,0.6451612903225806,1.0,1.0,2/8,5.86%,AGRN;SPTBN4
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.4498604246751192,-0.7642093670067596,0.7692307692307693,1.0,1.0,4/7,35.27%,DFFA;BCL2L1;PAK2;RNF34
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.3714833125109911,-0.7637585192203051,0.7441860465116279,1.0,1.0,1/18,1.79%,BCL2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.43672014844909,-0.763653866895688,0.6818181818181818,1.0,1.0,1/7,0.98%,APOH
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.47750893652233783,0.7635225007478387,0.8333333333333334,1.0,1.0,1/9,6.51%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4365495614648979,0.763510613229688,0.7794117647058824,1.0,1.0,2/10,16.81%,EPCAM;PLG
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.39420213565963297,-0.7634600752475424,0.75,1.0,1.0,4/21,11.22%,APOE;DHFR;SCARB1;TERT
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.39445127990274254,0.7633990724613579,0.8450704225352113,1.0,1.0,2/18,13.51%,ITGAM;CDK5R1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.38813676541376074,0.7633827262587016,0.7796610169491526,1.0,1.0,2/29,5.64%,ITGB2;ITGAM
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.4195139199095267,0.7630380380475258,0.8461538461538461,1.0,1.0,4/19,18.00%,CCL5;IGF1;PLAU;VTN
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.3070434707115084,-0.7630134838854499,0.9473684210526315,1.0,1.0,19/115,17.06%,SYNJ2;EFR3B;DPM3;VAC14;TMEM150A;TTC7A;PI4KB;TTC7B;RAB5A;PITPNM1;MTMR14;MTMR8;PITPNM3;RUFY1;CDS1;ITPKA;PIGQ;PI4KA;MTMR1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.380903988166832,0.7629367992693306,0.835820895522388,1.0,1.0,5/27,16.85%,KIF14;STMN4;VIL1;KIF18A;CFL1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.48748483140416254,-0.762723001017724,0.7073170731707317,1.0,1.0,2/6,14.75%,CDK6;DLL1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5279332283312854,-0.7626085936516718,0.8611111111111112,1.0,1.0,2/6,18.27%,ATPAF2;ATPAF1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.35127519931731316,0.7624189715599243,0.8289473684210527,1.0,1.0,6/74,5.42%,CCL5;STOML2;VAPB;FAM20A;TRPV6;CASR
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.3602175556869589,-0.7620349027969431,0.8235294117647058,1.0,1.0,3/17,13.13%,MAP3K10;DAB2IP;DUSP19
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.4287177900165727,0.761907360689156,0.8507462686567164,1.0,1.0,3/17,16.42%,CD81;ATP5IF1;MSN
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.44909070477551594,0.7618309974395585,0.803030303030303,1.0,1.0,2/10,13.58%,NODAL;PLAC1
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.4712832005921591,0.7617774386441188,0.7931034482758621,1.0,1.0,3/6,24.45%,ANGPTL4;ANGPTL3;RGS2
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.41706207948182583,-0.7617474328106733,0.75,1.0,1.0,4/9,27.00%,NXF5;SIDT1;RBFOX1;ATXN2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.26279986002197037,-0.7615480739886324,1.0,1.0,1.0,46/290,16.31%,NR4A1;CPSF1;TEAD2;DTX1;HDAC10;HDAC7;INTS11;NR4A3;LSM10;MAML1;IWS1;TTF2;TEAD4;CBFB;NFX1;GTF2I;TAF12;CCN2;RARB;TFDP1;INTS9;HDAC3;NR2C1;GTF2H2;NR1D1;SNRPB;SYMPK;ARRB2;TRIP13;GTF2E2;CSTF2;POLR2F;SSRP1;TFCP2;ERCC2;ESRRB;CPSF7;RTF1;ESRRG;ELOA;POLR2C;NR1H2;HDAC5;RBMX;PCF11;ELOF1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.298342555701875,0.7612378766759752,0.956989247311828,1.0,1.0,18/359,9.62%,GATA4;CRX;ESR1;ZNF284;ZNF676;TCF7;VSX1;AHR;MYT1;NFIL3;ATF7;SNAI3;ZNF98;IFNK;NFIA;TAF5;REST;ZNF723
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.41794486348126747,-0.7612354953463741,0.825,1.0,1.0,4/8,19.36%,CRY1;ABL1;MAPK12;ATM
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4235354273318975,0.7612111137804171,0.8260869565217391,1.0,1.0,1/14,8.09%,WAS
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.46975523694111393,-0.7609034964914848,0.6857142857142857,1.0,1.0,2/5,10.09%,SERPINE1;SERPINE2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.4617419452664363,0.7606719031853291,0.8115942028985508,1.0,1.0,1/11,1.51%,CASQ2
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.44048419413521644,0.7605679166254209,0.7857142857142857,1.0,1.0,2/10,18.26%,CD99;AGER
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.32365585407242614,-0.7604525734776486,0.8,1.0,1.0,8/53,11.87%,CD14;NKIRAS2;MAP3K14;TBKBP1;TICAM2;SHARPIN;DAB2IP;RIPK2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3519853202783306,0.7604520083620735,0.8607594936708861,1.0,1.0,11/61,27.08%,PSMB9;LMO2;METTL14;PSMC5;MYB;PSMB6;PSMD6;PSMA3;PSMA7;SPI1;LMO1
prerank,GO_Biological_Process_2021__regulation of urine volume (GO:0035809),0.4948317570183017,0.7603722252961184,0.7833333333333333,1.0,1.0,1/6,11.99%,NPR3
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.35077661367621193,-0.7601206670334554,0.7804878048780488,1.0,1.0,9/23,22.27%,ABCA4;ATP10A;ATP9A;RFT1;ABCC1;ATP8A2;ATP8B2;ATP9B;ABCB4
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.35819606399410164,-0.7601043902650281,0.8387096774193549,1.0,1.0,2/24,10.81%,PEX7;PEX14
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.4205137901856628,-0.7599152916398285,0.8157894736842105,1.0,1.0,4/8,23.79%,DRD2;DTNBP1;PALM;DRD3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.5038945966856941,0.7598004715154549,0.7936507936507936,1.0,1.0,1/6,4.64%,FGF2
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.38804905317884203,-0.7597821405910725,0.8125,1.0,1.0,2/13,5.31%,NDOR1;ENOX2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.40364839224168714,0.7596124963819492,0.7878787878787878,1.0,1.0,6/17,29.35%,TOMM20;TIMM17A;ROMO1;PAM16;TIMM21;DNAJC19
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.4702788148652466,-0.759605455199601,0.782608695652174,1.0,1.0,4/5,34.73%,MACROH2A1;SLF2;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.4702788148652466,-0.759605455199601,0.782608695652174,1.0,1.0,4/5,34.73%,MACROH2A1;SLF2;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.4702788148652466,-0.759605455199601,0.782608695652174,1.0,1.0,4/5,34.73%,MACROH2A1;SLF2;NSMCE2;SMC5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.42464319533254724,-0.7595418120427446,0.7894736842105263,1.0,1.0,3/10,20.31%,CACNB1;BIN1;NOS1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.312650926693471,-0.7595332107908632,0.9130434782608695,1.0,1.0,3/57,3.86%,MT1G;KIT;IFI16
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.45670425775954565,0.7594367212561627,0.7358490566037735,1.0,1.0,1/9,3.08%,PTPRC
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.4617793905063545,-0.7589671799709106,0.7368421052631579,1.0,1.0,1/6,7.99%,NLRP1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3523023003294225,-0.758956531029954,0.7741935483870968,1.0,1.0,6/23,15.84%,CLIP3;ZDHHC23;ZDHHC11B;ZDHHC14;ZDHHC18;ZDHHC3
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3523023003294225,-0.758956531029954,0.7741935483870968,1.0,1.0,6/23,15.84%,CLIP3;ZDHHC23;ZDHHC11B;ZDHHC14;ZDHHC18;ZDHHC3
prerank,GO_Biological_Process_2021__regulation of inositol phosphate biosynthetic process (GO:0010919),0.4924056746186596,0.758920595104431,0.7962962962962963,1.0,1.0,1/5,11.47%,CD244
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.3114610781624621,0.758777706100082,0.9054054054054054,1.0,1.0,15/105,13.05%,TIMP3;C1QTNF1;PRRX1;ADAM33;LMOD1;UACA;MYH11;ACTA2;CYP1B1;DCN;ANGPTL2;COL1A1;ADGRL4;ASPN;RASD1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.33688449222368505,-0.7582516142322703,0.8,1.0,1.0,4/36,6.28%,P2RY10;SELL;CD247;LTB
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.394415600035072,-0.7581565832882183,0.7714285714285715,1.0,1.0,1/10,1.38%,ADAMTS12
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.4093664706161557,-0.7581413523470113,0.8611111111111112,1.0,1.0,1/14,0.34%,SKAP1
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.40198205450524027,-0.7579844823783523,0.8108108108108109,1.0,1.0,2/8,7.65%,SCUBE1;FSTL1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3948065177715494,-0.757983290833479,0.8529411764705882,1.0,1.0,1/12,3.90%,NR4A3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.41030579887632906,0.7579813867562205,0.7910447761194029,1.0,1.0,6/22,17.92%,OR51I2;OR52A5;OR8A1;SYT10;OR51M1;OR3A2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.37815940486887223,0.757826570625463,0.7638888888888888,1.0,1.0,1/27,1.32%,DISC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2686410457923828,-0.7577143555736162,0.9444444444444444,1.0,1.0,22/128,15.61%,NR4A1;TEAD2;HDAC10;HDAC7;NR4A3;MAML1;TEAD4;TAF12;CCN2;RARB;HDAC3;NR2C1;GTF2H2;NR1D1;GTF2E2;POLR2F;ERCC2;ESRRB;ESRRG;POLR2C;NR1H2;HDAC5
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.3651837111151372,-0.7576451173206002,0.7941176470588235,1.0,1.0,9/23,28.78%,BICDL2;KIF1C;TRAK2;CLN3;BICDL1;KIF3B;TRAK1;HTT;PAFAH1B1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.41771341006797563,-0.7575008379454358,0.8285714285714286,1.0,1.0,6/12,16.68%,PNP;NT5C1A;GPX1;DNPH1;NT5C;ITPA
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.39223115565857736,-0.7572730143191266,0.7575757575757576,1.0,1.0,1/18,0.79%,PLK3
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.2995212017036189,-0.7572051627333396,0.9545454545454546,1.0,1.0,12/75,17.52%,EFNB1;MMP2;EPHB2;EPHA6;ARPC3;GRIN1;CRK;SDCBP;FYN;RHOA;PAK3;ARPC2
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.3513638298295858,-0.7571948335431411,0.8076923076923077,1.0,1.0,1/21,1.63%,PNPLA3
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.3810874197511531,0.7570750518186816,0.8571428571428571,1.0,1.0,3/24,4.45%,FGF20;SYT15;SYT2
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.3751929919125288,-0.7570520153695541,0.7647058823529411,1.0,1.0,2/23,3.86%,MT1G;IFI16
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.3837386633474734,0.7570166495248184,0.8311688311688312,1.0,1.0,3/23,14.98%,HHIP;RFX4;GLI3
prerank,MSigDB_Hallmark_2020__Apoptosis,0.3103979767121953,0.7568824033901645,0.9080459770114943,1.0,1.0,21/132,16.79%,TIMP3;ANXA1;CASP7;H1-0;LEF1;DNAJA1;SOD2;DCN;IRF1;PPT1;HGF;RHOB;CCND1;IGFBP6;CDKN1B;CCND2;CDKN1A;CD44;TXNIP;CYLD;PLAT
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.4289045736897537,0.7565235239143518,0.8,1.0,1.0,5/13,29.19%,CD4;CSF1;HLA-DRB1;CD74;DCSTAMP
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.33528398500220086,0.7564855750358764,0.927710843373494,1.0,1.0,19/112,24.82%,PSMB9;HSPA8;IGF2BP2;PRR5L;EXOSC2;ZC3HAV1;EXOSC8;RPS27A;CARHSP1;SET;PSMC5;PSMB6;EXOSC4;CNOT8;PSMD6;PSMA3;ZFP36;PSMA7;UPF1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.3735514862129531,0.7562266337543002,0.8260869565217391,1.0,1.0,3/28,4.45%,FGF20;SYT15;SYT2
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.26505527956399694,-0.7561710336361935,1.0,1.0,1.0,31/198,16.88%,DTX1;TEFM;TBPL2;PPP5C;IWS1;TTF2;MLF1;CBFB;NFX1;TAF12;TFDP1;GTF2H2;HSF1;ARRB2;TRIP13;GTF2E2;SLC25A33;POLR2F;SSRP1;POLR3K;ERCC2;POLR3A;BAZ2A;NAT14;RTF1;ELOA;POLR2C;TAF1B;RBMX;LEO1;SMN1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.5108892230687658,0.7560918685460903,0.7878787878787878,1.0,1.0,1/5,6.28%,PHF23
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.4586303381890411,0.7557648852694541,0.7910447761194029,1.0,1.0,1/10,5.95%,JCHAIN
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.3360637608250053,-0.755466487603643,1.0,1.0,1.0,2/38,6.47%,NR4A3;MTFR2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.34169585473042596,0.7554099811130693,0.8148148148148148,1.0,1.0,12/59,16.13%,KIF14;FGF20;SIX4;CRLF1;CLCF1;PINK1;SOD2;PPT1;TGFB3;FOXB1;RASA1;SET
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.3179896334908006,-0.7552997500134866,0.8518518518518519,1.0,1.0,4/42,6.94%,CD38;BCL2;SH3KBP1;EPHB2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.28829050538274037,-0.7548144513905951,0.9333333333333333,1.0,1.0,10/61,10.53%,DGKD;CDH13;RHBDF1;TGFA;SH3KBP1;PTPRJ;CNOT9;HIP1;NEU3;DAB2IP
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.36392701655510973,-0.7547922970639546,0.7837837837837838,1.0,1.0,4/13,24.50%,SIRT7;PARP2;AURKC;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.4817084857777735,0.7547856807593925,0.8214285714285714,1.0,1.0,1/5,13.15%,TJP3
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.27519720001114995,-0.7545583267674709,1.0,1.0,1.0,34/181,16.06%,FBP2;NDST3;GALE;CHPF2;PC;SDC3;GYS1;HS6ST2;TGFA;AGRN;GPC4;QSOX1;B4GALT2;EGLN3;PGLS;CDK1;PMM2;CHST12;PAM;PFKP;CHST6;CAPN5;VCAN;GPC1;B3GAT3;POLR3K;G6PD;B4GALT4;LHPP;IDUA;NSDHL;TKTL1;EXT1;GUSB
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.4547887165501936,0.7545180470996071,0.8,1.0,1.0,3/7,13.43%,IRF1;SYK;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.3356777141640808,-0.7545122439765046,0.9032258064516129,1.0,1.0,7/33,11.57%,BCL6;PNP;SOX12;HLA-DRA;ADAM8;NKAP;ZMIZ1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.41716985965995046,0.7541847536537771,0.7611940298507462,1.0,1.0,1/19,4.08%,SYNE2
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.378744160756874,0.7538614369325909,0.7777777777777778,1.0,1.0,2/24,4.02%,LIPI;LIPH
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.30198789039694546,-0.7536760297964332,0.9285714285714286,1.0,1.0,18/118,9.80%,SLITRK6;KIRREL3;GPC6;NLGN3;PTPRF;AGRN;GPC4;SLC8A3;PPFIBP2;CACNB1;CX3CR1;CHRNA1;SNCB;PTPRS;PCDHB6;SDK2;SLITRK2;NLGN2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.32999349092077557,0.7535225747039541,0.8918918918918919,1.0,1.0,19/79,31.95%,MRPS34;MRPL34;MRPL20;MRPL50;GADD45GIP1;MRPL54;GFM2;MRPS2;MRPL19;MRPL28;MRPL40;MRPL10;MRPL14;MRPL44;MRPL37;MRPL49;MRPS26;MRPS12;MRPS22
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.4262832981051325,-0.7533855434041709,0.8387096774193549,1.0,1.0,9/16,28.02%,ADGRG6;TGFBR3;NOTCH1;TGFB2;RBP4;TGFBR1;S1PR1;TEK;DLL4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.4654839105522374,0.7533060770500271,0.7941176470588235,1.0,1.0,5/8,42.02%,CASP8;BIRC3;ARHGEF2;SLC25A4;YBX3
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.359138006609221,0.7532270642704786,0.8695652173913043,1.0,1.0,6/30,25.14%,B4GALNT2;ASGR2;ASGR1;OSTC;MCFD2;LMAN1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.4200734217766087,0.7531819519972501,0.8,1.0,1.0,2/11,13.64%,SCIN;VIL1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.3458455342516035,0.7530885284756833,0.8513513513513513,1.0,1.0,5/47,12.77%,GP1BA;FAXDC2;SCIN;EIF6;PITHD1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.4502770450341129,-0.7528851061547709,0.7741935483870968,1.0,1.0,2/8,9.34%,NOP9;NOP14
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.3251880011252544,0.7528480165493071,0.9047619047619048,1.0,1.0,2/77,3.01%,PSMB9;WNT5A
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.4240767880933337,-0.7527767222301449,0.7021276595744681,1.0,1.0,2/7,10.80%,OVGP1;AMDHD2
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.4202843948700493,-0.7526025670513603,0.7352941176470589,1.0,1.0,4/11,15.47%,UST;CHST12;VCAN;CSPG5
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.433867364484157,-0.7525953368856065,0.7666666666666667,1.0,1.0,1/9,1.85%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.433867364484157,-0.7525953368856065,0.7666666666666667,1.0,1.0,1/9,1.85%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.433867364484157,-0.7525953368856065,0.7666666666666667,1.0,1.0,1/9,1.85%,H1-4
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.2997435443666856,0.7524692852437486,0.9325842696629213,1.0,1.0,24/121,18.21%,TIMP3;PRRX1;TYR;AHR;LOX;GNG12;MLANA;UACA;OSMR;ANGPTL2;SYNC;COL1A1;FLG;CCND1;AHNAK2;FILIP1L;SOX9;GLI3;BMI1;HMCN1;DDR2;PLAT;RAB38;FN1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3436643062674183,-0.7523834959233484,0.8787878787878788,1.0,1.0,5/34,9.47%,EFR3B;TMEM150A;TTC7A;PI4KB;TTC7B
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.42051381415523237,-0.7523510520504361,0.7941176470588235,1.0,1.0,4/7,28.73%,PLK5;DLEC1;LAPTM5;RBMS3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.3910004632145632,0.7521901665764532,0.7971014492753623,1.0,1.0,5/23,22.53%,MISP;NDC80;GPSM2;DYNLT1;DCTN1
prerank,GO_Biological_Process_2021__calcitonin family receptor signaling pathway (GO:0097646),0.49509284489579947,0.7521422633814506,0.7966101694915254,1.0,1.0,2/5,22.71%,RAMP3;CALCR
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.322714248871998,0.7521271547243457,0.9102564102564102,1.0,1.0,10/79,16.39%,CDC25A;SPDYA;CRLF3;CDKN2A;CCND1;CDKN1B;FBXO5;CCNE2;CDKN1A;LATS2
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.47404514648129176,0.7521125142585126,0.7903225806451613,1.0,1.0,2/6,27.31%,CELSR1;VANGL2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.2982522988468079,-0.7520058676080833,0.9130434782608695,1.0,1.0,10/111,6.58%,PER2;AOAH;PNPLA3;LIPC;THEM4;LTC4S;MECR;MLYCD;HPGD;SLC27A2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.3353471084918759,0.7517141625880663,0.9166666666666666,1.0,1.0,15/80,17.81%,CAPN13;ACE2;GPRIN2;PLEKHG3;CYP4F12;TMEM45B;HSD11B2;PPP1R1B;ANPEP;TMC4;TJP3;AP1M2;SLC5A9;SPINT1;SLC44A3
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.46730362591996866,0.7515624366376447,0.9,1.0,1.0,2/9,19.32%,EXOSC8;EXOSC4
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.3129389640871396,0.7513416061139302,0.9333333333333333,1.0,1.0,16/115,12.81%,TIMP3;C1QTNF1;PRRX1;ADAM33;LMOD1;FBXL7;PCDH18;ACTA2;DCN;ANGPTL2;NR1H4;COL1A1;ADGRL4;HGF;COL6A2;IGFBP6
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.36859439690929574,-0.7512042628348948,0.8518518518518519,1.0,1.0,2/27,2.30%,TRIB2;FOXO1
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.4433597732911825,-0.7511108620891762,0.7142857142857143,1.0,1.0,1/5,9.16%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.34096369201293053,0.7508511940357965,0.863013698630137,1.0,1.0,10/53,19.48%,TLR2;WNT5A;PTPRC;C1QTNF4;SYK;CYBA;OAS2;AGER;THBS1;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.38713653644028917,0.7506461968647136,0.8142857142857143,1.0,1.0,3/29,16.39%,CAV3;DNAJA1;LATS2
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.39187703461223145,0.7505676823405437,0.8051948051948052,1.0,1.0,8/30,22.02%,PWP2;RPS16;RPS19;RPP40;RPS21;TSR2;RPS14;HELB
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4084439452855945,-0.7502363323269519,0.8285714285714286,1.0,1.0,3/12,11.83%,SNX8;STX5;EHD3
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.4119028868102841,-0.7498347530562347,0.7272727272727273,1.0,1.0,2/9,3.72%,UBASH3B;COL4A2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.34662751728831664,-0.7498059345411123,0.7941176470588235,1.0,1.0,3/28,7.64%,MFSD2A;APOE;STAT5B
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.45689049988363095,-0.7494542373118331,0.7,1.0,1.0,4/8,30.27%,NOTCH1;LRP6;DLL4;PHACTR4
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.2357999990062732,-0.7493720290128847,1.0,1.0,1.0,70/446,17.62%,CAMK1G;GRK5;TRIB2;LMTK3;SBK1;ERG;PRKCD;CSK;PRAG1;TYRO3;LIMK1;KIT;BCKDK;STK10;MAML1;MAST2;EEF2K;ERBB2;MAP3K10;CRY1;EPHB2;TRIB1;TTBK1;ACVR1;MYLK3;PAK6;EFEMP1;ERN1;WNK2;CDK1;BCR;INSRR;ATR;GDF7;DAB2IP;TGFBR3;DAPK2;NTRK1;COPS8;MAPKAPK2;TAOK2;SLK;CDK4;MAP3K12;CDK14;CILK1;SIK3;CDK6;FRK;FGFR2;MARK2;RPS6KA3;CLSPN;CSNK1G2;CSNK1E;WNK3;FYN;EIF2AK3;MAP3K13;NEK10;MARK4;MARK3;PRKCA;MATK;CDK5;TSSK4;PAK3;AKT2;ABL1;GRK4
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),0.487842498967632,0.7489965955861648,0.7894736842105263,1.0,1.0,2/6,12.58%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.487842498967632,0.7489965955861648,0.7894736842105263,1.0,1.0,2/6,12.58%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.36034826323789587,0.7487030487264563,0.8133333333333334,1.0,1.0,7/53,14.84%,DONSON;DTL;TICRR;CCND1;SDE2;NOP53;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.38156863289225756,0.7486664222980112,0.7887323943661971,1.0,1.0,2/25,15.30%,PINK1;BMI1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.4252636799173848,0.7482749170274297,0.8387096774193549,1.0,1.0,4/19,8.79%,PTPRC;HLA-F;IL12A;HLA-A
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.34748172137306615,-0.7482218863366721,0.8787878787878788,1.0,1.0,7/25,26.47%,GBF1;COG7;GCC2;RAB6A;SORL1;ARFRP1;CSNK1D
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.26791729754470306,-0.747929662866354,1.0,1.0,1.0,13/102,15.56%,BCL2;CREB3L1;QRICH1;ERN1;RHBDD1;CHAC1;DAB2IP;ATF3;CREB3L2;RASGRF1;BAG6;TMEM117;EIF2AK3
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4382516238173979,0.7476899008747061,0.7692307692307693,1.0,1.0,1/11,22.79%,UQCRFS1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.44035977560010336,0.7472950103034812,0.8,1.0,1.0,3/9,25.04%,NLRP12;ENG;ERRFI1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.39874505901396673,0.7471280411364677,0.8529411764705882,1.0,1.0,4/26,5.69%,BLK;BLNK;PTPRC;NFAM1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.4553253299395775,0.7468642314437064,0.8245614035087719,1.0,1.0,3/10,20.86%,GPER1;IL4;CD300LF
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.34520314222378873,0.7468562371481373,0.7681159420289855,1.0,1.0,8/41,15.23%,CYP3A4;CYP3A5;ALOX12;PLPP6;MBOAT1;ALOX15B;PLA2G7;ALOX15
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.42940916968045806,-0.7467467329180165,0.8529411764705882,1.0,1.0,1/9,2.82%,TMEM106A
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.3831651757154455,-0.7466061504598606,0.7333333333333333,1.0,1.0,6/11,21.13%,PTPRO;NPHS1;JAG1;CD24;MAGI2;PODXL
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.41714651686092025,0.7462708581626941,0.7777777777777778,1.0,1.0,1/14,4.21%,NID1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.41459975475369026,-0.7462667175758102,0.8571428571428571,1.0,1.0,1/11,0.91%,KLRC1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.34060445564780933,-0.7460291925493807,0.8108108108108109,1.0,1.0,9/23,19.77%,SLIT3;ACVR1;HES1;TGFBR3;SLIT2;PROX1;NOTCH1;TGFB2;ROBO2
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.44476847637020744,-0.7459734120968045,0.8285714285714286,1.0,1.0,2/7,23.74%,NR1H2;PRKN
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.3393957209737112,0.7458836372642668,0.9078947368421053,1.0,1.0,3/61,7.14%,SMAD6;LRP2;DAND5
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.32859403537480447,0.7456966635218168,0.9285714285714286,1.0,1.0,6/78,9.64%,GATA4;TNFRSF1B;FGF2;HLA-F;PINK1;KANK2
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.4030837390070918,-0.7456886266344002,0.7619047619047619,1.0,1.0,5/10,15.86%,ADAM8;RHBDD1;NKD2;CCBE1;ASTL
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.26775052080666106,-0.745569705040249,1.0,1.0,1.0,34/238,13.35%,TEAD2;WNT3A;CALD1;P3H4;CFAP46;FSCN3;CD247;NLGN3;QRICH2;MATN1;PARD3;QSOX1;RP1L1;JHY;WNT7A;PARVA;SHANK1;LPXN;NDUFAF1;HES1;FSCN1;FANCA;FLNA;CORO1B;NLGN2;HFE;WASF3;PEX14;TUBGCP2;TRIP13;TLCD2;LLGL1;LRRTM3;BAG6
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.27799971341738605,-0.74549605542947,0.9545454545454546,1.0,1.0,18/122,12.95%,FIBIN;BOC;CALD1;GPC6;GFRA2;COL4A2;SDC3;ABCC8;SYNDIG1;CAP2;CBS;SRRM3;EDNRA;DAB2IP;SLIT2;ANTXR1;PTH1R;GPC1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.34442745723024315,0.7454954248162713,0.8481012658227848,1.0,1.0,5/43,15.20%,AHR;GLRA2;GLRA1;TNFSF4;ADCY7
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.28033381207155067,0.7450316489398898,0.9893617021276596,1.0,1.0,96/602,20.56%,CLEC5A;SMAD6;CAPN13;KIF14;ANXA1;LRP2;WNT5A;SIX4;DDX20;ALPK2;CARD14;CIDEB;BOK;SCIN;GPER1;STK26;FLT4;ANGPTL4;MOAP1;RTKN;SOCS2;TNFRSF10A;TP53I3;CASP10;MMP9;LEF1;HSPA5;NLRC4;DNAJA1;REST;PINK1;DAB2;CYP1B1;IGF1;HCK;NR1H4;AXL;NAA38;PPT1;MYDGF;TP53BP2;MAP3K11;RPS3A;DDX3X;BCL2L14;STAT1;ECT2;HGF;RHOB;IL7;TGFB3;PXT1;PLAUR;RPS27A;IFI6;PNMA1;ING3;MTCH1;NOP53;CCND2;RABGGTB;KNG1;TGM2;TFPT;SOX9;RASA1;NDRG1;SIAH1;SFRP4;CD44;THOC6;LATS2;PNMA2;CFL1;COPS5;RASGRF2;IL4;STK17B;STK17A;HTR2B;AGT;BCAR1;OBSCN;BAG1;ZNF622;THBS1;TAF9B;PRAME;PHLDA1;ITGB3BP;DKKL1;HMGA2;RPS6;WFS1;GADD45B;APAF1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.47024915384894816,-0.7447777342317772,0.7446808510638298,1.0,1.0,2/6,16.74%,RTF1;LEO1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.36649996542616164,-0.7447629688921634,0.8695652173913043,1.0,1.0,6/25,13.30%,FOS;EGR1;FOSL1;ETS1;TERT;SMARCA4
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.2915951688548658,-0.7446804535124785,0.9473684210526315,1.0,1.0,37/115,18.67%,BOC;COL12A1;COL4A2;FRMD6;RND3;KITLG;RHBDF1;FZD7;ERBB2;PARVA;BARX2;CAP2;CDCP1;FSTL1;EFEMP1;GNA11;EDNRA;NTN4;DAB2IP;ANTXR1;PAX3;GPC1;AMOTL2;SCRIB;SNAI2;COL5A2;SH3D19;SPRY1;COL4A1;COL16A1;FKBP9;RBFOX2;DAG1;PTPN21;CHST3;ADCY6;DDAH1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.4050437255955859,0.7446665590628704,0.8787878787878788,1.0,1.0,5/22,15.82%,ARHGAP24;LCP1;ITGA5;TOR1A;CD44
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.31114141348172586,-0.7445406960471295,0.9666666666666667,1.0,1.0,9/50,19.33%,APOE;RHBDF1;COMMD1;DAB2IP;NUPR1;GPX1;OSBPL7;FOXF2;GNA12
prerank,GO_Biological_Process_2021__negative regulation of meiotic nuclear division (GO:0045835),0.4951758179325267,0.7442376782794388,0.8656716417910447,1.0,1.0,2/6,13.85%,RAD1;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4573060753248393,0.7441804951832086,0.7941176470588235,1.0,1.0,2/7,19.48%,CD80;RASGRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4573060753248393,0.7441804951832086,0.7941176470588235,1.0,1.0,2/7,19.48%,CD80;RASGRP1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.3320862830670111,0.7441504534885977,0.8933333333333333,1.0,1.0,11/61,16.56%,LRRC19;ANXA1;ACE2;WNT5A;IRF1;HCK;TNFSF4;ALOX15;LACC1;CYLD;USP18
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.4960484994369786,-0.7441373474147084,0.7380952380952381,1.0,1.0,1/5,11.90%,IRGM
prerank,GO_Biological_Process_2021__cannabinoid signaling pathway (GO:0038171),0.49794599352016156,0.7440709102301941,0.8769230769230769,1.0,1.0,3/5,26.43%,ALOX15B;CNR1;CNR2
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.4236017907870385,0.7438157142451076,0.8307692307692308,1.0,1.0,2/10,14.17%,GCHFR;SPR
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.4461169680816861,0.7437577436727898,0.8450704225352113,1.0,1.0,4/10,26.11%,UCP1;CCN6;ALOX5;THRSP
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.2755797950104041,0.7436473654319128,1.0,1.0,1.0,48/857,9.62%,GATA4;RHOXF2;EOLA1;CRX;ESR1;C1QTNF1;TLR2;ZNF284;TRIM58;LRRC19;ZNF676;ITGAX;TCF7;ACE2;VSX1;WNT5A;PIK3R3;AHR;FGF20;PTPRC;METTL18;MYT1;VSIR;NFIL3;ALPK2;ATF7;FGF2;SFTPD;SNAI3;ACTG1;HEY2;TGFB1;ZNF98;CTCFL;GPER1;ABCC2;PRDM12;RNF187;IGF2BP2;IFNK;NFIA;ACTA2;LEF1;TAF5;RAMP3;REST;PINK1;ZNF723
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.35966987710134224,-0.743579736534805,0.7741935483870968,1.0,1.0,3/23,11.32%,AUP1;TECPR2;PREB
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.3460515062381722,0.7434894385867036,0.8591549295774648,1.0,1.0,3/52,7.67%,AMBP;HHIP;NLRP12
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.29638687399598734,0.7434568068171048,0.9777777777777777,1.0,1.0,21/252,15.90%,MCM2;ENDOG;UBE2U;SP100;POLE2;POLQ;TICRR;RAD1;MCM3;RAD54L;NT5E;DNASE2;POLD4;RPA3;RPS27A;UHRF2;NOP53;RMI2;TDG;RECQL4;LRWD1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3734705626632785,-0.7433707212916522,0.8,1.0,1.0,1/23,1.79%,BCL2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.38035627135404276,0.7432979957509465,0.855072463768116,1.0,1.0,7/22,30.45%,IFIT1;PLN;ATP5IF1;PARP9;NES;CAND1;PHPT1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3648833885629552,0.7431703926406497,0.8194444444444444,1.0,1.0,1/27,0.46%,RASGRP4
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.44444941926546916,0.7429996694284946,0.8450704225352113,1.0,1.0,2/8,10.98%,S100A13;PIK3CG
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.41565509372678366,-0.742864816714871,0.8461538461538461,1.0,1.0,1/10,3.11%,UST
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.42338515906522006,0.7427625493163247,0.7910447761194029,1.0,1.0,8/17,30.84%,CAV3;GRM6;PLN;CXCL12;PLPP4;SLC30A1;CTNNB1;EGF
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.363917140195767,0.7426360075895547,0.8235294117647058,1.0,1.0,7/34,26.06%,PINK1;FUNDC1;GABARAPL2;FIS1;ULK1;GABARAPL1;FBXO7
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.49455970525438003,0.7423623639015906,0.8709677419354839,1.0,1.0,1/7,9.95%,IGF1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.3476939003972318,-0.7422829302559871,0.7,1.0,1.0,3/23,9.12%,F11R;CBFB;RAPGEF1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.38129739248630684,-0.7419095185693202,0.8,1.0,1.0,1/11,3.40%,F11R
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3649316847297723,-0.7417778396127245,0.9032258064516129,1.0,1.0,4/23,13.16%,CTC1;STN1;SLX4;EXOSC10
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.32787047700299987,0.741445336251188,0.8625,1.0,1.0,17/95,18.34%,AQP3;CAPN13;ACE2;ITGB6;TMEM45B;SMIM22;EPN3;HSD11B2;TMC4;TRIM29;EPCAM;AP1M2;AQP4;ADGRG1;SLC5A1;SLC44A3;PTGES
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.34883852570214946,-0.7414083428933748,0.84375,1.0,1.0,6/10,24.81%,PTCH1;TGFB2;SKI;FBXW4;MYH3;LRP6
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4096791307320559,0.7413416809027555,0.8382352941176471,1.0,1.0,2/18,9.51%,SLC18A2;PINK1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.41399632592298075,0.7408969812215945,0.8253968253968254,1.0,1.0,4/13,23.73%,SOX9;BRCA1;CEACAM1;ACADL
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.48146621722918626,0.7408918772017702,0.8153846153846154,1.0,1.0,1/6,5.66%,SCIMP
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.41636788361050014,0.7406861721159075,0.8153846153846154,1.0,1.0,4/17,9.95%,CCL5;PIK3R3;TGFB1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.36950092534009615,0.7403704385666492,0.8831168831168831,1.0,1.0,6/34,18.23%,WNT5A;TGFB1;TGFB3;ISG15;ATRAID;FBN2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.3742150259967336,0.7401196267906679,0.8441558441558441,1.0,1.0,5/25,23.70%,CCL5;GRM6;WFS1;CXCL12;MYLK
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.3619162663048716,0.7400193950813968,0.9047619047619048,1.0,1.0,9/31,32.07%,MAPK3;FAM47E;BRCA1;RPS6KA5;PAF1;KDM1A;CDK9;PPARGC1A;PAXIP1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.36033083192051496,0.7399889252678128,0.8356164383561644,1.0,1.0,5/29,11.13%,FLT1;CNMD;IL12A;COL4A3;STAT1
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.4756892718343303,0.73991054220867,0.796875,1.0,1.0,4/6,26.68%,UPK3A;SLC14A1;AQP11;SLC14A2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.32166862500122345,0.7397467922832568,0.925,1.0,1.0,17/101,20.53%,ENPP2;ELOVL2;CERS3;VAPB;HACD4;PSAP;PPT1;ORMDL3;PRKD3;UGT8;CLN8;GBA3;DEGS1;ALOX12B;ALDH3A2;SERINC1;DEGS2
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.42376873372754664,0.7394297849241904,0.78125,1.0,1.0,3/12,12.96%,CD81;JAM2;ERVW-1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.3458675162045179,-0.7393257119429598,0.8695652173913043,1.0,1.0,7/17,24.91%,EMP2;LDB1;SPTSSB;ATM;FEM1A;LDB2;SMG6
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.27625620161545716,-0.7389573696434657,1.0,1.0,1.0,34/124,21.86%,PROKR2;GRID2;CASKIN1;ELAVL3;ASCL1;PRR36;MPP2;INA;MSI1;TAGLN3;RCOR2;CCKBR;JPH3;MARK2;MAPK7;ERC2;IGDCC3;LINGO1;CSPG5;POU3F2;RHBDL3;BRSK1;LRP8;POU6F2;FBLL1;PAK5;MAPK4;CUX2;DAB1;NCAM1;ST8SIA2;UNC5D;TMEM179;KIF5C
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.3602459499411423,0.738557967644839,0.8666666666666667,1.0,1.0,5/29,10.20%,ITGB2;NODAL;MMP9;MMP15;ITGA5
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4504851453329829,-0.7385413781615077,0.8378378378378378,1.0,1.0,2/7,16.19%,CARD9;IL23A
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.3491764288555475,0.7384252438893049,0.9117647058823529,1.0,1.0,14/44,23.60%,C3;DAB2;AXL;PPT1;TOR1A;LDLRAP1;IL4;VTN;F2RL1;B2M;CBLL1;HNRNPK;RAB21;TF
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.35340600722077276,-0.7382139608210164,0.8666666666666667,1.0,1.0,1/19,2.90%,PIWIL2
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.4803734315208018,0.7379943392656958,0.7894736842105263,1.0,1.0,2/5,13.71%,GPR183;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.328713828969959,0.7378849161012374,0.9230769230769231,1.0,1.0,20/103,21.71%,TP53TG5;TGFB1;CRLF3;CDKN2A;EI24;GNG4;PPT1;DDX3X;CDKN1B;RERG;BTG1;CDKN1A;CCDC85B;MAG;TCHP;CDKN2C;PSRC1;RBBP7;NAIF1;FRZB
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3635261643752371,-0.7378771027914224,0.896551724137931,1.0,1.0,4/21,15.04%,BCL2;TFDP1;PPP1R13B;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3635261643752371,-0.7378771027914224,0.896551724137931,1.0,1.0,4/21,15.04%,BCL2;TFDP1;PPP1R13B;YWHAQ
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.3734876892978659,0.7378384538935485,0.8805970149253731,1.0,1.0,4/32,15.59%,SEMA3A;PLXNA3;SEMA3B;SEMA3F
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),-0.48459112202352717,-0.7378046650303228,0.7894736842105263,1.0,1.0,4/6,22.54%,CCDC78;CEP152;PLK4;CCNO
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.3405573772692039,-0.7377768302077783,0.8214285714285714,1.0,1.0,6/30,18.04%,PHLDB2;CDK1;NIBAN2;BAG6;DAG1;PLCB1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3487899190458524,0.7375660109751442,0.8875,1.0,1.0,8/47,22.37%,HIPK1;PELI3;TRAIP;SYK;CYLD;F2RL1;SPATA2;TRADD
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.41712583990524843,-0.7375129178497589,0.775,1.0,1.0,2/6,15.36%,TRPC6;WNK3
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.28359553791382724,-0.7374342723052992,1.0,1.0,1.0,11/99,8.38%,IL1RL2;SIGIRR;PTPN9;DCPS;NDOR1;KHSRP;ERBB2;SLIT3;STAT5B;ACVR1;PID1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.24944725873142873,-0.7374243578375288,1.0,1.0,1.0,32/179,19.39%,ANXA8;SMPD4;COG4;MYO18A;UBXN2A;TRAPPC12;GOLGA8A;TMED4;FAM174B;GBF1;TICAM2;DOP1B;ZNF501;SNX33;SPTSSB;BLZF1;TLCD2;REEP6;GOLGA8B;TOR1B;COG7;EIF2AK3;MIA3;CTDNEP1;RAB22A;TRAPPC11;DNAJC28;FER1L5;ALS2CL;UBXN2B;HOOK3;GOLGB1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.39875780261580357,0.7373693740495714,0.8285714285714286,1.0,1.0,5/22,18.78%,HEY2;TGFB1;AGGF1;RASA1;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.2847329911403156,0.7371448613420833,0.9891304347826086,1.0,1.0,54/366,18.21%,TBX1;CDCA7L;KIF14;S100A13;ITGAX;CCL5;WNT5A;FGF20;PTPRC;TSHR;CRLF1;SPDYA;FGF2;CLCF1;FLT1;TGFB1;GPER1;CD81;FLT4;ERBB4;RNF187;NODAL;TBX6;LEF1;RPS9;OSMR;IGF1;HCK;CLDN5;STAT1;LAMC2;IL7;TGFB3;FOXM1;EPCAM;TNFSF4;CCND2;FBXO5;COX17;LIFR;CDKN1A;SOX9;TTK;BMI1;RPS4X;GDF9;DDR2;IL4;SIRPG;HTR2B;AGT;RHOG;CSF1R;FN1
prerank,GO_Biological_Process_2021__DNA protection (GO:0042262),-0.49298351968696097,-0.7370180550843916,0.7837837837837838,1.0,1.0,1/5,7.64%,CBS
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.32880252498983153,0.7369878120694283,0.9,1.0,1.0,7/77,14.77%,KIF14;NDC80;CXCR5;IGF1;ECT2;GPSM2;CDC14A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.3244952843316731,0.7368023086653099,0.8846153846153846,1.0,1.0,4/66,6.32%,RORC;WNT5A;TGFB1;GPER1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.4413023878936412,-0.7365284770880044,0.9166666666666666,1.0,1.0,1/7,5.49%,MDGA1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.27600566526893083,-0.7364316713388155,0.9523809523809523,1.0,1.0,6/84,9.29%,UBXN8;AUP1;FBXO27;MAN1A1;SEL1L2;RHBDD1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.2976536719325052,0.7363961461409916,0.95,1.0,1.0,15/137,10.66%,TIMP3;PRRX1;ADAM33;LMOD1;ANGPT2;FBXL7;PCDH18;ABI3BP;ACTA2;LEF1;DAB2;DCN;ANGPTL2;COL1A1;ADGRL4
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.30791026869862465,0.7362132051729593,0.9113924050632911,1.0,1.0,18/123,17.61%,SHISA6;STMN4;HTR5A;LRRC3B;LY6H;PLP1;ARHGDIG;PPP1R1B;TCEAL5;NPY;GPR88;VSTM2A;CCK;AQP4;CNTN2;PENK;GFAP;ZNF536
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.32790894142724797,0.7360003711038581,0.891566265060241,1.0,1.0,13/79,20.27%,LMOD1;CAV3;C15ORF62;BAIAP2L1;VASP;HCK;CDK5R1;VIL1;ALOX15;CARMIL1;F2RL1;LMOD2;PSRC1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.27596015740015617,-0.7359623848629993,0.95,1.0,1.0,18/91,15.73%,ST3GAL3;DPM3;POFUT1;POFUT2;GALNT13;RXYLT1;XXYLT1;GALNT12;ST3GAL2;MUC19;POGLUT3;TMTC4;FKTN;MUC13;ST3GAL4;GALNT18;PLOD3;GALNT9
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.3381511096162925,-0.7359092630685125,0.9310344827586207,1.0,1.0,1/22,0.41%,MT1G
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.33481143310425154,0.735900940014665,0.88,1.0,1.0,7/63,13.17%,DEPDC5;BOK;PSAP;RRAGA;DRAM1;WDR24;USP13
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.3349560264066834,-0.735856080211964,0.9,1.0,1.0,5/24,10.09%,APOH;APOE;EPHB2;SERPINE1;SERPINE2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.2963932705009563,-0.7358052338634138,0.88,1.0,1.0,11/91,13.98%,EHF;RAB20;CD14;JUNB;EHD4;TBC1D2;BATF2;LRP10;NFIB;SLC8B1;SBNO2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3528754962410716,0.7356814938058145,0.859375,1.0,1.0,5/36,8.13%,BLNK;PTPRC;CLCF1;NFAM1;IFNK
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4059543257603797,0.7355793422348694,0.873015873015873,1.0,1.0,3/17,22.08%,EPCAM;PLG;PTPRU
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.3421165118933309,-0.7354834208794174,0.9117647058823529,1.0,1.0,3/20,7.20%,WNT3A;WNT7A;PCM1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.43795992721738475,0.7350136342489647,0.8059701492537313,1.0,1.0,2/9,15.30%,RABGGTB;AIPL1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.43958225334770273,-0.7347906655635854,0.7380952380952381,1.0,1.0,2/6,11.48%,PACSIN2;EMP2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.35869228039158363,-0.7347243275195675,0.78125,1.0,1.0,1/18,5.28%,APOE
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.48852341310504294,-0.7347064135780779,0.8157894736842105,1.0,1.0,1/6,12.17%,FAM120B
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4370208640175741,0.7347004761574284,0.8955223880597015,1.0,1.0,3/10,21.15%,CD81;TNFSF4;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.4063682992597957,-0.7346510013969669,0.7948717948717948,1.0,1.0,2/7,23.74%,VAT1;PRKN
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.2843477738019935,-0.7345396798455782,1.0,1.0,1.0,28/106,18.77%,ARC;CLYBL;IKZF4;UPB1;EHD4;MPP2;GLRA3;PKD2;APIP;TRMT61B;CBY1;EHD3;SPAST;ALDH1A2;TRPM2;CARD9;USP16;LETM1;RBMX;SAMHD1;THG1L;TRIM72;TDO2;PKD2L1;TRPV1;ACACB;TRPV5;MICU1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.4118373715366488,0.7345133752127243,0.9,1.0,1.0,2/18,8.30%,MCMDC2;MCM3
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.37110501611260915,0.7341497340632244,0.746031746031746,1.0,1.0,2/14,8.27%,PHKA1;PHKG1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.4137933185308075,0.7340268647704316,0.8260869565217391,1.0,1.0,4/12,22.53%,CSF1R;F2RL1;CBLN1;DCTN1
prerank,GO_Biological_Process_2021__glucocorticoid biosynthetic process (GO:0006704),0.4595360655020497,0.73394880598001,0.84375,1.0,1.0,1/7,7.69%,HSD11B2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.34682157030203503,-0.733469290460082,0.8157894736842105,1.0,1.0,1/15,3.29%,TCOF1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.49695290968854655,0.7334235544441586,0.8064516129032258,1.0,1.0,2/6,5.54%,ALOX12;PTGR1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.35833593102392397,-0.733281317541073,0.8181818181818182,1.0,1.0,4/26,8.15%,CFAP46;RP1L1;JHY;TTC12
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.33014327882961403,0.7332412475766804,0.9210526315789473,1.0,1.0,8/59,18.72%,HEY2;CDKN2A;LEF1;CCND1;CDKN1A;SOX9;CSF1R;HNF1A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3147172005794358,-0.7323843253434471,0.9642857142857143,1.0,1.0,12/47,16.84%,TBC1D10A;APOE;ADAM8;PERP;RHBDD1;NKD2;SNX33;PACSIN3;CCBE1;SH3D19;ASTL;SNX9
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.3193849800087607,-0.7322289377226804,0.8571428571428571,1.0,1.0,1/43,0.77%,ANXA8
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.3707675687270393,-0.7321332759768087,0.75,1.0,1.0,4/17,16.90%,POLD3;TERT;RFC3;PPIA
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.3034991315789358,0.732086773153308,0.926829268292683,1.0,1.0,24/148,23.54%,SGO1;BUB1;CENPU;MISP;NDC80;ERCC6L;RAB11A;SKA2;DYNLL1;GPSM2;SPC25;TTK;KIF18A;RCC1;NUF2;ITGB3BP;TBCE;CENPL;BUB1B;CENPN;CCNB1;DYNLL2;CENPM;RPS27
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.3616165569290807,0.7320362610834978,0.859375,1.0,1.0,8/30,21.48%,BOK;ERBB4;SOD2;IFI6;BBC3;GGCT;FIS1;NAIF1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.38525589902894153,0.7320047083118733,0.7611940298507462,1.0,1.0,2/24,4.81%,KIF14;STMN4
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.3670950612860626,-0.7317510002595978,0.8888888888888888,1.0,1.0,2/16,5.72%,IL11;FZD7
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.31172517500614183,0.7316829471186411,0.9459459459459459,1.0,1.0,15/120,18.29%,SLC9A2;SLC12A7;KCNA7;SLC12A3;KCNJ15;KCNA5;KCNG2;KCNS2;ATP1A4;KCNK7;SLC9C1;KCNAB1;SLC24A1;KCNK13;KCNE3
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.2997774340337715,0.731610982813833,0.9629629629629629,1.0,1.0,25/168,18.70%,LRP4;SMAD6;ALPK2;HEY2;TGFB1;SLC6A4;NLRP12;NODAL;PON1;ID1;NR1H4;MCC;MARVELD3;APOM;CRHBP;NPR3;RPS19;LRPAP1;SOX9;PGAM5;HEY1;IL4;SPX;AGER;ZNF750
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.28799272403311654,0.7312540006524598,0.989247311827957,1.0,1.0,32/304,12.89%,CLEC5A;SMAD6;CAPN13;KIF14;ANXA1;LRP2;WNT5A;SIX4;CARD14;FLT4;ANGPTL4;SOCS2;MMP9;LEF1;HSPA5;DNAJA1;DAB2;KANK2;IGF1;HCK;NR1H4;AXL;NAA38;PPT1;MYDGF;RPS3A;DDX3X;HGF;IL7;PLAUR;RPS27A;IFI6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2904678883641232,-0.7312487622341683,0.84,1.0,1.0,5/51,9.75%,PLK3;CARM1;CDK1;CNOT9;TFDP1
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.4030179946997377,-0.7311774132974316,0.7567567567567568,1.0,1.0,1/9,4.24%,PTCH1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3239374990459767,-0.7311350864289219,0.9130434782608695,1.0,1.0,8/35,13.30%,FOS;EGR1;NFATC3;FOSL1;ETS1;TERT;NFIB;SMARCA4
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.4137498253081633,0.7311144837243235,0.8382352941176471,1.0,1.0,2/15,4.02%,LIPI;LIPH
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32490553256198335,0.7310905979860326,0.8873239436619719,1.0,1.0,7/62,11.65%,BLK;FCGR3A;ACTG1;WAS;HCK;NCKIPSD;SYK
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.35620305147657494,0.731027681410193,0.8656716417910447,1.0,1.0,8/45,12.39%,CLDN2;CLDN6;CLDN18;CLDN5;MARVELD2;MARVELD3;ECT2;CLDN9
prerank,GO_Biological_Process_2021__kidney mesenchyme development (GO:0072074),-0.4552810128281993,-0.7309592317281239,0.8,1.0,1.0,2/5,8.95%,OSR1;PKD2
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.41311643044034835,0.7308892137372196,0.8970588235294118,1.0,1.0,1/15,1.35%,MYH8
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.43642291495507113,0.7306338157014435,0.8615384615384616,1.0,1.0,2/11,17.00%,SLC22A6;SLC22A4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.40207321766249415,0.7305345665715355,0.828125,1.0,1.0,10/19,29.50%,KCNA5;CAV3;NPPA;KCNE3;SCN4B;KCNE4;SCN1B;NOS1AP;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.31671915926764954,0.7303315819453662,0.9113924050632911,1.0,1.0,14/96,13.46%,ST18;BOK;GPER1;UACA;NLRP12;TNFRSF10A;CASP10;NODAL;COL4A3;NLRC4;REST;DDX3X;SYK;MTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.31166375835134436,0.7302656321414367,0.9759036144578314,1.0,1.0,21/91,23.06%,WNT5A;SPDYA;FGF2;FLT1;TGFB1;PIK3CG;DDX3X;CCND1;CCND2;MTCP1;HTR2B;CSF1R;RASGRP1;HMGA2;MAP2K1;PSRC1;PIK3R6;ETAA1;DIRAS2;TPD52L1;ELANE
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.36112673066896656,0.7298104447844058,0.8552631578947368,1.0,1.0,6/31,21.70%,PHF23;CAV3;PINK1;FEZ1;TCHP;BRCA1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.37315422944299015,0.7297824228545865,0.8108108108108109,1.0,1.0,2/33,5.82%,CASQ2;KCNJ15
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.46157771423461696,0.729763648553754,0.7936507936507936,1.0,1.0,4/7,39.56%,MSN;EGF;EZR;RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.46157771423461696,0.729763648553754,0.7936507936507936,1.0,1.0,4/7,39.56%,MSN;EGF;EZR;RDX
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.46157771423461696,0.729763648553754,0.7936507936507936,1.0,1.0,4/7,39.56%,MSN;EGF;EZR;RDX
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.4197067584819529,-0.7297111680316026,0.7435897435897436,1.0,1.0,6/6,58.04%,SMURF1;FNBP1L;SNX3;FCHO2;CHMP2A;HGS
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.28555441567711914,0.7294739895335598,0.968421052631579,1.0,1.0,22/287,16.67%,PSMB9;UBE2U;DTL;UBE2L6;FBXL7;TRIM62;ZNF738;PELI3;ARIH2;TRAF3IP2;RNF26;RNF187;TRIM68;RPS27A;KBTBD7;UBE3A;FBXL13;FBXL3;SIAH1;KBTBD6;MKRN3;PSMC5
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.4284155354707323,-0.7294303533947855,0.7777777777777778,1.0,1.0,2/6,26.70%,RAD21L1;NIPBL
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3818117535734127,0.7293556679699638,0.8309859154929577,1.0,1.0,3/24,12.59%,POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.3856681186032954,0.7289359246911499,0.8571428571428571,1.0,1.0,6/17,19.65%,ALOX12;FLG;TMEM79;FLG2;ALOX12B;HRNR
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.3856681186032954,0.7289359246911499,0.8571428571428571,1.0,1.0,6/17,19.65%,ALOX12;FLG;TMEM79;FLG2;ALOX12B;HRNR
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.41624150494823675,-0.7286175177980386,0.8536585365853658,1.0,1.0,1/11,3.34%,PC
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3157462673684547,0.72838865156887,0.927536231884058,1.0,1.0,24/85,20.95%,SLC38A3;SLCO1A2;SLC10A1;SLC7A7;ABCG2;SLC16A8;ABCC2;SLC26A6;SLC51A;ABCC11;NR1H4;SLC22A6;SLC38A4;SLC38A2;SLC16A1;SLC23A1;SLC7A4;SLC7A3;SLC6A12;SLC10A5;SLC7A10;SLC46A1;SLC3A1;SLCO2B1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3047420935251981,-0.7281400776474265,0.9615384615384616,1.0,1.0,6/48,12.13%,PTPN9;CLIP3;EPHB2;ZDHHC5;NKD2;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.4209932713693199,-0.7278751861610495,0.8611111111111112,1.0,1.0,4/9,23.35%,DBNL;LRP8;CUX2;DHX36
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.42761589252740234,0.7277580256052838,0.84375,1.0,1.0,4/11,28.11%,NOS2;PARK7;ISCU;ORAI1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.38400697013882706,0.7276239103992639,0.8245614035087719,1.0,1.0,2/21,7.16%,TGFB1;MYH11
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.3664643700713902,-0.7275604932461335,0.8108108108108109,1.0,1.0,3/13,19.88%,AK8;ITPA;AK7
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.3483668570978962,0.7274567592310953,0.8529411764705882,1.0,1.0,11/38,33.11%,PINK1;FUNDC1;GABARAPL2;FIS1;ULK1;GABARAPL1;FBXO7;SPATA18;BNIP3;PHB2;CTSK
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.4510442617728895,0.7269230494994466,0.7868852459016393,1.0,1.0,1/7,8.13%,IFNK
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.3447936105706324,-0.7267695417868274,0.96875,1.0,1.0,7/21,11.45%,CATSPERG;SLIT3;HSD3B2;CATSPER4;TGFBR3;CATSPER2;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.3667162803276515,-0.7267602510302269,0.8,1.0,1.0,7/16,30.05%,LST1;SAMSN1;LAPTM5;DUSP3;PIBF1;LGALS3;JAK3
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.4667012670471785,0.7267417621502982,0.8076923076923077,1.0,1.0,1/6,19.36%,BLOC1S2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.34672754045615517,0.7267374290897267,0.8985507246376812,1.0,1.0,2/29,9.07%,TCF7;LEF1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4099680891792335,0.7265527902619737,0.8,1.0,1.0,1/12,2.43%,TNFRSF1B
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.279677141126357,-0.726508760871241,1.0,1.0,1.0,19/81,22.22%,NAA40;PTCH1;CPN1;METAP2;ADAMTS3;PCSK1;CIAO2A;XPNPEP3;ADAMTS13;TYSND1;GALNT2;TESC;TSPAN14;PCSK7;NNAT;LIPT2;AFG3L2;CLN3;KEL
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.39623987115767867,0.7264780519773427,0.8524590163934426,1.0,1.0,1/15,1.98%,RORC
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.3037217752930838,-0.7264312497812371,0.9230769230769231,1.0,1.0,10/35,23.79%,THEM4;OTUD3;PTPRJ;ARRB2;DAG1;DRD2;MAGI2;XDH;PKHD1;DRD3
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.446843933484814,0.7261554767895574,0.8833333333333333,1.0,1.0,2/10,19.32%,EXOSC8;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.3544745783481861,0.7256722222595214,0.8860759493670886,1.0,1.0,11/46,23.45%,BOK;GPER1;GSDME;SIAH1;BBC3;CYLD;AGT;FIS1;DDIT3;TPD52L1;BCAP31
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.304823356622553,0.7255481459025467,0.92,1.0,1.0,6/81,11.82%,ARHGAP24;TBC1D28;TBC1D3L;USP6;ECT2;ARHGAP45
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.3176660331719983,-0.7255442221933751,0.8620689655172413,1.0,1.0,9/38,24.16%,APOE;GSAP;SNF8;TRAF3;MAPK7;SPOPL;SSH1;FAF1;MAPK8
prerank,GO_Biological_Process_2021__establishment of protein localization to telomere (GO:0070200),-0.4692348341662395,-0.7255432191859342,0.8604651162790697,1.0,1.0,1/5,11.22%,TERT
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.3209137660892736,-0.7255383269851015,0.9375,1.0,1.0,8/27,19.83%,ACER2;IFI16;FHIT;PPP1R13B;MYBBP1A;USP10;GREM1;NBN
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.37099193325869995,-0.725537590610595,0.7241379310344828,1.0,1.0,2/14,15.68%,SNCAIP;SYN1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3143406575559632,0.7253951371338843,0.9210526315789473,1.0,1.0,11/76,20.58%,HSPA1L;HSPA8;IER5;DNAJB1;RPA3;FKBP4;MAPK3;BAG1;HSPH1;BAG5;RAE1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.30649852751975987,0.725353453015482,0.9876543209876543,1.0,1.0,10/151,10.41%,ESR1;FGF2;HEY2;TGFB1;GPER1;ABCC2;REST;PINK1;IGF1;CLDN5
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.24962617628840764,-0.7252599465630243,1.0,1.0,1.0,20/150,13.45%,RGS16;F11R;ADCYAP1;ARHGAP11A;AGRN;ERBB2;ASAP3;TBC1D2;RAPGEF1;SRGAP2;FGD1;DAB2IP;FGD5;GNB5;NTRK1;RGS6;PLXNA4;RASGRF1;RGS7;CRK
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.40746993451592806,0.7252250999730673,0.8088235294117647,1.0,1.0,2/16,4.86%,PLA2G10;C3
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2827308532782056,0.7251793763745787,1.0,1.0,1.0,19/396,9.62%,GATA4;CRX;ESR1;ZNF284;ZNF676;TCF7;VSX1;AHR;METTL18;MYT1;NFIL3;ATF7;SNAI3;ZNF98;IFNK;NFIA;TAF5;REST;ZNF723
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4400176774587707,0.7251528699902746,0.7941176470588235,1.0,1.0,1/8,9.95%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.4400176774587707,0.7251528699902746,0.7941176470588235,1.0,1.0,1/8,9.95%,IGF1
prerank,GO_Biological_Process_2021__negative regulation of vitamin metabolic process (GO:0046137),-0.41968621717453625,-0.7251505330887609,0.75,1.0,1.0,3/5,21.98%,AKR1C3;SNAI2;NFKB1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.33831591115041953,-0.7248571663262077,0.9642857142857143,1.0,1.0,10/27,17.92%,PNKP;KMT5C;WRAP53;HSF1;KDM4D;SIRT7;SMCHD1;SHLD2;SHLD1;MAD2L2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.2782734934760268,0.7247011268585114,1.0,1.0,1.0,40/461,16.69%,PSMB9;UBE2U;TRIM58;ASB5;DTL;UBE2L6;FBXL7;TRIM62;ZNF738;PELI3;ARIH2;DTX2;TRIM25;RNF26;RNF187;HLA-A;PINK1;ANKRD9;RRAGA;SPSB2;TRAIP;TRIM68;KLHL2;SDE2;VPS18;TRIM74;RNFT1;TRIM77;RPS27A;KLHL13;UHRF2;UBE3A;FBXL13;ISG15;RNF138;FBXL3;SIAH1;MKRN3;PSMC5;TRIM23
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.44443529404694393,-0.7245752846695277,0.8108108108108109,1.0,1.0,2/8,15.86%,SPAST;LETM1
prerank,GO_Biological_Process_2021__lipoprotein metabolic process (GO:0042157),0.4747705190612476,0.7242789419282948,0.8703703703703703,1.0,1.0,2/5,18.31%,NPC1L1;MTTP
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.4529866380533271,-0.7241683155870068,0.8461538461538461,1.0,1.0,2/5,9.97%,FLNA;MACROH2A2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.32370705639058583,-0.7240618070125983,0.8125,1.0,1.0,6/24,17.23%,NLGN3;SLIT3;SLIT2;ALCAM;AUTS2;CDK5
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.3369921582912446,-0.7234157622455182,0.868421052631579,1.0,1.0,2/22,8.54%,ADAMTS12;EFEMP1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.4487741188824545,0.7230125242146654,0.782608695652174,1.0,1.0,3/9,33.76%,CHMP1A;VPS4A;CHMP2B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.4487741188824545,0.7230125242146654,0.782608695652174,1.0,1.0,3/9,33.76%,CHMP1A;VPS4A;CHMP2B
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.4299452995543145,0.7229547068020374,0.8513513513513513,1.0,1.0,5/12,35.38%,DDX3X;KAT5;TERF2IP;RAPGEF3;CAMK1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.3441536999774138,0.722752390083939,0.961038961038961,1.0,1.0,3/54,4.64%,GATA4;WNT5A;FGF2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.26222786802190967,-0.7227425158300739,1.0,1.0,1.0,17/105,15.61%,WNT3A;BAMBI;PRKCD;DDX11;RALB;MEN1;TTBK1;HFE;PEX14;TERT;SYMPK;RIPK2;CRK;MARK2;CSNK1E;PPP1CA;HDAC5
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.2807848412623741,-0.7221386036276889,0.9166666666666666,1.0,1.0,12/72,20.24%,F11R;CAPN2;CLEC16A;STX5;PREB;EHD3;MARK2;SIRT7;CAMSAP3;AKAP9;MAPT;STX18
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.359091436752699,-0.722113711707102,0.8285714285714286,1.0,1.0,12/12,64.11%,ZBTB7B;NIPBL;SAP30BP;AKAP8L;PRKD2;ING2;C6ORF89;SDR16C5;CTBP1;PRKD1;VEGFA;AKAP8
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.339242348813925,0.7218516259791026,0.9436619718309859,1.0,1.0,2/40,2.84%,PKP2;CCL5
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.3375678278226432,-0.72158005472174,0.9230769230769231,1.0,1.0,4/31,9.31%,CALD1;FSCN3;FSCN1;CORO1B
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.41511070094356695,0.7215332430422206,0.847457627118644,1.0,1.0,2/11,7.23%,DBH;SLC6A4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.3564376693462513,0.7214559582947466,0.8666666666666667,1.0,1.0,5/24,20.26%,TGFB1;DAB2;PPP2R5A;RHOQ;MRAP
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.2878846129631811,-0.7212745511881073,1.0,1.0,1.0,11/66,15.70%,SMPD4;MOSPD3;STX5;DOP1B;EMD;SPTSSB;REEP6;STEEP1;TOR1B;EIF2AK3;MIA3
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3909451753131233,0.7212658199082401,0.8615384615384616,1.0,1.0,3/18,6.32%,PDE6H;C3;GPER1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.29808314462061636,0.721154738240524,0.975609756097561,1.0,1.0,22/151,17.91%,ALPK2;CIDEB;STK26;MOAP1;RTKN;TNFRSF10A;TP53I3;CASP10;NLRC4;PINK1;KANK2;TP53BP2;BCL2L14;STAT1;NOP53;RABGGTB;TGM2;SOX9;NDRG1;PSMC5;AGT;BCAR1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.25183535517402345,-0.7209717198998047,1.0,1.0,1.0,24/170,17.32%,PIWIL2;TCOF1;TRIM71;PUM3;KLHL25;UPF3A;ERBB2;HSPB1;DHFR;NANOS3;PCIF1;CNOT9;IGF2BP1;FXR2;CIRBP;IMPACT;RPS6KA3;ZCCHC4;GEMIN5;PUS7;EIF2AK3;RPS27L;ETF1;SAMD4B
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.33974110200883695,0.7208983934656567,0.92,1.0,1.0,1/49,0.49%,LRP4
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.3693539818300885,0.720769045007646,0.8656716417910447,1.0,1.0,5/20,18.33%,ALOX12;PTGR1;GGT5;ALOX15;ALOX5AP
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.3970789690411931,-0.7204352461577551,0.8076923076923077,1.0,1.0,4/16,16.74%,LDB1;CDK6;MAFB;LEO1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.3957253386244273,0.7203183856365649,0.8208955223880597,1.0,1.0,1/17,5.45%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.43222549579000324,0.7201952194689507,0.8307692307692308,1.0,1.0,2/11,5.16%,C1QTNF1;ALOX12
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.3949182990742342,-0.7198658157381984,0.85,1.0,1.0,1/9,9.12%,MECP2
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.4123120536642311,0.7188538465483415,0.8387096774193549,1.0,1.0,3/18,5.16%,BLK;C1QTNF1;ALOX12
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2519975993551439,-0.7186801956812157,1.0,1.0,1.0,21/160,15.70%,SEC24C;KDELR1;COG4;TGFA;SPTBN4;SPTB;TRAPPC12;TMED4;GBF1;TICAM2;STX5;PREB;SPAST;CNIH3;CAPZB;TRAPPC1;STEEP1;PGAP1;F5;COG7;MIA3
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.37261855652093917,-0.71818028739505,0.8333333333333334,1.0,1.0,1/9,15.25%,PIH1D1
prerank,GO_Biological_Process_2021__regulation of glycogen (starch) synthase activity (GO:2000465),-0.4066924564796905,-0.7180609509949074,0.6764705882352942,1.0,1.0,5/5,59.34%,INPP5K;GSK3B;EPM2AIP1;PPP1R3F;GSK3A
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.4513904804813005,0.7179661780048662,0.8472222222222222,1.0,1.0,3/7,36.45%,STK25;RIPOR1;PDCD10
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.3551760579214813,0.7178547076966583,0.8507462686567164,1.0,1.0,6/23,26.20%,RPS27A;SEL1L;SYVN1;RNF5;AMFR;DERL2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.26200519887054047,-0.7177872882260603,1.0,1.0,1.0,41/243,16.84%,SEC24C;TEAD2;PPP6R1;CD247;PDZD11;MATN1;PARD3;BCL9L;TGFA;MEFV;MEN1;SHANK1;LPXN;NDUFAF1;HES1;FANCA;TRAPPC9;STX5;TLE2;HFE;WASF3;PEX14;TERT;PREB;TUBGCP2;HSF1;CNIH3;LLGL1;SMARCA4;CAND2;DBNL;TRAPPC1;HGSNAT;GEMIN5;F5;ANKRD28;SAMM50;PARD6B;LEO1;COL16A1;SNX9
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3199928733066531,0.7177171391729182,0.9078947368421053,1.0,1.0,3/44,7.49%,MYRF;SOX10;PLP1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.4781834377519446,0.7176656174479992,0.9365079365079365,1.0,1.0,1/5,6.51%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.28429886994730125,-0.7172317225183894,0.96,1.0,1.0,13/55,19.52%,PLK3;MYO18A;ADAM8;PCM1;APBB3;B3GAT3;CHP1;ABCG1;PPIA;CEP290;ICE1;TGFB2;FRMD4A
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.33970468885302746,0.7171675324648105,0.9861111111111112,1.0,1.0,13/52,27.02%,SLC25A31;TIMM22;TOMM20;BCS1L;TIMM17A;FIS1;TOMM7;BCAP31;TIMM10;SLC25A6;FBXO7;TOMM34;AIP
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.28172095693787164,0.7169328385003401,0.9878048780487805,1.0,1.0,24/266,12.05%,CHRNA9;ZACN;DBH;GAD1;SLC12A7;HSPA8;SYPL1;SLC18A2;SHISA6;SLC17A8;HTR5A;UTS2;CHRNA5;PLP1;PDYN;HTR3E;NQO1;HTR1B;NPY;PCDHB5;GLRA2;GRIN2D;CRHBP;GLRA1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.29749705023056083,-0.7164876467173408,0.8787878787878788,1.0,1.0,3/31,6.16%,IWS1;THAP7;MYOCD
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.32727084512004984,-0.716314067393828,0.9117647058823529,1.0,1.0,4/28,9.84%,SLC38A5;SLC6A20;SLC3A2;SLC7A5
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),-0.46686811783544324,-0.7161469491363655,0.85,1.0,1.0,3/5,27.96%,FGFR2;NIPBL;ID2
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.4267974654344109,-0.7161197892259088,0.7083333333333334,1.0,1.0,2/6,10.08%,DHX30;MTERF3
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3524059194227457,-0.715972755695373,0.8484848484848485,1.0,1.0,4/30,7.50%,PACSIN2;QRICH2;PARVA;KIF17
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.33186063734105653,-0.7158086326418756,0.9259259259259259,1.0,1.0,7/27,19.18%,KMT5C;WRAP53;ERCC2;SHLD2;SHLD1;MAD2L2;RAD51AP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.33444139486498925,0.7156657175855161,0.92,1.0,1.0,13/74,19.01%,SP100;RRAS;WNT5A;FGF2;FLT4;DCN;PIK3CG;RHOB;ZNF580;GLUL;AGT;BCAR1;THBS1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.24619181734398135,-0.7151922651385506,1.0,1.0,1.0,23/210,13.35%,ATP6V0D2;BCL2;FOXO1;ACER2;IFI16;DHRSX;EXOC7;USP36;HSPB1;MEFV;TRIM8;ERN1;ATP6V1E2;SNX32;ATP6V0A2;DAPK2;SNX5;IRGM;TRIM14;NUPR1;RUBCN;MTMR8;NPRL2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.4624584662633996,0.7151912125299315,0.8615384615384616,1.0,1.0,2/6,31.14%,RBX1;SASH1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.3356346732486497,-0.7150176897939301,0.8333333333333334,1.0,1.0,3/22,11.55%,MEN1;ATR;HSF1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2823711937977521,0.7148789509204542,0.9883720930232558,1.0,1.0,40/302,23.68%,FBXO48;PSMB9;UBE2U;KIF14;FBXL7;TRIM25;RNF187;HSPA5;ANKRD9;SPSB2;RPS27A;KBTBD7;FBXO5;FBXL13;FBXL3;SIAH1;KBTBD6;HERPUD1;YOD1;PSMC5;DNAJB9;PSMB6;KCTD17;PRAME;SEL1L;SYVN1;WFS1;ZFAND2A;FEM1B;RBX1;DDIT3;RMND5A;BUB1B;LTN1;CCNB1;PSMD6;PSMA3;STUB1;RNF5;AMFR
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3419035851432404,0.714811463655265,0.9230769230769231,1.0,1.0,7/48,18.23%,NOTUM;TGFB1;TGFB3;ISG15;DDR2;ATRAID;FBN2
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.4895471748006281,0.7147874549064235,0.8360655737704918,1.0,1.0,1/5,8.74%,ATP6AP1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.3561438322124697,-0.7145970924659465,0.8095238095238095,1.0,1.0,2/19,9.84%,SLC6A20;SLC7A5
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.281662475046261,0.714523442113869,0.989247311827957,1.0,1.0,21/317,12.03%,PCLAF;BLK;UBE2U;FANCF;TNFRSF1B;POLE2;DTL;POLQ;SPDYA;TICRR;CIDEB;BOK;MOAP1;RAD1;RAD54L;SUV39H1;FAAP20;WDR76;TRAIP;CCND1;HIC1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.32518834537635405,0.714454044870269,0.8823529411764706,1.0,1.0,11/65,16.81%,PTPRC;TGFB1;ADAMDEC1;ARHGDIG;B4GALNT2;CYP1B1;PLXNA3;KNG1;RASA1;TGFBI;PLG
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.27815011213184976,0.7144284371169877,1.0,1.0,1.0,52/251,19.56%,ITGB2;ITGAX;SMOC1;COL18A1;LOX;ECM2;MMP19;NID1;ITGB6;FGF2;TGFB1;ITGAM;JAM2;ADAMTS17;SCUBE3;COL4A4;ITGA2;MMP9;COL4A3;LCP1;MMP15;CYP1B1;DCN;COL4A5;MMP21;ITGA5;COL1A1;COL4A6;COL21A1;LAMC2;COL6A2;P4HA3;TGFBI;CD44;MMP11;VWF;DDR2;TLL2;MMP23B;PLG;ITGA2B;NOXO1;VTN;FN1;FBN2;WASHC1;HAPLN1;ITGB8;THBS1;A2M;ITGAD;LAMB2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.40344274003594893,0.713859916730054,0.8088235294117647,1.0,1.0,1/14,6.54%,CD81
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.3042129799480057,-0.7138005417180007,0.8636363636363636,1.0,1.0,8/46,12.67%,ACER2;SMPD4;ACER3;PNPLA1;NSMAF;PLPP2;SPTSSB;ST6GALNAC3
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4891139525059559,-0.7132913627667972,0.7727272727272727,1.0,1.0,2/5,16.74%,RTF1;LEO1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.47338259261595467,-0.713278011183825,0.8055555555555556,1.0,1.0,1/6,2.54%,GALE
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.38424177217139466,0.7131603819499608,0.8666666666666667,1.0,1.0,5/19,24.34%,FBXO5;RPL11;RPS7;RPL23;BAG2
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.4426211905829006,0.7130690262699666,0.803921568627451,1.0,1.0,4/5,40.81%,NAAA;NAPEPLD;GDE1;GDPD3
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.4426211905829006,0.7130690262699666,0.803921568627451,1.0,1.0,4/5,40.81%,NAAA;NAPEPLD;GDE1;GDPD3
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.3549155300891482,-0.7130528799510201,0.8333333333333334,1.0,1.0,4/15,18.25%,ADCY2;ADCY3;PRKAR2A;ADCY6
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.35338872906667107,-0.7125239179027787,0.7575757575757576,1.0,1.0,1/15,4.33%,AUP1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.29446022352360596,0.7122700127195623,0.8961038961038961,1.0,1.0,19/139,20.89%,CRX;STMN4;GPR179;HTR5A;NR2E3;TCEAL5;NEFM;GRM6;ROM1;VSTM2A;CNTN2;LRTM1;B3GALT2;ZNF536;ZDHHC22;RCVRN;PDC;ADAMTS5;SYT4
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.38316547938440126,0.7119035943306763,0.8484848484848485,1.0,1.0,5/22,18.84%,SCIN;RHOU;RHOG;RHOQ;PARVG
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.4699793808513052,0.7118761588510581,0.8846153846153846,1.0,1.0,1/5,13.71%,P2RY12
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.35181967365765693,0.7116771455369065,0.8571428571428571,1.0,1.0,7/23,29.63%,KCNA5;ATP1A4;KCNE3;KCNE4;ATP1A1;KCNQ1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.3733808154192802,0.7115825255748292,0.8135593220338984,1.0,1.0,2/13,11.13%,DDX3X;STAT1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3471594182998051,0.7110989395083209,0.8714285714285714,1.0,1.0,3/39,11.84%,LPAR1;FHOD1;TGFB3
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.3450396016240544,-0.7110524498095376,0.8846153846153846,1.0,1.0,4/18,19.77%,EPB41L4B;FGFR2;SNAI2;MED1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.338858956619117,-0.7108284229495078,0.967741935483871,1.0,1.0,1/19,1.79%,BCL2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.44693872488378444,0.7105721299525986,0.8596491228070176,1.0,1.0,3/7,31.15%,ATP2A2;STX17;CALM1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.2625811384172387,-0.7105608782901052,0.9666666666666667,1.0,1.0,11/97,10.93%,MFSD2A;ABCC4;ABCA4;APOE;SLC25A17;ABCA9;SLC10A3;CHKA;SCARB1;PITPNM1;SLC27A4
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.2714869812022745,0.7105163651960371,1.0,1.0,1.0,79/604,15.87%,TBX1;SMAD6;GML;CDCA7L;KIF14;S100A13;ITGAX;ACE2;FGF20;TSHR;COL18A1;SIX4;CRLF1;SPDYA;SSTR1;FGF2;CLCF1;STAT5A;FLT1;ST18;TGFB1;BOK;SCIN;GPER1;IER5;CD81;FLT4;GSDME;ERBB4;DUX4;SMIM22;RNF187;IFNK;CDKN2A;COL4A3;TBX6;MYO16;LEF1;RPS9;REST;OSMR;KANK2;SOD2;CYP1B1;IGF1;FTH1;DUSP22;IRF1;HCK;CLDN5;STAT1;LAMC2;IL7;GNRH1;TGFB3;NPR3;IGFBP6;FOXM1;CDKN1B;EPCAM;TNFSF4;CCND2;RERG;FBXO5;COX17;TFAP2E;ALOX15B;LIFR;BTG1;INCA1;CDKN1A;SOX9;TTK;HMGA1;RPS4X;SFRP4;OPRM1;WDR6;GDF9
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.29323745261340184,0.7104386054026648,0.9620253164556962,1.0,1.0,12/117,10.66%,TIMP3;C1QTNF1;AOX1;LOX;GNG12;SCARA3;UACA;OSMR;RSPO1;DCN;COL1A1;ADGRL4
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.4502905616349371,0.7103859374618726,0.8771929824561403,1.0,1.0,1/6,6.70%,CD99
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.32790086669888896,0.7102692125238866,0.918918918918919,1.0,1.0,9/62,14.84%,KIF14;ANXA1;CDKN2A;MYO16;KANK2;DDX3X;CCND1;CCND2;CDKN1A
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.36743723920306615,0.7100928955533138,0.8235294117647058,1.0,1.0,5/20,23.77%,SIX4;CSRP3;OBSCN;LMOD2;MYPN
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.24068323965316749,-0.7098959783660332,1.0,1.0,1.0,43/298,17.64%,TBC1D10A;RAB20;RASSF9;TBC1D16;STX11;CLIP3;PRICKLE1;SYNDIG1;STX6;TECPR2;POM121C;SNX8;RAB7A;NUP42;NUP214;SCFD2;TBC1D22B;ARFIP2;TBC1D2;TMED4;ANKLE1;TICAM2;STX5;SNF8;RAB5A;PREB;TBC1D8;GGA2;CHP1;RAB28;AP4S1;RANBP17;RABL2A;COG7;CAMSAP3;TBC1D9;SNX9;STXBP2;RAB22A;RAB31;AKT2;CCHCR1;STX8
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3281257719509179,-0.709580168354428,0.8333333333333334,1.0,1.0,2/22,5.97%,APOB;PLA2G5
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.3358882619795417,-0.7095677477522527,0.8157894736842105,1.0,1.0,1/21,1.59%,NDST3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.3351125939120341,-0.7092788207927773,0.9696969696969697,1.0,1.0,5/21,16.64%,NAMPT;RNLS;NAXE;PARP16;PTGIS
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.41007757161382097,-0.7091926633523196,0.813953488372093,1.0,1.0,1/5,12.34%,LPL
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.42330462519266326,0.7091479618914449,0.8548387096774194,1.0,1.0,1/8,5.87%,CTCFL
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.35032289125104,-0.7089764862946465,0.7647058823529411,1.0,1.0,8/22,29.22%,SNF8;MVB12A;UBAP1L;TSG101;UBAP1;MVB12B;PLAA;PTPN23
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.33363197675800466,0.708975215525036,0.875,1.0,1.0,8/47,19.13%,PTPRC;PELI3;TRAIP;OTUD4;ISG15;USP18;PARP14;F2RL1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.3524626625390296,0.7086047573062388,0.9253731343283582,1.0,1.0,2/33,11.79%,TENT5B;MEIOC
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.34457465411745275,-0.7085006738700961,0.8108108108108109,1.0,1.0,3/18,13.16%,CTC1;STN1;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2769738154874469,-0.7084179330615861,1.0,1.0,1.0,12/78,17.75%,TRIB2;PRICKLE1;TRIB1;NKD2;DAB2IP;NUPR1;BAG6;CSNK1E;HSPBP1;FBXO22;OSBPL7;SUMO2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.3263949994184187,0.7083387083567163,0.8918918918918919,1.0,1.0,12/40,22.73%,IL12A;IL27;HLA-A;CD244;TNFSF4;HLA-DPB1;ISG15;CRTAM;F2RL1;RASGRP1;HLA-DPA1;ZFPM1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.4173362525523386,-0.7083051424280886,0.7777777777777778,1.0,1.0,3/10,7.20%,WNT3A;WNT7A;PCM1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.33132498640052327,0.7082349837718103,0.9078947368421053,1.0,1.0,1/42,0.46%,RASGRP4
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.31599749260553706,0.708163445302862,0.8933333333333333,1.0,1.0,11/76,12.47%,TBX1;SIX4;FGF2;TGFB1;FUT2;NODAL;IGF1;MCC;MARVELD3;IL26;NLRC3
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.42545888386161823,-0.7081102655196315,0.875,1.0,1.0,1/9,0.22%,NOX4
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),0.40359005917386825,0.7080419933635876,0.8461538461538461,1.0,1.0,4/15,31.13%,SYK;CD27;PPP2R3C;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.411430928390338,-0.707988695215777,0.8125,1.0,1.0,1/5,7.37%,CAP2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.31087650844278275,0.70778694852897,0.975,1.0,1.0,13/77,16.13%,KIF14;FGF20;SIX4;CRLF1;CLCF1;PINK1;SOD2;PPT1;TGFB3;CDK5R1;FOXB1;RASA1;SET
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.36817889031791157,0.7077569207370025,0.8529411764705882,1.0,1.0,5/20,33.75%,MPV17L2;TRUB2;COA3;MTG1;SHMT2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.36321403510295097,0.7076160774928084,0.8405797101449275,1.0,1.0,4/24,14.93%,ACTG1;SOX10;FLG2;SOX9
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.36222092838343417,0.7073416525223186,0.9014084507042254,1.0,1.0,8/30,28.33%,PLD4;NLRC3;ADCY7;NOS2;APOD;ALOX5;HIF1A;NLRP7
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.44764802020190764,-0.707118293344828,0.7954545454545454,1.0,1.0,2/7,12.27%,RAB7A;SERPINB9
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.33651808875032574,0.7071048353408437,0.855072463768116,1.0,1.0,8/29,29.35%,CHCHD4;TOMM20;TIMM17A;ROMO1;PAM16;TIMM21;PEX12;DNAJC19
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.34169800285826074,-0.7070341680996254,0.9032258064516129,1.0,1.0,9/24,28.12%,AGRN;FSCN1;NEURL1;MIEN1;PALM;NLGN1;BCAS3;DOCK11;TENM2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.37799103118662436,-0.7069439405849259,0.7714285714285715,1.0,1.0,2/10,16.27%,DGCR8;PUS10
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.2664354278541967,-0.7068539137538727,0.9565217391304348,1.0,1.0,11/67,14.07%,DDX41;CD14;IFI16;IRF5;POLR3D;LRRFIP1;POLR3E;RIPK2;POLR2F;POLR3K;POLR3A
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.4456616660729587,0.7067830999285845,0.8769230769230769,1.0,1.0,2/9,15.05%,OGFOD1;P4HA3
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.44737563936487135,0.7067453914147558,0.8307692307692308,1.0,1.0,1/7,13.89%,TEKT5
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.30383983509256063,0.7067347477450965,0.948051948051948,1.0,1.0,12/94,14.93%,AHR;TSHR;P2RY6;SLC26A6;RRAGA;HTR1B;GLRA2;NR1H4;CRHBP;GLRA1;P2RY12;SOX9
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.3937047212848509,0.7065904201157324,0.8,1.0,1.0,6/14,39.06%,RHOQ;IMPDH2;RAB23;GNAI3;RAN;OPA1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.2980703627457133,-0.7061824670779573,0.8,1.0,1.0,3/25,6.87%,NR4A3;CLIP3;CAPN10
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.39470697419258527,-0.7051863804938151,0.8461538461538461,1.0,1.0,2/8,12.98%,MEFV;CMKLR1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.4592659885067664,0.7050725980738826,0.8571428571428571,1.0,1.0,2/6,37.34%,NOS1AP;TXN
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.4144654502619861,-0.7047719163463971,0.8372093023255814,1.0,1.0,4/7,14.45%,CTCF;MECP2;DNMT3A;KDM1B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.31431825862304025,0.7047381201124033,0.9294117647058824,1.0,1.0,9/59,23.69%,TMEM35A;TGFB1;NDC80;ORMDL3;GPR137B;PDZK1;PARK7;GNL3;PARP9
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.2716416768527862,-0.7045183103295521,1.0,1.0,1.0,13/111,11.55%,MT1G;SYT12;FOS;CPNE6;SYT17;PKD2;AQP1;HPCA;CARF;AKR1C3;HFE;NEUROD2;HSF1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.34482214779167397,0.7043400575793132,0.810126582278481,1.0,1.0,4/31,16.41%,SEMA3A;SEMA3B;SEMA3F;LRTM1
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.45725593374405377,0.7039545758638476,0.8360655737704918,1.0,1.0,2/5,17.95%,OPRM1;OPRL1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.49064004396786887,0.7039390038836841,0.8421052631578947,1.0,1.0,2/5,31.64%,DNAJB2;SGTB
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.37830155024308376,-0.7038455577276009,0.8108108108108109,1.0,1.0,4/14,14.96%,TRPC3;VGF;AKR1C1;RFC3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3781481115911253,0.7038302141735612,0.8695652173913043,1.0,1.0,5/21,16.39%,CDKN2A;CDKN1B;INCA1;CDKN1A;LATS2
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.39105096937740175,-0.7034659871132933,0.8571428571428571,1.0,1.0,1/7,22.82%,NMD3
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.3542735639128109,0.7034340157645771,0.8382352941176471,1.0,1.0,5/31,17.72%,KIF14;CXCR5;ECT2;CDC14A;HTR2B
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.3011781360161322,0.7032424766642404,0.9390243902439024,1.0,1.0,19/93,28.81%,MRPS34;MRPL34;MRPL20;EEF1A1;MRPL50;GADD45GIP1;MRPL54;EEF2;GFM2;MRPS2;LTN1;MRPL19;MRPL28;MRPL40;MRPL10;MRPL14;EEF1B2;MRPL44;MRPL37
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3072256440640245,0.7030370814190184,0.9358974358974359,1.0,1.0,5/67,14.76%,DDX20;RANBP6;GEMIN4;SYK;SNRPD2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.3021771918510356,0.7030153759349856,0.9404761904761905,1.0,1.0,18/102,18.08%,CCDC60;VWA3B;FAM81B;CFAP126;MAP3K19;MYO16;ANGPTL2;ZMYND10;AKAP14;AQP4;DRC3;MORN5;USP18;DNAI1;MYB;GFAP;BPIFB1;HSPA2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.340178884635305,0.7030117013035847,0.9393939393939394,1.0,1.0,6/38,12.54%,SP100;TGFB1;MMP9;LEF1;IGF1;PLAUR
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.3587614286126075,-0.7029710745336388,0.9,1.0,1.0,4/12,31.41%,SSRP1;METTL4;TLK2;SETD1A
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.3829485174903886,-0.7028225286282707,0.868421052631579,1.0,1.0,2/8,15.20%,OTUD3;OTUD7A
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3142400635590123,0.7028028838825491,0.9367088607594937,1.0,1.0,6/67,11.84%,LPAR1;ACTG1;WAS;ARHGAP28;FHOD1;TGFB3
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.44596312167448626,-0.7024974692429345,0.868421052631579,1.0,1.0,2/6,17.62%,CDK1;NF1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.4801032571323711,-0.7024389935690047,0.90625,1.0,1.0,4/5,39.49%,NCSTN;ADAM10;PSEN1;APH1B
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.30681860879537787,-0.702230529892308,1.0,1.0,1.0,7/27,20.21%,SKA1;GAS2L2;MAPRE1;CAMSAP3;ABL1;MAPT;GBA2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2961428779572126,-0.702060412688782,0.9166666666666666,1.0,1.0,10/45,20.85%,FLNA;CUX1;CRK;LIMS1;CRKL;CSPG5;ABL1;CUX2;S100A10;CUL7
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.4334968208284679,0.7019996459697312,0.8032786885245902,1.0,1.0,1/9,3.00%,IYD
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.35296036205995074,-0.7012605602588403,0.8888888888888888,1.0,1.0,5/15,18.09%,HSPB1;MAPK7;NME5;PPIA;HTRA2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.32399249870083663,-0.7010432078265108,0.8,1.0,1.0,4/15,19.38%,POP1;DTD1;THG1L;ADAT1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.27233387169685264,0.701028684144929,1.0,1.0,1.0,60/464,16.01%,TBX1;SMAD6;GML;TLR2;SP100;TNFRSF1B;COL18A1;TP53TG5;SSTR1;FGF2;ST18;TGFB1;ADAMDEC1;SCIN;CRLF3;GPER1;JAM2;GSDME;ERBB4;DUX4;IFNK;ARHGDIG;CDKN2A;COL4A3;MYO16;EI24;REST;TDRD9;KANK2;SOD2;CYP1B1;FTH1;GNG4;IRF1;PPT1;TP53BP2;DDX3X;RHOB;GNRH1;TGFB3;PLXNA3;IGFBP6;FOXM1;CDKN1B;LRPAP1;RERG;FBXO5;ALOX15B;KNG1;BTG1;INCA1;CDKN1A;CCDC85B;RASA1;HMGA1;SFRP4;OPRM1;TGFBI;WDR6;TXNIP
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.44122204894244416,-0.7009806958464245,0.8333333333333334,1.0,1.0,2/5,11.48%,PACSIN2;EMP2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3268949920694372,-0.700914030046658,0.8620689655172413,1.0,1.0,5/33,11.31%,THEM4;MLYCD;ACOT1;OGDH;ACOT9
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.33925081179152383,0.7009112571720044,0.9393939393939394,1.0,1.0,2/31,7.62%,DEPDC5;DDIT4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.31940050134126874,-0.7008080565610435,1.0,1.0,1.0,10/64,14.65%,EYA4;BCL2;CFLAR;SH3RF1;ACVR1;SERPINE1;TERT;GPX1;MAPK7;SNAI2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.4732620879039249,0.7007874332061428,0.828125,1.0,1.0,3/5,31.20%,ZNF473;CPSF2;LSM11
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.388928710436526,-0.7006187519306205,0.8064516129032258,1.0,1.0,2/9,6.45%,TST;GLYATL2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.36642967040929136,0.7005172703987532,0.8666666666666667,1.0,1.0,3/27,16.53%,SEMA3A;IGSF10;ADGRG1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.2967375888610473,-0.7005079336984271,0.9629629629629629,1.0,1.0,12/48,17.98%,PRAG1;ERBB2;IGBP1;TGFBR3;ETS1;ZSWIM5;CDK6;RHOA;CD9;ABL1;NRG2;BTC
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.4450239919337832,0.7004698251359275,0.9016393442622951,1.0,1.0,3/8,20.02%,C17ORF99;GPR183;MSH6
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.40423232177839113,-0.7004002483059143,0.7708333333333334,1.0,1.0,2/7,18.70%,GTF2H2;MSH3
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.3162644103623994,-0.699939607398573,0.8611111111111112,1.0,1.0,1/19,5.69%,JADE2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.2739865893826844,-0.6998992647512425,0.9230769230769231,1.0,1.0,19/108,13.92%,KCNIP3;SHC3;TBC1D16;TYRO3;SDC3;PTPRF;KIAA1549L;CAP2;SRRM3;GNA11;NLGN2;NCS1;DAB2IP;NAV2;ALCAM;ANTXR1;GPC1;CAMK2N1;AMOTL2
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.45073931435570175,-0.6998862942663552,0.7894736842105263,1.0,1.0,4/5,33.39%,NFKB1;HRAS;RC3H1;RC3H2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.28184710652296924,0.6996401906152504,0.9666666666666667,1.0,1.0,18/215,12.08%,RAB34;DISC1;TLR2;PDE6H;PTPRC;C3;SCIMP;MESP1;GPER1;P2RY6;F7;RSPO1;IGF1;ITGA5;AXL;CD80;IL7;CD63
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.4185706079000786,-0.6993760505406534,0.717948717948718,1.0,1.0,1/6,7.26%,EGLN3
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.34013919059982956,0.6993532383761154,0.9285714285714286,1.0,1.0,11/43,24.33%,PINK1;RSPO1;CYP1B1;EIF6;FOXM1;PDK4;STK17A;PM20D2;PANK2;STUB1;BCO2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.43204681654320093,0.6992362430732856,0.8591549295774648,1.0,1.0,3/9,24.51%,ATRAID;ANXA2;EFNA1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.3933482345368844,0.6990098722080434,0.8939393939393939,1.0,1.0,2/15,14.84%,LEF1;CDKN1A
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.3417489837993929,0.6989819909673388,0.8589743589743589,1.0,1.0,1/40,1.96%,SLFN14
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.3580926557012293,0.698868356894634,0.8732394366197183,1.0,1.0,2/22,16.42%,CAV3;MSN
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.2722649861669257,0.6988608092134911,1.0,1.0,1.0,46/303,16.94%,SMAD6;GML;WNT5A;COL18A1;SSTR1;ST18;TGFB1;IL12A;SCIN;GPER1;GSDME;OGN;ERBB4;DUX4;IFNK;CDKN2A;NODAL;COL4A3;MYO16;REST;KANK2;SOD2;CYP1B1;FTH1;IRF1;MCC;MARVELD3;IL26;GNRH1;TGFB3;NLRC3;IGFBP6;CDKN1B;RERG;ALOX15B;BTG1;INCA1;CDKN1A;SOX9;HMGA1;SFRP4;OPRM1;WDR6;ADGRG1;PLG;ATRAID
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.3349968935678453,0.6988360756684381,0.8933333333333333,1.0,1.0,4/44,15.81%,POLQ;POLD4;RPA3;TDG
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3002641289670577,0.6987975908383656,0.9873417721518988,1.0,1.0,9/113,12.59%,SMAD6;TMEM100;TGFB1;NODAL;ID1;DUSP22;CLDN5;TGFB3;RPS27A
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.47143846474108303,0.6982188646738571,0.8636363636363636,1.0,1.0,1/5,6.85%,RFK
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.47143846474108303,0.6982188646738571,0.8636363636363636,1.0,1.0,1/5,6.85%,RFK
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.3078755625878347,0.6982057806502511,0.927536231884058,1.0,1.0,14/64,19.13%,AQP3;TCN1;PLEKHG6;TMEM45B;ANGPTL4;TRIM29;TJP3;AP1M2;SPINT1;LY6D;CYP24A1;RDH12;SERPINB5;F2RL1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.27108311662144746,-0.6981682011859752,1.0,1.0,1.0,18/90,14.21%,RASSF2;DUSP15;SH3RF1;FZD7;MAP3K10;WNT7A;MEN1;CCN2;SH3RF3;HDAC3;DAB2IP;TGFBR3;TAOK2;FKTN;DUSP19;CARD9;TRAF3;SDCBP
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.36941357838855315,-0.6981624925399387,0.8387096774193549,1.0,1.0,6/13,23.38%,SYNDIG1;RAB27A;CDK5;DNM2;KIF5C;NLGN1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.3897526275821849,0.6980991521130497,0.8985507246376812,1.0,1.0,6/13,29.83%,MAPK3;ITK;AATK;DDR1;BMX;TEC
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.3649362192571879,0.6980740016492922,0.90625,1.0,1.0,5/27,17.38%,TCF7;IL7;ZAP70;IL4;CRTAM
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.2872713004284633,-0.6979796825329031,0.9285714285714286,1.0,1.0,13/50,18.70%,H1-4;PARPBP;RADX;ZSCAN4;POLR2F;POLR2C;SMCHD1;SHLD2;SHLD1;RTEL1;MAD2L2;FBH1;MSH3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3750192369344256,-0.697625529776391,0.7741935483870968,1.0,1.0,2/11,11.31%,CREB3L1;ATF3
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.39068435723187867,0.6976043240136237,0.890625,1.0,1.0,2/17,13.38%,RAB11A;TOR1A
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.3300967288701291,0.6975606065380138,0.8840579710144928,1.0,1.0,8/29,25.68%,LIX1;CHMP3;LAMP2;GABARAPL2;ATP2A2;VAMP7;STX17;GABARAPL1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.30474241123627743,0.6972667749071723,0.9736842105263158,1.0,1.0,8/114,6.51%,MCUB;CCL5;STOML2;VAPB;TRPC7;CASR;GPER1;CAV3
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4043910006666578,0.6970363688968211,0.8676470588235294,1.0,1.0,2/11,15.20%,IGF2BP2;RASA1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.38856965067074617,0.6969412166273531,0.8194444444444444,1.0,1.0,6/19,25.26%,LY6H;CDK5R1;CHRNB2;RGS10;CHRNA3;CHRM5
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.3090835534846855,0.6962604279133359,0.9848484848484849,1.0,1.0,4/103,6.42%,PLA2G10;PIK3R3;FGF2;IMPA1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.31972305818599517,0.6962266475355515,0.8961038961038961,1.0,1.0,8/74,13.87%,TNFRSF1B;ASB5;WNT5A;DTL;C4BPA;C4BPB;CDKN1B;OAZ2
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 cell differentiation (GO:2000320),0.4560051650592355,0.6957434725290328,0.8448275862068966,1.0,1.0,1/6,17.19%,IL4
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.38334758185574136,-0.6953997195174328,0.7804878048780488,1.0,1.0,3/11,15.25%,MACROH2A2;TERT;PIH1D1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.27462768478416255,-0.6950823078987144,1.0,1.0,1.0,13/104,13.51%,ATP6V0D2;EXOC7;USP36;QSOX1;CLEC16A;ERN1;ATP6V1E2;LZTS1;SNX32;ATP6V0A2;SNX5;MTMR8;EPM2A
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.4203020772834867,-0.6950650270962975,0.75,1.0,1.0,2/5,29.22%,ROBO2;GAP43
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3896518489241931,0.6949157047617956,0.9166666666666666,1.0,1.0,1/18,3.62%,CD160
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.28747030093398174,-0.6945134257119747,0.9375,1.0,1.0,10/71,16.74%,CPSF1;MAGOHB;SRRM1;SRSF4;SYMPK;U2AF2;CSTF2;CPSF7;PCF11;LEO1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3071549170408271,0.6943843349093921,0.9625,1.0,1.0,6/98,9.25%,CCL5;TRPV6;NMUR2;TRPC7;CASR;RAMP3
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.2879284968286595,0.6942976062196069,1.0,1.0,1.0,24/114,29.75%,PSMB9;ZFP69;NQO1;PSAP;OAZ2;TNFAIP8L3;FDFT1;SCD;PSMC5;AZIN1;PSMB6;NFYB;PSMD6;PSMA3;PRKAB2;PSMA7;SQLE;FASN;HMGCR;PLPP1;GPS2;PSMB1;FGFR4;HMGCS1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2912957066666231,0.6936240109870303,0.9733333333333334,1.0,1.0,16/112,20.58%,HSPA1L;HSPA8;MANF;DNAJB1;PINK1;CRHBP;RPA3;OPRM1;SLC38A2;CHCHD2;FKBP4;MAPK3;BAG1;HSPH1;BAG5;RAE1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.400720149825806,0.6934559816133615,0.8656716417910447,1.0,1.0,2/11,18.23%,DAND5;FBN2
prerank,GO_Biological_Process_2021__negative regulation of T-helper 17 type immune response (GO:2000317),0.4607992954406256,0.6931612464532042,0.8392857142857143,1.0,1.0,1/5,17.19%,IL4
prerank,GO_Biological_Process_2021__epithelial tube branching involved in lung morphogenesis (GO:0060441),0.4621501647095913,0.6931468795094665,0.9142857142857143,1.0,1.0,1/5,14.36%,CELSR1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.43929831179771833,0.6930349594871392,0.9032258064516129,1.0,1.0,2/9,4.86%,PLA2G10;C3
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.3912053954297732,-0.693004029530217,0.7631578947368421,1.0,1.0,2/8,14.17%,EARS2;WARS2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.33108038822367003,0.6929529543877836,0.8888888888888888,1.0,1.0,2/29,18.26%,GPER1;AGER
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.4313160925767017,0.6929035910597913,0.85,1.0,1.0,1/7,10.99%,DDX3X
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.25660299785417545,-0.6928609623341871,1.0,1.0,1.0,19/51,28.49%,DCPS;LSM7;CNOT9;EXOSC1;SAMD4B;DCP1B;TNKS1BP1;LSM2;PARN;DCP1A;LSM6;TUT7;SAMD4A;CNOT10;CNOT6;CNOT3;PATL1;DIS3;RC3H1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.29523742911815587,-0.6927202425076762,0.9473684210526315,1.0,1.0,5/42,13.07%,CELF5;TXNL4A;LUC7L;CELF4;SF3A2
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.3933412836389772,0.692707011550891,0.8412698412698413,1.0,1.0,5/11,23.73%,ALDH9A1;BBOX1;CRAT;TMLHE;ACADL
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.35805222418575083,-0.6927069668665128,0.8108108108108109,1.0,1.0,5/11,19.91%,TAS2R8;RTP1;AZGP1;CA6;TAS2R5
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.3949320890511728,0.6926343461046168,0.8095238095238095,1.0,1.0,3/10,18.19%,PIK3CG;PLN;SPX
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.35399518280326636,0.6924952964844914,0.8596491228070176,1.0,1.0,3/16,12.47%,DDX3X;STAT1;NLRC3
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.3069646139250091,-0.6923366642611438,1.0,1.0,1.0,7/34,15.68%,SYT12;RAB3D;SYT17;RAB5A;RAB27A;SYT3;SYN1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.39440597315176606,-0.6918617716378164,0.7619047619047619,1.0,1.0,6/6,60.57%,UXT;LRPPRC;MAP1S;RHOT1;RHOT2;UBB
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3017907203154092,-0.6918320445142021,0.8857142857142857,1.0,1.0,7/26,23.89%,LSM10;SNRPB;EXOSC10;ATM;SNRPF;CPSF3;TUT7
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.3876898871278113,-0.6918159129628645,0.8571428571428571,1.0,1.0,4/8,30.74%,KDM1B;KDM5C;KDM5A;KDM5D
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.44674743710570736,0.6916844248358693,0.875,1.0,1.0,1/7,4.59%,RP1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.30146517849460425,0.6915364626774749,0.9571428571428572,1.0,1.0,10/68,19.49%,ATP6V1G2;DEPDC5;RRAGA;ATP6V0E2;WDR24;CDKN1A;MAPK3;LAMTOR3;ATP6V1D;ATP6V0B
prerank,GO_Biological_Process_2021__negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-0.41066798055351245,-0.6914583874416268,0.7647058823529411,1.0,1.0,2/5,13.82%,MEFV;NLRP2B
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.3082312147699223,-0.6914341098849219,0.9545454545454546,1.0,1.0,8/32,23.09%,APOE;GSAP;BIN1;LRRTM3;ABCG1;NTRK2;SLC2A13;CASP3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3512915669886508,0.6912050771537849,0.9384615384615385,1.0,1.0,6/23,26.52%,RPS27A;TIFA;CYLD;IFIH1;IRAK1;CASP8
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.4225643253387907,0.69116303608083,0.8840579710144928,1.0,1.0,2/9,17.35%,TAF7;TAF7L
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3507877525174972,0.6908278570318159,0.9054054054054054,1.0,1.0,3/26,15.88%,ANXA1;PIF1;RECQL4
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.40848561308312903,0.6908152040024601,0.8591549295774648,1.0,1.0,3/15,25.82%,PIGH;PIGC;PIGB
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3599040359091437,-0.6904733945712739,0.8235294117647058,1.0,1.0,12/12,64.03%,ANAPC7;ANAPC4;CDC16;NSMCE2;RB1;ANAPC11;CDC23;CUL3;ANAPC5;CDC27;ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3599040359091437,-0.6904733945712739,0.8235294117647058,1.0,1.0,12/12,64.03%,ANAPC7;ANAPC4;CDC16;NSMCE2;RB1;ANAPC11;CDC23;CUL3;ANAPC5;CDC27;ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3599040359091437,-0.6904733945712739,0.8235294117647058,1.0,1.0,12/12,64.03%,ANAPC7;ANAPC4;CDC16;NSMCE2;RB1;ANAPC11;CDC23;CUL3;ANAPC5;CDC27;ESPL1;DLGAP5
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3169247401215206,0.6903008727341913,0.9358974358974359,1.0,1.0,2/68,6.19%,NEK2;MISP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.38126115321294035,-0.69022726682739,0.8285714285714286,1.0,1.0,1/7,8.05%,FSCN1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.3359627189328538,-0.6901353404014998,0.7948717948717948,1.0,1.0,8/27,15.23%,APOH;VASH1;APOE;PTPRR;DAB2IP;SLIT2;EVL;ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.27041313842507897,0.6898992126576436,1.0,1.0,1.0,42/290,20.40%,RHOXF2;C1QTNF1;TLR2;ITGAX;WNT5A;PIK3R3;FGF20;VSIR;FGF2;ACTG1;HEY2;TGFB1;CTCFL;GPER1;ACTA2;LEF1;RAMP3;IGF1;CLDN5;DDX3X;CD63;VSTM2A;SOX9;SFRP4;MSN;SLC38A2;HEY1;ZNF580;IL4;MAPK3;RPL11;RPS7;WNT6;FN1;ANXA2;ALOX12B;ITGB8;CSF1;HCFC1;HMGA2;MAP2K1;WFS1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.27685701636404403,-0.6897857595593851,1.0,1.0,1.0,3/64,4.12%,ATP6V0D2;FOXO1;SH2B2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.339081170925196,0.6895893982146262,0.8831168831168831,1.0,1.0,5/28,22.53%,MISP;NDC80;GPSM2;DYNLT1;DCTN1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2682407972348779,0.6892835125196243,1.0,1.0,1.0,54/322,28.44%,PSMB9;UBE2U;KIF14;DTL;UBE2L6;FBXL7;ARIH2;TRIM25;RNF187;PINK1;ANKRD9;SPSB2;KBTBD7;SIAH1;KBTBD6;HERPUD1;PSMC5;UBL7;PSMB6;KCTD17;PRAME;SYVN1;ZFAND2A;FEM1B;RBX1;DDIT3;RMND5A;BUB1B;PSMD6;PSMA3;STUB1;RNF5;AMFR;RNF144B;PSMA7;TNFAIP1;SPSB3;KCTD10;RNF20;UBA6;FBXO7;SPSB4;BUB3;RNF6;KLHL15;FEM1C;KAT5;FBXO10;KLHL8;CBLC;TOM1L1;RNF213;AURKA;RAD23B
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.4257116529618064,-0.6891768418184567,0.9696969696969697,1.0,1.0,3/6,37.13%,NUAK1;ROCK1;NCKAP1L
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.32383504902841237,0.6890238456299276,0.9130434782608695,1.0,1.0,10/46,24.22%,H1-0;GRWD1;NAP1L2;SOX9;H2BC18;HMGA2;POLE3;M1AP;CHAF1A;PAF1
prerank,GO_Biological_Process_2021__skeletal muscle cell differentiation (GO:0035914),-0.4287727158473331,-0.6890177806759504,0.8333333333333334,1.0,1.0,2/5,6.12%,KLHL41;MEGF10
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.38838118124920396,-0.6889525876335014,0.7804878048780488,1.0,1.0,4/8,11.70%,TTBK1;HES1;SERPINE2;BIN1
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.4057214075804635,0.6887215384694373,0.8923076923076924,1.0,1.0,1/9,6.28%,MESP1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.2955974221934739,-0.6886226561654831,1.0,1.0,1.0,6/49,8.92%,EMP1;LAMA3;STS;DCT;CRABP2;CCN2
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.38919980865413445,0.6884652877638824,0.9047619047619048,1.0,1.0,1/15,4.64%,FGF2
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.3114627377810781,0.6883752132438333,0.9342105263157895,1.0,1.0,9/61,16.56%,PTPRC;HIPK1;AXL;STAT1;IL7;SYK;LIFR;CYLD;USP18
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.35147455802001104,0.6883384382130147,0.8867924528301887,1.0,1.0,3/18,9.14%,FUT2;MPDU1;B4GALNT2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.3886419704442009,-0.6879675421587378,1.0,1.0,1.0,3/14,10.27%,SERPINE1;SERPINE2;CHAC1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.36124940810150086,-0.6875728889567915,0.868421052631579,1.0,1.0,5/10,19.91%,TAS2R8;RTP1;AZGP1;CA6;TAS2R5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.3674735655496342,0.6875581196109478,0.9154929577464789,1.0,1.0,3/21,12.72%,NLRP12;IGF1;SERPINB1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.27423443083633553,-0.6875536417200945,1.0,1.0,1.0,5/76,5.43%,MT1G;CCDC22;ACO1;FLVCR1;SLC30A10
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.3085446300288154,-0.6875500344714227,0.896551724137931,1.0,1.0,5/28,10.71%,PAQR7;CATSPERG;MGARP;CATSPER4;CATSPER2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2920281208451221,-0.6873572603278633,0.9310344827586207,1.0,1.0,9/21,27.05%,CNOT9;SAMD4B;TNKS1BP1;PARN;TUT7;SAMD4A;CNOT10;CNOT6;CNOT3
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.38426519712270923,0.6872447224846945,0.828125,1.0,1.0,7/14,34.83%,RAET1G;VAMP7;TUBB4B;TUBB;ULBP3;CLEC2A;CEBPG
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.3919599788879548,0.6872313337198959,0.8873239436619719,1.0,1.0,1/11,2.42%,ABCC6
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.34092700856971897,-0.6870214403806909,0.8048780487804879,1.0,1.0,1/14,2.60%,TBC1D16
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.298261572674587,0.6865582053858427,0.9714285714285714,1.0,1.0,10/69,19.49%,ATP6V1G2;DEPDC5;RRAGA;ATP6V0E2;WDR24;CDKN1A;MAPK3;LAMTOR3;ATP6V1D;ATP6V0B
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.2633962180446097,-0.6862640796171422,1.0,1.0,1.0,8/64,8.50%,PC;PDZD11;MTHFR;PRSS3;MTHFD1L;DHFR;FLAD1;FPGS
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.26844412019727804,0.6861783870695902,0.9891304347826086,1.0,1.0,41/381,16.07%,ACTL6A;LPAR1;WNT8B;ROGDI;GFRAL;FGF2;IRF2BPL;NMUR2;SOX10;MOBP;TGFB1;SCIN;MESP1;JRKL;LY6H;SCRG1;ERBB4;PRDM12;IGF2BP2;TBX6;SPINK6;GDF11;NDUFS2;PCDHB5;AXL;PPT1;GFRA1;EMX1;ECT2;SDCBP2;B3GNT5;ZIC1;NPAS1;UGT8;CELSR1;NHLH1;PCDHB10;CLN8;SIAH1;NAB1;THOC6
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.3593125688491542,0.6860234118398653,0.9104477611940298,1.0,1.0,5/24,21.78%,OGFOD1;FKBP4;FKBP5;PPIC;PPID
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.4222392562706801,0.6857952268220348,0.8382352941176471,1.0,1.0,1/9,3.91%,SLC38A3
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.42201539873764604,0.6856713969677763,0.8636363636363636,1.0,1.0,2/9,19.68%,GGCT;CHAC2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.30555404628077776,0.6856699392661941,0.9459459459459459,1.0,1.0,11/84,24.54%,PSMB9;CDKN1B;FBXO5;CDKN1A;PSMC5;PSMB6;BUB1B;CCNB1;PSMD6;PSMA3;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.31642558064511866,0.6856552505246728,0.9382716049382716,1.0,1.0,9/59,17.72%,WNT5A;FGF2;STAT5A;FLT4;AGGF1;MYDGF;VASH2;ZNF580;HTR2B
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.34397046409647447,0.6856547459886511,0.8714285714285714,1.0,1.0,2/27,11.81%,RAB11A;CHMP3
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.2914827151278881,0.6856340625605647,1.0,1.0,1.0,8/118,12.35%,ST6GALNAC1;GALNTL5;FUT2;B3GNT9;C1GALT1C1;B4GAT1;TMEM258;B3GNT5
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.3426178761741422,0.6854775407295619,0.9384615384615385,1.0,1.0,3/38,6.32%,BANF2;H1-0;GPER1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.385194378804038,-0.6854526308298665,0.8205128205128205,1.0,1.0,2/11,8.48%,TRIM35;TRIM8
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.27867083254548103,-0.6849996427867409,0.9285714285714286,1.0,1.0,8/25,24.91%,RAD50;RTEL1;ERCC1;PML;NBN;SMG5;DHX36;SMG6
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.43477183246998513,0.6848104329952832,0.847457627118644,1.0,1.0,2/5,24.46%,SFRP4;ZFP36
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.34973661234199355,0.6847941706698416,0.9452054794520548,1.0,1.0,2/25,6.20%,FGF2;CCDC39
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.36860506158441636,0.6847647236712388,0.9324324324324325,1.0,1.0,2/18,8.30%,MCMDC2;MCM3
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.2885216735760723,0.6847304602466309,0.9647058823529412,1.0,1.0,5/93,11.84%,LRP4;TGFB1;DAB2;SYK;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.36199871538977396,-0.6847208642822387,0.8484848484848485,1.0,1.0,2/13,5.97%,APOB;PLA2G5
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.3104604267693684,0.6847179357454204,0.9746835443037974,1.0,1.0,12/73,14.93%,CAPN13;ACE2;SCTR;ITGB6;MISP;SMIM22;TMC4;TJP3;EPCAM;AP1M2;AQP4;SOX9
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.3159887223511756,-0.6844235129952453,0.8529411764705882,1.0,1.0,1/14,3.90%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.29453061237836214,-0.6843337556390224,0.9210526315789473,1.0,1.0,12/35,22.16%,ZNF703;ASS1;MAPK7;MIA3;MAD2L2;NOTCH1;JAG1;SPINT2;AKNA;NOTCH4;PODXL;ADTRP
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.294948899827344,0.6843281437761447,0.9761904761904762,1.0,1.0,12/123,14.59%,MAPKAPK3;TIMP3;ANXA1;SP100;NLRP12;LEF1;OSMR;STAT1;GGT5;LDLRAP1;LIFR;ISG15
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.3593789140921289,0.6841248257953134,0.9016393442622951,1.0,1.0,1/17,4.45%,SYT2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.29673977392211587,0.6840160312568137,1.0,1.0,1.0,18/86,21.70%,TNFRSF1B;CIDEB;BOK;MOAP1;CYP1B1;TP53BP2;DDX3X;HIC1;IFI6;ERN2;CDKN1A;BBC3;HINT1;ZNF622;MSH6;APAF1;DDIT3;BRCA1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.42990161079797,0.683808406312476,0.9178082191780822,1.0,1.0,1/9,7.33%,KLF15
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.44791331832666975,0.6837246851735563,0.9473684210526315,1.0,1.0,2/5,19.31%,P2RY12;CSF1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.4590092832310052,0.6836999923852178,0.7966101694915254,1.0,1.0,3/6,21.37%,TRDN;PLN;ATP2A2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.36611395473698605,0.683544669162074,0.90625,1.0,1.0,3/14,24.22%,CTCFL;FAM47E;PAF1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.440889748549323,-0.6832273178181809,0.8918918918918919,1.0,1.0,5/5,55.92%,AK3;ENTPD4;AK5;DHODH;CMPK1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.2714396729173379,-0.6832127093315712,0.9655172413793104,1.0,1.0,8/60,12.76%,PNPLA3;VGF;ACOX3;PNPLA1;WNK2;SLC4A11;KLHL3;TLCD2
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.42699919553217797,0.6830566658337232,0.8484848484848485,1.0,1.0,4/7,18.33%,ALOX12;ALOX15B;ALOX15;ALOX5AP
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.38220048759255815,-0.682583197905044,0.8421052631578947,1.0,1.0,1/5,11.87%,RIPK2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.36761226247975526,0.6825010306783712,0.9054054054054054,1.0,1.0,3/13,28.65%,NPY;LHX6;HSP90AB1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3477769450369951,-0.6824685998922639,0.7931034482758621,1.0,1.0,6/23,16.31%,RHEBL1;EIF4EBP1;SYAP1;CCDC88A;MLST8;MEAK7
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.4171749291890275,-0.6823648319086951,0.8333333333333334,1.0,1.0,1/7,5.57%,MRRF
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.28647045249077036,0.6822129917153127,0.9866666666666667,1.0,1.0,18/146,13.40%,TNFRSF1B;TSHR;FCGR3A;GPR27;SCTR;GPER1;NLRP12;GPHB5;RAMP3;ADRB1;IGF1;HCK;RXFP2;NR1H4;SYK;NLRC3;RPS19;GGT5
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.25755635654771963,-0.6814184951022116,1.0,1.0,1.0,20/111,15.18%,CELF5;CASKIN1;SLC17A6;ELAVL3;ABCC8;LHFPL4;PRR36;TTBK1;MSI1;SNCB;KCNJ6;HPCA;KCNB2;NEUROD6;ADGRA1;CELF4;JPH3;ERC2;CDH22;LINGO1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.37531717880603477,0.6813940158117995,0.8846153846153846,1.0,1.0,1/12,4.99%,HEY2
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.37294620173709797,0.6811610041161145,0.9166666666666666,1.0,1.0,3/14,15.65%,TMEM204;LRIT3;SFRP4
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.3438048715273034,0.6805179665330661,0.8840579710144928,1.0,1.0,5/27,19.13%,MARVELD2;RAPGEF6;TJP3;MSN;F2RL1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.3708405237545839,0.6800008950320543,0.9295774647887324,1.0,1.0,4/14,21.83%,AIF1L;CARMIL1;CSF1R;PLEKHA1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.3614343140055456,-0.67979715755157,0.9761904761904762,1.0,1.0,1/11,2.05%,CBARP
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.35184603928946623,0.6797935889426527,0.8888888888888888,1.0,1.0,3/17,9.14%,FUT2;MPDU1;B4GALNT2
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.42165092363892254,-0.6797036737734875,0.7837837837837838,1.0,1.0,1/6,14.43%,FHIT
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.26175159971491785,0.6797028206260556,1.0,1.0,1.0,72/327,24.26%,ANGPT2;ADAD2;DDX20;RPL21;ADARB2;RPL37A;RPL18A;RPL9;SRSF9;RPL3;RPL15;RPL13;RPL13A;RPS16;RPS9;RPS3A;RPS5;MRPL34;EEF1A1;RPL36;RPS27A;RPS19;RPL41;YARS2;RPS11;RPL27A;TFIP11;RPS4X;RPS12;THOC6;XAB2;RPL32;RPS21;RPL35A;COPS5;RPSA;RPL7A;RPS13;RPL11;RPS7;RSL24D1;RPL23A;RPL7;DHX38;RPLP2;FIP1L1;RPLP0;RPS14;RPS6;RAE1;SRSF3;SRSF5;RPL38;RPL23;RPS15;M1AP;HNRNPK;DUSP11;RPL24;RPL18;RPL35;STUB1;ASMT;RPS27;RPL8;RPL10;RPS15A;RPS28;RPS20;MRPL28;RPL27;RPS24
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.3758611696576093,0.6794042579272204,0.8873239436619719,1.0,1.0,3/12,28.11%,MAPK3;NOS2;ORAI1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.4415471805940501,-0.6793768790700702,0.9069767441860465,1.0,1.0,2/5,24.85%,PPIB;TBC1D20
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.4253759828981657,0.6793631381032501,0.8518518518518519,1.0,1.0,2/6,25.74%,DACH1;BHLHE41
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.36467431712272375,0.6790161850014163,0.9,1.0,1.0,6/16,32.86%,SNAI1;CXCL12;CDKN2D;RPS3;CLU;SFRP2
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.25290343362546913,-0.6790040909091969,1.0,1.0,1.0,13/117,12.43%,CNGA3;ADCYAP1;CFC1;SLC17A6;ZNF385D;HFM1;AGA;RNF150;GNB3;GRIA4;PCSK1;NOVA1;CELF4
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.266104307729446,0.6789621858966001,1.0,1.0,1.0,37/421,13.41%,GATA4;TBX1;ESR1;MYRF;RORC;SP100;WNT5A;AHR;SIX4;NFIL3;FGF2;HEY2;SOX10;TGFB1;CTCFL;CRLF3;MESP1;ERBB4;RNF187;AFAP1L2;ACTA2;LEF1;REST;FLI1;EBF3;IGF1;IRF1;NR1H4;COL1A1;STAT1;CD80;TGFB3;KDM3A;PITHD1;FOXM1;ZIC1;IRF4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.35426192675651236,0.6789309077732116,0.8695652173913043,1.0,1.0,2/24,9.82%,PINK1;DCN
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.32768904750249667,-0.6785040986203377,0.7560975609756098,1.0,1.0,3/18,7.72%,ASPG;MTHFR;ASS1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.38081628326132716,0.6783897789593482,0.9402985074626866,1.0,1.0,4/15,32.37%,TDG;OGG1;TERF2IP;UNG
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.3329480404115679,-0.6783012317156363,0.8787878787878788,1.0,1.0,9/20,31.02%,CPT1A;ACACB;PRKAG2;SLC25A20;ABCD3;PRKAA2;ABCD2;CERT1;ARV1
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.217262704690499,-0.6781350359092954,1.0,1.0,1.0,75/372,19.74%,KLHL41;CFAP221;IFT88;ABCC4;DCDC2;MKS1;SYNPO;AUP1;CNGA4;EXOC7;CFAP410;HAUS1;SCLT1;EHD4;PARVA;UBXN2A;TTC36;PCM1;CEP83;RAB7A;TMEM138;GOLGA8A;PLA2G4C;FLNA;GBF1;RILPL1;DZIP1L;HDAC3;SNF8;CLUAP1;MAPRE1;ASAP1;TUBGCP2;EHD3;RAB11FIP3;IRGM;CFAP44;ABLIM3;CIRBP;CEP250;ATG2A;AVIL;FBF1;CORO1A;CILK1;DNAH5;CFAP70;DBNL;GOLGA8B;HAUS7;DYNC2I1;CDS1;MVB12A;B9D1;IFT81;AHI1;PRRC2C;CCDC57;TCTN1;TEKT3;CEP290;ARMC9;TRAF3IP1;KIF27;CYS1;IFT43;ATG16L2;NOTCH1;UBXN2B;ATG9B;CEP41;KIF24;IFT52;TSG101;MAPT
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.3919329151218962,0.6777356232405002,0.9242424242424242,1.0,1.0,1/11,8.71%,MMP9
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.40854643778347577,0.6775689250156197,0.9354838709677419,1.0,1.0,2/8,33.15%,FIS1;PEX11A
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.29380796691163946,0.6773203132392833,0.9759036144578314,1.0,1.0,4/98,4.70%,CAPN13;TRIL;TSPAN11;SHISA6
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.39896724150821583,-0.6772803506373246,0.8571428571428571,1.0,1.0,2/5,20.57%,TRAPPC11;RAB11B
prerank,PanglaoDB_Augmented_2021__Neurons,0.26362847782978227,0.6772317004326215,1.0,1.0,1.0,22/267,14.64%,AIM2;GAD1;STMN4;FAM181B;HTR5A;LY6H;SCRG1;ARHGDIG;PPP1R1B;CXCR5;TCEAL5;IGF1;PNMA8A;NPY;NEFM;SPOCK3;BEX1;CALB1;OGFOD1;ZIC1;VSTM2A;CCK
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.39349528949668305,0.6762071692716373,0.8939393939393939,1.0,1.0,4/18,23.73%,GPER1;BRCA1;CEACAM1;ACADL
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.3553626814756755,-0.6759723700931546,0.8214285714285714,1.0,1.0,3/16,13.01%,SIGIRR;MYLK3;AHSG
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3461457059906973,0.6759212123180545,0.9402985074626866,1.0,1.0,1/22,2.96%,ARHGAP24
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.3811320860874221,0.6758471543352634,0.9032258064516129,1.0,1.0,1/13,8.66%,NODAL
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.39016300172623264,0.6757400043349565,0.921875,1.0,1.0,3/16,17.40%,HEY2;HEY1;SNAI1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.4388943985605803,0.6755343438036902,0.8888888888888888,1.0,1.0,1/8,17.91%,BCAR1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.38526798327576056,0.6754367763054802,0.9253731343283582,1.0,1.0,2/15,11.99%,IHO1;STRA8
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.26167093949686693,-0.6752174517518068,0.92,1.0,1.0,8/72,10.56%,SYT12;KCNJ16;WWP2;SPTBN4;NKAIN3;SYT17;KCNJ6;HFE
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),0.4617718786822061,0.6751129585945612,0.8823529411764706,1.0,1.0,1/5,10.99%,DDX3X
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),0.4617718786822061,0.6751129585945612,0.8823529411764706,1.0,1.0,1/5,10.99%,DDX3X
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.3355490376817038,-0.6750719355777346,0.9,1.0,1.0,10/24,21.26%,EXO1;MSH4;POLD3;XPC;PMS1;ABL1;ERCC1;MSH3;MLH3;MCM9
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.28457100613911,-0.6749616209045676,1.0,1.0,1.0,11/31,23.35%,FGF1;HSF1;TRPV4;TCIM;TRPV1;HTRA2;MAPT;YWHAE;HSPA1A;TPR;DHX36
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.4072789174413095,0.6747006699007216,0.9215686274509803,1.0,1.0,3/8,24.98%,IL4;EHD2;EHD1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3884083065470809,0.6743565502840868,0.8939393939393939,1.0,1.0,3/17,12.08%,IL12A;DCN;CD63
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.27103088349252613,-0.6742085632915038,1.0,1.0,1.0,9/59,16.67%,MAP3K10;TRIB1;NOD1;RIPK2;TAOK2;MAP3K12;CRKL;MAP3K13;MAP2K7
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3993916425529305,0.674194799527536,0.859375,1.0,1.0,2/10,9.51%,REST;PINK1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.404027820091604,0.6741690442799959,0.8611111111111112,1.0,1.0,2/8,22.79%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.404027820091604,0.6741690442799959,0.8611111111111112,1.0,1.0,2/8,22.79%,BCS1L;UQCRFS1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.2273294270273857,-0.6739530025955071,1.0,1.0,1.0,27/142,21.02%,PLK3;CHD4;RAD50;EXO1;SMYD2;RPF2;TAF12;CDK1;ATR;PRDM1;SSRP1;PPP1R13B;RFC3;MLST8;CDK5;ATRIP;RAD17;TTC5;CHD5;PML;ATM;TAF11;KMT5A;NBN;RAD9A;PIP4K2B;PRKAG2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.3189673090520265,0.6738369181834625,0.9154929577464789,1.0,1.0,13/39,26.78%,SLC38A3;SLC7A7;SLC38A4;SLC38A2;SLC16A1;SLC23A1;SLC7A10;SLC38A10;ABCB1;SLC36A3;SLC7A11;SLC25A11;SLC38A11
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.35202393471217536,0.6737821160955543,0.9142857142857143,1.0,1.0,2/23,6.20%,FGF2;CCDC39
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.4691743643754347,0.6737006933483761,0.9310344827586207,1.0,1.0,3/5,30.36%,BRCA1;CTNNA1;CTNNB1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.4691743643754347,0.6737006933483761,0.9310344827586207,1.0,1.0,3/5,30.36%,BRCA1;CTNNA1;CTNNB1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.29457743024077493,0.6736071159209418,1.0,1.0,1.0,19/79,31.95%,MRPS34;MRPL34;MRPL20;MRPL50;GADD45GIP1;MRPL54;GFM2;MRPS2;MRPL19;MRPL28;MRPL40;MRPL10;MRPL14;MRPL44;MRPL37;MRPL49;MRPS26;MRPS12;MRPS22
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.32220504524129745,-0.6731320236807266,0.9615384615384616,1.0,1.0,1/20,3.82%,CFLAR
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.40975704796763096,0.6730144154956371,0.918918918918919,1.0,1.0,1/13,4.08%,SYNE2
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.32872737399146795,0.6729945851212116,0.927536231884058,1.0,1.0,3/28,11.97%,WNT5A;DTX2;CCND1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.4321626066608518,0.6728303574988909,0.8181818181818182,1.0,1.0,2/5,33.60%,SLC25A11;SLC25A30
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.3987049803072039,0.6728044716324468,0.8857142857142857,1.0,1.0,4/12,26.63%,TAF7;SET;BRCA1;SPI1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.31759006267486733,-0.672589511630399,0.9259259259259259,1.0,1.0,2/20,8.29%,KCNMB2;CHRNA1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.39614067784042506,0.6725426299055762,0.859375,1.0,1.0,2/14,10.20%,FGF2;ITGA5
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.4097515123996289,0.6724802645037798,0.873015873015873,1.0,1.0,3/8,32.37%,TDG;OGG1;UNG
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.39360885254815325,-0.6722562144708435,0.8787878787878788,1.0,1.0,2/8,19.88%,AK8;AK7
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3069027696816664,-0.6721870072742752,0.9629629629629629,1.0,1.0,14/36,28.78%,MYO5C;BICDL2;MYO19;TRAK2;CLN3;BICDL1;MYO1C;MYO1H;MYO5A;TRAK1;HTT;MYO7A;PPFIA2;PAFAH1B1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.3948976672194854,0.6719560555154528,0.9206349206349206,1.0,1.0,4/10,30.73%,PDCD1LG2;CRTAM;PRKAR1A;LGALS9
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.366292816399554,0.671512595555227,0.85,1.0,1.0,5/20,20.31%,CDKN2A;SUV39H1;HMGA1;HMGA2;POLE3
prerank,GO_Biological_Process_2021__blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),-0.39257253384912955,-0.6714762834204552,0.84,1.0,1.0,5/5,60.75%,BMP4;ITGB1BP1;BMPER;SEMA5A;NRARP
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.34377195037261454,0.6713095772630348,0.9420289855072463,1.0,1.0,5/25,26.52%,IRF1;TRIM5;TKFC;ERAP1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.3892699150150703,0.671274871006131,0.984375,1.0,1.0,2/17,4.86%,PLA2G10;C3
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.4009354099938847,0.671083533050521,0.8548387096774194,1.0,1.0,1/9,3.01%,WNT5A
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.4229059395387515,0.6708946871618189,0.875,1.0,1.0,1/6,8.79%,HLA-A
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.4142133531247484,-0.6708660481648048,0.868421052631579,1.0,1.0,1/6,9.12%,MECP2
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.31167253970796877,-0.6708349720499187,0.9393939393939394,1.0,1.0,4/28,11.31%,THEM4;MLYCD;ACOT1;ACOT9
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.31167253970796877,-0.6708349720499187,0.9393939393939394,1.0,1.0,4/28,11.31%,THEM4;MLYCD;ACOT1;ACOT9
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.42659067838894527,-0.6708125503277166,0.7872340425531915,1.0,1.0,1/5,10.37%,PTPRR
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.3021499836020729,0.6705416987484172,0.971830985915493,1.0,1.0,5/67,15.01%,RANBP6;PINK1;RAB11A;SYK;LAMP2
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.3668428017187958,0.6705392205227153,0.875,1.0,1.0,1/15,5.45%,TGFB1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.307270036081804,-0.6700959409996937,0.9642857142857143,1.0,1.0,9/30,24.07%,CAPN10;PID1;OSBPL8;AKT2;OCLN;C1QTNF12;PRKAG2;INSR;IRS2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.2746653679254393,0.6698234687414161,0.9888888888888889,1.0,1.0,4/111,5.32%,PSMB9;CCL5;PELI3;ST18
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.36722632436171365,0.6697531364641162,0.8450704225352113,1.0,1.0,2/16,11.68%,SCIMP;IL26
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.37357854531668216,-0.6696297107503206,0.7948717948717948,1.0,1.0,3/8,15.29%,AUP1;PLA2G4C;CDS1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.4091739814942458,-0.6694691290145042,0.8461538461538461,1.0,1.0,3/7,22.89%,ATG2A;ATG9B;ATG7
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),-0.4388208378644777,-0.6694595958214867,0.8717948717948718,1.0,1.0,1/5,15.64%,OSBPL8
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.36943897416966726,-0.669246853209288,0.8529411764705882,1.0,1.0,3/9,18.25%,ADCY2;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.3479131924158123,-0.6686654048361871,0.8387096774193549,1.0,1.0,4/11,21.22%,HSF1;INHA;PRKCA;PTPN2
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.42826576573395314,0.6685662001687254,0.8412698412698413,1.0,1.0,1/7,3.91%,SLC38A3
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.4112614399478124,-0.6685435430145353,0.8604651162790697,1.0,1.0,2/7,19.16%,MVK;PDSS2
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.41625478086994544,0.668364995675686,0.8688524590163934,1.0,1.0,1/6,2.84%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),-0.36253464016245557,-0.6681329497428647,0.868421052631579,1.0,1.0,5/13,27.80%,AKT2;GPLD1;PTPN2;IRS2;AKT1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2906679819644932,0.6681057834875345,0.9722222222222222,1.0,1.0,14/63,26.63%,AIM2;NLRP12;CDKN2A;CYP1B1;NLRC3;CYLD;NFKBIA;DDIT3;NLRP2;CACTIN;TCEAL7;PARP10;IRAK1;SPI1
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.33891021526508647,-0.6679656477487538,0.9166666666666666,1.0,1.0,6/12,19.91%,TAS2R8;RTP1;AZGP1;PKD2L1;CA6;TAS2R5
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.3618481540658489,0.6679389552009768,0.922077922077922,1.0,1.0,5/23,18.52%,GPIHBP1;ANGPTL4;NR1H4;ANGPTL3;MTLN
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),-0.41065411432719157,-0.6677224886680133,0.8292682926829268,1.0,1.0,1/5,5.75%,GSTZ1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.41978419877536194,0.6676220053632198,0.8852459016393442,1.0,1.0,3/8,17.38%,HLA-A;IRF1;CRTAM
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.2811414498475819,0.6673474036537935,0.9878048780487805,1.0,1.0,31/178,21.71%,KIF14;ROS1;TP53TG5;TGFB1;CRLF3;SOCS2;CDKN2A;EI24;GNG4;EXOSC2;PPT1;DDX3X;CDKN1B;RERG;BTG1;CDKN1A;CCDC85B;AGT;NUBP1;BCAR1;TCHP;TAF9B;EXOSC4;CDKN2C;IL17RB;PAPPA2;PSRC1;TMC8;RBBP7;NAIF1;FRZB
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.37156026961900324,0.6669658250411343,0.9076923076923077,1.0,1.0,2/15,9.34%,TLR2;REST
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.43639068249287244,0.6667172800951284,0.8928571428571429,1.0,1.0,2/7,17.10%,TMEM126A;CHRNB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.27961686804239305,-0.6666720180982987,1.0,1.0,1.0,6/48,12.13%,PTPN9;CLIP3;EPHB2;ZDHHC5;NKD2;ITGA3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.33560791914577515,0.6666632873431643,0.8904109589041096,1.0,1.0,1/33,1.37%,CAVIN1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.3488540532626649,0.6661991170041687,0.927536231884058,1.0,1.0,5/31,21.70%,PTX3;PINK1;LRPAP1;DLG4;BRCA1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.34808055301767005,0.6659788789760018,0.8955223880597015,1.0,1.0,7/12,33.43%,CCT7;GNL3;CCT8;CCT2;CCT6A;DKC1;CCT3
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.2649946309701132,-0.6658280013542038,0.96,1.0,1.0,4/57,8.29%,PNPLA3;APOE;ACOX3;PNPLA1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.3696544343830665,-0.6656379356469024,0.9393939393939394,1.0,1.0,6/17,27.40%,MYO5C;MYO19;MYO1C;MYO1H;MYO5A;MYO7A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.3903439204611397,-0.6651973319206483,0.9047619047619048,1.0,1.0,6/6,60.98%,DHX36;PKM;CNBP;YBX3;LIN28A;DHX9
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.2912891986062718,-0.6649137667732237,0.9444444444444444,1.0,1.0,25/25,70.90%,POLR2F;POLR2C;CCNT1;RSF1;CTDP1;GTF2F2;GTF2F1;NELFCD;NELFA;POLR2D;POLR2G;SUPT5H;NELFE;POLR2J;POLR2I;MDFIC;DHX9;POLR2L;POLR2A;POLR2E;CDK9;POLR2K;POLR2B;NELFB;POLR2H
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.36436245487205393,0.664798657190462,0.8769230769230769,1.0,1.0,10/19,36.27%,STAT1;PARP14;PARP9;IFNGR1;HSP90AB1;PIAS1;ARG1;TXK;IFNGR2;JAK2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.36195254104101776,0.6644432776198083,0.90625,1.0,1.0,1/14,3.20%,SHCBP1L
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.345216500273133,0.6642850283135435,0.9333333333333333,1.0,1.0,5/19,20.26%,TGFB1;DAB2;PPP2R5A;RHOQ;MRAP
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3033990817485802,0.6642404505453823,1.0,1.0,1.0,11/61,21.70%,SYCP1;TK1;SOD2;AQP4;GNMT;RYR3;ALDH9A1;HLA-DRB1;MCOLN1;KCNJ2;B2M
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.27326729994095544,0.6640351866644257,1.0,1.0,1.0,11/156,11.03%,ESR1;CAVIN1;RORC;NR1I3;TBPL1;NR2E3;TAF5;GTF2E1;NR1H4;HNF4G;TAF7
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.3351344766700931,-0.6638065588403129,0.8823529411764706,1.0,1.0,5/15,21.47%,CTCF;CDK1;IK;MTBP;CHAMP1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.33511475432514937,0.6637781422045397,0.8961038961038961,1.0,1.0,8/25,31.85%,YWHAH;KCNJ2;SCN7A;SCN4B;SCN1B;SCN9A;SCN5A;SCN2B
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.36261792944369736,0.663777148975254,0.873015873015873,1.0,1.0,8/15,29.50%,CAV3;KCNE3;SCN4B;KCNE4;SCN1B;NOS1AP;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.39658916763682905,-0.663701775279317,0.9411764705882353,1.0,1.0,2/7,23.49%,SRF;HPSE
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.34847275999215244,0.6635914302194252,0.9154929577464789,1.0,1.0,2/19,6.51%,CASQ2;CAV3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3313589096848847,-0.6635791884818757,0.92,1.0,1.0,3/23,14.50%,AUP1;BAG6;NGLY1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.3798400931505658,0.6634589085079879,0.8548387096774194,1.0,1.0,2/11,18.19%,NPPA;SPX
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.3975905728963135,0.6633643899510524,0.8955223880597015,1.0,1.0,2/8,11.65%,CCL5;SYK
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.39822887080570124,0.6632891955335491,0.847457627118644,1.0,1.0,1/9,3.01%,WNT5A
prerank,GO_Biological_Process_2021__cellular ion homeostasis (GO:0006873),-0.4397530930565321,-0.6631249433457791,0.8095238095238095,1.0,1.0,2/5,9.99%,RHCG;SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3415247034099238,0.6630916701133204,0.9393939393939394,1.0,1.0,1/25,3.08%,PTPRC
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.3567835589769935,0.6630284752057217,0.8875,1.0,1.0,6/14,40.22%,DCTN1;LGMN;PICK1;PLS1;PRNP;APP
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.3705959966561423,0.6628575473900105,0.9113924050632911,1.0,1.0,2/15,11.84%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2556969141144778,0.6625438652883086,1.0,1.0,1.0,41/393,19.22%,GATA4;ARHGAP9;ARHGAP31;RRAS;ARHGAP24;WNT5A;ROS1;HIPK1;DDIT4;NLRP12;RAD1;ARHGDIG;TAF5;ARHGAP28;TP53BP2;TAF7;ECT2;RHOB;RHOU;ARHGAP45;RPA3;ARHGAP15;NOP53;CDK5R1;RMI2;TAF13;TAGAP;ATP6AP2;VWF;CYLD;RASGRF2;MAPK3;TAF6;RPL11;RHOG;OBSCN;AGER;RHOQ;TAF9B;F2RL1;A2M
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.44813745928418536,0.6620130538245322,0.927536231884058,1.0,1.0,1/6,6.52%,SCARA3
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.4160436089012414,0.6618474689714962,0.8571428571428571,1.0,1.0,1/7,13.15%,TJP3
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.24793881591246356,-0.6616519844502079,1.0,1.0,1.0,50/317,17.25%,APOB;ATP6V0D2;TBC1D10A;RAB20;TBC1D16;OLFM2;STX11;APOE;RAB3D;SYNDIG1;STX6;TVP23A;SNX8;RAB7A;SCFD2;ATP6V1E2;TBC1D22B;ARFIP2;TBC1D2;LRSAM1;TMED4;TICAM2;ARRDC2;STX5;ATP6V0A2;HFE;RAB5A;ARRDC5;SNX33;PREB;RAMP1;TBC1D8;BLZF1;GGA2;GOLGA4;RUFY1;RAB28;RABL2A;SCAMP4;COG7;SCAMP2;MIA3;ABCG1;TBC1D9;SNX9;STXBP2;RAB26;RAB22A;RAB31;CEP290
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.3886417269526868,-0.6615123150532444,0.8461538461538461,1.0,1.0,6/6,61.15%,UFD1;GPATCH3;NPLOC4;DHX58;SEC14L1;C1QBP
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),-0.37582008224996166,-0.6614181973844214,0.8787878787878788,1.0,1.0,2/8,8.95%,OSR1;PKD2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.36191261216049087,-0.6612880599253042,0.9642857142857143,1.0,1.0,6/14,25.07%,DAGLA;GRM2;HOMER1;GRM7;TRPM1;GRM4
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.4068071273475739,0.6607737296582326,0.9032258064516129,1.0,1.0,3/8,29.08%,FBXO5;TOM1L1;CHEK1
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),-0.3512785242821516,-0.6607307676626553,0.9047619047619048,1.0,1.0,4/8,17.40%,MMP2;OPN5;TIMP1;OPN3
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.3761055617246973,-0.660674340796191,0.9722222222222222,1.0,1.0,2/6,12.45%,SPTBN4;RNLS
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.32577280817396703,0.6606263469413537,0.8923076923076924,1.0,1.0,2/33,6.51%,GLRX;CAV3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3642540428622132,0.6605613406340691,0.8529411764705882,1.0,1.0,6/21,25.65%,SLC18A2;CYBA;UCP1;PARK7;CCN6;ALOX5
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.39099680847094526,0.6605187334730264,0.9047619047619048,1.0,1.0,2/9,19.13%,CSF1R;F2RL1
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.4442257341617719,0.6602204969415209,0.9791666666666666,1.0,1.0,1/6,15.86%,COLEC12
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.39204779159499803,-0.6593770541961423,0.7931034482758621,1.0,1.0,2/7,14.99%,G6PD;XYLB
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.41486342798909526,0.6589027606888784,0.875,1.0,1.0,1/6,3.91%,SLC38A3
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.4033326321461923,-0.6588894372774836,0.8205128205128205,1.0,1.0,3/5,21.86%,COQ2;GK5;GK
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.3842101314978732,0.6588855354019194,0.8787878787878788,1.0,1.0,2/8,20.22%,ITGA2;HMGA2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2739184391505113,0.6580667148116485,0.9880952380952381,1.0,1.0,29/191,25.08%,PSMB9;UBE2U;KIF14;RNF187;ANKRD9;SPSB2;KBTBD7;SIAH1;KBTBD6;PSMC5;PSMB6;KCTD17;PRAME;SEL1L;SYVN1;ZFAND2A;FEM1B;RBX1;DDIT3;RMND5A;PSMD6;PSMA3;STUB1;SOCS6;RNF5;PSMA7;TNFAIP1;SPSB3;KCTD10
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.3918033046059466,-0.657964021875495,0.8292682926829268,1.0,1.0,2/5,23.74%,MAPT;PRKN
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.3453364436129091,0.6578897698838978,0.9846153846153847,1.0,1.0,2/24,11.13%,ST18;STAT1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.41216819212501166,0.6576236056596632,0.9180327868852459,1.0,1.0,2/8,32.01%,OGG1;TERF2IP
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.2675176385970883,0.6574889652532111,1.0,1.0,1.0,14/195,15.20%,NEK2;BUB1;CEP72;NDC80;GEMIN4;MAP3K11;RAPGEF6;ECT2;PIF1;FBXO5;ANLN;TTK;TUBA4A;RASA1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.37164287675303925,0.6574265847701907,0.9142857142857143,1.0,1.0,6/20,13.70%,NOX5;ALOX12;SOD2;DUOX1;TAFA4;CYBA
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.421667167190981,0.6574129866318509,0.8461538461538461,1.0,1.0,1/6,23.46%,CEACAM1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.40094582797822664,0.6573576807828126,0.8985507246376812,1.0,1.0,1/8,9.51%,PINK1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.3910604557780343,-0.6563942790957383,0.8787878787878788,1.0,1.0,1/8,4.69%,JMJD4
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.39686819963778863,0.6561383818322934,0.8428571428571429,1.0,1.0,2/10,11.65%,ATP6AP1;SYK
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.30919483097730766,-0.6558779756312155,0.9166666666666666,1.0,1.0,5/17,20.24%,STX5;EHD3;CAMSAP3;AKAP9;STX18
prerank,GO_Biological_Process_2021__regulation of growth rate (GO:0040009),-0.4087211308276886,-0.6555609918348548,0.8723404255319149,1.0,1.0,2/5,18.82%,BNIPL;NOTCH1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.2766751627657861,0.6554907332044118,0.9868421052631579,1.0,1.0,10/72,20.26%,TGFB1;GPER1;RAMP3;DAB2;LDLRAP1;STAC;PPP2R5A;RHOG;RHOQ;MRAP
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.3605241802243323,-0.6553124614005178,0.85,1.0,1.0,3/12,20.71%,GPRC5A;TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.4345353317150622,0.6552542712753869,0.9193548387096774,1.0,1.0,3/7,35.90%,HIF1A;ARNT;MT3
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.34942983688660545,-0.6551461088621398,0.8857142857142857,1.0,1.0,1/9,6.60%,HM13
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.39195144743627636,0.6549429969891137,0.9545454545454546,1.0,1.0,1/10,8.71%,MMP9
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.41626838720170556,0.6549269368575205,0.828125,1.0,1.0,2/7,23.67%,HAAO;QPRT
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.313227775237095,0.6548268305359566,0.9264705882352942,1.0,1.0,14/42,25.30%,SLC38A3;SLC7A7;SLC47A1;SLC25A18;SLC38A4;SLC38A2;SLC22A4;SLC7A10;SLC25A22;SLC1A6;SLC38A10;MFSD12;SLC36A3;SLC7A11
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.2544027587973664,-0.6541020770330289,1.0,1.0,1.0,8/57,13.20%,TWIST1;CBFB;CDK1;MECP2;FOSL1;CDK4;MED25;TNRC6C
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.2852351952450801,0.653868044137959,0.9861111111111112,1.0,1.0,20/85,31.95%,MRPS34;MRPL34;MRPL20;MRPL50;GADD45GIP1;MRPL54;GFM2;MRPS2;MRPL19;MRPL28;MRPL40;MRPL10;MRPL14;MRPL44;MRPL37;MRPL49;MRPS26;MRPS12;GSPT2;MRPS22
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.35910234087831305,-0.6537499766209597,0.9166666666666666,1.0,1.0,10/10,64.11%,STAT3;BBS4;LEPR;UGCG;SIRT1;EBI3;LEP;MKKS;BBS2;MT3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.358331819917139,0.6536831741234654,0.9253731343283582,1.0,1.0,4/19,16.39%,CDKN2A;CDKN1B;INCA1;LATS2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.4058248610101356,0.653667000322741,0.8387096774193549,1.0,1.0,2/8,15.59%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.4058248610101356,0.653667000322741,0.8387096774193549,1.0,1.0,2/8,15.59%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3582769123242911,0.6535884335540273,0.9137931034482759,1.0,1.0,6/12,35.38%,IL4;EHD2;EHD1;DCSTAMP;RAPGEF3;CAMK1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.33877945484318067,-0.6534998514426564,0.9090909090909091,1.0,1.0,4/16,24.06%,APOE;ABCG1;CLN3;NCSTN
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.29064353377988295,0.6534558200326693,0.9178082191780822,1.0,1.0,5/69,11.39%,ANXA1;TICRR;RAD1;ECT2;RHOB
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.37989514523779416,0.6533166210768507,0.8333333333333334,1.0,1.0,3/10,14.93%,ANXA1;ALOX15B;SOX9
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.3340906537948978,-0.6530240247362763,0.9375,1.0,1.0,4/18,18.64%,OPRD1;TSSK4;CRTC1;LRP8
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.3578909679212914,-0.6528940546914423,0.9285714285714286,1.0,1.0,1/8,4.89%,KCNE1
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.37720519962859794,-0.6525451662797844,0.9090909090909091,1.0,1.0,7/7,62.29%,NCSTN;ABCA7;PSEN1;APH1B;DYRK1A;APH1A;BACE1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3291131513219945,0.6525445522594435,0.96875,1.0,1.0,14/31,33.70%,VPS18;HOOK2;ACP4;HOOK1;SNAPIN;GAA;ACP2;LAMTOR1;ACP3;GRN;NAGPA;TFEB;HPS4;AKTIP
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.33960625042208825,-0.65226952873637,0.9705882352941176,1.0,1.0,1/13,10.61%,SNF8
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.3534343378102287,0.6520920128432252,0.90625,1.0,1.0,1/15,4.99%,INTS5
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.32129602417865627,0.6517719700043408,0.9701492537313433,1.0,1.0,3/31,17.10%,SDC2;YWHAH;CHRNB2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.2672986896903642,-0.6514283231026016,1.0,1.0,1.0,11/63,14.42%,SYT12;CPNE6;SYT17;PKD2;HPCA;CARF;AKR1C3;NEUROD2;TRPM2;CPNE4;SYT3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.3947553813752299,0.6513025530763996,0.90625,1.0,1.0,2/7,9.69%,GPER1;SOD2
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.33217964096405284,0.6512157457332559,0.9253731343283582,1.0,1.0,3/20,10.43%,RORC;FMO5;NR1H4
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.2928293174863496,0.6511414755392522,0.9863013698630136,1.0,1.0,7/61,15.27%,TNFRSF1B;METTL18;IGF2BP2;AHNAK2;AFF2;RASA1;BRDT
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.3560077797979744,0.6509389520175897,0.8767123287671232,1.0,1.0,2/15,5.67%,SOX10;SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.3064612408927771,-0.6508850508350135,1.0,1.0,1.0,5/25,13.16%,MEN1;CTC1;NIBAN2;STN1;EXOSC10
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.3585209572536133,0.6507396972922095,0.8983050847457628,1.0,1.0,1/9,9.51%,PINK1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.3227107742223889,0.6505470250602523,0.9538461538461539,1.0,1.0,1/31,2.46%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.4289748549323017,-0.6502730300430777,0.8484848484848485,1.0,1.0,5/5,57.11%,KCNMA1;SHANK3;CLCN3;ANO6;P2RX7
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.35768692421461057,-0.6500165500738045,0.9310344827586207,1.0,1.0,2/14,9.22%,CCDC22;COMMD1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.31925566577948783,-0.6497968802186731,0.8461538461538461,1.0,1.0,1/14,3.62%,CREB3L1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.31319909514410554,0.6497438067036021,0.9428571428571428,1.0,1.0,1/42,1.96%,SLFN14
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.30335976568313233,0.6494090143288666,0.95,1.0,1.0,1/51,2.05%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.3493984407467579,0.6494085248681128,0.9344262295081968,1.0,1.0,9/16,36.97%,NOP53;IL4;NOS2;PRELID1;CBFA2T3;ACTN3;SHMT2;IFNAR1;IDE
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.2891825460752148,0.6491358187213679,1.0,1.0,1.0,5/75,9.25%,LRP2;CCL5;TRPV6;NMUR2;RAMP3
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.35533492876566813,-0.6487990386573266,0.8636363636363636,1.0,1.0,3/8,18.89%,ALDH18A1;ASL;AZIN2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.34223788240251696,-0.6485445910860876,0.71875,1.0,1.0,2/13,10.06%,EIF4EBP1;AGO2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.3111890829594912,0.6484505817695589,0.9577464788732394,1.0,1.0,15/35,33.70%,VPS18;ATP10B;HOOK2;ACP4;HOOK1;SNAPIN;GAA;ACP2;LAMTOR1;ACP3;GRN;NAGPA;TFEB;HPS4;AKTIP
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.3324517839938248,0.6483666496415078,0.9382716049382716,1.0,1.0,7/24,24.49%,PINK1;FBXO5;BMI1;BAG5;FEM1B;PARK7;ARRDC3
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.40223192153666826,-0.6482877905736294,0.7777777777777778,1.0,1.0,2/5,22.89%,IRGM;ATG7
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.3515016191116117,-0.6481629742687398,0.926829268292683,1.0,1.0,3/12,12.34%,LIPC;PLIN5;LPL
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.29232712875074013,0.648152690536151,0.9736842105263158,1.0,1.0,15/58,25.17%,MMP9;DNAJA1;PINK1;SOD2;DDX3X;PLAUR;HERPUD1;SNAI1;CREB3;SYVN1;BAG5;CXCL12;PARK7;BCL2L2;CDKN2D
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.277999934391945,0.6480194683288043,0.9871794871794872,1.0,1.0,7/129,6.45%,TBX1;RORC;SMOC1;HEY2;TGFB1;SCIN;HEMGN
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),-0.41262779733935423,-0.6479868853514461,0.9,1.0,1.0,2/6,17.78%,PEX13;EFHC1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.4191110536337539,0.6479845979135205,0.8333333333333334,1.0,1.0,1/5,18.10%,RAB38
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.28765097374659165,-0.647825761414287,1.0,1.0,1.0,1/29,0.79%,PLK3
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.3559123393117428,-0.6477181380551131,0.9722222222222222,1.0,1.0,3/8,23.23%,ZC3H14;CCNT1;RNF40
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.41342185477373955,0.6475050957793849,0.9166666666666666,1.0,1.0,1/6,18.27%,CD4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.41342185477373955,0.6475050957793849,0.9166666666666666,1.0,1.0,1/6,18.27%,CD4
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.3123262986866136,0.647418097218333,0.92,1.0,1.0,12/40,19.90%,TIMP3;SERPINB7;SERPIND1;SPOCK3;SERPINE3;SERPINB1;KNG1;AGT;VTN;SERPINA10;SERPINB5;SERPINF1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2899246402637935,-0.6469001570236936,0.9090909090909091,1.0,1.0,8/24,20.31%,CACNB1;HPCA;JSRP1;JPH3;JPH4;JPH1;YWHAE;NOS1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.25387810840725467,-0.6468618324690838,1.0,1.0,1.0,16/89,16.37%,LIN28B;CACNG4;VGF;CRABP1;CASKIN1;MPP2;INA;MSI1;KLHL23;KCNB2;RCOR2;JPH3;IGDCC3;LINGO1;CSPG5;POU3F2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.3174545801865979,0.6467956898451511,0.9583333333333334,1.0,1.0,11/36,29.50%,PKP2;KCNA5;CTNNA3;KCNE3;DSC2;KCNJ2;SCN4B;KCNE4;SCN1B;SCN5A;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.24747506482406426,-0.6464651459487292,1.0,1.0,1.0,9/82,11.70%,TRIM71;APOE;DHFR;NANOS3;PCIF1;CNOT9;IGF2BP1;FXR2;BIN1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2675600727490775,-0.6461607566424971,0.9655172413793104,1.0,1.0,4/41,10.56%,CCDC22;QRICH2;COMMD1;HFE
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.33512951059195817,0.6461492003512095,0.96875,1.0,1.0,1/18,4.45%,SYT2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.2482588661362511,-0.6461464597619849,1.0,1.0,1.0,13/109,10.00%,KCNK6;KCNJ16;KCNMB2;KCNG1;KCNE1;ABCC8;TMEM175;KCNQ4;PKD2;KCNC3;AQP1;KCNJ6;KCNB2
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.25990842173068,-0.6458257763900249,1.0,1.0,1.0,9/53,16.31%,H1-4;POLR1A;PHF2;ZMIZ1;POLR2F;TAF1B;MYBBP1A;TAF1D;ELOF1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4074529154894285,0.6458080100927998,0.8923076923076924,1.0,1.0,2/10,5.33%,PTPRC;HLA-F
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.2765287842615744,0.6457412403502184,0.9866666666666667,1.0,1.0,16/123,20.48%,KIF14;HSPA8;WNT5A;ROS1;SOCS2;PINK1;STON2;GFAP;AGT;NUBP1;BCAR1;HCFC1;IL17RB;PAPPA2;BAG5;TMC8
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.2881480689447606,0.645344028684048,0.9879518072289156,1.0,1.0,6/75,9.55%,TBX1;ANXA1;MESP1;UPK1B;ERBB4;DAB2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.36884194140399845,0.6453345825905549,0.9375,1.0,1.0,3/10,26.91%,F7;APOD;F3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.2789967199555886,0.6453240196201899,1.0,1.0,1.0,14/98,20.48%,HSPA8;TGFB1;HSPA5;PINK1;HCK;DDX3X;SYK;NOP53;TFIP11;FBLIM1;GFAP;MTLN;HCFC1;TMC8
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.39725338491295936,-0.6451678721831888,0.9148936170212766,1.0,1.0,5/5,60.29%,DLAT;PDHA1;DLD;PDHX;PDHB
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.27264105801999783,0.6450684801802511,0.9875,1.0,1.0,20/108,25.68%,LIX1;EI24;PINK1;TOMM20;CHMP3;DYNLL1;ATG101;LAMP2;FUNDC1;YOD1;PGAM5;GABARAPL2;TOMM7;DYNLL2;VAMP7;ULK1;PRKAB2;STX17;VDAC1;GABARAPL1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.3950506512826192,0.6450469643081568,0.9285714285714286,1.0,1.0,2/8,25.89%,INSIG2;INSIG1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.2464814296626933,-0.6444957220647759,1.0,1.0,1.0,11/42,21.76%,PAPSS2;PPCDC;AMPD3;ADCY2;ADCY3;IMPDH1;ADCY6;PANK1;PPCS;DCAKD;ACOT7
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.3298367563679642,-0.6443950973525787,0.8888888888888888,1.0,1.0,7/18,28.68%,CPT1A;ACACB;PRKAG2;SLC25A20;ABCD3;PRKAA2;ABCD2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.40506778540890626,0.644218814993844,0.8888888888888888,1.0,1.0,3/8,33.15%,DDIT3;ZNF593;LAMTOR5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.35711652965197493,-0.6442170454165538,0.8148148148148148,1.0,1.0,1/12,5.04%,DOC2B
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.31103360549484527,0.6439890480533018,0.9726027397260274,1.0,1.0,5/52,12.47%,CCL5;SH2D1B;IFNK;IRF1;NLRC3
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.37972793145957096,0.6439889720094991,0.88,1.0,1.0,2/12,15.59%,SEMA3A;SEMA3F
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),0.3953041660570564,0.6439607185577659,0.8548387096774194,1.0,1.0,1/6,11.65%,SYK
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.29049412113548384,0.6437906385691144,1.0,1.0,1.0,14/64,24.22%,H1-0;GRWD1;NAP1L2;SMARCE1;SOX9;BRDT;HMGA1;SET;TNP1;H2BC18;POLE3;CHAF1A;ANP32E;PAF1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.2788449953499114,-0.6437497975292655,1.0,1.0,1.0,6/30,19.39%,CACNG4;CACNG2;CACNA1A;KCNH2;ABL1;CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.3545352461925003,-0.6435584709859383,0.9428571428571428,1.0,1.0,3/9,23.23%,ZC3H14;CCNT1;RNF40
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.3228536960765681,0.6435035287189558,0.9444444444444444,1.0,1.0,4/30,15.32%,CASQ2;KCNA5;CD63;KCNAB1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.25189327335984785,-0.6434385933551997,0.9523809523809523,1.0,1.0,6/59,9.75%,PLK3;CARM1;CDK1;CNOT9;FBXO31;TFDP1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2899525483289326,0.6433394318008941,0.9743589743589743,1.0,1.0,2/68,2.41%,GML;SP100
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.3232999042909429,-0.6432492562527476,0.9032258064516129,1.0,1.0,2/18,10.27%,FPGS;CHAC1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2886860797515597,0.6431666262117477,0.9871794871794872,1.0,1.0,13/68,19.62%,GPER1;UACA;NLRP12;NODAL;REST;DDX3X;HGF;SYK;IFI6;CD44;BEX3;THBS1;FIS1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.32195827246706454,0.6429692217207386,0.9696969696969697,1.0,1.0,6/26,23.60%,CP;FTL;TMC8;CYBRD1;B2M;TF
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.4345819751564612,-0.6426503541659713,0.95,1.0,1.0,1/5,14.38%,MAPK7
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.3211053522746956,0.6421400800881052,0.9855072463768116,1.0,1.0,1/33,2.83%,LRP2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.38371539958295997,-0.6420749683160689,0.8888888888888888,1.0,1.0,3/7,27.67%,ATM;NBR1;PJVK
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.249347948336625,0.6419619629965558,1.0,1.0,1.0,51/264,22.94%,DDX20;BOK;SCIN;GPER1;MOAP1;TNFRSF10A;NLRC4;DNAJA1;REST;CYP1B1;TP53BP2;MAP3K11;DDX3X;ECT2;RHOB;TGFB3;PXT1;RPS27A;PNMA1;ING3;MTCH1;CDK5R1;KNG1;BTG1;TGM2;TFPT;SIAH1;SFRP4;LATS2;PNMA2;RASGRF2;STK17B;STK17A;PTRH2;OBSCN;ZNF622;PHLDA1;ITGB3BP;DKKL1;HMGA2;RPS6;GADD45B;APAF1;SAP18;DDIT3;FRZB;PPID;TRADD;TPD52L1;MLLT11;PRR7
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.3531835787712257,-0.6415484363926585,0.95,1.0,1.0,6/15,26.18%,AAAS;NUP98;NUTF2;ANP32A;RGS14;NXT1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.29912980031490843,0.6413167384222945,0.972972972972973,1.0,1.0,3/45,10.43%,BLK;PINK1;NR1H4
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.25223402054848887,-0.6412293403090429,0.95,1.0,1.0,25/85,24.10%,LSM10;SRRM4;ERN1;SRSF4;KIN;SNRPB;ZC3H12D;PRPF18;HSF1;U2AF2;PTBP1;SF3A2;PCF11;TBRG4;LSM2;TCERG1;DXO;LSM6;SNRPF;HSPA1A;CPSF3;SF3B4;SF3A3;SON;RIDA
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.3991627872806358,0.6411047297932359,0.896551724137931,1.0,1.0,1/7,9.02%,ACTA2
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.33179253476189857,-0.6410492274775753,0.8857142857142857,1.0,1.0,2/10,14.23%,ZNF692;SIRT7
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.37228875324564575,0.6408682807033774,0.9333333333333333,1.0,1.0,2/11,16.85%,VIL1;CFL1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.4004819002251463,0.6408269644235086,0.9090909090909091,1.0,1.0,5/9,44.18%,H3-3A;TERF2IP;DAXX;ACD;POT1
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.4004819002251463,0.6408269644235086,0.9090909090909091,1.0,1.0,5/9,44.18%,H3-3A;TERF2IP;DAXX;ACD;POT1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3067721951348648,0.6405626357417135,0.918918918918919,1.0,1.0,8/37,23.96%,RAD1;ECT2;RHOB;GPR88;CDKN1A;FIGNL1;RAD9B;RRH
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.384233050804748,0.6402726929747398,0.9285714285714286,1.0,1.0,2/12,12.81%,IGF1;IGFBP6
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.34492745385796975,0.6402047248699777,0.9444444444444444,1.0,1.0,8/24,29.69%,LEF1;CD4;CSF1;HLA-DRB1;CASP8;CD74;DCSTAMP;RUNX1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.2615132646341046,-0.6401604516377533,1.0,1.0,1.0,13/50,18.14%,ST3GAL3;POFUT1;GALNT13;XXYLT1;GALNT12;ST3GAL2;MUC19;MUC13;ST3GAL4;GALNT9;GALNT7;MUC3A;GALNT2
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.3661539997040797,-0.6400316320526234,0.8333333333333334,1.0,1.0,2/6,20.43%,DHDDS;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.3661539997040797,-0.6400316320526234,0.8333333333333334,1.0,1.0,2/6,20.43%,DHDDS;DOLPP1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.3977385131014902,-0.6399344774651662,0.8378378378378378,1.0,1.0,1/9,18.85%,XRCC4
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.35680656146383305,0.6397535931268262,0.859375,1.0,1.0,1/11,9.14%,B4GALNT2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.2813749142407621,-0.6395969957790717,1.0,1.0,1.0,10/40,18.82%,PTPRO;FZD7;EMP2;WASHC2C;CORO2B;RELL2;LIMS1;RHOA;NF1;NOTCH1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2955665332292364,0.63940897271068,0.9875,1.0,1.0,9/52,23.68%,ARIH2;RNF187;KBTBD7;UBE3A;KBTBD6;SYVN1;RBX1;RNF5;AMFR
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.33798726439434734,-0.6393168467254451,0.8888888888888888,1.0,1.0,3/14,17.16%,SLC2A9;SLC2A11;SLC2A8
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3188082726246386,-0.6393079282544469,0.9736842105263158,1.0,1.0,2/14,4.89%,KCNG1;KCNE1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.3880138757784022,0.6389191949322695,0.9423076923076923,1.0,1.0,3/8,21.69%,HSPA5;HERPUD1;DDIT3
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.3259629162478226,0.6387057996168474,0.9130434782608695,1.0,1.0,2/26,6.20%,FGF2;CCDC39
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.2968836430917222,0.6386453127015821,0.9583333333333334,1.0,1.0,1/38,4.40%,TRIM62
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.2757545819288131,0.6386124843168721,0.9878048780487805,1.0,1.0,11/96,18.52%,ESR1;TGFB1;USP50;LCP1;DDX3X;SYK;RPA3;ISG15;PSMC5;IL5;MTLN
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.25339532502514905,-0.6382484881706855,1.0,1.0,1.0,11/75,15.37%,SMYD5;SP7;CBFB;HES1;SLC4A11;LDB1;PSMB2;ESRRB;PSME4;PSMA1;PUS7
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3309554800332545,0.6380148012044892,0.8923076923076924,1.0,1.0,1/21,4.92%,ACTG1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.24061874668331906,-0.6375252023042851,1.0,1.0,1.0,16/63,22.46%,RAD50;MUS81;FAN1;POLD3;ANKLE1;GTF2H2;DNASE1L1;ERCC2;RFC3;ERCC1;DCP1B;FBH1;XRN2;DXO;DCP1A;SETMAR
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.2852423429318942,0.6374884779337222,0.972972972972973,1.0,1.0,5/65,16.31%,CDC25A;MMP9;SDE2;CDKN1A;MME
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.38294592000630284,-0.6374571238502744,0.9318181818181818,1.0,1.0,2/7,22.89%,ATG2A;ATG7
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.38294592000630284,-0.6374571238502744,0.9318181818181818,1.0,1.0,2/7,22.89%,ATG2A;ATG7
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.288302717946219,-0.6364032385889665,0.9375,1.0,1.0,4/33,10.56%,ATP6V0D2;ATP6V1E2;ATP6V0A2;HFE
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.31491598512582064,0.6362564733126936,0.958904109589041,1.0,1.0,5/23,20.26%,CDKN2A;CDKN1A;HMGA1;HMGA2;MAP2K1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.2396448974417026,-0.6361879982814879,1.0,1.0,1.0,18/95,20.09%,GBP2;PRICKLE1;RPF2;POM121C;NUP214;NOL8;ZBTB7A;RANBP17;TOR1B;CTDNEP1;IPO7;MORC3;E2F3;CHCHD10;NUTF2;SUPT7L;PML;YWHAE
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.37265602857122454,0.6360267837900815,0.9117647058823529,1.0,1.0,1/11,5.45%,TGFB1
prerank,GO_Biological_Process_2021__equilibrioception (GO:0050957),-0.3894019368126872,-0.6360141682128155,0.7631578947368421,1.0,1.0,4/5,35.51%,PCDH15;MYO7A;CLRN1;CDH23
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.279128785471604,-0.6359197457969357,0.9523809523809523,1.0,1.0,5/38,9.37%,KCNJ16;KCNMB2;KCNE1;FLNA;KCNJ6
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.34504834211102614,-0.6357606259584333,0.8823529411764706,1.0,1.0,3/9,24.90%,EHD3;RAB11B;SORL1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.28271105693145654,0.6357172924220549,1.0,1.0,1.0,9/90,14.19%,STK26;WAS;CYP1B1;DUSP22;CLDN5;RHOB;SPOCK3;DACH1;ALOX15B
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.3814443280105206,0.6357129966087178,0.9047619047619048,1.0,1.0,1/9,6.28%,MESP1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.39480249040464716,-0.635663307342424,0.8648648648648649,1.0,1.0,1/8,9.31%,ERCC8
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.27806288238603605,0.6356425830395215,0.9759036144578314,1.0,1.0,17/68,30.66%,INTS5;TAF5;GTF2E1;TAF13;TAF6;PHAX;SNAPC5;INTS2;GTF2A1;ELL2;NCBP1;SNAPC1;POLR2H;CDK7;POLR2B;POLR2K;CDK9
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.3587009636528612,-0.6354428135448205,0.9230769230769231,1.0,1.0,2/9,5.28%,PC;APOE
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.327349402251712,-0.6353325899903096,0.8918918918918919,1.0,1.0,8/8,67.28%,PRKN;AMBRA1;BECN1;ATG13;SQSTM1;ATG14;MAP1LC3B;PHB2
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3073339514592395,0.6352853435628423,0.9857142857142858,1.0,1.0,4/45,13.64%,LPAR1;FHOD1;TGFB3;VIL1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.2697857999160885,-0.6351715959168337,1.0,1.0,1.0,6/25,20.83%,DPM3;PGAP1;PIGQ;GPLD1;PGAP3;PIGW
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.26175556237549774,0.6350180230578002,1.0,1.0,1.0,18/142,20.14%,ACAA2;ACSL5;INMT;UBE2L6;H2AZ1;XIST;ACSM3;RDH16;PRDX6;HSDL2;YWHAH;GLUL;GRHPR;HSPH1;ALDH9A1;ENO2;ALDH3A2;SERINC1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.3143349444988167,0.6350147262704774,0.9701492537313433,1.0,1.0,7/34,19.01%,TLR2;SCIMP;SYK;TNFSF4;AGER;TIGIT;THBS1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.3278537838664225,0.6348558010892107,0.9846153846153847,1.0,1.0,2/17,12.47%,FTH1;NLRC3
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.3062520656502981,-0.6346541796813447,0.8918918918918919,1.0,1.0,1/18,2.73%,EGR1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.4151569442271147,-0.6346390938955577,0.9591836734693877,1.0,1.0,1/5,20.49%,PBXIP1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.22581743233621723,-0.634461169886877,1.0,1.0,1.0,39/201,18.94%,TTC21A;DCDC2;CNGA4;MLF1;TRIM66;CASKIN1;PTPRF;SPTBN4;LRRC73;PRR36;CAP2;MPP2;EPB41L4B;MORN4;SRRM3;HPCA;NCS1;RTP1;ATP9A;OSCP1;GPC1;KCTD1;NAT14;NME5;WDR54;LINGO1;CSPG5;FAM81A;B9D1;TRAF3IP1;IMPDH1;RIC8B;SYT7;CNPPD1;KLHDC9;SRCIN1;IFT43;TESC;TTC5
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.37370734682590817,0.6342826519521781,0.9285714285714286,1.0,1.0,1/12,6.28%,PHF23
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.32769115467378745,0.6341353980835593,0.9402985074626866,1.0,1.0,3/24,13.30%,TGFB1;ECT2;ZIC1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.32715635188318837,-0.6340252798806187,0.90625,1.0,1.0,4/13,11.96%,MUS81;MSH4;HFM1;SLX4
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.3616182747854196,0.6338020399010705,0.8888888888888888,1.0,1.0,3/15,18.52%,MESP1;POPDC2;MTLN
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.367315518443872,0.6337133762165977,0.927536231884058,1.0,1.0,2/14,16.02%,TRPV6;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.367315518443872,0.6337133762165977,0.927536231884058,1.0,1.0,2/14,16.02%,TRPV6;SLC24A1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.3600303598883513,-0.6335282975027319,0.868421052631579,1.0,1.0,5/10,28.22%,CPT1A;ACACB;PRKAG2;SLC25A20;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.3879624997640996,0.6334149386214046,0.9137931034482759,1.0,1.0,3/8,30.73%,AGER;XRCC6;LGALS9
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.3872675899858393,-0.6331352689218959,0.8636363636363636,1.0,1.0,1/5,6.40%,CBFB
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.2559936056034217,-0.6331046971484711,1.0,1.0,1.0,5/38,12.50%,BCL2;PID1;SLC4A11;OPRD1;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3337179470317802,0.6330969533935212,0.9473684210526315,1.0,1.0,1/21,5.45%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.3398552467697456,-0.6328579921006751,0.918918918918919,1.0,1.0,1/14,10.84%,DAPK2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.27611766860658515,0.6325711626228936,0.975609756097561,1.0,1.0,17/69,30.66%,INTS5;TAF5;GTF2E1;TAF13;TAF6;PHAX;SNAPC5;INTS2;GTF2A1;ELL2;NCBP1;SNAPC1;POLR2H;CDK7;POLR2B;POLR2K;CDK9
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.26242081869792433,-0.6325036898700513,0.9583333333333334,1.0,1.0,12/78,15.84%,PARD3;SLC25A17;ZDHHC23;ZDHHC11B;PEX13;PEX14;ZDHHC14;RTP1;TAOK2;SDCBP;ZDHHC18;ZDHHC3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.32614028712296805,0.6321100177739639,0.95,1.0,1.0,9/22,23.81%,RPL3;MRPL20;NOP53;RPL11;RSL24D1;RPL23A;RPLP0;RPL24;RPL10
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.2298367376658791,-0.6318322690869144,1.0,1.0,1.0,28/82,24.90%,CCDC22;KLHL20;COMMD1;GBF1;DOP1B;LLGL1;AP4S1;OSBPL5;SH3D19;SCAMP2;CLINT1;ACBD3;AP1B1;SORCS1;RAB10;GOLGB1;DNM2;ARRB1;CLVS1;RABEP1;DTNBP1;VAMP8;STXBP6;VPS35L;AP1M1;AP4E1;EXOC2;SORL1
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",0.3764411948935402,0.6316315179039572,0.8484848484848485,1.0,1.0,3/7,21.15%,TNFSF4;MYB;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.41057242258646814,-0.6314701323881529,0.9,1.0,1.0,3/5,21.53%,LETM1;MICU1;CLN3
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.4019442840588443,-0.6312435341183975,0.8648648648648649,1.0,1.0,1/6,10.73%,SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.4019442840588443,-0.6312435341183975,0.8648648648648649,1.0,1.0,1/6,10.73%,SCARB1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.31909854516376246,-0.6309229948423369,0.9655172413793104,1.0,1.0,8/19,31.62%,TUBGCP2;CCDC57;AKAP9;CSNK1D;TUBG1;TPPP;GOLGA2;TUBG2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.2884629954734836,-0.6307066709974344,1.0,1.0,1.0,6/29,17.98%,ERBB2;PTPRR;PRKCA;MATK;NRG2;BTC
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.27502668320500634,0.6304577226437812,0.9876543209876543,1.0,1.0,26/100,25.17%,TP53TG5;TGFB1;CRLF3;CDKN2A;EI24;GNG4;PPT1;DDX3X;CDKN1B;RERG;ALOX15B;BTG1;CDKN1A;CCDC85B;MT1M;TCHP;CDKN2C;PSRC1;RBBP7;NAIF1;FRZB;MT2A;NOTCH2;HYAL1;TMPRSS4;CDKN2D
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.40334054548837417,-0.6299738410937368,0.8888888888888888,1.0,1.0,2/5,16.90%,TRIM44;PPIA
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.42282398452611214,0.629863928976826,0.9253731343283582,1.0,1.0,5/5,57.73%,SRP54;SEC61A2;SEC61A1;SEC61B;ZFAND2B
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3232486126106696,0.6298078189944784,0.9230769230769231,1.0,1.0,4/21,16.35%,EXOSC2;EXOSC8;RPP40;RPS21
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.3497923549761517,-0.6294794114968503,0.8780487804878049,1.0,1.0,2/6,21.19%,RPUSD1;RPUSD4
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.3873075890805524,0.6293771881443254,0.9041095890410958,1.0,1.0,1/7,23.74%,NOTCH2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.360531521893413,0.6290426654292022,0.9420289855072463,1.0,1.0,3/10,23.81%,TIMM22;ROMO1;TIMM10
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.32818112169557123,-0.6286095416929205,0.8787878787878788,1.0,1.0,5/13,29.64%,FOXP3;ZBTB7B;NIPBL;SAP30BP;AKAP8L
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.24026803753296283,0.6283825659616595,1.0,1.0,1.0,89/908,17.53%,NEK2;NOTUM;APOL1;ST6GALNAC1;PSMB9;GALNTL5;PTPRH;ITIH2;GAD1;ANXA1;ART1;ASB5;GMFG;SDC2;PTPRC;ROS1;DTL;GLRX;UBE2L6;FCGR3A;FBXL7;LOX;FAM20A;MAK;STRADA;HIPK1;C3;ASB14;TGFB1;GRK7;STK26;FUT2;SOCS2;SERPIND1;USP6;PPP2R3A;MMP15;PINK1;B3GNT9;ANKRD9;ASB15;SPSB2;HCK;RAB11A;FLG;ZC3HAV1;MAP3K11;ASB17;SYK;KLHL2;PP2D1;B3GNT5;CP;OGFOD1;PIGH;GLYCTK;KLHL13;TGOLN2;PDK4;KBTBD7;DUSP29;RABGGTB;ERN2;UBE2M;KNG1;PPP2R5A;COPS4;FBXL13;ISG15;TGM2;CHST4;ENGASE;DUSP16;FBXL3;KBTBD6;LATS2;ZAP70;GNMT;ART3;PSMC5;PLAT;COPS5;PENK;B3GALT2;PARP14;MAPK3;STK17B;STRADB;STK17A
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.2862804600871541,0.6281353606160599,1.0,1.0,1.0,4/45,16.68%,IMPA1;PLD4;PLCD1;IMPA2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.3139673376525459,0.6277088090210124,1.0,1.0,1.0,4/32,12.77%,FAXDC2;SCIN;STAT1;PITHD1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.3208271821420444,-0.6275021285719521,0.9696969696969697,1.0,1.0,2/12,16.53%,EPHB2;ARHGAP35
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.37674366469205844,0.6274619854726202,0.9137931034482759,1.0,1.0,2/9,17.72%,ACTA2;HTR2B
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.35986226108488745,-0.6269738429594713,0.8,1.0,1.0,9/9,64.03%,CENPF;CENPE;CENPW;CENPT;CENPC;POGZ;MIS12;CENPA;DLGAP5
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.300717071581772,-0.6268616718859534,0.967741935483871,1.0,1.0,6/25,11.02%,SARDH;THNSL2;GSTZ1;CBS;ALDH4A1;KYAT1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.2852607231826927,0.6267589595186335,0.9875,1.0,1.0,20/67,31.39%,NFIL3;ACTG1;PNRC1;SEMA3B;PLAUR;FDFT1;SCD;ATF5;CXCL16;ERRFI1;SQLE;TMEM97;FASN;HMGCR;CLU;LGMN;HMGCS1;CTNNB1;PDK3;FADS2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.2850144528582749,0.6267526708743212,0.974025974025974,1.0,1.0,12/69,24.15%,PTPRC;NMUR2;CXCR5;ACKR4;P2RY12;XCR1;HTR2B;ACKR2;FIS1;ATP2A2;BCAP31;MCTP2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2681800383824986,-0.6265516717988058,0.9565217391304348,1.0,1.0,2/28,6.52%,DCPS;LSM7
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.2926357085038858,-0.6265170199554267,0.896551724137931,1.0,1.0,1/23,3.90%,NR4A3
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),-0.3753658761950544,-0.626516606009298,0.8604651162790697,1.0,1.0,2/5,17.06%,MRAP2;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.2804917099879888,0.6263859617577195,0.975,1.0,1.0,15/63,24.34%,DISC1;IFIT1;DAB2;LRPAP1;CDKN1A;TFIP11;MITD1;EFHB;TMC8;ATP2A2;B2M;PARK7;ZFPM1;CTSZ;BAG2
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.3376417099334144,-0.6263556379791434,0.84375,1.0,1.0,5/14,21.04%,TRPC3;CIB2;P2RY11;TRPV1;SSH1
prerank,GO_Biological_Process_2021__glutathione catabolic process (GO:0006751),0.40355102248424124,0.6263102257860563,0.8333333333333334,1.0,1.0,2/5,19.68%,GGT5;CHAC2
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.2610329750813791,-0.6260522489911371,1.0,1.0,1.0,8/32,22.12%,STX11;UBXN2A;CHP1;FER1L5;UBXN2B;DNM2;RABEP1;NSFL1C
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.2897807216488163,-0.6254410978766209,1.0,1.0,1.0,10/33,25.25%,TIE1;PKD2;SLIT2;COL4A1;NOTCH4;PKHD1;RASIP1;LRP6;BMP4;PAX2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2873773768878811,-0.6253407007922707,1.0,1.0,1.0,8/24,32.40%,LDB1;CCNT1;WDR43;ZMYND11;THOC1;HMGN1;ALYREF;KAT7
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.24785792295093484,0.6252149750905996,1.0,1.0,1.0,29/225,16.53%,MYRF;ROGDI;SCTR;C3;PCDH18;NMUR2;SOX10;ITGAM;SCIN;JRKL;DDIT4;TBX6;SPINK6;PPT1;EMX1;GRIN2D;B3GNT5;ZIC1;NPAS1;CDK5R1;UGT8;UBE3A;CELSR1;NHLH1;AFF2;SOX9;ATP6AP2;THOC6;ADGRG1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.38645972021884206,0.6247659680058792,0.8392857142857143,1.0,1.0,3/6,30.73%,AGER;HLA-B;LGALS9
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.2903456927268761,0.6246246551686937,1.0,1.0,1.0,9/50,20.02%,FANCF;FAAP20;DCLRE1A;RPA3;DCLRE1C;RPS27A;CENPX;RAD51AP2;MSH6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.2912843888286374,0.6245971115420675,0.9855072463768116,1.0,1.0,19/59,25.83%,CNMD;TGFB1;MCC;MARVELD3;STAT1;IL26;NLRC3;SOX9;ATP5IF1;THBS1;B2M;GHRL;AQP11;CEACAM1;KLF9;CAV2;MTSS1;ALOX5;BRCA2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.31730994228314224,0.6242388114449473,0.9710144927536232,1.0,1.0,6/21,22.64%,PDE6A;GRK7;GUCY2F;CNGA1;PDE6B;PDE6G
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.3532961802874852,0.62423651468777,0.9836065573770492,1.0,1.0,4/14,34.04%,LDLRAP1;STAR;VPS4A;STARD4
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.2912328236887943,-0.6241759947126925,0.9285714285714286,1.0,1.0,20/20,70.90%,POLR2F;POLR2C;TERF1;TERF2;ATRX;POLR2D;POLR2G;TINF2;POLR2J;POT1;ACD;POLR2I;DAXX;POLR2L;POLR2A;POLR2E;TERF2IP;POLR2K;POLR2B;POLR2H
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.2912328236887943,-0.6241759947126925,0.9285714285714286,1.0,1.0,20/20,70.90%,POLR2F;POLR2C;TERF1;TERF2;ATRX;POLR2D;POLR2G;TINF2;POLR2J;POT1;ACD;POLR2I;DAXX;POLR2L;POLR2A;POLR2E;TERF2IP;POLR2K;POLR2B;POLR2H
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.31909118565870176,0.6237763619135732,0.9253731343283582,1.0,1.0,4/19,21.78%,FKBP4;FKBP5;PPIC;PPID
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.3032027432747398,0.6237273978104131,0.9836065573770492,1.0,1.0,2/36,8.89%,ENDOG;RAD54L
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.313773925220936,0.6237019665591649,0.9583333333333334,1.0,1.0,8/33,23.45%,BOK;GSDME;SIAH1;BBC3;RPS7;FIS1;DDIT3;BCAP31
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.3840165995075436,0.6236955979323461,0.9,1.0,1.0,1/8,7.14%,DAND5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.312511788720048,0.6226743901040865,0.9166666666666666,1.0,1.0,5/23,28.63%,CAV3;YWHAH;SCN4B;SCN1B;SCN5A
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),0.4117230835301794,0.6224291947310899,0.9090909090909091,1.0,1.0,1/7,11.99%,STRA8
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.27268482176834535,-0.6218863151002895,0.9655172413793104,1.0,1.0,6/26,14.75%,ERBB2;STAT5B;SYAP1;DAB2IP;SNAI2;MARS1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-0.4073343628872418,-0.6213946954837379,0.9069767441860465,1.0,1.0,2/5,11.90%,RIPK2;IRGM
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.32648663535499667,0.6213364746978872,0.953125,1.0,1.0,3/25,13.30%,TGFB1;ECT2;ZIC1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.3208940168758609,0.6213220284354977,0.9242424242424242,1.0,1.0,6/15,24.55%,ASIC1;GPR68;PKD1L3;MCOLN1;HVCN1;HYAL1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.2885978046398754,0.6209266590071095,0.96,1.0,1.0,5/38,20.53%,CERS3;CLN8;DEGS1;ALOX12B;DEGS2
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3292029678295091,0.620666115620872,0.927536231884058,1.0,1.0,2/13,14.93%,REST;SOX9
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.24570312409102224,0.620626924882402,1.0,1.0,1.0,15/272,10.99%,ESR1;SLFN14;FGF2;HEY2;TGFB1;GPER1;ABCC2;NLRP12;IGF2BP2;RPL13A;REST;PINK1;IGF1;CLDN5;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.2799961282333008,0.6202397543160069,1.0,1.0,1.0,7/64,16.31%,DISC1;LRP2;GPER1;PLXNA3;TGM2;OPRM1;MME
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.32869883818713186,0.620179214455652,0.9333333333333333,1.0,1.0,1/11,12.09%,KDM3A
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.3782654337762108,0.619937045907693,0.8823529411764706,1.0,1.0,1/8,8.70%,DAAM2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.350532044734185,0.6197468943345463,0.9152542372881356,1.0,1.0,1/17,6.70%,CD99
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.328147437478921,-0.6196391884935588,0.9629629629629629,1.0,1.0,6/14,25.45%,CDK1;CTDNEP1;PRKCA;NEK9;NEK6;LPIN1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.35818348309401116,0.6194766986759257,0.9682539682539683,1.0,1.0,3/11,17.16%,NR1H4;PDK4;UCP1
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.3605640734040566,-0.6192986075650909,0.86,1.0,1.0,1/6,5.28%,APOE
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.35793620713069874,-0.6188018901427833,0.95,1.0,1.0,1/7,4.89%,KCNE1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.24679213427612387,0.6185615626975408,1.0,1.0,1.0,30/256,16.14%,CDC25A;PCLAF;PTPRC;DTL;SPATA22;TGFB1;IL12A;CRLF3;GPER1;SMIM22;CDKN2A;AFAP1L2;IRF1;TP53BP2;RHOB;CKS1B;CCND1;FOXM1;CDKN1B;UHRF2;NOP53;FBXO5;ALOX15B;CDC14A;CDKN1A;SOX9;GADD45GIP1;FBXL3;WDR6;CYLD
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.2758892555143351,0.618406290030803,0.9743589743589743,1.0,1.0,6/67,14.77%,KIF14;CXCR5;RAB11A;ECT2;KLHL13;CDC14A
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.40059034476007704,0.617555068461903,0.9253731343283582,1.0,1.0,4/8,31.25%,EFHB;GRAMD2A;SARAF;CASQ1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.32560920863926957,0.6174619888064382,0.9605263157894737,1.0,1.0,6/25,26.58%,CAV3;CDK5R1;PSRC1;DCTN1;ANKRD53;RPS3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2644455420524914,-0.6172796150093871,1.0,1.0,1.0,2/30,6.52%,DCPS;LSM7
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.24287325963206347,0.6172038620655781,1.0,1.0,1.0,47/246,22.94%,DDX20;BOK;SCIN;GPER1;MOAP1;TNFRSF10A;NLRC4;DNAJA1;REST;CYP1B1;MAP3K11;DDX3X;ECT2;RHOB;SYK;TGFB3;PXT1;RPS27A;PNMA1;ING3;MTCH1;KNG1;TGM2;TFPT;SIAH1;SFRP4;LATS2;PNMA2;RASGRF2;STK17B;STK17A;OBSCN;ZNF622;NOS2;PHLDA1;ITGB3BP;DKKL1;HMGA2;RPS6;GADD45B;APAF1;SAP18;FRZB;PPID;TRADD;MLLT11;PRR7
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.2673454701045752,0.6171871488494629,1.0,1.0,1.0,11/74,21.50%,STRADA;TGFB1;SRSF9;RANBP3L;THOC6;STRADB;DHX38;RAE1;SRSF3;PHAX;SRSF5
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.30691779930781865,-0.6171409555747237,0.9487179487179487,1.0,1.0,2/15,8.39%,GALP;CXCL14
prerank,GO_Biological_Process_2021__sinoatrial node development (GO:0003163),0.3906291105505398,0.6170953794242225,0.9076923076923077,1.0,1.0,1/6,6.28%,MESP1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.33461233979453875,0.617047631967579,0.9696969696969697,1.0,1.0,2/16,16.20%,TGFB1;DDR2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.33795024567648085,-0.6168745388231126,0.8888888888888888,1.0,1.0,8/8,66.22%,CRMP1;DPYSL2;DPYSL4;DPYS;DPYSL5;ALDH6A1;DPYSL3;DPYD
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.3326334704682242,-0.6166655001585044,0.9428571428571428,1.0,1.0,4/10,22.00%,CX3CR1;SBNO2;FER1L5;LBP
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.2135835461795263,-0.6165020138447944,1.0,1.0,1.0,19/163,15.18%,CDH4;GRID2;SLC17A6;ELAVL3;GALNT13;MEGF10;INA;SNCB;INSYN2A;LINGO2;TAGLN3;TRIM44;NOVA1;BRINP1;CIB2;HAR1A;ST3GAL5;ERC2;LINGO1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.36755972476965376,-0.6156653424870275,0.9347826086956522,1.0,1.0,2/7,9.54%,TIE1;EMILIN1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.2455571359755969,-0.6156231360903774,1.0,1.0,1.0,6/37,12.86%,E2F6;TFDP1;RRM2;DAB2IP;PCGF6;RING1
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.35398267495867114,-0.6150338697358839,0.8918918918918919,1.0,1.0,1/5,3.88%,PTPRO
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.35398267495867114,-0.6150338697358839,0.8918918918918919,1.0,1.0,1/5,3.88%,PTPRO
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.25019971411375536,0.6147109471900353,1.0,1.0,1.0,29/154,26.42%,LIX1;SHISA6;STMN4;TMEM35A;CYB561;LY6H;TCEAL5;NEFM;VSTM2A;CCK;CNTN2;SNX21;ZNF536;TSHZ1;LRRTM1;SYT4;LSAMP;SULT4A1;ATF5;CHRNA3;CDK5R2;SCN7A;RGS3;SLC10A4;CPE;TCEAL7;FBXO7;IGF2BP3;CARTPT
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.2370700607261279,-0.6145630221386553,1.0,1.0,1.0,6/38,12.86%,E2F6;TFDP1;RRM2;DAB2IP;PCGF6;RING1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.24805433754448286,0.6140489555050287,1.0,1.0,1.0,56/234,28.63%,NOX5;SLC9A2;KCNA7;SLC12A3;TRPV6;TRPC7;KCNA5;KCNG2;SLC6A4;ASIC5;KCNS2;ATP6V0E2;ATP1A4;ASIC1;KCNK7;SLC9C1;SLC39A7;KCNAB1;SLC24A1;UCP1;KCNK13;RYR3;SLC6A12;SLC30A2;SLC46A1;RHD;KCNJ4;MCOLN1;ATP2A2;KCNJ2;SCNN1G;KCND1;SLC24A5;HVCN1;LRRC38;LRRC55;KCNJ11;SCN7A;SCN4B;SLC36A3;TRPM8;SCNN1A;ATP1A1;SLC30A4;CACNA2D4;KCNA4;SCN1B;ATP6V0D1;ASIC4;KCNS3;ORAI1;KCNK9;KCNF1;SCN9A;SLC30A1;SCN5A
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.3840038607633087,0.6133760683257009,0.9230769230769231,1.0,1.0,2/10,19.68%,GGCT;CHAC2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.32979113094014134,-0.6126333075785638,0.9444444444444444,1.0,1.0,5/9,32.40%,BAG6;CREBBP;KAT2A;EP300;KAT7
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.29107138438050606,0.6123723533881563,0.987012987012987,1.0,1.0,9/66,17.98%,BACE2;CPM;ERAP2;LVRN;ANPEP;HPGDS;MME;SPCS2;DNPEP
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.3432602701493116,-0.6110210209290492,0.9512195121951219,1.0,1.0,1/7,6.51%,MAFG
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.2597383803266425,0.6108494331629383,1.0,1.0,1.0,8/133,10.49%,NEK2;ROS1;FLT1;TGFB1;FLT4;ERBB4;PINK1;AXL
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.3527226543482529,-0.6107869577104597,0.9024390243902439,1.0,1.0,1/6,7.22%,TAC3
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.3597570411637264,-0.6105706414888223,0.9714285714285714,1.0,1.0,7/7,64.04%,KDM5A;PRKD2;C6ORF89;SPHK2;CAMK2D;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__choline transport (GO:0015871),-0.4131528046421663,-0.610278937522739,0.9722222222222222,1.0,1.0,5/5,58.70%,SLC44A2;SLC44A4;SLC22A2;SEC14L1;SLC44A1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.3660751104365712,0.6101330328967259,0.9130434782608695,1.0,1.0,1/10,8.62%,PRDX4
prerank,GO_Biological_Process_2021__skin morphogenesis (GO:0043589),0.40754137813776425,0.6100821880537953,0.9,1.0,1.0,3/5,27.81%,COL1A1;ERRFI1;ABCA12
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.25532168453411747,0.6098588399705835,1.0,1.0,1.0,29/125,24.45%,PWP2;DDX20;STRAP;SRSF9;RPL3;GEMIN4;EIF6;RPS5;MRPL20;RPS19;NOP53;SNRPD2;XAB2;DDX23;RPSA;RPL11;RSL24D1;RPL23A;RPLP0;DENR;RPS14;SRSF5;RPL38;RPS15;RPL24;RPS27;RPL10;RPS28;ABT1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.3116388515069806,-0.6095871473071928,0.875,1.0,1.0,2/19,13.35%,AUP1;BAG6
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.29649301234420766,0.6089479755287099,0.9230769230769231,1.0,1.0,1/40,3.49%,PTX3
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.29704719230758503,-0.6088510456425688,0.925,1.0,1.0,5/29,15.94%,EPHB2;CRH;GRIN1;GRIA4;SLC6A9
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.2982982966826532,0.608304663446258,0.9552238805970149,1.0,1.0,1/31,1.98%,RORC
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2417754576892315,0.6082081408474119,1.0,1.0,1.0,26/264,19.48%,RASGRP4;PSMB9;CSF2RA;CCL5;FGF20;FGF2;TGFB1;ERBB4;IGF1;GFRA1;KLB;HGF;RPS27A;KBTBD7;SOX9;RASA1;PSMC5;RASGRF2;MAPK3;HTR2B;IL5;LAMTOR3;DLG4;IL3RA;PSMB6;RASGRP1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.3171691447084121,0.6076775968474328,0.9710144927536232,1.0,1.0,5/21,32.37%,TDG;EXOSC4;OGG1;TERF2IP;UNG
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.38459569089280465,-0.6075441433807887,0.875,1.0,1.0,1/6,20.57%,RAB11B
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.2801610079033224,-0.6070289029751419,0.9629629629629629,1.0,1.0,11/24,26.87%,SCARB1;PITPNM1;OSBPL5;OSBPL8;PITPNA;PRELID3A;PITPNB;EPG5;ABCA3;PRELID2;PITPNC1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.34996032833621993,0.6070075631721837,0.9322033898305084,1.0,1.0,2/11,19.32%,EXOSC2;EXOSC4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3090110390105498,0.6068591712856507,0.9545454545454546,1.0,1.0,4/21,26.52%,RPS27A;CYLD;IRAK1;CASP8
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.26777818190277775,-0.6068043472610134,1.0,1.0,1.0,7/32,20.55%,FLNA;CRK;LIMS1;CRKL;CSPG5;ABL1;S100A10
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.2767906040612202,0.60594155196527,0.9733333333333334,1.0,1.0,11/39,23.87%,ATP5PF;PLP1;RAD1;HSPA5;CKB;DYNLL1;YWHAH;BASP1;COX6B1;GNB4;PADI2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.3442662861841629,-0.6058046203432017,0.9047619047619048,1.0,1.0,2/8,22.80%,DNM2;MIEF2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.3442662861841629,-0.6058046203432017,0.9047619047619048,1.0,1.0,2/8,22.80%,DNM2;MIEF2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.34010477348809276,-0.6052870493194954,0.8333333333333334,1.0,1.0,1/11,3.84%,CCDC22
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.307397907987712,0.6052223361725537,0.9714285714285714,1.0,1.0,2/28,11.81%,RAB11A;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.35325672767438737,0.6050971869769007,0.8412698412698413,1.0,1.0,2/7,24.11%,TMEM33;AGR2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.284304159466991,0.604934392317087,0.9861111111111112,1.0,1.0,11/56,22.60%,ANXA1;MMP9;CYP1B1;ECT2;RHOB;ZNF580;UCP1;MAPK3;ROMO1;PLEKHA1;PARK7
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.29008942950473465,0.6046851099736668,0.9242424242424242,1.0,1.0,9/22,33.77%,HSD17B2;CYP21A2;FDXR;STAR;HSD17B6;FDX1;AKR1B1;AKR1B15;CYP19A1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.3671856824095782,-0.603861567138197,0.8529411764705882,1.0,1.0,2/7,23.74%,PNKD;PRKN
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.25514306971822104,0.6037463273912789,1.0,1.0,1.0,6/78,16.44%,RORC;ZFP69;PSAP;TNFAIP8L3;FDFT1;SCD
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.3622330911182959,0.6036529425840711,0.9137931034482759,1.0,1.0,4/13,17.10%,GLRA2;GLRA1;ADCY7;CHRNB2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.2875128952937711,0.6034810789991815,0.974025974025974,1.0,1.0,3/36,12.79%,A4GALT;B3GNT5;PIGH
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3302166193833965,0.6032839620310753,0.9428571428571428,1.0,1.0,2/17,13.83%,POLQ;RMI2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.37889551569716623,-0.603060710573878,0.8888888888888888,1.0,1.0,4/8,28.02%,NOTCH1;TGFB2;TGFBR1;DLL4
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.38691734816127304,-0.6027642294222734,0.9024390243902439,1.0,1.0,1/6,9.71%,GBF1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.38691734816127304,-0.6027642294222734,0.9024390243902439,1.0,1.0,1/6,9.71%,GBF1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.38691734816127304,-0.6027642294222734,0.9024390243902439,1.0,1.0,1/6,9.71%,GBF1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.28964569412395214,0.6017740322130132,0.9571428571428572,1.0,1.0,7/47,21.79%,SCIN;WAS;VIL1;PSTPIP1;CFL1;GAS7;GHRL
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.3790041232974356,0.6015723417880419,0.8923076923076924,1.0,1.0,1/7,8.70%,DAAM2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.2781144744426267,-0.6015572455998266,1.0,1.0,1.0,7/27,24.43%,TGFA;EDN3;BTC;INSR;ANAPC7;DRD3;PDGFB
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2304427778853522,0.6013262330691468,1.0,1.0,1.0,28/353,15.29%,TRIM58;ASB5;FBXL7;TRIM62;ARIH2;DTX2;RNF26;RNF187;HLA-A;PINK1;ANKRD9;RRAGA;SPSB2;RNF212B;TRAIP;TRIM68;KLHL2;SDE2;VPS18;TRIM74;TRIM77;RPS27A;KLHL13;UHRF2;UBE2M;ISG15;RNF138;FBXL3
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.24923940388392696,-0.6010679457688503,1.0,1.0,1.0,6/50,11.32%,EXTL1;DDX11;PDIA6;ERN1;CTDSP2;PREB
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.23785023885341217,-0.6008524912646811,0.9655172413793104,1.0,1.0,7/36,17.93%,FAN1;POLD3;GTF2H2;ERCC2;RFC3;NTHL1;ERCC1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.25852277328166745,0.6005146444278342,1.0,1.0,1.0,8/106,15.30%,CAPN13;CHDH;HAMP;PPP1R1B;SOWAHA;CP;AQP4;BMI1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.21893578588076576,-0.6002555007931896,1.0,1.0,1.0,8/80,11.23%,APOE;PRICKLE1;SLC25A17;POM121C;NUP214;PEX13;PEX14;SNX33
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.2960991761849425,0.6000924410953209,0.9558823529411765,1.0,1.0,8/27,33.76%,CHMP3;CEP76;CHMP1A;C10ORF90;CCNF;CHMP4B;FBXW5;CHMP2B
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.27987674820081215,-0.5997646596209064,1.0,1.0,1.0,1/26,3.40%,IFT88
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.33335375120058997,0.5995858701195307,0.9117647058823529,1.0,1.0,2/9,22.13%,ACOT4;CRAT
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.3341246742538068,0.5992169900681554,0.9016393442622951,1.0,1.0,2/12,13.15%,TGFB1;TJP3
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.3094859354765037,-0.5988805114413547,1.0,1.0,1.0,7/18,24.43%,TGFA;EDN3;BTC;INSR;NPM2;DRD3;PDGFB
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.26705633548650326,0.5988049485025987,0.9861111111111112,1.0,1.0,6/69,18.17%,RANBP6;RGPD1;SYK;RGPD3;RGPD4;KPNA5
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3017921391326496,0.598539578787,1.0,1.0,1.0,3/24,16.14%,RPS27A;LACC1;CYLD
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.35384912959381043,-0.5983979443434326,0.851063829787234,1.0,1.0,5/5,64.63%,CAMK2B;FRMPD4;SHANK3;CTNNA2;CAMK1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.2599248982167901,0.5980092366407744,0.9879518072289156,1.0,1.0,11/86,21.23%,PTPRC;USP6;HCK;RAB11A;SYK;CHMP3;STON2;MAPK3;DENND10;MAP2K1;OLFM4
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.2937857372808088,-0.5978601632425031,0.9393939393939394,1.0,1.0,9/20,32.11%,BCR;TAOK2;PEAK1;SRC;WHAMM;ACTN2;PIP5K1A;TRIP6;ACTN1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.30166509691781296,-0.5978562573750156,0.9428571428571428,1.0,1.0,4/12,20.51%,KCNE1;KCNH2;YWHAE;KCND3
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.3167973056718573,-0.5976920956988834,0.9743589743589743,1.0,1.0,2/15,12.33%,PID1;NUPR1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.3440249384039852,0.5976912378717749,0.9393939393939394,1.0,1.0,5/14,29.48%,SNAI1;HMGA2;POLE3;LOXL2;MECOM
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.25019029604402115,0.5976832813205107,1.0,1.0,1.0,10/139,12.69%,LPAR1;S100A13;TRIM62;TRAF3IP2;TRIM25;CASP10;PINK1;TRIM68;ECT2;TIFA
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.31426029093160013,-0.597402960866308,0.9705882352941176,1.0,1.0,7/7,68.59%,ME2;FH;ME3;MDH2;MDH1B;MDH1;ME1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3621797998979232,0.5972564727928743,0.9393939393939394,1.0,1.0,2/11,19.37%,PON1;PDZK1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.294970878566718,0.5971518698202996,1.0,1.0,1.0,3/28,17.62%,DNAJA1;MAP3K11;NPPA
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.34519345033588145,0.5968544673071073,0.9508196721311475,1.0,1.0,6/12,27.22%,PARP14;PARP4;PARP15;PARP9;PARP10;PARP8
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.2952854809333571,0.5966725785589544,0.961038961038961,1.0,1.0,11/34,33.06%,NOP53;RPL11;GABARAPL2;BAG5;PARK7;AQP11;WAC;HSP90AB1;UBXN1;UCHL5;CAMLG
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.2899631581600466,0.5966155618337884,0.9857142857142858,1.0,1.0,4/34,19.37%,CAV3;TCAF2;YWHAH;PDZK1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.2985857238870778,-0.5962689086401673,0.9615384615384616,1.0,1.0,3/16,11.60%,RAD50;CTC1;STN1
prerank,GO_Biological_Process_2021__negative regulation of pinocytosis (GO:0048550),-0.352373747955784,-0.5961968831690702,0.8918918918918919,1.0,1.0,1/5,15.37%,NR1H2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.31737519652339097,0.5958054796938811,0.9722222222222222,1.0,1.0,1/19,4.65%,C12ORF57
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.3411923690449231,0.5957484004790197,0.9242424242424242,1.0,1.0,2/12,14.06%,PGM5;CSRP3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.2548159588485626,-0.5957481375881235,0.9655172413793104,1.0,1.0,9/38,21.22%,KIT;FLVCR1;TGFBR3;INHA;ACIN1;MED1;ABCB10;CDIN1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.30187680817376206,0.5956134981263741,0.9743589743589743,1.0,1.0,7/34,18.23%,TGFB1;TGFB3;FBXO5;ISG15;ATRAID;WNT6;FBN2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.3299160509110604,-0.5952579647061069,0.9210526315789473,1.0,1.0,6/6,67.02%,ADAR;PPM1F;ADARB1;NPM1;CORO1C;DUSP26
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.28101675569330264,0.5946766158575834,1.0,1.0,1.0,8/43,20.40%,CCL5;CASR;CAV3;PLN;EFHB;GRAMD2A;CD4;WFS1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.33319336186181414,0.5945981643039978,0.9583333333333334,1.0,1.0,4/15,28.33%,NLRC3;ADCY7;APOD;NLRP7
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.31069552484939567,0.594362160103467,0.9615384615384616,1.0,1.0,2/25,9.75%,CTCFL;SUV39H1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.29070372386579846,0.5942062556241597,0.953125,1.0,1.0,5/45,12.52%,ATP6V1G2;ATP6AP1;FTH1;ATP6V0E2;CP
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.32717675336513174,-0.5940053878318162,0.9696969696969697,1.0,1.0,3/10,25.40%,KLHL22;SESN3;RPTOR
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.32717675336513174,-0.5940053878318162,0.9696969696969697,1.0,1.0,3/10,25.40%,KLHL22;SESN3;RPTOR
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.39251233298643184,0.5937493632325627,0.9272727272727272,1.0,1.0,2/6,20.31%,HMGA2;POLE3
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.34468323054513095,-0.593706244857585,0.8958333333333334,1.0,1.0,3/7,25.58%,IRGM;ATG7;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.28480811818003277,0.5934997062375477,0.9850746268656716,1.0,1.0,13/31,35.97%,CYLD;AGER;RASGRP1;GADD45B;SPI1;PRMT1;PJA2;LGALS9;SASH1;DUSP10;BMP2;DUSP1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.37274512959415235,0.5917675025632424,0.921875,1.0,1.0,2/6,17.19%,LRPAP1;IL4
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.34858192869353616,0.591115798921871,0.9473684210526315,1.0,1.0,1/15,4.99%,INTS5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.3297736506094022,-0.5909048693367621,0.9487179487179487,1.0,1.0,10/10,67.04%,CDC14B;GOLGA2;PLK1;GORASP1;BTRC;FZR1;PTEN;SKP1;UBE2S;RAB1A
prerank,GO_Biological_Process_2021__response to heparin (GO:0071503),0.3929886350088285,0.5906192001521261,0.9152542372881356,1.0,1.0,2/5,14.93%,GPIHBP1;SOX9
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.31326321691600395,-0.590595781572438,0.9333333333333333,1.0,1.0,5/15,18.55%,CCN1;FGFR2;MN1;RHOA;GREM1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.2774417858653201,0.5905163128690519,0.9859154929577465,1.0,1.0,5/39,18.64%,LCP1;FHOD1;RHOB;RHOG;RHOQ
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide metabolic process (GO:0010310),0.39497813097999523,0.5904878770643521,0.9491525423728814,1.0,1.0,1/5,17.66%,NOXO1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.2809593389899992,0.5904405273031381,0.9558823529411765,1.0,1.0,5/31,18.33%,ALOX12;PPT1;GGT5;SCD;ALOX5AP
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.30630700571755154,0.5900938017732553,0.9253731343283582,1.0,1.0,3/24,15.20%,WAS;ARHGAP28;RASA1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.3476128572501602,-0.5900445399729763,0.8333333333333334,1.0,1.0,2/7,24.90%,SLC39A8;SLC39A4
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.2510148581119782,0.5894402325981836,1.0,1.0,1.0,13/118,17.19%,FGF2;STK26;NODAL;CYP1B1;DUSP22;CLDN5;MCC;MARVELD3;RHOB;DACH1;ALOX15B;ADGRG1;IL4
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.3683596837414479,0.589121685477249,0.9666666666666667,1.0,1.0,4/10,27.42%,ACMSD;IDO1;HAAO;IDO2
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.3683596837414479,0.589121685477249,0.9666666666666667,1.0,1.0,4/10,27.42%,ACMSD;IDO1;HAAO;IDO2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.32488559399579686,-0.5890988600767543,1.0,1.0,1.0,2/9,16.70%,NR1H2;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.37048683264844756,0.588716207119792,0.90625,1.0,1.0,1/7,17.16%,PARP14
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.37275054687012965,-0.5883045570678922,0.926829268292683,1.0,1.0,3/6,28.02%,NOTCH1;LRP6;DLL4
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.35833964910557725,0.5878889097467965,0.971830985915493,1.0,1.0,2/11,18.94%,LRPAP1;DLG4
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.35487351452997057,-0.5878812548363744,0.8888888888888888,1.0,1.0,3/7,14.97%,FLNA;EMP2;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.27946345292629554,-0.5875359345990053,0.9655172413793104,1.0,1.0,5/20,23.09%,GSAP;LRRTM3;ABCG1;SLC2A13;CASP3
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.38648056755587357,-0.5873360810141545,0.8292682926829268,1.0,1.0,2/5,29.22%,ADD1;PTPN23
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),0.389570536645269,0.5871936844923441,0.9433962264150944,1.0,1.0,2/5,21.83%,DHDH;RPE
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.25099384606532615,-0.5867690601369973,1.0,1.0,1.0,8/31,25.18%,B3GAT3;ABL1;MSH3;XRCC4;AZIN2;NCSTN;MAPK8;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.29416211855918817,-0.5863711645041012,0.9459459459459459,1.0,1.0,6/14,23.30%,SRSF4;U2AF2;PTBP1;RBMX;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.2915933699591393,0.5861347900543812,0.9864864864864865,1.0,1.0,8/30,23.15%,TBPL1;TAF5;TAF7;TAF13;TAF6;HELB;TAF10;TCEA2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.2961023798262514,0.5859520420827388,0.974025974025974,1.0,1.0,3/22,17.76%,CAV3;IGF1;AGT
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.3453285942193357,0.5854611864034344,0.9736842105263158,1.0,1.0,7/12,44.90%,H3-3A;TERF2IP;DAXX;MIER1;ACD;POT1;UBE2N
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.22848200454443837,-0.5854016099241022,1.0,1.0,1.0,9/51,23.11%,UBXN2A;CDK1;EMD;SPAST;NUP37;NUP98;UBXN2B;NSFL1C;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.3868317822769838,0.5853702335508311,0.9038461538461539,1.0,1.0,1/5,22.72%,APOD
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.30135766849992457,0.5851163663536576,1.0,1.0,1.0,1/25,4.70%,GPIHBP1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.281991537238627,0.585008999656229,0.9878048780487805,1.0,1.0,16/43,32.84%,POLQ;WAS;RMI2;HELB;FIGNL1;MAGEF1;KDM1A;KLHL15;CHEK1;PPP4R2;OOEP;TERF2IP;TIMELESS;ACTR2;RPA2;RAD51
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.3205557421201223,-0.5849464917865775,0.8837209302325582,1.0,1.0,3/10,16.64%,PTGS1;AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.36084397572116017,-0.5848951399429241,0.9545454545454546,1.0,1.0,2/6,15.25%,MACROH2A2;PIH1D1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.3023329999149099,0.5838574626990023,0.9571428571428572,1.0,1.0,8/22,27.81%,ABCG2;UPK3A;SLC14A1;SLC46A1;TAP1;AQP11;SLC14A2;ABCA12
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.34722416448411575,0.5837886918275471,0.9076923076923077,1.0,1.0,4/11,32.95%,CD4;CBLL1;CTNNB1;ITGAV
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.3509728291637064,-0.5836320282133559,1.0,1.0,1.0,2/6,19.48%,NFS1;GPHN
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.3597292069632495,-0.5835950289228472,0.813953488372093,1.0,1.0,5/5,64.04%,DSCAM;MEGF8;NRP1;SEMA5A;VEGFA
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.3191124095650192,0.5832131676533613,0.9310344827586207,1.0,1.0,3/11,21.69%,HSPA5;HERPUD1;DDIT3
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.2928035734133114,-0.5830537669277218,0.9761904761904762,1.0,1.0,5/14,21.32%,IGBP1;GNB3;RAD17;CD24;SMG5
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.24868930459388938,-0.5826874776358238,1.0,1.0,1.0,5/33,16.86%,PNKP;POLD3;LIG3;RFC3;NTHL1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.30770421390705416,-0.5825226442174009,0.926829268292683,1.0,1.0,12/12,69.25%,ATM;NBR1;PJVK;PIK3R4;PIK3C3;TRAPPC8;SQSTM1;USP30;RB1CC1;MAP1LC3B;PEX5;ACBD5
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.33793717115444133,-0.582377524595878,0.9523809523809523,1.0,1.0,7/7,66.22%,CRMP1;DPYSL2;DPYSL4;DPYS;DPYSL5;DPYSL3;DPYD
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.3792095503578634,0.5822891259971448,0.9558823529411765,1.0,1.0,2/6,29.43%,SLC25A19;ACP3
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.31755276050049613,0.5820619326552307,0.9516129032258065,1.0,1.0,6/10,33.43%,CCT7;CCT8;CCT2;CCT6A;DKC1;CCT3
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.37537889145973036,0.5812422261818075,0.9152542372881356,1.0,1.0,2/5,17.70%,MAF;WNT5B
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.3266973580984239,0.5808104109033366,0.9710144927536232,1.0,1.0,3/9,21.73%,WDR76;FEM1B;ETAA1
prerank,GO_Biological_Process_2021__negative regulation of cellular respiration (GO:1901856),-0.3339651837524178,-0.5799552969277981,0.9387755102040817,1.0,1.0,5/5,66.61%,MLXIPL;TRAP1;PPIF;PDE12;ACTN3
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.30494190279444405,-0.579855700522052,0.9761904761904762,1.0,1.0,5/11,28.88%,ZMIZ1;ELOF1;SMARCD1;ZMIZ2;CDCA4
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.31438851704259685,-0.5796040162760804,0.9655172413793104,1.0,1.0,8/8,68.57%,BRF1;GTF3C5;GTF3C2;GTF3C4;GTF3C1;GTF3C3;POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__regulation of natural killer cell proliferation (GO:0032817),-0.3900078276894893,-0.5795923442066601,0.9523809523809523,1.0,1.0,1/6,16.19%,IL23A
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.25444425962538075,-0.5793169255884002,0.9411764705882353,1.0,1.0,1/29,2.70%,TWIST1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.23916183091897927,-0.5788277974499398,1.0,1.0,1.0,7/50,15.70%,ADCYAP1;OLFM2;RAB3D;TVP23A;PREB;SLC30A8;MIA3
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.3879443664447304,0.5785758695753106,0.9375,1.0,1.0,2/5,30.66%,RNF20;CDK9
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.38041384953150986,0.5784767487048758,0.9259259259259259,1.0,1.0,2/6,32.66%,BAP1;USP1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.3301577388598428,-0.5781883483296958,0.9666666666666667,1.0,1.0,1/9,12.33%,NUPR1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.28904335093275135,0.578150920514066,0.9859154929577465,1.0,1.0,6/25,31.72%,TAF6;TAF6L;ATAT1;KAT5;MORF4L2;KAT2B
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.294500737082215,-0.5779274385724912,0.9444444444444444,1.0,1.0,6/13,23.30%,SRSF4;U2AF2;PTBP1;RBMX;PCBP4;SFSWAP
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.3303331442086014,0.5778779222029653,0.8970588235294118,1.0,1.0,2/10,19.15%,P2RY12;RYR3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.3465708767745307,-0.5778727707216589,0.9411764705882353,1.0,1.0,1/9,5.28%,APOE
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.361038483178531,0.5778184169604641,0.9137931034482759,1.0,1.0,2/6,33.12%,TTPA;PLEKHA3
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.2501874689614298,0.577578672029778,0.9880952380952381,1.0,1.0,6/90,15.16%,NEK2;CEP72;RAB11A;CEP70;DYNLL1;TUBA4A
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.333963342895306,-0.5774204287385479,0.9705882352941176,1.0,1.0,2/10,16.53%,EPHB2;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3330308544414219,0.5772419516900242,0.9230769230769231,1.0,1.0,1/13,8.18%,NDC80
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.2665925760826687,0.576776253306831,0.9863013698630136,1.0,1.0,13/65,24.00%,ACOT6;ACSM3;ABHD14B;ACSM6;ACOT4;RHOQ;HINT1;ADSS1;GMPR2;BPNT2;SULT4A1;SULT6B1;PTHLH
prerank,GO_Biological_Process_2021__spinal cord dorsal/ventral patterning (GO:0021513),0.3978317466636681,0.5767724953352467,0.9,1.0,1.0,1/5,10.42%,RFX4
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.29917732584181134,-0.576721543975204,1.0,1.0,1.0,5/16,16.80%,CD151;CCN1;FLNA;ARHGAP35;RHOA
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.3100487457563462,-0.5765981118711796,0.9523809523809523,1.0,1.0,3/9,25.59%,BDH1;HMGCL;BDH2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.30920416295895076,-0.5764699576854772,0.9318181818181818,1.0,1.0,8/8,69.09%,DNM2;SNAP91;DNM1;AP3D1;DNM3;MX2;PICALM;MX1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.32350440684239357,0.5764278642500406,0.9493670886075949,1.0,1.0,4/18,18.52%,GPIHBP1;ANGPTL4;ANGPTL3;MTLN
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.29617173654421336,0.5762091039094625,0.9855072463768116,1.0,1.0,4/27,14.84%,CDKN2A;MYO16;KANK2;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.403845444813717,0.5761200145317308,0.9655172413793104,1.0,1.0,2/5,18.07%,LCP1;IL5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.29310732534878625,0.5757381347249859,0.9558823529411765,1.0,1.0,8/26,32.80%,RPA3;RPS27A;RBX1;CETN2;RAD23B;CDK7;DDB1;RPA2
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.36040078919880847,-0.5754456263123985,0.9393939393939394,1.0,1.0,6/6,63.97%,INPP5K;GSK3B;SELENOS;GSK3A;ENPP1;PASK
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.36040078919880847,-0.5754456263123985,0.9393939393939394,1.0,1.0,6/6,63.97%,INPP5K;GSK3B;SELENOS;GSK3A;ENPP1;PASK
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.32956270039754415,-0.5741974744869979,0.9736842105263158,1.0,1.0,3/8,25.59%,BDH1;HMGCL;BDH2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.27114736804946316,0.5740975833847023,1.0,1.0,1.0,4/42,15.88%,SP100;POLD4;RPA3;RECQL4
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.33620843442180787,0.5726010901248902,0.9824561403508771,1.0,1.0,5/11,26.00%,HSPA5;KDELR3;INSIG2;INSIG1;GPAA1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.3310970449380804,0.5714534860718626,0.9344262295081968,1.0,1.0,2/11,19.62%,SLIRP;FIS1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.34281821397747103,-0.570944569435379,0.9032258064516129,1.0,1.0,4/8,34.00%,CARD9;STAT3;IL17RA;CD6
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.28687628013616734,0.5707730739212289,0.971830985915493,1.0,1.0,4/28,18.33%,RRAGA;GLRA2;GLRA1;LAMTOR3
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.3234253002817567,-0.569597387965993,0.9512195121951219,1.0,1.0,1/5,14.55%,SLC13A3
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.3078201278830543,-0.5695639449724381,0.9069767441860465,1.0,1.0,4/11,19.03%,HES1;ESRRB;NOTCH1;JAG1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.3288170272760596,-0.5694288888247533,0.8888888888888888,1.0,1.0,2/7,25.40%,MAPT;RNF122
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.3601792891972867,0.5690208226580473,0.9682539682539683,1.0,1.0,4/7,38.31%,MOGAT1;PNPLA2;MOGAT2;DGAT2
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),-0.3428145914436896,-0.5686841294211968,0.8913043478260869,1.0,1.0,1/5,14.81%,TMEM86B
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.32248596837488713,-0.5684795209453755,0.9117647058823529,1.0,1.0,3/10,19.77%,MACROH2A2;NCOA3;MED1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.29121462643590934,0.5680690627467823,0.9594594594594594,1.0,1.0,6/34,19.22%,VSIG4;NLRC3;RPS19;ISG15;USP18;A2M
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2388717048576077,-0.5678811965746121,1.0,1.0,1.0,16/66,22.41%,PIAS3;PRICKLE1;CRY1;FBXO4;COMMD1;HDAC3;RIPK2;PIAS4;HSPBP1;MALT1;SPRTN;UBE2L3;HDAC4;RASD2;AXIN1;LAPTM5
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.28877258885036017,-0.567754937569569,1.0,1.0,1.0,2/16,13.63%,POLR1A;CHP1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.30391648456004283,-0.5677340521996871,1.0,1.0,1.0,2/14,14.26%,KLHL18;ZNF16
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.3421131378663286,0.5677221027395406,0.984375,1.0,1.0,1/11,9.34%,REST
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),0.38166230623640074,0.5676375222475435,0.9402985074626866,1.0,1.0,1/5,26.58%,RPS3
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.32475584811114994,-0.5666293374485104,0.9736842105263158,1.0,1.0,2/16,5.28%,CHRNA10;APOE
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.28957719292231154,0.5657061620656006,0.9705882352941176,1.0,1.0,3/25,15.87%,IHO1;STRA8;GDF9
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.30881858648974014,-0.5649024212787814,0.9473684210526315,1.0,1.0,4/11,15.47%,ARSB;VCAN;IDUA;CSPG5
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.24378435889163436,0.5645305808213898,1.0,1.0,1.0,13/81,19.71%,CLDN6;SALL4;PHF21B;LEF1;TMEM200C;EPCAM;VASH2;L1TD1;ZDHHC22;CAMKV;SLC7A3;CBLN1;EFNB3
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.361285732979175,0.5639942600641039,0.9538461538461539,1.0,1.0,4/8,40.64%,PARK7;PYCR1;TXN;GPR37
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.30618102202694336,-0.563977637338586,0.9166666666666666,1.0,1.0,2/10,10.93%,SLC27A2;SLC27A4
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.24963230122526947,0.5639646309418708,0.9864864864864865,1.0,1.0,12/49,32.54%,PINK1;DCN;IL4;SESN1;WAC;VDAC1;SCOC;FYCO1;PIP4K2C;OPTN;BNIP3;SLC25A5
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.2244780916822998,-0.5638706546908333,1.0,1.0,1.0,7/37,15.97%,FADS1;PPIP5K1;GK5;G6PD;AGPAT5;ITPKA;NFS1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.21589568700831369,-0.5637257456166082,1.0,1.0,1.0,15/106,15.56%,PSAT1;EIF4EBP1;KHSRP;PDIA6;ERN1;SLC30A5;NOP14;SLC7A5;CHAC1;ATF3;PREB;EXOSC10;EXOSC1;ALDH18A1;EIF2AK3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.36162505238925646,0.5634832384981876,0.9433962264150944,1.0,1.0,1/6,23.10%,TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.36162505238925646,0.5634832384981876,0.9433962264150944,1.0,1.0,1/6,23.10%,TACC3
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.29019979099253174,-0.5634791636684205,0.96875,1.0,1.0,5/12,20.68%,SCRIB;CAMSAP3;RHOA;RAB10;RAP2A
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.31547836093041853,-0.5633306522529038,0.8421052631578947,1.0,1.0,2/8,10.93%,SLC27A2;SLC27A4
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.29141344334392777,0.5633271611200951,1.0,1.0,1.0,4/27,15.20%,TSHR;ADRB1;RXFP2;ADCY7
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.2594477007783613,0.563192734304437,0.9868421052631579,1.0,1.0,14/46,33.72%,ID1;NPR3;PGAM5;FIS1;ADAMTS5;DDIT3;ARRDC3;LNPEP;IL18R1;IL15;ZDHHC7;ACVR2B;ACTN3;PLCL1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.28290551135265535,0.5631371822334965,0.9868421052631579,1.0,1.0,12/38,28.69%,CCL5;IFIT1;ZC3HAV1;ISG15;OAS2;HMGA2;IFIH1;PARP10;ISG20;SRPK1;OAS1;OASL
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.2570398637120414,0.5628997463434673,1.0,1.0,1.0,9/67,20.45%,PLA2G10;PON1;PIGH;PLA2G7;PRDX6;PLCD1;CSF1R;SERINC1;PIGC
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.33563735076689233,0.5624764610160788,0.9206349206349206,1.0,1.0,4/11,27.42%,ACMSD;IDO1;HAAO;IDO2
prerank,GO_Biological_Process_2021__regulation of epinephrine secretion (GO:0014060),-0.34653605126993103,-0.5624543228755654,0.925,1.0,1.0,1/5,9.25%,CRH
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.24737062802273257,0.5621942598091039,1.0,1.0,1.0,21/89,28.44%,NDC80;SUV39H1;RPS27A;COPS4;LRWD1;COPS5;GPS1;NUF2;TCF7L1;MSH6;HMGA2;POLE3;RAE1;RBX1;PADI2;CETN2;MTF2;NUP155;DOT1L;TOP2B;RAD23B
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.33369089706554006,-0.562064665792556,0.96875,1.0,1.0,4/8,22.70%,RPS6KA3;TCIM;INO80;RGS14
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.26010046840713963,-0.5618155865064177,1.0,1.0,1.0,2/19,8.66%,FLVCR1;ALB
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.2531030057353224,-0.5616199275544208,1.0,1.0,1.0,7/20,24.07%,CAPN10;OSBPL8;AKT2;OCLN;C1QTNF12;INSR;IRS2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.3396302170916618,0.5614077946761139,0.9852941176470589,1.0,1.0,1/13,5.45%,TGFB1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.37385662082793863,0.5609909192586577,0.9285714285714286,1.0,1.0,1/5,17.33%,DDX23
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.3397810360168672,-0.5607702631092428,0.8421052631578947,1.0,1.0,6/6,66.03%,ACAA1;GSTM3;GSTM4;CRYZ;GSTM2;GSTO1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.3479803206067663,0.560554458543923,0.9365079365079365,1.0,1.0,2/8,21.69%,WFS1;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.3273306515301042,0.5601632618870085,0.9333333333333333,1.0,1.0,2/10,23.30%,LRRC38;LRRC55
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.30654570263671094,0.5601313003891942,0.971830985915493,1.0,1.0,4/17,22.60%,PINK1;SOD2;BAG5;PARK7
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.283561545198154,-0.5600451643722798,0.9473684210526315,1.0,1.0,4/13,21.47%,CDK1;IK;MTBP;CHAMP1
prerank,MSigDB_Hallmark_2020__DNA Repair,0.23413485622101948,0.5596510280668345,1.0,1.0,1.0,32/140,30.67%,ADA;GSDME;NPR2;POLD4;RPA3;COX17;TAF13;POLR1C;EIF1B;TAF6;IMPDH2;GMPR2;RAE1;RBX1;TAF10;PDE6G;SNAPC5;BCAP31;CETN2;MRPL40;PCNA;GPX4;CSTF3;ERCC4;POLR2H;POLR3GL;CMPK2;AK1;NELFB;POLR2K;DDB1;CANT1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2718295234370387,0.5589161890242262,0.9848484848484849,1.0,1.0,3/34,12.59%,POLD4;RPA3;RPS27A
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.3687956980927696,-0.5588231952444036,0.9523809523809523,1.0,1.0,6/6,63.13%,SRC;ACTN2;CA2;CAV1;CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.28708216062688086,0.5587313454394305,0.9753086419753086,1.0,1.0,13/31,36.47%,GPER1;VPS18;CHRNA3;MCTP2;SNAPIN;SLC30A1;PREPL;SYT11;KCNMB4;MCTP1;RIMS3;CPLX2;BAIAP3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.24484097861979062,0.5586391517241456,0.9885057471264368,1.0,1.0,13/94,21.54%,PLA2G10;TGFB1;EIF6;DDX3X;RPS4X;METTL14;EEF2;MSN;AGT;THBS1;CSF1;LARP6;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.2943244189040431,-0.5585639461899305,0.9629629629629629,1.0,1.0,4/14,21.22%,NR1H2;OSBPL8;ABCG1;PTPN2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.3149103830755965,0.5581674395337497,0.971830985915493,1.0,1.0,4/11,21.78%,MMP9;CCND1;MME;PPID
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2628141589370687,-0.5581132345528834,1.0,1.0,1.0,2/23,5.57%,APOE;RHBDF1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.27664208906143833,0.5580072928351718,1.0,1.0,1.0,4/33,14.05%,TRPC7;FTH1;CP;COX17
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2828881373280385,0.557558376565701,0.9852941176470589,1.0,1.0,4/19,20.54%,PAICS;ADSS1;IMPDH2;GMPR2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.2711699739375436,0.5572540681802431,0.9866666666666667,1.0,1.0,3/32,13.30%,TGFB1;ECT2;ZIC1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.320930778621569,0.5572328897796547,0.9411764705882353,1.0,1.0,1/10,6.02%,KCNA5
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.29623553440154327,0.5570233614506876,0.9705882352941176,1.0,1.0,2/15,15.20%,PRRC1;ADCY7
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.22953215572030436,0.5569100891019044,1.0,1.0,1.0,32/162,28.86%,HIGD1C;STOML2;CHCHD4;TIMM22;PINK1;TOMM20;COX7A2;BCS1L;SLIRP;CHCHD2;TIMM17A;RAB38;FIS1;TOMM7;HCFC1;RAB29;PARK7;BCAP31;TIMM10;COX7A1;POLG2;CAV2;SLC25A6;FBXO7;TOMM34;AIP;MTFR1;HK2;MIEF1;HAP1;TMEM11;MTX3
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.3265369012436219,0.5568067691996015,0.96875,1.0,1.0,1/12,13.90%,LDLRAP1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.24619712521170656,-0.5566730944872987,1.0,1.0,1.0,8/33,15.47%,TST;MLYCD;ARSB;CHAC1;PRELP;VCAN;IDUA;CSPG5
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),-0.31879862505192225,-0.5563760489968327,0.9512195121951219,1.0,1.0,2/6,17.78%,PEX13;EFHC1
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.35265140111175175,0.5562971895922932,0.96,1.0,1.0,1/7,13.43%,TNFSF4
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.29482747372764295,0.5555944924165455,0.971830985915493,1.0,1.0,2/17,16.94%,MSN;ATRAID
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.2818436836751149,0.5554574309799053,0.9871794871794872,1.0,1.0,6/26,26.58%,CAV3;CDK5R1;PSRC1;DCTN1;ANKRD53;RPS3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.2915225497574309,-0.5552284371023626,0.9615384615384616,1.0,1.0,2/17,11.70%,APOE;BIN1
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3211002309275681,0.5550591208953044,1.0,1.0,1.0,3/11,20.30%,PAICS;ADSS1;IMPDH2
prerank,GO_Biological_Process_2021__negative regulation of neuron migration (GO:2001223),-0.3279713558118055,-0.5548164569945795,0.8636363636363636,1.0,1.0,1/5,9.84%,SRGAP2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.3171046772761935,0.5543777166502515,0.9859154929577465,1.0,1.0,2/13,26.10%,TMEM33;REEP4
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.26020901270490604,0.5540894532562332,1.0,1.0,1.0,2/47,7.87%,DONSON;RAD1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.2880717260028874,-0.5536661239710051,1.0,1.0,1.0,1/17,6.47%,MTFR2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.31602907058824414,-0.5535075180105823,0.8787878787878788,1.0,1.0,3/8,24.43%,NFATC3;NFATC1;PDGFB
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.2676917992876031,0.553426501455928,1.0,1.0,1.0,3/36,14.76%,DDX20;GEMIN4;SNRPD2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.22783255003171862,-0.5531757994614225,1.0,1.0,1.0,22/76,23.52%,AGRN;FSCN1;CROCC;PLEKHM1;AVIL;NEURL1;CDC42EP5;CCDC88A;AUTS2;MARK4;ENTR1;ARHGAP35;ARPC2;DEF8;WASF2;OCLN;MIEN1;PLCE1;CEP120;PALM;NLGN1;HRAS
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.36600201902236285,0.5528796555369764,0.9180327868852459,1.0,1.0,1/5,22.17%,LTN1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.286609907120743,-0.5528170882569611,1.0,1.0,1.0,15/15,71.36%,GPLD1;MAGI2;PTPA;PLEK;MTOR;PPP1R15B;PPP1R15A;PDGFRB;MTMR9;MEF2C;CALM3;ITGA1;BMP2;CALM1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.29109672201307624,0.5525032483279491,1.0,1.0,1.0,2/32,9.75%,DEPDC5;RRAGA
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.2713499473510485,0.5522203692869254,0.9850746268656716,1.0,1.0,10/45,25.54%,RAD1;ECT2;RHOB;CDKN1A;TMEM109;FIGNL1;XRCC6;RAD9B;CRYAB;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.33790202426165705,-0.5519948151454809,0.9545454545454546,1.0,1.0,2/8,13.80%,GRIN1;RAB27A
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.3148291586809083,0.5517762372894396,0.9538461538461539,1.0,1.0,3/10,23.73%,BRCA1;CEACAM1;ACADL
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.31630560338933855,-0.5514254491085174,0.9473684210526315,1.0,1.0,1/8,9.99%,ADH4
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.29362529227414924,0.5509712727241324,0.967741935483871,1.0,1.0,1/15,6.02%,KCNA5
prerank,"GO_Biological_Process_2021__positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",0.3845062393836963,0.5505516078941483,0.9701492537313433,1.0,1.0,1/5,9.55%,DAB2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.3212754068395272,-0.5500928441652827,0.9310344827586207,1.0,1.0,2/10,13.18%,WWP2;CORO2B
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.36128732200423175,0.5500676958391308,0.9672131147540983,1.0,1.0,2/6,27.18%,ALOX5;IL18R1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.36128732200423175,0.5500676958391308,0.9672131147540983,1.0,1.0,2/6,27.18%,ALOX5;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3065349178976181,0.5495610965137762,0.9545454545454546,1.0,1.0,5/19,32.07%,MAPK3;BRCA1;RPS6KA5;PPARGC1A;PAXIP1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.30867376332948393,0.5493298818963033,0.9516129032258065,1.0,1.0,2/12,19.10%,NT5E;ADSS1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.3308759595752354,-0.5493247980973843,0.9285714285714286,1.0,1.0,3/13,23.14%,NUP98;SEH1L;TPR
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.24604127143908008,-0.5493099097054035,1.0,1.0,1.0,26/26,75.42%,DLL1;SGIP1;SNAP91;ITSN1;CLTA;GPR107;DNAJC6;ITSN2;AP2A2;FCHSD2;FNBP1L;GAK;CLTB;AP2A1;PIP5K1C;CLTC;AP2B1;LMBRD1;FCHO2;AP2M1;AP2S1;PICALM;FCHO1;CANX;INPP5F;SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.24961357671202247,-0.549230761685546,1.0,1.0,1.0,1/26,1.85%,H1-4
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.3474178534296897,-0.5488284423401522,0.9333333333333333,1.0,1.0,1/5,16.68%,ITPA
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.28085374902894167,0.5487600758787197,0.9861111111111112,1.0,1.0,7/31,22.02%,POLQ;NUDT16L1;RMI2;TFIP11;HMGA2;OTUB1;HELB
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),-0.32847195357833653,-0.5483672115035175,1.0,1.0,1.0,5/5,67.16%,HMGB1;PARP3;APLF;XRCC1;RAD51
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.27692722249857893,0.5479213234698945,1.0,1.0,1.0,4/29,16.75%,BOK;TP53BP2;BBC3;YWHAH
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.33129867384646117,0.5477916800988488,0.9714285714285714,1.0,1.0,1/9,13.43%,TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.32736104435849933,0.5477618171320697,0.9682539682539683,1.0,1.0,2/8,32.09%,CCNB1;CDC6
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),-0.3489250719993238,-0.547290812063768,0.9736842105263158,1.0,1.0,1/5,7.86%,FNTA
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.3609663648596068,0.5470485508674889,0.9436619718309859,1.0,1.0,1/7,9.55%,DAB2
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.23507454986349594,0.5460762086292226,1.0,1.0,1.0,24/98,33.72%,PSMB9;SYK;PSMC5;MAPK3;ITK;PSMB6;PSMD6;PSMA3;VAV3;PSMA7;NFATC2;MAP2K4;PRKCQ;LAT2;PSMB1;PIK3CB;TEC;CALM1;PSMA5;RAC1;RELA;PSMB7;PDPK1;VAV1
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),0.34058545348014974,0.5457439708937906,0.9464285714285714,1.0,1.0,2/5,30.32%,ADRA2A;ADRA2C
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3057845243009316,0.545372327913515,0.9866666666666667,1.0,1.0,2/17,11.84%,TGFB1;TGFB3
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.24349684086237497,-0.544827321651826,1.0,1.0,1.0,6/42,12.82%,OSR1;WNT7A;CCN3;CREB3L2;NFIB;SULF2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.25459466577678624,-0.5445016515872353,0.9534883720930233,1.0,1.0,3/11,24.18%,ATG9B;WIPI1;PACS2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.24056859892787186,-0.5444148719610289,1.0,1.0,1.0,2/21,8.66%,FLVCR1;ALB
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.2820620573495435,0.5433882638430431,0.9861111111111112,1.0,1.0,8/19,35.97%,AGER;GADD45B;SPI1;PRMT1;PJA2;SASH1;BMP2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.2915533202879912,-0.5432791118409007,1.0,1.0,1.0,3/16,16.53%,SCAI;ITGA3;ARHGAP35
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.2519687059034265,-0.5432182262797516,1.0,1.0,1.0,3/32,12.16%,MGARP;AP3B2;SPAST
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.3219012403175751,0.5428729501979028,0.9428571428571428,1.0,1.0,2/8,34.49%,PEX12;PEX1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.3009762285598687,0.5427986531764152,0.9836065573770492,1.0,1.0,4/22,18.94%,MARVELD3;HEG1;TJP3;DLG4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.3239883089780598,-0.5427561931402191,1.0,1.0,1.0,1/7,7.31%,DHX8
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.3192276107489762,0.5425717989900851,0.9384615384615385,1.0,1.0,4/12,32.99%,RPS19;GRN;ENPP3;CD47
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.2714855086483767,-0.5421320255302468,0.9032258064516129,1.0,1.0,12/12,72.87%,ATXN2;PATL1;RC3H1;LSM14A;DYNC1H1;EIF4ENIF1;LIMD1;PATL2;EDC3;LSM4;LSM3;DDX6
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.34910164670110544,0.5420844421916593,0.9473684210526315,1.0,1.0,3/6,21.73%,WDR76;FEM1B;ETAA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.25875399797396925,-0.5419317138163321,1.0,1.0,1.0,3/20,13.29%,GTF2H2;XPC;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.3275196307600558,-0.5418459437663719,0.9333333333333333,1.0,1.0,1/5,6.16%,MYOCD
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.29893219311597863,0.5410810229174796,0.9726027397260274,1.0,1.0,5/17,31.85%,KCNJ2;SCN4B;SCN1B;SCN5A;SCN2B
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.2932214637308365,0.5408021666422753,0.9841269841269841,1.0,1.0,6/11,33.43%,CCT7;CCT8;CCT2;CCT6A;DKC1;CCT3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.2850199348600721,0.5406484655577589,0.9701492537313433,1.0,1.0,3/27,15.09%,WAS;VIL1;PSTPIP1
prerank,GO_Biological_Process_2021__dehydroascorbic acid transport (GO:0070837),0.35363011959212454,0.5402607607154641,0.8947368421052632,1.0,1.0,1/5,18.14%,SLC23A1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.34023237798395395,0.5402259945946079,0.953125,1.0,1.0,2/8,30.36%,CBLL1;CTNNB1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.31630181672178426,0.5399280350283608,1.0,1.0,1.0,2/9,21.41%,MSN;SYNE4
prerank,GO_Biological_Process_2021__regulation of sequestering of zinc ion (GO:0061088),0.34340366576240455,0.5395163999950955,0.9193548387096774,1.0,1.0,2/5,25.63%,SLC30A2;SLC30A4
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.23203776473910886,0.5389720088775609,1.0,1.0,1.0,24/98,33.72%,PSMB9;SYK;PSMC5;MAPK3;ITK;PSMB6;PSMD6;PSMA3;VAV3;PSMA7;NFATC2;MAP2K4;PRKCQ;LAT2;PSMB1;PIK3CB;TEC;CALM1;PSMA5;RAC1;RELA;PSMB7;PDPK1;VAV1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3085547210761119,-0.5388503107210183,1.0,1.0,1.0,4/9,18.04%,RAMP1;SOAT1;CHP1;PLCB1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.33701202016466614,0.5387290109994032,0.9830508474576272,1.0,1.0,3/6,33.75%,PAICS;PRPS1;SHMT2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.30919220055710306,-0.5387094589910246,0.9767441860465116,1.0,1.0,7/7,69.09%,DNM2;SNAP91;DNM1;DNM3;MX2;PICALM;MX1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.3226876040698856,0.5383887022467376,1.0,1.0,1.0,3/12,25.96%,UBA5;UBA3;UBA6
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.3145819630904941,-0.5383539880020318,1.0,1.0,1.0,8/8,68.56%,METTL4;MTRES1;NSUN3;TSFM;MTG2;ALKBH1;SHMT2;MTG1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.22504388945950138,0.5381065061833287,1.0,1.0,1.0,10/153,14.93%,ENPP2;WNT5A;NLRP5;REST;PINK1;DCN;TMEM79;VIL1;FBXO5;SOX9
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.2180242994715626,-0.5377823618832744,1.0,1.0,1.0,5/58,11.22%,PRKCD;FLNA;CDK1;HDAC3;TERT
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.29508260146245213,-0.5376438925106349,0.8947368421052632,1.0,1.0,8/8,70.50%,SNCA;SLC9A1;PDE4B;PRKACA;SIRT2;ATP2B4;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.29508260146245213,-0.5376438925106349,0.8947368421052632,1.0,1.0,8/8,70.50%,SNCA;SLC9A1;PDE4B;PRKACA;SIRT2;ATP2B4;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.326706303761055,-0.5370863432207676,0.9743589743589743,1.0,1.0,1/8,9.83%,TICAM2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.24527376592098962,0.5365679355261753,1.0,1.0,1.0,10/71,19.80%,TGFB1;NODAL;DAB2;GDF11;BMP3;TGFB3;TTK;GDF9;THBS1;INHBC
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.28679228247770716,-0.5362990956406019,1.0,1.0,1.0,3/13,19.40%,CELF4;CAMSAP3;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.28655051300437473,-0.5355084978546538,1.0,1.0,1.0,4/15,15.25%,CLEC16A;SIK3;KLHL22;PIH1D1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.2985187449258548,0.5352697809315099,1.0,1.0,1.0,1/19,4.90%,TMEM35A
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.35476821961889077,0.5350369400290625,0.9655172413793104,1.0,1.0,1/7,15.88%,RECQL4
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.23254165824929002,-0.5348884378990088,0.9565217391304348,1.0,1.0,2/37,3.68%,F11R;MAP3K14
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.2702597085328655,0.5348699052397474,0.9852941176470589,1.0,1.0,2/19,13.38%,GPER1;TOR1A
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.31444865521888166,-0.5348206624992924,0.9459459459459459,1.0,1.0,1/7,12.84%,KIF1C
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.3366473486276795,-0.5344964588608738,0.9148936170212766,1.0,1.0,3/5,31.36%,SETMAR;ASH1L;SETD2
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.29918365767787364,-0.5333565819741514,1.0,1.0,1.0,8/8,70.09%,CCNH;CDK13;GTF2H3;GTF2H1;GTF2H5;CDK12;CDK9;CDK7
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.29928368157468266,-0.5330009471266705,0.95,1.0,1.0,4/10,24.90%,ATP9A;EIPR1;RAB11B;SORL1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.28273488526926754,-0.5327146860100459,1.0,1.0,1.0,2/19,11.70%,APOE;BIN1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.28578367175252534,-0.5326773858353121,0.9444444444444444,1.0,1.0,4/11,21.47%,CDK1;IK;MTBP;CHAMP1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),-0.3342369287072841,-0.5324926629177187,0.9565217391304348,1.0,1.0,1/5,6.63%,LHFPL2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.2294840181343169,0.5310489188871524,1.0,1.0,1.0,12/100,22.16%,SHISA6;TMEM35A;PLP1;TCEAL5;TMEM200C;NEFM;CNTN2;PNMA2;ZDHHC22;LRRTM1;LSAMP;SULT4A1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.342782202024488,0.5309370043903147,0.9508196721311475,1.0,1.0,2/6,27.65%,PARK7;HIF1A
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.36301624956451634,0.5299779620408138,0.9846153846153847,1.0,1.0,3/6,39.63%,SPI1;KLF7;TRPM4
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.28592324721101886,-0.5297070496640037,1.0,1.0,1.0,3/11,18.25%,ADCY2;ADCY3;ADCY6
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.2393380698553302,0.5295956795022998,1.0,1.0,1.0,4/49,15.88%,SP100;POLD4;RPA3;RECQL4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.30433426892034693,-0.5295738011582937,0.967741935483871,1.0,1.0,3/13,13.94%,ATF3;HSF1;GSTO2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.28370892016867727,-0.5290935091095662,0.9743589743589743,1.0,1.0,2/12,16.64%,PTGS1;PTGIS
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.30307315778653976,0.528977873842993,0.9850746268656716,1.0,1.0,4/12,27.07%,MPDU1;ALG2;ALG6;DPAGT1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.3226255743634511,0.5287731618319766,0.9824561403508771,1.0,1.0,4/8,37.01%,PLAAT4;PLAAT5;NAAA;NAPEPLD
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.30102696445059424,0.5283556173529235,0.984375,1.0,1.0,6/15,27.42%,ACMSD;HPD;IDO1;HAAO;FAH;IDO2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-0.29769172592682713,-0.5280280949278111,0.918918918918919,1.0,1.0,2/9,16.64%,PLIN5;PTGIS
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.23111472490029814,-0.5279370397831299,1.0,1.0,1.0,28/28,76.92%,POLR3K;ICE1;SNAPC3;BRF1;ZNF345;GTF3C5;GTF3C2;ICE2;SNAPC2;GTF3C4;POLR3G;GTF3C1;GTF3C3;SNAPC4;CRCP;ZC3H8;RO60;ELL;TBP;GTF3A;POLR2L;POLR3H;GTF3C6;POLR2K;IVNS1ABP;POLR3GL;SNAPC1;SNAPC5
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.2470483841635123,-0.5278773403411773,1.0,1.0,1.0,6/36,21.28%,FLNA;NUPR1;PDE3B;MAD2L2;AZIN2;HDAC4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.21637299014699324,0.527564434345097,1.0,1.0,1.0,3/118,4.68%,ADAD2;DDX20;ADARB2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3229726623964946,0.5275487926815414,0.9344262295081968,1.0,1.0,1/8,12.11%,PLXNA3
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.2670742560848199,-0.5274042317853319,0.9795918367346939,1.0,1.0,12/12,73.31%,ABCG1;ARV1;ABCA1;OSBPL2;SERAC1;OSBP;RELCH;NPC1;NPC2;STARD4;VPS4A;STAR
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.28464752766385515,-0.5268870722319777,0.9555555555555556,1.0,1.0,9/9,71.55%,FOXP3;AKT1;FADD;JAK3;FAS;NCKAP1L;ZC3H8;PPP2R3C;TNFSF14
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.30053994523962974,0.526816216570898,1.0,1.0,1.0,6/14,32.45%,PPT1;SCD;FASN;ACLY;GCDH;ACAT1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.3136453540663761,0.5266292505893165,0.9841269841269841,1.0,1.0,3/9,21.70%,MMP9;ATP2A2;B2M
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.29461518674787707,0.5262932257638256,1.0,1.0,1.0,4/16,28.26%,IGF1;AGER;RPS3;IGFBP2
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.3028435966380893,0.5259502353694588,0.9848484848484849,1.0,1.0,3/11,20.29%,CDKN2A;MME;ROMO1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.2648156776656697,0.5253737002433534,1.0,1.0,1.0,2/27,17.38%,RPS27A;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.2455275096268819,0.5249676486823428,1.0,1.0,1.0,12/57,29.08%,SPDYA;CCND1;CDKN1B;CCND2;HCFC1;PSRC1;CCNB1;RPS15A;CITED2;SMOC2;LGMN;CHEK1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.33301165968949487,0.5248553499977945,0.9830508474576272,1.0,1.0,1/5,19.55%,SLC6A12
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.24581166717882785,-0.5242020039479541,1.0,1.0,1.0,6/17,20.91%,CRYM;OGDH;HYKK;AADAT;PHYKPL;GOT2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.30473396122897956,0.5239592117358371,0.9846153846153847,1.0,1.0,1/12,8.66%,NODAL
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.32879651986515396,0.5235612756898395,0.9354838709677419,1.0,1.0,2/10,20.17%,NOP10;TSR3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.30916827852998063,-0.5229436433616351,0.9782608695652174,1.0,1.0,5/5,69.09%,DNM2;DNM1;DNM3;MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.30916827852998063,-0.5229436433616351,0.9782608695652174,1.0,1.0,5/5,69.09%,DNM2;DNM1;DNM3;MX2;MX1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.31436419203837673,-0.5224382422489939,0.9722222222222222,1.0,1.0,6/6,68.57%,GTF3C5;GTF3C2;GTF3C4;GTF3C1;GTF3C3;GTF3C6
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.28106492047624215,0.521748280625104,0.9855072463768116,1.0,1.0,5/19,28.31%,PINK1;PARK7;VDAC1;FBXO7;CSNK2A2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.32495048794755976,0.5211604548268485,0.96875,1.0,1.0,2/7,22.53%,CBLN1;DCTN1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.28480047573645495,-0.5210844130513729,1.0,1.0,1.0,2/10,14.11%,PLA2G5;FGFR2
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.3225818061385013,0.5210044808884244,0.9538461538461539,1.0,1.0,2/7,34.49%,PEX12;PEX1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.2430626618854847,0.5209354575690441,1.0,1.0,1.0,5/34,24.03%,BAIAP2L1;HCK;CSF1R;NOTCH2;IQGAP2
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.3541373517598892,-0.5205476550103102,0.975,1.0,1.0,1/5,18.27%,ATPAF1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.2711723023433621,0.5205352944857199,1.0,1.0,1.0,3/18,21.21%,SRSF9;RPS13;SAP18
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.28355246706407516,-0.5203953356767411,0.9722222222222222,1.0,1.0,3/10,22.44%,ADH4;SULT1C4;ACSS2
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.3143763540699474,-0.5197042890178847,1.0,1.0,1.0,7/7,68.57%,GTF3C5;GTF3C2;GTF3C4;GTF3C1;GTF3C3;POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.28980585072937276,0.5197025696126546,1.0,1.0,1.0,5/15,27.84%,CNTN2;NEXN;MYPN;PALLD;EMB
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.31365929166255235,0.5196531430058767,1.0,1.0,1.0,3/10,27.98%,F2RL1;CD74;OAS1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.20611785771888935,0.5195401345257146,1.0,1.0,1.0,16/269,13.83%,UBE2U;FANCF;POLE2;POLQ;TICRR;RAD1;RAD54L;FAAP20;TRAIP;POLD4;DCLRE1A;RPA3;DCLRE1C;RPS27A;NOP53;RMI2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.2777810459391916,0.5195054767238498,0.9838709677419355,1.0,1.0,5/18,25.70%,ABHD14B;BPNT2;SULT4A1;SULT6B1;SULT2A1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.3119726135217245,0.5194787363515944,0.9473684210526315,1.0,1.0,2/8,18.29%,PPP2R5A;WASHC1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.2518764153607687,-0.5194409356646243,1.0,1.0,1.0,3/18,16.41%,PTPRR;FGFR2;ARNT2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.2809259810587958,0.5193411697120798,0.9855072463768116,1.0,1.0,7/14,24.34%,FBXO5;RPL11;RPS7;BAG5;RPL23;PARK7;BAG2
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.2859531723748221,0.519263484979895,1.0,1.0,1.0,2/19,16.55%,IGF1;EFHB
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),0.3207181707138861,0.5192001863661154,0.9655172413793104,1.0,1.0,1/7,10.43%,NR1H4
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.29790024499968826,-0.5191558983448968,1.0,1.0,1.0,4/10,31.90%,IRAK4;EPG5;PIK3R4;TRAF6
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.33652194665262347,0.5191162046933832,0.9848484848484849,1.0,1.0,1/5,17.72%,HTR2B
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.3012624050270232,-0.519058141281269,0.9285714285714286,1.0,1.0,2/10,16.40%,MACROH2A2;SMCHD1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.28835184500742633,-0.5188833488032764,0.9487179487179487,1.0,1.0,3/10,25.58%,IMPACT;SESN3;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.25001996825266365,0.5179524926678795,1.0,1.0,1.0,10/46,21.79%,SCIMP;IL26;FOXM1;COPS5;MAPK3;AGER;F2RL1;RASGRP1;MAP2K1;STK25
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.2217352916857577,-0.5179501430662856,1.0,1.0,1.0,5/28,20.83%,DPM3;PGAP1;PIGQ;PGAP3;PIGW
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.3030901443500176,0.5178599080012456,0.984375,1.0,1.0,1/10,11.47%,CD244
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.3142500787365763,-0.5177902524662095,0.972972972972973,1.0,1.0,1/8,9.27%,IGBP1
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.31937752540869807,0.5176288330422973,0.9183673469387755,1.0,1.0,3/8,37.77%,CD300LF;CD226;NECTIN2
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.3094187370158644,-0.5174422241665754,1.0,1.0,1.0,2/7,19.30%,METAP2;FKBP7
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.24178500759711416,0.5174233155300244,1.0,1.0,1.0,7/44,23.81%,TIMM22;ATP5PF;ATP5F1E;ATP5MC3;ROMO1;ATP5ME;TIMM10
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.258486377707811,0.5173353475578221,0.9875,1.0,1.0,10/28,33.06%,NOP53;RPL11;BAG5;PARK7;WAC;HSP90AB1;UBXN1;SVIP;UCHL5;CAMLG
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2854883272757286,0.5167205377733566,1.0,1.0,1.0,7/25,27.26%,TNFRSF10A;DDX3X;BRCA1;TRADD;PARK7;CASP8;TNFRSF10B
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.2979498434668928,0.5161749628568002,1.0,1.0,1.0,1/12,11.65%,SYK
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),-0.2962275541215383,-0.515897894780153,0.8823529411764706,1.0,1.0,1/6,11.09%,EML1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.2624000851842169,-0.515834826826949,1.0,1.0,1.0,4/13,22.04%,ALMS1;CDK5RAP2;CEP295;PLK4
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.31506530803761185,0.5156990669934403,0.967741935483871,1.0,1.0,2/8,16.42%,JAM2;MSN
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.3020428808800223,0.5151762515353054,1.0,1.0,1.0,2/12,14.36%,ACTG1;CELSR1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.3317579628054588,-0.5151666102146085,0.9459459459459459,1.0,1.0,2/7,16.19%,HLA-DRA;IL23A
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.3317579628054588,-0.5151666102146085,0.9459459459459459,1.0,1.0,2/7,16.19%,HLA-DRA;IL23A
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.2693110507105493,-0.5144084325774692,1.0,1.0,1.0,1/14,4.89%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.2837287753557162,-0.51343463036731,0.972972972972973,1.0,1.0,2/9,21.28%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.2837287753557162,-0.51343463036731,0.972972972972973,1.0,1.0,2/9,21.28%,NUPR1;HDAC4
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),-0.2862669245647969,-0.5130055568288439,0.9142857142857143,1.0,1.0,5/5,71.38%,CACNA1G;CACNA1C;CACNB2;TRPM4;SCN5A
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.33228652738596287,0.5129486543520616,0.9814814814814815,1.0,1.0,1/5,27.91%,FYCO1
prerank,GO_Biological_Process_2021__glyoxylate metabolic process (GO:0046487),-0.30054246575751437,-0.512723381911389,1.0,1.0,1.0,2/6,20.91%,ALDH4A1;GOT2
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.2942473596657511,-0.5124418708514897,0.975609756097561,1.0,1.0,6/6,70.59%,SAT2;SRM;SAT1;SMS;AMD1;SMOX
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.2506266863395659,-0.5121111796748684,1.0,1.0,1.0,6/27,16.33%,ACVR1;HES1;PKD2;SLIT2;SCRIB;COL4A1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.31114119922630556,-0.5118954085774665,0.9,1.0,1.0,5/5,68.90%,STXBP1;NAPA;UNC13B;STX1B;NAPB
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.29117499129492785,-0.5116667419058011,0.9411764705882353,1.0,1.0,8/8,70.90%,MAPT;RNF122;PIP5KL1;HEBP2;BAX;ARL6IP5;BNIP3;PRELID1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.34310426433267793,0.510732602307534,0.9454545454545454,1.0,1.0,1/5,14.93%,SOX9
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.2785849444901714,0.5103807579453704,0.9558823529411765,1.0,1.0,2/16,14.98%,CYP26B1;GLI3
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.34883681105564346,0.5099268984990443,0.9193548387096774,1.0,1.0,3/6,35.73%,CARD8;BCL2L12;CARD18
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.3372901056344566,0.5096723839815526,0.9682539682539683,1.0,1.0,1/5,29.52%,FAM91A1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.3064722039537313,-0.5091794639425795,1.0,1.0,1.0,6/6,69.36%,PTPN2;SIRT1;NNMT;ARPP19;PPARGC1A;DDB1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.2811049210770659,-0.5080174888898618,0.9705882352941176,1.0,1.0,7/7,71.90%,NF1;CACNA1D;CACNA1C;STIM1;AKAP5;DRD5;ORAI1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.2906423712283196,0.5080168611517513,1.0,1.0,1.0,6/18,26.92%,CDK5R1;OPRM1;RGS10;HRH4;CHRM5;GNA15
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.2425173582832574,0.50747628064645,1.0,1.0,1.0,7/38,26.63%,LEF1;TAF5;TAF6L;POLE3;TAF10;BRCA2;SPI1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.3012099679526863,0.5072321524726925,0.9692307692307692,1.0,1.0,3/9,25.51%,PAF1;WAC;RNF20
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.3014326756518543,-0.5071487178771615,0.9523809523809523,1.0,1.0,3/8,23.74%,ARMC10;EIF5A;PRKN
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.23257946399588167,0.5070063565844531,1.0,1.0,1.0,15/63,27.07%,MPDU1;B4GALNT2;ASGR2;TMEM258;ALG10;ASGR1;PGM3;OSTC;MCFD2;ALG10B;ALG2;LMAN1;ALG6;MGAT4A;DPAGT1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24779952744263734,-0.5068760894083862,0.96875,1.0,1.0,2/14,15.64%,RPF2;PES1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.28437669271840904,-0.5061200370524129,1.0,1.0,1.0,9/9,71.58%,HMGB1;TOP1MT;ERCC3;TOP3B;TOP2A;TOP3A;TOP1;HMGB2;TOP2B
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.32282939248349946,-0.5054096915681645,0.9487179487179487,1.0,1.0,2/5,18.82%,SNAI2;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.3291871809817484,0.5051626129490038,0.9855072463768116,1.0,1.0,2/9,17.70%,DAB2;WNT5B
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.2522338392536039,0.5049557256037382,0.9859154929577465,1.0,1.0,3/25,17.42%,ATP5PF;ATP5F1E;ATP5MC3
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.31624652631486216,0.5045220538046583,0.9827586206896551,1.0,1.0,2/5,33.49%,VAMP7;VAMP3
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),-0.29505977020387636,-0.503563492598092,0.9767441860465116,1.0,1.0,6/6,70.50%,SGK1;EPB41;TYMP;FGF10;OPRK1;KCNQ1
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.3254976099594776,-0.50342239414341,0.9459459459459459,1.0,1.0,2/5,25.11%,ABCB4;ABCA3
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.3067290772300667,-0.5033556452790083,1.0,1.0,1.0,4/8,24.59%,AGA;NGLY1;MAN2B1;MAN2A1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.22613966839914046,0.5029262455744954,1.0,1.0,1.0,7/70,17.76%,POLD4;RPA3;RPS27A;COPS4;XAB2;COPS5;GPS1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.23262944339218403,0.5026674491679226,1.0,1.0,1.0,13/69,26.27%,PHF23;PINK1;UBE3A;BMI1;CENPX;WFS1;RBX1;BRCA1;STUB1;ARRDC3;FANCI;KDM1A;SPSB4
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.261767318131335,0.5000618166206575,1.0,1.0,1.0,9/24,30.30%,HERPUD1;CREB3;SYVN1;WFS1;PARK7;AQP11;ALOX5;CLU;UBXN1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.24116826268312386,-0.49979561292824315,1.0,1.0,1.0,1/24,6.47%,MTFR2
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.3450905959659,-0.49924924821722727,1.0,1.0,1.0,1/5,19.56%,RABL3
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),-0.30128825099617007,-0.4992093499791275,0.9523809523809523,1.0,1.0,6/6,69.88%,JAK3;PTK6;FER;LEP;JAK2;IL15
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.2742678067087089,-0.49891765729350257,0.972972972972973,1.0,1.0,8/8,72.59%,ERCC1;SETMAR;TOP2A;TERF2;ESPL1;WAPL;TERF2IP;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.22398306709087076,-0.49735180826979863,1.0,1.0,1.0,5/20,21.10%,SMARCB1;PIH1D1;ARRB1;NOS1;FOXP3
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.27978330299847015,0.4965885266093093,1.0,1.0,1.0,3/11,24.99%,M1AP;CHAF1A;MTA2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.31956919378306614,0.49636334385022435,0.9649122807017544,1.0,1.0,3/10,24.01%,SOX9;HEY1;ENG
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.2721023600539903,0.49624179775171845,0.9852941176470589,1.0,1.0,2/21,19.62%,VPS18;FIS1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.24168927802779128,0.49622482589848077,1.0,1.0,1.0,4/38,18.33%,RRAGA;WDR24;GPR137B;LAMTOR3
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.3104061895551257,-0.4961436161509,0.9444444444444444,1.0,1.0,5/5,68.97%,GRM7;HRH3;SLC43A2;ARL6IP5;SLC43A1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.2671678409039505,-0.49599272506381065,0.972972972972973,1.0,1.0,4/15,18.49%,CHRNA1;DTNA;ERC2;RIMBP2
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.3148825114201125,0.4959178568970223,1.0,1.0,1.0,5/10,39.75%,PSMG1;OTUD6B;POMP;PSMD11;PSMD13
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.2836663493958359,0.49562236300720225,0.9841269841269841,1.0,1.0,2/13,23.86%,ULK1;UBA5
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.23963907214569186,0.49544836422180244,1.0,1.0,1.0,8/41,27.18%,ID1;NPR3;PGAM5;ADAMTS5;DDIT3;ARRDC3;LNPEP;IL18R1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.22722730859017737,0.49525757098018214,1.0,1.0,1.0,12/55,28.08%,GP1BA;EIF6;ITGA2B;THBS1;MYL9;ZFPM1;PURB;PAF1;RBBP5;SPI1;PRMT1;PRKCQ
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.34709606608437293,0.49479670302174455,1.0,1.0,1.0,1/5,11.13%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.30616222919999136,0.494741999096313,0.9848484848484849,1.0,1.0,1/8,16.94%,ATRAID
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.33223243138527375,0.49423263420898694,0.9846153846153847,1.0,1.0,1/5,28.68%,GPS2
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-0.3193635895965166,-0.4940409074091199,0.9696969696969697,1.0,1.0,1/5,19.39%,CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.32949332481164695,0.4938919351774652,0.9830508474576272,1.0,1.0,2/7,25.15%,NLRC3;CACTIN
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.19026625467556593,-0.4938016630262347,1.0,1.0,1.0,13/51,25.55%,UBXN2A;RAB7A;IRGM;ATG2A;ATG16L2;UBXN2B;ATG9B;WIPI1;NSFL1C;ATG7;PACS2;TP53INP2;AMBRA1
prerank,GO_Biological_Process_2021__myeloid dendritic cell differentiation (GO:0043011),-0.28933842232855594,-0.49348305015676813,0.918918918918919,1.0,1.0,2/6,18.98%,BATF2;BATF3
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.241176979192587,-0.4934323606111047,1.0,1.0,1.0,2/12,17.52%,ARPC3;ARPC2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.25101970202020135,0.4934081479289961,1.0,1.0,1.0,8/25,29.16%,RPL11;RPS7;GABARAPL2;RPL23;EFNA1;CSNK2A2;HSP90AB1;RPL5
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.30086672279807825,0.49312841618728936,1.0,1.0,1.0,2/8,24.98%,EHD2;EHD1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.2487942547979912,0.4930265885141114,1.0,1.0,1.0,7/25,30.04%,EIF6;RPL7A;RPL7;RPL35;WDR12;RPL7L1;RPL10A
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.3043099097395833,0.49279661129888774,0.9818181818181818,1.0,1.0,2/8,33.06%,PPP2R3C;CAMLG
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.30128825099617007,-0.4926317451097817,0.9705882352941176,1.0,1.0,6/6,69.88%,IL23A;ROCK1;ROCK2;IL18;TMBIM1;IL15
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.22499262455991023,0.49133131169409683,1.0,1.0,1.0,7/56,22.44%,A4GALT;CAV3;AHNAK2;DEGS1;EHD2;MICALL1;FER1L6
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.2611948088440453,-0.4911757072326244,1.0,1.0,1.0,3/12,18.82%,HDAC5;RHOA;NOTCH1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2478141042550409,-0.49069603518998023,1.0,1.0,1.0,4/15,17.48%,AMPD3;LHPP;GART;IMPDH1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.2693775219464869,-0.49042106592140583,0.9743589743589743,1.0,1.0,3/12,19.40%,RARB;FGFR2;TGFB2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.2684846952290159,-0.489654001945504,0.975609756097561,1.0,1.0,2/11,18.45%,ABHD12;AWAT2
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.32605152033762663,-0.48959080859399207,0.9534883720930233,1.0,1.0,2/5,17.57%,OGDH;SUCLA2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.28997478562616963,0.4888596922195162,0.9833333333333333,1.0,1.0,2/9,24.51%,AGER;EFNA1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.30242357814460147,0.48876702724728527,1.0,1.0,1.0,1/7,17.81%,PAICS
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.3119965507254716,0.48822959103106234,1.0,1.0,1.0,2/6,28.22%,MAPK3;RNF213
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),-0.3182777633128816,-0.48753326929025687,0.95,1.0,1.0,1/5,15.05%,PGAP1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.28674126240078285,0.4865115714980152,0.9850746268656716,1.0,1.0,3/9,21.62%,ANGPTL3;TPI1;TKFC
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.28199984345986506,-0.4864941048372279,1.0,1.0,1.0,2/6,20.14%,TRPV4;AKNA
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.21459410434315496,0.4859740134319059,1.0,1.0,1.0,9/71,22.35%,POLQ;MEIOB;RPA3;RNF138;RECQL4;RAD51AP2;SWSAP1;BRCA1;TONSL
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.22839661486193757,-0.4859650000738479,0.9705882352941176,1.0,1.0,5/19,24.07%,LPL;SLC30A8;EIF2B3;GPLD1;IRS2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.23962050679198665,-0.4854492536087959,1.0,1.0,1.0,3/17,15.64%,RPF1;EXOSC10;PES1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.2487014792545738,0.4851259764645349,1.0,1.0,1.0,1/28,6.54%,CD81
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.20539482337662648,0.48511112340738965,1.0,1.0,1.0,38/161,29.91%,FKBPL;GPIHBP1;PINK1;IGF1;USP13;NOP53;CDKN1A;LAMP2;GBA3;RPL11;RPS7;BAG1;TAF9B;HCFC1;CCT7;SEL1L;SYVN1;BAG5;SWSAP1;WFS1;RPL23;PARK7;RAB21;CRYAB;BAG2;EFNA1;C10ORF90;CDC37L1;DVL3;CLU;CCT8;HSP90AB1;RPL5;CHEK2;USP27X;CREBL2;GRN;CDK7
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.33013407270603845,-0.4837152932924915,1.0,1.0,1.0,1/5,16.76%,ATP8A2
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.31273212880380613,0.4827587152787292,1.0,1.0,1.0,4/7,39.63%,SCN4B;SCN5A;SCN10A;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.2977990376653786,0.4827283540736434,1.0,1.0,1.0,1/9,12.40%,PIF1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.21347933708108524,-0.4821392722101159,1.0,1.0,1.0,7/28,21.10%,CLC;HHLA2;SCRIB;IL23A;TNFSF9;CD24;FOXP3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.26083966203912395,0.48164044765025116,1.0,1.0,1.0,2/18,12.72%,IGF1;SERPINB1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.27769482147747104,0.4812659890598086,0.9852941176470589,1.0,1.0,3/12,21.02%,TAF7;TAF7L;POLR1E
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.258036645624114,-0.48090992950077227,0.9459459459459459,1.0,1.0,5/12,26.23%,VHL;ADIPOR1;PTPN2;NF2;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of histone deacetylation (GO:0031064),-0.292246859911262,-0.4805549540670657,0.9473684210526315,1.0,1.0,2/5,26.96%,FOXP3;KDM5A
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.23182421258991026,0.4797959536985249,1.0,1.0,1.0,9/32,30.36%,SEMA3A;SEMA3F;ULK1;LLPH;FLRT1;FLRT3;HSP90AB1;NRP2;CTNNB1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.2331584048677566,0.4795718041216205,1.0,1.0,1.0,3/33,12.05%,RRAGA;GLRA2;GLRA1
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.2577232012433756,0.47891046651945,1.0,1.0,1.0,4/16,27.07%,MPDU1;ALG2;ALG6;DPAGT1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.24303255636391216,-0.47853886133366996,1.0,1.0,1.0,5/11,26.34%,PLEKHM1;DEF8;NLGN1;HRAS;CARMIL2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.23723335106741417,0.47852553437937084,1.0,1.0,1.0,7/27,24.46%,PIF1;CDKN1B;FBXO5;BAG5;EIF4A2;PARK7;ZFP36
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.28875389540210644,0.4783212751556666,0.96875,1.0,1.0,5/14,31.13%,CRTAM;XRCC6;PRELID1;SPINK5;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.3031748916657899,0.47818847485028454,0.9636363636363636,1.0,1.0,2/7,32.09%,RIOK2;CDC6
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.31077148746566186,0.4781417498022407,1.0,1.0,1.0,4/6,35.17%,NOS2;ARG1;OAT;ARG2
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.27824279287465614,-0.47794599281442307,1.0,1.0,1.0,1/6,14.55%,SLC13A3
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.26648606763585675,0.4765723725283661,1.0,1.0,1.0,1/17,6.32%,GPER1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.28590910387263946,0.47645884193785365,1.0,1.0,1.0,3/11,24.01%,SOX9;HEY1;ENG
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.3073883620828689,0.4760391816721234,0.9818181818181818,1.0,1.0,3/6,36.87%,ATP2A2;CALM1;AHCYL1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.20792460451925124,-0.47600757808118394,1.0,1.0,1.0,5/35,14.43%,QRICH2;HFE;BAG6;SDCBP;FHIT
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.2775498261883873,0.4750054614529315,0.9855072463768116,1.0,1.0,2/10,18.92%,NPPA;NOS2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.2147761371500006,-0.47489264187444674,1.0,1.0,1.0,4/30,15.30%,GTF2H2;POLR2F;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.2147761371500006,-0.47489264187444674,1.0,1.0,1.0,4/30,15.30%,GTF2H2;POLR2F;ERCC2;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell differentiation (GO:2001200),0.30913944986551406,0.47443323276417587,1.0,1.0,1.0,2/5,30.73%,AGER;LGALS9
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.28940648456240814,-0.47398494339143465,0.967741935483871,1.0,1.0,9/9,71.07%,NUP98;TPR;NUP107;NUP205;NUP153;AHCTF1;RTN4;NDC1;NUP93
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.27138380594994005,-0.47353260490917876,0.9069767441860465,1.0,1.0,6/6,72.87%,CARD9;SLA2;MSH2;CD70;CD27;CD74
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.24573335994686515,-0.47270805819189093,0.9714285714285714,1.0,1.0,3/16,16.64%,PTGS1;AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.20492228755713826,0.4724262750285554,1.0,1.0,1.0,6/82,14.84%,TGFB1;CDKN2A;PRR5L;CDKN1B;DYNLL1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.21585831333029398,-0.47207330882405407,1.0,1.0,1.0,3/18,14.90%,NEU3;SDCBP;WDR54
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.31442388722876224,0.47170700105789204,0.9824561403508771,1.0,1.0,1/5,25.32%,MAPK8IP2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.2362408426975442,0.47154379829463794,1.0,1.0,1.0,8/20,35.97%,CREB3;HIF1A;SMAD1;RELA;BMP2;SMAD4;MT3;VEGFA
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.3026891404123479,-0.46821447148522,0.9714285714285714,1.0,1.0,3/6,27.27%,EMP2;S100A10;RFTN1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.2890060756675006,0.46763477902438916,1.0,1.0,1.0,2/7,28.22%,MAPK3;RNF213
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.2584152286620754,-0.46736526348733803,0.9736842105263158,1.0,1.0,9/9,74.17%,STARD3NL;STARD3;CACNA1H;TSPO;TSPOAP1;AKR1B1;FDX1;STAR;FDXR
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.2810831721470019,-0.46651219815529255,1.0,1.0,1.0,5/5,71.90%,CRACR2A;STIM2;STIM1;ORAI2;ORAI1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.31990299265079497,0.4659924741417909,0.9830508474576272,1.0,1.0,3/5,39.87%,TAP1;CALR;SEC22B
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.28410058027079305,-0.4649026007908662,1.0,1.0,1.0,5/5,71.60%,SLC39A8;SLC11A2;SLC39A14;SLC11A1;SLC30A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.28410058027079305,-0.4649026007908662,1.0,1.0,1.0,5/5,71.60%,SLC39A8;SLC11A2;SLC39A14;SLC11A1;SLC30A1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.27939185268288913,-0.46421470909056783,1.0,1.0,1.0,6/6,72.07%,NUTF2;PLK1;INTS13;NUP54;TOR1AIP2;NUP155
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.3096730776489179,0.4638155029844035,0.9827586206896551,1.0,1.0,2/5,23.60%,B2M;TF
prerank,GO_Biological_Process_2021__epithelial tube formation (GO:0072175),-0.30494909483985433,-0.46329359505014034,0.9142857142857143,1.0,1.0,4/5,25.25%,FGFR2;CEP290;PODXL;PAX2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.2764903864752989,-0.46191813205989574,0.975,1.0,1.0,6/6,72.36%,TGFB2;CDH3;BMPR1A;SMAD4;SMAD3;HIF1A
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.28187129588845716,-0.46116803092723635,1.0,1.0,1.0,1/9,5.93%,CARM1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.22044249876492794,0.46087734323867124,1.0,1.0,1.0,6/42,24.82%,PRR5L;ZC3HAV1;METTL14;CNOT8;ZFP36;UPF1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.28309477756286267,-0.4593307264691967,0.9767441860465116,1.0,1.0,5/5,71.70%,TPR;NUMA1;PLSCR1;CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2610171364242171,0.4587179229548357,1.0,1.0,1.0,3/13,31.89%,GLRX5;MAGEF1;CISD3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.2222652410316329,-0.4577869418155157,0.9583333333333334,1.0,1.0,4/15,23.41%,CLEC16A;ETF1;CLN3;INSR
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.23020194515158074,0.4577531698394586,1.0,1.0,1.0,7/24,30.64%,RPS27A;RBX1;CETN2;ERCC4;RAD23B;USP45;DDB1
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),-0.2862669245647969,-0.4576335946321371,1.0,1.0,1.0,5/5,71.38%,CACNA1G;CACNA1D;ANK2;HCN4;SCN5A
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.2785212475256609,0.457462546428941,0.9710144927536232,1.0,1.0,2/8,19.96%,SNAI1;DKKL1
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),-0.26627722542458127,-0.4570651380147764,1.0,1.0,1.0,6/6,73.38%,BMP4;FLT3;SHH;LIG4;SOX4;SPI1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.286542053106463,0.45692878107799884,1.0,1.0,1.0,1/7,21.23%,OLFM4
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.3057112757360231,-0.456123438749633,0.9672131147540983,1.0,1.0,2/5,26.59%,DLL1;DOCK11
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),-0.2749215533474707,-0.4555086487126504,0.9761904761904762,1.0,1.0,1/6,9.25%,CRH
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.22822371967961433,0.4549624059979175,1.0,1.0,1.0,3/27,16.67%,CAV3;ATP5IF1;PSMC5
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.2865848303044979,0.45450146485903525,1.0,1.0,1.0,1/6,14.93%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),-0.2594242473614252,-0.4540999092690568,1.0,1.0,1.0,2/5,23.79%,PRMT5;DRD3
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.2871932031186859,0.4527186425884614,1.0,1.0,1.0,3/7,33.01%,PUS3;TRUB2;DKC1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.26622189119888945,-0.4523144883110151,1.0,1.0,1.0,2/10,17.11%,GPC1;CD9
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.31159942759045756,0.4523125559013789,0.9838709677419355,1.0,1.0,1/6,17.16%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.31159942759045756,0.4523125559013789,0.9838709677419355,1.0,1.0,1/6,17.16%,PARP14
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.1733257862292893,-0.4517814856216529,1.0,1.0,1.0,7/91,14.48%,GLA;GNAS;PAM;GBF1;RAB5A;GOLGA4;RPS6KA3
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.2652093814299832,0.4516639080674032,0.984375,1.0,1.0,2/10,24.13%,ANGPTL3;ADRA2A
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.24511751075652694,0.45053969576569386,1.0,1.0,1.0,3/17,20.70%,SPCS2;ZFAND2A;SRP14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.23749192509615707,0.4492831525658313,1.0,1.0,1.0,5/18,32.80%,RPA3;RBX1;ERCC4;DDB1;RPA2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.23749192509615707,0.4492831525658313,1.0,1.0,1.0,5/18,32.80%,RPA3;RBX1;ERCC4;DDB1;RPA2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.1931011321621075,0.44922734726251407,1.0,1.0,1.0,26/114,28.26%,TIMM22;ZDHHC11;TOMM20;ZDHHC24;AP1M2;LAMP2;TIMM17A;SPCS2;RPL11;ZDHHC22;FIS1;TOMM7;ZFAND2A;SRP14;MICALL1;AQP11;RABGEF1;BCAP31;TIMM10;SLC25A6;FBXO7;TOMM34;RAB3IP;AIP;PEX12;HAP1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.24461211065970206,-0.4479328695457648,0.9722222222222222,1.0,1.0,10/10,75.55%,XPO5;STAT3;WTIP;FMR1;PUM2;LIMD1;PUM1;DHX9;FXR1;ZFP36
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.26694926181101125,0.4478824621652921,0.9846153846153847,1.0,1.0,3/11,27.48%,BLOC1S2;SNAPIN;AP3M2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.26694926181101125,0.4478824621652921,0.9846153846153847,1.0,1.0,3/11,27.48%,BLOC1S2;SNAPIN;AP3M2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.24596345079597093,0.4477135014393406,1.0,1.0,1.0,4/14,34.09%,TACC3;RIOK2;CDC6;PTTG1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.2779234431176323,0.4468335953928588,1.0,1.0,1.0,1/8,22.53%,DCTN1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.23091693863063162,-0.4468209612143637,1.0,1.0,1.0,3/11,23.60%,PLPP2;PLPP3;SPTLC3
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.24880166496884581,0.4451160857302079,1.0,1.0,1.0,4/9,32.83%,BRCA1;CCNF;KAT2B;TRIM37
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.21848869816069705,0.44435725300502493,1.0,1.0,1.0,13/30,40.55%,MSN;VAV3;RIN3;NEB;RAC1;PEX11A;LAMTOR5;VAV1;PICALM;EZR;RDX;LARS1;PEX11B
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.23059259314634228,0.44409949451063374,0.9833333333333333,1.0,1.0,4/14,30.57%,EXOSC4;UPF1;DCP2;SSB
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.24618563010353772,0.4424620709674131,0.9861111111111112,1.0,1.0,4/18,28.65%,DAB2;THBS1;CITED2;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.24618563010353772,0.4424620709674131,0.9861111111111112,1.0,1.0,4/18,28.65%,DAB2;THBS1;CITED2;HSP90AB1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.27014500424521537,0.44238400155903057,0.9841269841269841,1.0,1.0,1/7,20.02%,MSH6
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.27908236295407945,-0.4423257571585704,1.0,1.0,1.0,6/6,72.10%,MAPT;KIF3B;KIF13A;KIFAP3;KIF3A;FYCO1
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.2509220595103207,-0.44168202456673666,1.0,1.0,1.0,1/5,12.11%,CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.2876958388054271,0.44162808665895636,1.0,1.0,1.0,1/5,25.69%,MTF2
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.2686072946186189,0.44161864062286754,0.9846153846153847,1.0,1.0,2/6,27.94%,RAE1;NUP155
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.26222482542705516,0.4410898386347428,1.0,1.0,1.0,2/9,25.68%,GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.26222482542705516,0.4410898386347428,1.0,1.0,1.0,2/9,25.68%,GABARAPL2;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.2135562173193109,-0.4410002517981717,1.0,1.0,1.0,5/19,23.38%,RAB5A;SYN1;SEPTIN5;DTNBP1;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.24150033805279364,0.44067648674368043,1.0,1.0,1.0,9/21,31.17%,AXL;CHMP3;CD4;HLA-DRB1;TMPRSS4;CD74;DDB1;LGALS9;VPS4A
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.28911093832953877,0.4382816377727063,1.0,1.0,1.0,2/5,28.68%,CITED2;GPS2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.2562422133693981,0.4366190131366744,1.0,1.0,1.0,5/13,29.72%,FAM47E;PADI2;SPI1;CHEK1;SERTAD1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.2331261483983989,-0.43445816736520015,1.0,1.0,1.0,5/13,22.95%,TRIM72;SYT7;FER1L5;MYH9;ANXA6
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.2681816476271037,0.43304561375647177,1.0,1.0,1.0,1/8,17.19%,IL4
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),0.2985138618095962,0.4330099860321594,1.0,1.0,1.0,2/5,35.32%,SMOC2;NPTN
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.24222256616622814,-0.4311926296856279,0.9722222222222222,1.0,1.0,11/11,75.79%,LEO1;DHX36;ZC3H3;CDC73;BARD1;PAPOLA;AHCYL1;ZFP36L1;NCBP2;NCBP1;PAF1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.23007348604966443,0.4310856862628443,1.0,1.0,1.0,1/16,9.25%,RAMP3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.21583934187025006,-0.4251726614257569,1.0,1.0,1.0,2/12,13.42%,PGLS;G6PD
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.2487623547900152,-0.4251100857083711,1.0,1.0,1.0,2/9,17.54%,SLX4;RTEL1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.2764796905222437,-0.42494853718570214,1.0,1.0,1.0,5/5,72.36%,NOTCH1;NFE2L2;RBPJ;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.27181987000928504,-0.4244700683804215,0.972972972972973,1.0,1.0,7/7,72.83%,IL23A;IL23R;IL12RB1;IL18;IL1R1;SLC11A1;IL18R1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.18233231190969573,0.42330201599762735,1.0,1.0,1.0,7/94,16.57%,MRPS34;MRPL34;MRPL20;MRPL50;GADD45GIP1;MRPL54;GFM2
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.24467948190396394,-0.4189403371377781,1.0,1.0,1.0,1/7,13.63%,CHP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.24467948190396394,-0.4189403371377781,1.0,1.0,1.0,1/7,13.63%,CHP1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.25713937159291744,0.41806582437202766,1.0,1.0,1.0,2/8,27.94%,SNAPC5;SNAPC1
prerank,GO_Biological_Process_2021__tryptophan catabolic process to kynurenine (GO:0019441),0.273523358062781,0.4150115223187257,1.0,1.0,1.0,2/5,27.42%,IDO1;IDO2
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),-0.2592410212499189,-0.4142529447569184,1.0,1.0,1.0,2/6,19.89%,ABCC5;CEMIP
prerank,GO_Biological_Process_2021__epithelial cell differentiation involved in kidney development (GO:0035850),-0.2561027505899648,-0.410404325710177,0.9767441860465116,1.0,1.0,6/6,74.40%,BMP4;PAX2;PAX8;SALL1;MEF2C;MTSS1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.26774403920479306,-0.41035023240727037,1.0,1.0,1.0,2/7,21.63%,DCP1B;DCP1A
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.19011260851143075,-0.4101793215990601,1.0,1.0,1.0,5/19,21.61%,EMD;TOR1B;CTDNEP1;TMEM43;NEMP1
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.2855332985064118,0.4101151577085953,1.0,1.0,1.0,2/5,26.15%,IDH1;IDH3G
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.22202691411475717,-0.4085524381665439,1.0,1.0,1.0,2/11,16.70%,TLCD2;ABCG1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.23953624582146593,0.407674075202161,0.9848484848484849,1.0,1.0,1/13,9.70%,NOP10
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.2167642079502144,0.4075642825539791,1.0,1.0,1.0,5/22,33.97%,SLC24A1;CBLN1;SLC30A1;SYT11;PICK1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.2411498433087012,-0.4069399225729405,1.0,1.0,1.0,8/8,75.90%,FGFR2;NIPBL;ID2;EPHB3;PDGFRA;BBS7;RBPMS2;AGR2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.2568764749119889,-0.40591203318586955,1.0,1.0,1.0,6/6,74.32%,PHF1;PHF19;MACROH2A1;OGT;SUPT6H;MTF2
prerank,GO_Biological_Process_2021__monoacylglycerol biosynthetic process (GO:0006640),-0.25200201168323727,-0.4049450296166512,1.0,1.0,1.0,6/6,74.81%,AWAT2;DGAT1;DGAT2;DGAT2L6;MOGAT2;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.28140515844589886,0.4021342737219006,1.0,1.0,1.0,1/5,17.88%,CARMIL1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.23794108521751262,0.4004947846107978,1.0,1.0,1.0,3/8,29.19%,IL4;DOCK2;DCSTAMP
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.21792292214827427,-0.3990973751811723,1.0,1.0,1.0,11/11,78.22%,TBCCD1;HOOK3;ARHGAP21;UVRAG;YWHAZ;COPG1;CDC42;PDCD10;ARCN1;RIPOR1;STK25
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.23823937908481652,0.3971384274308273,1.0,1.0,1.0,2/11,24.20%,TOR1A;SNAPIN
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.21468063265799148,0.3958915699286517,1.0,1.0,1.0,3/14,26.58%,SFRP4;PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.22720061907525635,-0.3947843772874026,0.9782608695652174,1.0,1.0,10/10,77.29%,MIA3;CD200R1;ADTRP;AKT1;LRCH1;RIPOR2;CD200;WASL;PADI2;APOD
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.21704136516658284,-0.3946545126685035,1.0,1.0,1.0,12/12,78.31%,SMCHD1;PCGF5;LRIF1;METTL3;CDYL;HNRNPU;YTHDC1;PCGF3;RBM15;RLIM;RBM15B;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.2717921138713566,-0.394375632157297,1.0,1.0,1.0,2/5,21.22%,NR1H2;PTPN2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.2084222987100361,-0.39222134477297155,1.0,1.0,1.0,2/16,11.55%,ATR;HSF1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.2401810935262934,-0.3910571621320043,1.0,0.9998075858720253,1.0,12/12,76.00%,COL4A1;NOTCH4;DLL4;SHH;NRP1;NRARP;VEGFA;TGFBR2;SFRP2;CTNNB1;SEMA3E;ENG
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.2551632848525117,0.38799457774908014,1.0,1.0,1.0,2/5,33.38%,XRCC6;NUCKS1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.17784577837077323,0.38711621764592374,1.0,1.0,1.0,9/53,25.68%,ATG101;RAB19;GABARAPL2;TMEM41B;ATP2A2;EMC6;ULK1;STX17;GABARAPL1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.2388780087879864,0.3870176785003525,1.0,1.0,1.0,1/8,21.62%,TKFC
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.23404002025115206,0.3863346952595402,1.0,1.0,1.0,4/11,39.52%,CXCL12;DUSP1;DOCK8;SLC12A2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.17750128121908335,0.3807176412963261,1.0,1.0,1.0,16/48,38.13%,CHMP3;RCC1;CCNB1;REEP4;NUP155;NUP93;CC2D1B;VPS4A;CHMP4B;CHMP2B;NDC1;PPP2R2A;RAN;LBR;NUP188;VRK1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.17750128121908335,0.3807176412963261,1.0,1.0,1.0,16/48,38.13%,CHMP3;RCC1;CCNB1;REEP4;NUP155;NUP93;CC2D1B;VPS4A;CHMP4B;CHMP2B;NDC1;PPP2R2A;RAN;LBR;NUP188;VRK1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.21453046773135,0.375322234546834,1.0,1.0,1.0,3/10,29.08%,FBXO5;TOM1L1;CHEK1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.20826526343168353,0.3681146302032059,1.0,1.0,1.0,3/15,33.11%,IL4;CD74;RAC1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.23431334622823982,-0.3672556529473907,1.0,1.0,1.0,5/5,76.58%,AUTS2;TMEM108;SLC9A6;SH3GL2;LLPH
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.18460654858305656,0.36017483420981267,1.0,1.0,1.0,3/25,23.23%,FBXO5;CCNB1;RIOK2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.22893118592763212,0.3493780833548818,1.0,0.9999038548988528,1.0,1/7,21.61%,RAB29
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.19977557653613992,-0.3473571476344544,1.0,0.9999411654587758,1.0,11/11,80.03%,CCDC40;SPEF2;DYNC1I2;HTT;SPA17;ADCY10;ROPN1L;SPAG17;DYNC1I1;DNAAF2;CABYR
